data_2mvf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mvf _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 11.4 t80 . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -78.91 58.21 2.32 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.038 0.447 . . . . 0.0 111.678 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -138.37 148.65 44.75 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.293 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -145.93 149.64 34.58 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.472 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -81.33 103.24 10.96 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.6 t -92.65 118.82 39.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.237 0.541 . . . . 0.0 110.604 -176.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.4 m -94.13 122.53 36.75 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.272 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -105.06 108.33 61.03 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.3 -28.0 63.7 Favored 'Trans proline' 0 N--CA 1.471 0.192 0 C-N-CA 122.261 1.974 . . . . 0.0 112.007 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 81.1 m -65.66 -41.69 92.21 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.722 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.447 ' HB2' HG12 ' A' ' 191' ' ' VAL . 33.4 mt -96.05 -19.0 19.77 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.066 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 64.3 t30 61.47 51.32 4.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.424 -175.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.447 HG12 ' HB2' ' A' ' 189' ' ' LEU . 5.9 p -149.92 144.12 17.63 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.912 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 11.4 t -111.6 124.34 52.09 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.423 0.63 . . . . 0.0 109.466 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 67.4 t -131.82 136.53 56.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.249 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -79.91 116.76 20.24 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.04 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 7.5 mp -111.73 150.82 42.83 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.841 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.61 140.21 38.98 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.66 1.574 . . . . 0.0 110.028 174.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 37.5 mm -86.98 114.82 26.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.082 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.28 -42.41 75.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.802 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.4 t -161.77 149.43 14.69 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.349 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 221' ' ' ILE . 32.0 m -119.79 146.62 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -119.97 122.91 42.25 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -52.57 155.2 2.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.638 -1.164 . . . . 0.0 112.585 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 . . . . . 0 N--CA 1.438 -1.06 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 170.498 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 CA--C 1.503 -0.835 0 CA-C-O 121.32 0.581 . . . . 0.0 111.467 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 66.7 p -90.15 166.6 13.3 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.138 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 245' ' ' ILE . 19.2 ptpt -65.37 142.62 58.15 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.873 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.4 1.64 55.61 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.209 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.569 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 85.4 m -66.81 138.12 57.11 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.8 mm -94.38 128.84 45.36 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.046 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.323 -174.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.437 HG21 HG11 ' A' ' 200' ' ' VAL . 47.1 pt -126.1 159.39 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 CA-C-O 120.774 0.321 . . . . 0.0 110.314 176.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -116.8 117.91 31.06 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.69 157.83 43.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.288 0.566 . . . . 0.0 111.635 -177.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -105.17 106.61 17.18 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.438 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 239' ' ' TRP . 7.2 p -83.84 78.26 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 122.43 1.11 . . . . 0.0 110.446 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 22.2 m -158.77 -34.06 0.07 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.058 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -75.47 9.77 2.0 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.216 -176.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.52 -40.68 97.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.131 0.491 . . . . 0.0 109.689 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 79.43 -2.03 73.94 Favored Glycine 0 C--O 1.226 -0.351 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.799 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.8 pt -80.1 -31.24 13.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 122.71 -0.288 . . . . 0.0 111.684 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 20.8 t 48.91 72.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 O-C-N 123.558 0.536 . . . . 0.0 110.643 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 13.5 t -110.96 -8.27 14.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.564 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.683 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . -128.06 31.89 5.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.717 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 19.7 m 59.86 9.79 1.85 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 79.78 3.07 89.04 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.962 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.683 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 65.0 pttt -72.02 -11.37 60.73 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.188 0.518 . . . . 0.0 111.804 -177.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 34.9 pt -95.91 -0.86 10.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.641 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -62.48 112.15 2.34 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 123.354 0.409 . . . . 0.0 111.965 -175.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . 0.489 ' O ' HG12 ' A' ' 225' ' ' VAL . 71.0 t-105 -175.13 146.91 0.88 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.875 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -73.7 120.39 6.88 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -128.6 162.76 26.55 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.912 0.387 . . . . 0.0 111.214 -173.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -102.45 136.28 42.56 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.94 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -127.02 158.3 37.31 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.096 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -105.73 132.31 52.01 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.875 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 217' ' ' LYS . 49.1 mm -79.07 130.28 36.37 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.192 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.541 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 4.4 t -140.09 104.14 4.77 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -80.76 119.75 23.75 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 120.842 0.354 . . . . 0.0 110.748 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -128.09 72.17 79.31 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-O 121.405 0.622 . . . . 0.0 109.381 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.477 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 71.8 Cg_endo -71.53 -17.84 29.8 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.884 2.389 . . . . 0.0 112.964 -176.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -82.2 -21.61 36.36 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.797 0.332 . . . . 0.0 110.803 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -105.67 -56.86 2.12 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.141 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.408 ' CB ' HD22 ' A' ' 256' ' ' ASN . 18.9 m-20 -93.37 -31.08 14.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.936 0.398 . . . . 0.0 111.44 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 82.99 4.85 89.81 Favored Glycine 0 C--N 1.321 -0.281 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.503 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 65.3 m -132.6 174.14 10.59 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.515 0.197 . . . . 0.0 110.935 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 90.6 t -79.48 121.87 33.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' ' 246' ' ' THR . 5.3 m120 -110.13 152.28 26.21 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.612 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -134.38 144.83 48.44 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.508 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.68 135.94 61.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.006 0.431 . . . . 0.0 110.215 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 64.7 tp -95.57 127.06 41.29 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.23 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 2.1 pp -90.31 136.71 32.88 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.405 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.266 1.957 0 CA-C-O 117.702 -1.142 . . . . 0.0 111.011 -178.106 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -97.39 34.71 1.75 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.069 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -118.2 144.83 45.42 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.15 0.5 . . . . 0.0 111.114 -176.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -129.44 152.22 49.22 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.026 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -81.53 99.57 8.88 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.3 t -89.68 126.05 42.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.211 -174.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.9 m -114.87 128.3 56.21 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.576 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.51 ' NE2' HD21 ' A' ' 228' ' ' LEU . 30.9 m170 -104.46 117.96 57.85 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.04 -24.89 77.1 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 122.829 2.353 . . . . 0.0 113.492 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 11.6 t -79.67 -23.53 42.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.834 0.35 . . . . 0.0 111.628 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.401 ' HB2' HG12 ' A' ' 191' ' ' VAL . 40.5 mt -103.55 -24.32 13.43 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 59.06 46.95 12.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.513 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' A' ' 189' ' ' LEU . 8.9 p -133.49 145.27 33.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.174 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 87.9 m -116.42 119.43 35.62 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 228' ' ' LEU . 61.0 t -133.73 138.84 49.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -87.57 118.25 26.92 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.881 0.372 . . . . 0.0 111.037 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.71 153.5 77.81 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.195 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.85 146.86 54.52 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.334 2.023 . . . . 0.0 111.26 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 80.6 mt -89.46 116.51 31.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.323 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 95.8 mt -71.78 -42.18 67.45 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.503 ' HB2' ' HB3' ' A' ' 222' ' ' GLU . 16.6 m -140.92 147.19 38.46 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 26.7 m -125.97 146.09 32.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.328 0.585 . . . . 0.0 111.508 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -127.65 106.91 9.47 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.094 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -56.6 156.91 5.72 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.44 0.462 . . . . 0.0 111.661 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 C--N 1.32 -0.676 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.202 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 61.6 tp . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 24.2 p -95.75 159.18 15.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.863 0.363 . . . . 0.0 111.23 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -61.7 152.15 31.82 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.049 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 109.69 9.76 24.33 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.581 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 21.2 m -73.08 142.12 47.58 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.5 mm -100.2 127.84 52.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.961 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.405 HD12 HD11 ' A' ' 245' ' ' ILE . 45.5 pt -127.53 163.16 31.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.591 0.234 . . . . 0.0 110.598 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 199' ' ' SER . 8.4 tm-20 -124.43 125.65 44.62 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.035 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.3 m -131.15 141.86 44.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.145 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.562 ' HA ' ' HA2' ' A' ' 240' ' ' GLY . 50.8 t-20 -114.82 107.1 14.98 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.967 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.705 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 7.8 p -175.03 -56.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.902 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.411 ' N ' HG12 ' A' ' 225' ' ' VAL . 10.8 t 72.76 -56.16 0.66 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.396 0.678 . . . . 0.0 111.268 -177.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' A' ' 230' ' ' ILE . 1.6 m-20 -63.01 -21.95 66.51 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.344 0.258 . . . . 0.0 111.678 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.51 HD21 ' NE2' ' A' ' 186' ' ' HIS . 96.7 mt 67.23 18.29 10.32 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 92.68 -5.29 76.73 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.63 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.447 ' O ' ' HB3' ' A' ' 227' ' ' ASP . 48.2 pt -107.23 170.46 2.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 231' ' ' VAL . 7.7 p -96.42 90.41 2.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.693 0.758 . . . . 0.0 111.929 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 10.6 t -101.37 -34.96 9.39 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 174.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.525 ' HB2' HG12 ' A' ' 237' ' ' ILE . . . -138.44 9.87 2.71 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.736 174.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 9.3 t 63.37 31.52 15.13 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.155 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 85.13 3.44 87.45 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.083 -0.58 . . . . 0.0 113.192 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -65.12 -39.8 93.59 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 121.25 0.548 . . . . 0.0 111.205 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.525 HG12 ' HB2' ' A' ' 233' ' ' ALA . 30.4 pt -93.04 18.88 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.468 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.705 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -54.01 120.59 6.59 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -153.07 150.68 29.39 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.886 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 224' ' ' ASN . . . -96.22 116.01 5.33 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.847 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -129.3 171.97 11.95 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.735 0.302 . . . . 0.0 111.151 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -102.2 140.48 36.43 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.282 0.563 . . . . 0.0 111.214 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -129.48 154.49 46.94 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.36 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -101.17 133.15 46.15 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.581 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 47.9 mm -80.39 124.64 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.709 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 12.6 p -119.42 76.29 1.12 Allowed 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.082 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -68.66 121.8 17.2 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.352 0.596 . . . . 0.0 110.964 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -128.95 71.29 81.79 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.275 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -72.19 -25.33 19.05 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 121.4 1.4 . . . . 0.0 112.216 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -74.05 -33.02 63.56 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.062 0.458 . . . . 0.0 110.609 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -96.9 -57.1 2.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.937 -176.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -95.0 -29.91 14.38 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.77 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 76.62 18.56 78.9 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.375 -0.917 . . . . 0.0 110.875 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 49.7 t -149.18 160.71 43.12 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.375 -0.413 . . . . 0.0 109.96 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 85.3 t -80.39 126.85 39.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.946 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 246' ' ' THR . 42.3 m-80 -110.46 153.74 24.6 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.19 148.54 35.12 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.703 0.287 . . . . 0.0 110.65 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.59 130.64 56.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 8.9 tt -75.46 127.96 34.27 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.102 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.458 ' O ' HD13 ' A' ' 260' ' ' LEU . 4.2 pp -84.94 132.5 34.35 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.133 0.492 . . . . 0.0 111.229 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 10.6 m . . . . . 0 C--O 1.279 2.641 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.924 179.646 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 . . . . . 0 CA--C 1.511 -0.553 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -79.47 87.82 5.07 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -156.91 137.28 12.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.489 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -145.86 157.07 43.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.963 0.411 . . . . 0.0 111.392 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 56.8 t30 -83.5 99.46 10.14 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 257' ' ' ALA . 53.1 t -92.65 118.93 39.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.279 0.562 . . . . 0.0 112.067 -172.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 89.6 m -94.31 124.18 38.17 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.259 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.411 ' CE1' HD21 ' A' ' 228' ' ' LEU . 64.1 m80 -104.84 111.18 65.22 Favored Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -62.93 -28.2 75.1 Favored 'Trans proline' 0 N--CA 1.475 0.407 0 C-N-CA 122.543 2.162 . . . . 0.0 112.621 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.9 t -70.99 -31.88 68.54 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.309 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.469 ' HB2' HG11 ' A' ' 191' ' ' VAL . 43.6 mt -98.53 -22.36 16.03 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.3 t30 60.47 44.89 11.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.99 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.469 HG11 ' HB2' ' A' ' 189' ' ' LEU . 4.0 p -145.75 150.5 15.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.984 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.588 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 14.4 t -121.87 128.79 52.0 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 121.343 0.592 . . . . 0.0 110.175 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.83 138.24 52.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 63.0 tt0 -81.18 118.36 22.49 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.413 HD12 ' C ' ' A' ' 194' ' ' GLN . 7.1 mp -128.11 151.85 76.72 Favored Pre-proline 0 C--O 1.239 0.507 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.894 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 180' ' ' LYS . 45.2 Cg_exo -61.05 143.81 99.25 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.642 2.228 . . . . 0.0 110.921 173.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 46.1 mm -84.8 117.79 30.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.439 HD21 ' HA ' ' A' ' 223' ' ' VAL . 3.6 mm? -70.05 -40.85 74.88 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 38.2 t -155.02 150.24 27.09 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.58 146.2 33.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.093 0.473 . . . . 0.0 110.975 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -133.64 143.52 48.64 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.493 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -79.34 151.43 31.02 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.178 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 . . . . . 0 C--N 1.311 -1.099 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 174.416 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.7 t -117.64 -170.83 1.94 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.114 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.499 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 14.0 ptmm? -54.02 148.42 10.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.381 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 114.49 4.77 21.58 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.145 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.471 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 50.5 m -72.09 140.08 48.75 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.2 mm -92.8 127.33 45.0 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.963 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 46.3 pt -133.46 165.38 32.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 120.814 0.34 . . . . 0.0 110.943 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -121.21 126.77 50.46 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.439 ' HA ' HD21 ' A' ' 198' ' ' LEU . 35.6 m -131.25 156.65 42.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.213 0.53 . . . . 0.0 111.717 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -99.92 107.01 18.88 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.025 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 7.5 p -85.52 79.35 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 122.276 1.036 . . . . 0.0 110.536 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 57.0 p -175.77 -26.39 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.711 -1.586 . . . . 0.0 108.569 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -62.04 -13.48 26.49 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.324 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.411 HD21 ' CE1' ' A' ' 186' ' ' HIS . 6.9 mp -60.11 -37.3 79.59 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.015 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 90.62 8.11 66.04 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.425 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 41.3 pt -122.91 155.41 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 77.9 t -127.0 123.81 63.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.911 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.3 t -79.16 -52.22 8.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.099 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -161.64 98.95 1.12 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.675 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 25.8 t 65.26 -2.61 0.75 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.72 31.2 70.37 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.764 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.6 pttp -64.08 -13.63 48.76 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -177.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 19.9 pt -107.5 4.2 9.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.188 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -71.11 107.58 4.23 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.777 0.323 . . . . 0.0 111.658 -176.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 -164.09 176.58 9.16 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.041 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -91.47 122.77 6.89 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 108.894 -1.683 . . . . 0.0 108.894 173.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 75.9 mtt-85 -128.93 168.35 16.1 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 117.233 0.516 . . . . 0.0 111.319 -174.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.444 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 93.1 m-85 -101.36 143.55 31.26 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.164 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -136.92 166.3 23.96 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.359 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -116.6 136.98 52.52 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.054 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.471 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 88.2 mt -81.59 121.06 34.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 71.8 p -123.52 92.62 3.73 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.757 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -83.76 125.51 31.99 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.256 -176.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -131.59 70.28 81.44 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.504 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 73.4 Cg_endo -73.83 -17.8 22.43 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.032 1.822 . . . . 0.0 111.858 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -86.96 -14.82 40.67 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.235 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -111.3 -57.16 2.28 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.249 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -93.42 -28.14 16.31 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.846 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 92.08 -6.34 78.84 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.896 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 81.8 m -128.65 164.7 22.32 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.709 0.29 . . . . 0.0 111.069 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 92.6 t -80.38 118.09 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.548 ' HB2' ' O ' ' A' ' 246' ' ' THR . 78.4 m-20 -105.89 154.89 19.92 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.152 -174.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.411 ' HB2' HG22 ' A' ' 184' ' ' VAL . . . -135.2 146.55 48.79 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 10.7 p -123.44 134.99 64.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 120.997 0.427 . . . . 0.0 110.78 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 57.9 tp -84.1 130.77 34.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.353 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 242' ' ' TYR . 4.1 pp -101.4 146.01 28.17 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.857 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 C--O 1.268 2.068 0 CA-C-O 117.801 -1.095 . . . . 0.0 110.184 177.348 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 32.6 t80 . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -79.0 97.77 6.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.982 0.42 . . . . 0.0 111.625 -177.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -129.55 144.03 51.09 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.024 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.405 ' HB3' HD12 ' A' ' 197' ' ' ILE . . . -137.18 153.0 50.53 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.753 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -87.07 101.66 13.68 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 60.3 t -95.29 125.84 47.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.452 0.644 . . . . 0.0 112.266 -172.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 92.8 m -107.08 127.77 53.78 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.74 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -104.27 108.93 61.7 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.2 -23.99 59.26 Favored 'Trans proline' 0 N--CA 1.476 0.449 0 C-N-CA 123.002 2.468 . . . . 0.0 113.629 -175.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 13.2 t -81.13 -21.11 40.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.783 0.325 . . . . 0.0 111.546 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 39.8 mt -109.45 -20.59 12.84 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.5 t30 60.43 48.89 7.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.425 -1.262 . . . . 0.0 109.843 -175.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.82 139.24 49.03 Favored 'Isoleucine or valine' 0 C--O 1.248 1.015 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.979 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 86.2 m -115.87 118.64 33.55 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 60.4 t -137.41 145.54 29.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.859 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -77.23 120.04 21.73 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.8 mp -123.02 145.4 45.75 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.788 0.327 . . . . 0.0 111.077 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.06 145.0 43.65 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.423 2.082 . . . . 0.0 110.051 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.5 HD11 HD13 ' A' ' 221' ' ' ILE . 31.7 mm -95.68 124.06 48.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.574 -178.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 98.3 mt -70.37 -43.67 69.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.052 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 26.3 m -142.13 141.78 32.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.186 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 18.8 m -126.14 128.49 71.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.787 0.327 . . . . 0.0 111.098 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -141.18 149.97 42.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.972 0.415 . . . . 0.0 111.229 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -99.01 159.29 15.07 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 174.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 . . . . . 0 C--N 1.318 -0.793 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.346 178.278 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.465 ' H ' HD21 ' A' ' 215' ' ' LEU . 2.6 pt? . . . . . 0 N--CA 1.449 -0.521 0 CA-C-O 121.177 0.513 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 39.1 p -109.67 171.78 7.24 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.276 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -61.68 150.85 35.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.971 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 96.87 4.18 59.0 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.735 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.617 ' OG1' ' HB ' ' A' ' 245' ' ' ILE . 1.9 p -79.35 157.2 27.69 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.557 0.218 . . . . 0.0 111.425 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.6 mm -108.43 127.76 64.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.269 0.556 . . . . 0.0 112.127 -174.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.5 HD13 HD11 ' A' ' 197' ' ' ILE . 26.9 pt -131.88 162.49 39.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.404 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -110.91 129.02 56.0 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.77 153.34 33.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.34 0.59 . . . . 0.0 111.637 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -103.01 104.89 15.11 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.531 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 6.1 p -101.32 80.1 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-O 122.277 1.037 . . . . 0.0 109.934 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 38.4 p -160.02 -32.59 0.06 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.055 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -85.97 21.42 1.96 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.575 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 98.4 mt -60.0 -38.15 81.77 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.617 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 150.37 -32.18 1.03 Allowed Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.901 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 44.9 pt -125.93 156.62 35.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.339 0.59 . . . . 0.0 111.68 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 30.6 m -138.15 152.7 26.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.425 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 34.8 p -85.7 -83.8 0.17 Allowed 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -178.53 9.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.6 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 23.9 m -151.33 14.68 0.69 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.213 -176.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.74 30.42 72.69 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.624 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -61.77 -41.46 97.73 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.185 0.517 . . . . 0.0 110.977 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 12.6 pt -109.53 11.79 8.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.389 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -102.57 107.76 18.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.075 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -141.63 155.85 45.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.784 0.326 . . . . 0.0 111.186 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -107.94 110.31 3.12 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 170.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 31.6 mtp180 -131.0 169.39 15.9 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -102.56 146.02 28.75 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.276 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -131.19 168.15 17.97 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.525 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -114.04 130.85 56.53 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.424 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.617 ' HB ' ' OG1' ' A' ' 219' ' ' THR . 93.8 mt -81.33 130.1 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-O 120.82 0.343 . . . . 0.0 110.778 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 2.2 t -130.59 87.34 2.48 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -84.88 116.48 23.35 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.342 0.591 . . . . 0.0 111.437 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -129.1 72.06 81.99 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.459 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.41 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 33.4 Cg_exo -62.06 -24.9 77.04 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.618 2.212 . . . . 0.0 111.057 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.27 -34.97 79.2 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.702 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -96.9 -57.05 2.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.373 -177.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -98.14 -29.72 13.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.894 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.41 ' CA ' ' HA ' ' A' ' 249' ' ' PRO . . . 83.99 5.82 87.32 Favored Glycine 0 C--N 1.315 -0.593 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.876 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 78.7 m -130.92 161.43 31.91 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 97.8 t -81.0 117.25 26.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 175.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.548 ' HB2' ' O ' ' A' ' 246' ' ' THR . 76.8 m-20 -103.32 147.57 26.93 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -174.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -136.53 144.92 44.51 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.1 p -132.03 136.28 56.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-O 121.18 0.514 . . . . 0.0 110.668 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.6 tt -95.3 119.88 34.58 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 3.0 pp -90.46 137.96 31.93 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.305 0.574 . . . . 0.0 111.965 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 C--O 1.276 2.46 0 CA-C-O 117.287 -1.339 . . . . 0.0 110.11 179.348 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 . . . . . 0 CA--C 1.501 -0.937 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -81.09 79.4 7.76 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.91 148.43 51.22 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.178 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.1 151.39 51.36 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.814 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -84.93 99.85 11.23 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 65.7 t -91.77 120.47 40.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.717 -173.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.9 m -107.53 126.89 53.1 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.697 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -101.01 112.68 65.31 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.75 -22.43 63.91 Favored 'Trans proline' 0 N--CA 1.473 0.282 0 C-N-CA 122.925 2.417 . . . . 0.0 113.103 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 89.2 m -64.45 -42.61 95.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.137 0.494 . . . . 0.0 110.786 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.42 ' HB2' HG11 ' A' ' 191' ' ' VAL . 29.6 mt -105.82 -14.29 15.27 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.064 -176.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 20.3 m120 59.96 45.16 12.57 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.244 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.42 HG11 ' HB2' ' A' ' 189' ' ' LEU . 10.2 p -128.34 147.85 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 11.9 t -127.71 135.13 49.75 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.556 0.693 . . . . 0.0 111.416 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.408 HG23 ' CD1' ' A' ' 195' ' ' LEU . 7.8 m -139.89 152.08 22.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.709 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.4 ' C ' HD13 ' A' ' 195' ' ' LEU . 35.5 tt0 -92.94 122.53 35.4 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.002 -178.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.408 ' CD1' HG23 ' A' ' 193' ' ' VAL . 6.9 mp -121.39 148.14 49.12 Favored Pre-proline 0 C--O 1.239 0.511 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.487 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.37 142.27 90.27 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.723 2.282 . . . . 0.0 111.65 175.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 78.9 mt -89.97 117.49 33.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 98.5 mt -70.14 -40.65 74.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.951 0.405 . . . . 0.0 111.123 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 33.5 t -157.68 148.19 20.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.17 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.6 m -112.93 139.64 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.835 0.35 . . . . 0.0 110.104 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -133.07 136.61 46.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.995 0.426 . . . . 0.0 110.587 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -89.91 159.53 16.89 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 . . . . . 0 C--N 1.311 -1.08 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.485 178.202 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 55.3 tp . . . . . 0 C--O 1.235 0.323 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 11.9 t -92.09 158.52 16.16 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.611 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -68.79 152.99 44.59 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.953 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.77 8.87 27.55 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.932 -0.652 . . . . 0.0 111.949 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 91.4 m -76.25 139.82 41.31 Favored 'General case' 0 C--O 1.212 -0.894 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.6 mm -105.78 127.97 60.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 O-C-N 122.052 -0.405 . . . . 0.0 111.476 -176.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.424 HD12 HD12 ' A' ' 245' ' ' ILE . 45.2 pt -122.88 158.56 27.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.704 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -103.95 123.14 46.62 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.16 159.3 43.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.871 0.367 . . . . 0.0 110.226 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -112.61 123.41 50.24 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 46.8 t -76.42 77.3 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 121.476 0.655 . . . . 0.0 109.968 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 68.6 m -158.38 -13.63 0.07 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.788 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -90.79 18.76 6.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.732 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.75 -38.44 81.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.111 0.482 . . . . 0.0 110.084 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 94.56 -12.72 68.43 Favored Glycine 0 CA--C 1.506 -0.483 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.507 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.3 pt -136.15 165.19 29.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.33 127.45 71.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-O 121.217 0.532 . . . . 0.0 110.545 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 11.9 t -119.93 -14.22 8.96 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.313 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.453 ' HB1' HG12 ' A' ' 237' ' ' ILE . . . -143.5 27.08 1.56 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.322 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.0 m 55.08 23.92 5.65 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.741 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 80.28 7.56 88.42 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.367 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -64.58 -38.45 91.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.597 0.713 . . . . 0.0 109.976 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.453 HG12 ' HB1' ' A' ' 233' ' ' ALA . 28.7 pt -85.86 10.33 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.343 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -64.71 124.2 21.32 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 121.132 -0.227 . . . . 0.0 110.427 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -173.36 157.27 3.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -86.89 120.74 5.56 Favored Glycine 0 C--O 1.224 -0.485 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.955 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 75.5 mtp85 -129.25 164.35 23.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.967 0.413 . . . . 0.0 111.099 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -104.25 134.83 46.82 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.404 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -114.63 146.75 40.47 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.722 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -95.55 124.72 39.71 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.241 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.447 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 49.9 mm -79.54 118.73 27.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.75 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 3.0 t -125.29 91.77 3.49 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -89.5 115.72 27.14 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.169 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -142.92 80.32 13.89 Favored Pre-proline 0 C--N 1.312 -1.025 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.374 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.542 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 33.7 Cg_exo -60.96 -28.06 85.73 Favored 'Trans proline' 0 C--O 1.218 -0.51 0 C-N-CA 122.981 2.454 . . . . 0.0 111.877 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -65.94 -37.08 85.11 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.845 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -91.64 -55.95 3.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.957 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.522 ' CB ' HD22 ' A' ' 256' ' ' ASN . 5.1 t70 -98.24 -30.18 12.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.114 0.483 . . . . 0.0 111.085 -176.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 95.09 6.22 60.35 Favored Glycine 0 C--N 1.319 -0.4 0 C-N-CA 120.89 -0.672 . . . . 0.0 113.328 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 27.9 p -156.02 171.55 19.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.065 0.433 . . . . 0.0 111.825 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 68.1 t -80.34 119.73 30.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.522 HD22 ' CB ' ' A' ' 252' ' ' ASP . 79.7 m-20 -112.43 151.64 29.62 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.413 -173.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -131.2 131.05 43.72 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.13 176.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.62 129.4 64.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.192 0.52 . . . . 0.0 110.193 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.0 tt -95.89 121.08 37.24 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.531 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.437 ' O ' HD11 ' A' ' 260' ' ' LEU . 1.4 pp -88.31 143.08 27.23 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.814 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--O 1.267 1.987 0 CA-C-O 117.699 -1.143 . . . . 0.0 110.768 -179.259 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 . . . . . 0 CA--C 1.513 -0.466 0 CA-C-O 121.128 0.489 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -80.03 85.56 5.61 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -136.15 137.42 40.94 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.84 -176.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -128.57 157.47 41.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.129 0.49 . . . . 0.0 111.715 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -85.61 100.8 12.2 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 192' ' ' THR . 48.7 t -93.97 120.18 42.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -172.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 92.5 m -109.33 128.0 54.76 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.376 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -105.83 105.67 53.97 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -57.07 -38.66 95.19 Favored 'Trans proline' 0 N--CA 1.483 0.889 0 C-N-CA 123.047 2.498 . . . . 0.0 113.366 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 89.6 m -63.23 -42.0 99.18 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.827 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.424 ' HB2' HG13 ' A' ' 191' ' ' VAL . 28.2 mt -99.72 -16.95 17.97 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.086 -175.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 65.5 t30 59.1 53.21 5.63 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.738 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' A' ' 189' ' ' LEU . 12.4 p -133.96 133.52 56.2 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.866 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 93.9 m -116.93 128.46 55.23 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.652 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.4 139.01 29.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.722 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -88.75 117.44 27.74 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.488 HD12 ' HD2' ' A' ' 196' ' ' PRO . 23.2 tp -134.24 141.56 39.77 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.251 -173.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.488 ' HD2' HD12 ' A' ' 195' ' ' LEU . 34.4 Cg_endo -65.28 146.33 85.89 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.916 1.744 . . . . 0.0 110.415 176.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 33.2 mm -81.14 119.93 31.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.012 0.434 . . . . 0.0 111.672 -175.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.95 -39.39 76.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.862 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.3 t -149.59 143.68 25.72 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 15.3 m -126.12 141.84 44.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.78 0.324 . . . . 0.0 111.355 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -130.59 123.31 29.22 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-O 121.008 0.433 . . . . 0.0 110.689 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.569 ' HD2' ' O ' ' A' ' 203' ' ' ASN . 1.7 tmmt? -110.42 150.81 28.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.726 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.569 ' O ' ' HD2' ' A' ' 202' ' ' LYS . 3.2 m-20 . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.415 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 CA--C 1.507 -0.692 0 CA-C-O 120.942 0.401 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 12.0 t -156.6 173.89 16.27 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.236 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.421 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 18.0 ptpt -67.21 152.68 45.29 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.86 178.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.52 8.12 31.09 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -176.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.526 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 66.1 m -77.07 136.75 38.67 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 51.2 mm -92.32 127.14 44.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.78 0.324 . . . . 0.0 111.116 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 43.3 pt -130.85 161.08 41.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.093 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.421 ' HB2' ' CE1' ' A' ' 242' ' ' TYR . 35.7 tt0 -110.9 128.49 55.83 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.1 m -126.34 157.54 36.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.718 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -98.18 110.62 23.17 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.563 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.649 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 10.7 t -91.41 18.94 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.445 ' HB3' ' N ' ' A' ' 239' ' ' TRP . 23.5 p -120.06 -35.24 3.51 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.658 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -64.48 -39.3 93.55 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.649 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.73 -36.59 83.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.075 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 102.03 -88.17 0.67 Allowed Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 50.7 mt 62.2 -74.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.932 0.893 . . . . 0.0 111.435 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 42.0 t 57.11 77.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 123.872 0.869 . . . . 0.0 111.353 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 23.6 p -70.35 -40.62 73.98 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.228 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -161.37 110.36 1.57 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.017 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 22.4 m 58.39 13.23 2.34 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.384 0.673 . . . . 0.0 112.591 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.19 29.31 74.69 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.055 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -61.99 -43.54 98.63 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 120.992 0.425 . . . . 0.0 111.363 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 26.4 pt -78.3 -1.88 4.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.299 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.649 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -76.01 108.01 8.6 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.721 0.296 . . . . 0.0 111.274 -177.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . 0.445 ' N ' ' HB3' ' A' ' 226' ' ' SER . 6.8 t90 -178.75 163.22 1.42 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.938 178.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -74.66 123.47 7.58 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.214 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -129.98 165.26 22.51 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -177.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.421 ' CE1' ' HB2' ' A' ' 222' ' ' GLU . 96.8 m-85 -101.07 141.38 34.04 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.238 0.542 . . . . 0.0 111.892 -177.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -128.6 170.14 13.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.873 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -115.26 131.25 56.99 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.771 0.32 . . . . 0.0 111.096 -178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.526 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 44.3 mm -77.0 128.04 37.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.676 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.421 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 3.8 t -132.76 101.73 5.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.799 0.809 . . . . 0.0 109.36 175.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -73.03 117.67 15.04 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.3 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . 0.419 ' HB2' ' ND2' ' A' ' 256' ' ' ASN . 17.5 m120 -130.82 70.81 82.58 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.856 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.78 -22.45 17.7 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.009 1.806 . . . . 0.0 112.079 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -76.26 -28.72 57.2 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.497 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -94.4 -57.55 2.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.683 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -100.01 -29.57 12.47 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 120.89 0.376 . . . . 0.0 111.914 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 84.46 8.41 83.29 Favored Glycine 0 C--N 1.316 -0.553 0 C-N-CA 120.311 -0.947 . . . . 0.0 110.91 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 68.8 m -129.5 161.59 30.08 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.333 -0.433 . . . . 0.0 109.992 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 81.7 t -83.1 118.46 30.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.419 ' ND2' ' HB2' ' A' ' 248' ' ' ASN . 81.4 m-20 -103.02 152.19 21.64 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.992 -172.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -130.96 137.21 49.16 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 176.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.7 p -128.71 136.37 60.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.022 0.439 . . . . 0.0 110.434 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 7.6 tt -86.2 119.79 26.87 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.464 ' O ' HD13 ' A' ' 260' ' ' LEU . 1.1 pp -81.54 133.75 35.42 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.997 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 C--O 1.27 2.133 0 CA-C-O 117.467 -1.254 . . . . 0.0 110.419 178.992 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.401 ' CD2' ' HB2' ' A' ' 181' ' ' LYS . 66.3 t80 . . . . . 0 N--CA 1.452 -0.367 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -78.79 80.22 5.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.734 0.302 . . . . 0.0 111.091 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.629 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 84.3 tttt -154.27 129.69 9.83 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -122.74 157.27 32.7 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.26 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 15.2 m120 -87.04 106.19 17.68 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 61.8 t -98.34 119.79 46.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.351 0.596 . . . . 0.0 111.838 -174.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.1 m -93.48 125.93 38.36 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -104.14 110.89 64.85 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.7 -38.65 91.29 Favored 'Trans proline' 0 N--CA 1.483 0.877 0 C-N-CA 123.575 2.85 . . . . 0.0 114.02 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 8.0 t -70.64 -30.95 67.71 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.498 ' HB2' HG13 ' A' ' 191' ' ' VAL . 37.7 mt -98.68 -21.84 16.21 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.27 0.557 . . . . 0.0 109.608 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 23.7 m120 58.3 42.85 20.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.206 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' A' ' 189' ' ' LEU . 9.5 p -135.38 145.36 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.019 -178.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 8.8 t -106.12 121.57 44.42 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.419 0.628 . . . . 0.0 109.998 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.84 126.58 71.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.805 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.629 ' HG2' ' HG2' ' A' ' 181' ' ' LYS . 58.3 tt0 -79.11 122.61 26.45 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.409 ' C ' ' HG3' ' A' ' 181' ' ' LYS . 95.4 mt -128.18 150.52 74.18 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.832 -176.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.07 149.44 71.27 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.547 2.165 . . . . 0.0 112.085 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 35.5 mm -94.0 115.57 33.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.091 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 97.3 mt -70.39 -41.64 72.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.073 0.463 . . . . 0.0 110.462 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.5 t -160.9 153.11 20.19 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.129 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 33.4 m -118.72 146.18 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-O 121.005 0.431 . . . . 0.0 110.318 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -128.14 143.59 51.06 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -60.45 144.36 51.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.961 0.41 . . . . 0.0 111.141 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 11.7 p30 . . . . . 0 C--N 1.316 -0.853 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.851 178.177 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 5.1 tt . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 121.1 0.476 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 70.6 p -126.34 167.48 15.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.078 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -63.77 152.58 38.99 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.221 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 102.49 7.33 45.81 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -176.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.528 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 90.8 m -79.9 140.96 36.52 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.9 mm -101.9 130.46 51.58 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.706 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.297 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.411 HD11 HD11 ' A' ' 245' ' ' ILE . 42.3 pt -126.9 159.87 36.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.773 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -109.94 127.85 55.01 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 32.3 m -130.23 159.08 42.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.179 0.514 . . . . 0.0 111.455 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -95.38 109.38 21.56 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 92.6 t -97.0 87.91 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 48.6 m -129.84 -50.87 1.14 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.158 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -98.3 -51.15 4.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.579 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.449 HD21 HG11 ' A' ' 225' ' ' VAL . 84.5 mt 60.49 26.4 16.03 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.661 -176.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 92.69 -9.25 75.99 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.978 -0.556 . . . . 0.0 113.019 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 47.1 pt -131.97 175.19 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.798 0.332 . . . . 0.0 110.762 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 64.5 t -117.69 119.36 61.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 10.0 p -89.27 -86.24 0.19 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.198 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -150.2 82.01 1.37 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.543 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 44.7 m 53.87 39.59 30.58 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.017 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.24 42.27 83.8 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.685 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -61.13 -40.73 94.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.344 0.592 . . . . 0.0 110.872 -176.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 13.9 pt -103.87 23.54 2.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.445 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.572 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -73.68 106.9 5.63 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.155 0.503 . . . . 0.0 111.975 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -139.49 149.28 43.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.755 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -78.04 125.83 7.39 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -128.72 155.91 44.33 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 120.883 0.373 . . . . 0.0 111.02 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.481 ' CE2' HD12 ' A' ' 260' ' ' LEU . 49.2 p90 -109.11 142.25 40.12 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -122.55 154.82 37.4 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 120.96 0.409 . . . . 0.0 111.308 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -94.0 122.69 36.76 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.056 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 42.8 mm -77.24 119.38 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.351 177.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 80.2 p -122.5 86.65 2.62 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -90.49 129.61 36.63 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.113 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -142.66 76.33 17.82 Favored Pre-proline 0 C--N 1.304 -1.384 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.285 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.511 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 58.7 Cg_endo -70.34 -17.52 34.87 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.326 2.017 . . . . 0.0 111.354 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -69.06 -37.54 78.59 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.124 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -105.7 -60.15 1.67 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.015 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.66 -39.71 61.87 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.48 0.657 . . . . 0.0 110.642 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 94.09 -7.11 72.88 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.999 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 79.4 m -131.67 168.02 18.46 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.053 0.454 . . . . 0.0 111.888 -177.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 75.5 t -83.35 119.23 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -111.46 152.96 26.82 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -133.26 150.6 51.92 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.4 p -126.91 136.57 60.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 120.901 0.381 . . . . 0.0 110.031 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 57.2 tp -87.64 125.16 34.22 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.966 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.481 HD12 ' CE2' ' A' ' 242' ' ' TYR . 4.2 pp -98.6 148.91 23.32 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.584 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 11.9 m . . . . . 0 C--O 1.263 1.799 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.851 -179.513 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 63.2 t80 . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.533 ' HB3' ' HB ' ' A' ' 197' ' ' ILE . 10.1 mptt -79.53 88.81 5.06 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.572 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt -151.92 139.25 19.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.329 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -142.98 154.45 44.03 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.977 0.418 . . . . 0.0 111.367 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -89.19 108.42 19.6 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 61.3 t -100.2 125.52 53.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -171.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 94.7 m -103.69 127.36 51.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.143 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -104.72 107.62 58.77 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.34 -35.65 98.88 Favored 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 123.132 2.555 . . . . 0.0 113.504 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 5.3 t -73.88 -34.62 64.52 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -177.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.448 ' HB2' HG11 ' A' ' 191' ' ' VAL . 38.5 mt -95.86 -16.27 21.93 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 120.817 0.342 . . . . 0.0 110.125 -177.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 60.27 42.48 15.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.046 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 189' ' ' LEU . 9.9 p -134.97 139.01 48.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.6 -176.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 87.0 m -114.32 119.02 35.55 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.806 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.474 HG21 HD21 ' A' ' 228' ' ' LEU . 9.6 m -135.54 147.19 28.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.435 -177.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.485 ' C ' HD12 ' A' ' 195' ' ' LEU . 64.4 tt0 -101.0 118.97 38.05 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.739 0.304 . . . . 0.0 110.614 -177.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.485 HD12 ' C ' ' A' ' 194' ' ' GLN . 5.6 mp -129.02 147.8 66.33 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.53 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -61.16 143.26 98.59 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.349 2.033 . . . . 0.0 110.02 172.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.533 ' HB ' ' HB3' ' A' ' 180' ' ' LYS . 82.4 mt -80.54 121.47 34.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.411 HD21 ' HA ' ' A' ' 223' ' ' VAL . 4.1 mm? -67.77 -43.92 78.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.643 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 52.4 m -152.19 153.43 33.8 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.266 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 31.3 m -117.79 145.93 22.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -127.86 121.17 29.37 Favored 'General case' 0 C--O 1.256 1.427 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -66.44 138.96 57.93 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.425 ' OD1' ' HA ' ' A' ' 219' ' ' THR . 87.1 m-20 . . . . . 0 C--N 1.309 -1.152 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.654 -174.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.824 0.345 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 19.5 p -91.2 170.13 10.26 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.138 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -54.18 153.35 5.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.476 -0.783 . . . . 0.0 112.549 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 116.65 10.11 10.58 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.417 -175.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.425 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 59.8 m -67.09 137.04 56.07 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.9 mm -91.11 130.84 39.66 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.424 -174.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 46.9 pt -129.11 156.82 41.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.061 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 198' ' ' LEU . 52.9 mt-10 -114.74 125.95 54.29 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.411 ' HA ' HD21 ' A' ' 198' ' ' LEU . 35.9 m -130.59 155.9 42.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.248 0.547 . . . . 0.0 111.105 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -97.51 106.81 19.19 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.608 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 31.6 t -80.74 77.35 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 121.565 0.698 . . . . 0.0 110.394 -177.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 38.6 p -169.37 -16.0 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.329 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -81.24 9.28 7.21 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.434 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.474 HD21 HG21 ' A' ' 193' ' ' VAL . 87.9 mt -63.19 -34.57 77.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.902 -176.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 83.79 22.39 55.73 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.094 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 42.0 pt -116.91 161.18 15.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.924 0.392 . . . . 0.0 110.495 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 66.8 t -117.7 123.86 72.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.806 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 19.1 p -117.05 -70.43 0.79 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.076 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -169.31 97.35 0.34 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.553 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 19.2 t 63.32 15.97 9.1 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.43 34.03 78.58 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.84 -1.171 . . . . 0.0 111.495 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -63.44 -18.56 63.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.98 0.419 . . . . 0.0 111.639 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 33.6 pt -90.9 -0.1 9.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.512 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.644 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -75.98 107.81 8.44 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.159 0.504 . . . . 0.0 111.711 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -164.73 131.74 3.06 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.488 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -70.78 113.57 4.85 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.133 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -129.54 157.11 42.96 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.93 0.395 . . . . 0.0 111.224 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -102.38 148.74 25.11 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.378 0.609 . . . . 0.0 111.446 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -131.84 170.18 15.21 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.129 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -116.65 141.78 47.76 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.391 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 84.1 mt -83.25 124.47 39.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.43 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.499 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 2.8 t -141.28 100.91 3.9 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.753 176.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -75.35 135.11 40.86 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.063 0.459 . . . . 0.0 111.413 -177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -140.79 72.46 29.12 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.481 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.404 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 23.4 Cg_exo -66.84 -21.13 51.16 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.798 2.332 . . . . 0.0 111.554 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -67.68 -38.32 83.56 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.226 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -107.64 -57.97 2.02 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.53 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.54 -37.53 63.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.207 0.527 . . . . 0.0 110.667 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 89.27 5.5 72.6 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.139 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 33.0 t -145.49 177.4 8.88 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 96.9 t -80.21 122.14 34.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 246' ' ' THR . 8.1 m120 -105.95 152.97 22.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.287 0.565 . . . . 0.0 111.414 -174.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.574 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -134.73 140.01 45.62 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 174.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 12.5 p -126.25 135.69 63.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.811 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 64.7 tp -80.69 129.22 34.4 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.847 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 4.1 pp -95.52 143.63 26.67 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.164 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 C--O 1.269 2.101 0 CA-C-O 117.411 -1.281 . . . . 0.0 110.422 179.707 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 80.4 t80 . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -69.09 68.05 0.17 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.167 0.292 . . . . 0.0 110.717 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.421 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 41.1 ttmt -154.88 137.27 14.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.524 0.202 . . . . 0.0 110.531 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -135.15 151.05 50.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.883 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 53.8 t-20 -85.22 103.52 14.26 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.429 HG23 ' HB3' ' A' ' 257' ' ' ALA . 54.1 t -93.59 121.91 44.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.177 0.513 . . . . 0.0 112.247 -173.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 62.9 m -98.26 124.78 43.04 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.207 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -106.04 106.87 58.38 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.24 -29.11 64.22 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.342 2.028 . . . . 0.0 112.796 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.2 t -73.73 -23.69 59.8 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.416 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.464 ' HB2' HG12 ' A' ' 191' ' ' VAL . 36.2 mt -104.85 -19.8 13.78 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.3 t30 61.16 47.56 7.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.568 -1.197 . . . . 0.0 109.405 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.464 HG12 ' HB2' ' A' ' 189' ' ' LEU . 5.9 p -145.09 146.54 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -177.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.2 t -121.07 120.7 36.1 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 121.555 0.693 . . . . 0.0 109.639 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.4 t -129.09 135.18 62.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.156 -177.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 62.0 tt0 -87.66 119.75 28.29 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.852 0.358 . . . . 0.0 110.747 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.3 mp -125.21 155.34 71.39 Favored Pre-proline 0 C--O 1.237 0.407 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.375 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.39 151.75 71.16 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.473 2.115 . . . . 0.0 111.655 177.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 83.4 mt -88.57 111.92 23.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.848 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.0 mp -69.28 -43.98 72.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.101 0.476 . . . . 0.0 111.934 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 50.6 m -151.34 157.85 43.02 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.329 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 33.0 m -123.42 146.7 28.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.224 0.535 . . . . 0.0 111.315 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.414 ' HB2' ' HB ' ' A' ' 220' ' ' ILE . 74.3 mmtt -125.58 110.42 13.81 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.474 176.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.438 ' HD3' ' O ' ' A' ' 203' ' ' ASN . 1.6 tmtp? -75.3 125.34 28.78 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.438 ' O ' ' HD3' ' A' ' 202' ' ' LYS . 95.1 m-20 . . . . . 0 C--N 1.324 -0.542 0 CA-C-O 120.718 0.294 . . . . 0.0 110.54 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 9.8 mp . . . . . 0 N--CA 1.447 -0.586 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 71.2 p -114.46 155.08 27.03 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -62.74 150.69 40.6 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.99 10.55 34.41 Favored Glycine 0 N--CA 1.436 -1.309 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -173.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 95.1 m -68.08 138.78 56.04 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' ' 201' ' ' LYS . 51.1 mm -90.46 129.63 40.99 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 CA-C-O 120.726 0.298 . . . . 0.0 111.703 -174.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 44.9 pt -131.62 159.06 43.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.558 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -107.22 126.05 51.92 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.87 151.88 35.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.611 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -106.55 106.67 17.3 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.089 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 3.0 p -82.21 85.34 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-O 121.912 0.863 . . . . 0.0 110.193 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 15.0 p -123.7 -84.87 0.65 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.176 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -64.43 -46.68 82.16 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 97.0 mt 56.45 16.18 2.36 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.109 0.481 . . . . 0.0 110.774 -175.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 83.77 0.58 89.86 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 115.989 -0.551 . . . . 0.0 113.037 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 44.9 pt -133.67 171.71 17.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.297 0.57 . . . . 0.0 111.582 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 66.6 t -113.66 114.82 47.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 11.7 t -154.58 146.07 23.11 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.638 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . 52.93 25.18 3.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.147 0.579 . . . . 0.0 112.008 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 58.2 m 56.79 18.78 3.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.34 0.656 . . . . 0.0 111.971 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.57 26.21 74.72 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.077 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -66.01 -18.99 65.7 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.204 0.526 . . . . 0.0 111.135 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 30.9 pt -87.6 8.85 2.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.991 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -66.68 106.3 1.79 Allowed 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.084 0.469 . . . . 0.0 111.457 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -142.33 151.88 42.38 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.309 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -93.07 112.76 4.33 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 174.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.95 164.34 23.37 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 120.741 0.305 . . . . 0.0 111.065 -177.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -102.35 139.92 37.32 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.221 0.534 . . . . 0.0 111.61 -175.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -127.63 154.51 45.17 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.775 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -97.81 132.73 43.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.593 0.235 . . . . 0.0 110.725 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 87.1 mt -79.71 119.9 29.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.49 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 4.3 t -133.83 98.51 4.19 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -81.19 123.64 28.62 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.947 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -129.76 72.1 82.01 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.017 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.53 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 59.5 Cg_endo -70.16 -22.24 30.53 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.267 1.978 . . . . 0.0 112.228 -178.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -70.22 -37.73 75.09 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.27 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -96.29 -57.51 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.923 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -82.36 -39.57 22.57 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.343 0.592 . . . . 0.0 110.767 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 96.78 8.96 56.77 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.239 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 14.0 t -153.61 -179.93 8.25 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 93.7 t -79.87 126.64 39.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 246' ' ' THR . 10.0 m120 -113.33 154.28 27.12 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.861 0.362 . . . . 0.0 110.764 -174.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.429 ' HB3' HG23 ' A' ' 184' ' ' VAL . . . -131.98 147.96 52.49 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.9 p -123.43 131.0 73.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.025 0.44 . . . . 0.0 110.418 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.9 tt -100.53 123.84 45.29 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.801 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 2.8 pp -92.51 151.29 20.26 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.139 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.262 1.728 0 CA-C-O 117.75 -1.119 . . . . 0.0 110.876 -179.231 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 18.3 t80 . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 180' ' ' LYS . 11.1 mptt -82.42 81.19 8.36 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -176.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -138.19 150.55 46.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.743 0.417 . . . . 0.0 110.921 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -141.94 151.16 42.32 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.714 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 20.0 m120 -86.53 100.44 12.39 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 120.557 -0.457 . . . . 0.0 109.833 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 64.5 t -85.34 120.31 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.72 -176.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 63.7 m -105.33 126.46 52.13 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.458 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -104.33 111.64 65.23 Favored Pre-proline 0 C--N 1.312 -1.035 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.34 -27.14 77.49 Favored 'Trans proline' 0 N--CA 1.474 0.334 0 C-N-CA 122.556 2.171 . . . . 0.0 112.462 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 89.3 m -63.35 -42.64 98.92 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.31 0.576 . . . . 0.0 110.568 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.454 ' HB2' HG11 ' A' ' 191' ' ' VAL . 28.3 mt -95.05 -21.38 18.6 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.364 -177.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 65.6 t30 59.57 51.66 6.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.496 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' A' ' 189' ' ' LEU . 10.0 p -140.14 148.86 22.21 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.817 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 13.6 t -119.47 122.75 42.42 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.497 0.665 . . . . 0.0 110.44 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.446 HG11 ' HA3' ' A' ' 229' ' ' GLY . 57.3 t -128.88 131.06 68.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.665 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 29.6 tt0 -78.24 124.51 28.16 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.834 0.35 . . . . 0.0 111.099 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.415 HD12 ' C ' ' A' ' 194' ' ' GLN . 7.4 mp -127.27 149.33 69.43 Favored Pre-proline 0 C--O 1.238 0.499 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.155 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -61.4 142.58 96.03 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.844 2.363 . . . . 0.0 112.307 176.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 81.6 mt -90.84 120.78 40.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.9 mp -72.29 -45.13 61.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.771 0.32 . . . . 0.0 111.389 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.2 t -162.91 157.12 20.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.889 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 33.6 m -119.1 146.19 24.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-O 120.9 0.381 . . . . 0.0 110.72 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -129.31 142.45 50.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.827 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -77.92 158.57 29.32 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.586 0.708 . . . . 0.0 112.436 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 . . . . . 0 C--N 1.308 -1.212 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.125 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 63.7 tp . . . . . 0 N--CA 1.442 -0.831 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 40.2 m -115.18 141.66 47.72 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.974 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -46.83 151.23 0.63 Allowed 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.727 0.642 . . . . 0.0 111.927 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 111.3 8.58 23.18 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -176.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.501 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 25.7 m -74.49 144.44 44.15 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.2 mm -104.1 127.18 58.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.699 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.47 HD11 HD12 ' A' ' 245' ' ' ILE . 46.1 pt -125.97 160.18 33.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.876 0.369 . . . . 0.0 111.114 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -103.8 126.38 50.9 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.372 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.58 151.59 36.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.078 0.466 . . . . 0.0 110.885 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -92.36 105.87 17.98 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 22.8 t -93.86 70.45 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 121.423 0.63 . . . . 0.0 110.108 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 50.7 m -125.99 -42.85 1.86 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.496 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -73.48 -43.57 59.89 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.227 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.437 ' O ' HG11 ' A' ' 193' ' ' VAL . 7.1 mp 54.02 17.29 1.34 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.46 -176.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.446 ' HA3' HG11 ' A' ' 193' ' ' VAL . . . 77.33 -47.98 2.75 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -176.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 44.3 pt -128.27 157.86 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.6 m -96.74 43.97 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-O 121.099 0.476 . . . . 0.0 111.269 -177.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.1 t -48.93 -46.68 43.44 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.986 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -98.86 10.74 40.67 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 16.5 t 60.35 38.05 19.81 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.77 -127.78 28.6 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -174.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? 75.08 -45.54 0.57 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.64 0.776 . . . . 0.0 110.488 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 21.3 pt -88.85 18.57 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.801 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -69.46 112.94 6.32 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.38 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . 0.503 ' O ' ' HB ' ' A' ' 225' ' ' VAL . 23.1 t90 -169.25 138.21 2.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.718 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -68.11 131.84 28.0 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.083 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.44 176.08 8.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.821 0.343 . . . . 0.0 110.855 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -111.79 138.54 48.25 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.783 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -122.48 149.85 43.32 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.787 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -95.29 127.09 41.06 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.151 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.501 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 48.0 mm -78.47 120.7 29.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 178.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.8 t -134.97 98.32 3.98 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.934 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -80.5 126.24 30.97 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.875 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -135.82 72.18 62.59 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.52 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 35.5 Cg_exo -63.94 -26.52 66.71 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.062 2.508 . . . . 0.0 112.03 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -67.58 -37.44 82.62 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.403 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -96.68 -56.96 2.42 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.309 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -87.22 -40.2 14.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.072 0.463 . . . . 0.0 110.729 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 99.7 9.36 49.94 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.879 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 30.6 p -152.21 179.16 8.76 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.658 -0.319 . . . . 0.0 110.996 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 66.9 t -80.65 123.39 37.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -114.38 153.27 30.15 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.787 0.327 . . . . 0.0 110.147 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -128.3 146.88 50.63 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.6 p -122.39 129.71 75.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 121.127 0.489 . . . . 0.0 110.291 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 8.8 tt -105.32 124.43 49.52 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.906 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 3.4 pp -99.43 150.34 22.27 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.375 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 23.9 m . . . . . 0 C--O 1.272 2.268 0 CA-C-O 117.679 -1.153 . . . . 0.0 110.71 179.742 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 84.6 t80 . . . . . 0 N--CA 1.443 -0.809 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -69.38 85.51 0.41 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -177.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -151.8 137.6 18.0 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.978 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -140.1 159.21 42.7 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.145 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 89.9 m-20 -82.18 104.28 12.4 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 59.9 t -95.73 120.14 44.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.244 0.545 . . . . 0.0 112.119 -173.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 192' ' ' THR . 90.5 m -95.2 125.28 39.74 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.318 176.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -105.26 107.78 59.82 Favored Pre-proline 0 C--N 1.313 -1.009 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.96 -26.23 66.64 Favored 'Trans proline' 0 N--CA 1.474 0.374 0 C-N-CA 122.548 2.165 . . . . 0.0 112.644 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 86.4 m -64.6 -41.58 96.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.389 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.453 ' HB2' HG12 ' A' ' 191' ' ' VAL . 35.0 mt -99.3 -14.54 19.19 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.757 -177.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 60.22 45.23 11.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.26 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.453 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.8 p -138.79 144.72 29.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.439 -176.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 185' ' ' THR . 86.1 m -107.49 119.7 40.14 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.2 130.18 69.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 63.4 tt0 -75.51 120.26 20.69 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.41 ' CD2' HD21 ' A' ' 228' ' ' LEU . 87.2 mt -129.55 149.88 74.11 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.605 -174.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.74 144.98 50.23 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.353 2.036 . . . . 0.0 110.749 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.423 HG22 ' HB ' ' A' ' 221' ' ' ILE . 80.2 mt -93.48 116.85 35.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.248 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.4 mp -71.8 -46.15 59.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.675 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 39.2 m -141.25 148.33 39.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.597 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.2 m -129.72 137.66 56.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.628 0.251 . . . . 0.0 110.633 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -143.79 142.95 31.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.03 0.443 . . . . 0.0 110.835 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -112.07 146.67 37.54 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.991 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 C--N 1.316 -0.851 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.432 -176.77 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.122 0.487 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.3 m -133.28 162.99 30.32 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.175 -174.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -47.18 151.01 0.74 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.486 0.66 . . . . 0.0 112.454 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 113.35 9.09 18.29 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.507 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.542 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 60.5 m -76.27 139.05 40.93 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.4 mm -97.48 126.41 50.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 120.803 0.335 . . . . 0.0 110.364 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.447 HD12 HD13 ' A' ' 245' ' ' ILE . 44.6 pt -125.98 165.03 24.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.118 0.485 . . . . 0.0 111.561 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -112.09 128.11 56.11 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.798 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.82 158.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.93 0.395 . . . . 0.0 110.902 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -110.33 112.18 23.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.267 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 3.2 p -102.4 79.39 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.788 0.804 . . . . 0.0 109.683 176.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 32.4 t -156.85 -42.35 0.07 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.145 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -94.2 19.57 9.18 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.864 -178.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.41 HD21 ' CD2' ' A' ' 195' ' ' LEU . 39.8 mt -70.76 -16.96 62.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.621 -175.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 82.73 2.96 90.69 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.533 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.4 pt -113.31 162.01 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.81 124.62 44.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.862 0.839 . . . . 0.0 111.249 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 9.9 t -99.07 -151.57 0.39 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -67.2 85.71 0.15 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.936 0.398 . . . . 0.0 110.641 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 39.7 m 64.77 13.11 8.21 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.912 0.885 . . . . 0.0 112.298 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 63.31 33.36 87.03 Favored Glycine 0 C--O 1.225 -0.446 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.972 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -65.35 -14.58 61.15 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 23.7 pt -105.86 12.18 8.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.974 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -75.46 106.02 6.79 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.987 0.423 . . . . 0.0 111.483 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -165.53 177.22 7.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.844 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -87.94 118.78 5.13 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 173.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 62.6 mtp85 -127.38 166.74 17.29 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.971 0.386 . . . . 0.0 111.0 -173.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -108.28 139.38 43.07 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.289 0.566 . . . . 0.0 111.692 -176.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -127.28 161.69 27.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.28 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -106.17 130.93 53.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.885 0.374 . . . . 0.0 111.107 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.542 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 41.9 mm -80.29 125.61 39.15 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.127 177.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 4.9 t -135.5 90.17 2.58 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 173.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -80.17 123.53 28.0 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.249 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -130.42 71.71 82.18 Favored Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.615 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.51 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 51.3 Cg_endo -67.8 -23.38 41.78 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.985 1.79 . . . . 0.0 111.07 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -73.12 -26.34 61.19 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.464 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -104.57 -56.18 2.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.066 -176.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -90.86 -40.07 11.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.063 0.459 . . . . 0.0 110.717 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 105.08 -8.54 45.53 Favored Glycine 0 C--N 1.316 -0.578 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.424 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 75.2 m -132.72 175.94 8.9 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.702 0.287 . . . . 0.0 111.061 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 86.6 t -79.95 124.34 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 246' ' ' THR . 3.2 m120 -107.34 151.95 24.8 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -176.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -139.88 150.43 44.61 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 177.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.58 135.91 53.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 120.837 0.351 . . . . 0.0 110.429 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 64.3 tp -73.71 126.52 30.53 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.473 ' O ' HD11 ' A' ' 260' ' ' LEU . 3.2 pp -82.98 131.13 35.2 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.119 0.485 . . . . 0.0 111.117 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--O 1.272 2.24 0 CA-C-O 117.815 -1.088 . . . . 0.0 110.336 179.463 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 . . . . . 0 N--CA 1.445 -0.684 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 180' ' ' LYS . 0.1 OUTLIER -88.65 116.12 26.67 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.231 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -149.13 140.13 22.93 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.6 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -138.45 157.29 46.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.953 0.406 . . . . 0.0 112.003 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -90.45 103.85 16.5 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 59.6 t -97.35 123.11 49.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.154 0.502 . . . . 0.0 111.95 -173.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 89.8 m -105.03 126.62 52.26 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.599 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -105.33 110.69 64.65 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.938 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.95 -33.64 89.7 Favored 'Trans proline' 0 N--CA 1.481 0.774 0 C-N-CA 123.331 2.688 . . . . 0.0 113.111 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 88.7 m -60.79 -44.4 96.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.255 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.439 ' HB2' HG11 ' A' ' 191' ' ' VAL . 32.0 mt -98.27 -17.0 19.17 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.647 -176.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 59.71 50.1 7.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.042 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.439 HG11 ' HB2' ' A' ' 189' ' ' LEU . 9.6 p -138.67 149.04 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.839 -178.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 12.4 t -119.67 129.57 54.62 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.405 0.622 . . . . 0.0 109.779 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 10.6 m -134.32 147.48 30.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.527 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.501 ' C ' HD11 ' A' ' 195' ' ' LEU . 35.5 tt0 -96.68 118.52 33.32 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.501 HD11 ' C ' ' A' ' 194' ' ' GLN . 7.0 mp -128.05 148.12 66.12 Favored Pre-proline 0 C--O 1.237 0.44 0 CA-C-O 120.664 0.269 . . . . 0.0 111.399 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.53 145.82 92.29 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.767 2.311 . . . . 0.0 110.978 173.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 83.9 mt -91.53 120.03 39.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 96.5 mt -68.02 -41.51 82.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.713 0.292 . . . . 0.0 111.356 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 93.4 p -156.1 157.25 35.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.713 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 17.7 m -122.25 135.58 61.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.338 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -136.24 137.17 40.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.779 0.324 . . . . 0.0 110.805 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -111.74 145.52 39.2 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.369 174.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 . . . . . 0 C--N 1.314 -0.939 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 176.014 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 CA--C 1.504 -0.796 0 CA-C-O 121.705 0.764 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 94.2 m -118.37 140.78 49.32 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.564 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 12.4 ptmm? -49.39 145.89 4.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.618 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 111.55 9.77 20.7 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.862 -176.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.432 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 61.7 m -84.35 134.86 34.48 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.476 HD11 ' N ' ' A' ' 220' ' ' ILE . 3.7 mp -95.98 127.08 48.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.905 0.384 . . . . 0.0 111.12 -178.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.423 HD12 HD13 ' A' ' 245' ' ' ILE . 46.0 pt -124.79 157.91 32.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.521 178.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -110.84 124.65 52.45 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.86 157.01 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.722 0.296 . . . . 0.0 110.633 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -98.15 123.14 42.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.315 0.578 . . . . 0.0 110.991 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 9.1 m -100.04 80.35 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-O 121.67 0.748 . . . . 0.0 110.114 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 18.5 m -112.93 -63.48 1.44 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.44 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -99.03 -39.73 8.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.157 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 8.2 mp 65.0 -2.57 0.7 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.441 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 83.22 7.5 86.7 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.082 -178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.5 pt -126.16 169.91 16.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 5.6 p -118.38 85.73 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 122.128 0.966 . . . . 0.0 111.57 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.3 t -113.14 -41.02 3.79 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 173.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -168.19 136.22 2.25 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.357 177.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 47.4 m -75.17 76.63 2.31 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.538 0.685 . . . . 0.0 111.167 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 70.75 40.63 64.94 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 114.998 -1.001 . . . . 0.0 115.25 175.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -63.7 -25.53 68.24 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.936 0.868 . . . . 0.0 109.714 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 13.5 pt -129.65 33.71 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.541 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -63.66 105.71 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.098 0.475 . . . . 0.0 111.514 -177.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -151.83 166.43 31.45 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.629 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -93.13 118.73 5.72 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -127.29 163.24 24.38 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 120.9 0.381 . . . . 0.0 110.968 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -103.33 139.51 38.65 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.491 -175.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -128.47 147.36 50.67 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.27 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 18.1 pm0 -98.34 131.34 44.72 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.476 0.655 . . . . 0.0 111.374 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 48.9 mm -77.54 125.22 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.29 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 4.1 t -134.46 102.95 5.5 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -84.69 126.81 33.71 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.285 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -127.6 72.29 77.9 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.17 -23.89 28.44 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.401 2.067 . . . . 0.0 112.381 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -77.65 -16.09 58.77 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.112 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -113.31 -56.25 2.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.032 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -93.29 -31.17 14.8 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.776 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 77.42 20.46 74.69 Favored Glycine 0 C--N 1.322 -0.22 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.86 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 48.8 t -151.15 164.87 35.52 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.695 0.283 . . . . 0.0 110.441 -177.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 95.1 t -79.91 121.84 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 246' ' ' THR . 78.8 m-20 -112.55 152.8 28.41 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.198 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -132.5 141.91 48.98 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.83 133.27 69.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 7.4 tt -101.19 123.81 45.92 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.218 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.457 ' O ' HD12 ' A' ' 260' ' ' LEU . 3.1 pp -65.49 137.65 57.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.236 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.269 2.122 0 CA-C-O 117.3 -1.333 . . . . 0.0 110.717 -179.065 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.413 ' C ' ' H ' ' A' ' 181' ' ' LYS . 52.3 t80 . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -74.57 38.93 0.12 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.662 0.268 . . . . 0.0 111.005 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.456 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 40.3 ttmt -154.01 140.7 18.99 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -177.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.401 ' HB2' HD11 ' A' ' 197' ' ' ILE . . . -138.28 157.02 47.09 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.711 0.291 . . . . 0.0 111.509 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -87.0 101.49 13.49 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 58.9 t -90.56 125.94 43.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.859 -175.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.7 m -107.02 124.07 49.11 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.245 0.545 . . . . 0.0 110.011 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -104.51 115.91 62.03 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.841 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.83 -18.88 65.77 Favored 'Trans proline' 0 N--CA 1.476 0.458 0 C-N-CA 122.581 2.187 . . . . 0.0 111.258 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 72.0 m -64.11 -40.65 96.66 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.218 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.452 ' HB2' HG11 ' A' ' 191' ' ' VAL . 27.4 mt -107.3 -16.37 14.41 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.069 -177.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 60.16 41.32 17.08 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.986 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.452 HG11 ' HB2' ' A' ' 189' ' ' LEU . 6.6 p -134.94 148.84 28.97 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.74 -177.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 84.8 m -105.68 120.91 42.87 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.5 m -127.06 138.41 54.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.901 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.456 ' HG2' ' HG2' ' A' ' 181' ' ' LYS . 36.0 tt0 -94.21 119.54 33.17 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.156 -175.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -128.94 153.32 80.13 Favored Pre-proline 0 C--O 1.237 0.426 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.209 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.37 146.42 97.24 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.303 2.669 . . . . 0.0 112.645 177.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.401 HD11 ' HB2' ' A' ' 182' ' ' ALA . 76.9 mt -94.28 118.61 40.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.658 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.38 -46.52 15.89 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.808 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 27.3 m -140.64 150.29 43.37 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.177 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.415 ' HA ' HG22 ' A' ' 221' ' ' ILE . 30.9 m -128.19 144.13 38.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.521 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -140.34 102.54 4.37 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.281 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -70.8 146.01 50.01 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 . . . . . 0 C--N 1.312 -1.043 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.073 -177.586 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 48.4 tp . . . . . 0 N--CA 1.446 -0.666 0 CA-C-O 120.795 0.331 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 36.8 p -108.21 162.3 14.2 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.675 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 3.8 ptpp? -66.78 151.61 47.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.133 0.492 . . . . 0.0 111.589 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.02 4.3 41.75 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.235 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 88.1 m -80.12 134.9 36.21 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.522 0.201 . . . . 0.0 111.265 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 48.5 mm -93.78 126.29 46.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.863 0.363 . . . . 0.0 110.882 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.415 HG22 ' HA ' ' A' ' 200' ' ' VAL . 47.3 pt -130.73 165.17 31.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.368 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -108.68 129.41 55.35 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 31.5 m -126.82 153.66 36.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.106 0.479 . . . . 0.0 111.167 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -97.64 107.14 19.58 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.243 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 34.3 m -105.35 24.18 2.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.939 0.876 . . . . 0.0 110.255 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 238' ' ' ALA . 23.6 t -86.27 -23.5 26.33 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.395 175.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -60.68 -40.35 91.82 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.231 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.508 HD22 ' H ' ' A' ' 228' ' ' LEU . 2.3 pt? -98.11 -1.33 42.59 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.904 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.452 ' HA3' ' HB1' ' A' ' 238' ' ' ALA . . . -84.64 45.58 3.53 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.732 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 79.9 mt -82.77 -73.96 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.155 0.503 . . . . 0.0 110.877 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.04 11.15 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.426 0.631 . . . . 0.0 110.367 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 36.8 p -64.17 -38.56 91.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.474 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.631 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . -143.2 58.98 1.41 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.297 177.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 25.5 m 60.94 10.54 2.83 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.645 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 79.65 2.08 87.6 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.245 -0.503 . . . . 0.0 113.149 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.631 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 19.6 ptpt -71.51 -20.74 62.02 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -176.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 32.6 pt -81.65 -4.42 7.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 226' ' ' SER . . . -73.47 108.5 6.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.842 -178.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -169.35 -175.28 2.18 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -108.5 126.63 8.28 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -128.6 157.09 42.23 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 117.256 0.528 . . . . 0.0 111.748 -175.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -102.64 133.9 46.88 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.79 176.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -129.77 155.0 46.65 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.933 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -100.47 124.87 46.56 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.112 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 90.9 mt -76.71 125.77 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 CA-C-O 120.918 0.389 . . . . 0.0 110.934 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 4.3 t -132.35 94.56 3.46 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 174.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -81.21 117.16 21.5 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.65 -176.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -131.22 71.6 81.82 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.551 177.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.572 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 66.7 Cg_endo -71.78 -19.44 27.45 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.027 1.818 . . . . 0.0 112.461 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -86.92 -24.58 24.76 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.963 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -101.78 -58.09 1.95 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.921 0.391 . . . . 0.0 110.904 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -84.73 -39.27 18.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.414 0.625 . . . . 0.0 110.518 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 103.77 -9.31 51.73 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.171 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 70.2 m -135.93 169.23 17.92 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.783 0.325 . . . . 0.0 110.936 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 86.2 t -86.95 119.91 35.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 174.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -115.53 150.8 35.98 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 120.868 0.366 . . . . 0.0 111.045 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -121.63 140.96 51.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.4 p -119.12 137.48 52.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 120.697 0.284 . . . . 0.0 110.453 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 60.6 tp -74.88 124.29 26.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.841 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.85 91.31 8.61 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.268 2.047 0 CA-C-O 117.68 -1.152 . . . . 0.0 110.666 -175.247 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 56.1 t80 . . . . . 0 C--O 1.223 -0.339 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -69.3 90.77 0.51 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.45 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 41.0 ttmt -154.28 140.47 18.5 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.978 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -128.95 158.11 39.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.375 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -84.55 106.14 15.9 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 58.1 t -104.17 125.37 58.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.475 0.655 . . . . 0.0 112.504 -172.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 94.0 m -104.48 126.87 51.97 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.406 ' HD1' HD13 ' A' ' 259' ' ' LEU . 80.9 m-70 -103.47 107.97 57.73 Favored Pre-proline 0 C--N 1.315 -0.93 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.18 -20.22 56.36 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 122.626 2.217 . . . . 0.0 112.158 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 70.1 m -63.68 -40.89 97.93 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.217 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.402 ' HB2' HG11 ' A' ' 191' ' ' VAL . 26.4 mt -107.74 -15.35 14.59 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.51 -178.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 67.2 t30 60.35 52.87 4.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.686 -175.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.402 HG11 ' HB2' ' A' ' 189' ' ' LEU . 12.2 p -135.24 143.39 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.667 -177.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 95.5 m -105.6 116.45 31.97 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.078 0.466 . . . . 0.0 110.249 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 63.7 t -131.19 129.9 63.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.144 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.45 ' HG2' ' HG2' ' A' ' 181' ' ' LYS . 48.3 tt0 -77.99 121.23 23.94 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.459 HD12 ' HD2' ' A' ' 196' ' ' PRO . 18.5 tp -126.86 141.2 39.8 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.216 -171.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.459 ' HD2' HD12 ' A' ' 195' ' ' LEU . 53.7 Cg_endo -67.88 151.48 78.19 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.75 2.3 . . . . 0.0 112.604 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 83.1 mt -97.12 118.2 43.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.231 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.2 mp -73.2 -43.79 60.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.147 0.499 . . . . 0.0 110.781 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 87.1 p -157.07 161.96 39.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.597 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.98 138.74 51.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.621 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -124.03 127.71 48.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.661 -177.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -90.08 125.2 35.34 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 9.1 p30 . . . . . 0 C--N 1.313 -1.004 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.444 179.456 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 14.9 t -131.28 174.44 10.05 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 120.786 0.327 . . . . 0.0 110.418 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -73.47 152.3 40.78 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.532 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.81 8.5 48.34 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.497 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 86.9 m -82.83 140.0 33.18 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 51.2 mm -102.17 127.36 55.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 O-C-N 121.919 -0.488 . . . . 0.0 111.093 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.433 HD12 HD12 ' A' ' 245' ' ' ILE . 43.0 pt -124.67 157.27 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.349 177.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -109.7 126.29 53.55 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 33.6 m -128.35 158.88 40.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 120.985 0.421 . . . . 0.0 110.954 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -89.94 107.09 18.91 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 43.6 t -90.92 78.76 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 30.0 t -167.76 -46.78 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.308 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -75.0 -4.59 39.22 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.416 ' HG ' ' H ' ' A' ' 230' ' ' ILE . 2.6 pt? -63.32 -15.56 57.71 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.893 0.378 . . . . 0.0 111.005 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 92.03 -12.68 68.91 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.933 174.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.416 ' H ' ' HG ' ' A' ' 228' ' ' LEU . 39.8 pt -131.98 153.86 39.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.587 0.708 . . . . 0.0 111.657 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 8.1 p -173.83 125.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 114.281 -1.327 . . . . 0.0 108.357 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 9.2 t -93.27 -10.76 34.43 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.264 0.554 . . . . 0.0 110.877 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.468 ' HB1' HG12 ' A' ' 237' ' ' ILE . . . -94.63 20.34 8.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.189 -177.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 37.0 m 59.59 27.88 17.18 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.004 0.43 . . . . 0.0 111.84 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 82.38 6.17 88.92 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.943 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -61.39 -39.26 90.04 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.056 0.455 . . . . 0.0 110.206 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.468 HG12 ' HB1' ' A' ' 233' ' ' ALA . 22.2 pt -98.12 15.42 3.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.04 -178.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -87.1 105.16 16.98 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.614 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -153.97 175.1 13.79 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.961 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -79.22 113.16 3.6 Favored Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 171.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -125.02 156.77 37.61 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 120.693 0.282 . . . . 0.0 110.407 -173.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -101.7 148.84 24.79 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.406 0.622 . . . . 0.0 112.185 -176.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -134.1 159.63 40.25 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.137 -177.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -99.31 127.73 45.35 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.183 0.516 . . . . 0.0 111.404 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.497 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 47.5 mm -76.22 125.62 36.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.341 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.7 t -129.61 101.91 6.13 Favored 'General case' 0 N--CA 1.425 -1.698 0 O-C-N 124.401 1.063 . . . . 0.0 108.679 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -76.32 121.07 22.44 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.4 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -129.78 71.33 82.16 Favored Pre-proline 0 C--N 1.314 -0.935 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.42 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 74.5 Cg_endo -72.31 -19.82 25.1 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.49 2.127 . . . . 0.0 112.545 -177.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -85.93 -24.08 26.71 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.042 0.449 . . . . 0.0 110.646 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -92.7 -55.3 3.43 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.155 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -105.67 -37.65 6.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.096 0.474 . . . . 0.0 110.664 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 100.91 10.94 41.59 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.817 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 30.6 p -147.04 177.69 8.96 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.491 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 96.4 t -79.58 122.12 34.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.693 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -112.94 150.15 32.24 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.739 -177.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -130.26 142.81 50.53 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 120.942 0.401 . . . . 0.0 110.73 177.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.8 p -123.67 131.42 73.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.94 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.406 HD13 ' HD1' ' A' ' 186' ' ' HIS . 10.1 tt -83.82 126.51 33.01 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.064 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 4.1 pp -92.81 130.03 38.54 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.515 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.27 2.154 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.652 -178.302 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 38.6 t80 . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.445 ' HB3' ' HB ' ' A' ' 197' ' ' ILE . 98.4 mttt -76.23 89.05 3.1 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.698 0.285 . . . . 0.0 111.608 -178.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -124.79 143.99 50.51 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.573 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -137.07 144.28 43.05 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.863 176.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 66.5 t30 -85.7 99.8 11.56 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.7 t -91.68 120.98 41.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.265 0.555 . . . . 0.0 112.14 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 90.4 m -98.23 124.09 42.65 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.542 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -100.65 113.55 65.61 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.541 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.39 -16.51 51.56 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.647 2.231 . . . . 0.0 111.675 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 41.2 m -65.19 -43.13 92.6 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.264 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.453 ' HB2' HG12 ' A' ' 191' ' ' VAL . 23.8 mt -114.78 -9.17 12.56 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.699 -175.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 60.97 42.34 12.91 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.083 -176.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.453 HG12 ' HB2' ' A' ' 189' ' ' LEU . 10.5 p -129.26 147.7 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 14.8 t -123.77 129.63 51.35 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.307 0.575 . . . . 0.0 110.579 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 58.9 t -134.53 138.5 49.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.209 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 61.0 tt0 -80.51 113.31 18.61 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.302 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 7.6 mp -116.41 155.7 48.22 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.367 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.55 147.03 56.93 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.265 1.977 . . . . 0.0 111.535 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 180' ' ' LYS . 84.7 mt -87.3 107.27 16.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.892 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.87 -42.89 76.41 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.014 0.435 . . . . 0.0 111.088 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 222' ' ' GLU . 18.8 m -141.67 146.09 35.71 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.428 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.7 138.62 44.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.019 0.438 . . . . 0.0 111.379 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.07 147.79 51.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.531 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -73.25 158.85 34.39 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.801 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 . . . . . 0 C--N 1.324 -0.522 0 CA-C-O 120.608 0.242 . . . . 0.0 110.695 179.881 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 C--O 1.238 0.466 0 CA-C-O 121.129 0.49 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 75.1 p -91.68 163.67 14.01 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.531 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -70.57 151.36 45.12 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.894 0.378 . . . . 0.0 110.719 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.12 7.69 30.48 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.135 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.637 ' OG1' ' HB ' ' A' ' 245' ' ' ILE . 50.6 p -79.96 157.69 26.79 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.3 mm -115.78 129.04 72.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.017 0.437 . . . . 0.0 111.672 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.408 ' HB ' HG21 ' A' ' 197' ' ' ILE . 46.1 pt -125.86 158.3 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.999 178.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 199' ' ' SER . 44.1 tt0 -107.52 124.68 50.27 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.283 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.06 156.69 40.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.106 0.479 . . . . 0.0 110.951 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -100.64 113.49 26.38 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.338 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 22.3 t -83.96 70.6 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 18.7 m -159.78 -22.56 0.07 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.707 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.41 8.34 11.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.669 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.44 -22.26 65.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.049 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 95.73 -9.07 68.63 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.748 -0.66 . . . . 0.0 113.281 178.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 48.8 mm -115.8 135.52 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 CA-C-O 122.258 1.028 . . . . 0.0 112.515 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 4.7 m -112.46 118.22 57.24 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.475 0 CA-C-N 113.067 -1.879 . . . . 0.0 108.867 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.463 ' O ' ' HB3' ' A' ' 233' ' ' ALA . 61.1 p -68.48 -41.77 79.65 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.661 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 232' ' ' THR . . . 163.49 -39.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.079 0.952 . . . . 0.0 110.41 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 18.9 m -137.83 12.45 2.91 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.02 -176.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.35 50.67 54.7 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 119.724 -1.227 . . . . 0.0 110.74 -176.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -57.22 -37.76 72.72 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 123.417 0.687 . . . . 0.0 110.332 -174.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 11.8 pt -118.66 19.19 6.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.814 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -81.17 107.71 14.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.82 0.343 . . . . 0.0 111.441 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 -159.34 169.43 24.03 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.568 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -94.05 119.14 5.94 Favored Glycine 0 N--CA 1.437 -1.241 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 172.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.427 ' CB ' HD12 ' A' ' 259' ' ' LEU . 37.3 mmt180 -127.86 164.05 23.08 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.953 0.406 . . . . 0.0 111.419 -174.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.539 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 96.6 m-85 -104.09 140.73 37.36 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.148 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -125.07 148.57 48.45 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.051 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 219' ' ' THR . 37.0 tt0 -98.68 125.69 44.06 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.195 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.637 ' HB ' ' OG1' ' A' ' 219' ' ' THR . 90.8 mt -80.75 127.77 39.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.048 0.452 . . . . 0.0 111.066 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 4.8 t -135.57 102.6 5.17 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.811 176.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -78.63 116.92 19.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.612 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -131.53 73.98 78.87 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.869 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.93 -23.14 41.21 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.285 1.99 . . . . 0.0 112.179 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -80.42 -12.55 59.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.333 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -113.1 -57.7 2.25 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.128 0.49 . . . . 0.0 111.001 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.476 ' HB2' HD22 ' A' ' 256' ' ' ASN . 26.9 m-20 -96.86 -27.6 14.61 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.881 -176.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 80.5 16.66 75.31 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.944 -178.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 48.5 t -155.48 165.3 37.01 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 96.1 t -81.06 121.95 35.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.476 HD22 ' HB2' ' A' ' 252' ' ' ASP . 48.1 m-80 -113.14 152.7 29.31 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 120.838 0.352 . . . . 0.0 111.257 -174.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -128.86 131.22 47.64 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.16 126.1 58.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.134 0.492 . . . . 0.0 109.908 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.427 HD12 ' CB ' ' A' ' 241' ' ' ARG . 51.5 tp -75.28 129.13 36.92 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.805 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 242' ' ' TYR . 3.0 pp -100.99 127.78 47.33 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 C--O 1.262 1.739 0 CA-C-O 117.951 -1.023 . . . . 0.0 111.065 -178.579 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 69.5 t80 . . . . . 0 N--CA 1.446 -0.671 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.467 ' HB3' ' HB ' ' A' ' 197' ' ' ILE . 56.3 mtmt -73.4 80.74 1.4 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.048 0.451 . . . . 0.0 111.92 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.436 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 84.8 tttt -155.72 135.2 12.44 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -141.96 160.54 40.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.97 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 17.8 m120 -80.9 103.56 10.82 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 64.1 t -85.68 122.06 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 121.338 0.59 . . . . 0.0 110.798 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.1 m -102.96 125.67 49.82 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.279 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -103.99 105.88 50.54 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.56 -32.39 79.76 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.465 2.11 . . . . 0.0 113.209 -176.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 87.9 m -67.22 -41.81 85.09 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.995 0.426 . . . . 0.0 110.872 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.403 ' HB2' HG11 ' A' ' 191' ' ' VAL . 41.7 mt -88.13 -20.66 25.35 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.414 0.626 . . . . 0.0 109.326 -178.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.4 t30 60.03 50.73 6.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.654 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.403 HG11 ' HB2' ' A' ' 189' ' ' LEU . 9.9 p -139.97 147.67 23.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.658 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 60.0 m -116.97 119.26 34.77 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 65.6 t -128.94 127.95 66.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 46.1 tt0 -78.2 118.98 20.94 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 91.7 mt -126.19 149.74 67.71 Favored Pre-proline 0 C--N 1.312 -1.022 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.28 -176.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.48 146.2 55.05 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.012 1.808 . . . . 0.0 110.919 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' A' ' 180' ' ' LYS . 80.7 mt -91.47 117.77 35.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.66 -43.54 80.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.14 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 67.9 m -152.19 149.66 28.98 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.528 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 36.0 m -116.52 142.24 30.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -130.94 142.7 50.38 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.406 0.622 . . . . 0.0 110.827 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -71.9 134.65 46.16 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.981 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 9.6 p30 . . . . . 0 C--N 1.312 -1.039 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.863 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 N--CA 1.446 -0.629 0 CA-C-O 121.16 0.505 . . . . 0.0 111.681 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 74.7 p -127.14 -172.51 2.67 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.455 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.491 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 18.2 ptpt -50.59 150.83 2.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.275 0.559 . . . . 0.0 112.409 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 114.99 6.11 19.2 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.804 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 244' ' ' GLN . 56.9 m -71.6 138.92 49.1 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.5 mm -92.37 125.69 44.96 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.717 0 CA-C-O 120.522 0.201 . . . . 0.0 110.502 -176.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 47.3 pt -133.54 160.12 42.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 120.961 0.41 . . . . 0.0 111.2 177.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -107.32 126.96 53.11 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.455 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.33 153.16 30.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.145 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -102.61 111.12 23.29 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.295 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 46.6 t -78.71 79.39 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 32.7 t -174.71 -27.55 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.949 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.31 5.11 9.2 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.291 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.65 -38.58 88.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.768 0.318 . . . . 0.0 110.677 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 83.39 7.01 87.11 Favored Glycine 0 CA--C 1.509 -0.325 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.531 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 49.3 pt -107.93 0.27 9.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 120.6 0.238 . . . . 0.0 110.822 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 39.7 t 62.74 96.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.903 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 14.0 m -85.08 101.13 12.18 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.982 -175.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.532 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . 50.08 52.72 14.16 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.69 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 41.8 m 64.13 10.12 5.23 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.293 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 80.98 5.63 90.01 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.991 -0.623 . . . . 0.0 113.184 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 65.3 pttt -67.12 -24.22 65.89 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.211 0.529 . . . . 0.0 111.043 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 13.0 pt -110.5 19.76 6.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.37 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -78.0 105.68 9.37 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.168 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -145.11 158.14 43.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.888 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -81.25 132.28 11.07 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 175.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -128.5 172.42 11.16 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.915 0.388 . . . . 0.0 110.804 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -101.35 140.07 36.14 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.104 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -135.78 159.2 42.38 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.28 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 219' ' ' THR . 49.0 mt-30 -113.81 136.26 53.06 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.406 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 89.5 mt -79.85 124.19 37.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.491 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 4.9 t -124.72 92.45 3.65 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 122.12 0.962 . . . . 0.0 108.72 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . 0.425 ' C ' ' HD3' ' A' ' 249' ' ' PRO . 20.1 p-10 -74.48 118.94 18.01 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.586 -177.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -130.22 67.87 80.41 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.88 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' A' ' 247' ' ' ASN . 6.5 Cg_exo -77.35 -23.06 10.46 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.139 1.893 . . . . 0.0 109.99 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -67.9 -36.96 81.1 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.792 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -107.22 -58.09 1.99 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.421 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -72.27 -39.78 68.12 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.327 0.584 . . . . 0.0 110.854 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 100.77 7.24 51.21 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.404 -0.817 . . . . 0.0 112.399 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 39.4 t -152.44 164.71 36.99 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.781 0.324 . . . . 0.0 111.165 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 86.9 t -80.63 123.78 37.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -117.61 152.88 34.26 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.689 -174.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -124.41 145.68 49.34 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.5 p -121.09 131.94 71.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.043 0.449 . . . . 0.0 110.63 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.4 tt -100.86 128.35 46.94 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.251 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 2.7 pp -100.8 150.47 22.77 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.076 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.261 1.699 0 CA-C-O 118.102 -0.951 . . . . 0.0 111.037 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 . . . . . 0 N--CA 1.445 -0.714 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 64.19 43.72 4.79 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 122.284 1.04 . . . . 0.0 109.299 -170.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.525 ' HD3' ' HG2' ' A' ' 194' ' ' GLN . 4.0 tmmm? -124.26 133.69 53.43 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 113.597 -1.638 . . . . 0.0 107.561 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -135.7 159.79 40.54 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.221 0.534 . . . . 0.0 112.132 -175.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 58.2 t30 -87.22 105.68 17.38 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.92 119.02 41.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.441 0.639 . . . . 0.0 111.693 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 86.6 m -105.27 126.26 51.9 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.082 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -105.52 108.92 62.54 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 40.4 Cg_endo -66.69 -30.49 41.77 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 122.017 1.811 . . . . 0.0 112.576 -178.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 88.6 m -65.57 -43.37 90.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.283 0.563 . . . . 0.0 111.03 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.412 ' HB2' HG12 ' A' ' 191' ' ' VAL . 36.1 mt -96.17 -16.96 21.17 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.748 -177.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.4 t30 60.66 52.58 4.39 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.613 -176.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.412 HG12 ' HB2' ' A' ' 189' ' ' LEU . 10.2 p -138.04 137.25 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.002 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 9.3 t -115.94 116.86 28.68 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.529 0.681 . . . . 0.0 110.181 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 64.3 t -129.11 129.3 67.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.182 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.525 ' HG2' ' HD3' ' A' ' 181' ' ' LYS . 33.0 tt0 -77.38 124.29 27.67 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.482 HD13 ' HD2' ' A' ' 196' ' ' PRO . 25.2 tp -142.7 139.23 16.94 Favored Pre-proline 0 C--N 1.317 -0.848 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.767 -173.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.482 ' HD2' HD13 ' A' ' 195' ' ' LEU . 40.9 Cg_endo -67.87 147.24 74.3 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 121.882 1.721 . . . . 0.0 109.873 173.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 79.1 mt -84.48 124.5 39.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 120.918 0.39 . . . . 0.0 111.565 -175.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.65 -40.51 84.51 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.219 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 33.4 t -159.57 150.85 19.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 30.7 m -126.21 148.22 30.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.906 0.384 . . . . 0.0 110.932 -178.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -116.31 117.81 31.01 Favored 'General case' 0 C--O 1.253 1.283 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 174.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.81 141.07 54.15 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 124.475 1.109 . . . . 0.0 111.292 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 . . . . . 0 C--O 1.233 0.208 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.472 -178.647 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 N--CA 1.444 -0.76 0 CA-C-O 121.649 0.738 . . . . 0.0 112.223 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 57.1 m -124.73 151.3 45.22 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.818 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.441 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 8.3 ptpp? -43.88 151.24 0.22 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 113.5 4.38 23.42 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.766 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.563 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 88.6 m -78.38 136.75 37.74 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.5 mm -100.82 128.56 52.84 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.495 HD11 HD11 ' A' ' 245' ' ' ILE . 46.8 pt -126.86 162.44 31.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -99.62 121.96 41.96 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.774 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 28.5 m -129.81 155.04 41.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 O-C-N 123.386 0.429 . . . . 0.0 110.519 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.422 ' OD1' HD21 ' A' ' 195' ' ' LEU . 16.5 p-10 -101.94 116.85 33.6 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.375 0.607 . . . . 0.0 110.961 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.52 ' HB ' HH11 ' A' ' 241' ' ' ARG . 53.0 t -109.76 87.69 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 38.7 t -118.83 -79.79 0.6 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.038 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -99.74 -30.13 12.25 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.021 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 91.7 mt 63.73 23.56 13.53 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.14 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 92.69 -8.3 76.8 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 121.016 -0.611 . . . . 0.0 113.228 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.8 pt -129.19 169.12 21.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.818 0.309 . . . . 0.0 110.607 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 15.9 m -90.3 89.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-O 121.712 0.768 . . . . 0.0 110.075 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 5.1 t -80.99 -51.47 8.49 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.747 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.446 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . -170.42 53.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.641 0.258 . . . . 0.0 111.636 -177.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 19.9 m 58.52 20.01 7.14 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.096 177.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.89 21.59 76.75 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.082 -0.58 . . . . 0.0 113.545 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 19.2 ptpt -69.81 -18.94 63.49 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.622 0.711 . . . . 0.0 111.738 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 28.9 pt -96.26 13.33 3.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.136 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -72.07 107.2 4.65 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.234 0.54 . . . . 0.0 112.195 -177.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -143.99 144.13 31.53 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.307 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -74.76 125.73 8.59 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.52 HH11 ' HB ' ' A' ' 225' ' ' VAL . 85.5 mtt85 -128.46 165.46 20.64 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.917 0.358 . . . . 0.0 111.185 -175.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.417 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 99.5 m-85 -101.03 136.08 41.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.542 -177.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -123.36 148.08 46.41 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.093 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -97.19 125.33 41.65 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.718 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.563 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 46.5 mm -83.11 122.38 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.918 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.018 177.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.441 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 1.3 t -128.64 86.86 2.5 Favored 'General case' 0 N--CA 1.428 -1.544 0 O-C-N 124.339 1.024 . . . . 0.0 108.78 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -80.5 115.87 20.25 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.339 0.59 . . . . 0.0 110.749 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -131.04 73.36 81.01 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.434 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.487 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 43.5 Cg_endo -66.73 -22.76 49.48 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.811 1.674 . . . . 0.0 110.673 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -69.1 -37.57 78.47 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.284 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' ASN . . . . . 0.433 ' C ' HD21 ' A' ' 251' ' ' ASN . 0.2 OUTLIER -92.72 -55.9 3.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.262 -175.043 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -100.44 -32.31 10.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.194 0.521 . . . . 0.0 110.966 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 95.6 -4.95 66.81 Favored Glycine 0 C--N 1.315 -0.593 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.657 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 85.9 m -131.22 167.3 19.42 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.773 0.321 . . . . 0.0 110.77 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 87.5 t -80.74 121.37 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -108.47 146.5 33.06 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.578 -174.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -137.82 146.57 43.66 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.449 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.3 p -132.32 136.38 56.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.431 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.437 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 56.4 tp -73.05 130.53 40.51 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.098 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 242' ' ' TYR . 4.0 pp -102.82 144.46 31.12 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.861 176.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 26.5 m . . . . . 0 C--O 1.268 2.042 0 CA-C-O 117.905 -1.045 . . . . 0.0 111.043 -179.49 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 20.7 t80 . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -76.26 92.56 3.31 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 120.943 0.402 . . . . 0.0 110.995 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.441 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 22.5 ttmm -144.83 137.92 26.69 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.918 -177.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -139.07 154.78 48.23 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.787 0.327 . . . . 0.0 111.345 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -88.57 111.59 22.06 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.012 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 65.1 t -99.12 125.8 52.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.248 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.0 m -104.4 127.97 52.17 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.693 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -104.48 110.6 64.52 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -55.94 -36.36 95.65 Favored 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 123.448 2.766 . . . . 0.0 113.562 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 87.0 m -66.07 -41.27 90.97 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.127 0.489 . . . . 0.0 111.392 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.408 ' HB2' HG13 ' A' ' 191' ' ' VAL . 40.0 mt -94.42 -18.66 21.32 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.403 -175.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 58.77 44.14 17.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.141 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 189' ' ' LEU . 9.9 p -134.23 144.49 35.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.75 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 86.2 m -113.73 120.25 40.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.173 0.511 . . . . 0.0 109.861 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 10.9 m -126.14 143.78 38.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.636 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.441 ' HG2' ' HG2' ' A' ' 181' ' ' LYS . 59.0 tt0 -97.76 122.37 40.77 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.603 -175.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -128.73 156.87 76.88 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.494 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.61 149.68 68.18 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.28 1.987 . . . . 0.0 110.674 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 79.3 mt -84.78 112.16 21.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.525 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 223' ' ' VAL . 3.9 mm? -68.0 -42.13 81.18 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.221 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' A' ' 222' ' ' GLU . 37.3 t -150.91 148.6 28.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.222 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.03 140.85 45.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.999 0.428 . . . . 0.0 111.275 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -133.8 131.91 39.85 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -111.01 144.77 39.59 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.223 177.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--N 1.315 -0.914 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.077 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 78.8 mt . . . . . 0 CA--C 1.495 -1.162 0 CA-C-O 121.752 0.786 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.2 p -116.43 -178.1 3.34 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.937 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.455 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 18.0 ptpt -60.68 144.91 51.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.286 0.565 . . . . 0.0 112.123 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 112.13 5.54 24.95 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.184 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.641 ' OG1' ' HB ' ' A' ' 245' ' ' ILE . 1.3 p -86.09 158.14 19.88 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 122.211 0.204 . . . . 0.0 111.239 178.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 48.4 mm -114.56 129.8 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -174.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.4 ' CG2' HD11 ' A' ' 245' ' ' ILE . 44.9 pt -132.65 162.94 39.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.025 0.44 . . . . 0.0 111.09 176.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 199' ' ' SER . 43.9 tt0 -112.86 131.39 55.73 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.42 ' HA ' HD23 ' A' ' 198' ' ' LEU . 26.8 m -129.08 150.88 35.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.092 0.472 . . . . 0.0 110.785 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -103.54 106.1 16.52 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.319 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 7.6 p -84.13 71.22 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-O 122.585 1.183 . . . . 0.0 110.149 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 228' ' ' LEU . 14.9 m -154.37 -37.13 0.09 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.638 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -81.46 20.72 0.85 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.161 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.401 HD13 HG23 ' A' ' 225' ' ' VAL . 98.9 mt -61.33 -39.1 89.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.78 -177.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 174.22 -92.64 0.09 OUTLIER Glycine 0 N--CA 1.428 -1.841 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.617 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 63.9 mt -132.76 -86.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.075 0.464 . . . . 0.0 111.338 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.94 77.1 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.611 0.719 . . . . 0.0 110.759 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 23.9 p -71.14 -60.18 2.37 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.912 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -143.31 49.39 1.43 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.919 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 20.9 t 65.0 12.81 8.2 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.493 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 74.15 11.2 81.82 Favored Glycine 0 C--O 1.225 -0.411 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.859 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -67.66 -33.47 75.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.019 0.914 . . . . 0.0 109.499 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 35.9 pt -86.54 10.57 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.742 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -77.35 107.77 10.01 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -176.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . 0.467 ' O ' HG11 ' A' ' 225' ' ' VAL . 26.7 t90 -170.3 146.95 2.99 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.893 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -72.08 129.96 15.94 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.653 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -130.48 175.04 9.3 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -113.19 147.32 37.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.386 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -138.39 153.17 48.91 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.628 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -102.09 136.0 42.69 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.053 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.641 ' HB ' ' OG1' ' A' ' 219' ' ' THR . 87.3 mt -85.84 126.3 40.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.116 0.484 . . . . 0.0 110.777 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.455 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 3.1 t -127.24 87.83 2.7 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 174.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -68.7 117.22 10.14 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.371 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -128.2 69.62 78.08 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.795 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -84.86 -13.29 6.83 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.569 2.179 . . . . 0.0 111.727 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -68.9 -37.67 79.13 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.095 -177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -115.18 -57.53 2.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.39 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 254' ' ' CYS . 35.9 t70 -67.9 -39.5 83.59 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.345 0.593 . . . . 0.0 109.841 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 89.6 0.11 79.51 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.973 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . 0.476 ' HB2' ' OD2' ' A' ' 252' ' ' ASP . 74.3 m -130.23 164.03 25.43 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.847 0.356 . . . . 0.0 111.181 -177.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 62.8 t -82.74 117.19 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -106.74 149.67 27.08 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.433 -176.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -136.35 144.36 44.57 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.12 131.06 70.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 121.146 0.498 . . . . 0.0 110.664 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.7 tt -99.51 125.36 45.26 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.672 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.434 ' O ' HD11 ' A' ' 260' ' ' LEU . 3.2 pp -92.9 144.52 25.18 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.244 0.545 . . . . 0.0 111.805 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.269 2.083 0 CA-C-O 117.729 -1.129 . . . . 0.0 110.442 179.441 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 . . . . . 0 CA--C 1.507 -0.708 0 CA-C-O 120.636 0.255 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -75.98 83.76 2.87 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.213 -177.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -128.24 144.58 51.14 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.956 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -132.69 150.62 52.13 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.646 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -87.88 100.46 12.9 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 192' ' ' THR . 67.3 t -84.21 117.37 29.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.202 -172.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.4 m -100.1 128.37 46.19 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.494 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -103.21 111.77 65.29 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.26 -25.0 57.56 Favored 'Trans proline' 0 N--CA 1.479 0.633 0 C-N-CA 122.986 2.457 . . . . 0.0 114.37 -175.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 39.6 p -66.79 -43.32 84.26 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.498 ' CD1' HG13 ' A' ' 191' ' ' VAL . 0.6 OUTLIER -116.52 -4.44 11.75 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.118 0.485 . . . . 0.0 111.802 -179.192 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.7 t30 59.44 61.59 1.98 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.218 -0.901 . . . . 0.0 113.292 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.498 HG13 ' CD1' ' A' ' 189' ' ' LEU . 3.2 p -138.52 147.77 25.08 Favored 'Isoleucine or valine' 0 C--O 1.248 1.005 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 175.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 15.3 t -127.62 135.88 50.87 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 120.266 -0.573 . . . . 0.0 111.529 -177.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 6.6 m -140.8 147.68 22.56 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.494 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -85.55 123.71 31.28 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.773 0.321 . . . . 0.0 111.582 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -128.08 151.51 76.12 Favored Pre-proline 0 C--O 1.24 0.558 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.314 176.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.91 144.42 47.87 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.365 2.044 . . . . 0.0 111.169 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.419 HG22 ' HB ' ' A' ' 221' ' ' ILE . 73.0 mt -92.24 119.37 39.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.423 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.4 -42.16 68.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.853 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 44.3 m -141.7 144.28 33.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.394 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.9 m -127.35 139.64 51.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.009 0.433 . . . . 0.0 111.683 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.436 ' O ' HG21 ' A' ' 219' ' ' THR . 57.3 mtpt -139.23 132.01 29.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.38 174.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -92.0 160.14 15.39 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 15.8 m120 . . . . . 0 C--N 1.314 -0.966 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.358 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 60.2 tp . . . . . 0 N--CA 1.444 -0.771 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 14.8 t -89.84 148.72 23.02 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.426 ' HE2' ' OG1' ' A' ' 246' ' ' THR . 14.1 ptmm? -74.5 148.16 41.23 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.614 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.72 7.98 49.74 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.591 -176.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.436 HG21 ' O ' ' A' ' 201' ' ' LYS . 79.9 m -71.09 134.33 46.95 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 122.416 0.286 . . . . 0.0 110.623 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.415 HD11 ' HG2' ' A' ' 244' ' ' GLN . 45.5 mm -93.19 124.06 45.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.591 -176.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.419 ' HB ' HG22 ' A' ' 197' ' ' ILE . 47.3 pt -131.71 160.64 42.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.314 0.578 . . . . 0.0 112.027 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -109.3 126.11 53.02 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.326 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 31.6 m -131.13 157.5 43.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.103 0.478 . . . . 0.0 111.281 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -107.02 106.72 17.38 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.439 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 44.9 t -82.39 78.67 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 22.2 t -179.3 -21.7 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.411 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -60.34 -35.42 75.61 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.726 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -53.32 -23.56 9.58 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.901 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 91.42 -12.13 70.17 Favored Glycine 0 C--N 1.329 0.174 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.833 175.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 45.2 pt -122.37 159.25 25.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.134 0.492 . . . . 0.0 110.371 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.35 149.95 31.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.336 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 6.8 t -72.81 -41.92 64.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.252 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.04 91.14 1.25 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.343 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 50.1 m 58.56 23.83 11.3 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 173.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.05 32.98 82.16 Favored Glycine 0 C--O 1.222 -0.602 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.82 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.25 -39.88 88.34 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.424 0.631 . . . . 0.0 110.71 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 15.5 pt -102.05 12.41 7.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.837 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -83.35 106.47 15.14 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.518 -176.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 -166.67 176.8 6.95 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.172 0.989 . . . . 0.0 109.037 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -76.13 125.32 7.72 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -128.36 177.92 6.63 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.118 0.485 . . . . 0.0 111.164 -177.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -120.05 145.88 46.43 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.533 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -135.45 158.43 44.39 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.394 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.415 ' HG2' HD11 ' A' ' 220' ' ' ILE . 78.8 mt-30 -114.26 128.45 56.37 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.694 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 86.2 mt -82.18 127.13 39.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.176 0.512 . . . . 0.0 111.67 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.426 ' OG1' ' HE2' ' A' ' 217' ' ' LYS . 4.0 t -137.72 102.68 4.81 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.275 175.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -75.44 124.84 27.85 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.553 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -128.67 71.32 80.9 Favored Pre-proline 0 N--CA 1.443 -0.8 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.156 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.515 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 54.7 Cg_endo -68.99 -19.6 39.61 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.92 1.747 . . . . 0.0 110.089 178.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -66.6 -37.87 85.81 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.917 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -98.21 -57.1 2.29 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.033 0.444 . . . . 0.0 110.76 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -94.5 -37.33 11.45 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.384 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.515 ' CA ' ' HA ' ' A' ' 249' ' ' PRO . . . 100.73 -4.39 56.36 Favored Glycine 0 C--N 1.312 -0.783 0 C-N-CA 120.657 -0.783 . . . . 0.0 111.55 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 79.9 m -128.04 167.95 16.01 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.806 0.336 . . . . 0.0 110.965 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 81.5 t -80.55 121.03 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -115.95 152.83 32.72 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.935 -173.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -124.63 141.51 52.05 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.0 p -108.69 134.08 51.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.082 0.468 . . . . 0.0 110.549 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 62.0 tp -88.29 123.39 32.84 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.458 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.57 105.5 17.65 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.476 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.278 2.585 0 CA-C-O 117.481 -1.247 . . . . 0.0 110.224 178.485 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 . . . . . 0 CA--C 1.499 -0.993 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 196' ' ' PRO . 3.2 mppt? -80.88 73.06 7.9 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.636 -0.426 . . . . 0.0 109.954 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -123.08 139.02 54.51 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.585 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.464 ' HB2' HD13 ' A' ' 197' ' ' ILE . . . -136.55 148.2 47.45 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.563 176.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -84.74 102.04 12.7 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 58.9 t -93.72 120.34 42.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.312 0.577 . . . . 0.0 111.908 -173.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 90.5 m -112.13 128.71 56.3 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.04 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -104.44 108.39 60.39 Favored Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.55 -27.65 61.59 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 122.535 2.157 . . . . 0.0 113.557 -175.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.3 t -77.77 -27.92 50.45 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.748 0.309 . . . . 0.0 111.695 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.403 ' HB2' HG11 ' A' ' 191' ' ' VAL . 37.4 mt -104.25 -22.02 13.44 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.276 0.56 . . . . 0.0 109.801 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.8 t30 60.21 52.79 4.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.928 -175.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.403 HG11 ' HB2' ' A' ' 189' ' ' LEU . 11.2 p -133.41 137.09 53.76 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.512 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 92.9 m -119.29 124.33 46.4 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.984 0.421 . . . . 0.0 111.042 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 10.3 m -142.95 149.59 18.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.127 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.493 ' C ' HD12 ' A' ' 195' ' ' LEU . 35.3 tt0 -102.89 119.82 39.52 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.85 178.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.493 HD12 ' C ' ' A' ' 194' ' ' GLN . 7.1 mp -128.38 150.59 74.71 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.58 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 180' ' ' LYS . 38.3 Cg_exo -61.37 141.09 91.37 Favored 'Trans proline' 0 C--O 1.24 0.608 0 C-N-CA 122.556 2.17 . . . . 0.0 111.23 175.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.484 HD12 HD11 ' A' ' 221' ' ' ILE . 34.8 mm -91.67 119.85 39.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.193 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 96.6 mt -69.25 -42.19 75.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.597 -177.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.4 t -154.39 149.57 26.99 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.767 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.443 HG13 HG21 ' A' ' 221' ' ' ILE . 32.1 m -128.96 148.09 33.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.45 ' O ' HG21 ' A' ' 219' ' ' THR . 14.5 ptmm? -139.65 149.33 43.6 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -66.75 154.96 39.4 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.351 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 11.7 p30 . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 121.144 0.497 . . . . 0.0 110.986 179.031 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 61.4 tp . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 32.1 p -91.11 168.3 11.73 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -176.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -60.94 153.94 23.68 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.812 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 106.7 10.19 29.24 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -176.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.574 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 87.8 m -71.57 128.5 36.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.438 ' HB ' ' CG ' ' A' ' 201' ' ' LYS . 48.5 mm -90.36 129.03 41.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.762 0.315 . . . . 0.0 110.301 -177.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.484 HD11 HD12 ' A' ' 197' ' ' ILE . 39.0 pt -127.56 154.82 38.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -177.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -102.04 119.32 38.6 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.347 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.31 156.73 40.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.596 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -103.55 108.57 19.89 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.005 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 239' ' ' TRP . 35.2 m -87.58 21.06 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 122.067 0.937 . . . . 0.0 109.288 176.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 21.2 m -105.21 -14.0 15.51 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.561 173.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.85 1.11 55.32 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.287 -174.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.444 HD11 HG12 ' A' ' 230' ' ' ILE . 0.3 OUTLIER -64.35 -31.14 72.22 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.582 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 69.5 31.97 71.26 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.92 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.444 HG12 HD11 ' A' ' 228' ' ' LEU . 42.2 pt -119.39 151.83 21.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 117.214 0.507 . . . . 0.0 110.649 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 27.1 m -121.75 8.35 5.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.694 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 14.6 t -58.66 -18.38 30.28 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.769 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.531 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . -119.26 29.13 7.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.847 0.356 . . . . 0.0 110.553 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 23.0 m 66.75 3.26 2.92 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.637 0.775 . . . . 0.0 112.138 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 81.04 0.71 89.26 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.942 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 19.2 ptpt -70.14 -15.52 62.97 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.122 0.487 . . . . 0.0 111.333 -179.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 33.8 pt -80.93 -4.64 7.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.568 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.16 109.26 2.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.0 0.428 . . . . 0.0 110.149 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . 0.405 ' H ' HG23 ' A' ' 225' ' ' VAL . 5.0 m95 -151.96 176.29 11.64 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.627 -178.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -109.8 112.73 3.43 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 171.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -129.44 161.32 30.64 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 117.118 0.459 . . . . 0.0 111.882 -174.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -102.62 133.81 47.02 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.193 175.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -114.68 162.73 16.41 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.613 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -110.24 128.41 55.49 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.083 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.574 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 89.1 mt -81.85 127.23 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.773 0 CA-C-O 120.969 0.414 . . . . 0.0 111.18 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.622 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 2.7 t -128.17 101.32 6.21 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.166 175.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -78.35 117.81 19.94 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.451 0.643 . . . . 0.0 112.148 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -128.57 72.12 80.72 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.355 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.419 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 56.5 Cg_endo -68.77 -19.55 40.96 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.389 2.059 . . . . 0.0 111.568 -178.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -70.13 -30.63 67.85 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.026 177.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -94.1 -56.49 2.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.316 -177.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -104.39 -28.03 11.6 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' A' ' 249' ' ' PRO . . . 83.43 10.4 82.04 Favored Glycine 0 C--N 1.315 -0.585 0 C-N-CA 120.34 -0.933 . . . . 0.0 111.755 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 83.4 m -135.32 173.48 11.67 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 122.408 0.283 . . . . 0.0 110.263 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 86.3 t -79.56 122.42 34.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.622 ' HB2' ' O ' ' A' ' 246' ' ' THR . 6.3 m120 -103.82 152.09 22.31 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -176.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -136.48 143.88 44.06 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 11.0 p -134.54 140.84 44.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-O 120.903 0.382 . . . . 0.0 110.445 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 63.0 tp -79.04 126.02 30.16 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.463 ' O ' HD12 ' A' ' 260' ' ' LEU . 2.8 pp -67.04 133.96 50.96 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.169 0.509 . . . . 0.0 111.512 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 C--O 1.263 1.777 0 CA-C-O 117.684 -1.151 . . . . 0.0 110.794 179.571 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 46.9 p90 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 121.315 0.579 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -89.49 -9.66 49.2 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.445 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -83.34 131.98 35.03 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -94.68 120.78 35.45 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.174 0.512 . . . . 0.0 111.103 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.409 HD13 ' HB3' ' A' ' 202' ' ' LYS . 4.9 tt -142.12 134.77 27.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.876 -176.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.22 165.72 17.73 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -81.29 -81.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.189 1.926 . . . . 0.0 111.062 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 60.2 ttm -160.86 92.45 0.94 Allowed 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.263 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.53 44.57 94.96 Favored Glycine 0 C--N 1.323 -0.18 0 C-N-CA 120.743 -0.742 . . . . 0.0 113.747 174.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -59.85 157.81 11.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -51.59 -50.91 59.24 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -177.53 173.08 1.71 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 176.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -78.91 58.21 2.32 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.038 0.447 . . . . 0.0 111.678 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -138.37 148.65 44.75 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.293 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -145.93 149.64 34.58 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.472 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -81.33 103.24 10.96 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.6 t -92.65 118.82 39.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.237 0.541 . . . . 0.0 110.604 -176.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.4 m -94.13 122.53 36.75 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.272 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -105.06 108.33 61.03 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.3 -28.0 63.7 Favored 'Trans proline' 0 N--CA 1.471 0.192 0 C-N-CA 122.261 1.974 . . . . 0.0 112.007 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 81.1 m -65.66 -41.69 92.21 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.722 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.447 ' HB2' HG12 ' A' ' 191' ' ' VAL . 33.4 mt -96.05 -19.0 19.77 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.066 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 64.3 t30 61.47 51.32 4.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.424 -175.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.447 HG12 ' HB2' ' A' ' 189' ' ' LEU . 5.9 p -149.92 144.12 17.63 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.912 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 11.4 t -111.6 124.34 52.09 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.423 0.63 . . . . 0.0 109.466 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 67.4 t -131.82 136.53 56.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.249 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -79.91 116.76 20.24 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.04 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 7.5 mp -111.73 150.82 42.83 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.841 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.61 140.21 38.98 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.66 1.574 . . . . 0.0 110.028 174.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 37.5 mm -86.98 114.82 26.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.082 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.28 -42.41 75.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.802 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.4 t -161.77 149.43 14.69 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.349 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 221' ' ' ILE . 32.0 m -119.79 146.62 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -119.97 122.91 42.25 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.409 ' HB3' HD13 ' A' ' 172' ' ' ILE . 20.0 ptpt -52.57 155.2 2.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.638 -1.164 . . . . 0.0 112.585 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -74.38 131.2 80.76 Favored Pre-proline 0 N--CA 1.438 -1.06 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 170.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -59.1 -30.9 94.46 Favored 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 122.547 2.165 . . . . 0.0 114.14 -172.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 25.1 t -108.84 -17.9 13.82 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.129 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 58.18 84.41 0.2 Allowed Pre-proline 0 N--CA 1.472 0.665 0 CA-C-O 121.174 0.511 . . . . 0.0 110.79 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.84 -5.37 16.73 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.359 2.706 . . . . 0.0 114.093 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 75.7 mt -59.13 127.08 30.37 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.396 0.617 . . . . 0.0 111.332 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -90.87 60.52 4.44 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.372 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.3 m 63.08 20.58 12.37 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.464 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -63.29 -40.97 98.86 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.291 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 86.0 mt 56.58 24.11 8.39 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.309 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -105.48 -86.45 1.91 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.014 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.31 162.12 28.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 83.9 mt -72.84 162.65 29.23 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.32 0.581 . . . . 0.0 111.467 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 66.7 p -90.15 166.6 13.3 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.138 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 245' ' ' ILE . 19.2 ptpt -65.37 142.62 58.15 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.873 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.4 1.64 55.61 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.209 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.569 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 85.4 m -66.81 138.12 57.11 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.8 mm -94.38 128.84 45.36 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.046 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.323 -174.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.437 HG21 HG11 ' A' ' 200' ' ' VAL . 47.1 pt -126.1 159.39 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 CA-C-O 120.774 0.321 . . . . 0.0 110.314 176.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -116.8 117.91 31.06 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.69 157.83 43.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.288 0.566 . . . . 0.0 111.635 -177.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -105.17 106.61 17.18 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.438 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 239' ' ' TRP . 7.2 p -83.84 78.26 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 122.43 1.11 . . . . 0.0 110.446 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 22.2 m -158.77 -34.06 0.07 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.058 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -75.47 9.77 2.0 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.216 -176.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.52 -40.68 97.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.131 0.491 . . . . 0.0 109.689 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 79.43 -2.03 73.94 Favored Glycine 0 C--O 1.226 -0.351 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.799 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.8 pt -80.1 -31.24 13.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 122.71 -0.288 . . . . 0.0 111.684 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 20.8 t 48.91 72.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 O-C-N 123.558 0.536 . . . . 0.0 110.643 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 13.5 t -110.96 -8.27 14.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.564 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.683 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . -128.06 31.89 5.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.717 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 19.7 m 59.86 9.79 1.85 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 79.78 3.07 89.04 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.962 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.683 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 65.0 pttt -72.02 -11.37 60.73 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.188 0.518 . . . . 0.0 111.804 -177.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 34.9 pt -95.91 -0.86 10.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.641 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -62.48 112.15 2.34 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 123.354 0.409 . . . . 0.0 111.965 -175.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . 0.489 ' O ' HG12 ' A' ' 225' ' ' VAL . 71.0 t-105 -175.13 146.91 0.88 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.875 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -73.7 120.39 6.88 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -128.6 162.76 26.55 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.912 0.387 . . . . 0.0 111.214 -173.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -102.45 136.28 42.56 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.94 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -127.02 158.3 37.31 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.096 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -105.73 132.31 52.01 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.875 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 217' ' ' LYS . 49.1 mm -79.07 130.28 36.37 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.192 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.541 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 4.4 t -140.09 104.14 4.77 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -80.76 119.75 23.75 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 120.842 0.354 . . . . 0.0 110.748 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -128.09 72.17 79.31 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-O 121.405 0.622 . . . . 0.0 109.381 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.477 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 71.8 Cg_endo -71.53 -17.84 29.8 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.884 2.389 . . . . 0.0 112.964 -176.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -82.2 -21.61 36.36 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.797 0.332 . . . . 0.0 110.803 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -105.67 -56.86 2.12 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.141 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.408 ' CB ' HD22 ' A' ' 256' ' ' ASN . 18.9 m-20 -93.37 -31.08 14.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.936 0.398 . . . . 0.0 111.44 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 82.99 4.85 89.81 Favored Glycine 0 C--N 1.321 -0.281 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.503 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 65.3 m -132.6 174.14 10.59 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.515 0.197 . . . . 0.0 110.935 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 90.6 t -79.48 121.87 33.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' ' 246' ' ' THR . 5.3 m120 -110.13 152.28 26.21 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.612 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -134.38 144.83 48.44 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.508 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.68 135.94 61.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.006 0.431 . . . . 0.0 110.215 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 64.7 tp -95.57 127.06 41.29 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.23 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 2.1 pp -90.31 136.71 32.88 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.405 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.266 1.957 0 CA-C-O 117.702 -1.142 . . . . 0.0 111.011 -178.106 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 44.2 p90 . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 120.824 0.345 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -63.9 -39.64 94.66 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.644 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -80.41 -28.91 37.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.25 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 25.0 t80 71.74 -54.93 0.67 Allowed 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.432 1.093 . . . . 0.0 110.605 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.453 HG12 ' HB3' ' A' ' 202' ' ' LYS . 5.8 tp -67.89 136.43 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 49.4 ptt85 -135.91 145.61 53.42 Favored Pre-proline 0 N--CA 1.436 -1.174 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.499 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -69.34 -67.43 0.03 OUTLIER 'Trans proline' 0 CA--C 1.512 -0.587 0 C-N-CA 121.944 1.762 . . . . 0.0 110.129 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.415 ' HE2' ' O ' ' A' ' 212' ' ' LEU . 95.3 mmm -135.83 -4.25 2.24 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.257 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 66.87 36.29 90.86 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.2 pp -82.49 -165.7 1.1 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -173.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -54.84 -44.54 74.02 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -173.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -138.96 167.3 22.35 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -174.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -97.39 34.71 1.75 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.069 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -118.2 144.83 45.42 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.15 0.5 . . . . 0.0 111.114 -176.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -129.44 152.22 49.22 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.026 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -81.53 99.57 8.88 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.3 t -89.68 126.05 42.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.211 -174.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.9 m -114.87 128.3 56.21 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.576 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.51 ' NE2' HD21 ' A' ' 228' ' ' LEU . 30.9 m170 -104.46 117.96 57.85 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.04 -24.89 77.1 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 122.829 2.353 . . . . 0.0 113.492 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 11.6 t -79.67 -23.53 42.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.834 0.35 . . . . 0.0 111.628 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.401 ' HB2' HG12 ' A' ' 191' ' ' VAL . 40.5 mt -103.55 -24.32 13.43 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 59.06 46.95 12.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.513 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' A' ' 189' ' ' LEU . 8.9 p -133.49 145.27 33.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.174 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 87.9 m -116.42 119.43 35.62 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 228' ' ' LEU . 61.0 t -133.73 138.84 49.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -87.57 118.25 26.92 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.881 0.372 . . . . 0.0 111.037 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.71 153.5 77.81 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.195 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.85 146.86 54.52 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.334 2.023 . . . . 0.0 111.26 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 80.6 mt -89.46 116.51 31.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.323 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 95.8 mt -71.78 -42.18 67.45 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.503 ' HB2' ' HB3' ' A' ' 222' ' ' GLU . 16.6 m -140.92 147.19 38.46 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 26.7 m -125.97 146.09 32.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.328 0.585 . . . . 0.0 111.508 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -127.65 106.91 9.47 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.094 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.453 ' HB3' HG12 ' A' ' 172' ' ' ILE . 18.7 ptpt -56.6 156.91 5.72 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.44 0.462 . . . . 0.0 111.661 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 206' ' ' ASN . 3.3 m-20 -71.55 119.74 75.75 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.44 -40.37 5.92 Favored 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.343 2.028 . . . . 0.0 114.048 -174.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 17.6 m -154.74 22.75 0.45 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.826 0.346 . . . . 0.0 111.043 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 203' ' ' ASN . 1.9 m-20 -71.38 133.34 85.25 Favored Pre-proline 0 C--N 1.318 -0.774 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.16 141.31 68.92 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 122.284 1.989 . . . . 0.0 112.113 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 75.3 mt -107.35 119.65 39.98 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.624 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -113.03 -18.27 12.23 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.277 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.5 p -89.87 112.99 24.52 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 121.03 0.443 . . . . 0.0 111.53 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -70.49 -39.72 74.03 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.177 0.513 . . . . 0.0 110.011 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.44 HD13 ' N ' ' A' ' 213' ' ' GLY . 4.2 pp -62.46 -38.23 88.99 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.916 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.44 ' N ' HD13 ' A' ' 212' ' ' LEU . . . -119.45 126.94 6.96 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.767 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.54 -25.53 24.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 120.704 0.288 . . . . 0.0 111.532 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 61.6 tp -105.41 125.14 50.65 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.473 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 24.2 p -95.75 159.18 15.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.863 0.363 . . . . 0.0 111.23 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -61.7 152.15 31.82 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.049 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 109.69 9.76 24.33 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.581 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 21.2 m -73.08 142.12 47.58 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.5 mm -100.2 127.84 52.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.961 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.405 HD12 HD11 ' A' ' 245' ' ' ILE . 45.5 pt -127.53 163.16 31.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.591 0.234 . . . . 0.0 110.598 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 199' ' ' SER . 8.4 tm-20 -124.43 125.65 44.62 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.035 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.3 m -131.15 141.86 44.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.145 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.562 ' HA ' ' HA2' ' A' ' 240' ' ' GLY . 50.8 t-20 -114.82 107.1 14.98 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.967 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.705 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 7.8 p -175.03 -56.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.902 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.411 ' N ' HG12 ' A' ' 225' ' ' VAL . 10.8 t 72.76 -56.16 0.66 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.396 0.678 . . . . 0.0 111.268 -177.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' A' ' 230' ' ' ILE . 1.6 m-20 -63.01 -21.95 66.51 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.344 0.258 . . . . 0.0 111.678 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.51 HD21 ' NE2' ' A' ' 186' ' ' HIS . 96.7 mt 67.23 18.29 10.32 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 92.68 -5.29 76.73 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.63 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.447 ' O ' ' HB3' ' A' ' 227' ' ' ASP . 48.2 pt -107.23 170.46 2.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 231' ' ' VAL . 7.7 p -96.42 90.41 2.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.693 0.758 . . . . 0.0 111.929 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 10.6 t -101.37 -34.96 9.39 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 174.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.525 ' HB2' HG12 ' A' ' 237' ' ' ILE . . . -138.44 9.87 2.71 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.736 174.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 9.3 t 63.37 31.52 15.13 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.155 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 85.13 3.44 87.45 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.083 -0.58 . . . . 0.0 113.192 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -65.12 -39.8 93.59 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 121.25 0.548 . . . . 0.0 111.205 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.525 HG12 ' HB2' ' A' ' 233' ' ' ALA . 30.4 pt -93.04 18.88 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.468 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.705 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -54.01 120.59 6.59 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -153.07 150.68 29.39 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.886 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 224' ' ' ASN . . . -96.22 116.01 5.33 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.847 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -129.3 171.97 11.95 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.735 0.302 . . . . 0.0 111.151 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -102.2 140.48 36.43 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.282 0.563 . . . . 0.0 111.214 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -129.48 154.49 46.94 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.36 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -101.17 133.15 46.15 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.581 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 47.9 mm -80.39 124.64 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.709 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 12.6 p -119.42 76.29 1.12 Allowed 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.082 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -68.66 121.8 17.2 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.352 0.596 . . . . 0.0 110.964 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -128.95 71.29 81.79 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.275 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -72.19 -25.33 19.05 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 121.4 1.4 . . . . 0.0 112.216 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -74.05 -33.02 63.56 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.062 0.458 . . . . 0.0 110.609 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -96.9 -57.1 2.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.937 -176.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -95.0 -29.91 14.38 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.77 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 76.62 18.56 78.9 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.375 -0.917 . . . . 0.0 110.875 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 49.7 t -149.18 160.71 43.12 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.375 -0.413 . . . . 0.0 109.96 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 85.3 t -80.39 126.85 39.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.946 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 246' ' ' THR . 42.3 m-80 -110.46 153.74 24.6 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.19 148.54 35.12 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.703 0.287 . . . . 0.0 110.65 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.59 130.64 56.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 8.9 tt -75.46 127.96 34.27 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.102 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.458 ' O ' HD13 ' A' ' 260' ' ' LEU . 4.2 pp -84.94 132.5 34.35 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.133 0.492 . . . . 0.0 111.229 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 10.6 m . . . . . 0 C--O 1.279 2.641 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.924 179.646 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.712 0.291 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -63.31 -43.85 96.67 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.712 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 53.08 40.2 30.81 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 123.667 0.604 . . . . 0.0 111.241 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -81.11 50.34 1.39 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.789 0.804 . . . . 0.0 111.099 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.74 116.68 44.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -135.48 87.49 26.88 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -60.65 -33.03 93.86 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 122.748 2.299 . . . . 0.0 110.347 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 53.2 tpp -163.05 -37.91 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.708 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 142.73 86.94 0.09 OUTLIER Glycine 0 N--CA 1.44 -1.082 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.6 pp -88.42 111.52 21.87 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.658 0.742 . . . . 0.0 111.756 -176.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.431 ' HG3' ' CD2' ' A' ' 179' ' ' TYR . 17.0 ptp180 -69.04 -30.29 68.62 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.982 176.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.431 ' CD2' ' HG3' ' A' ' 178' ' ' ARG . 89.8 m-85 -140.0 154.62 47.2 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.828 176.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -79.47 87.82 5.07 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -156.91 137.28 12.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.489 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -145.86 157.07 43.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.963 0.411 . . . . 0.0 111.392 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 56.8 t30 -83.5 99.46 10.14 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 257' ' ' ALA . 53.1 t -92.65 118.93 39.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.279 0.562 . . . . 0.0 112.067 -172.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 89.6 m -94.31 124.18 38.17 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.259 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.411 ' CE1' HD21 ' A' ' 228' ' ' LEU . 64.1 m80 -104.84 111.18 65.22 Favored Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -62.93 -28.2 75.1 Favored 'Trans proline' 0 N--CA 1.475 0.407 0 C-N-CA 122.543 2.162 . . . . 0.0 112.621 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.9 t -70.99 -31.88 68.54 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.309 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.469 ' HB2' HG11 ' A' ' 191' ' ' VAL . 43.6 mt -98.53 -22.36 16.03 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.3 t30 60.47 44.89 11.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.99 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.469 HG11 ' HB2' ' A' ' 189' ' ' LEU . 4.0 p -145.75 150.5 15.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.984 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.588 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 14.4 t -121.87 128.79 52.0 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 121.343 0.592 . . . . 0.0 110.175 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.83 138.24 52.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 63.0 tt0 -81.18 118.36 22.49 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.413 HD12 ' C ' ' A' ' 194' ' ' GLN . 7.1 mp -128.11 151.85 76.72 Favored Pre-proline 0 C--O 1.239 0.507 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.894 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 180' ' ' LYS . 45.2 Cg_exo -61.05 143.81 99.25 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.642 2.228 . . . . 0.0 110.921 173.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 46.1 mm -84.8 117.79 30.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.439 HD21 ' HA ' ' A' ' 223' ' ' VAL . 3.6 mm? -70.05 -40.85 74.88 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 38.2 t -155.02 150.24 27.09 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.58 146.2 33.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.093 0.473 . . . . 0.0 110.975 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -133.64 143.52 48.64 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.493 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -79.34 151.43 31.02 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.178 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -129.46 105.58 17.47 Favored Pre-proline 0 C--N 1.311 -1.099 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 174.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.05 -18.73 35.47 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.168 2.578 . . . . 0.0 116.013 -172.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 30.7 p -121.2 -45.96 2.32 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -174.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -60.81 -51.53 78.9 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -172.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.602 ' O ' HG22 ' A' ' 216' ' ' THR . 68.8 Cg_endo -84.79 7.06 5.39 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 122.419 2.079 . . . . 0.0 114.33 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 9.9 mp -104.99 108.83 20.55 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.184 -0.607 . . . . 0.0 111.351 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -70.03 -39.65 75.65 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.358 0.599 . . . . 0.0 110.331 177.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.3 p -130.66 -177.4 4.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.965 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -63.84 -39.55 94.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.532 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 4.6 pp -140.62 162.34 35.61 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.365 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 143.41 -114.11 0.81 Allowed Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.929 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 13.7 p -139.46 147.02 24.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.3 mp -73.66 145.94 44.91 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 207' ' ' PRO . 7.7 t -117.64 -170.83 1.94 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.114 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.499 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 14.0 ptmm? -54.02 148.42 10.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.381 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 114.49 4.77 21.58 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.145 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.471 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 50.5 m -72.09 140.08 48.75 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.2 mm -92.8 127.33 45.0 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.963 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 46.3 pt -133.46 165.38 32.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 120.814 0.34 . . . . 0.0 110.943 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -121.21 126.77 50.46 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.439 ' HA ' HD21 ' A' ' 198' ' ' LEU . 35.6 m -131.25 156.65 42.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.213 0.53 . . . . 0.0 111.717 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -99.92 107.01 18.88 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.025 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 7.5 p -85.52 79.35 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 122.276 1.036 . . . . 0.0 110.536 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 57.0 p -175.77 -26.39 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.711 -1.586 . . . . 0.0 108.569 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -62.04 -13.48 26.49 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.324 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.411 HD21 ' CE1' ' A' ' 186' ' ' HIS . 6.9 mp -60.11 -37.3 79.59 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.015 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 90.62 8.11 66.04 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.425 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 41.3 pt -122.91 155.41 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 77.9 t -127.0 123.81 63.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.911 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.3 t -79.16 -52.22 8.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.099 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -161.64 98.95 1.12 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.675 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 25.8 t 65.26 -2.61 0.75 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.72 31.2 70.37 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.764 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.6 pttp -64.08 -13.63 48.76 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -177.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 19.9 pt -107.5 4.2 9.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.188 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -71.11 107.58 4.23 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.777 0.323 . . . . 0.0 111.658 -176.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 -164.09 176.58 9.16 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.041 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -91.47 122.77 6.89 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 108.894 -1.683 . . . . 0.0 108.894 173.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 75.9 mtt-85 -128.93 168.35 16.1 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 117.233 0.516 . . . . 0.0 111.319 -174.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.444 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 93.1 m-85 -101.36 143.55 31.26 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.164 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -136.92 166.3 23.96 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.359 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -116.6 136.98 52.52 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.054 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.471 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 88.2 mt -81.59 121.06 34.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 71.8 p -123.52 92.62 3.73 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.757 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -83.76 125.51 31.99 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.256 -176.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -131.59 70.28 81.44 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.504 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 73.4 Cg_endo -73.83 -17.8 22.43 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.032 1.822 . . . . 0.0 111.858 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -86.96 -14.82 40.67 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.235 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -111.3 -57.16 2.28 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.249 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -93.42 -28.14 16.31 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.846 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 92.08 -6.34 78.84 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.896 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 81.8 m -128.65 164.7 22.32 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.709 0.29 . . . . 0.0 111.069 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 92.6 t -80.38 118.09 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.548 ' HB2' ' O ' ' A' ' 246' ' ' THR . 78.4 m-20 -105.89 154.89 19.92 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.152 -174.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.411 ' HB2' HG22 ' A' ' 184' ' ' VAL . . . -135.2 146.55 48.79 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 10.7 p -123.44 134.99 64.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 120.997 0.427 . . . . 0.0 110.78 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 57.9 tp -84.1 130.77 34.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.353 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 242' ' ' TYR . 4.1 pp -101.4 146.01 28.17 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.857 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 C--O 1.268 2.068 0 CA-C-O 117.801 -1.095 . . . . 0.0 110.184 177.348 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 121.45 0.643 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -103.15 -5.14 23.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.737 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -59.69 141.62 54.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.146 0.498 . . . . 0.0 111.338 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -74.81 149.66 39.57 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.31 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.67 113.65 44.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.749 0.309 . . . . 0.0 111.037 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -121.01 110.17 34.98 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.347 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 213' ' ' GLY . 13.2 Cg_endo -60.8 -61.65 0.17 Allowed 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.55 2.167 . . . . 0.0 112.226 -178.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 55.5 ttm -154.63 25.32 0.45 Allowed 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 89.25 134.42 5.2 Favored Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.445 ' O ' HD11 ' A' ' 177' ' ' LEU . 4.2 pp -139.14 143.88 38.4 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 120.714 0.292 . . . . 0.0 110.477 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -76.23 -36.96 58.3 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.101 0.477 . . . . 0.0 111.407 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -165.25 140.57 5.21 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -176.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -79.0 97.77 6.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.982 0.42 . . . . 0.0 111.625 -177.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -129.55 144.03 51.09 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.024 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.405 ' HB3' HD12 ' A' ' 197' ' ' ILE . . . -137.18 153.0 50.53 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.753 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -87.07 101.66 13.68 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 60.3 t -95.29 125.84 47.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.452 0.644 . . . . 0.0 112.266 -172.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 92.8 m -107.08 127.77 53.78 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.74 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -104.27 108.93 61.7 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.2 -23.99 59.26 Favored 'Trans proline' 0 N--CA 1.476 0.449 0 C-N-CA 123.002 2.468 . . . . 0.0 113.629 -175.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 13.2 t -81.13 -21.11 40.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.783 0.325 . . . . 0.0 111.546 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 39.8 mt -109.45 -20.59 12.84 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.5 t30 60.43 48.89 7.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.425 -1.262 . . . . 0.0 109.843 -175.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.82 139.24 49.03 Favored 'Isoleucine or valine' 0 C--O 1.248 1.015 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.979 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 86.2 m -115.87 118.64 33.55 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 60.4 t -137.41 145.54 29.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.859 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -77.23 120.04 21.73 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.8 mp -123.02 145.4 45.75 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.788 0.327 . . . . 0.0 111.077 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.06 145.0 43.65 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.423 2.082 . . . . 0.0 110.051 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.5 HD11 HD13 ' A' ' 221' ' ' ILE . 31.7 mm -95.68 124.06 48.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.574 -178.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 98.3 mt -70.37 -43.67 69.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.052 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 26.3 m -142.13 141.78 32.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.186 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 18.8 m -126.14 128.49 71.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.787 0.327 . . . . 0.0 111.098 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -141.18 149.97 42.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.972 0.415 . . . . 0.0 111.229 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -99.01 159.29 15.07 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 174.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -79.33 121.31 82.78 Favored Pre-proline 0 C--N 1.318 -0.793 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.346 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.2 -22.26 54.03 Favored 'Trans proline' 0 CA--C 1.523 -0.055 0 C-N-CA 122.527 2.152 . . . . 0.0 111.279 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 77.6 p -84.12 -3.83 58.36 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.533 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -112.1 98.91 44.33 Favored Pre-proline 0 C--O 1.237 0.414 0 CA-C-O 121.192 0.52 . . . . 0.0 111.621 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -94.09 111.53 0.18 Allowed 'Trans proline' 0 N--CA 1.439 -1.727 0 C-N-CA 122.947 2.431 . . . . 0.0 110.729 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.16 151.82 44.02 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.312 0.577 . . . . 0.0 111.864 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -60.73 -39.04 87.19 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.951 -1.022 . . . . 0.0 113.01 -173.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.0 t -150.38 -34.1 0.17 Allowed 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.707 -0.797 . . . . 0.0 112.664 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -92.56 96.92 10.5 Favored 'General case' 0 C--O 1.215 -0.737 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.447 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 90.2 mt -95.59 -19.16 19.99 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.859 0.361 . . . . 0.0 111.093 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 174' ' ' PRO . . . -90.49 2.35 80.5 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.89 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 75.4 t -116.62 128.33 74.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.465 ' H ' HD21 ' A' ' 215' ' ' LEU . 2.6 pt? -85.24 136.97 33.28 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.177 0.513 . . . . 0.0 110.707 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 39.1 p -109.67 171.78 7.24 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.276 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -61.68 150.85 35.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.971 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 96.87 4.18 59.0 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.735 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.617 ' OG1' ' HB ' ' A' ' 245' ' ' ILE . 1.9 p -79.35 157.2 27.69 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.557 0.218 . . . . 0.0 111.425 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.6 mm -108.43 127.76 64.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.269 0.556 . . . . 0.0 112.127 -174.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.5 HD13 HD11 ' A' ' 197' ' ' ILE . 26.9 pt -131.88 162.49 39.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.404 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -110.91 129.02 56.0 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.77 153.34 33.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.34 0.59 . . . . 0.0 111.637 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -103.01 104.89 15.11 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.531 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 6.1 p -101.32 80.1 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-O 122.277 1.037 . . . . 0.0 109.934 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 38.4 p -160.02 -32.59 0.06 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.055 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -85.97 21.42 1.96 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.575 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 98.4 mt -60.0 -38.15 81.77 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.617 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 150.37 -32.18 1.03 Allowed Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.901 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 44.9 pt -125.93 156.62 35.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.339 0.59 . . . . 0.0 111.68 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 30.6 m -138.15 152.7 26.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.425 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 34.8 p -85.7 -83.8 0.17 Allowed 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -178.53 9.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.6 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 23.9 m -151.33 14.68 0.69 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.213 -176.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.74 30.42 72.69 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.624 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -61.77 -41.46 97.73 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.185 0.517 . . . . 0.0 110.977 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 12.6 pt -109.53 11.79 8.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.389 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -102.57 107.76 18.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.075 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -141.63 155.85 45.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.784 0.326 . . . . 0.0 111.186 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -107.94 110.31 3.12 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 170.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 31.6 mtp180 -131.0 169.39 15.9 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -102.56 146.02 28.75 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.276 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -131.19 168.15 17.97 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.525 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -114.04 130.85 56.53 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.424 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.617 ' HB ' ' OG1' ' A' ' 219' ' ' THR . 93.8 mt -81.33 130.1 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-O 120.82 0.343 . . . . 0.0 110.778 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 2.2 t -130.59 87.34 2.48 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -84.88 116.48 23.35 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.342 0.591 . . . . 0.0 111.437 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -129.1 72.06 81.99 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.459 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.41 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 33.4 Cg_exo -62.06 -24.9 77.04 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.618 2.212 . . . . 0.0 111.057 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.27 -34.97 79.2 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.702 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -96.9 -57.05 2.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.373 -177.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -98.14 -29.72 13.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.894 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.41 ' CA ' ' HA ' ' A' ' 249' ' ' PRO . . . 83.99 5.82 87.32 Favored Glycine 0 C--N 1.315 -0.593 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.876 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 78.7 m -130.92 161.43 31.91 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 97.8 t -81.0 117.25 26.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 175.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.548 ' HB2' ' O ' ' A' ' 246' ' ' THR . 76.8 m-20 -103.32 147.57 26.93 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -174.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -136.53 144.92 44.51 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.1 p -132.03 136.28 56.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-O 121.18 0.514 . . . . 0.0 110.668 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.6 tt -95.3 119.88 34.58 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 3.0 pp -90.46 137.96 31.93 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.305 0.574 . . . . 0.0 111.965 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 C--O 1.276 2.46 0 CA-C-O 117.287 -1.339 . . . . 0.0 110.11 179.348 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.475 0.821 0 CA-C-O 121.119 0.485 . . . . 0.0 111.797 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.518 ' HB3' ' NH2' ' A' ' 173' ' ' ARG . 5.3 mp0 -67.97 -36.66 80.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.77 176.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 70.06 167.56 0.29 Allowed 'General case' 0 C--N 1.342 0.25 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.978 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -100.08 3.62 44.12 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.635 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 81.8 mt -106.94 110.92 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.946 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.518 ' NH2' ' HB3' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -159.74 150.53 15.76 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 177.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.495 ' HA ' ' HB3' ' A' ' 215' ' ' LEU . 30.2 Cg_endo -66.27 -42.66 9.91 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 121.811 1.674 . . . . 0.0 111.503 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 55.3 ttm -174.93 17.12 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 103.13 144.74 14.34 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -172.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -148.52 136.22 20.67 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 117.14 0.47 . . . . 0.0 111.134 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.9 ptt-85 -62.37 -43.96 97.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.841 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -138.11 149.1 45.62 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -81.09 79.4 7.76 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.91 148.43 51.22 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.178 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.1 151.39 51.36 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.814 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -84.93 99.85 11.23 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 65.7 t -91.77 120.47 40.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.717 -173.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.9 m -107.53 126.89 53.1 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.697 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -101.01 112.68 65.31 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.75 -22.43 63.91 Favored 'Trans proline' 0 N--CA 1.473 0.282 0 C-N-CA 122.925 2.417 . . . . 0.0 113.103 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 89.2 m -64.45 -42.61 95.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.137 0.494 . . . . 0.0 110.786 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.42 ' HB2' HG11 ' A' ' 191' ' ' VAL . 29.6 mt -105.82 -14.29 15.27 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.064 -176.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 20.3 m120 59.96 45.16 12.57 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.244 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.42 HG11 ' HB2' ' A' ' 189' ' ' LEU . 10.2 p -128.34 147.85 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 11.9 t -127.71 135.13 49.75 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.556 0.693 . . . . 0.0 111.416 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.408 HG23 ' CD1' ' A' ' 195' ' ' LEU . 7.8 m -139.89 152.08 22.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.709 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.4 ' C ' HD13 ' A' ' 195' ' ' LEU . 35.5 tt0 -92.94 122.53 35.4 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.002 -178.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.408 ' CD1' HG23 ' A' ' 193' ' ' VAL . 6.9 mp -121.39 148.14 49.12 Favored Pre-proline 0 C--O 1.239 0.511 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.487 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.37 142.27 90.27 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.723 2.282 . . . . 0.0 111.65 175.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 78.9 mt -89.97 117.49 33.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 98.5 mt -70.14 -40.65 74.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.951 0.405 . . . . 0.0 111.123 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 33.5 t -157.68 148.19 20.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.17 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.6 m -112.93 139.64 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.835 0.35 . . . . 0.0 110.104 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -133.07 136.61 46.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.995 0.426 . . . . 0.0 110.587 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -89.91 159.53 16.89 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -67.73 148.4 98.53 Favored Pre-proline 0 C--N 1.311 -1.08 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.485 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.16 -35.23 65.46 Favored 'Trans proline' 0 N--CA 1.474 0.381 0 C-N-CA 122.956 2.437 . . . . 0.0 111.624 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 30.2 t -156.05 88.24 1.09 Allowed 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.583 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -127.56 79.77 72.9 Favored Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.314 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -71.06 139.39 35.64 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.51 2.14 . . . . 0.0 111.063 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 10.6 mp -84.95 144.68 28.18 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -61.42 -44.13 97.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.331 0.586 . . . . 0.0 109.478 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 73.5 p -77.46 161.92 27.58 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.949 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -62.03 -44.24 97.12 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.6 pp -147.4 172.83 13.3 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.198 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 162.76 -169.82 38.1 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.819 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 35.0 m -82.44 -177.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.495 ' HB3' ' HA ' ' A' ' 174' ' ' PRO . 55.3 tp -65.7 128.99 38.17 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 11.9 t -92.09 158.52 16.16 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.611 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -68.79 152.99 44.59 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.953 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.77 8.87 27.55 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.932 -0.652 . . . . 0.0 111.949 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 91.4 m -76.25 139.82 41.31 Favored 'General case' 0 C--O 1.212 -0.894 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.6 mm -105.78 127.97 60.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 O-C-N 122.052 -0.405 . . . . 0.0 111.476 -176.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.424 HD12 HD12 ' A' ' 245' ' ' ILE . 45.2 pt -122.88 158.56 27.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.704 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -103.95 123.14 46.62 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.16 159.3 43.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.871 0.367 . . . . 0.0 110.226 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -112.61 123.41 50.24 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 46.8 t -76.42 77.3 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 121.476 0.655 . . . . 0.0 109.968 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 68.6 m -158.38 -13.63 0.07 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.788 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -90.79 18.76 6.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.732 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.75 -38.44 81.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.111 0.482 . . . . 0.0 110.084 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 94.56 -12.72 68.43 Favored Glycine 0 CA--C 1.506 -0.483 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.507 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.3 pt -136.15 165.19 29.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.33 127.45 71.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-O 121.217 0.532 . . . . 0.0 110.545 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 11.9 t -119.93 -14.22 8.96 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.313 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.453 ' HB1' HG12 ' A' ' 237' ' ' ILE . . . -143.5 27.08 1.56 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.322 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.0 m 55.08 23.92 5.65 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.741 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 80.28 7.56 88.42 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.367 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -64.58 -38.45 91.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.597 0.713 . . . . 0.0 109.976 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.453 HG12 ' HB1' ' A' ' 233' ' ' ALA . 28.7 pt -85.86 10.33 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.343 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -64.71 124.2 21.32 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 121.132 -0.227 . . . . 0.0 110.427 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -173.36 157.27 3.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -86.89 120.74 5.56 Favored Glycine 0 C--O 1.224 -0.485 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.955 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 75.5 mtp85 -129.25 164.35 23.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.967 0.413 . . . . 0.0 111.099 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -104.25 134.83 46.82 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.404 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -114.63 146.75 40.47 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.722 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -95.55 124.72 39.71 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.241 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.447 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 49.9 mm -79.54 118.73 27.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.75 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 3.0 t -125.29 91.77 3.49 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -89.5 115.72 27.14 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.169 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -142.92 80.32 13.89 Favored Pre-proline 0 C--N 1.312 -1.025 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.374 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.542 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 33.7 Cg_exo -60.96 -28.06 85.73 Favored 'Trans proline' 0 C--O 1.218 -0.51 0 C-N-CA 122.981 2.454 . . . . 0.0 111.877 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -65.94 -37.08 85.11 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.845 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -91.64 -55.95 3.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.957 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.522 ' CB ' HD22 ' A' ' 256' ' ' ASN . 5.1 t70 -98.24 -30.18 12.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.114 0.483 . . . . 0.0 111.085 -176.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 95.09 6.22 60.35 Favored Glycine 0 C--N 1.319 -0.4 0 C-N-CA 120.89 -0.672 . . . . 0.0 113.328 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 27.9 p -156.02 171.55 19.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.065 0.433 . . . . 0.0 111.825 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 68.1 t -80.34 119.73 30.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.522 HD22 ' CB ' ' A' ' 252' ' ' ASP . 79.7 m-20 -112.43 151.64 29.62 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.413 -173.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -131.2 131.05 43.72 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.13 176.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.62 129.4 64.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.192 0.52 . . . . 0.0 110.193 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.0 tt -95.89 121.08 37.24 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.531 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.437 ' O ' HD11 ' A' ' 260' ' ' LEU . 1.4 pp -88.31 143.08 27.23 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.814 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--O 1.267 1.987 0 CA-C-O 117.699 -1.143 . . . . 0.0 110.768 -179.259 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 86.2 t80 . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 121.783 0.801 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -63.41 -40.26 96.72 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.975 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 88.7 mtt-85 60.07 69.32 0.71 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.098 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -66.05 -27.88 68.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.873 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.434 HD12 ' HB2' ' A' ' 202' ' ' LYS . 4.0 mp -78.34 121.56 31.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 120.991 0.424 . . . . 0.0 111.476 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.71 147.8 60.91 Favored Pre-proline 0 N--CA 1.443 -0.823 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.2 -62.15 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.587 2.192 . . . . 0.0 112.528 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 57.1 ttp -168.89 44.0 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 72.23 28.72 67.61 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.905 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -81.33 166.84 20.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.911 0.386 . . . . 0.0 111.063 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 10.4 ptm85 -59.08 -37.31 76.81 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.524 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -133.61 156.78 47.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.128 0.489 . . . . 0.0 111.832 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -80.03 85.56 5.61 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -136.15 137.42 40.94 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.84 -176.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -128.57 157.47 41.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.129 0.49 . . . . 0.0 111.715 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -85.61 100.8 12.2 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 192' ' ' THR . 48.7 t -93.97 120.18 42.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -172.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 92.5 m -109.33 128.0 54.76 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.376 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -105.83 105.67 53.97 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -57.07 -38.66 95.19 Favored 'Trans proline' 0 N--CA 1.483 0.889 0 C-N-CA 123.047 2.498 . . . . 0.0 113.366 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 89.6 m -63.23 -42.0 99.18 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.827 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.424 ' HB2' HG13 ' A' ' 191' ' ' VAL . 28.2 mt -99.72 -16.95 17.97 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.086 -175.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 65.5 t30 59.1 53.21 5.63 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.738 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' A' ' 189' ' ' LEU . 12.4 p -133.96 133.52 56.2 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.866 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 93.9 m -116.93 128.46 55.23 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.652 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.4 139.01 29.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.722 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -88.75 117.44 27.74 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.488 HD12 ' HD2' ' A' ' 196' ' ' PRO . 23.2 tp -134.24 141.56 39.77 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.251 -173.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.488 ' HD2' HD12 ' A' ' 195' ' ' LEU . 34.4 Cg_endo -65.28 146.33 85.89 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.916 1.744 . . . . 0.0 110.415 176.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 33.2 mm -81.14 119.93 31.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.012 0.434 . . . . 0.0 111.672 -175.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.95 -39.39 76.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.862 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.3 t -149.59 143.68 25.72 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 15.3 m -126.12 141.84 44.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.78 0.324 . . . . 0.0 111.355 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -130.59 123.31 29.22 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-O 121.008 0.433 . . . . 0.0 110.689 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.569 ' HD2' ' O ' ' A' ' 203' ' ' ASN . 1.7 tmmt? -110.42 150.81 28.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.726 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.569 ' O ' ' HD2' ' A' ' 202' ' ' LYS . 3.2 m-20 -59.32 152.39 53.9 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.415 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.49 -30.66 89.04 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.635 2.223 . . . . 0.0 112.711 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 26.3 p -109.01 -92.58 0.43 Allowed 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -134.92 146.8 60.19 Favored Pre-proline 0 N--CA 1.442 -0.837 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.433 ' HG2' ' HA ' ' A' ' 215' ' ' LEU . 74.3 Cg_exo -56.73 -40.85 81.43 Favored 'Trans proline' 0 N--CA 1.471 0.203 0 C-N-CA 122.618 2.212 . . . . 0.0 110.155 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 71.9 mt -119.63 99.1 6.45 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.727 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -67.02 -40.35 87.25 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.52 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.3 t -64.14 -52.98 56.47 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.854 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 212' ' ' LEU . 50.0 tt0 -70.17 -36.24 74.54 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.418 0.151 . . . . 0.0 111.072 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 211' ' ' GLN . 85.3 mt 83.08 126.19 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.164 0.986 . . . . 0.0 113.652 176.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 79.51 -53.06 4.21 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 115.082 0.793 . . . . 0.0 115.082 174.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 35.1 m -58.28 155.44 2.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -174.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.433 ' HA ' ' HG2' ' A' ' 207' ' ' PRO . 2.1 mm? -93.13 163.03 13.79 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.355 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 12.0 t -156.6 173.89 16.27 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.236 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.421 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 18.0 ptpt -67.21 152.68 45.29 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.86 178.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.52 8.12 31.09 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -176.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.526 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 66.1 m -77.07 136.75 38.67 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 51.2 mm -92.32 127.14 44.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.78 0.324 . . . . 0.0 111.116 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 43.3 pt -130.85 161.08 41.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.093 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.421 ' HB2' ' CE1' ' A' ' 242' ' ' TYR . 35.7 tt0 -110.9 128.49 55.83 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.1 m -126.34 157.54 36.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.718 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -98.18 110.62 23.17 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.563 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.649 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 10.7 t -91.41 18.94 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.445 ' HB3' ' N ' ' A' ' 239' ' ' TRP . 23.5 p -120.06 -35.24 3.51 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.658 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -64.48 -39.3 93.55 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.649 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.73 -36.59 83.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.075 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 102.03 -88.17 0.67 Allowed Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 50.7 mt 62.2 -74.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.932 0.893 . . . . 0.0 111.435 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 42.0 t 57.11 77.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 123.872 0.869 . . . . 0.0 111.353 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 23.6 p -70.35 -40.62 73.98 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.228 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -161.37 110.36 1.57 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.017 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 22.4 m 58.39 13.23 2.34 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.384 0.673 . . . . 0.0 112.591 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.19 29.31 74.69 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.055 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -61.99 -43.54 98.63 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 120.992 0.425 . . . . 0.0 111.363 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 26.4 pt -78.3 -1.88 4.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.299 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.649 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -76.01 108.01 8.6 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.721 0.296 . . . . 0.0 111.274 -177.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . 0.445 ' N ' ' HB3' ' A' ' 226' ' ' SER . 6.8 t90 -178.75 163.22 1.42 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.938 178.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -74.66 123.47 7.58 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.214 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -129.98 165.26 22.51 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -177.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.421 ' CE1' ' HB2' ' A' ' 222' ' ' GLU . 96.8 m-85 -101.07 141.38 34.04 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.238 0.542 . . . . 0.0 111.892 -177.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -128.6 170.14 13.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.873 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -115.26 131.25 56.99 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.771 0.32 . . . . 0.0 111.096 -178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.526 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 44.3 mm -77.0 128.04 37.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.676 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.421 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 3.8 t -132.76 101.73 5.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.799 0.809 . . . . 0.0 109.36 175.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -73.03 117.67 15.04 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.3 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . 0.419 ' HB2' ' ND2' ' A' ' 256' ' ' ASN . 17.5 m120 -130.82 70.81 82.58 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.856 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.78 -22.45 17.7 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.009 1.806 . . . . 0.0 112.079 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -76.26 -28.72 57.2 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.497 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -94.4 -57.55 2.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.683 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -100.01 -29.57 12.47 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 120.89 0.376 . . . . 0.0 111.914 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 84.46 8.41 83.29 Favored Glycine 0 C--N 1.316 -0.553 0 C-N-CA 120.311 -0.947 . . . . 0.0 110.91 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 68.8 m -129.5 161.59 30.08 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.333 -0.433 . . . . 0.0 109.992 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 81.7 t -83.1 118.46 30.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.419 ' ND2' ' HB2' ' A' ' 248' ' ' ASN . 81.4 m-20 -103.02 152.19 21.64 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.992 -172.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -130.96 137.21 49.16 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 176.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.7 p -128.71 136.37 60.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.022 0.439 . . . . 0.0 110.434 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 7.6 tt -86.2 119.79 26.87 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.464 ' O ' HD13 ' A' ' 260' ' ' LEU . 1.1 pp -81.54 133.75 35.42 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.997 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 C--O 1.27 2.133 0 CA-C-O 117.467 -1.254 . . . . 0.0 110.419 178.992 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.647 0.261 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -61.98 -39.57 92.63 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.148 0.499 . . . . 0.0 111.648 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -73.8 -14.44 61.1 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -115.41 -25.47 7.95 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.947 0.404 . . . . 0.0 111.899 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.414 HG22 ' HG3' ' A' ' 173' ' ' ARG . 85.7 mt -120.48 129.08 75.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.414 ' HG3' HG22 ' A' ' 172' ' ' ILE . 94.0 mtt180 66.65 79.11 0.24 Allowed Pre-proline 0 N--CA 1.469 0.514 0 O-C-N 123.644 0.59 . . . . 0.0 110.763 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -52.33 -68.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.976 2.45 . . . . 0.0 111.517 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 53.7 ttm -146.13 20.6 1.41 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.75 146.1 19.24 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -174.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -138.09 147.25 43.82 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -63.52 -38.63 91.86 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.401 ' CD2' ' HB2' ' A' ' 181' ' ' LYS . 66.3 t80 -162.82 143.37 9.59 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.131 -178.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -78.79 80.22 5.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.734 0.302 . . . . 0.0 111.091 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.629 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 84.3 tttt -154.27 129.69 9.83 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -122.74 157.27 32.7 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.26 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 15.2 m120 -87.04 106.19 17.68 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 61.8 t -98.34 119.79 46.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.351 0.596 . . . . 0.0 111.838 -174.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.1 m -93.48 125.93 38.36 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -104.14 110.89 64.85 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.7 -38.65 91.29 Favored 'Trans proline' 0 N--CA 1.483 0.877 0 C-N-CA 123.575 2.85 . . . . 0.0 114.02 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 8.0 t -70.64 -30.95 67.71 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.498 ' HB2' HG13 ' A' ' 191' ' ' VAL . 37.7 mt -98.68 -21.84 16.21 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.27 0.557 . . . . 0.0 109.608 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 23.7 m120 58.3 42.85 20.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.206 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' A' ' 189' ' ' LEU . 9.5 p -135.38 145.36 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.019 -178.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 8.8 t -106.12 121.57 44.42 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.419 0.628 . . . . 0.0 109.998 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.84 126.58 71.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.805 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.629 ' HG2' ' HG2' ' A' ' 181' ' ' LYS . 58.3 tt0 -79.11 122.61 26.45 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.409 ' C ' ' HG3' ' A' ' 181' ' ' LYS . 95.4 mt -128.18 150.52 74.18 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.832 -176.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.07 149.44 71.27 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.547 2.165 . . . . 0.0 112.085 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 35.5 mm -94.0 115.57 33.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.091 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 97.3 mt -70.39 -41.64 72.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.073 0.463 . . . . 0.0 110.462 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.5 t -160.9 153.11 20.19 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.129 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 33.4 m -118.72 146.18 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-O 121.005 0.431 . . . . 0.0 110.318 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -128.14 143.59 51.06 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -60.45 144.36 51.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.961 0.41 . . . . 0.0 111.141 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -72.64 157.14 89.38 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.851 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.402 ' HB2' ' OD1' ' A' ' 206' ' ' ASN . 33.3 Cg_endo -63.78 -11.42 26.59 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.046 2.497 . . . . 0.0 112.428 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 22.4 m 67.56 21.06 9.58 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 123.403 0.681 . . . . 0.0 111.8 178.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.48 ' N ' ' HD2' ' A' ' 207' ' ' PRO . 4.6 m-20 -62.95 -49.29 82.43 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.827 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 206' ' ' ASN . 49.1 Cg_endo -68.35 -16.73 43.99 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.389 2.06 . . . . 0.0 112.87 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 85.0 mt -98.71 136.87 38.15 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.547 0.689 . . . . 0.0 111.563 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -117.71 -32.93 4.69 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.593 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 72.2 p -82.1 164.49 21.31 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.066 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -95.46 12.4 29.52 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.026 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 98.6 mt -61.92 -40.32 95.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.797 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 80.19 85.61 0.62 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.864 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.42 HG23 HG22 ' A' ' 216' ' ' THR . 35.8 m -129.74 159.81 41.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 5.1 tt -82.68 113.57 20.45 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.1 0.476 . . . . 0.0 109.917 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.42 HG22 HG23 ' A' ' 214' ' ' VAL . 70.6 p -126.34 167.48 15.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.078 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -63.77 152.58 38.99 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.221 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 102.49 7.33 45.81 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -176.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.528 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 90.8 m -79.9 140.96 36.52 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.9 mm -101.9 130.46 51.58 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.706 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.297 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.411 HD11 HD11 ' A' ' 245' ' ' ILE . 42.3 pt -126.9 159.87 36.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.773 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -109.94 127.85 55.01 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 32.3 m -130.23 159.08 42.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.179 0.514 . . . . 0.0 111.455 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -95.38 109.38 21.56 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 92.6 t -97.0 87.91 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 48.6 m -129.84 -50.87 1.14 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.158 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -98.3 -51.15 4.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.579 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.449 HD21 HG11 ' A' ' 225' ' ' VAL . 84.5 mt 60.49 26.4 16.03 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.661 -176.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 92.69 -9.25 75.99 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.978 -0.556 . . . . 0.0 113.019 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 47.1 pt -131.97 175.19 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.798 0.332 . . . . 0.0 110.762 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 64.5 t -117.69 119.36 61.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 10.0 p -89.27 -86.24 0.19 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.198 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -150.2 82.01 1.37 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.543 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 44.7 m 53.87 39.59 30.58 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.017 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.24 42.27 83.8 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.685 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -61.13 -40.73 94.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.344 0.592 . . . . 0.0 110.872 -176.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 13.9 pt -103.87 23.54 2.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.445 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.572 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -73.68 106.9 5.63 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.155 0.503 . . . . 0.0 111.975 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -139.49 149.28 43.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.755 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -78.04 125.83 7.39 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -128.72 155.91 44.33 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 120.883 0.373 . . . . 0.0 111.02 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.481 ' CE2' HD12 ' A' ' 260' ' ' LEU . 49.2 p90 -109.11 142.25 40.12 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -122.55 154.82 37.4 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 120.96 0.409 . . . . 0.0 111.308 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -94.0 122.69 36.76 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.056 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 42.8 mm -77.24 119.38 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.351 177.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 80.2 p -122.5 86.65 2.62 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -90.49 129.61 36.63 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.113 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -142.66 76.33 17.82 Favored Pre-proline 0 C--N 1.304 -1.384 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.285 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.511 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 58.7 Cg_endo -70.34 -17.52 34.87 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.326 2.017 . . . . 0.0 111.354 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -69.06 -37.54 78.59 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.124 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -105.7 -60.15 1.67 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.015 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.66 -39.71 61.87 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.48 0.657 . . . . 0.0 110.642 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 94.09 -7.11 72.88 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.999 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 79.4 m -131.67 168.02 18.46 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.053 0.454 . . . . 0.0 111.888 -177.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 75.5 t -83.35 119.23 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -111.46 152.96 26.82 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -133.26 150.6 51.92 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.4 p -126.91 136.57 60.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 120.901 0.381 . . . . 0.0 110.031 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 57.2 tp -87.64 125.16 34.22 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.966 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.481 HD12 ' CE2' ' A' ' 242' ' ' TYR . 4.2 pp -98.6 148.91 23.32 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.584 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 11.9 m . . . . . 0 C--O 1.263 1.799 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.851 -179.513 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 121.063 0.458 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.28 -35.7 81.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.605 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -67.43 -17.49 64.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.783 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -103.6 117.85 35.37 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.4 mp -104.11 129.19 56.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.98 -176.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -107.4 105.09 54.98 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.34 -41.91 46.08 Favored 'Trans proline' 0 N--CA 1.475 0.414 0 C-N-CA 122.348 2.032 . . . . 0.0 110.858 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 53.6 ttm -178.2 29.77 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 95.36 98.03 1.74 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.469 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.455 ' H ' HD21 ' A' ' 177' ' ' LEU . 2.5 pt? -112.35 116.34 30.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.446 0.641 . . . . 0.0 111.268 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -71.86 -25.75 62.08 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.147 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -161.08 146.33 14.11 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.533 ' HB3' ' HB ' ' A' ' 197' ' ' ILE . 10.1 mptt -79.53 88.81 5.06 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.572 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt -151.92 139.25 19.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.329 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -142.98 154.45 44.03 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.977 0.418 . . . . 0.0 111.367 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -89.19 108.42 19.6 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 61.3 t -100.2 125.52 53.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -171.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 94.7 m -103.69 127.36 51.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.143 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -104.72 107.62 58.77 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.34 -35.65 98.88 Favored 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 123.132 2.555 . . . . 0.0 113.504 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 5.3 t -73.88 -34.62 64.52 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -177.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.448 ' HB2' HG11 ' A' ' 191' ' ' VAL . 38.5 mt -95.86 -16.27 21.93 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 120.817 0.342 . . . . 0.0 110.125 -177.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 60.27 42.48 15.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.046 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 189' ' ' LEU . 9.9 p -134.97 139.01 48.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.6 -176.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 87.0 m -114.32 119.02 35.55 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.806 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.474 HG21 HD21 ' A' ' 228' ' ' LEU . 9.6 m -135.54 147.19 28.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.435 -177.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.485 ' C ' HD12 ' A' ' 195' ' ' LEU . 64.4 tt0 -101.0 118.97 38.05 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.739 0.304 . . . . 0.0 110.614 -177.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.485 HD12 ' C ' ' A' ' 194' ' ' GLN . 5.6 mp -129.02 147.8 66.33 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.53 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -61.16 143.26 98.59 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.349 2.033 . . . . 0.0 110.02 172.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.533 ' HB ' ' HB3' ' A' ' 180' ' ' LYS . 82.4 mt -80.54 121.47 34.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.411 HD21 ' HA ' ' A' ' 223' ' ' VAL . 4.1 mm? -67.77 -43.92 78.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.643 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 52.4 m -152.19 153.43 33.8 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.266 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 31.3 m -117.79 145.93 22.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -127.86 121.17 29.37 Favored 'General case' 0 C--O 1.256 1.427 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -66.44 138.96 57.93 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.425 ' OD1' ' HA ' ' A' ' 219' ' ' THR . 87.1 m-20 -63.19 121.67 70.77 Favored Pre-proline 0 C--N 1.309 -1.152 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.654 -174.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.29 -33.59 18.03 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.978 1.786 . . . . 0.0 110.693 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 35.7 t -70.04 -41.93 73.56 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.626 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 52.84 75.75 0.61 Allowed Pre-proline 0 N--CA 1.474 0.737 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.301 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -55.55 -38.87 93.67 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.437 2.091 . . . . 0.0 110.74 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 10.8 mp -123.63 115.02 20.79 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.383 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -61.71 -48.88 78.74 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 11.2 t 176.87 141.16 0.07 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.219 174.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -142.55 -58.64 0.44 Allowed 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.3 10.01 41.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.281 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 91.34 -9.29 77.78 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.82 162.79 36.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 122.886 0.474 . . . . 0.0 109.808 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 11.1 mp -99.0 170.28 8.83 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.498 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 19.5 p -91.2 170.13 10.26 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.138 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -54.18 153.35 5.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.476 -0.783 . . . . 0.0 112.549 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 116.65 10.11 10.58 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.417 -175.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.425 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 59.8 m -67.09 137.04 56.07 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.9 mm -91.11 130.84 39.66 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.424 -174.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 46.9 pt -129.11 156.82 41.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.061 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 198' ' ' LEU . 52.9 mt-10 -114.74 125.95 54.29 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.411 ' HA ' HD21 ' A' ' 198' ' ' LEU . 35.9 m -130.59 155.9 42.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.248 0.547 . . . . 0.0 111.105 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -97.51 106.81 19.19 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.608 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 31.6 t -80.74 77.35 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 121.565 0.698 . . . . 0.0 110.394 -177.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 38.6 p -169.37 -16.0 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.329 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -81.24 9.28 7.21 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.434 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.474 HD21 HG21 ' A' ' 193' ' ' VAL . 87.9 mt -63.19 -34.57 77.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.902 -176.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 83.79 22.39 55.73 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.094 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 42.0 pt -116.91 161.18 15.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.924 0.392 . . . . 0.0 110.495 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 66.8 t -117.7 123.86 72.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.806 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 19.1 p -117.05 -70.43 0.79 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.076 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -169.31 97.35 0.34 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.553 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 19.2 t 63.32 15.97 9.1 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.43 34.03 78.58 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.84 -1.171 . . . . 0.0 111.495 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -63.44 -18.56 63.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.98 0.419 . . . . 0.0 111.639 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 33.6 pt -90.9 -0.1 9.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.512 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.644 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -75.98 107.81 8.44 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.159 0.504 . . . . 0.0 111.711 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -164.73 131.74 3.06 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.488 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -70.78 113.57 4.85 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.133 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -129.54 157.11 42.96 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.93 0.395 . . . . 0.0 111.224 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -102.38 148.74 25.11 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.378 0.609 . . . . 0.0 111.446 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -131.84 170.18 15.21 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.129 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -116.65 141.78 47.76 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.391 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 84.1 mt -83.25 124.47 39.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.43 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.499 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 2.8 t -141.28 100.91 3.9 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.753 176.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -75.35 135.11 40.86 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.063 0.459 . . . . 0.0 111.413 -177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -140.79 72.46 29.12 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.481 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.404 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 23.4 Cg_exo -66.84 -21.13 51.16 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.798 2.332 . . . . 0.0 111.554 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -67.68 -38.32 83.56 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.226 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -107.64 -57.97 2.02 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.53 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.54 -37.53 63.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.207 0.527 . . . . 0.0 110.667 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 89.27 5.5 72.6 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.139 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 33.0 t -145.49 177.4 8.88 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 96.9 t -80.21 122.14 34.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 246' ' ' THR . 8.1 m120 -105.95 152.97 22.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.287 0.565 . . . . 0.0 111.414 -174.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.574 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -134.73 140.01 45.62 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 174.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 12.5 p -126.25 135.69 63.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.811 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 64.7 tp -80.69 129.22 34.4 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.847 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 4.1 pp -95.52 143.63 26.67 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.164 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 C--O 1.269 2.101 0 CA-C-O 117.411 -1.281 . . . . 0.0 110.422 179.707 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 50.0 p90 . . . . . 0 N--CA 1.484 1.267 0 CA-C-O 121.16 0.505 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -124.99 73.52 1.3 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.318 0.58 . . . . 0.0 110.186 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 80.4 mtp85 -77.83 149.4 34.37 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.544 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -96.86 140.63 31.13 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.778 0.323 . . . . 0.0 111.31 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.418 ' N ' HD13 ' A' ' 172' ' ' ILE . 3.9 mp -86.03 105.94 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.502 ' O ' ' HB2' ' A' ' 215' ' ' LEU . 36.7 ptt180 -154.43 147.77 18.36 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.009 -176.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.24 -33.28 39.95 Favored 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 122.672 2.248 . . . . 0.0 111.054 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 59.7 ttm -179.32 -48.5 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -161.99 144.99 10.24 Favored Glycine 0 N--CA 1.41 -3.096 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.5 145.3 36.7 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 117.054 0.427 . . . . 0.0 110.717 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -86.15 -26.0 25.41 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.52 -176.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -170.21 163.74 9.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -175.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -69.09 68.05 0.17 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.167 0.292 . . . . 0.0 110.717 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.421 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 41.1 ttmt -154.88 137.27 14.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.524 0.202 . . . . 0.0 110.531 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -135.15 151.05 50.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.883 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 53.8 t-20 -85.22 103.52 14.26 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.429 HG23 ' HB3' ' A' ' 257' ' ' ALA . 54.1 t -93.59 121.91 44.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.177 0.513 . . . . 0.0 112.247 -173.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 62.9 m -98.26 124.78 43.04 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.207 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -106.04 106.87 58.38 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.24 -29.11 64.22 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.342 2.028 . . . . 0.0 112.796 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.2 t -73.73 -23.69 59.8 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.416 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.464 ' HB2' HG12 ' A' ' 191' ' ' VAL . 36.2 mt -104.85 -19.8 13.78 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.3 t30 61.16 47.56 7.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.568 -1.197 . . . . 0.0 109.405 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.464 HG12 ' HB2' ' A' ' 189' ' ' LEU . 5.9 p -145.09 146.54 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -177.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.2 t -121.07 120.7 36.1 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 121.555 0.693 . . . . 0.0 109.639 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.4 t -129.09 135.18 62.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.156 -177.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 62.0 tt0 -87.66 119.75 28.29 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.852 0.358 . . . . 0.0 110.747 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.3 mp -125.21 155.34 71.39 Favored Pre-proline 0 C--O 1.237 0.407 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.375 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.39 151.75 71.16 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.473 2.115 . . . . 0.0 111.655 177.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 83.4 mt -88.57 111.92 23.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.848 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.0 mp -69.28 -43.98 72.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.101 0.476 . . . . 0.0 111.934 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 50.6 m -151.34 157.85 43.02 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.329 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 33.0 m -123.42 146.7 28.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.224 0.535 . . . . 0.0 111.315 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.414 ' HB2' ' HB ' ' A' ' 220' ' ' ILE . 74.3 mmtt -125.58 110.42 13.81 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.474 176.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.438 ' HD3' ' O ' ' A' ' 203' ' ' ASN . 1.6 tmtp? -75.3 125.34 28.78 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.44 ' HB3' ' OD1' ' A' ' 206' ' ' ASN . 95.1 m-20 -64.79 131.82 95.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 120.718 0.294 . . . . 0.0 110.54 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -60.02 -42.51 43.55 Favored 'Trans proline' 0 N--CA 1.476 0.47 0 C-N-CA 123.141 2.561 . . . . 0.0 113.656 -173.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 33.6 t -162.55 88.13 0.63 Allowed 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.227 0.536 . . . . 0.0 111.493 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.44 ' OD1' ' HB3' ' A' ' 203' ' ' ASN . 4.5 m-20 -102.44 149.77 36.98 Favored Pre-proline 0 C--N 1.308 -1.204 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.586 174.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.453 ' O ' HG21 ' A' ' 216' ' ' THR . 50.0 Cg_exo -55.37 112.58 1.09 Allowed 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.888 2.392 . . . . 0.0 112.6 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 54.8 mt -104.49 55.88 0.71 Allowed 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 122.115 0.96 . . . . 0.0 109.51 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -62.49 -39.93 95.03 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 113.666 -1.606 . . . . 0.0 110.248 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.451 ' HB ' ' HG ' ' A' ' 212' ' ' LEU . 62.7 p -100.28 -40.43 7.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.395 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 59.14 17.79 5.9 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.722 0.409 . . . . 0.0 111.711 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.451 ' HG ' ' HB ' ' A' ' 210' ' ' THR . 97.9 mt -64.96 -39.82 94.06 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -102.52 14.9 56.4 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.723 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 47.2 t 73.92 -55.74 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 173' ' ' ARG . 9.8 mp -105.0 175.44 5.49 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.453 HG21 ' O ' ' A' ' 207' ' ' PRO . 71.2 p -114.46 155.08 27.03 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -62.74 150.69 40.6 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.99 10.55 34.41 Favored Glycine 0 N--CA 1.436 -1.309 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -173.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 95.1 m -68.08 138.78 56.04 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' ' 201' ' ' LYS . 51.1 mm -90.46 129.63 40.99 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 CA-C-O 120.726 0.298 . . . . 0.0 111.703 -174.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 44.9 pt -131.62 159.06 43.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.558 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -107.22 126.05 51.92 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.87 151.88 35.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.611 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -106.55 106.67 17.3 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.089 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 3.0 p -82.21 85.34 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-O 121.912 0.863 . . . . 0.0 110.193 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 15.0 p -123.7 -84.87 0.65 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.176 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -64.43 -46.68 82.16 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 97.0 mt 56.45 16.18 2.36 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.109 0.481 . . . . 0.0 110.774 -175.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 83.77 0.58 89.86 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 115.989 -0.551 . . . . 0.0 113.037 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 44.9 pt -133.67 171.71 17.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.297 0.57 . . . . 0.0 111.582 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 66.6 t -113.66 114.82 47.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 11.7 t -154.58 146.07 23.11 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.638 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . 52.93 25.18 3.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.147 0.579 . . . . 0.0 112.008 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 58.2 m 56.79 18.78 3.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.34 0.656 . . . . 0.0 111.971 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.57 26.21 74.72 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.077 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -66.01 -18.99 65.7 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.204 0.526 . . . . 0.0 111.135 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 30.9 pt -87.6 8.85 2.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.991 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -66.68 106.3 1.79 Allowed 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.084 0.469 . . . . 0.0 111.457 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -142.33 151.88 42.38 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.309 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -93.07 112.76 4.33 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 174.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.95 164.34 23.37 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 120.741 0.305 . . . . 0.0 111.065 -177.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -102.35 139.92 37.32 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.221 0.534 . . . . 0.0 111.61 -175.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -127.63 154.51 45.17 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.775 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -97.81 132.73 43.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.593 0.235 . . . . 0.0 110.725 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 87.1 mt -79.71 119.9 29.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.49 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 4.3 t -133.83 98.51 4.19 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -81.19 123.64 28.62 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.947 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -129.76 72.1 82.01 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.017 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.53 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 59.5 Cg_endo -70.16 -22.24 30.53 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.267 1.978 . . . . 0.0 112.228 -178.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -70.22 -37.73 75.09 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.27 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -96.29 -57.51 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.923 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -82.36 -39.57 22.57 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.343 0.592 . . . . 0.0 110.767 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 96.78 8.96 56.77 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.239 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 14.0 t -153.61 -179.93 8.25 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 93.7 t -79.87 126.64 39.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 246' ' ' THR . 10.0 m120 -113.33 154.28 27.12 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.861 0.362 . . . . 0.0 110.764 -174.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.429 ' HB3' HG23 ' A' ' 184' ' ' VAL . . . -131.98 147.96 52.49 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.9 p -123.43 131.0 73.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.025 0.44 . . . . 0.0 110.418 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.9 tt -100.53 123.84 45.29 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.801 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 2.8 pp -92.51 151.29 20.26 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.139 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.262 1.728 0 CA-C-O 117.75 -1.119 . . . . 0.0 110.876 -179.231 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 47.9 p90 . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 121.4 0.619 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -82.52 61.33 5.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.294 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -124.09 148.11 47.37 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.33 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -87.8 151.48 22.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.813 0.339 . . . . 0.0 111.753 -177.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.522 HD12 ' HB3' ' A' ' 202' ' ' LYS . 83.1 mt 66.29 90.21 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.891 -175.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 174' ' ' PRO . 79.4 mtp180 59.28 82.64 0.23 Allowed Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.275 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 173' ' ' ARG . 10.7 Cg_endo -55.75 -38.91 93.8 Favored 'Trans proline' 0 N--CA 1.478 0.611 0 C-N-CA 123.342 2.694 . . . . 0.0 112.196 -176.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 60.1 ttm 179.34 -25.21 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 151.04 176.16 23.64 Favored Glycine 1 N--CA 1.394 -4.126 0 N-CA-C 107.281 -2.327 . . . . 0.0 107.281 -177.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -153.77 175.48 13.25 Favored 'General case' 0 C--N 1.273 -2.75 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 11.8 ptm85 -59.46 -41.93 90.86 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.015 0.197 . . . . 0.0 111.472 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -176.28 152.78 1.15 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 180' ' ' LYS . 11.1 mptt -82.42 81.19 8.36 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -176.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -138.19 150.55 46.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.743 0.417 . . . . 0.0 110.921 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -141.94 151.16 42.32 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.714 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 20.0 m120 -86.53 100.44 12.39 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 120.557 -0.457 . . . . 0.0 109.833 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 64.5 t -85.34 120.31 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.72 -176.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 63.7 m -105.33 126.46 52.13 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.458 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -104.33 111.64 65.23 Favored Pre-proline 0 C--N 1.312 -1.035 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.34 -27.14 77.49 Favored 'Trans proline' 0 N--CA 1.474 0.334 0 C-N-CA 122.556 2.171 . . . . 0.0 112.462 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 89.3 m -63.35 -42.64 98.92 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.31 0.576 . . . . 0.0 110.568 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.454 ' HB2' HG11 ' A' ' 191' ' ' VAL . 28.3 mt -95.05 -21.38 18.6 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.364 -177.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 65.6 t30 59.57 51.66 6.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.496 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' A' ' 189' ' ' LEU . 10.0 p -140.14 148.86 22.21 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.817 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 13.6 t -119.47 122.75 42.42 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.497 0.665 . . . . 0.0 110.44 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.446 HG11 ' HA3' ' A' ' 229' ' ' GLY . 57.3 t -128.88 131.06 68.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.665 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 29.6 tt0 -78.24 124.51 28.16 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.834 0.35 . . . . 0.0 111.099 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.415 HD12 ' C ' ' A' ' 194' ' ' GLN . 7.4 mp -127.27 149.33 69.43 Favored Pre-proline 0 C--O 1.238 0.499 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.155 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -61.4 142.58 96.03 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.844 2.363 . . . . 0.0 112.307 176.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 81.6 mt -90.84 120.78 40.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.9 mp -72.29 -45.13 61.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.771 0.32 . . . . 0.0 111.389 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.2 t -162.91 157.12 20.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.889 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 33.6 m -119.1 146.19 24.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-O 120.9 0.381 . . . . 0.0 110.72 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -129.31 142.45 50.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.827 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.522 ' HB3' HD12 ' A' ' 172' ' ' ILE . 26.4 pttm -77.92 158.57 29.32 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.586 0.708 . . . . 0.0 112.436 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -127.6 137.68 31.24 Favored Pre-proline 0 C--N 1.308 -1.212 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.32 -21.35 60.2 Favored 'Trans proline' 0 N--CA 1.478 0.583 0 C-N-CA 122.834 2.356 . . . . 0.0 113.575 -176.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 52.4 m -93.42 0.55 56.85 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -64.23 -52.42 54.81 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.95 109.23 2.8 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 121.691 1.594 . . . . 0.0 111.738 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 79.5 mt -125.87 -13.51 6.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.211 -0.449 . . . . 0.0 112.133 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.436 ' C ' ' HG1' ' A' ' 210' ' ' THR . 51.9 t80 -64.8 -33.47 76.06 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.699 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.436 ' HG1' ' C ' ' A' ' 209' ' ' TYR . 40.1 p 65.85 -41.28 0.34 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.369 1.468 . . . . 0.0 114.791 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.413 ' HB2' ' CE2' ' A' ' 209' ' ' TYR . 15.3 mm100 -68.89 -40.05 79.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.008 0.433 . . . . 0.0 110.924 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 86.6 mt -137.08 -80.79 0.38 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.225 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 178.5 157.38 19.03 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.584 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 8.5 p -166.41 153.33 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 63.7 tp -104.03 123.7 47.7 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 40.2 m -115.18 141.66 47.72 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.974 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -46.83 151.23 0.63 Allowed 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.727 0.642 . . . . 0.0 111.927 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 111.3 8.58 23.18 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -176.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.501 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 25.7 m -74.49 144.44 44.15 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.2 mm -104.1 127.18 58.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.699 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.47 HD11 HD12 ' A' ' 245' ' ' ILE . 46.1 pt -125.97 160.18 33.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.876 0.369 . . . . 0.0 111.114 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -103.8 126.38 50.9 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.372 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.58 151.59 36.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.078 0.466 . . . . 0.0 110.885 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -92.36 105.87 17.98 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 22.8 t -93.86 70.45 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 121.423 0.63 . . . . 0.0 110.108 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 50.7 m -125.99 -42.85 1.86 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.496 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -73.48 -43.57 59.89 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.227 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.437 ' O ' HG11 ' A' ' 193' ' ' VAL . 7.1 mp 54.02 17.29 1.34 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.46 -176.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.446 ' HA3' HG11 ' A' ' 193' ' ' VAL . . . 77.33 -47.98 2.75 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -176.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 44.3 pt -128.27 157.86 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.6 m -96.74 43.97 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-O 121.099 0.476 . . . . 0.0 111.269 -177.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.1 t -48.93 -46.68 43.44 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.986 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -98.86 10.74 40.67 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 16.5 t 60.35 38.05 19.81 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.77 -127.78 28.6 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -174.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? 75.08 -45.54 0.57 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.64 0.776 . . . . 0.0 110.488 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 21.3 pt -88.85 18.57 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.801 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -69.46 112.94 6.32 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.38 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . 0.503 ' O ' ' HB ' ' A' ' 225' ' ' VAL . 23.1 t90 -169.25 138.21 2.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.718 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -68.11 131.84 28.0 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.083 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.44 176.08 8.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.821 0.343 . . . . 0.0 110.855 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -111.79 138.54 48.25 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.783 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -122.48 149.85 43.32 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.787 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -95.29 127.09 41.06 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.151 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.501 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 48.0 mm -78.47 120.7 29.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 178.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.8 t -134.97 98.32 3.98 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.934 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -80.5 126.24 30.97 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.875 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -135.82 72.18 62.59 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.52 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 35.5 Cg_exo -63.94 -26.52 66.71 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.062 2.508 . . . . 0.0 112.03 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -67.58 -37.44 82.62 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.403 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -96.68 -56.96 2.42 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.309 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -87.22 -40.2 14.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.072 0.463 . . . . 0.0 110.729 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 99.7 9.36 49.94 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.879 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 30.6 p -152.21 179.16 8.76 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.658 -0.319 . . . . 0.0 110.996 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 66.9 t -80.65 123.39 37.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -114.38 153.27 30.15 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.787 0.327 . . . . 0.0 110.147 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -128.3 146.88 50.63 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.6 p -122.39 129.71 75.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 121.127 0.489 . . . . 0.0 110.291 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 8.8 tt -105.32 124.43 49.52 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.906 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 3.4 pp -99.43 150.34 22.27 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.375 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 23.9 m . . . . . 0 C--O 1.272 2.268 0 CA-C-O 117.679 -1.153 . . . . 0.0 110.71 179.742 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 52.9 p90 . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 121.114 0.483 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -142.55 96.77 3.0 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 121.592 0.71 . . . . 0.0 109.732 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -138.04 32.22 2.41 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.151 176.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -98.61 109.56 22.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.644 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.496 ' C ' ' HD2' ' A' ' 173' ' ' ARG . 4.5 mp -118.6 98.48 6.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.603 176.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.496 ' HD2' ' C ' ' A' ' 172' ' ' ILE . 2.3 mpt_? -123.19 103.52 35.93 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -55.51 -39.08 93.07 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.257 2.638 . . . . 0.0 112.738 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 57.4 ttp -151.28 14.9 0.7 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.278 0.561 . . . . 0.0 110.209 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 69.27 29.62 71.9 Favored Glycine 0 C--O 1.229 -0.211 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.831 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.416 HD22 ' N ' ' A' ' 177' ' ' LEU . 1.6 pt? -54.59 141.26 32.24 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.793 0.437 . . . . 0.0 111.895 -178.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -59.9 -34.86 73.75 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.545 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -139.2 142.29 37.9 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -69.38 85.51 0.41 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -177.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -151.8 137.6 18.0 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.978 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -140.1 159.21 42.7 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.145 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 89.9 m-20 -82.18 104.28 12.4 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 59.9 t -95.73 120.14 44.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.244 0.545 . . . . 0.0 112.119 -173.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 192' ' ' THR . 90.5 m -95.2 125.28 39.74 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.318 176.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -105.26 107.78 59.82 Favored Pre-proline 0 C--N 1.313 -1.009 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.96 -26.23 66.64 Favored 'Trans proline' 0 N--CA 1.474 0.374 0 C-N-CA 122.548 2.165 . . . . 0.0 112.644 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 86.4 m -64.6 -41.58 96.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.389 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.453 ' HB2' HG12 ' A' ' 191' ' ' VAL . 35.0 mt -99.3 -14.54 19.19 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.757 -177.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 60.22 45.23 11.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.26 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.453 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.8 p -138.79 144.72 29.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.439 -176.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 185' ' ' THR . 86.1 m -107.49 119.7 40.14 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.2 130.18 69.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 63.4 tt0 -75.51 120.26 20.69 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.41 ' CD2' HD21 ' A' ' 228' ' ' LEU . 87.2 mt -129.55 149.88 74.11 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.605 -174.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.74 144.98 50.23 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.353 2.036 . . . . 0.0 110.749 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.423 HG22 ' HB ' ' A' ' 221' ' ' ILE . 80.2 mt -93.48 116.85 35.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.248 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.4 mp -71.8 -46.15 59.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.675 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 39.2 m -141.25 148.33 39.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.597 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.2 m -129.72 137.66 56.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.628 0.251 . . . . 0.0 110.633 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -143.79 142.95 31.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.03 0.443 . . . . 0.0 110.835 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -112.07 146.67 37.54 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.991 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -120.07 140.22 29.54 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.432 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.58 -12.76 36.75 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.433 2.755 . . . . 0.0 111.98 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 47.0 t -60.0 -39.7 86.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.263 178.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.444 ' ND2' ' HA3' ' A' ' 218' ' ' GLY . 2.1 m-20 -76.29 130.46 77.42 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.835 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.01 -20.23 29.2 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.757 2.305 . . . . 0.0 112.143 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.7 mp 63.04 -166.67 0.22 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.255 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -64.06 -29.1 70.26 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 30.1 m 72.15 -59.01 0.57 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.801 177.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -61.85 -41.44 97.83 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -175.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 84.5 mt -93.68 -32.94 13.85 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.053 0.454 . . . . 0.0 111.164 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 89.46 -7.06 82.75 Favored Glycine 0 C--O 1.228 -0.224 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.672 -177.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 88.7 t -69.65 141.23 17.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 122.785 0.434 . . . . 0.0 110.021 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 10.3 mp -54.29 142.12 27.5 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.122 0.487 . . . . 0.0 110.63 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.3 m -133.28 162.99 30.32 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.175 -174.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -47.18 151.01 0.74 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.486 0.66 . . . . 0.0 112.454 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.444 ' HA3' ' ND2' ' A' ' 206' ' ' ASN . . . 113.35 9.09 18.29 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.507 -176.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.542 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 60.5 m -76.27 139.05 40.93 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.4 mm -97.48 126.41 50.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 120.803 0.335 . . . . 0.0 110.364 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.447 HD12 HD13 ' A' ' 245' ' ' ILE . 44.6 pt -125.98 165.03 24.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.118 0.485 . . . . 0.0 111.561 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -112.09 128.11 56.11 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.798 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.82 158.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.93 0.395 . . . . 0.0 110.902 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -110.33 112.18 23.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.267 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 3.2 p -102.4 79.39 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.788 0.804 . . . . 0.0 109.683 176.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 32.4 t -156.85 -42.35 0.07 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.145 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -94.2 19.57 9.18 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.864 -178.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.41 HD21 ' CD2' ' A' ' 195' ' ' LEU . 39.8 mt -70.76 -16.96 62.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.621 -175.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 82.73 2.96 90.69 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.533 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.4 pt -113.31 162.01 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.81 124.62 44.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.862 0.839 . . . . 0.0 111.249 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 9.9 t -99.07 -151.57 0.39 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -67.2 85.71 0.15 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.936 0.398 . . . . 0.0 110.641 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 39.7 m 64.77 13.11 8.21 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.912 0.885 . . . . 0.0 112.298 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 63.31 33.36 87.03 Favored Glycine 0 C--O 1.225 -0.446 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.972 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -65.35 -14.58 61.15 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 23.7 pt -105.86 12.18 8.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.974 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -75.46 106.02 6.79 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.987 0.423 . . . . 0.0 111.483 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -165.53 177.22 7.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.844 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -87.94 118.78 5.13 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 173.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 62.6 mtp85 -127.38 166.74 17.29 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.971 0.386 . . . . 0.0 111.0 -173.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -108.28 139.38 43.07 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.289 0.566 . . . . 0.0 111.692 -176.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -127.28 161.69 27.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.28 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -106.17 130.93 53.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.885 0.374 . . . . 0.0 111.107 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.542 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 41.9 mm -80.29 125.61 39.15 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.127 177.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 4.9 t -135.5 90.17 2.58 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 173.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -80.17 123.53 28.0 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.249 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -130.42 71.71 82.18 Favored Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.615 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.51 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 51.3 Cg_endo -67.8 -23.38 41.78 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.985 1.79 . . . . 0.0 111.07 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -73.12 -26.34 61.19 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.464 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -104.57 -56.18 2.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.066 -176.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -90.86 -40.07 11.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.063 0.459 . . . . 0.0 110.717 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 105.08 -8.54 45.53 Favored Glycine 0 C--N 1.316 -0.578 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.424 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 75.2 m -132.72 175.94 8.9 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.702 0.287 . . . . 0.0 111.061 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 86.6 t -79.95 124.34 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 246' ' ' THR . 3.2 m120 -107.34 151.95 24.8 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -176.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -139.88 150.43 44.61 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 177.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.58 135.91 53.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 120.837 0.351 . . . . 0.0 110.429 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 64.3 tp -73.71 126.52 30.53 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.473 ' O ' HD11 ' A' ' 260' ' ' LEU . 3.2 pp -82.98 131.13 35.2 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.119 0.485 . . . . 0.0 111.117 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--O 1.272 2.24 0 CA-C-O 117.815 -1.088 . . . . 0.0 110.336 179.463 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 121.243 0.544 . . . . 0.0 111.802 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.469 ' HB2' ' NZ ' ' A' ' 180' ' ' LYS . 48.2 mt-10 -106.0 68.7 0.78 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -71.27 -22.4 61.97 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.756 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -79.04 156.17 28.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.795 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.403 ' CG1' ' HG3' ' A' ' 202' ' ' LYS . 4.8 mp 66.11 81.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.776 0.798 . . . . 0.0 109.534 -174.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -139.67 149.13 58.53 Favored Pre-proline 0 N--CA 1.439 -1.011 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.089 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.618 ' O ' ' HA ' ' A' ' 214' ' ' VAL . 44.8 Cg_exo -60.71 -40.94 50.65 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.627 2.218 . . . . 0.0 110.566 176.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 65.9 ttp 170.36 -50.06 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -154.03 111.36 0.48 Allowed Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.023 177.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.22 151.09 49.33 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.726 0.298 . . . . 0.0 111.238 -177.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -81.52 -50.89 8.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.448 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -141.4 158.82 43.37 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.029 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.469 ' NZ ' ' HB2' ' A' ' 169' ' ' GLU . 0.1 OUTLIER -88.65 116.12 26.67 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.231 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -149.13 140.13 22.93 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.6 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -138.45 157.29 46.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.953 0.406 . . . . 0.0 112.003 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -90.45 103.85 16.5 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 59.6 t -97.35 123.11 49.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.154 0.502 . . . . 0.0 111.95 -173.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 89.8 m -105.03 126.62 52.26 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.599 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -105.33 110.69 64.65 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.938 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.95 -33.64 89.7 Favored 'Trans proline' 0 N--CA 1.481 0.774 0 C-N-CA 123.331 2.688 . . . . 0.0 113.111 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 88.7 m -60.79 -44.4 96.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.255 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.439 ' HB2' HG11 ' A' ' 191' ' ' VAL . 32.0 mt -98.27 -17.0 19.17 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.647 -176.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 59.71 50.1 7.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.042 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.439 HG11 ' HB2' ' A' ' 189' ' ' LEU . 9.6 p -138.67 149.04 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.839 -178.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 12.4 t -119.67 129.57 54.62 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.405 0.622 . . . . 0.0 109.779 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 10.6 m -134.32 147.48 30.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.527 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.501 ' C ' HD11 ' A' ' 195' ' ' LEU . 35.5 tt0 -96.68 118.52 33.32 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.501 HD11 ' C ' ' A' ' 194' ' ' GLN . 7.0 mp -128.05 148.12 66.12 Favored Pre-proline 0 C--O 1.237 0.44 0 CA-C-O 120.664 0.269 . . . . 0.0 111.399 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.53 145.82 92.29 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.767 2.311 . . . . 0.0 110.978 173.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 83.9 mt -91.53 120.03 39.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 96.5 mt -68.02 -41.51 82.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.713 0.292 . . . . 0.0 111.356 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 93.4 p -156.1 157.25 35.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.713 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 17.7 m -122.25 135.58 61.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.338 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -136.24 137.17 40.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.779 0.324 . . . . 0.0 110.805 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.403 ' HG3' ' CG1' ' A' ' 172' ' ' ILE . 56.8 mtmt -111.74 145.52 39.2 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.369 174.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.485 ' ND2' ' HB2' ' A' ' 205' ' ' SER . 31.6 p-10 -74.49 157.2 86.52 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 176.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.0 -28.11 80.23 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.301 2.0 . . . . 0.0 112.602 -178.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.485 ' HB2' ' ND2' ' A' ' 203' ' ' ASN . 69.4 m -65.3 -39.63 92.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.99 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 58.2 t30 58.26 83.61 0.22 Allowed Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 122.913 0.485 . . . . 0.0 111.786 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.438 ' HD3' ' OD1' ' A' ' 203' ' ' ASN . 89.8 Cg_endo -81.94 52.97 4.39 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.826 2.351 . . . . 0.0 111.574 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 31.7 tp -79.89 95.52 6.1 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.157 0.503 . . . . 0.0 110.149 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.413 ' H ' HG23 ' A' ' 216' ' ' THR . 75.0 t80 -62.25 -45.59 92.62 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.657 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 20.8 p -69.16 151.43 46.36 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.779 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -62.6 -44.54 96.05 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 3.8 pp -174.85 172.01 3.02 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.614 0.245 . . . . 0.0 111.155 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 80.44 -79.81 1.71 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.914 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.618 ' HA ' ' O ' ' A' ' 174' ' ' PRO . 26.3 m -80.08 148.39 5.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.063 0.459 . . . . 0.0 111.802 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.9 mt -79.48 162.72 25.26 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.705 0.764 . . . . 0.0 112.122 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 209' ' ' TYR . 94.2 m -118.37 140.78 49.32 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.564 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 12.4 ptmm? -49.39 145.89 4.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.618 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 111.55 9.77 20.7 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.862 -176.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.432 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 61.7 m -84.35 134.86 34.48 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.476 HD11 ' N ' ' A' ' 220' ' ' ILE . 3.7 mp -95.98 127.08 48.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.905 0.384 . . . . 0.0 111.12 -178.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.423 HD12 HD13 ' A' ' 245' ' ' ILE . 46.0 pt -124.79 157.91 32.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.521 178.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -110.84 124.65 52.45 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.86 157.01 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.722 0.296 . . . . 0.0 110.633 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -98.15 123.14 42.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.315 0.578 . . . . 0.0 110.991 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 9.1 m -100.04 80.35 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-O 121.67 0.748 . . . . 0.0 110.114 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 18.5 m -112.93 -63.48 1.44 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.44 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -99.03 -39.73 8.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.157 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 8.2 mp 65.0 -2.57 0.7 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.441 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 83.22 7.5 86.7 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.082 -178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.5 pt -126.16 169.91 16.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 5.6 p -118.38 85.73 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 122.128 0.966 . . . . 0.0 111.57 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.3 t -113.14 -41.02 3.79 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 173.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -168.19 136.22 2.25 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.357 177.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 47.4 m -75.17 76.63 2.31 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.538 0.685 . . . . 0.0 111.167 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 70.75 40.63 64.94 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 114.998 -1.001 . . . . 0.0 115.25 175.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -63.7 -25.53 68.24 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.936 0.868 . . . . 0.0 109.714 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 13.5 pt -129.65 33.71 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.541 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -63.66 105.71 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.098 0.475 . . . . 0.0 111.514 -177.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -151.83 166.43 31.45 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.629 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -93.13 118.73 5.72 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -127.29 163.24 24.38 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 120.9 0.381 . . . . 0.0 110.968 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -103.33 139.51 38.65 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.491 -175.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -128.47 147.36 50.67 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.27 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 18.1 pm0 -98.34 131.34 44.72 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.476 0.655 . . . . 0.0 111.374 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 48.9 mm -77.54 125.22 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.29 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 4.1 t -134.46 102.95 5.5 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -84.69 126.81 33.71 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.285 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -127.6 72.29 77.9 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.17 -23.89 28.44 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.401 2.067 . . . . 0.0 112.381 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -77.65 -16.09 58.77 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.112 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -113.31 -56.25 2.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.032 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -93.29 -31.17 14.8 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.776 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 77.42 20.46 74.69 Favored Glycine 0 C--N 1.322 -0.22 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.86 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 48.8 t -151.15 164.87 35.52 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.695 0.283 . . . . 0.0 110.441 -177.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 95.1 t -79.91 121.84 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 246' ' ' THR . 78.8 m-20 -112.55 152.8 28.41 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.198 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -132.5 141.91 48.98 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.83 133.27 69.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 7.4 tt -101.19 123.81 45.92 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.218 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.457 ' O ' HD12 ' A' ' 260' ' ' LEU . 3.1 pp -65.49 137.65 57.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.236 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.269 2.122 0 CA-C-O 117.3 -1.333 . . . . 0.0 110.717 -179.065 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.42 ' C ' ' H ' ' A' ' 170' ' ' ARG . 67.8 m-85 . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 120.818 0.342 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 69.97 -13.7 0.41 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.156 0.982 . . . . 0.0 112.612 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.42 ' H ' ' C ' ' A' ' 168' ' ' TYR . 38.5 mmt180 -80.09 91.25 5.49 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.092 0.472 . . . . 0.0 111.049 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -120.96 116.12 24.49 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.063 176.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.425 HG21 ' H ' ' A' ' 202' ' ' LYS . 12.3 tt -80.72 103.98 8.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.806 0.812 . . . . 0.0 110.166 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.451 ' HB3' HG23 ' A' ' 200' ' ' VAL . 35.9 ptt-85 -135.36 161.78 61.27 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.587 -174.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.435 ' HG3' ' HB2' ' A' ' 215' ' ' LEU . 24.3 Cg_endo -85.86 -131.46 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 122.843 2.362 . . . . 0.0 110.924 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 63.0 ttp -90.75 44.16 1.18 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.554 0.692 . . . . 0.0 110.414 -176.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 80.02 1.2 87.35 Favored Glycine 0 CA--C 1.517 0.178 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.297 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 42.57 -150.26 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.475 0.71 . . . . 0.0 111.456 -177.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.417 ' HG3' ' N ' ' A' ' 179' ' ' TYR . 11.1 ptm85 -71.64 -47.38 54.84 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.024 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.417 ' N ' ' HG3' ' A' ' 178' ' ' ARG . 52.3 t80 -178.52 171.8 1.52 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -177.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -74.57 38.93 0.12 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.662 0.268 . . . . 0.0 111.005 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.456 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 40.3 ttmt -154.01 140.7 18.99 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -177.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.401 ' HB2' HD11 ' A' ' 197' ' ' ILE . . . -138.28 157.02 47.09 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.711 0.291 . . . . 0.0 111.509 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -87.0 101.49 13.49 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 58.9 t -90.56 125.94 43.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.859 -175.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.7 m -107.02 124.07 49.11 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.245 0.545 . . . . 0.0 110.011 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -104.51 115.91 62.03 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.841 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.83 -18.88 65.77 Favored 'Trans proline' 0 N--CA 1.476 0.458 0 C-N-CA 122.581 2.187 . . . . 0.0 111.258 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 72.0 m -64.11 -40.65 96.66 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.218 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.452 ' HB2' HG11 ' A' ' 191' ' ' VAL . 27.4 mt -107.3 -16.37 14.41 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.069 -177.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 60.16 41.32 17.08 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.986 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.452 HG11 ' HB2' ' A' ' 189' ' ' LEU . 6.6 p -134.94 148.84 28.97 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.74 -177.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 84.8 m -105.68 120.91 42.87 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.5 m -127.06 138.41 54.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.901 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.456 ' HG2' ' HG2' ' A' ' 181' ' ' LYS . 36.0 tt0 -94.21 119.54 33.17 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.156 -175.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -128.94 153.32 80.13 Favored Pre-proline 0 C--O 1.237 0.426 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.209 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.37 146.42 97.24 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.303 2.669 . . . . 0.0 112.645 177.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.401 HD11 ' HB2' ' A' ' 182' ' ' ALA . 76.9 mt -94.28 118.61 40.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.658 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.38 -46.52 15.89 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.808 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 27.3 m -140.64 150.29 43.37 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.177 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.451 HG23 ' HB3' ' A' ' 173' ' ' ARG . 30.9 m -128.19 144.13 38.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.521 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -140.34 102.54 4.37 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.281 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.425 ' H ' HG21 ' A' ' 172' ' ' ILE . 60.2 mtpt -70.8 146.01 50.01 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -85.78 116.97 67.78 Favored Pre-proline 0 C--N 1.312 -1.043 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.073 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.3 -22.47 21.91 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.036 1.824 . . . . 0.0 110.261 175.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 57.2 m -66.9 -40.13 87.63 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.004 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -69.01 127.93 92.92 Favored Pre-proline 0 CA--C 1.515 -0.371 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.731 -177.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.64 80.95 2.45 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.946 2.431 . . . . 0.0 113.168 -178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 61.1 mt -70.79 142.85 51.32 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.942 174.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -60.64 -46.41 90.4 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.39 0.614 . . . . 0.0 109.593 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 59.3 m -111.76 132.6 54.55 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.96 -40.31 88.6 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.162 0.506 . . . . 0.0 110.431 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 87.3 mt -97.04 20.19 11.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.701 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.06 171.62 38.84 Favored Glycine 0 C--O 1.244 0.735 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.618 -176.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 33.2 m -63.87 167.25 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.548 0 CA-C-O 121.364 0.602 . . . . 0.0 112.209 -177.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.435 ' HB2' ' HG3' ' A' ' 174' ' ' PRO . 48.4 tp -75.31 128.7 36.0 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.688 -176.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 36.8 p -108.21 162.3 14.2 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.675 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 3.8 ptpp? -66.78 151.61 47.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.133 0.492 . . . . 0.0 111.589 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.02 4.3 41.75 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.235 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 88.1 m -80.12 134.9 36.21 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.522 0.201 . . . . 0.0 111.265 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 48.5 mm -93.78 126.29 46.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.863 0.363 . . . . 0.0 110.882 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.415 HG22 ' HA ' ' A' ' 200' ' ' VAL . 47.3 pt -130.73 165.17 31.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.368 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -108.68 129.41 55.35 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 31.5 m -126.82 153.66 36.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.106 0.479 . . . . 0.0 111.167 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -97.64 107.14 19.58 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.243 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 34.3 m -105.35 24.18 2.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.939 0.876 . . . . 0.0 110.255 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 238' ' ' ALA . 23.6 t -86.27 -23.5 26.33 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.395 175.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -60.68 -40.35 91.82 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.231 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.508 HD22 ' H ' ' A' ' 228' ' ' LEU . 2.3 pt? -98.11 -1.33 42.59 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.904 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.452 ' HA3' ' HB1' ' A' ' 238' ' ' ALA . . . -84.64 45.58 3.53 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.732 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 79.9 mt -82.77 -73.96 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.155 0.503 . . . . 0.0 110.877 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.04 11.15 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.426 0.631 . . . . 0.0 110.367 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 36.8 p -64.17 -38.56 91.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.474 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.631 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . -143.2 58.98 1.41 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.297 177.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 25.5 m 60.94 10.54 2.83 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.645 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 79.65 2.08 87.6 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.245 -0.503 . . . . 0.0 113.149 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.631 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 19.6 ptpt -71.51 -20.74 62.02 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -176.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 32.6 pt -81.65 -4.42 7.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 226' ' ' SER . . . -73.47 108.5 6.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.842 -178.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -169.35 -175.28 2.18 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -108.5 126.63 8.28 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -128.6 157.09 42.23 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 117.256 0.528 . . . . 0.0 111.748 -175.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -102.64 133.9 46.88 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.79 176.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -129.77 155.0 46.65 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.933 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -100.47 124.87 46.56 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.112 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 90.9 mt -76.71 125.77 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 CA-C-O 120.918 0.389 . . . . 0.0 110.934 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 4.3 t -132.35 94.56 3.46 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 174.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -81.21 117.16 21.5 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.65 -176.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -131.22 71.6 81.82 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.551 177.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.572 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 66.7 Cg_endo -71.78 -19.44 27.45 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.027 1.818 . . . . 0.0 112.461 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -86.92 -24.58 24.76 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.963 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -101.78 -58.09 1.95 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.921 0.391 . . . . 0.0 110.904 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -84.73 -39.27 18.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.414 0.625 . . . . 0.0 110.518 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 103.77 -9.31 51.73 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.171 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 70.2 m -135.93 169.23 17.92 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.783 0.325 . . . . 0.0 110.936 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 86.2 t -86.95 119.91 35.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 174.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -115.53 150.8 35.98 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 120.868 0.366 . . . . 0.0 111.045 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -121.63 140.96 51.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.4 p -119.12 137.48 52.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 120.697 0.284 . . . . 0.0 110.453 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 60.6 tp -74.88 124.29 26.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.841 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.85 91.31 8.61 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.268 2.047 0 CA-C-O 117.68 -1.152 . . . . 0.0 110.666 -175.247 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 120.661 0.267 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -127.26 74.33 1.5 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.656 0.741 . . . . 0.0 110.357 -178.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -128.17 149.99 50.19 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.955 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -104.64 107.83 18.98 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 120.861 0.362 . . . . 0.0 110.804 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.404 ' N ' HD11 ' A' ' 172' ' ' ILE . 3.9 mp -104.19 100.97 11.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.447 ' HD2' ' HA2' ' A' ' 176' ' ' GLY . 38.3 ptt180 -161.77 153.67 16.13 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.941 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -60.43 -45.11 23.66 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.299 1.999 . . . . 0.0 111.257 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 17.2 tmm? -157.28 -48.58 0.07 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.447 ' HA2' ' HD2' ' A' ' 173' ' ' ARG . . . 148.88 84.01 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.17 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.703 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.42 ' H ' HD22 ' A' ' 177' ' ' LEU . 2.1 pt? -72.51 166.96 21.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.811 0.339 . . . . 0.0 111.498 -177.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -61.23 -28.65 69.32 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -175.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -156.7 143.77 18.77 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -69.3 90.77 0.51 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.45 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 41.0 ttmt -154.28 140.47 18.5 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.978 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -128.95 158.11 39.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.375 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -84.55 106.14 15.9 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 58.1 t -104.17 125.37 58.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.475 0.655 . . . . 0.0 112.504 -172.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 94.0 m -104.48 126.87 51.97 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.406 ' HD1' HD13 ' A' ' 259' ' ' LEU . 80.9 m-70 -103.47 107.97 57.73 Favored Pre-proline 0 C--N 1.315 -0.93 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.18 -20.22 56.36 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 122.626 2.217 . . . . 0.0 112.158 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 70.1 m -63.68 -40.89 97.93 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.217 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.402 ' HB2' HG11 ' A' ' 191' ' ' VAL . 26.4 mt -107.74 -15.35 14.59 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.51 -178.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 67.2 t30 60.35 52.87 4.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.686 -175.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.402 HG11 ' HB2' ' A' ' 189' ' ' LEU . 12.2 p -135.24 143.39 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.667 -177.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 95.5 m -105.6 116.45 31.97 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.078 0.466 . . . . 0.0 110.249 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 63.7 t -131.19 129.9 63.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.144 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.45 ' HG2' ' HG2' ' A' ' 181' ' ' LYS . 48.3 tt0 -77.99 121.23 23.94 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.459 HD12 ' HD2' ' A' ' 196' ' ' PRO . 18.5 tp -126.86 141.2 39.8 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.216 -171.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.459 ' HD2' HD12 ' A' ' 195' ' ' LEU . 53.7 Cg_endo -67.88 151.48 78.19 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.75 2.3 . . . . 0.0 112.604 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 83.1 mt -97.12 118.2 43.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.231 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.2 mp -73.2 -43.79 60.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.147 0.499 . . . . 0.0 110.781 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 87.1 p -157.07 161.96 39.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.597 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.98 138.74 51.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.621 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -124.03 127.71 48.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.661 -177.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -90.08 125.2 35.34 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -107.2 143.08 26.42 Favored Pre-proline 0 C--N 1.313 -1.004 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.444 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.23 -17.99 35.08 Favored 'Trans proline' 0 N--CA 1.472 0.214 0 C-N-CA 123.156 2.571 . . . . 0.0 112.337 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 68.1 m -61.79 -40.43 95.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.537 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -118.53 101.88 50.47 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.059 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.22 148.05 67.67 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.384 2.056 . . . . 0.0 112.164 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.62 161.56 29.58 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.267 0.556 . . . . 0.0 111.687 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -60.16 -44.56 94.91 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.05 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 11.5 t -141.03 176.94 8.41 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.522 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -63.9 -39.06 93.3 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.403 ' O ' HD13 ' A' ' 212' ' ' LEU . 4.3 pp -143.46 133.73 24.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.785 0.326 . . . . 0.0 110.683 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.05 173.51 49.71 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 26.8 t 44.82 88.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.391 0.676 . . . . 0.0 112.668 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -83.7 175.26 9.82 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.102 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 14.9 t -131.28 174.44 10.05 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 120.786 0.327 . . . . 0.0 110.418 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -73.47 152.3 40.78 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.532 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.81 8.5 48.34 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.497 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 86.9 m -82.83 140.0 33.18 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 51.2 mm -102.17 127.36 55.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 O-C-N 121.919 -0.488 . . . . 0.0 111.093 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.433 HD12 HD12 ' A' ' 245' ' ' ILE . 43.0 pt -124.67 157.27 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.349 177.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -109.7 126.29 53.55 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 33.6 m -128.35 158.88 40.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 120.985 0.421 . . . . 0.0 110.954 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -89.94 107.09 18.91 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 43.6 t -90.92 78.76 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 30.0 t -167.76 -46.78 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.308 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -75.0 -4.59 39.22 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.416 ' HG ' ' H ' ' A' ' 230' ' ' ILE . 2.6 pt? -63.32 -15.56 57.71 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.893 0.378 . . . . 0.0 111.005 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 92.03 -12.68 68.91 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.933 174.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.416 ' H ' ' HG ' ' A' ' 228' ' ' LEU . 39.8 pt -131.98 153.86 39.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.587 0.708 . . . . 0.0 111.657 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 8.1 p -173.83 125.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 114.281 -1.327 . . . . 0.0 108.357 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 9.2 t -93.27 -10.76 34.43 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.264 0.554 . . . . 0.0 110.877 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.468 ' HB1' HG12 ' A' ' 237' ' ' ILE . . . -94.63 20.34 8.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.189 -177.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 37.0 m 59.59 27.88 17.18 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.004 0.43 . . . . 0.0 111.84 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 82.38 6.17 88.92 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.943 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -61.39 -39.26 90.04 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.056 0.455 . . . . 0.0 110.206 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.468 HG12 ' HB1' ' A' ' 233' ' ' ALA . 22.2 pt -98.12 15.42 3.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.04 -178.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -87.1 105.16 16.98 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.614 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -153.97 175.1 13.79 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.961 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -79.22 113.16 3.6 Favored Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 171.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -125.02 156.77 37.61 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 120.693 0.282 . . . . 0.0 110.407 -173.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -101.7 148.84 24.79 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.406 0.622 . . . . 0.0 112.185 -176.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -134.1 159.63 40.25 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.137 -177.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -99.31 127.73 45.35 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.183 0.516 . . . . 0.0 111.404 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.497 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 47.5 mm -76.22 125.62 36.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.341 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.7 t -129.61 101.91 6.13 Favored 'General case' 0 N--CA 1.425 -1.698 0 O-C-N 124.401 1.063 . . . . 0.0 108.679 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -76.32 121.07 22.44 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.4 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -129.78 71.33 82.16 Favored Pre-proline 0 C--N 1.314 -0.935 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.42 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 74.5 Cg_endo -72.31 -19.82 25.1 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.49 2.127 . . . . 0.0 112.545 -177.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -85.93 -24.08 26.71 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.042 0.449 . . . . 0.0 110.646 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -92.7 -55.3 3.43 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.155 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -105.67 -37.65 6.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.096 0.474 . . . . 0.0 110.664 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 100.91 10.94 41.59 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.817 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 30.6 p -147.04 177.69 8.96 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.491 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 96.4 t -79.58 122.12 34.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.693 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -112.94 150.15 32.24 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.739 -177.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -130.26 142.81 50.53 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 120.942 0.401 . . . . 0.0 110.73 177.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.8 p -123.67 131.42 73.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.94 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.406 HD13 ' HD1' ' A' ' 186' ' ' HIS . 10.1 tt -83.82 126.51 33.01 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.064 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 4.1 pp -92.81 130.03 38.54 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.515 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.27 2.154 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.652 -178.302 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 120.691 0.281 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 59.55 28.76 18.24 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.538 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -127.69 -3.13 5.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.909 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.528 ' HA ' ' NH1' ' A' ' 173' ' ' ARG . 52.7 t80 -92.2 78.21 5.19 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.145 0.497 . . . . 0.0 110.785 -178.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.0 mp -122.58 117.73 52.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.075 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.528 ' NH1' ' HA ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -164.12 155.84 14.25 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.934 177.583 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.35 -43.38 23.24 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.343 2.029 . . . . 0.0 112.168 178.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 51.9 ttm 177.39 30.63 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 105.79 151.33 19.67 Favored Glycine 0 N--CA 1.423 -2.193 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -172.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -151.59 154.6 36.76 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 116.894 0.347 . . . . 0.0 110.588 -178.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -68.88 -35.38 76.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.612 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -168.08 150.4 5.47 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.445 ' HB3' ' HB ' ' A' ' 197' ' ' ILE . 98.4 mttt -76.23 89.05 3.1 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.698 0.285 . . . . 0.0 111.608 -178.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -124.79 143.99 50.51 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.573 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -137.07 144.28 43.05 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.863 176.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 66.5 t30 -85.7 99.8 11.56 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.7 t -91.68 120.98 41.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.265 0.555 . . . . 0.0 112.14 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 90.4 m -98.23 124.09 42.65 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.542 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -100.65 113.55 65.61 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.541 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.39 -16.51 51.56 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.647 2.231 . . . . 0.0 111.675 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 41.2 m -65.19 -43.13 92.6 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.264 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.453 ' HB2' HG12 ' A' ' 191' ' ' VAL . 23.8 mt -114.78 -9.17 12.56 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.699 -175.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 60.97 42.34 12.91 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.083 -176.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.453 HG12 ' HB2' ' A' ' 189' ' ' LEU . 10.5 p -129.26 147.7 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 14.8 t -123.77 129.63 51.35 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.307 0.575 . . . . 0.0 110.579 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 58.9 t -134.53 138.5 49.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.209 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 61.0 tt0 -80.51 113.31 18.61 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.302 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 7.6 mp -116.41 155.7 48.22 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.367 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.55 147.03 56.93 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.265 1.977 . . . . 0.0 111.535 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 180' ' ' LYS . 84.7 mt -87.3 107.27 16.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.892 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.87 -42.89 76.41 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.014 0.435 . . . . 0.0 111.088 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 222' ' ' GLU . 18.8 m -141.67 146.09 35.71 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.428 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.7 138.62 44.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.019 0.438 . . . . 0.0 111.379 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.07 147.79 51.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.531 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -73.25 158.85 34.39 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.801 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.446 ' OD1' ' HB2' ' A' ' 205' ' ' SER . 26.3 t-20 -62.47 127.77 90.46 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.608 0.242 . . . . 0.0 110.695 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.4 -20.43 70.06 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.532 2.822 . . . . 0.0 113.965 -175.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.446 ' HB2' ' OD1' ' A' ' 203' ' ' ASN . 48.8 m -79.92 -10.03 59.74 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.931 0.396 . . . . 0.0 110.351 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 51.91 57.73 15.94 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -84.44 -5.56 10.1 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.501 2.134 . . . . 0.0 111.026 177.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.402 HD21 ' H ' ' A' ' 216' ' ' THR . 93.7 mt -72.94 148.74 44.0 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.016 -177.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.621 ' HB2' ' O ' ' A' ' 212' ' ' LEU . 62.8 m-85 -96.69 -11.48 25.08 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.753 177.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 35.4 m 67.09 -74.29 0.07 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.656 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -74.6 -16.21 60.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.893 0.377 . . . . 0.0 111.732 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.621 ' O ' ' HB2' ' A' ' 209' ' ' TYR . 96.4 mt -126.45 151.23 48.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.714 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 77.59 -171.37 55.15 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.613 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 30.9 m -127.94 172.11 15.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -58.88 128.26 36.33 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.129 0.49 . . . . 0.0 110.752 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.402 ' H ' HD21 ' A' ' 208' ' ' LEU . 75.1 p -91.68 163.67 14.01 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.531 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -70.57 151.36 45.12 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.894 0.378 . . . . 0.0 110.719 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.12 7.69 30.48 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.135 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.637 ' OG1' ' HB ' ' A' ' 245' ' ' ILE . 50.6 p -79.96 157.69 26.79 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.3 mm -115.78 129.04 72.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.017 0.437 . . . . 0.0 111.672 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.408 ' HB ' HG21 ' A' ' 197' ' ' ILE . 46.1 pt -125.86 158.3 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.999 178.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 199' ' ' SER . 44.1 tt0 -107.52 124.68 50.27 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.283 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.06 156.69 40.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.106 0.479 . . . . 0.0 110.951 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -100.64 113.49 26.38 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.338 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 22.3 t -83.96 70.6 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 18.7 m -159.78 -22.56 0.07 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.707 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.41 8.34 11.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.669 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.44 -22.26 65.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.049 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 95.73 -9.07 68.63 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.748 -0.66 . . . . 0.0 113.281 178.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 48.8 mm -115.8 135.52 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 CA-C-O 122.258 1.028 . . . . 0.0 112.515 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 4.7 m -112.46 118.22 57.24 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.475 0 CA-C-N 113.067 -1.879 . . . . 0.0 108.867 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.463 ' O ' ' HB3' ' A' ' 233' ' ' ALA . 61.1 p -68.48 -41.77 79.65 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.661 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 232' ' ' THR . . . 163.49 -39.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.079 0.952 . . . . 0.0 110.41 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 18.9 m -137.83 12.45 2.91 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.02 -176.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.35 50.67 54.7 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 119.724 -1.227 . . . . 0.0 110.74 -176.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -57.22 -37.76 72.72 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 123.417 0.687 . . . . 0.0 110.332 -174.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 11.8 pt -118.66 19.19 6.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.814 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -81.17 107.71 14.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.82 0.343 . . . . 0.0 111.441 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 -159.34 169.43 24.03 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.568 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -94.05 119.14 5.94 Favored Glycine 0 N--CA 1.437 -1.241 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 172.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.427 ' CB ' HD12 ' A' ' 259' ' ' LEU . 37.3 mmt180 -127.86 164.05 23.08 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.953 0.406 . . . . 0.0 111.419 -174.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.539 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 96.6 m-85 -104.09 140.73 37.36 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.148 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -125.07 148.57 48.45 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.051 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 219' ' ' THR . 37.0 tt0 -98.68 125.69 44.06 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.195 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.637 ' HB ' ' OG1' ' A' ' 219' ' ' THR . 90.8 mt -80.75 127.77 39.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.048 0.452 . . . . 0.0 111.066 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 4.8 t -135.57 102.6 5.17 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.811 176.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -78.63 116.92 19.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.612 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -131.53 73.98 78.87 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.869 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.93 -23.14 41.21 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.285 1.99 . . . . 0.0 112.179 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -80.42 -12.55 59.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.333 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -113.1 -57.7 2.25 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.128 0.49 . . . . 0.0 111.001 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.476 ' HB2' HD22 ' A' ' 256' ' ' ASN . 26.9 m-20 -96.86 -27.6 14.61 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.881 -176.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 80.5 16.66 75.31 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.944 -178.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 48.5 t -155.48 165.3 37.01 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 96.1 t -81.06 121.95 35.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.476 HD22 ' HB2' ' A' ' 252' ' ' ASP . 48.1 m-80 -113.14 152.7 29.31 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 120.838 0.352 . . . . 0.0 111.257 -174.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -128.86 131.22 47.64 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.16 126.1 58.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.134 0.492 . . . . 0.0 109.908 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.427 HD12 ' CB ' ' A' ' 241' ' ' ARG . 51.5 tp -75.28 129.13 36.92 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.805 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 242' ' ' TYR . 3.0 pp -100.99 127.78 47.33 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 C--O 1.262 1.739 0 CA-C-O 117.951 -1.023 . . . . 0.0 111.065 -178.579 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 121.284 0.564 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -63.04 -41.51 99.51 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.385 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -87.51 12.36 12.54 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -100.25 114.46 27.93 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.4 HD13 ' N ' ' A' ' 172' ' ' ILE . 4.1 mp -93.23 126.95 45.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.178 -175.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -127.47 81.26 70.45 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.318 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.62 -41.37 64.87 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.291 1.994 . . . . 0.0 111.077 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 56.7 ttm -173.84 13.02 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.505 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 85.64 101.31 0.71 Allowed Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -175.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.458 ' O ' HD13 ' A' ' 177' ' ' LEU . 4.1 pp -106.89 135.25 48.76 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.087 0.47 . . . . 0.0 111.301 -178.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -73.43 -29.68 62.72 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.392 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -160.51 143.41 13.25 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.467 ' HB3' ' HB ' ' A' ' 197' ' ' ILE . 56.3 mtmt -73.4 80.74 1.4 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.048 0.451 . . . . 0.0 111.92 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.436 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 84.8 tttt -155.72 135.2 12.44 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -141.96 160.54 40.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.97 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 17.8 m120 -80.9 103.56 10.82 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 64.1 t -85.68 122.06 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 121.338 0.59 . . . . 0.0 110.798 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.1 m -102.96 125.67 49.82 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.279 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -103.99 105.88 50.54 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.56 -32.39 79.76 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.465 2.11 . . . . 0.0 113.209 -176.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 87.9 m -67.22 -41.81 85.09 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.995 0.426 . . . . 0.0 110.872 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.403 ' HB2' HG11 ' A' ' 191' ' ' VAL . 41.7 mt -88.13 -20.66 25.35 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.414 0.626 . . . . 0.0 109.326 -178.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.4 t30 60.03 50.73 6.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.654 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.403 HG11 ' HB2' ' A' ' 189' ' ' LEU . 9.9 p -139.97 147.67 23.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.658 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 60.0 m -116.97 119.26 34.77 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 65.6 t -128.94 127.95 66.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 46.1 tt0 -78.2 118.98 20.94 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 91.7 mt -126.19 149.74 67.71 Favored Pre-proline 0 C--N 1.312 -1.022 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.28 -176.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.48 146.2 55.05 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.012 1.808 . . . . 0.0 110.919 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' A' ' 180' ' ' LYS . 80.7 mt -91.47 117.77 35.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.66 -43.54 80.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.14 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 67.9 m -152.19 149.66 28.98 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.528 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 36.0 m -116.52 142.24 30.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -130.94 142.7 50.38 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.406 0.622 . . . . 0.0 110.827 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -71.9 134.65 46.16 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.981 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.436 ' HB2' ' HD2' ' A' ' 204' ' ' PRO . 9.6 p30 -75.14 159.9 81.51 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.552 ' HB2' ' OD1' ' A' ' 206' ' ' ASN . 19.0 Cg_endo -59.3 -21.21 59.41 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.506 2.137 . . . . 0.0 112.599 -178.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 34.8 m 61.21 34.22 18.88 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.262 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.552 ' OD1' ' HB2' ' A' ' 204' ' ' PRO . 19.5 m120 -70.36 -56.56 6.61 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.771 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.8 -32.48 11.49 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 121.937 1.758 . . . . 0.0 112.235 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 66.1 tp -126.06 108.59 11.51 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -122.04 10.38 10.08 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.526 ' O ' ' HG ' ' A' ' 212' ' ' LEU . 43.9 p -66.93 -46.22 75.44 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.124 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 62.3 -63.33 0.1 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.249 1.02 . . . . 0.0 113.222 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 210' ' ' THR . 2.6 pp -65.39 -18.19 65.12 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 123.191 0.596 . . . . 0.0 111.955 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -92.15 17.31 57.39 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.778 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 59.8 t 76.49 128.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.548 0.739 . . . . 0.0 110.193 -178.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 4.6 pp -89.23 175.49 7.34 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.681 -176.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 74.7 p -127.14 -172.51 2.67 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.455 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.491 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 18.2 ptpt -50.59 150.83 2.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.275 0.559 . . . . 0.0 112.409 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 114.99 6.11 19.2 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.804 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 244' ' ' GLN . 56.9 m -71.6 138.92 49.1 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.5 mm -92.37 125.69 44.96 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.717 0 CA-C-O 120.522 0.201 . . . . 0.0 110.502 -176.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 47.3 pt -133.54 160.12 42.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 120.961 0.41 . . . . 0.0 111.2 177.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -107.32 126.96 53.11 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.455 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.33 153.16 30.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.145 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -102.61 111.12 23.29 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.295 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 46.6 t -78.71 79.39 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 32.7 t -174.71 -27.55 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.949 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.31 5.11 9.2 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.291 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.65 -38.58 88.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.768 0.318 . . . . 0.0 110.677 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 83.39 7.01 87.11 Favored Glycine 0 CA--C 1.509 -0.325 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.531 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 49.3 pt -107.93 0.27 9.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 120.6 0.238 . . . . 0.0 110.822 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 39.7 t 62.74 96.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.903 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 14.0 m -85.08 101.13 12.18 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.982 -175.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.532 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . 50.08 52.72 14.16 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.69 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 41.8 m 64.13 10.12 5.23 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.293 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 80.98 5.63 90.01 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.991 -0.623 . . . . 0.0 113.184 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 65.3 pttt -67.12 -24.22 65.89 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.211 0.529 . . . . 0.0 111.043 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 13.0 pt -110.5 19.76 6.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.37 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -78.0 105.68 9.37 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.168 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -145.11 158.14 43.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.888 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -81.25 132.28 11.07 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 175.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -128.5 172.42 11.16 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.915 0.388 . . . . 0.0 110.804 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -101.35 140.07 36.14 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.104 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -135.78 159.2 42.38 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.28 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 219' ' ' THR . 49.0 mt-30 -113.81 136.26 53.06 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.406 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 89.5 mt -79.85 124.19 37.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.491 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 4.9 t -124.72 92.45 3.65 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 122.12 0.962 . . . . 0.0 108.72 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . 0.425 ' C ' ' HD3' ' A' ' 249' ' ' PRO . 20.1 p-10 -74.48 118.94 18.01 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.586 -177.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -130.22 67.87 80.41 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.88 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' A' ' 247' ' ' ASN . 6.5 Cg_exo -77.35 -23.06 10.46 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.139 1.893 . . . . 0.0 109.99 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -67.9 -36.96 81.1 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.792 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -107.22 -58.09 1.99 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.421 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -72.27 -39.78 68.12 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.327 0.584 . . . . 0.0 110.854 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 100.77 7.24 51.21 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.404 -0.817 . . . . 0.0 112.399 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 39.4 t -152.44 164.71 36.99 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.781 0.324 . . . . 0.0 111.165 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 86.9 t -80.63 123.78 37.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -117.61 152.88 34.26 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.689 -174.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -124.41 145.68 49.34 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.5 p -121.09 131.94 71.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.043 0.449 . . . . 0.0 110.63 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.4 tt -100.86 128.35 46.94 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.251 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 2.7 pp -100.8 150.47 22.77 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.076 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.261 1.699 0 CA-C-O 118.102 -0.951 . . . . 0.0 111.037 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 . . . . . 0 N--CA 1.469 0.51 0 CA-C-O 120.676 0.274 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 49.92 75.87 0.15 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.964 177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.444 ' NE ' ' HA ' ' A' ' 170' ' ' ARG . 4.5 mmp_? -64.25 139.62 58.78 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.712 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -61.77 132.79 54.3 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.412 -174.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 97.2 mt -112.37 115.86 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.687 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.538 ' NH1' ' HA ' ' A' ' 175' ' ' MET . 3.0 tmt_? 55.0 85.27 0.19 Allowed Pre-proline 0 CA--C 1.535 0.367 0 O-C-N 123.72 0.638 . . . . 0.0 111.239 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -67.58 -74.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.618 1.545 . . . . 0.0 111.569 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.538 ' HA ' ' NH1' ' A' ' 173' ' ' ARG . 44.7 tpp -163.12 17.58 0.08 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.978 0.418 . . . . 0.0 110.63 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 66.07 40.3 95.05 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.18 -1.009 . . . . 0.0 112.098 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.525 ' H ' HD22 ' A' ' 177' ' ' LEU . 1.5 pt? -94.08 -164.3 1.16 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.658 0.266 . . . . 0.0 110.943 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -60.43 -25.57 66.07 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.108 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.428 ' H ' ' HG ' ' A' ' 177' ' ' LEU . 76.1 m-85 -94.67 147.96 22.77 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 64.19 43.72 4.79 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 122.284 1.04 . . . . 0.0 109.299 -170.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.525 ' HD3' ' HG2' ' A' ' 194' ' ' GLN . 4.0 tmmm? -124.26 133.69 53.43 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 113.597 -1.638 . . . . 0.0 107.561 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -135.7 159.79 40.54 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.221 0.534 . . . . 0.0 112.132 -175.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 58.2 t30 -87.22 105.68 17.38 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.92 119.02 41.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.441 0.639 . . . . 0.0 111.693 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 86.6 m -105.27 126.26 51.9 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.082 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -105.52 108.92 62.54 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 40.4 Cg_endo -66.69 -30.49 41.77 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 122.017 1.811 . . . . 0.0 112.576 -178.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 88.6 m -65.57 -43.37 90.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.283 0.563 . . . . 0.0 111.03 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.412 ' HB2' HG12 ' A' ' 191' ' ' VAL . 36.1 mt -96.17 -16.96 21.17 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.748 -177.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.4 t30 60.66 52.58 4.39 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.613 -176.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.412 HG12 ' HB2' ' A' ' 189' ' ' LEU . 10.2 p -138.04 137.25 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.002 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 9.3 t -115.94 116.86 28.68 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.529 0.681 . . . . 0.0 110.181 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 64.3 t -129.11 129.3 67.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.182 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.525 ' HG2' ' HD3' ' A' ' 181' ' ' LYS . 33.0 tt0 -77.38 124.29 27.67 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.482 HD13 ' HD2' ' A' ' 196' ' ' PRO . 25.2 tp -142.7 139.23 16.94 Favored Pre-proline 0 C--N 1.317 -0.848 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.767 -173.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.482 ' HD2' HD13 ' A' ' 195' ' ' LEU . 40.9 Cg_endo -67.87 147.24 74.3 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 121.882 1.721 . . . . 0.0 109.873 173.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 79.1 mt -84.48 124.5 39.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 120.918 0.39 . . . . 0.0 111.565 -175.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.65 -40.51 84.51 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.219 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 33.4 t -159.57 150.85 19.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 30.7 m -126.21 148.22 30.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.906 0.384 . . . . 0.0 110.932 -178.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -116.31 117.81 31.01 Favored 'General case' 0 C--O 1.253 1.283 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 174.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.81 141.07 54.15 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 124.475 1.109 . . . . 0.0 111.292 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -58.45 124.12 70.0 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.472 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.53 -35.83 4.42 Favored 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 123.188 2.592 . . . . 0.0 114.056 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 50.0 m -154.98 87.78 1.15 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -175.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -153.16 147.02 18.41 Favored Pre-proline 0 C--N 1.305 -1.344 0 CA-C-O 120.931 0.396 . . . . 0.0 110.718 172.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 208' ' ' LEU . 71.7 Cg_endo -76.26 -8.05 18.37 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.167 2.578 . . . . 0.0 112.687 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 207' ' ' PRO . 9.4 mp 71.96 -81.9 0.03 OUTLIER 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.432 0.693 . . . . 0.0 110.26 -176.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 86.4 t80 72.02 -21.93 0.22 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.514 0.725 . . . . 0.0 112.721 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 208' ' ' LEU . 46.7 m -100.49 111.76 24.05 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.693 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 58.58 -179.67 0.07 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.434 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 94.7 mt -128.94 141.7 51.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.339 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 82.48 -1.49 87.53 Favored Glycine 0 C--N 1.323 -0.166 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.319 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.41 170.87 17.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 4.2 pp -98.61 175.0 6.15 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.649 0.738 . . . . 0.0 112.223 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 57.1 m -124.73 151.3 45.22 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.818 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.441 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 8.3 ptpp? -43.88 151.24 0.22 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 113.5 4.38 23.42 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.766 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.563 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 88.6 m -78.38 136.75 37.74 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.5 mm -100.82 128.56 52.84 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.495 HD11 HD11 ' A' ' 245' ' ' ILE . 46.8 pt -126.86 162.44 31.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -99.62 121.96 41.96 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.774 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 28.5 m -129.81 155.04 41.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 O-C-N 123.386 0.429 . . . . 0.0 110.519 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.422 ' OD1' HD21 ' A' ' 195' ' ' LEU . 16.5 p-10 -101.94 116.85 33.6 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.375 0.607 . . . . 0.0 110.961 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.52 ' HB ' HH11 ' A' ' 241' ' ' ARG . 53.0 t -109.76 87.69 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 38.7 t -118.83 -79.79 0.6 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.038 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -99.74 -30.13 12.25 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.021 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 91.7 mt 63.73 23.56 13.53 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.14 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 92.69 -8.3 76.8 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 121.016 -0.611 . . . . 0.0 113.228 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.8 pt -129.19 169.12 21.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.818 0.309 . . . . 0.0 110.607 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 15.9 m -90.3 89.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-O 121.712 0.768 . . . . 0.0 110.075 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 5.1 t -80.99 -51.47 8.49 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.747 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.446 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . -170.42 53.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.641 0.258 . . . . 0.0 111.636 -177.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 19.9 m 58.52 20.01 7.14 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.096 177.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.89 21.59 76.75 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.082 -0.58 . . . . 0.0 113.545 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 19.2 ptpt -69.81 -18.94 63.49 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.622 0.711 . . . . 0.0 111.738 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 28.9 pt -96.26 13.33 3.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.136 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -72.07 107.2 4.65 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.234 0.54 . . . . 0.0 112.195 -177.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -143.99 144.13 31.53 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.307 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -74.76 125.73 8.59 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.52 HH11 ' HB ' ' A' ' 225' ' ' VAL . 85.5 mtt85 -128.46 165.46 20.64 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.917 0.358 . . . . 0.0 111.185 -175.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.417 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 99.5 m-85 -101.03 136.08 41.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.542 -177.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -123.36 148.08 46.41 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.093 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -97.19 125.33 41.65 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.718 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.563 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 46.5 mm -83.11 122.38 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.918 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.018 177.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.441 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 1.3 t -128.64 86.86 2.5 Favored 'General case' 0 N--CA 1.428 -1.544 0 O-C-N 124.339 1.024 . . . . 0.0 108.78 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -80.5 115.87 20.25 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.339 0.59 . . . . 0.0 110.749 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -131.04 73.36 81.01 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.434 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.487 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 43.5 Cg_endo -66.73 -22.76 49.48 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.811 1.674 . . . . 0.0 110.673 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -69.1 -37.57 78.47 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.284 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . 0.433 ' C ' HD21 ' A' ' 251' ' ' ASN . 0.2 OUTLIER -92.72 -55.9 3.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.262 -175.043 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -100.44 -32.31 10.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.194 0.521 . . . . 0.0 110.966 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 95.6 -4.95 66.81 Favored Glycine 0 C--N 1.315 -0.593 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.657 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 85.9 m -131.22 167.3 19.42 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.773 0.321 . . . . 0.0 110.77 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 87.5 t -80.74 121.37 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -108.47 146.5 33.06 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.578 -174.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -137.82 146.57 43.66 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.449 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.3 p -132.32 136.38 56.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.431 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.437 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 56.4 tp -73.05 130.53 40.51 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.098 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 242' ' ' TYR . 4.0 pp -102.82 144.46 31.12 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.861 176.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 26.5 m . . . . . 0 C--O 1.268 2.042 0 CA-C-O 117.905 -1.045 . . . . 0.0 111.043 -179.49 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 121.085 0.469 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -90.83 -33.78 15.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.033 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -112.91 108.39 17.32 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.043 -173.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -118.31 120.78 38.67 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.845 174.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.451 HG23 ' HB ' ' A' ' 200' ' ' VAL . 2.9 mp -114.14 21.97 5.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 122.046 0.927 . . . . 0.0 109.657 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.27 151.07 46.94 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.279 176.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -58.31 -72.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.832 2.355 . . . . 0.0 112.526 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.518 ' HA ' ' HE3' ' A' ' 175' ' ' MET . 3.6 tpt -146.17 27.16 1.17 Allowed 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 104.57 143.74 12.49 Favored Glycine 0 N--CA 1.422 -2.237 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -174.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -132.85 169.05 17.3 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 120.276 -0.569 . . . . 0.0 111.168 -178.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -61.37 -41.96 97.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.257 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -172.28 140.27 1.12 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -76.26 92.56 3.31 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 120.943 0.402 . . . . 0.0 110.995 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.441 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 22.5 ttmm -144.83 137.92 26.69 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.918 -177.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -139.07 154.78 48.23 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.787 0.327 . . . . 0.0 111.345 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -88.57 111.59 22.06 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.012 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 65.1 t -99.12 125.8 52.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.248 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.0 m -104.4 127.97 52.17 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.693 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -104.48 110.6 64.52 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -55.94 -36.36 95.65 Favored 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 123.448 2.766 . . . . 0.0 113.562 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 87.0 m -66.07 -41.27 90.97 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.127 0.489 . . . . 0.0 111.392 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.408 ' HB2' HG13 ' A' ' 191' ' ' VAL . 40.0 mt -94.42 -18.66 21.32 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.403 -175.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 58.77 44.14 17.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.141 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 189' ' ' LEU . 9.9 p -134.23 144.49 35.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.75 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 86.2 m -113.73 120.25 40.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.173 0.511 . . . . 0.0 109.861 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 10.9 m -126.14 143.78 38.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.636 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.441 ' HG2' ' HG2' ' A' ' 181' ' ' LYS . 59.0 tt0 -97.76 122.37 40.77 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.603 -175.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -128.73 156.87 76.88 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.494 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.61 149.68 68.18 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.28 1.987 . . . . 0.0 110.674 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 79.3 mt -84.78 112.16 21.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.525 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 223' ' ' VAL . 3.9 mm? -68.0 -42.13 81.18 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.221 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' A' ' 222' ' ' GLU . 37.3 t -150.91 148.6 28.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.222 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' A' ' 172' ' ' ILE . 16.7 m -123.03 140.85 45.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.999 0.428 . . . . 0.0 111.275 -178.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -133.8 131.91 39.85 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -111.01 144.77 39.59 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.223 177.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.51 ' HB2' ' HD3' ' A' ' 207' ' ' PRO . 2.6 m-20 -77.49 131.86 70.55 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.93 -19.64 64.04 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.836 2.357 . . . . 0.0 111.933 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 80.0 p -72.35 -13.2 61.42 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.694 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 59.73 81.02 0.25 Allowed Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.137 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' A' ' 203' ' ' ASN . 98.5 Cg_endo -83.41 51.81 3.68 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.933 2.422 . . . . 0.0 111.613 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 9.1 mp -91.75 119.74 31.85 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -103.88 8.58 36.97 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.156 0.503 . . . . 0.0 110.312 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.466 HG22 ' H ' ' A' ' 212' ' ' LEU . 54.7 m -132.81 132.44 42.19 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.991 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -74.8 4.1 6.96 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.466 ' H ' HG22 ' A' ' 210' ' ' THR . 95.1 mt -81.59 0.6 37.57 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.76 0.314 . . . . 0.0 111.417 -177.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 72.68 32.78 61.17 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.468 -0.873 . . . . 0.0 111.944 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.81 153.66 27.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 78.8 mt -79.07 145.22 33.94 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 121.752 0.786 . . . . 0.0 111.905 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.2 p -116.43 -178.1 3.34 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.937 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.455 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 18.0 ptpt -60.68 144.91 51.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.286 0.565 . . . . 0.0 112.123 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 112.13 5.54 24.95 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.184 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.641 ' OG1' ' HB ' ' A' ' 245' ' ' ILE . 1.3 p -86.09 158.14 19.88 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 122.211 0.204 . . . . 0.0 111.239 178.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 48.4 mm -114.56 129.8 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -174.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.4 ' CG2' HD11 ' A' ' 245' ' ' ILE . 44.9 pt -132.65 162.94 39.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.025 0.44 . . . . 0.0 111.09 176.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 199' ' ' SER . 43.9 tt0 -112.86 131.39 55.73 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.42 ' HA ' HD23 ' A' ' 198' ' ' LEU . 26.8 m -129.08 150.88 35.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.092 0.472 . . . . 0.0 110.785 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -103.54 106.1 16.52 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.319 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 7.6 p -84.13 71.22 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-O 122.585 1.183 . . . . 0.0 110.149 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 228' ' ' LEU . 14.9 m -154.37 -37.13 0.09 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.638 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -81.46 20.72 0.85 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.161 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.401 HD13 HG23 ' A' ' 225' ' ' VAL . 98.9 mt -61.33 -39.1 89.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.78 -177.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 174.22 -92.64 0.09 OUTLIER Glycine 0 N--CA 1.428 -1.841 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.617 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 63.9 mt -132.76 -86.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.075 0.464 . . . . 0.0 111.338 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.94 77.1 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.611 0.719 . . . . 0.0 110.759 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 23.9 p -71.14 -60.18 2.37 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.912 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -143.31 49.39 1.43 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.919 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 20.9 t 65.0 12.81 8.2 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.493 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 74.15 11.2 81.82 Favored Glycine 0 C--O 1.225 -0.411 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.859 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -67.66 -33.47 75.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.019 0.914 . . . . 0.0 109.499 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 35.9 pt -86.54 10.57 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.742 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -77.35 107.77 10.01 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -176.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . 0.467 ' O ' HG11 ' A' ' 225' ' ' VAL . 26.7 t90 -170.3 146.95 2.99 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.893 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -72.08 129.96 15.94 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.653 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -130.48 175.04 9.3 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -113.19 147.32 37.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.386 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -138.39 153.17 48.91 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.628 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -102.09 136.0 42.69 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.053 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.641 ' HB ' ' OG1' ' A' ' 219' ' ' THR . 87.3 mt -85.84 126.3 40.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.116 0.484 . . . . 0.0 110.777 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.455 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 3.1 t -127.24 87.83 2.7 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 174.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -68.7 117.22 10.14 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.371 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -128.2 69.62 78.08 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.795 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -84.86 -13.29 6.83 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.569 2.179 . . . . 0.0 111.727 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -68.9 -37.67 79.13 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.095 -177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -115.18 -57.53 2.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.39 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 254' ' ' CYS . 35.9 t70 -67.9 -39.5 83.59 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.345 0.593 . . . . 0.0 109.841 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 89.6 0.11 79.51 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.973 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . 0.476 ' HB2' ' OD2' ' A' ' 252' ' ' ASP . 74.3 m -130.23 164.03 25.43 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.847 0.356 . . . . 0.0 111.181 -177.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 62.8 t -82.74 117.19 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -106.74 149.67 27.08 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.433 -176.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -136.35 144.36 44.57 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.12 131.06 70.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 121.146 0.498 . . . . 0.0 110.664 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.7 tt -99.51 125.36 45.26 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.672 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.434 ' O ' HD11 ' A' ' 260' ' ' LEU . 3.2 pp -92.9 144.52 25.18 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.244 0.545 . . . . 0.0 111.805 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.269 2.083 0 CA-C-O 117.729 -1.129 . . . . 0.0 110.442 179.441 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.898 0.38 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.443 ' C ' ' H ' ' A' ' 171' ' ' PHE . 48.5 mt-10 -83.77 -0.09 49.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.25 0.547 . . . . 0.0 110.949 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -84.29 25.26 0.87 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.559 0.695 . . . . 0.0 109.522 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.443 ' H ' ' C ' ' A' ' 169' ' ' GLU . 86.5 t80 -60.13 -39.11 85.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.071 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 86.5 mt -55.36 124.86 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.468 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.475 ' HG3' ' H ' ' A' ' 176' ' ' GLY . 18.4 ptp180 -144.26 154.03 56.86 Favored Pre-proline 0 N--CA 1.438 -1.043 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.419 -177.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.411 ' HB2' HD13 ' A' ' 177' ' ' LEU . 51.4 Cg_exo -57.62 -42.31 61.8 Favored 'Trans proline' 0 N--CA 1.482 0.794 0 C-N-CA 122.97 2.447 . . . . 0.0 113.302 -176.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 53.5 ttp -178.62 46.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.349 0.595 . . . . 0.0 109.531 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.475 ' H ' ' HG3' ' A' ' 173' ' ' ARG . . . 78.39 22.2 68.12 Favored Glycine 0 C--N 1.316 -0.555 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.079 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.411 HD13 ' HB2' ' A' ' 174' ' ' PRO . 10.2 mp -71.73 156.14 39.67 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.093 0.473 . . . . 0.0 110.75 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -59.66 -36.25 76.06 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.237 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -139.16 160.03 40.76 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.022 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -75.98 83.76 2.87 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.213 -177.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -128.24 144.58 51.14 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.956 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -132.69 150.62 52.13 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.646 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -87.88 100.46 12.9 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 192' ' ' THR . 67.3 t -84.21 117.37 29.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.202 -172.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.4 m -100.1 128.37 46.19 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.494 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -103.21 111.77 65.29 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.26 -25.0 57.56 Favored 'Trans proline' 0 N--CA 1.479 0.633 0 C-N-CA 122.986 2.457 . . . . 0.0 114.37 -175.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 39.6 p -66.79 -43.32 84.26 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.498 ' CD1' HG13 ' A' ' 191' ' ' VAL . 0.6 OUTLIER -116.52 -4.44 11.75 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.118 0.485 . . . . 0.0 111.802 -179.192 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.7 t30 59.44 61.59 1.98 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.218 -0.901 . . . . 0.0 113.292 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.498 HG13 ' CD1' ' A' ' 189' ' ' LEU . 3.2 p -138.52 147.77 25.08 Favored 'Isoleucine or valine' 0 C--O 1.248 1.005 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 175.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 15.3 t -127.62 135.88 50.87 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 120.266 -0.573 . . . . 0.0 111.529 -177.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 6.6 m -140.8 147.68 22.56 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.494 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -85.55 123.71 31.28 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.773 0.321 . . . . 0.0 111.582 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -128.08 151.51 76.12 Favored Pre-proline 0 C--O 1.24 0.558 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.314 176.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.91 144.42 47.87 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.365 2.044 . . . . 0.0 111.169 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.419 HG22 ' HB ' ' A' ' 221' ' ' ILE . 73.0 mt -92.24 119.37 39.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.423 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.4 -42.16 68.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.853 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 44.3 m -141.7 144.28 33.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.394 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.9 m -127.35 139.64 51.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.009 0.433 . . . . 0.0 111.683 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.436 ' O ' HG21 ' A' ' 219' ' ' THR . 57.3 mtpt -139.23 132.01 29.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.38 174.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -92.0 160.14 15.39 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 206' ' ' ASN . 15.8 m120 -65.36 127.95 93.37 Favored Pre-proline 0 C--N 1.314 -0.966 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.81 -29.75 50.24 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.619 2.213 . . . . 0.0 113.673 -176.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 20.4 m -111.18 -15.03 13.76 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -177.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 203' ' ' ASN . 79.9 m-20 -98.56 118.92 62.54 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 121.092 0.473 . . . . 0.0 111.458 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.83 170.23 18.36 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 123.507 2.805 . . . . 0.0 112.67 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 92.4 mt -76.8 166.06 23.87 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.241 177.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.534 ' CE2' ' HA ' ' A' ' 216' ' ' THR . 75.0 m-85 -61.76 -38.96 89.93 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.732 -178.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 11.2 m -110.97 -73.12 0.69 Allowed 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.406 ' HG3' ' HG ' ' A' ' 212' ' ' LEU . 12.7 pt20 177.21 -26.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.859 0.864 . . . . 0.0 109.026 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.406 ' HG ' ' HG3' ' A' ' 211' ' ' GLN . 4.0 pp -154.24 172.01 18.31 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.366 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 85.22 -82.05 1.71 Allowed Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.69 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 28.7 m -82.18 142.59 13.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.199 0.524 . . . . 0.0 111.556 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 173' ' ' ARG . 60.2 tp -96.12 149.76 21.26 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.564 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.534 ' HA ' ' CE2' ' A' ' 209' ' ' TYR . 14.8 t -89.84 148.72 23.02 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.426 ' HE2' ' OG1' ' A' ' 246' ' ' THR . 14.1 ptmm? -74.5 148.16 41.23 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.614 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.72 7.98 49.74 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.591 -176.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.436 HG21 ' O ' ' A' ' 201' ' ' LYS . 79.9 m -71.09 134.33 46.95 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 122.416 0.286 . . . . 0.0 110.623 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.415 HD11 ' HG2' ' A' ' 244' ' ' GLN . 45.5 mm -93.19 124.06 45.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.591 -176.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.419 ' HB ' HG22 ' A' ' 197' ' ' ILE . 47.3 pt -131.71 160.64 42.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.314 0.578 . . . . 0.0 112.027 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -109.3 126.11 53.02 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.326 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 31.6 m -131.13 157.5 43.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.103 0.478 . . . . 0.0 111.281 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -107.02 106.72 17.38 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.439 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 44.9 t -82.39 78.67 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 22.2 t -179.3 -21.7 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.411 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -60.34 -35.42 75.61 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.726 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -53.32 -23.56 9.58 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.901 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 91.42 -12.13 70.17 Favored Glycine 0 C--N 1.329 0.174 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.833 175.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 45.2 pt -122.37 159.25 25.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.134 0.492 . . . . 0.0 110.371 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.35 149.95 31.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.336 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 6.8 t -72.81 -41.92 64.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.252 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.04 91.14 1.25 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.343 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 50.1 m 58.56 23.83 11.3 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 173.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.05 32.98 82.16 Favored Glycine 0 C--O 1.222 -0.602 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.82 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.25 -39.88 88.34 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.424 0.631 . . . . 0.0 110.71 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 15.5 pt -102.05 12.41 7.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.837 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -83.35 106.47 15.14 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.518 -176.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 -166.67 176.8 6.95 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.172 0.989 . . . . 0.0 109.037 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -76.13 125.32 7.72 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -128.36 177.92 6.63 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.118 0.485 . . . . 0.0 111.164 -177.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -120.05 145.88 46.43 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.533 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -135.45 158.43 44.39 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.394 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.415 ' HG2' HD11 ' A' ' 220' ' ' ILE . 78.8 mt-30 -114.26 128.45 56.37 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.694 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 86.2 mt -82.18 127.13 39.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.176 0.512 . . . . 0.0 111.67 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.426 ' OG1' ' HE2' ' A' ' 217' ' ' LYS . 4.0 t -137.72 102.68 4.81 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.275 175.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -75.44 124.84 27.85 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.553 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -128.67 71.32 80.9 Favored Pre-proline 0 N--CA 1.443 -0.8 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.156 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.515 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 54.7 Cg_endo -68.99 -19.6 39.61 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.92 1.747 . . . . 0.0 110.089 178.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -66.6 -37.87 85.81 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.917 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -98.21 -57.1 2.29 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.033 0.444 . . . . 0.0 110.76 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -94.5 -37.33 11.45 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.384 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.515 ' CA ' ' HA ' ' A' ' 249' ' ' PRO . . . 100.73 -4.39 56.36 Favored Glycine 0 C--N 1.312 -0.783 0 C-N-CA 120.657 -0.783 . . . . 0.0 111.55 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 79.9 m -128.04 167.95 16.01 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.806 0.336 . . . . 0.0 110.965 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 81.5 t -80.55 121.03 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -115.95 152.83 32.72 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.935 -173.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -124.63 141.51 52.05 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.0 p -108.69 134.08 51.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.082 0.468 . . . . 0.0 110.549 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 62.0 tp -88.29 123.39 32.84 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.458 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.57 105.5 17.65 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.476 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.278 2.585 0 CA-C-O 117.481 -1.247 . . . . 0.0 110.224 178.485 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 121.078 0.466 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.9 -40.13 83.51 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.135 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.469 ' HD2' ' N ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 52.43 96.9 0.01 OUTLIER 'General case' 0 C--N 1.34 0.189 0 O-C-N 124.227 0.954 . . . . 0.0 113.194 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -62.46 -37.34 85.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.952 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.405 HG22 HG22 ' A' ' 200' ' ' VAL . 6.4 tp -67.2 125.32 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 176.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -136.0 152.06 74.91 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.137 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -63.39 -73.47 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.81 1.673 . . . . 0.0 111.294 176.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.547 ' SD ' HG22 ' A' ' 214' ' ' VAL . 95.4 mmm -131.54 -0.3 3.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.335 0.588 . . . . 0.0 109.8 176.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 102.17 101.94 2.61 Favored Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -177.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.454 HD11 ' O ' ' A' ' 177' ' ' LEU . 1.5 pp -115.25 149.78 37.22 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.784 0.326 . . . . 0.0 110.938 -178.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -72.75 -34.23 66.88 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.443 ' O ' HD13 ' A' ' 177' ' ' LEU . 93.4 m-85 -138.2 148.49 44.87 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 177.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 196' ' ' PRO . 3.2 mppt? -80.88 73.06 7.9 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.636 -0.426 . . . . 0.0 109.954 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -123.08 139.02 54.51 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.585 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.464 ' HB2' HD13 ' A' ' 197' ' ' ILE . . . -136.55 148.2 47.45 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.563 176.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -84.74 102.04 12.7 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 58.9 t -93.72 120.34 42.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.312 0.577 . . . . 0.0 111.908 -173.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 90.5 m -112.13 128.71 56.3 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.04 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -104.44 108.39 60.39 Favored Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.55 -27.65 61.59 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 122.535 2.157 . . . . 0.0 113.557 -175.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.3 t -77.77 -27.92 50.45 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.748 0.309 . . . . 0.0 111.695 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.403 ' HB2' HG11 ' A' ' 191' ' ' VAL . 37.4 mt -104.25 -22.02 13.44 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.276 0.56 . . . . 0.0 109.801 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.8 t30 60.21 52.79 4.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.928 -175.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.403 HG11 ' HB2' ' A' ' 189' ' ' LEU . 11.2 p -133.41 137.09 53.76 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.512 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 92.9 m -119.29 124.33 46.4 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.984 0.421 . . . . 0.0 111.042 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 10.3 m -142.95 149.59 18.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.127 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.493 ' C ' HD12 ' A' ' 195' ' ' LEU . 35.3 tt0 -102.89 119.82 39.52 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.85 178.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.493 HD12 ' C ' ' A' ' 194' ' ' GLN . 7.1 mp -128.38 150.59 74.71 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.58 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 180' ' ' LYS . 38.3 Cg_exo -61.37 141.09 91.37 Favored 'Trans proline' 0 C--O 1.24 0.608 0 C-N-CA 122.556 2.17 . . . . 0.0 111.23 175.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.484 HD12 HD11 ' A' ' 221' ' ' ILE . 34.8 mm -91.67 119.85 39.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.193 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 96.6 mt -69.25 -42.19 75.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.597 -177.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.4 t -154.39 149.57 26.99 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.767 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.443 HG13 HG21 ' A' ' 221' ' ' ILE . 32.1 m -128.96 148.09 33.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.45 ' O ' HG21 ' A' ' 219' ' ' THR . 14.5 ptmm? -139.65 149.33 43.6 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -66.75 154.96 39.4 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.351 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -80.07 116.61 62.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.144 0.497 . . . . 0.0 110.986 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.43 -33.25 9.05 Favored 'Trans proline' 0 N--CA 1.472 0.212 0 C-N-CA 122.737 2.291 . . . . 0.0 113.033 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 49.6 m -133.92 69.44 1.47 Allowed 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.325 0.583 . . . . 0.0 111.568 -177.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -153.5 139.08 11.93 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.625 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.0 140.11 40.99 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.495 2.13 . . . . 0.0 112.906 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.435 ' HA ' ' CG2' ' A' ' 216' ' ' THR . 4.9 mp -117.96 145.04 45.0 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.81 177.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -67.68 -42.27 82.36 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.8 m 63.32 -11.78 0.09 Allowed 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 173.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -61.68 -40.48 95.12 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.8 pp -119.34 15.23 13.02 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.731 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 75.29 76.78 0.74 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.188 -1.006 . . . . 0.0 110.797 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.547 HG22 ' SD ' ' A' ' 175' ' ' MET . 7.6 p -135.34 140.5 44.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 120.909 0.385 . . . . 0.0 111.428 -176.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 61.4 tp -97.66 128.88 44.68 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.435 ' CG2' ' HA ' ' A' ' 208' ' ' LEU . 32.1 p -91.11 168.3 11.73 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -176.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -60.94 153.94 23.68 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.812 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 106.7 10.19 29.24 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -176.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.574 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 87.8 m -71.57 128.5 36.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.438 ' HB ' ' CG ' ' A' ' 201' ' ' LYS . 48.5 mm -90.36 129.03 41.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.762 0.315 . . . . 0.0 110.301 -177.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.484 HD11 HD12 ' A' ' 197' ' ' ILE . 39.0 pt -127.56 154.82 38.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -177.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -102.04 119.32 38.6 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.347 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.31 156.73 40.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.596 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -103.55 108.57 19.89 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.005 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 239' ' ' TRP . 35.2 m -87.58 21.06 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 122.067 0.937 . . . . 0.0 109.288 176.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 21.2 m -105.21 -14.0 15.51 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.561 173.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.85 1.11 55.32 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.287 -174.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.444 HD11 HG12 ' A' ' 230' ' ' ILE . 0.3 OUTLIER -64.35 -31.14 72.22 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.582 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 69.5 31.97 71.26 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.92 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.444 HG12 HD11 ' A' ' 228' ' ' LEU . 42.2 pt -119.39 151.83 21.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 117.214 0.507 . . . . 0.0 110.649 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 27.1 m -121.75 8.35 5.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.694 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 14.6 t -58.66 -18.38 30.28 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.769 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.531 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . -119.26 29.13 7.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.847 0.356 . . . . 0.0 110.553 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 23.0 m 66.75 3.26 2.92 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.637 0.775 . . . . 0.0 112.138 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 81.04 0.71 89.26 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.942 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 19.2 ptpt -70.14 -15.52 62.97 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.122 0.487 . . . . 0.0 111.333 -179.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 33.8 pt -80.93 -4.64 7.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.568 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.16 109.26 2.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.0 0.428 . . . . 0.0 110.149 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . 0.405 ' H ' HG23 ' A' ' 225' ' ' VAL . 5.0 m95 -151.96 176.29 11.64 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.627 -178.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -109.8 112.73 3.43 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 171.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -129.44 161.32 30.64 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 117.118 0.459 . . . . 0.0 111.882 -174.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -102.62 133.81 47.02 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.193 175.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -114.68 162.73 16.41 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.613 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -110.24 128.41 55.49 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.083 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.574 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 89.1 mt -81.85 127.23 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.773 0 CA-C-O 120.969 0.414 . . . . 0.0 111.18 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.622 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 2.7 t -128.17 101.32 6.21 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.166 175.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -78.35 117.81 19.94 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.451 0.643 . . . . 0.0 112.148 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -128.57 72.12 80.72 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.355 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.419 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 56.5 Cg_endo -68.77 -19.55 40.96 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.389 2.059 . . . . 0.0 111.568 -178.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -70.13 -30.63 67.85 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.026 177.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -94.1 -56.49 2.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.316 -177.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -104.39 -28.03 11.6 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' A' ' 249' ' ' PRO . . . 83.43 10.4 82.04 Favored Glycine 0 C--N 1.315 -0.585 0 C-N-CA 120.34 -0.933 . . . . 0.0 111.755 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 83.4 m -135.32 173.48 11.67 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 122.408 0.283 . . . . 0.0 110.263 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 86.3 t -79.56 122.42 34.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.622 ' HB2' ' O ' ' A' ' 246' ' ' THR . 6.3 m120 -103.82 152.09 22.31 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -176.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -136.48 143.88 44.06 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 11.0 p -134.54 140.84 44.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-O 120.903 0.382 . . . . 0.0 110.445 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 63.0 tp -79.04 126.02 30.16 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.463 ' O ' HD12 ' A' ' 260' ' ' LEU . 2.8 pp -67.04 133.96 50.96 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.169 0.509 . . . . 0.0 111.512 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 C--O 1.263 1.777 0 CA-C-O 117.684 -1.151 . . . . 0.0 110.794 179.571 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 11.4 t80 . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -78.91 58.21 2.32 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.038 0.447 . . . . 0.0 111.678 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -138.37 148.65 44.75 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.293 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.499 ' HB3' HD11 ' A' ' 197' ' ' ILE . . . -145.93 149.64 34.58 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.472 176.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -81.33 103.24 10.96 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.479 HG22 ' HB3' ' A' ' 257' ' ' ALA . 58.6 t -92.65 118.82 39.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.237 0.541 . . . . 0.0 110.604 -176.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.4 m -94.13 122.53 36.75 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.272 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -105.06 108.33 61.03 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.3 -28.0 63.7 Favored 'Trans proline' 0 N--CA 1.471 0.192 0 C-N-CA 122.261 1.974 . . . . 0.0 112.007 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 81.1 m -65.66 -41.69 92.21 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.722 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.534 ' HB2' HG12 ' A' ' 191' ' ' VAL . 33.4 mt -96.05 -19.0 19.77 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.066 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 64.3 t30 61.47 51.32 4.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.424 -175.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.534 HG12 ' HB2' ' A' ' 189' ' ' LEU . 5.9 p -149.92 144.12 17.63 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.912 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 11.4 t -111.6 124.34 52.09 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.423 0.63 . . . . 0.0 109.466 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 67.4 t -131.82 136.53 56.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.249 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -79.91 116.76 20.24 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.04 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.442 HD21 HD11 ' A' ' 228' ' ' LEU . 7.5 mp -111.73 150.82 42.83 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.841 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.61 140.21 38.98 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.66 1.574 . . . . 0.0 110.028 174.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' A' ' 182' ' ' ALA . 37.5 mm -86.98 114.82 26.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.082 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 223' ' ' VAL . 4.1 mm? -69.28 -42.41 75.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.802 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.4 t -161.77 149.43 14.69 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.349 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.614 HG12 HG22 ' A' ' 221' ' ' ILE . 32.0 m -119.79 146.62 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -119.97 122.91 42.25 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -52.57 155.2 2.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.638 -1.164 . . . . 0.0 112.585 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 . . . . . 0 N--CA 1.438 -1.06 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 170.498 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.489 HD13 HG21 ' A' ' 219' ' ' THR . 83.9 mt . . . . . 0 CA--C 1.503 -0.835 0 CA-C-O 121.32 0.581 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 66.7 p -90.15 166.6 13.3 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.138 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.612 ' HA ' ' O ' ' A' ' 245' ' ' ILE . 19.2 ptpt -65.37 142.62 58.15 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.873 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.4 1.64 55.61 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.209 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.609 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 85.4 m -66.81 138.12 57.11 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.8 mm -94.38 128.84 45.36 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.046 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.323 -174.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.614 HG22 HG12 ' A' ' 200' ' ' VAL . 47.1 pt -126.1 159.39 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 CA-C-O 120.774 0.321 . . . . 0.0 110.314 176.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -116.8 117.91 31.06 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.417 ' HA ' HD23 ' A' ' 198' ' ' LEU . 28.1 m -130.69 157.83 43.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.288 0.566 . . . . 0.0 111.635 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -105.17 106.61 17.18 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.438 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 239' ' ' TRP . 7.2 p -83.84 78.26 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 122.43 1.11 . . . . 0.0 110.446 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 22.2 m -158.77 -34.06 0.07 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.058 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -75.47 9.77 2.0 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.216 -176.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.442 HD11 HD21 ' A' ' 195' ' ' LEU . 7.0 mp -63.52 -40.68 97.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.131 0.491 . . . . 0.0 109.689 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 79.43 -2.03 73.94 Favored Glycine 0 C--O 1.226 -0.351 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.799 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.8 pt -80.1 -31.24 13.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 122.71 -0.288 . . . . 0.0 111.684 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 20.8 t 48.91 72.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 O-C-N 123.558 0.536 . . . . 0.0 110.643 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 13.5 t -110.96 -8.27 14.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.564 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.686 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . -128.06 31.89 5.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.717 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 19.7 m 59.86 9.79 1.85 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 79.78 3.07 89.04 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.962 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.686 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 65.0 pttt -72.02 -11.37 60.73 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.188 0.518 . . . . 0.0 111.804 -177.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 34.9 pt -95.91 -0.86 10.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.641 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -62.48 112.15 2.34 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 123.354 0.409 . . . . 0.0 111.965 -175.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' TRP . . . . . 0.505 ' O ' HG12 ' A' ' 225' ' ' VAL . 71.0 t-105 -175.13 146.91 0.88 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.875 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -73.7 120.39 6.88 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -128.6 162.76 26.55 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.912 0.387 . . . . 0.0 111.214 -173.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -102.45 136.28 42.56 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.94 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -127.02 158.3 37.31 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.096 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -105.73 132.31 52.01 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.875 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 217' ' ' LYS . 49.1 mm -79.07 130.28 36.37 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.192 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.536 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 4.4 t -140.09 104.14 4.77 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -80.76 119.75 23.75 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 120.842 0.354 . . . . 0.0 110.748 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -128.09 72.17 79.31 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-O 121.405 0.622 . . . . 0.0 109.381 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.485 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 71.8 Cg_endo -71.53 -17.84 29.8 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.884 2.389 . . . . 0.0 112.964 -176.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -82.2 -21.61 36.36 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.797 0.332 . . . . 0.0 110.803 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -105.67 -56.86 2.12 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.141 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.442 ' CB ' HD21 ' A' ' 256' ' ' ASN . 18.9 m-20 -93.37 -31.08 14.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.936 0.398 . . . . 0.0 111.44 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 82.99 4.85 89.81 Favored Glycine 0 C--N 1.321 -0.281 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.503 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 65.3 m -132.6 174.14 10.59 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.515 0.197 . . . . 0.0 110.935 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 90.6 t -79.48 121.87 33.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.536 ' HB2' ' O ' ' A' ' 246' ' ' THR . 5.3 m120 -110.13 152.28 26.21 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.612 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.479 ' HB3' HG22 ' A' ' 184' ' ' VAL . . . -134.38 144.83 48.44 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.508 177.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.68 135.94 61.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.006 0.431 . . . . 0.0 110.215 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 64.7 tp -95.57 127.06 41.29 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.23 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.464 ' H ' ' HG ' ' A' ' 260' ' ' LEU . 2.1 pp -90.31 136.71 32.88 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.405 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.266 1.957 0 CA-C-O 117.702 -1.142 . . . . 0.0 111.011 -178.106 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -97.39 34.71 1.75 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.069 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.428 ' HB3' ' HG2' ' A' ' 194' ' ' GLN . 59.5 mtmt -118.2 144.83 45.42 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.15 0.5 . . . . 0.0 111.114 -176.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -129.44 152.22 49.22 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.026 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -81.53 99.57 8.88 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.3 t -89.68 126.05 42.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.211 -174.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.9 m -114.87 128.3 56.21 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.576 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.518 ' NE2' HD21 ' A' ' 228' ' ' LEU . 30.9 m170 -104.46 117.96 57.85 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.04 -24.89 77.1 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 122.829 2.353 . . . . 0.0 113.492 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 11.6 t -79.67 -23.53 42.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.834 0.35 . . . . 0.0 111.628 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.479 ' HB2' HG12 ' A' ' 191' ' ' VAL . 40.5 mt -103.55 -24.32 13.43 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.2 t30 59.06 46.95 12.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.513 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.479 HG12 ' HB2' ' A' ' 189' ' ' LEU . 8.9 p -133.49 145.27 33.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.174 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 87.9 m -116.42 119.43 35.62 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.436 HG11 ' O ' ' A' ' 228' ' ' LEU . 61.0 t -133.73 138.84 49.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.428 ' HG2' ' HB3' ' A' ' 181' ' ' LYS . 33.7 tt0 -87.57 118.25 26.92 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.881 0.372 . . . . 0.0 111.037 -177.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.71 153.5 77.81 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.195 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.85 146.86 54.52 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.334 2.023 . . . . 0.0 111.26 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.422 HG23 ' HB ' ' A' ' 221' ' ' ILE . 80.6 mt -89.46 116.51 31.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.323 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 95.8 mt -71.78 -42.18 67.45 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.528 ' HB2' ' HB3' ' A' ' 222' ' ' GLU . 16.6 m -140.92 147.19 38.46 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 26.7 m -125.97 146.09 32.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.328 0.585 . . . . 0.0 111.508 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -127.65 106.91 9.47 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.094 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -56.6 156.91 5.72 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.44 0.462 . . . . 0.0 111.661 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 C--N 1.32 -0.676 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.202 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 61.6 tp . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 24.2 p -95.75 159.18 15.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.863 0.363 . . . . 0.0 111.23 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -61.7 152.15 31.82 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.049 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 109.69 9.76 24.33 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.618 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 21.2 m -73.08 142.12 47.58 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.5 mm -100.2 127.84 52.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.961 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.554 HD13 HD11 ' A' ' 245' ' ' ILE . 45.5 pt -127.53 163.16 31.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.591 0.234 . . . . 0.0 110.598 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.528 ' HB3' ' HB2' ' A' ' 199' ' ' SER . 8.4 tm-20 -124.43 125.65 44.62 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.035 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.3 m -131.15 141.86 44.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.145 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.601 ' HA ' ' HA2' ' A' ' 240' ' ' GLY . 50.8 t-20 -114.82 107.1 14.98 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.967 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.718 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 7.8 p -175.03 -56.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.902 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.422 ' N ' HG13 ' A' ' 225' ' ' VAL . 10.8 t 72.76 -56.16 0.66 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.396 0.678 . . . . 0.0 111.268 -177.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' A' ' 230' ' ' ILE . 1.6 m-20 -63.01 -21.95 66.51 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.344 0.258 . . . . 0.0 111.678 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.518 HD21 ' NE2' ' A' ' 186' ' ' HIS . 96.7 mt 67.23 18.29 10.32 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 92.68 -5.29 76.73 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.63 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.451 ' O ' ' HB3' ' A' ' 227' ' ' ASP . 48.2 pt -107.23 170.46 2.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 231' ' ' VAL . 7.7 p -96.42 90.41 2.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.693 0.758 . . . . 0.0 111.929 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 10.6 t -101.37 -34.96 9.39 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 174.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.689 ' HB3' HG12 ' A' ' 237' ' ' ILE . . . -138.44 9.87 2.71 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.736 174.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 9.3 t 63.37 31.52 15.13 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.155 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 85.13 3.44 87.45 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.083 -0.58 . . . . 0.0 113.192 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -65.12 -39.8 93.59 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 121.25 0.548 . . . . 0.0 111.205 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.689 HG12 ' HB3' ' A' ' 233' ' ' ALA . 30.4 pt -93.04 18.88 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.468 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.718 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -54.01 120.59 6.59 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -153.07 150.68 29.39 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.886 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 224' ' ' ASN . . . -96.22 116.01 5.33 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.847 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -129.3 171.97 11.95 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.735 0.302 . . . . 0.0 111.151 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 96.8 m-85 -102.2 140.48 36.43 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.282 0.563 . . . . 0.0 111.214 -177.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -129.48 154.49 46.94 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.36 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -101.17 133.15 46.15 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.618 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 47.9 mm -80.39 124.64 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.709 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 12.6 p -119.42 76.29 1.12 Allowed 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.082 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -68.66 121.8 17.2 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.352 0.596 . . . . 0.0 110.964 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -128.95 71.29 81.79 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.275 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -72.19 -25.33 19.05 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 121.4 1.4 . . . . 0.0 112.216 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -74.05 -33.02 63.56 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.062 0.458 . . . . 0.0 110.609 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -96.9 -57.1 2.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.937 -176.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -95.0 -29.91 14.38 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.77 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 76.62 18.56 78.9 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.375 -0.917 . . . . 0.0 110.875 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 49.7 t -149.18 160.71 43.12 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.375 -0.413 . . . . 0.0 109.96 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 85.3 t -80.39 126.85 39.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.946 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 246' ' ' THR . 42.3 m-80 -110.46 153.74 24.6 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.19 148.54 35.12 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.703 0.287 . . . . 0.0 110.65 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.59 130.64 56.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 8.9 tt -75.46 127.96 34.27 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.102 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.467 ' O ' HD12 ' A' ' 260' ' ' LEU . 4.2 pp -84.94 132.5 34.35 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.133 0.492 . . . . 0.0 111.229 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 10.6 m . . . . . 0 C--O 1.279 2.641 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.924 179.646 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 . . . . . 0 CA--C 1.511 -0.553 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -79.47 87.82 5.07 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.655 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -156.91 137.28 12.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.489 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.545 ' HB3' HD11 ' A' ' 197' ' ' ILE . . . -145.86 157.07 43.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.963 0.411 . . . . 0.0 111.392 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 56.8 t30 -83.5 99.46 10.14 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.479 HG22 ' HB3' ' A' ' 257' ' ' ALA . 53.1 t -92.65 118.93 39.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.279 0.562 . . . . 0.0 112.067 -172.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 89.6 m -94.31 124.18 38.17 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.259 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -104.84 111.18 65.22 Favored Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -62.93 -28.2 75.1 Favored 'Trans proline' 0 N--CA 1.475 0.407 0 C-N-CA 122.543 2.162 . . . . 0.0 112.621 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.9 t -70.99 -31.88 68.54 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.309 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.547 ' HB2' HG12 ' A' ' 191' ' ' VAL . 43.6 mt -98.53 -22.36 16.03 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.3 t30 60.47 44.89 11.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.99 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.547 HG12 ' HB2' ' A' ' 189' ' ' LEU . 4.0 p -145.75 150.5 15.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.984 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.588 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 14.4 t -121.87 128.79 52.0 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 121.343 0.592 . . . . 0.0 110.175 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.83 138.24 52.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 63.0 tt0 -81.18 118.36 22.49 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.41 HD12 ' C ' ' A' ' 194' ' ' GLN . 7.1 mp -128.11 151.85 76.72 Favored Pre-proline 0 C--O 1.239 0.507 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.894 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 180' ' ' LYS . 45.2 Cg_exo -61.05 143.81 99.25 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.642 2.228 . . . . 0.0 110.921 173.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.545 HD11 ' HB3' ' A' ' 182' ' ' ALA . 46.1 mm -84.8 117.79 30.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 223' ' ' VAL . 3.6 mm? -70.05 -40.85 74.88 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 38.2 t -155.02 150.24 27.09 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.451 HG12 HG22 ' A' ' 221' ' ' ILE . 35.6 m -127.58 146.2 33.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.093 0.473 . . . . 0.0 110.975 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -133.64 143.52 48.64 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.493 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -79.34 151.43 31.02 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.178 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 . . . . . 0 C--N 1.311 -1.099 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 174.416 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.7 t -117.64 -170.83 1.94 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.114 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.514 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 14.0 ptmm? -54.02 148.42 10.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.381 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 114.49 4.77 21.58 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.145 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.5 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 50.5 m -72.09 140.08 48.75 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.2 mm -92.8 127.33 45.0 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.963 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.451 HG22 HG12 ' A' ' 200' ' ' VAL . 46.3 pt -133.46 165.38 32.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 120.814 0.34 . . . . 0.0 110.943 178.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -121.21 126.77 50.46 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.485 ' HA ' HD23 ' A' ' 198' ' ' LEU . 35.6 m -131.25 156.65 42.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.213 0.53 . . . . 0.0 111.717 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -99.92 107.01 18.88 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.025 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 7.5 p -85.52 79.35 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 122.276 1.036 . . . . 0.0 110.536 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 57.0 p -175.77 -26.39 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.711 -1.586 . . . . 0.0 108.569 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -62.04 -13.48 26.49 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.324 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.11 -37.3 79.59 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.015 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 90.62 8.11 66.04 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.425 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 41.3 pt -122.91 155.41 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 77.9 t -127.0 123.81 63.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.911 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.3 t -79.16 -52.22 8.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.099 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -161.64 98.95 1.12 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.675 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 25.8 t 65.26 -2.61 0.75 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.72 31.2 70.37 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.764 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.6 pttp -64.08 -13.63 48.76 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -177.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 19.9 pt -107.5 4.2 9.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.188 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -71.11 107.58 4.23 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.777 0.323 . . . . 0.0 111.658 -176.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 -164.09 176.58 9.16 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.041 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -91.47 122.77 6.89 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 108.894 -1.683 . . . . 0.0 108.894 173.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 75.9 mtt-85 -128.93 168.35 16.1 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 117.233 0.516 . . . . 0.0 111.319 -174.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.448 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 93.1 m-85 -101.36 143.55 31.26 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.164 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -136.92 166.3 23.96 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.359 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.432 ' HG3' HD23 ' A' ' 260' ' ' LEU . 98.3 mt-30 -116.6 136.98 52.52 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.054 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.5 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 88.2 mt -81.59 121.06 34.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.555 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 71.8 p -123.52 92.62 3.73 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.757 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -83.76 125.51 31.99 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.256 -176.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -131.59 70.28 81.44 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.51 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 73.4 Cg_endo -73.83 -17.8 22.43 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.032 1.822 . . . . 0.0 111.858 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -86.96 -14.82 40.67 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.235 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -111.3 -57.16 2.28 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.249 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -93.42 -28.14 16.31 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.846 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 92.08 -6.34 78.84 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.896 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 81.8 m -128.65 164.7 22.32 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.709 0.29 . . . . 0.0 111.069 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 92.6 t -80.38 118.09 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.555 ' HB2' ' O ' ' A' ' 246' ' ' THR . 78.4 m-20 -105.89 154.89 19.92 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.152 -174.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.479 ' HB3' HG22 ' A' ' 184' ' ' VAL . . . -135.2 146.55 48.79 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 10.7 p -123.44 134.99 64.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 120.997 0.427 . . . . 0.0 110.78 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 57.9 tp -84.1 130.77 34.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.353 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 242' ' ' TYR . 4.1 pp -101.4 146.01 28.17 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.857 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 C--O 1.268 2.068 0 CA-C-O 117.801 -1.095 . . . . 0.0 110.184 177.348 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 32.6 t80 . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -79.0 97.77 6.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.982 0.42 . . . . 0.0 111.625 -177.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -129.55 144.03 51.09 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.024 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.546 ' HB3' HD11 ' A' ' 197' ' ' ILE . . . -137.18 153.0 50.53 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.753 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -87.07 101.66 13.68 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 60.3 t -95.29 125.84 47.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.452 0.644 . . . . 0.0 112.266 -172.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 92.8 m -107.08 127.77 53.78 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.74 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -104.27 108.93 61.7 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.2 -23.99 59.26 Favored 'Trans proline' 0 N--CA 1.476 0.449 0 C-N-CA 123.002 2.468 . . . . 0.0 113.629 -175.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 13.2 t -81.13 -21.11 40.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.783 0.325 . . . . 0.0 111.546 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.478 ' HB2' HG12 ' A' ' 191' ' ' VAL . 39.8 mt -109.45 -20.59 12.84 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.5 t30 60.43 48.89 7.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.425 -1.262 . . . . 0.0 109.843 -175.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' A' ' 189' ' ' LEU . 7.9 p -133.82 139.24 49.03 Favored 'Isoleucine or valine' 0 C--O 1.248 1.015 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.979 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 86.2 m -115.87 118.64 33.55 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 60.4 t -137.41 145.54 29.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.859 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -77.23 120.04 21.73 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.8 mp -123.02 145.4 45.75 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.788 0.327 . . . . 0.0 111.077 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.06 145.0 43.65 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.423 2.082 . . . . 0.0 110.051 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.726 HD12 HD12 ' A' ' 221' ' ' ILE . 31.7 mm -95.68 124.06 48.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.574 -178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.432 HD11 ' HB2' ' A' ' 224' ' ' ASN . 98.3 mt -70.37 -43.67 69.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.052 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 26.3 m -142.13 141.78 32.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.186 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 18.8 m -126.14 128.49 71.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.787 0.327 . . . . 0.0 111.098 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -141.18 149.97 42.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.972 0.415 . . . . 0.0 111.229 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -99.01 159.29 15.07 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 174.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 . . . . . 0 C--N 1.318 -0.793 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.346 178.278 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.6 pt? . . . . . 0 N--CA 1.449 -0.521 0 CA-C-O 121.177 0.513 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 39.1 p -109.67 171.78 7.24 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.276 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -61.68 150.85 35.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.971 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 96.87 4.18 59.0 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.735 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.625 ' OG1' ' HB ' ' A' ' 245' ' ' ILE . 1.9 p -79.35 157.2 27.69 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.557 0.218 . . . . 0.0 111.425 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.6 mm -108.43 127.76 64.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.269 0.556 . . . . 0.0 112.127 -174.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.726 HD12 HD12 ' A' ' 197' ' ' ILE . 26.9 pt -131.88 162.49 39.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.404 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -110.91 129.02 56.0 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.77 153.34 33.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.34 0.59 . . . . 0.0 111.637 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.432 ' HB2' HD11 ' A' ' 198' ' ' LEU . 60.2 t30 -103.01 104.89 15.11 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.531 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 6.1 p -101.32 80.1 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-O 122.277 1.037 . . . . 0.0 109.934 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 38.4 p -160.02 -32.59 0.06 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.055 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -85.97 21.42 1.96 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.575 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 98.4 mt -60.0 -38.15 81.77 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.617 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 150.37 -32.18 1.03 Allowed Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.901 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 44.9 pt -125.93 156.62 35.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.339 0.59 . . . . 0.0 111.68 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 30.6 m -138.15 152.7 26.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.425 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 34.8 p -85.7 -83.8 0.17 Allowed 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.42 ' H ' ' H ' ' A' ' 234' ' ' SER . . . -178.53 9.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.6 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' SER . . . . . 0.42 ' H ' ' H ' ' A' ' 233' ' ' ALA . 23.9 m -151.33 14.68 0.69 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.213 -176.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.74 30.42 72.69 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.624 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -61.77 -41.46 97.73 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.185 0.517 . . . . 0.0 110.977 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 12.6 pt -109.53 11.79 8.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.389 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -102.57 107.76 18.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.075 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -141.63 155.85 45.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.784 0.326 . . . . 0.0 111.186 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -107.94 110.31 3.12 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 170.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 31.6 mtp180 -131.0 169.39 15.9 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -102.56 146.02 28.75 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.276 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -131.19 168.15 17.97 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.525 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -114.04 130.85 56.53 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.424 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.625 ' HB ' ' OG1' ' A' ' 219' ' ' THR . 93.8 mt -81.33 130.1 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-O 120.82 0.343 . . . . 0.0 110.778 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.552 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 2.2 t -130.59 87.34 2.48 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -84.88 116.48 23.35 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.342 0.591 . . . . 0.0 111.437 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -129.1 72.06 81.99 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.459 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.46 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 33.4 Cg_exo -62.06 -24.9 77.04 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.618 2.212 . . . . 0.0 111.057 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.27 -34.97 79.2 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.702 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -96.9 -57.05 2.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.373 -177.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -98.14 -29.72 13.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.894 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 249' ' ' PRO . . . 83.99 5.82 87.32 Favored Glycine 0 C--N 1.315 -0.593 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.876 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 78.7 m -130.92 161.43 31.91 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 97.8 t -81.0 117.25 26.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 175.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.552 ' HB2' ' O ' ' A' ' 246' ' ' THR . 76.8 m-20 -103.32 147.57 26.93 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -174.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -136.53 144.92 44.51 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.1 p -132.03 136.28 56.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-O 121.18 0.514 . . . . 0.0 110.668 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.6 tt -95.3 119.88 34.58 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.407 ' H ' ' HG ' ' A' ' 260' ' ' LEU . 3.0 pp -90.46 137.96 31.93 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.305 0.574 . . . . 0.0 111.965 -176.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 C--O 1.276 2.46 0 CA-C-O 117.287 -1.339 . . . . 0.0 110.11 179.348 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 . . . . . 0 CA--C 1.501 -0.937 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -81.09 79.4 7.76 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.91 148.43 51.22 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.178 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.1 151.39 51.36 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.814 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -84.93 99.85 11.23 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 65.7 t -91.77 120.47 40.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.717 -173.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.9 m -107.53 126.89 53.1 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.697 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -101.01 112.68 65.31 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.75 -22.43 63.91 Favored 'Trans proline' 0 N--CA 1.473 0.282 0 C-N-CA 122.925 2.417 . . . . 0.0 113.103 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 89.2 m -64.45 -42.61 95.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.137 0.494 . . . . 0.0 110.786 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.524 ' HB2' HG12 ' A' ' 191' ' ' VAL . 29.6 mt -105.82 -14.29 15.27 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.064 -176.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 20.3 m120 59.96 45.16 12.57 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.244 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.524 HG12 ' HB2' ' A' ' 189' ' ' LEU . 10.2 p -128.34 147.85 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 11.9 t -127.71 135.13 49.75 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.556 0.693 . . . . 0.0 111.416 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.489 HG23 ' CD1' ' A' ' 195' ' ' LEU . 7.8 m -139.89 152.08 22.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.709 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -92.94 122.53 35.4 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.002 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.489 ' CD1' HG23 ' A' ' 193' ' ' VAL . 6.9 mp -121.39 148.14 49.12 Favored Pre-proline 0 C--O 1.239 0.511 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.487 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.37 142.27 90.27 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.723 2.282 . . . . 0.0 111.65 175.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 78.9 mt -89.97 117.49 33.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' A' ' 224' ' ' ASN . 98.5 mt -70.14 -40.65 74.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.951 0.405 . . . . 0.0 111.123 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 33.5 t -157.68 148.19 20.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.17 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.6 m -112.93 139.64 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.835 0.35 . . . . 0.0 110.104 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -133.07 136.61 46.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.995 0.426 . . . . 0.0 110.587 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -89.91 159.53 16.89 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 . . . . . 0 C--N 1.311 -1.08 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.485 178.202 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 55.3 tp . . . . . 0 C--O 1.235 0.323 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 11.9 t -92.09 158.52 16.16 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.611 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -68.79 152.99 44.59 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.953 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.77 8.87 27.55 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.932 -0.652 . . . . 0.0 111.949 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.475 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 91.4 m -76.25 139.82 41.31 Favored 'General case' 0 C--O 1.212 -0.894 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.6 mm -105.78 127.97 60.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 O-C-N 122.052 -0.405 . . . . 0.0 111.476 -176.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.561 HD13 HD11 ' A' ' 245' ' ' ILE . 45.2 pt -122.88 158.56 27.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.704 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -103.95 123.14 46.62 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.16 159.3 43.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.871 0.367 . . . . 0.0 110.226 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.437 ' HB2' HD11 ' A' ' 198' ' ' LEU . 21.2 t-20 -112.61 123.41 50.24 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 46.8 t -76.42 77.3 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 121.476 0.655 . . . . 0.0 109.968 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 68.6 m -158.38 -13.63 0.07 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.788 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -90.79 18.76 6.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.732 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.412 ' H ' HD22 ' A' ' 228' ' ' LEU . 3.1 mm? -59.75 -38.44 81.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.111 0.482 . . . . 0.0 110.084 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 94.56 -12.72 68.43 Favored Glycine 0 CA--C 1.506 -0.483 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.507 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.3 pt -136.15 165.19 29.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.33 127.45 71.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-O 121.217 0.532 . . . . 0.0 110.545 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 11.9 t -119.93 -14.22 8.96 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.313 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.474 ' HB3' HG12 ' A' ' 237' ' ' ILE . . . -143.5 27.08 1.56 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.322 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.0 m 55.08 23.92 5.65 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.741 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 80.28 7.56 88.42 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.367 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.405 ' O ' ' HD3' ' A' ' 236' ' ' LYS . 8.0 tmtm? -64.58 -38.45 91.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.597 0.713 . . . . 0.0 109.976 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.474 HG12 ' HB3' ' A' ' 233' ' ' ALA . 28.7 pt -85.86 10.33 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.343 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -64.71 124.2 21.32 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 121.132 -0.227 . . . . 0.0 110.427 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -173.36 157.27 3.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -86.89 120.74 5.56 Favored Glycine 0 C--O 1.224 -0.485 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.955 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 75.5 mtp85 -129.25 164.35 23.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.967 0.413 . . . . 0.0 111.099 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -104.25 134.83 46.82 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.404 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -114.63 146.75 40.47 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.722 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -95.55 124.72 39.71 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.241 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.561 HD11 HD13 ' A' ' 221' ' ' ILE . 49.9 mm -79.54 118.73 27.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.75 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 3.0 t -125.29 91.77 3.49 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -89.5 115.72 27.14 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.169 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -142.92 80.32 13.89 Favored Pre-proline 0 C--N 1.312 -1.025 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.374 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.533 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 33.7 Cg_exo -60.96 -28.06 85.73 Favored 'Trans proline' 0 C--O 1.218 -0.51 0 C-N-CA 122.981 2.454 . . . . 0.0 111.877 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -65.94 -37.08 85.11 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.845 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -91.64 -55.95 3.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.957 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.571 ' CB ' HD21 ' A' ' 256' ' ' ASN . 5.1 t70 -98.24 -30.18 12.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.114 0.483 . . . . 0.0 111.085 -176.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 95.09 6.22 60.35 Favored Glycine 0 C--N 1.319 -0.4 0 C-N-CA 120.89 -0.672 . . . . 0.0 113.328 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 27.9 p -156.02 171.55 19.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.065 0.433 . . . . 0.0 111.825 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 68.1 t -80.34 119.73 30.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.571 HD21 ' CB ' ' A' ' 252' ' ' ASP . 79.7 m-20 -112.43 151.64 29.62 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.413 -173.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -131.2 131.05 43.72 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.13 176.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.62 129.4 64.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.192 0.52 . . . . 0.0 110.193 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.0 tt -95.89 121.08 37.24 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.531 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.434 ' O ' HD12 ' A' ' 260' ' ' LEU . 1.4 pp -88.31 143.08 27.23 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.814 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--O 1.267 1.987 0 CA-C-O 117.699 -1.143 . . . . 0.0 110.768 -179.259 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 . . . . . 0 CA--C 1.513 -0.466 0 CA-C-O 121.128 0.489 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -80.03 85.56 5.61 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 196' ' ' PRO . 41.0 ttmt -136.15 137.42 40.94 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.84 -176.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -128.57 157.47 41.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.129 0.49 . . . . 0.0 111.715 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -85.61 100.8 12.2 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 192' ' ' THR . 48.7 t -93.97 120.18 42.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -172.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 92.5 m -109.33 128.0 54.76 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.376 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -105.83 105.67 53.97 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -57.07 -38.66 95.19 Favored 'Trans proline' 0 N--CA 1.483 0.889 0 C-N-CA 123.047 2.498 . . . . 0.0 113.366 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 89.6 m -63.23 -42.0 99.18 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.827 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.517 ' HB2' HG12 ' A' ' 191' ' ' VAL . 28.2 mt -99.72 -16.95 17.97 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.086 -175.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 65.5 t30 59.1 53.21 5.63 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.738 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.517 HG12 ' HB2' ' A' ' 189' ' ' LEU . 12.4 p -133.96 133.52 56.2 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.866 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 93.9 m -116.93 128.46 55.23 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.652 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.4 139.01 29.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.722 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -88.75 117.44 27.74 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.627 HD12 ' HD2' ' A' ' 196' ' ' PRO . 23.2 tp -134.24 141.56 39.77 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.251 -173.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.627 ' HD2' HD12 ' A' ' 195' ' ' LEU . 34.4 Cg_endo -65.28 146.33 85.89 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.916 1.744 . . . . 0.0 110.415 176.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.431 HD12 HD12 ' A' ' 221' ' ' ILE . 33.2 mm -81.14 119.93 31.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.012 0.434 . . . . 0.0 111.672 -175.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.95 -39.39 76.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.862 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 222' ' ' GLU . 35.3 t -149.59 143.68 25.72 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 15.3 m -126.12 141.84 44.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.78 0.324 . . . . 0.0 111.355 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -130.59 123.31 29.22 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-O 121.008 0.433 . . . . 0.0 110.689 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.579 ' HD2' ' O ' ' A' ' 203' ' ' ASN . 1.7 tmmt? -110.42 150.81 28.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.726 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.579 ' O ' ' HD2' ' A' ' 202' ' ' LYS . 3.2 m-20 . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.415 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 CA--C 1.507 -0.692 0 CA-C-O 120.942 0.401 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 12.0 t -156.6 173.89 16.27 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.236 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.437 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 18.0 ptpt -67.21 152.68 45.29 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.86 178.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.52 8.12 31.09 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -176.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.561 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 66.1 m -77.07 136.75 38.67 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 51.2 mm -92.32 127.14 44.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.78 0.324 . . . . 0.0 111.116 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.555 HD13 HD11 ' A' ' 245' ' ' ILE . 43.3 pt -130.85 161.08 41.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.093 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 199' ' ' SER . 35.7 tt0 -110.9 128.49 55.83 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.1 m -126.34 157.54 36.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.718 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -98.18 110.62 23.17 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.563 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 10.7 t -91.41 18.94 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.442 ' HB3' ' N ' ' A' ' 239' ' ' TRP . 23.5 p -120.06 -35.24 3.51 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.658 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -64.48 -39.3 93.55 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.649 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.73 -36.59 83.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.075 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 102.03 -88.17 0.67 Allowed Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 50.7 mt 62.2 -74.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.932 0.893 . . . . 0.0 111.435 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 42.0 t 57.11 77.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 123.872 0.869 . . . . 0.0 111.353 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 23.6 p -70.35 -40.62 73.98 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.228 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -161.37 110.36 1.57 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.017 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 22.4 m 58.39 13.23 2.34 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.384 0.673 . . . . 0.0 112.591 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.19 29.31 74.69 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.055 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -61.99 -43.54 98.63 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 120.992 0.425 . . . . 0.0 111.363 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 26.4 pt -78.3 -1.88 4.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.299 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -76.01 108.01 8.6 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.721 0.296 . . . . 0.0 111.274 -177.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' TRP . . . . . 0.442 ' N ' ' HB3' ' A' ' 226' ' ' SER . 6.8 t90 -178.75 163.22 1.42 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.938 178.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -74.66 123.47 7.58 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.214 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -129.98 165.26 22.51 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -177.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.425 ' CE1' ' HB2' ' A' ' 222' ' ' GLU . 96.8 m-85 -101.07 141.38 34.04 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.238 0.542 . . . . 0.0 111.892 -177.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -128.6 170.14 13.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.873 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -115.26 131.25 56.99 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.771 0.32 . . . . 0.0 111.096 -178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.561 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 44.3 mm -77.0 128.04 37.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.676 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.437 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 3.8 t -132.76 101.73 5.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.799 0.809 . . . . 0.0 109.36 175.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -73.03 117.67 15.04 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.3 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' ASN . . . . . 0.423 ' HB2' ' ND2' ' A' ' 256' ' ' ASN . 17.5 m120 -130.82 70.81 82.58 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.856 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.78 -22.45 17.7 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.009 1.806 . . . . 0.0 112.079 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -76.26 -28.72 57.2 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.497 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -94.4 -57.55 2.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.683 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -100.01 -29.57 12.47 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 120.89 0.376 . . . . 0.0 111.914 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 84.46 8.41 83.29 Favored Glycine 0 C--N 1.316 -0.553 0 C-N-CA 120.311 -0.947 . . . . 0.0 110.91 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 68.8 m -129.5 161.59 30.08 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.333 -0.433 . . . . 0.0 109.992 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 81.7 t -83.1 118.46 30.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.423 ' ND2' ' HB2' ' A' ' 248' ' ' ASN . 81.4 m-20 -103.02 152.19 21.64 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.992 -172.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -130.96 137.21 49.16 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 176.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.7 p -128.71 136.37 60.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.022 0.439 . . . . 0.0 110.434 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 7.6 tt -86.2 119.79 26.87 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 260' ' ' LEU . 1.1 pp -81.54 133.75 35.42 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.997 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 C--O 1.27 2.133 0 CA-C-O 117.467 -1.254 . . . . 0.0 110.419 178.992 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.428 ' CD2' ' HB2' ' A' ' 181' ' ' LYS . 66.3 t80 . . . . . 0 N--CA 1.452 -0.367 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -78.79 80.22 5.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.734 0.302 . . . . 0.0 111.091 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.691 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 84.3 tttt -154.27 129.69 9.83 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -122.74 157.27 32.7 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.26 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 15.2 m120 -87.04 106.19 17.68 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 61.8 t -98.34 119.79 46.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.351 0.596 . . . . 0.0 111.838 -174.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 192' ' ' THR . 85.1 m -93.48 125.93 38.36 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 176.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.42 ' NE2' HD22 ' A' ' 228' ' ' LEU . 69.9 m80 -104.14 110.89 64.85 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.7 -38.65 91.29 Favored 'Trans proline' 0 N--CA 1.483 0.877 0 C-N-CA 123.575 2.85 . . . . 0.0 114.02 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 8.0 t -70.64 -30.95 67.71 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.581 ' HB2' HG12 ' A' ' 191' ' ' VAL . 37.7 mt -98.68 -21.84 16.21 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.27 0.557 . . . . 0.0 109.608 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 23.7 m120 58.3 42.85 20.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.206 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.581 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.5 p -135.38 145.36 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.019 -178.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 185' ' ' THR . 8.8 t -106.12 121.57 44.42 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.419 0.628 . . . . 0.0 109.998 177.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.84 126.58 71.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.805 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.691 ' HG2' ' HG2' ' A' ' 181' ' ' LYS . 58.3 tt0 -79.11 122.61 26.45 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.428 ' C ' ' HG3' ' A' ' 181' ' ' LYS . 95.4 mt -128.18 150.52 74.18 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.832 -176.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.07 149.44 71.27 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.547 2.165 . . . . 0.0 112.085 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.471 HD12 HD12 ' A' ' 221' ' ' ILE . 35.5 mm -94.0 115.57 33.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.091 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 97.3 mt -70.39 -41.64 72.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.073 0.463 . . . . 0.0 110.462 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.5 t -160.9 153.11 20.19 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.129 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 33.4 m -118.72 146.18 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-O 121.005 0.431 . . . . 0.0 110.318 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -128.14 143.59 51.06 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -60.45 144.36 51.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.961 0.41 . . . . 0.0 111.141 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.41 ' HB3' ' HA ' ' A' ' 219' ' ' THR . 11.7 p30 . . . . . 0 C--N 1.316 -0.853 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.851 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 5.1 tt . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 121.1 0.476 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 70.6 p -126.34 167.48 15.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.078 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -63.77 152.58 38.99 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.221 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 102.49 7.33 45.81 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -176.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.565 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 90.8 m -79.9 140.96 36.52 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.9 mm -101.9 130.46 51.58 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.706 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.297 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.59 HD13 HD11 ' A' ' 245' ' ' ILE . 42.3 pt -126.9 159.87 36.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.773 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -109.94 127.85 55.01 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 32.3 m -130.23 159.08 42.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.179 0.514 . . . . 0.0 111.455 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -95.38 109.38 21.56 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 92.6 t -97.0 87.91 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 48.6 m -129.84 -50.87 1.14 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.158 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -98.3 -51.15 4.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.579 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.491 HD21 HG13 ' A' ' 225' ' ' VAL . 84.5 mt 60.49 26.4 16.03 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.661 -176.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 92.69 -9.25 75.99 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.978 -0.556 . . . . 0.0 113.019 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 47.1 pt -131.97 175.19 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.798 0.332 . . . . 0.0 110.762 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 64.5 t -117.69 119.36 61.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 10.0 p -89.27 -86.24 0.19 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.198 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -150.2 82.01 1.37 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.543 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 44.7 m 53.87 39.59 30.58 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.017 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.24 42.27 83.8 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.685 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -61.13 -40.73 94.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.344 0.592 . . . . 0.0 110.872 -176.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 13.9 pt -103.87 23.54 2.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.445 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -73.68 106.9 5.63 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.155 0.503 . . . . 0.0 111.975 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -139.49 149.28 43.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.755 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -78.04 125.83 7.39 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -128.72 155.91 44.33 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 120.883 0.373 . . . . 0.0 111.02 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.494 ' CE2' HD11 ' A' ' 260' ' ' LEU . 49.2 p90 -109.11 142.25 40.12 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -122.55 154.82 37.4 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 120.96 0.409 . . . . 0.0 111.308 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -94.0 122.69 36.76 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.056 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.59 HD11 HD13 ' A' ' 221' ' ' ILE . 42.8 mm -77.24 119.38 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.351 177.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 80.2 p -122.5 86.65 2.62 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -90.49 129.61 36.63 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.113 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -142.66 76.33 17.82 Favored Pre-proline 0 C--N 1.304 -1.384 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.285 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.517 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 58.7 Cg_endo -70.34 -17.52 34.87 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.326 2.017 . . . . 0.0 111.354 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -69.06 -37.54 78.59 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.124 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -105.7 -60.15 1.67 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.015 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.66 -39.71 61.87 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.48 0.657 . . . . 0.0 110.642 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 94.09 -7.11 72.88 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.999 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 79.4 m -131.67 168.02 18.46 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.053 0.454 . . . . 0.0 111.888 -177.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 75.5 t -83.35 119.23 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -111.46 152.96 26.82 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -133.26 150.6 51.92 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.4 p -126.91 136.57 60.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 120.901 0.381 . . . . 0.0 110.031 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 57.2 tp -87.64 125.16 34.22 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.966 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.494 HD11 ' CE2' ' A' ' 242' ' ' TYR . 4.2 pp -98.6 148.91 23.32 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.584 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 11.9 m . . . . . 0 C--O 1.263 1.799 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.851 -179.513 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 63.2 t80 . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.571 ' HB3' ' HB ' ' A' ' 197' ' ' ILE . 10.1 mptt -79.53 88.81 5.06 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.572 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt -151.92 139.25 19.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.329 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -142.98 154.45 44.03 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.977 0.418 . . . . 0.0 111.367 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -89.19 108.42 19.6 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 61.3 t -100.2 125.52 53.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -171.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 94.7 m -103.69 127.36 51.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.143 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -104.72 107.62 58.77 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.34 -35.65 98.88 Favored 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 123.132 2.555 . . . . 0.0 113.504 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.438 HG23 ' HG ' ' A' ' 189' ' ' LEU . 5.3 t -73.88 -34.62 64.52 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -177.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.543 ' HB2' HG12 ' A' ' 191' ' ' VAL . 38.5 mt -95.86 -16.27 21.93 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 120.817 0.342 . . . . 0.0 110.125 -177.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 60.27 42.48 15.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.046 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.543 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.9 p -134.97 139.01 48.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.6 -176.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 87.0 m -114.32 119.02 35.55 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.806 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.571 HG21 HD22 ' A' ' 228' ' ' LEU . 9.6 m -135.54 147.19 28.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.435 -177.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.492 ' C ' HD12 ' A' ' 195' ' ' LEU . 64.4 tt0 -101.0 118.97 38.05 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.739 0.304 . . . . 0.0 110.614 -177.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 194' ' ' GLN . 5.6 mp -129.02 147.8 66.33 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.53 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -61.16 143.26 98.59 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.349 2.033 . . . . 0.0 110.02 172.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.571 ' HB ' ' HB3' ' A' ' 180' ' ' LYS . 82.4 mt -80.54 121.47 34.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 223' ' ' VAL . 4.1 mm? -67.77 -43.92 78.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.643 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 52.4 m -152.19 153.43 33.8 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.266 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 31.3 m -117.79 145.93 22.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -127.86 121.17 29.37 Favored 'General case' 0 C--O 1.256 1.427 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -66.44 138.96 57.93 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.425 ' OD1' ' HA ' ' A' ' 219' ' ' THR . 87.1 m-20 . . . . . 0 C--N 1.309 -1.152 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.654 -174.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.824 0.345 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 19.5 p -91.2 170.13 10.26 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.138 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -54.18 153.35 5.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.476 -0.783 . . . . 0.0 112.549 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 116.65 10.11 10.58 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.417 -175.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.425 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 59.8 m -67.09 137.04 56.07 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.9 mm -91.11 130.84 39.66 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.424 -174.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 46.9 pt -129.11 156.82 41.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.061 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 198' ' ' LEU . 52.9 mt-10 -114.74 125.95 54.29 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.424 ' HA ' HD23 ' A' ' 198' ' ' LEU . 35.9 m -130.59 155.9 42.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.248 0.547 . . . . 0.0 111.105 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -97.51 106.81 19.19 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.608 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 31.6 t -80.74 77.35 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 121.565 0.698 . . . . 0.0 110.394 -177.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.438 ' H ' ' H ' ' A' ' 227' ' ' ASP . 38.6 p -169.37 -16.0 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.329 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ASP . . . . . 0.438 ' H ' ' H ' ' A' ' 226' ' ' SER . 36.6 t70 -81.24 9.28 7.21 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.434 177.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.571 HD22 HG21 ' A' ' 193' ' ' VAL . 87.9 mt -63.19 -34.57 77.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.902 -176.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 83.79 22.39 55.73 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.094 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 42.0 pt -116.91 161.18 15.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.924 0.392 . . . . 0.0 110.495 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 66.8 t -117.7 123.86 72.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.806 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 19.1 p -117.05 -70.43 0.79 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.076 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -169.31 97.35 0.34 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.553 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 19.2 t 63.32 15.97 9.1 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.43 34.03 78.58 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.84 -1.171 . . . . 0.0 111.495 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -63.44 -18.56 63.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.98 0.419 . . . . 0.0 111.639 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 33.6 pt -90.9 -0.1 9.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.512 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -75.98 107.81 8.44 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.159 0.504 . . . . 0.0 111.711 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -164.73 131.74 3.06 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.488 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -70.78 113.57 4.85 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.133 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -129.54 157.11 42.96 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.93 0.395 . . . . 0.0 111.224 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -102.38 148.74 25.11 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.378 0.609 . . . . 0.0 111.446 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -131.84 170.18 15.21 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.129 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 219' ' ' THR . 11.8 pt20 -116.65 141.78 47.76 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.391 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 84.1 mt -83.25 124.47 39.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.43 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 2.8 t -141.28 100.91 3.9 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.753 176.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -75.35 135.11 40.86 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.063 0.459 . . . . 0.0 111.413 -177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -140.79 72.46 29.12 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.481 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.407 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 23.4 Cg_exo -66.84 -21.13 51.16 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.798 2.332 . . . . 0.0 111.554 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -67.68 -38.32 83.56 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.226 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -107.64 -57.97 2.02 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.53 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.54 -37.53 63.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.207 0.527 . . . . 0.0 110.667 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 89.27 5.5 72.6 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.139 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 33.0 t -145.49 177.4 8.88 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 96.9 t -80.21 122.14 34.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 246' ' ' THR . 8.1 m120 -105.95 152.97 22.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.287 0.565 . . . . 0.0 111.414 -174.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.586 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -134.73 140.01 45.62 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 174.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 12.5 p -126.25 135.69 63.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.811 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 64.7 tp -80.69 129.22 34.4 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.847 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 4.1 pp -95.52 143.63 26.67 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.164 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 C--O 1.269 2.101 0 CA-C-O 117.411 -1.281 . . . . 0.0 110.422 179.707 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 80.4 t80 . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -69.09 68.05 0.17 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.167 0.292 . . . . 0.0 110.717 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.469 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 41.1 ttmt -154.88 137.27 14.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.524 0.202 . . . . 0.0 110.531 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -135.15 151.05 50.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.883 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 53.8 t-20 -85.22 103.52 14.26 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 257' ' ' ALA . 54.1 t -93.59 121.91 44.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.177 0.513 . . . . 0.0 112.247 -173.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 62.9 m -98.26 124.78 43.04 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.207 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -106.04 106.87 58.38 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.24 -29.11 64.22 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.342 2.028 . . . . 0.0 112.796 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.2 t -73.73 -23.69 59.8 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.416 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.551 ' HB2' HG12 ' A' ' 191' ' ' VAL . 36.2 mt -104.85 -19.8 13.78 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.3 t30 61.16 47.56 7.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.568 -1.197 . . . . 0.0 109.405 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 189' ' ' LEU . 5.9 p -145.09 146.54 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -177.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.2 t -121.07 120.7 36.1 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 121.555 0.693 . . . . 0.0 109.639 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.4 t -129.09 135.18 62.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.156 -177.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 62.0 tt0 -87.66 119.75 28.29 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.852 0.358 . . . . 0.0 110.747 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.3 mp -125.21 155.34 71.39 Favored Pre-proline 0 C--O 1.237 0.407 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.375 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 181' ' ' LYS . 55.9 Cg_endo -69.39 151.75 71.16 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.473 2.115 . . . . 0.0 111.655 177.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 83.4 mt -88.57 111.92 23.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.848 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.0 mp -69.28 -43.98 72.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.101 0.476 . . . . 0.0 111.934 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 50.6 m -151.34 157.85 43.02 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.329 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 33.0 m -123.42 146.7 28.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.224 0.535 . . . . 0.0 111.315 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.446 ' HB2' ' HB ' ' A' ' 220' ' ' ILE . 74.3 mmtt -125.58 110.42 13.81 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.474 176.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.453 ' HD3' ' O ' ' A' ' 203' ' ' ASN . 1.6 tmtp? -75.3 125.34 28.78 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.453 ' O ' ' HD3' ' A' ' 202' ' ' LYS . 95.1 m-20 . . . . . 0 C--N 1.324 -0.542 0 CA-C-O 120.718 0.294 . . . . 0.0 110.54 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 9.8 mp . . . . . 0 N--CA 1.447 -0.586 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 71.2 p -114.46 155.08 27.03 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -62.74 150.69 40.6 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.99 10.55 34.41 Favored Glycine 0 N--CA 1.436 -1.309 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -173.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 95.1 m -68.08 138.78 56.04 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 201' ' ' LYS . 51.1 mm -90.46 129.63 40.99 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 CA-C-O 120.726 0.298 . . . . 0.0 111.703 -174.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.41 HG21 HD11 ' A' ' 245' ' ' ILE . 44.9 pt -131.62 159.06 43.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.558 175.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -107.22 126.05 51.92 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.87 151.88 35.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.611 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -106.55 106.67 17.3 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.089 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 3.0 p -82.21 85.34 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-O 121.912 0.863 . . . . 0.0 110.193 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 15.0 p -123.7 -84.87 0.65 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.176 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -64.43 -46.68 82.16 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.407 HD21 HG23 ' A' ' 225' ' ' VAL . 97.0 mt 56.45 16.18 2.36 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.109 0.481 . . . . 0.0 110.774 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 83.77 0.58 89.86 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 115.989 -0.551 . . . . 0.0 113.037 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 44.9 pt -133.67 171.71 17.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.297 0.57 . . . . 0.0 111.582 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 66.6 t -113.66 114.82 47.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 11.7 t -154.58 146.07 23.11 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.638 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . 52.93 25.18 3.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.147 0.579 . . . . 0.0 112.008 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 58.2 m 56.79 18.78 3.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.34 0.656 . . . . 0.0 111.971 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.57 26.21 74.72 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.077 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -66.01 -18.99 65.7 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.204 0.526 . . . . 0.0 111.135 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 30.9 pt -87.6 8.85 2.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.991 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -66.68 106.3 1.79 Allowed 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.084 0.469 . . . . 0.0 111.457 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -142.33 151.88 42.38 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.309 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -93.07 112.76 4.33 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 174.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.95 164.34 23.37 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 120.741 0.305 . . . . 0.0 111.065 -177.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 98.2 m-85 -102.35 139.92 37.32 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.221 0.534 . . . . 0.0 111.61 -175.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -127.63 154.51 45.17 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.775 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -97.81 132.73 43.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.593 0.235 . . . . 0.0 110.725 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.41 HD11 HG21 ' A' ' 221' ' ' ILE . 87.1 mt -79.71 119.9 29.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 4.3 t -133.83 98.51 4.19 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -81.19 123.64 28.62 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.947 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -129.76 72.1 82.01 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.017 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.529 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 59.5 Cg_endo -70.16 -22.24 30.53 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.267 1.978 . . . . 0.0 112.228 -178.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -70.22 -37.73 75.09 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.27 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -96.29 -57.51 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.923 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.409 ' CG ' HD21 ' A' ' 256' ' ' ASN . 34.6 t70 -82.36 -39.57 22.57 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.343 0.592 . . . . 0.0 110.767 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 96.78 8.96 56.77 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.239 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 14.0 t -153.61 -179.93 8.25 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 93.7 t -79.87 126.64 39.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 246' ' ' THR . 10.0 m120 -113.33 154.28 27.12 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.861 0.362 . . . . 0.0 110.764 -174.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.532 ' HB3' HG22 ' A' ' 184' ' ' VAL . . . -131.98 147.96 52.49 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.9 p -123.43 131.0 73.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.025 0.44 . . . . 0.0 110.418 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.9 tt -100.53 123.84 45.29 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.801 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 2.8 pp -92.51 151.29 20.26 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.139 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.262 1.728 0 CA-C-O 117.75 -1.119 . . . . 0.0 110.876 -179.231 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 18.3 t80 . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.457 ' HD2' ' N ' ' A' ' 180' ' ' LYS . 11.1 mptt -82.42 81.19 8.36 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -176.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -138.19 150.55 46.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.743 0.417 . . . . 0.0 110.921 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.457 ' HB2' HD11 ' A' ' 197' ' ' ILE . . . -141.94 151.16 42.32 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.714 177.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 20.0 m120 -86.53 100.44 12.39 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 120.557 -0.457 . . . . 0.0 109.833 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 64.5 t -85.34 120.31 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.72 -176.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 63.7 m -105.33 126.46 52.13 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.458 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -104.33 111.64 65.23 Favored Pre-proline 0 C--N 1.312 -1.035 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.34 -27.14 77.49 Favored 'Trans proline' 0 N--CA 1.474 0.334 0 C-N-CA 122.556 2.171 . . . . 0.0 112.462 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 89.3 m -63.35 -42.64 98.92 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.31 0.576 . . . . 0.0 110.568 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.553 ' HB2' HG12 ' A' ' 191' ' ' VAL . 28.3 mt -95.05 -21.38 18.6 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.364 -177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 65.6 t30 59.57 51.66 6.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.496 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.553 HG12 ' HB2' ' A' ' 189' ' ' LEU . 10.0 p -140.14 148.86 22.21 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.817 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 13.6 t -119.47 122.75 42.42 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.497 0.665 . . . . 0.0 110.44 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.477 HG11 ' HA3' ' A' ' 229' ' ' GLY . 57.3 t -128.88 131.06 68.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.665 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 29.6 tt0 -78.24 124.51 28.16 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.834 0.35 . . . . 0.0 111.099 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 194' ' ' GLN . 7.4 mp -127.27 149.33 69.43 Favored Pre-proline 0 C--O 1.238 0.499 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.155 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 180' ' ' LYS . 40.5 Cg_exo -61.4 142.58 96.03 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.844 2.363 . . . . 0.0 112.307 176.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.457 HD11 ' HB2' ' A' ' 182' ' ' ALA . 81.6 mt -90.84 120.78 40.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.9 mp -72.29 -45.13 61.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.771 0.32 . . . . 0.0 111.389 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.2 t -162.91 157.12 20.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.889 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.429 HG12 HG22 ' A' ' 221' ' ' ILE . 33.6 m -119.1 146.19 24.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-O 120.9 0.381 . . . . 0.0 110.72 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -129.31 142.45 50.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.827 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -77.92 158.57 29.32 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.586 0.708 . . . . 0.0 112.436 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 . . . . . 0 C--N 1.308 -1.212 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.125 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 63.7 tp . . . . . 0 N--CA 1.442 -0.831 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 40.2 m -115.18 141.66 47.72 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.974 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -46.83 151.23 0.63 Allowed 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.727 0.642 . . . . 0.0 111.927 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 111.3 8.58 23.18 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -176.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.535 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 25.7 m -74.49 144.44 44.15 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.2 mm -104.1 127.18 58.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.699 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.648 HD13 HD11 ' A' ' 245' ' ' ILE . 46.1 pt -125.97 160.18 33.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.876 0.369 . . . . 0.0 111.114 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -103.8 126.38 50.9 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.372 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.58 151.59 36.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.078 0.466 . . . . 0.0 110.885 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -92.36 105.87 17.98 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 22.8 t -93.86 70.45 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 121.423 0.63 . . . . 0.0 110.108 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 50.7 m -125.99 -42.85 1.86 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.496 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -73.48 -43.57 59.89 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.227 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.444 ' O ' HG11 ' A' ' 193' ' ' VAL . 7.1 mp 54.02 17.29 1.34 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.46 -176.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.477 ' HA3' HG11 ' A' ' 193' ' ' VAL . . . 77.33 -47.98 2.75 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -176.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 44.3 pt -128.27 157.86 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.6 m -96.74 43.97 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-O 121.099 0.476 . . . . 0.0 111.269 -177.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.1 t -48.93 -46.68 43.44 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.986 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -98.86 10.74 40.67 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -177.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 16.5 t 60.35 38.05 19.81 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.77 -127.78 28.6 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -174.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? 75.08 -45.54 0.57 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.64 0.776 . . . . 0.0 110.488 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 21.3 pt -88.85 18.57 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.801 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -69.46 112.94 6.32 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.38 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' TRP . . . . . 0.508 ' O ' ' HB ' ' A' ' 225' ' ' VAL . 23.1 t90 -169.25 138.21 2.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.718 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -68.11 131.84 28.0 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.083 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.44 176.08 8.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.821 0.343 . . . . 0.0 110.855 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -111.79 138.54 48.25 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.783 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -122.48 149.85 43.32 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.787 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -95.29 127.09 41.06 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.151 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.648 HD11 HD13 ' A' ' 221' ' ' ILE . 48.0 mm -78.47 120.7 29.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 178.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.8 t -134.97 98.32 3.98 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.934 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -80.5 126.24 30.97 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.875 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -135.82 72.18 62.59 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.518 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 35.5 Cg_exo -63.94 -26.52 66.71 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.062 2.508 . . . . 0.0 112.03 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -67.58 -37.44 82.62 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.403 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -96.68 -56.96 2.42 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.309 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -87.22 -40.2 14.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.072 0.463 . . . . 0.0 110.729 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 99.7 9.36 49.94 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.879 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 30.6 p -152.21 179.16 8.76 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.658 -0.319 . . . . 0.0 110.996 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 66.9 t -80.65 123.39 37.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -114.38 153.27 30.15 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.787 0.327 . . . . 0.0 110.147 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -128.3 146.88 50.63 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.6 p -122.39 129.71 75.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 121.127 0.489 . . . . 0.0 110.291 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 8.8 tt -105.32 124.43 49.52 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.906 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 260' ' ' LEU . 3.4 pp -99.43 150.34 22.27 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.375 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 23.9 m . . . . . 0 C--O 1.272 2.268 0 CA-C-O 117.679 -1.153 . . . . 0.0 110.71 179.742 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 84.6 t80 . . . . . 0 N--CA 1.443 -0.809 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -69.38 85.51 0.41 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -177.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -151.8 137.6 18.0 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.978 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -140.1 159.21 42.7 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.145 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 89.9 m-20 -82.18 104.28 12.4 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 59.9 t -95.73 120.14 44.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.244 0.545 . . . . 0.0 112.119 -173.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 192' ' ' THR . 90.5 m -95.2 125.28 39.74 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.318 176.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -105.26 107.78 59.82 Favored Pre-proline 0 C--N 1.313 -1.009 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 34.0 Cg_endo -63.96 -26.23 66.64 Favored 'Trans proline' 0 N--CA 1.474 0.374 0 C-N-CA 122.548 2.165 . . . . 0.0 112.644 -176.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 86.4 m -64.6 -41.58 96.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.389 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.594 ' HB2' HG12 ' A' ' 191' ' ' VAL . 35.0 mt -99.3 -14.54 19.19 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.757 -177.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 60.22 45.23 11.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.26 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.8 p -138.79 144.72 29.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.439 -176.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 185' ' ' THR . 86.1 m -107.49 119.7 40.14 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.2 130.18 69.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 63.4 tt0 -75.51 120.26 20.69 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.49 HD21 HD22 ' A' ' 228' ' ' LEU . 87.2 mt -129.55 149.88 74.11 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.605 -174.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.74 144.98 50.23 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.353 2.036 . . . . 0.0 110.749 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.491 HG23 ' HB ' ' A' ' 221' ' ' ILE . 80.2 mt -93.48 116.85 35.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.248 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.4 mp -71.8 -46.15 59.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.675 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 39.2 m -141.25 148.33 39.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.597 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.454 HG12 HG22 ' A' ' 221' ' ' ILE . 29.2 m -129.72 137.66 56.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.628 0.251 . . . . 0.0 110.633 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -143.79 142.95 31.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.03 0.443 . . . . 0.0 110.835 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -112.07 146.67 37.54 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.991 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 C--N 1.316 -0.851 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.432 -176.77 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.122 0.487 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.3 m -133.28 162.99 30.32 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.175 -174.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 246' ' ' THR . 18.3 ptpt -47.18 151.01 0.74 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.486 0.66 . . . . 0.0 112.454 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 113.35 9.09 18.29 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.507 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.574 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 60.5 m -76.27 139.05 40.93 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.4 mm -97.48 126.41 50.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 120.803 0.335 . . . . 0.0 110.364 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.681 HD13 HD11 ' A' ' 245' ' ' ILE . 44.6 pt -125.98 165.03 24.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.118 0.485 . . . . 0.0 111.561 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -112.09 128.11 56.11 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.798 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.82 158.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.93 0.395 . . . . 0.0 110.902 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -110.33 112.18 23.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.267 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 3.2 p -102.4 79.39 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.788 0.804 . . . . 0.0 109.683 176.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 32.4 t -156.85 -42.35 0.07 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.145 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -94.2 19.57 9.18 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.864 -178.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.49 HD22 HD21 ' A' ' 195' ' ' LEU . 39.8 mt -70.76 -16.96 62.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.621 -175.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 82.73 2.96 90.69 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.533 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.4 pt -113.31 162.01 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.81 124.62 44.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.862 0.839 . . . . 0.0 111.249 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 9.9 t -99.07 -151.57 0.39 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -67.2 85.71 0.15 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.936 0.398 . . . . 0.0 110.641 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 39.7 m 64.77 13.11 8.21 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.912 0.885 . . . . 0.0 112.298 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 63.31 33.36 87.03 Favored Glycine 0 C--O 1.225 -0.446 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.972 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -65.35 -14.58 61.15 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 23.7 pt -105.86 12.18 8.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.974 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -75.46 106.02 6.79 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.987 0.423 . . . . 0.0 111.483 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -165.53 177.22 7.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.844 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -87.94 118.78 5.13 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 173.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 62.6 mtp85 -127.38 166.74 17.29 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.971 0.386 . . . . 0.0 111.0 -173.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -108.28 139.38 43.07 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.289 0.566 . . . . 0.0 111.692 -176.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -127.28 161.69 27.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.28 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -106.17 130.93 53.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.885 0.374 . . . . 0.0 111.107 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.681 HD11 HD13 ' A' ' 221' ' ' ILE . 41.9 mm -80.29 125.61 39.15 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.127 177.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 4.9 t -135.5 90.17 2.58 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 173.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -80.17 123.53 28.0 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.249 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -130.42 71.71 82.18 Favored Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.615 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.511 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 51.3 Cg_endo -67.8 -23.38 41.78 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.985 1.79 . . . . 0.0 111.07 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -73.12 -26.34 61.19 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.464 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -104.57 -56.18 2.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.066 -176.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -90.86 -40.07 11.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.063 0.459 . . . . 0.0 110.717 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 105.08 -8.54 45.53 Favored Glycine 0 C--N 1.316 -0.578 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.424 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 75.2 m -132.72 175.94 8.9 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.702 0.287 . . . . 0.0 111.061 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 86.6 t -79.95 124.34 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 246' ' ' THR . 3.2 m120 -107.34 151.95 24.8 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -176.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -139.88 150.43 44.61 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 177.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.58 135.91 53.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 120.837 0.351 . . . . 0.0 110.429 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.409 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 64.3 tp -73.71 126.52 30.53 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 260' ' ' LEU . 3.2 pp -82.98 131.13 35.2 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.119 0.485 . . . . 0.0 111.117 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--O 1.272 2.24 0 CA-C-O 117.815 -1.088 . . . . 0.0 110.336 179.463 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 . . . . . 0 N--CA 1.445 -0.684 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.438 ' HD2' ' N ' ' A' ' 180' ' ' LYS . 0.1 OUTLIER -88.65 116.12 26.67 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.231 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -149.13 140.13 22.93 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.6 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -138.45 157.29 46.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.953 0.406 . . . . 0.0 112.003 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -90.45 103.85 16.5 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 59.6 t -97.35 123.11 49.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.154 0.502 . . . . 0.0 111.95 -173.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 192' ' ' THR . 89.8 m -105.03 126.62 52.26 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.599 177.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -105.33 110.69 64.65 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.938 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.95 -33.64 89.7 Favored 'Trans proline' 0 N--CA 1.481 0.774 0 C-N-CA 123.331 2.688 . . . . 0.0 113.111 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 88.7 m -60.79 -44.4 96.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.255 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.537 ' HB2' HG12 ' A' ' 191' ' ' VAL . 32.0 mt -98.27 -17.0 19.17 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.647 -176.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 59.71 50.1 7.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.042 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.537 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.6 p -138.67 149.04 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.839 -178.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 185' ' ' THR . 12.4 t -119.67 129.57 54.62 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.405 0.622 . . . . 0.0 109.779 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 10.6 m -134.32 147.48 30.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.527 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.509 ' C ' HD12 ' A' ' 195' ' ' LEU . 35.5 tt0 -96.68 118.52 33.32 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.509 HD12 ' C ' ' A' ' 194' ' ' GLN . 7.0 mp -128.05 148.12 66.12 Favored Pre-proline 0 C--O 1.237 0.44 0 CA-C-O 120.664 0.269 . . . . 0.0 111.399 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.53 145.82 92.29 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.767 2.311 . . . . 0.0 110.978 173.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.475 HG23 ' HB ' ' A' ' 221' ' ' ILE . 83.9 mt -91.53 120.03 39.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 96.5 mt -68.02 -41.51 82.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.713 0.292 . . . . 0.0 111.356 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 93.4 p -156.1 157.25 35.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.713 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 17.7 m -122.25 135.58 61.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.338 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -136.24 137.17 40.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.779 0.324 . . . . 0.0 110.805 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -111.74 145.52 39.2 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.369 174.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 . . . . . 0 C--N 1.314 -0.939 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 176.014 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 CA--C 1.504 -0.796 0 CA-C-O 121.705 0.764 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 94.2 m -118.37 140.78 49.32 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.564 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.423 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 12.4 ptmm? -49.39 145.89 4.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.618 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 111.55 9.77 20.7 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.862 -176.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.462 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 61.7 m -84.35 134.86 34.48 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 220' ' ' ILE . 3.7 mp -95.98 127.08 48.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.905 0.384 . . . . 0.0 111.12 -178.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.614 HD13 HD11 ' A' ' 245' ' ' ILE . 46.0 pt -124.79 157.91 32.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.521 178.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -110.84 124.65 52.45 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.86 157.01 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.722 0.296 . . . . 0.0 110.633 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -98.15 123.14 42.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.315 0.578 . . . . 0.0 110.991 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 9.1 m -100.04 80.35 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-O 121.67 0.748 . . . . 0.0 110.114 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 18.5 m -112.93 -63.48 1.44 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.44 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -99.03 -39.73 8.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.157 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 8.2 mp 65.0 -2.57 0.7 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.441 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 83.22 7.5 86.7 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.082 -178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.5 pt -126.16 169.91 16.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 5.6 p -118.38 85.73 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 122.128 0.966 . . . . 0.0 111.57 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.3 t -113.14 -41.02 3.79 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 173.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.402 ' CB ' ' HE3' ' A' ' 236' ' ' LYS . . . -168.19 136.22 2.25 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.357 177.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 47.4 m -75.17 76.63 2.31 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.538 0.685 . . . . 0.0 111.167 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 70.75 40.63 64.94 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 114.998 -1.001 . . . . 0.0 115.25 175.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.402 ' HE3' ' CB ' ' A' ' 233' ' ' ALA . 18.3 ptpt -63.7 -25.53 68.24 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.936 0.868 . . . . 0.0 109.714 177.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 13.5 pt -129.65 33.71 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.541 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -63.66 105.71 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.098 0.475 . . . . 0.0 111.514 -177.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -151.83 166.43 31.45 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.629 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -93.13 118.73 5.72 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -127.29 163.24 24.38 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 120.9 0.381 . . . . 0.0 110.968 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 95.4 m-85 -103.33 139.51 38.65 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.491 -175.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -128.47 147.36 50.67 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.27 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 18.1 pm0 -98.34 131.34 44.72 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.476 0.655 . . . . 0.0 111.374 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.614 HD11 HD13 ' A' ' 221' ' ' ILE . 48.9 mm -77.54 125.22 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.29 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.423 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 4.1 t -134.46 102.95 5.5 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -84.69 126.81 33.71 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.285 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -127.6 72.29 77.9 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.17 -23.89 28.44 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.401 2.067 . . . . 0.0 112.381 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -77.65 -16.09 58.77 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.112 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -113.31 -56.25 2.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.032 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -93.29 -31.17 14.8 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.776 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 77.42 20.46 74.69 Favored Glycine 0 C--N 1.322 -0.22 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.86 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 48.8 t -151.15 164.87 35.52 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.695 0.283 . . . . 0.0 110.441 -177.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 95.1 t -79.91 121.84 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 246' ' ' THR . 19.7 m120 -112.55 152.8 28.41 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.198 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -132.5 141.91 48.98 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.83 133.27 69.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 7.4 tt -101.19 123.81 45.92 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.218 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.465 ' O ' HD12 ' A' ' 260' ' ' LEU . 3.1 pp -65.49 137.65 57.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.236 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.269 2.122 0 CA-C-O 117.3 -1.333 . . . . 0.0 110.717 -179.065 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 52.3 t80 . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -74.57 38.93 0.12 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.662 0.268 . . . . 0.0 111.005 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.5 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 40.3 ttmt -154.01 140.7 18.99 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -177.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.434 ' HB2' HD11 ' A' ' 197' ' ' ILE . . . -138.28 157.02 47.09 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.711 0.291 . . . . 0.0 111.509 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -87.0 101.49 13.49 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 58.9 t -90.56 125.94 43.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.859 -175.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.7 m -107.02 124.07 49.11 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.245 0.545 . . . . 0.0 110.011 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -104.51 115.91 62.03 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.841 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.83 -18.88 65.77 Favored 'Trans proline' 0 N--CA 1.476 0.458 0 C-N-CA 122.581 2.187 . . . . 0.0 111.258 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 72.0 m -64.11 -40.65 96.66 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.218 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.554 ' HB2' HG12 ' A' ' 191' ' ' VAL . 27.4 mt -107.3 -16.37 14.41 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.069 -177.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 60.16 41.32 17.08 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.986 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.554 HG12 ' HB2' ' A' ' 189' ' ' LEU . 6.6 p -134.94 148.84 28.97 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.74 -177.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 84.8 m -105.68 120.91 42.87 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.5 m -127.06 138.41 54.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.901 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.5 ' HG2' ' HG2' ' A' ' 181' ' ' LYS . 26.6 tt0 -94.21 119.54 33.17 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.156 -175.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -128.94 153.32 80.13 Favored Pre-proline 0 C--O 1.237 0.426 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.209 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.37 146.42 97.24 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.303 2.669 . . . . 0.0 112.645 177.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.434 HD11 ' HB2' ' A' ' 182' ' ' ALA . 76.9 mt -94.28 118.61 40.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.658 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.38 -46.52 15.89 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.808 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 27.3 m -140.64 150.29 43.37 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.177 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.444 ' HA ' HG22 ' A' ' 221' ' ' ILE . 30.9 m -128.19 144.13 38.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.521 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -140.34 102.54 4.37 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.281 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -70.8 146.01 50.01 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 . . . . . 0 C--N 1.312 -1.043 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.073 -177.586 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 48.4 tp . . . . . 0 N--CA 1.446 -0.666 0 CA-C-O 120.795 0.331 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 36.8 p -108.21 162.3 14.2 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.675 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.4 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 3.8 ptpp? -66.78 151.61 47.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.133 0.492 . . . . 0.0 111.589 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.02 4.3 41.75 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.235 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 88.1 m -80.12 134.9 36.21 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.522 0.201 . . . . 0.0 111.265 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 48.5 mm -93.78 126.29 46.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.863 0.363 . . . . 0.0 110.882 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.556 HG21 HD11 ' A' ' 245' ' ' ILE . 47.3 pt -130.73 165.17 31.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.368 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -108.68 129.41 55.35 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 31.5 m -126.82 153.66 36.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.106 0.479 . . . . 0.0 111.167 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -97.64 107.14 19.58 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.243 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 34.3 m -105.35 24.18 2.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.939 0.876 . . . . 0.0 110.255 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 238' ' ' ALA . 23.6 t -86.27 -23.5 26.33 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.395 175.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -60.68 -40.35 91.82 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.231 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.65 ' H ' HD23 ' A' ' 228' ' ' LEU . 2.3 pt? -98.11 -1.33 42.59 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.904 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' A' ' 238' ' ' ALA . . . -84.64 45.58 3.53 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.732 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 79.9 mt -82.77 -73.96 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.155 0.503 . . . . 0.0 110.877 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.04 11.15 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.426 0.631 . . . . 0.0 110.367 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 36.8 p -64.17 -38.56 91.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.474 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.642 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . -143.2 58.98 1.41 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.297 177.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 25.5 m 60.94 10.54 2.83 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.645 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 79.65 2.08 87.6 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.245 -0.503 . . . . 0.0 113.149 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.642 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 19.6 ptpt -71.51 -20.74 62.02 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -176.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 32.6 pt -81.65 -4.42 7.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 226' ' ' SER . . . -73.47 108.5 6.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.842 -178.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -169.35 -175.28 2.18 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -108.5 126.63 8.28 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -128.6 157.09 42.23 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 117.256 0.528 . . . . 0.0 111.748 -175.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.402 ' O ' HD12 ' A' ' 259' ' ' LEU . 77.1 m-85 -102.64 133.9 46.88 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.79 176.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -129.77 155.0 46.65 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.933 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -100.47 124.87 46.56 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.112 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.556 HD11 HG21 ' A' ' 221' ' ' ILE . 90.9 mt -76.71 125.77 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 CA-C-O 120.918 0.389 . . . . 0.0 110.934 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.4 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 4.3 t -132.35 94.56 3.46 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 174.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -81.21 117.16 21.5 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.65 -176.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -131.22 71.6 81.82 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.551 177.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.573 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 66.7 Cg_endo -71.78 -19.44 27.45 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.027 1.818 . . . . 0.0 112.461 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -86.92 -24.58 24.76 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.963 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -101.78 -58.09 1.95 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.921 0.391 . . . . 0.0 110.904 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -84.73 -39.27 18.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.414 0.625 . . . . 0.0 110.518 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 103.77 -9.31 51.73 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.171 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 70.2 m -135.93 169.23 17.92 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.783 0.325 . . . . 0.0 110.936 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 86.2 t -86.95 119.91 35.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 174.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -115.53 150.8 35.98 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 120.868 0.366 . . . . 0.0 111.045 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -121.63 140.96 51.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.4 p -119.12 137.48 52.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 120.697 0.284 . . . . 0.0 110.453 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 242' ' ' TYR . 60.6 tp -74.88 124.29 26.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.841 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.432 ' H ' HD23 ' A' ' 260' ' ' LEU . 0.3 OUTLIER -86.85 91.31 8.61 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.485 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.268 2.047 0 CA-C-O 117.68 -1.152 . . . . 0.0 110.666 -175.247 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 56.1 t80 . . . . . 0 C--O 1.223 -0.339 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -69.3 90.77 0.51 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.492 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 41.0 ttmt -154.28 140.47 18.5 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.978 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -128.95 158.11 39.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.375 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 27.3 t-20 -84.55 106.14 15.9 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 257' ' ' ALA . 58.1 t -104.17 125.37 58.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.475 0.655 . . . . 0.0 112.504 -172.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 94.0 m -104.48 126.87 51.97 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -103.47 107.97 57.73 Favored Pre-proline 0 C--N 1.315 -0.93 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.18 -20.22 56.36 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 122.626 2.217 . . . . 0.0 112.158 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 70.1 m -63.68 -40.89 97.93 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.217 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.546 ' HB2' HG12 ' A' ' 191' ' ' VAL . 26.4 mt -107.74 -15.35 14.59 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.51 -178.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 67.2 t30 60.35 52.87 4.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.686 -175.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.546 HG12 ' HB2' ' A' ' 189' ' ' LEU . 12.2 p -135.24 143.39 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.667 -177.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 95.5 m -105.6 116.45 31.97 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.078 0.466 . . . . 0.0 110.249 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 63.7 t -131.19 129.9 63.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.144 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.492 ' HG2' ' HG2' ' A' ' 181' ' ' LYS . 48.3 tt0 -77.99 121.23 23.94 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.59 HD12 ' HD2' ' A' ' 196' ' ' PRO . 18.5 tp -126.86 141.2 39.8 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.216 -171.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.59 ' HD2' HD12 ' A' ' 195' ' ' LEU . 53.7 Cg_endo -67.88 151.48 78.19 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.75 2.3 . . . . 0.0 112.604 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 83.1 mt -97.12 118.2 43.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.231 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.2 mp -73.2 -43.79 60.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.147 0.499 . . . . 0.0 110.781 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 87.1 p -157.07 161.96 39.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.597 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.98 138.74 51.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.621 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -124.03 127.71 48.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.661 -177.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -90.08 125.2 35.34 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 9.1 p30 . . . . . 0 C--N 1.313 -1.004 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.444 179.456 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 14.9 t -131.28 174.44 10.05 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 120.786 0.327 . . . . 0.0 110.418 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -73.47 152.3 40.78 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.532 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.81 8.5 48.34 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.535 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 86.9 m -82.83 140.0 33.18 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 51.2 mm -102.17 127.36 55.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 O-C-N 121.919 -0.488 . . . . 0.0 111.093 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.597 HD13 HD11 ' A' ' 245' ' ' ILE . 43.0 pt -124.67 157.27 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.349 177.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -109.7 126.29 53.55 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 33.6 m -128.35 158.88 40.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 120.985 0.421 . . . . 0.0 110.954 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -89.94 107.09 18.91 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 43.6 t -90.92 78.76 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 30.0 t -167.76 -46.78 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.308 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -75.0 -4.59 39.22 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.495 ' HG ' ' H ' ' A' ' 230' ' ' ILE . 2.6 pt? -63.32 -15.56 57.71 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.893 0.378 . . . . 0.0 111.005 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 92.03 -12.68 68.91 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.933 174.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.495 ' H ' ' HG ' ' A' ' 228' ' ' LEU . 39.8 pt -131.98 153.86 39.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.587 0.708 . . . . 0.0 111.657 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 8.1 p -173.83 125.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 114.281 -1.327 . . . . 0.0 108.357 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 9.2 t -93.27 -10.76 34.43 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.264 0.554 . . . . 0.0 110.877 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.511 ' HB3' HG12 ' A' ' 237' ' ' ILE . . . -94.63 20.34 8.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.189 -177.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 37.0 m 59.59 27.88 17.18 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.004 0.43 . . . . 0.0 111.84 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 82.38 6.17 88.92 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.943 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -61.39 -39.26 90.04 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.056 0.455 . . . . 0.0 110.206 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.511 HG12 ' HB3' ' A' ' 233' ' ' ALA . 22.2 pt -98.12 15.42 3.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.04 -178.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -87.1 105.16 16.98 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.614 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -153.97 175.1 13.79 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.961 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -79.22 113.16 3.6 Favored Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 171.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -125.02 156.77 37.61 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 120.693 0.282 . . . . 0.0 110.407 -173.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 37.2 p90 -101.7 148.84 24.79 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.406 0.622 . . . . 0.0 112.185 -176.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -134.1 159.63 40.25 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.137 -177.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -99.31 127.73 45.35 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.183 0.516 . . . . 0.0 111.404 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.597 HD11 HD13 ' A' ' 221' ' ' ILE . 47.5 mm -76.22 125.62 36.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.341 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.7 t -129.61 101.91 6.13 Favored 'General case' 0 N--CA 1.425 -1.698 0 O-C-N 124.401 1.063 . . . . 0.0 108.679 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -76.32 121.07 22.44 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.4 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -129.78 71.33 82.16 Favored Pre-proline 0 C--N 1.314 -0.935 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.426 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 74.5 Cg_endo -72.31 -19.82 25.1 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.49 2.127 . . . . 0.0 112.545 -177.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -85.93 -24.08 26.71 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.042 0.449 . . . . 0.0 110.646 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -92.7 -55.3 3.43 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.155 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -105.67 -37.65 6.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.096 0.474 . . . . 0.0 110.664 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 100.91 10.94 41.59 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.817 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 30.6 p -147.04 177.69 8.96 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.491 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 96.4 t -79.58 122.12 34.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.693 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -112.94 150.15 32.24 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.739 -177.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.496 ' HB3' HG22 ' A' ' 184' ' ' VAL . . . -130.26 142.81 50.53 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 120.942 0.401 . . . . 0.0 110.73 177.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.8 p -123.67 131.42 73.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.94 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.1 tt -83.82 126.51 33.01 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.064 -177.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 4.1 pp -92.81 130.03 38.54 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.515 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.27 2.154 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.652 -178.302 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 38.6 t80 . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.49 ' HB3' ' HB ' ' A' ' 197' ' ' ILE . 98.4 mttt -76.23 89.05 3.1 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.698 0.285 . . . . 0.0 111.608 -178.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -124.79 143.99 50.51 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.573 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -137.07 144.28 43.05 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.863 176.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 66.5 t30 -85.7 99.8 11.56 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.7 t -91.68 120.98 41.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.265 0.555 . . . . 0.0 112.14 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 90.4 m -98.23 124.09 42.65 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.542 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -100.65 113.55 65.61 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.541 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.39 -16.51 51.56 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.647 2.231 . . . . 0.0 111.675 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 41.2 m -65.19 -43.13 92.6 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.264 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.597 ' HB2' HG12 ' A' ' 191' ' ' VAL . 23.8 mt -114.78 -9.17 12.56 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.699 -175.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 60.97 42.34 12.91 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.083 -176.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.597 HG12 ' HB2' ' A' ' 189' ' ' LEU . 10.5 p -129.26 147.7 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 14.8 t -123.77 129.63 51.35 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.307 0.575 . . . . 0.0 110.579 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 58.9 t -134.53 138.5 49.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.209 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 61.0 tt0 -80.51 113.31 18.61 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.302 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 7.6 mp -116.41 155.7 48.22 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.367 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 180' ' ' LYS . 58.7 Cg_endo -70.55 147.03 56.93 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.265 1.977 . . . . 0.0 111.535 177.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 180' ' ' LYS . 84.7 mt -87.3 107.27 16.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.892 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.87 -42.89 76.41 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.014 0.435 . . . . 0.0 111.088 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' A' ' 222' ' ' GLU . 18.8 m -141.67 146.09 35.71 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.428 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.7 138.62 44.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.019 0.438 . . . . 0.0 111.379 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.07 147.79 51.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.531 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -73.25 158.85 34.39 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.801 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 . . . . . 0 C--N 1.324 -0.522 0 CA-C-O 120.608 0.242 . . . . 0.0 110.695 179.881 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 C--O 1.238 0.466 0 CA-C-O 121.129 0.49 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 75.1 p -91.68 163.67 14.01 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.531 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -70.57 151.36 45.12 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.894 0.378 . . . . 0.0 110.719 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.12 7.69 30.48 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.135 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.65 ' OG1' ' HB ' ' A' ' 245' ' ' ILE . 50.6 p -79.96 157.69 26.79 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.3 mm -115.78 129.04 72.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.017 0.437 . . . . 0.0 111.672 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.504 HG21 HD11 ' A' ' 245' ' ' ILE . 46.1 pt -125.86 158.3 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.999 178.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 199' ' ' SER . 44.1 tt0 -107.52 124.68 50.27 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.283 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.06 156.69 40.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.106 0.479 . . . . 0.0 110.951 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -100.64 113.49 26.38 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.338 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 22.3 t -83.96 70.6 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.408 ' H ' ' H ' ' A' ' 227' ' ' ASP . 18.7 m -159.78 -22.56 0.07 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.707 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' ASP . . . . . 0.408 ' H ' ' H ' ' A' ' 226' ' ' SER . 5.4 m-20 -82.41 8.34 11.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.669 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.44 -22.26 65.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.049 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 95.73 -9.07 68.63 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.748 -0.66 . . . . 0.0 113.281 178.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 48.8 mm -115.8 135.52 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 CA-C-O 122.258 1.028 . . . . 0.0 112.515 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 4.7 m -112.46 118.22 57.24 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.475 0 CA-C-N 113.067 -1.879 . . . . 0.0 108.867 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 233' ' ' ALA . 61.1 p -68.48 -41.77 79.65 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.661 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 232' ' ' THR . . . 163.49 -39.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.079 0.952 . . . . 0.0 110.41 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 18.9 m -137.83 12.45 2.91 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.02 -176.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.35 50.67 54.7 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 119.724 -1.227 . . . . 0.0 110.74 -176.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.403 ' HD3' ' O ' ' A' ' 236' ' ' LYS . 9.0 tmtt? -57.22 -37.76 72.72 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 123.417 0.687 . . . . 0.0 110.332 -174.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 11.8 pt -118.66 19.19 6.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.814 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -81.17 107.71 14.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.82 0.343 . . . . 0.0 111.441 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 -159.34 169.43 24.03 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.568 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -94.05 119.14 5.94 Favored Glycine 0 N--CA 1.437 -1.241 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 172.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.44 ' CB ' HD11 ' A' ' 259' ' ' LEU . 37.3 mmt180 -127.86 164.05 23.08 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.953 0.406 . . . . 0.0 111.419 -174.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.545 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 96.6 m-85 -104.09 140.73 37.36 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.148 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -125.07 148.57 48.45 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.051 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 219' ' ' THR . 37.0 tt0 -98.68 125.69 44.06 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.195 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.65 ' HB ' ' OG1' ' A' ' 219' ' ' THR . 90.8 mt -80.75 127.77 39.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.048 0.452 . . . . 0.0 111.066 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 4.8 t -135.57 102.6 5.17 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.811 176.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -78.63 116.92 19.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.612 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -131.53 73.98 78.87 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.869 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.93 -23.14 41.21 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.285 1.99 . . . . 0.0 112.179 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -80.42 -12.55 59.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.333 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -113.1 -57.7 2.25 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.128 0.49 . . . . 0.0 111.001 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.549 ' HB2' HD21 ' A' ' 256' ' ' ASN . 26.9 m-20 -96.86 -27.6 14.61 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.881 -176.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 80.5 16.66 75.31 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.944 -178.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 48.5 t -155.48 165.3 37.01 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 96.1 t -81.06 121.95 35.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.549 HD21 ' HB2' ' A' ' 252' ' ' ASP . 48.1 m-80 -113.14 152.7 29.31 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 120.838 0.352 . . . . 0.0 111.257 -174.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -128.86 131.22 47.64 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.16 126.1 58.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.134 0.492 . . . . 0.0 109.908 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.44 HD11 ' CB ' ' A' ' 241' ' ' ARG . 51.5 tp -75.28 129.13 36.92 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.805 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 242' ' ' TYR . 3.0 pp -100.99 127.78 47.33 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 C--O 1.262 1.739 0 CA-C-O 117.951 -1.023 . . . . 0.0 111.065 -178.579 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 69.5 t80 . . . . . 0 N--CA 1.446 -0.671 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.486 ' HB3' ' HB ' ' A' ' 197' ' ' ILE . 56.3 mtmt -73.4 80.74 1.4 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.048 0.451 . . . . 0.0 111.92 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.474 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 84.8 tttt -155.72 135.2 12.44 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -141.96 160.54 40.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.97 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 17.8 m120 -80.9 103.56 10.82 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 64.1 t -85.68 122.06 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 121.338 0.59 . . . . 0.0 110.798 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.1 m -102.96 125.67 49.82 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.279 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -103.99 105.88 50.54 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.56 -32.39 79.76 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.465 2.11 . . . . 0.0 113.209 -176.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 87.9 m -67.22 -41.81 85.09 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.995 0.426 . . . . 0.0 110.872 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.48 ' HB2' HG12 ' A' ' 191' ' ' VAL . 41.7 mt -88.13 -20.66 25.35 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.414 0.626 . . . . 0.0 109.326 -178.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.4 t30 60.03 50.73 6.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.654 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.48 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.9 p -139.97 147.67 23.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.658 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 60.0 m -116.97 119.26 34.77 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 65.6 t -128.94 127.95 66.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 46.1 tt0 -78.2 118.98 20.94 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 91.7 mt -126.19 149.74 67.71 Favored Pre-proline 0 C--N 1.312 -1.022 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.28 -176.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.48 146.2 55.05 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.012 1.808 . . . . 0.0 110.919 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 180' ' ' LYS . 80.7 mt -91.47 117.77 35.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.66 -43.54 80.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.14 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 67.9 m -152.19 149.66 28.98 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.528 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.404 HG12 HG22 ' A' ' 221' ' ' ILE . 36.0 m -116.52 142.24 30.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -130.94 142.7 50.38 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.406 0.622 . . . . 0.0 110.827 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -71.9 134.65 46.16 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.981 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 9.6 p30 . . . . . 0 C--N 1.312 -1.039 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.863 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 N--CA 1.446 -0.629 0 CA-C-O 121.16 0.505 . . . . 0.0 111.681 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 74.7 p -127.14 -172.51 2.67 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.455 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.517 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 18.2 ptpt -50.59 150.83 2.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.275 0.559 . . . . 0.0 112.409 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 114.99 6.11 19.2 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.804 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 244' ' ' GLN . 56.9 m -71.6 138.92 49.1 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.5 mm -92.37 125.69 44.96 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.717 0 CA-C-O 120.522 0.201 . . . . 0.0 110.502 -176.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.409 ' HB ' HG23 ' A' ' 197' ' ' ILE . 47.3 pt -133.54 160.12 42.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 120.961 0.41 . . . . 0.0 111.2 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -107.32 126.96 53.11 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.455 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.33 153.16 30.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.145 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -102.61 111.12 23.29 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.295 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 46.6 t -78.71 79.39 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 32.7 t -174.71 -27.55 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.949 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.31 5.11 9.2 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.291 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.65 -38.58 88.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.768 0.318 . . . . 0.0 110.677 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 83.39 7.01 87.11 Favored Glycine 0 CA--C 1.509 -0.325 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.531 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 49.3 pt -107.93 0.27 9.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 120.6 0.238 . . . . 0.0 110.822 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 39.7 t 62.74 96.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.903 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.453 HG22 HD11 ' A' ' 237' ' ' ILE . 14.0 m -85.08 101.13 12.18 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.982 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.535 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . 50.08 52.72 14.16 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.69 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 41.8 m 64.13 10.12 5.23 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.293 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 80.98 5.63 90.01 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.991 -0.623 . . . . 0.0 113.184 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 65.3 pttt -67.12 -24.22 65.89 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.211 0.529 . . . . 0.0 111.043 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 232' ' ' THR . 13.0 pt -110.5 19.76 6.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.37 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -78.0 105.68 9.37 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.168 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -145.11 158.14 43.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.888 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -81.25 132.28 11.07 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 175.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -128.5 172.42 11.16 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.915 0.388 . . . . 0.0 110.804 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -101.35 140.07 36.14 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.104 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -135.78 159.2 42.38 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.28 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 219' ' ' THR . 49.0 mt-30 -113.81 136.26 53.06 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.406 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.446 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 89.5 mt -79.85 124.19 37.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.517 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 4.9 t -124.72 92.45 3.65 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 122.12 0.962 . . . . 0.0 108.72 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' ASN . . . . . 0.435 ' C ' ' HD3' ' A' ' 249' ' ' PRO . 20.1 p-10 -74.48 118.94 18.01 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.586 -177.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -130.22 67.87 80.41 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.88 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.435 ' HD3' ' C ' ' A' ' 247' ' ' ASN . 6.5 Cg_exo -77.35 -23.06 10.46 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.139 1.893 . . . . 0.0 109.99 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -67.9 -36.96 81.1 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.792 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -107.22 -58.09 1.99 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.421 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -72.27 -39.78 68.12 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.327 0.584 . . . . 0.0 110.854 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 100.77 7.24 51.21 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.404 -0.817 . . . . 0.0 112.399 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 39.4 t -152.44 164.71 36.99 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.781 0.324 . . . . 0.0 111.165 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 86.9 t -80.63 123.78 37.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -117.61 152.88 34.26 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.689 -174.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -124.41 145.68 49.34 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.5 p -121.09 131.94 71.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.043 0.449 . . . . 0.0 110.63 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.4 tt -100.86 128.35 46.94 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.251 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 2.7 pp -100.8 150.47 22.77 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.076 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.261 1.699 0 CA-C-O 118.102 -0.951 . . . . 0.0 111.037 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 . . . . . 0 N--CA 1.445 -0.714 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 64.19 43.72 4.79 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 122.284 1.04 . . . . 0.0 109.299 -170.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.567 ' HD3' ' HG2' ' A' ' 194' ' ' GLN . 4.0 tmmm? -124.26 133.69 53.43 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 113.597 -1.638 . . . . 0.0 107.561 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -135.7 159.79 40.54 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.221 0.534 . . . . 0.0 112.132 -175.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 58.2 t30 -87.22 105.68 17.38 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.92 119.02 41.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.441 0.639 . . . . 0.0 111.693 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 86.6 m -105.27 126.26 51.9 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.082 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -105.52 108.92 62.54 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 40.4 Cg_endo -66.69 -30.49 41.77 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 122.017 1.811 . . . . 0.0 112.576 -178.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 88.6 m -65.57 -43.37 90.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.283 0.563 . . . . 0.0 111.03 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.494 ' HB2' HG12 ' A' ' 191' ' ' VAL . 36.1 mt -96.17 -16.96 21.17 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.748 -177.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.4 t30 60.66 52.58 4.39 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.613 -176.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.494 HG12 ' HB2' ' A' ' 189' ' ' LEU . 10.2 p -138.04 137.25 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.002 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 9.3 t -115.94 116.86 28.68 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.529 0.681 . . . . 0.0 110.181 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 64.3 t -129.11 129.3 67.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.182 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.567 ' HG2' ' HD3' ' A' ' 181' ' ' LYS . 33.0 tt0 -77.38 124.29 27.67 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.619 HD12 ' HD2' ' A' ' 196' ' ' PRO . 25.2 tp -142.7 139.23 16.94 Favored Pre-proline 0 C--N 1.317 -0.848 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.767 -173.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.619 ' HD2' HD12 ' A' ' 195' ' ' LEU . 40.9 Cg_endo -67.87 147.24 74.3 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 121.882 1.721 . . . . 0.0 109.873 173.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.518 HG21 HG12 ' A' ' 200' ' ' VAL . 79.1 mt -84.48 124.5 39.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 120.918 0.39 . . . . 0.0 111.565 -175.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.65 -40.51 84.51 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.219 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 33.4 t -159.57 150.85 19.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.518 HG12 HG21 ' A' ' 197' ' ' ILE . 30.7 m -126.21 148.22 30.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.906 0.384 . . . . 0.0 110.932 -178.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -116.31 117.81 31.01 Favored 'General case' 0 C--O 1.253 1.283 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 174.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.81 141.07 54.15 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 124.475 1.109 . . . . 0.0 111.292 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 . . . . . 0 C--O 1.233 0.208 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.472 -178.647 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 N--CA 1.444 -0.76 0 CA-C-O 121.649 0.738 . . . . 0.0 112.223 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 57.1 m -124.73 151.3 45.22 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.818 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.459 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 8.3 ptpp? -43.88 151.24 0.22 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 113.5 4.38 23.42 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.766 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.598 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 88.6 m -78.38 136.75 37.74 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.5 mm -100.82 128.56 52.84 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.741 HD13 HD11 ' A' ' 245' ' ' ILE . 46.8 pt -126.86 162.44 31.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -99.62 121.96 41.96 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.774 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 28.5 m -129.81 155.04 41.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 O-C-N 123.386 0.429 . . . . 0.0 110.519 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.432 ' OD1' HD21 ' A' ' 195' ' ' LEU . 16.5 p-10 -101.94 116.85 33.6 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.375 0.607 . . . . 0.0 110.961 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.545 ' HB ' HH11 ' A' ' 241' ' ' ARG . 53.0 t -109.76 87.69 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 38.7 t -118.83 -79.79 0.6 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.038 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -99.74 -30.13 12.25 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.021 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 91.7 mt 63.73 23.56 13.53 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.14 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 92.69 -8.3 76.8 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 121.016 -0.611 . . . . 0.0 113.228 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.8 pt -129.19 169.12 21.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.818 0.309 . . . . 0.0 110.607 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 15.9 m -90.3 89.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-O 121.712 0.768 . . . . 0.0 110.075 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.421 HG21 HD11 ' A' ' 237' ' ' ILE . 5.1 t -80.99 -51.47 8.49 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.747 -176.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.445 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . -170.42 53.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.641 0.258 . . . . 0.0 111.636 -177.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 19.9 m 58.52 20.01 7.14 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.096 177.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.89 21.59 76.75 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.082 -0.58 . . . . 0.0 113.545 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 19.2 ptpt -69.81 -18.94 63.49 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.622 0.711 . . . . 0.0 111.738 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.421 HD11 HG21 ' A' ' 232' ' ' THR . 28.9 pt -96.26 13.33 3.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.136 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -72.07 107.2 4.65 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.234 0.54 . . . . 0.0 112.195 -177.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -143.99 144.13 31.53 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.307 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -74.76 125.73 8.59 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.545 HH11 ' HB ' ' A' ' 225' ' ' VAL . 85.5 mtt85 -128.46 165.46 20.64 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.917 0.358 . . . . 0.0 111.185 -175.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.425 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 99.5 m-85 -101.03 136.08 41.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.542 -177.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -123.36 148.08 46.41 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.093 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -97.19 125.33 41.65 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.718 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.741 HD11 HD13 ' A' ' 221' ' ' ILE . 46.5 mm -83.11 122.38 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.918 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.018 177.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.459 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 1.3 t -128.64 86.86 2.5 Favored 'General case' 0 N--CA 1.428 -1.544 0 O-C-N 124.339 1.024 . . . . 0.0 108.78 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -80.5 115.87 20.25 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.339 0.59 . . . . 0.0 110.749 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -131.04 73.36 81.01 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.434 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.49 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 43.5 Cg_endo -66.73 -22.76 49.48 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.811 1.674 . . . . 0.0 110.673 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -69.1 -37.57 78.47 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.284 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -92.72 -55.9 3.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.262 -175.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -100.44 -32.31 10.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.194 0.521 . . . . 0.0 110.966 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 95.6 -4.95 66.81 Favored Glycine 0 C--N 1.315 -0.593 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.657 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 85.9 m -131.22 167.3 19.42 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.773 0.321 . . . . 0.0 110.77 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 87.5 t -80.74 121.37 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -108.47 146.5 33.06 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.578 -174.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -137.82 146.57 43.66 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.449 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.3 p -132.32 136.38 56.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.431 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 56.4 tp -73.05 130.53 40.51 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.098 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 242' ' ' TYR . 4.0 pp -102.82 144.46 31.12 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.861 176.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 26.5 m . . . . . 0 C--O 1.268 2.042 0 CA-C-O 117.905 -1.045 . . . . 0.0 111.043 -179.49 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 20.7 t80 . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -76.26 92.56 3.31 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 120.943 0.402 . . . . 0.0 110.995 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.492 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 22.5 ttmm -144.83 137.92 26.69 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.918 -177.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -139.07 154.78 48.23 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.787 0.327 . . . . 0.0 111.345 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -88.57 111.59 22.06 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.012 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 65.1 t -99.12 125.8 52.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.248 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.0 m -104.4 127.97 52.17 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.693 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -104.48 110.6 64.52 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -55.94 -36.36 95.65 Favored 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 123.448 2.766 . . . . 0.0 113.562 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 87.0 m -66.07 -41.27 90.97 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.127 0.489 . . . . 0.0 111.392 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.508 ' HB2' HG12 ' A' ' 191' ' ' VAL . 40.0 mt -94.42 -18.66 21.32 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.403 -175.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 58.77 44.14 17.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.141 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.508 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.9 p -134.23 144.49 35.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.75 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 86.2 m -113.73 120.25 40.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.173 0.511 . . . . 0.0 109.861 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 10.9 m -126.14 143.78 38.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.636 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.492 ' HG2' ' HG2' ' A' ' 181' ' ' LYS . 59.0 tt0 -97.76 122.37 40.77 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.603 -175.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.43 HD11 ' HA ' ' A' ' 228' ' ' LEU . 2.7 mm? -128.73 156.87 76.88 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.494 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.61 149.68 68.18 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.28 1.987 . . . . 0.0 110.674 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 79.3 mt -84.78 112.16 21.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.525 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 223' ' ' VAL . 3.9 mm? -68.0 -42.13 81.18 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.221 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 222' ' ' GLU . 37.3 t -150.91 148.6 28.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.222 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.03 140.85 45.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.999 0.428 . . . . 0.0 111.275 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -133.8 131.91 39.85 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -111.01 144.77 39.59 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.223 177.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--N 1.315 -0.914 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.077 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 78.8 mt . . . . . 0 CA--C 1.495 -1.162 0 CA-C-O 121.752 0.786 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.2 p -116.43 -178.1 3.34 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.937 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.476 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 18.0 ptpt -60.68 144.91 51.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.286 0.565 . . . . 0.0 112.123 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 112.13 5.54 24.95 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.184 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.644 ' OG1' ' HB ' ' A' ' 245' ' ' ILE . 1.3 p -86.09 158.14 19.88 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 122.211 0.204 . . . . 0.0 111.239 178.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 48.4 mm -114.56 129.8 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -174.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.466 HG21 HD11 ' A' ' 245' ' ' ILE . 44.9 pt -132.65 162.94 39.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.025 0.44 . . . . 0.0 111.09 176.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 199' ' ' SER . 43.9 tt0 -112.86 131.39 55.73 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.438 ' HA ' HD23 ' A' ' 198' ' ' LEU . 26.8 m -129.08 150.88 35.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.092 0.472 . . . . 0.0 110.785 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -103.54 106.1 16.52 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.319 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 7.6 p -84.13 71.22 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-O 122.585 1.183 . . . . 0.0 110.149 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 14.9 m -154.37 -37.13 0.09 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.638 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -81.46 20.72 0.85 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.161 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.469 HD11 HG23 ' A' ' 225' ' ' VAL . 98.9 mt -61.33 -39.1 89.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.78 -177.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 174.22 -92.64 0.09 OUTLIER Glycine 0 N--CA 1.428 -1.841 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.617 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 63.9 mt -132.76 -86.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.075 0.464 . . . . 0.0 111.338 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.94 77.1 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.611 0.719 . . . . 0.0 110.759 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 23.9 p -71.14 -60.18 2.37 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.912 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -143.31 49.39 1.43 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.919 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 20.9 t 65.0 12.81 8.2 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.493 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 74.15 11.2 81.82 Favored Glycine 0 C--O 1.225 -0.411 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.859 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -67.66 -33.47 75.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.019 0.914 . . . . 0.0 109.499 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 35.9 pt -86.54 10.57 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.742 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -77.35 107.77 10.01 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -176.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' TRP . . . . . 0.476 ' O ' HG12 ' A' ' 225' ' ' VAL . 26.7 t90 -170.3 146.95 2.99 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.893 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -72.08 129.96 15.94 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.653 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -130.48 175.04 9.3 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -113.19 147.32 37.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.386 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -138.39 153.17 48.91 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.628 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -102.09 136.0 42.69 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.053 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.644 ' HB ' ' OG1' ' A' ' 219' ' ' THR . 87.3 mt -85.84 126.3 40.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.116 0.484 . . . . 0.0 110.777 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.476 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 3.1 t -127.24 87.83 2.7 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 174.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -68.7 117.22 10.14 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.371 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -128.2 69.62 78.08 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.795 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.445 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 65.1 Cg_endo -84.86 -13.29 6.83 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.569 2.179 . . . . 0.0 111.727 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -68.9 -37.67 79.13 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.095 -177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -115.18 -57.53 2.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.39 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.475 ' OD2' ' HB2' ' A' ' 254' ' ' CYS . 35.9 t70 -67.9 -39.5 83.59 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.345 0.593 . . . . 0.0 109.841 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.445 ' CA ' ' HA ' ' A' ' 249' ' ' PRO . . . 89.6 0.11 79.51 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.973 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.475 ' HB2' ' OD2' ' A' ' 252' ' ' ASP . 74.3 m -130.23 164.03 25.43 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.847 0.356 . . . . 0.0 111.181 -177.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 62.8 t -82.74 117.19 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -106.74 149.67 27.08 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.433 -176.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -136.35 144.36 44.57 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.12 131.06 70.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 121.146 0.498 . . . . 0.0 110.664 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.7 tt -99.51 125.36 45.26 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.672 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 260' ' ' LEU . 3.2 pp -92.9 144.52 25.18 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.244 0.545 . . . . 0.0 111.805 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.269 2.083 0 CA-C-O 117.729 -1.129 . . . . 0.0 110.442 179.441 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 . . . . . 0 CA--C 1.507 -0.708 0 CA-C-O 120.636 0.255 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -75.98 83.76 2.87 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.213 -177.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -128.24 144.58 51.14 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.956 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -132.69 150.62 52.13 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.646 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -87.88 100.46 12.9 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 192' ' ' THR . 67.3 t -84.21 117.37 29.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.202 -172.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.4 m -100.1 128.37 46.19 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.494 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -103.21 111.77 65.29 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.26 -25.0 57.56 Favored 'Trans proline' 0 N--CA 1.479 0.633 0 C-N-CA 122.986 2.457 . . . . 0.0 114.37 -175.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 39.6 p -66.79 -43.32 84.26 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.574 ' CD1' HG12 ' A' ' 191' ' ' VAL . 0.6 OUTLIER -116.52 -4.44 11.75 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.118 0.485 . . . . 0.0 111.802 -179.192 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.7 t30 59.44 61.59 1.98 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.218 -0.901 . . . . 0.0 113.292 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.574 HG12 ' CD1' ' A' ' 189' ' ' LEU . 3.2 p -138.52 147.77 25.08 Favored 'Isoleucine or valine' 0 C--O 1.248 1.005 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 175.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 15.3 t -127.62 135.88 50.87 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 120.266 -0.573 . . . . 0.0 111.529 -177.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.426 HG23 ' CD2' ' A' ' 195' ' ' LEU . 6.6 m -140.8 147.68 22.56 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.494 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -85.55 123.71 31.28 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.773 0.321 . . . . 0.0 111.582 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.426 ' CD2' HG23 ' A' ' 193' ' ' VAL . 3.1 mm? -128.08 151.51 76.12 Favored Pre-proline 0 C--O 1.24 0.558 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.314 176.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.91 144.42 47.87 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.365 2.044 . . . . 0.0 111.169 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.522 HG23 ' HB ' ' A' ' 221' ' ' ILE . 73.0 mt -92.24 119.37 39.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.423 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.4 -42.16 68.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.853 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 44.3 m -141.7 144.28 33.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.394 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.9 m -127.35 139.64 51.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.009 0.433 . . . . 0.0 111.683 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.436 ' O ' HG23 ' A' ' 219' ' ' THR . 57.3 mtpt -139.23 132.01 29.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.38 174.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -92.0 160.14 15.39 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 15.8 m120 . . . . . 0 C--N 1.314 -0.966 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.358 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 60.2 tp . . . . . 0 N--CA 1.444 -0.771 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 14.8 t -89.84 148.72 23.02 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.444 ' HE2' ' OG1' ' A' ' 246' ' ' THR . 14.1 ptmm? -74.5 148.16 41.23 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.614 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.72 7.98 49.74 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.591 -176.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.438 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 79.9 m -71.09 134.33 46.95 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 122.416 0.286 . . . . 0.0 110.623 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.451 HD13 ' HG2' ' A' ' 244' ' ' GLN . 45.5 mm -93.19 124.06 45.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.591 -176.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.522 ' HB ' HG23 ' A' ' 197' ' ' ILE . 47.3 pt -131.71 160.64 42.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.314 0.578 . . . . 0.0 112.027 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -109.3 126.11 53.02 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.326 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 31.6 m -131.13 157.5 43.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.103 0.478 . . . . 0.0 111.281 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -107.02 106.72 17.38 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.439 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 44.9 t -82.39 78.67 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 22.2 t -179.3 -21.7 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.411 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -60.34 -35.42 75.61 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.726 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.467 ' HG ' ' H ' ' A' ' 230' ' ' ILE . 2.3 pt? -53.32 -23.56 9.58 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.901 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 91.42 -12.13 70.17 Favored Glycine 0 C--N 1.329 0.174 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.833 175.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.467 ' H ' ' HG ' ' A' ' 228' ' ' LEU . 45.2 pt -122.37 159.25 25.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.134 0.492 . . . . 0.0 110.371 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.35 149.95 31.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.336 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 6.8 t -72.81 -41.92 64.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.252 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.04 91.14 1.25 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.343 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 50.1 m 58.56 23.83 11.3 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 173.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.05 32.98 82.16 Favored Glycine 0 C--O 1.222 -0.602 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.82 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.25 -39.88 88.34 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.424 0.631 . . . . 0.0 110.71 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 15.5 pt -102.05 12.41 7.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.837 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -83.35 106.47 15.14 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.518 -176.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 -166.67 176.8 6.95 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.172 0.989 . . . . 0.0 109.037 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.411 ' C ' ' HD2' ' A' ' 241' ' ' ARG . . . -76.13 125.32 7.72 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 174.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.411 ' HD2' ' C ' ' A' ' 240' ' ' GLY . 2.4 mpt_? -128.36 177.92 6.63 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.118 0.485 . . . . 0.0 111.164 -177.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -120.05 145.88 46.43 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.533 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -135.45 158.43 44.39 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.394 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.451 ' HG2' HD13 ' A' ' 220' ' ' ILE . 78.8 mt-30 -114.26 128.45 56.37 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.694 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.472 HD11 HG21 ' A' ' 221' ' ' ILE . 86.2 mt -82.18 127.13 39.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.176 0.512 . . . . 0.0 111.67 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.444 ' OG1' ' HE2' ' A' ' 217' ' ' LYS . 4.0 t -137.72 102.68 4.81 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.275 175.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' ASN . . . . . 0.408 ' HB3' HG13 ' A' ' 255' ' ' VAL . 5.5 p30 -75.44 124.84 27.85 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.553 -178.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -128.67 71.32 80.9 Favored Pre-proline 0 N--CA 1.443 -0.8 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.156 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.565 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 54.7 Cg_endo -68.99 -19.6 39.61 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.92 1.747 . . . . 0.0 110.089 178.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -66.6 -37.87 85.81 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.917 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -98.21 -57.1 2.29 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.033 0.444 . . . . 0.0 110.76 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.422 ' HB3' HD21 ' A' ' 256' ' ' ASN . 34.3 t70 -94.5 -37.33 11.45 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.384 -176.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 249' ' ' PRO . . . 100.73 -4.39 56.36 Favored Glycine 0 C--N 1.312 -0.783 0 C-N-CA 120.657 -0.783 . . . . 0.0 111.55 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 79.9 m -128.04 167.95 16.01 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.806 0.336 . . . . 0.0 110.965 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 247' ' ' ASN . 81.5 t -80.55 121.03 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.422 HD21 ' HB3' ' A' ' 252' ' ' ASP . 78.8 m-20 -115.95 152.83 32.72 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.935 -173.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -124.63 141.51 52.05 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.0 p -108.69 134.08 51.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.082 0.468 . . . . 0.0 110.549 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 62.0 tp -88.29 123.39 32.84 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.458 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.57 105.5 17.65 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.476 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.278 2.585 0 CA-C-O 117.481 -1.247 . . . . 0.0 110.224 178.485 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 . . . . . 0 CA--C 1.499 -0.993 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 196' ' ' PRO . 3.2 mppt? -80.88 73.06 7.9 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.636 -0.426 . . . . 0.0 109.954 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -123.08 139.02 54.51 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.585 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.635 ' HB3' HD11 ' A' ' 197' ' ' ILE . . . -136.55 148.2 47.45 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.563 176.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -84.74 102.04 12.7 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 257' ' ' ALA . 58.9 t -93.72 120.34 42.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.312 0.577 . . . . 0.0 111.908 -173.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 90.5 m -112.13 128.71 56.3 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.04 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -104.44 108.39 60.39 Favored Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.55 -27.65 61.59 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 122.535 2.157 . . . . 0.0 113.557 -175.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.438 HG23 ' HG ' ' A' ' 189' ' ' LEU . 9.3 t -77.77 -27.92 50.45 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.748 0.309 . . . . 0.0 111.695 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.472 ' HB2' HG12 ' A' ' 191' ' ' VAL . 37.4 mt -104.25 -22.02 13.44 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.276 0.56 . . . . 0.0 109.801 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.8 t30 60.21 52.79 4.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.928 -175.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.472 HG12 ' HB2' ' A' ' 189' ' ' LEU . 11.2 p -133.41 137.09 53.76 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.512 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 92.9 m -119.29 124.33 46.4 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.984 0.421 . . . . 0.0 111.042 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 10.3 m -142.95 149.59 18.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.127 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.504 ' C ' HD12 ' A' ' 195' ' ' LEU . 35.3 tt0 -102.89 119.82 39.52 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.85 178.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.504 HD12 ' C ' ' A' ' 194' ' ' GLN . 7.1 mp -128.38 150.59 74.71 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.58 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 180' ' ' LYS . 38.3 Cg_exo -61.37 141.09 91.37 Favored 'Trans proline' 0 C--O 1.24 0.608 0 C-N-CA 122.556 2.17 . . . . 0.0 111.23 175.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.71 HD12 HD12 ' A' ' 221' ' ' ILE . 34.8 mm -91.67 119.85 39.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.193 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.403 HD11 ' ND2' ' A' ' 224' ' ' ASN . 96.6 mt -69.25 -42.19 75.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.597 -177.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.4 t -154.39 149.57 26.99 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.767 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.603 HG12 HG22 ' A' ' 221' ' ' ILE . 32.1 m -128.96 148.09 33.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.451 ' O ' HG23 ' A' ' 219' ' ' THR . 14.5 ptmm? -139.65 149.33 43.6 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -66.75 154.96 39.4 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.351 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 11.7 p30 . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 121.144 0.497 . . . . 0.0 110.986 179.031 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 61.4 tp . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 32.1 p -91.11 168.3 11.73 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -176.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -60.94 153.94 23.68 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.812 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 106.7 10.19 29.24 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -176.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.612 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 87.8 m -71.57 128.5 36.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 201' ' ' LYS . 48.5 mm -90.36 129.03 41.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.762 0.315 . . . . 0.0 110.301 -177.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.71 HD12 HD12 ' A' ' 197' ' ' ILE . 39.0 pt -127.56 154.82 38.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -177.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -102.04 119.32 38.6 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.347 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.31 156.73 40.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.596 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.403 ' ND2' HD11 ' A' ' 198' ' ' LEU . 96.0 m-20 -103.55 108.57 19.89 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.005 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.472 HG23 ' H ' ' A' ' 239' ' ' TRP . 35.2 m -87.58 21.06 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 122.067 0.937 . . . . 0.0 109.288 176.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 21.2 m -105.21 -14.0 15.51 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.561 173.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.85 1.11 55.32 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.287 -174.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.492 HD13 HG12 ' A' ' 230' ' ' ILE . 0.3 OUTLIER -64.35 -31.14 72.22 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.582 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 69.5 31.97 71.26 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.92 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.492 HG12 HD13 ' A' ' 228' ' ' LEU . 42.2 pt -119.39 151.83 21.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 117.214 0.507 . . . . 0.0 110.649 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 27.1 m -121.75 8.35 5.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.694 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 14.6 t -58.66 -18.38 30.28 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.769 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.54 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . -119.26 29.13 7.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.847 0.356 . . . . 0.0 110.553 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 23.0 m 66.75 3.26 2.92 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.637 0.775 . . . . 0.0 112.138 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 81.04 0.71 89.26 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.942 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 19.2 ptpt -70.14 -15.52 62.97 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.122 0.487 . . . . 0.0 111.333 -179.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 33.8 pt -80.93 -4.64 7.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.568 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.16 109.26 2.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.0 0.428 . . . . 0.0 110.149 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' TRP . . . . . 0.472 ' H ' HG23 ' A' ' 225' ' ' VAL . 5.0 m95 -151.96 176.29 11.64 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.627 -178.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -109.8 112.73 3.43 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 171.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -129.44 161.32 30.64 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 117.118 0.459 . . . . 0.0 111.882 -174.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -102.62 133.81 47.02 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.193 175.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -114.68 162.73 16.41 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.613 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -110.24 128.41 55.49 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.083 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.612 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 89.1 mt -81.85 127.23 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.773 0 CA-C-O 120.969 0.414 . . . . 0.0 111.18 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 2.7 t -128.17 101.32 6.21 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.166 175.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.35 117.81 19.94 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.451 0.643 . . . . 0.0 112.148 -178.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -128.57 72.12 80.72 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.355 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.46 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 56.5 Cg_endo -68.77 -19.55 40.96 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.389 2.059 . . . . 0.0 111.568 -178.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -70.13 -30.63 67.85 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.026 177.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -94.1 -56.49 2.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.316 -177.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -104.39 -28.03 11.6 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 249' ' ' PRO . . . 83.43 10.4 82.04 Favored Glycine 0 C--N 1.315 -0.585 0 C-N-CA 120.34 -0.933 . . . . 0.0 111.755 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 83.4 m -135.32 173.48 11.67 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 122.408 0.283 . . . . 0.0 110.263 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 86.3 t -79.56 122.42 34.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.621 ' HB2' ' O ' ' A' ' 246' ' ' THR . 6.3 m120 -103.82 152.09 22.31 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -176.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.424 ' HB3' HG22 ' A' ' 184' ' ' VAL . . . -136.48 143.88 44.06 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 11.0 p -134.54 140.84 44.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-O 120.903 0.382 . . . . 0.0 110.445 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 63.0 tp -79.04 126.02 30.16 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.468 ' O ' HD12 ' A' ' 260' ' ' LEU . 2.8 pp -67.04 133.96 50.96 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.169 0.509 . . . . 0.0 111.512 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 C--O 1.263 1.777 0 CA-C-O 117.684 -1.151 . . . . 0.0 110.794 179.571 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 46.9 p90 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 121.315 0.579 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -89.49 -9.66 49.2 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.445 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -83.34 131.98 35.03 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -94.68 120.78 35.45 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.174 0.512 . . . . 0.0 111.103 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.466 HD11 ' HB3' ' A' ' 202' ' ' LYS . 4.9 tt -142.12 134.77 27.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.876 -176.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.22 165.72 17.73 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -81.29 -81.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.189 1.926 . . . . 0.0 111.062 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 60.2 ttm -160.86 92.45 0.94 Allowed 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.263 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.53 44.57 94.96 Favored Glycine 0 C--N 1.323 -0.18 0 C-N-CA 120.743 -0.742 . . . . 0.0 113.747 174.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -59.85 157.81 11.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -51.59 -50.91 59.24 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -177.53 173.08 1.71 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 176.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -78.91 58.21 2.32 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.038 0.447 . . . . 0.0 111.678 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -138.37 148.65 44.75 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.293 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.499 ' HB3' HD11 ' A' ' 197' ' ' ILE . . . -145.93 149.64 34.58 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.472 176.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -81.33 103.24 10.96 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.479 HG22 ' HB3' ' A' ' 257' ' ' ALA . 58.6 t -92.65 118.82 39.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.237 0.541 . . . . 0.0 110.604 -176.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.4 m -94.13 122.53 36.75 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.272 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -105.06 108.33 61.03 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.3 -28.0 63.7 Favored 'Trans proline' 0 N--CA 1.471 0.192 0 C-N-CA 122.261 1.974 . . . . 0.0 112.007 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 81.1 m -65.66 -41.69 92.21 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.722 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.534 ' HB2' HG12 ' A' ' 191' ' ' VAL . 33.4 mt -96.05 -19.0 19.77 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.066 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 64.3 t30 61.47 51.32 4.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.424 -175.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.534 HG12 ' HB2' ' A' ' 189' ' ' LEU . 5.9 p -149.92 144.12 17.63 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.912 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 11.4 t -111.6 124.34 52.09 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.423 0.63 . . . . 0.0 109.466 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 67.4 t -131.82 136.53 56.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.249 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -79.91 116.76 20.24 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.04 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.442 HD21 HD11 ' A' ' 228' ' ' LEU . 7.5 mp -111.73 150.82 42.83 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.841 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.61 140.21 38.98 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.66 1.574 . . . . 0.0 110.028 174.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' A' ' 182' ' ' ALA . 37.5 mm -86.98 114.82 26.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.082 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 223' ' ' VAL . 4.1 mm? -69.28 -42.41 75.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.802 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.4 t -161.77 149.43 14.69 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.349 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.614 HG12 HG22 ' A' ' 221' ' ' ILE . 32.0 m -119.79 146.62 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -119.97 122.91 42.25 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.466 ' HB3' HD11 ' A' ' 172' ' ' ILE . 20.0 ptpt -52.57 155.2 2.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.638 -1.164 . . . . 0.0 112.585 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -74.38 131.2 80.76 Favored Pre-proline 0 N--CA 1.438 -1.06 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 170.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -59.1 -30.9 94.46 Favored 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 122.547 2.165 . . . . 0.0 114.14 -172.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 25.1 t -108.84 -17.9 13.82 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.129 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 58.18 84.41 0.2 Allowed Pre-proline 0 N--CA 1.472 0.665 0 CA-C-O 121.174 0.511 . . . . 0.0 110.79 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.84 -5.37 16.73 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.359 2.706 . . . . 0.0 114.093 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.403 HD22 ' HB2' ' A' ' 211' ' ' GLN . 75.7 mt -59.13 127.08 30.37 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.396 0.617 . . . . 0.0 111.332 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -90.87 60.52 4.44 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.372 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.3 m 63.08 20.58 12.37 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.464 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.403 ' HB2' HD22 ' A' ' 208' ' ' LEU . 16.1 mm100 -63.29 -40.97 98.86 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.291 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 86.0 mt 56.58 24.11 8.39 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.309 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -105.48 -86.45 1.91 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.014 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.31 162.12 28.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.489 HD13 HG21 ' A' ' 219' ' ' THR . 83.9 mt -72.84 162.65 29.23 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.32 0.581 . . . . 0.0 111.467 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 66.7 p -90.15 166.6 13.3 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.138 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.612 ' HA ' ' O ' ' A' ' 245' ' ' ILE . 19.2 ptpt -65.37 142.62 58.15 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.873 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.4 1.64 55.61 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.209 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.609 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 85.4 m -66.81 138.12 57.11 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.8 mm -94.38 128.84 45.36 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.046 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.323 -174.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.614 HG22 HG12 ' A' ' 200' ' ' VAL . 47.1 pt -126.1 159.39 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 CA-C-O 120.774 0.321 . . . . 0.0 110.314 176.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -116.8 117.91 31.06 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.417 ' HA ' HD23 ' A' ' 198' ' ' LEU . 28.1 m -130.69 157.83 43.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.288 0.566 . . . . 0.0 111.635 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -105.17 106.61 17.18 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.438 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 239' ' ' TRP . 7.2 p -83.84 78.26 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 122.43 1.11 . . . . 0.0 110.446 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 22.2 m -158.77 -34.06 0.07 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.058 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -75.47 9.77 2.0 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.216 -176.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.442 HD11 HD21 ' A' ' 195' ' ' LEU . 7.0 mp -63.52 -40.68 97.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.131 0.491 . . . . 0.0 109.689 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 79.43 -2.03 73.94 Favored Glycine 0 C--O 1.226 -0.351 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.799 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.8 pt -80.1 -31.24 13.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 122.71 -0.288 . . . . 0.0 111.684 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 20.8 t 48.91 72.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 O-C-N 123.558 0.536 . . . . 0.0 110.643 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 13.5 t -110.96 -8.27 14.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.564 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.686 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . -128.06 31.89 5.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.717 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 19.7 m 59.86 9.79 1.85 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 79.78 3.07 89.04 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.962 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.686 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 65.0 pttt -72.02 -11.37 60.73 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.188 0.518 . . . . 0.0 111.804 -177.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 34.9 pt -95.91 -0.86 10.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.641 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -62.48 112.15 2.34 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 123.354 0.409 . . . . 0.0 111.965 -175.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' TRP . . . . . 0.505 ' O ' HG12 ' A' ' 225' ' ' VAL . 71.0 t-105 -175.13 146.91 0.88 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.875 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -73.7 120.39 6.88 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -128.6 162.76 26.55 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.912 0.387 . . . . 0.0 111.214 -173.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -102.45 136.28 42.56 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.94 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -127.02 158.3 37.31 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.096 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -105.73 132.31 52.01 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.875 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 217' ' ' LYS . 49.1 mm -79.07 130.28 36.37 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.192 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.536 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 4.4 t -140.09 104.14 4.77 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -80.76 119.75 23.75 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 120.842 0.354 . . . . 0.0 110.748 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -128.09 72.17 79.31 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-O 121.405 0.622 . . . . 0.0 109.381 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.485 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 71.8 Cg_endo -71.53 -17.84 29.8 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.884 2.389 . . . . 0.0 112.964 -176.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -82.2 -21.61 36.36 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.797 0.332 . . . . 0.0 110.803 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -105.67 -56.86 2.12 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.141 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.442 ' CB ' HD21 ' A' ' 256' ' ' ASN . 18.9 m-20 -93.37 -31.08 14.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.936 0.398 . . . . 0.0 111.44 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 82.99 4.85 89.81 Favored Glycine 0 C--N 1.321 -0.281 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.503 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 65.3 m -132.6 174.14 10.59 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.515 0.197 . . . . 0.0 110.935 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 90.6 t -79.48 121.87 33.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.536 ' HB2' ' O ' ' A' ' 246' ' ' THR . 5.3 m120 -110.13 152.28 26.21 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.612 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.479 ' HB3' HG22 ' A' ' 184' ' ' VAL . . . -134.38 144.83 48.44 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.508 177.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.68 135.94 61.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.006 0.431 . . . . 0.0 110.215 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 64.7 tp -95.57 127.06 41.29 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.23 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.464 ' H ' ' HG ' ' A' ' 260' ' ' LEU . 2.1 pp -90.31 136.71 32.88 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.405 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.266 1.957 0 CA-C-O 117.702 -1.142 . . . . 0.0 111.011 -178.106 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 44.2 p90 . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 120.824 0.345 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -63.9 -39.64 94.66 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.644 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -80.41 -28.91 37.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.25 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 25.0 t80 71.74 -54.93 0.67 Allowed 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.432 1.093 . . . . 0.0 110.605 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.464 HG12 ' HB3' ' A' ' 202' ' ' LYS . 5.8 tp -67.89 136.43 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.431 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 49.4 ptt85 -135.91 145.61 53.42 Favored Pre-proline 0 N--CA 1.436 -1.174 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.499 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 173' ' ' ARG . 16.2 Cg_exo -69.34 -67.43 0.03 OUTLIER 'Trans proline' 0 CA--C 1.512 -0.587 0 C-N-CA 121.944 1.762 . . . . 0.0 110.129 174.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 95.3 mmm -135.83 -4.25 2.24 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.257 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 66.87 36.29 90.86 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.412 HD21 HG23 ' A' ' 255' ' ' VAL . 3.2 pp -82.49 -165.7 1.1 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -173.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 179' ' ' TYR . 28.6 ptt180 -54.84 -44.54 74.02 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -173.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.4 ' N ' ' HG3' ' A' ' 178' ' ' ARG . 87.5 m-85 -138.96 167.3 22.35 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -174.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -97.39 34.71 1.75 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.069 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.428 ' HB3' ' HG2' ' A' ' 194' ' ' GLN . 59.5 mtmt -118.2 144.83 45.42 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.15 0.5 . . . . 0.0 111.114 -176.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -129.44 152.22 49.22 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.026 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -81.53 99.57 8.88 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.3 t -89.68 126.05 42.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.211 -174.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.9 m -114.87 128.3 56.21 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.576 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.518 ' NE2' HD21 ' A' ' 228' ' ' LEU . 30.9 m170 -104.46 117.96 57.85 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.04 -24.89 77.1 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 122.829 2.353 . . . . 0.0 113.492 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 11.6 t -79.67 -23.53 42.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.834 0.35 . . . . 0.0 111.628 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.479 ' HB2' HG12 ' A' ' 191' ' ' VAL . 40.5 mt -103.55 -24.32 13.43 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.2 t30 59.06 46.95 12.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.513 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.479 HG12 ' HB2' ' A' ' 189' ' ' LEU . 8.9 p -133.49 145.27 33.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.174 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 87.9 m -116.42 119.43 35.62 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.436 HG11 ' O ' ' A' ' 228' ' ' LEU . 61.0 t -133.73 138.84 49.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.428 ' HG2' ' HB3' ' A' ' 181' ' ' LYS . 33.7 tt0 -87.57 118.25 26.92 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.881 0.372 . . . . 0.0 111.037 -177.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.71 153.5 77.81 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.195 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.85 146.86 54.52 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.334 2.023 . . . . 0.0 111.26 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.422 HG23 ' HB ' ' A' ' 221' ' ' ILE . 80.6 mt -89.46 116.51 31.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.323 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 95.8 mt -71.78 -42.18 67.45 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.528 ' HB2' ' HB3' ' A' ' 222' ' ' GLU . 16.6 m -140.92 147.19 38.46 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 26.7 m -125.97 146.09 32.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.328 0.585 . . . . 0.0 111.508 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -127.65 106.91 9.47 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.094 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.464 ' HB3' HG12 ' A' ' 172' ' ' ILE . 18.7 ptpt -56.6 156.91 5.72 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.44 0.462 . . . . 0.0 111.661 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 206' ' ' ASN . 3.3 m-20 -71.55 119.74 75.75 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.44 -40.37 5.92 Favored 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.343 2.028 . . . . 0.0 114.048 -174.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 17.6 m -154.74 22.75 0.45 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.826 0.346 . . . . 0.0 111.043 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 203' ' ' ASN . 1.9 m-20 -71.38 133.34 85.25 Favored Pre-proline 0 C--N 1.318 -0.774 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.16 141.31 68.92 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 122.284 1.989 . . . . 0.0 112.113 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 75.3 mt -107.35 119.65 39.98 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.624 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -113.03 -18.27 12.23 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.277 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.5 p -89.87 112.99 24.52 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 121.03 0.443 . . . . 0.0 111.53 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -70.49 -39.72 74.03 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.177 0.513 . . . . 0.0 110.011 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 213' ' ' GLY . 4.2 pp -62.46 -38.23 88.99 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.916 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.447 ' N ' HD12 ' A' ' 212' ' ' LEU . . . -119.45 126.94 6.96 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.767 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.54 -25.53 24.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 120.704 0.288 . . . . 0.0 111.532 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 61.6 tp -105.41 125.14 50.65 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.473 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 24.2 p -95.75 159.18 15.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.863 0.363 . . . . 0.0 111.23 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -61.7 152.15 31.82 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.049 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 109.69 9.76 24.33 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.618 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 21.2 m -73.08 142.12 47.58 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.5 mm -100.2 127.84 52.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.961 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.554 HD13 HD11 ' A' ' 245' ' ' ILE . 45.5 pt -127.53 163.16 31.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.591 0.234 . . . . 0.0 110.598 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.528 ' HB3' ' HB2' ' A' ' 199' ' ' SER . 8.4 tm-20 -124.43 125.65 44.62 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.035 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.3 m -131.15 141.86 44.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.145 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.601 ' HA ' ' HA2' ' A' ' 240' ' ' GLY . 50.8 t-20 -114.82 107.1 14.98 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.967 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.718 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 7.8 p -175.03 -56.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.902 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.422 ' N ' HG13 ' A' ' 225' ' ' VAL . 10.8 t 72.76 -56.16 0.66 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.396 0.678 . . . . 0.0 111.268 -177.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' A' ' 230' ' ' ILE . 1.6 m-20 -63.01 -21.95 66.51 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.344 0.258 . . . . 0.0 111.678 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.518 HD21 ' NE2' ' A' ' 186' ' ' HIS . 96.7 mt 67.23 18.29 10.32 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 92.68 -5.29 76.73 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.63 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.451 ' O ' ' HB3' ' A' ' 227' ' ' ASP . 48.2 pt -107.23 170.46 2.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 231' ' ' VAL . 7.7 p -96.42 90.41 2.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.693 0.758 . . . . 0.0 111.929 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 10.6 t -101.37 -34.96 9.39 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 174.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.689 ' HB3' HG12 ' A' ' 237' ' ' ILE . . . -138.44 9.87 2.71 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.736 174.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 9.3 t 63.37 31.52 15.13 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.155 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 85.13 3.44 87.45 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.083 -0.58 . . . . 0.0 113.192 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -65.12 -39.8 93.59 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 121.25 0.548 . . . . 0.0 111.205 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.689 HG12 ' HB3' ' A' ' 233' ' ' ALA . 30.4 pt -93.04 18.88 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.468 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.718 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -54.01 120.59 6.59 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -153.07 150.68 29.39 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.886 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 224' ' ' ASN . . . -96.22 116.01 5.33 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.847 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -129.3 171.97 11.95 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.735 0.302 . . . . 0.0 111.151 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 96.8 m-85 -102.2 140.48 36.43 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.282 0.563 . . . . 0.0 111.214 -177.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -129.48 154.49 46.94 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.36 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -101.17 133.15 46.15 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.618 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 47.9 mm -80.39 124.64 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.709 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 12.6 p -119.42 76.29 1.12 Allowed 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.082 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -68.66 121.8 17.2 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.352 0.596 . . . . 0.0 110.964 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -128.95 71.29 81.79 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.275 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -72.19 -25.33 19.05 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 121.4 1.4 . . . . 0.0 112.216 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -74.05 -33.02 63.56 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.062 0.458 . . . . 0.0 110.609 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -96.9 -57.1 2.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.937 -176.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -95.0 -29.91 14.38 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.77 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 76.62 18.56 78.9 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.375 -0.917 . . . . 0.0 110.875 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 49.7 t -149.18 160.71 43.12 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.375 -0.413 . . . . 0.0 109.96 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.412 HG23 HD21 ' A' ' 177' ' ' LEU . 85.3 t -80.39 126.85 39.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.946 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 246' ' ' THR . 42.3 m-80 -110.46 153.74 24.6 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.19 148.54 35.12 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.703 0.287 . . . . 0.0 110.65 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.59 130.64 56.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 8.9 tt -75.46 127.96 34.27 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.102 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.467 ' O ' HD12 ' A' ' 260' ' ' LEU . 4.2 pp -84.94 132.5 34.35 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.133 0.492 . . . . 0.0 111.229 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 10.6 m . . . . . 0 C--O 1.279 2.641 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.924 179.646 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.712 0.291 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -63.31 -43.85 96.67 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.712 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 53.08 40.2 30.81 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 123.667 0.604 . . . . 0.0 111.241 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -81.11 50.34 1.39 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.789 0.804 . . . . 0.0 111.099 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.74 116.68 44.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -135.48 87.49 26.88 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -60.65 -33.03 93.86 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 122.748 2.299 . . . . 0.0 110.347 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 53.2 tpp -163.05 -37.91 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.708 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 142.73 86.94 0.09 OUTLIER Glycine 0 N--CA 1.44 -1.082 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.6 pp -88.42 111.52 21.87 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.658 0.742 . . . . 0.0 111.756 -176.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.438 ' HG3' ' CD2' ' A' ' 179' ' ' TYR . 17.0 ptp180 -69.04 -30.29 68.62 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.982 176.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.438 ' CD2' ' HG3' ' A' ' 178' ' ' ARG . 89.8 m-85 -140.0 154.62 47.2 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.828 176.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -79.47 87.82 5.07 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.655 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -156.91 137.28 12.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.489 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.545 ' HB3' HD11 ' A' ' 197' ' ' ILE . . . -145.86 157.07 43.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.963 0.411 . . . . 0.0 111.392 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 56.8 t30 -83.5 99.46 10.14 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.479 HG22 ' HB3' ' A' ' 257' ' ' ALA . 53.1 t -92.65 118.93 39.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.279 0.562 . . . . 0.0 112.067 -172.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 89.6 m -94.31 124.18 38.17 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.259 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -104.84 111.18 65.22 Favored Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -62.93 -28.2 75.1 Favored 'Trans proline' 0 N--CA 1.475 0.407 0 C-N-CA 122.543 2.162 . . . . 0.0 112.621 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.9 t -70.99 -31.88 68.54 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.309 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.547 ' HB2' HG12 ' A' ' 191' ' ' VAL . 43.6 mt -98.53 -22.36 16.03 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.3 t30 60.47 44.89 11.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.99 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.547 HG12 ' HB2' ' A' ' 189' ' ' LEU . 4.0 p -145.75 150.5 15.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.984 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.588 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 14.4 t -121.87 128.79 52.0 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 121.343 0.592 . . . . 0.0 110.175 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.83 138.24 52.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 63.0 tt0 -81.18 118.36 22.49 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.41 HD12 ' C ' ' A' ' 194' ' ' GLN . 7.1 mp -128.11 151.85 76.72 Favored Pre-proline 0 C--O 1.239 0.507 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.894 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 180' ' ' LYS . 45.2 Cg_exo -61.05 143.81 99.25 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.642 2.228 . . . . 0.0 110.921 173.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.545 HD11 ' HB3' ' A' ' 182' ' ' ALA . 46.1 mm -84.8 117.79 30.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 223' ' ' VAL . 3.6 mm? -70.05 -40.85 74.88 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 38.2 t -155.02 150.24 27.09 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.451 HG12 HG22 ' A' ' 221' ' ' ILE . 35.6 m -127.58 146.2 33.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.093 0.473 . . . . 0.0 110.975 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -133.64 143.52 48.64 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.493 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -79.34 151.43 31.02 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.178 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -129.46 105.58 17.47 Favored Pre-proline 0 C--N 1.311 -1.099 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 174.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.05 -18.73 35.47 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.168 2.578 . . . . 0.0 116.013 -172.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 30.7 p -121.2 -45.96 2.32 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -174.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -60.81 -51.53 78.9 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -172.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.611 ' O ' HG22 ' A' ' 216' ' ' THR . 68.8 Cg_endo -84.79 7.06 5.39 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 122.419 2.079 . . . . 0.0 114.33 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 9.9 mp -104.99 108.83 20.55 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.184 -0.607 . . . . 0.0 111.351 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -70.03 -39.65 75.65 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.358 0.599 . . . . 0.0 110.331 177.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.3 p -130.66 -177.4 4.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.965 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -63.84 -39.55 94.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.532 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 4.6 pp -140.62 162.34 35.61 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.365 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 143.41 -114.11 0.81 Allowed Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.929 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 13.7 p -139.46 147.02 24.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.3 mp -73.66 145.94 44.91 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.611 HG22 ' O ' ' A' ' 207' ' ' PRO . 7.7 t -117.64 -170.83 1.94 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.114 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.514 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 14.0 ptmm? -54.02 148.42 10.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.381 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 114.49 4.77 21.58 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.145 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.5 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 50.5 m -72.09 140.08 48.75 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.2 mm -92.8 127.33 45.0 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.963 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.451 HG22 HG12 ' A' ' 200' ' ' VAL . 46.3 pt -133.46 165.38 32.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 120.814 0.34 . . . . 0.0 110.943 178.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -121.21 126.77 50.46 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.485 ' HA ' HD23 ' A' ' 198' ' ' LEU . 35.6 m -131.25 156.65 42.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.213 0.53 . . . . 0.0 111.717 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -99.92 107.01 18.88 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.025 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 7.5 p -85.52 79.35 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 122.276 1.036 . . . . 0.0 110.536 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 57.0 p -175.77 -26.39 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.711 -1.586 . . . . 0.0 108.569 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -62.04 -13.48 26.49 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.324 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.11 -37.3 79.59 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.015 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 90.62 8.11 66.04 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.425 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 41.3 pt -122.91 155.41 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 77.9 t -127.0 123.81 63.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.911 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.3 t -79.16 -52.22 8.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.099 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -161.64 98.95 1.12 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.675 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 25.8 t 65.26 -2.61 0.75 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.72 31.2 70.37 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.764 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.6 pttp -64.08 -13.63 48.76 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -177.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 19.9 pt -107.5 4.2 9.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.188 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -71.11 107.58 4.23 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.777 0.323 . . . . 0.0 111.658 -176.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 -164.09 176.58 9.16 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.041 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -91.47 122.77 6.89 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 108.894 -1.683 . . . . 0.0 108.894 173.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 75.9 mtt-85 -128.93 168.35 16.1 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 117.233 0.516 . . . . 0.0 111.319 -174.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.448 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 93.1 m-85 -101.36 143.55 31.26 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.164 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -136.92 166.3 23.96 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.359 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.432 ' HG3' HD23 ' A' ' 260' ' ' LEU . 98.3 mt-30 -116.6 136.98 52.52 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.054 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.5 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 88.2 mt -81.59 121.06 34.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.555 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 71.8 p -123.52 92.62 3.73 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.757 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -83.76 125.51 31.99 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.256 -176.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -131.59 70.28 81.44 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.51 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 73.4 Cg_endo -73.83 -17.8 22.43 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.032 1.822 . . . . 0.0 111.858 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -86.96 -14.82 40.67 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.235 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -111.3 -57.16 2.28 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.249 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -93.42 -28.14 16.31 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.846 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 92.08 -6.34 78.84 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.896 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 81.8 m -128.65 164.7 22.32 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.709 0.29 . . . . 0.0 111.069 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 92.6 t -80.38 118.09 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.555 ' HB2' ' O ' ' A' ' 246' ' ' THR . 78.4 m-20 -105.89 154.89 19.92 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.152 -174.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.479 ' HB3' HG22 ' A' ' 184' ' ' VAL . . . -135.2 146.55 48.79 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 10.7 p -123.44 134.99 64.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 120.997 0.427 . . . . 0.0 110.78 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 57.9 tp -84.1 130.77 34.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.353 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 242' ' ' TYR . 4.1 pp -101.4 146.01 28.17 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.857 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 C--O 1.268 2.068 0 CA-C-O 117.801 -1.095 . . . . 0.0 110.184 177.348 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 121.45 0.643 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -103.15 -5.14 23.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.737 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -59.69 141.62 54.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.146 0.498 . . . . 0.0 111.338 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -74.81 149.66 39.57 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.31 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.67 113.65 44.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.749 0.309 . . . . 0.0 111.037 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -121.01 110.17 34.98 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.347 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 213' ' ' GLY . 13.2 Cg_endo -60.8 -61.65 0.17 Allowed 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.55 2.167 . . . . 0.0 112.226 -178.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 55.5 ttm -154.63 25.32 0.45 Allowed 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 89.25 134.42 5.2 Favored Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.452 ' O ' HD12 ' A' ' 177' ' ' LEU . 4.2 pp -139.14 143.88 38.4 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 120.714 0.292 . . . . 0.0 110.477 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -76.23 -36.96 58.3 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.101 0.477 . . . . 0.0 111.407 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -165.25 140.57 5.21 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -176.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -79.0 97.77 6.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.982 0.42 . . . . 0.0 111.625 -177.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -129.55 144.03 51.09 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.024 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.546 ' HB3' HD11 ' A' ' 197' ' ' ILE . . . -137.18 153.0 50.53 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.753 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -87.07 101.66 13.68 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 60.3 t -95.29 125.84 47.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.452 0.644 . . . . 0.0 112.266 -172.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 92.8 m -107.08 127.77 53.78 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.74 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -104.27 108.93 61.7 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.2 -23.99 59.26 Favored 'Trans proline' 0 N--CA 1.476 0.449 0 C-N-CA 123.002 2.468 . . . . 0.0 113.629 -175.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 13.2 t -81.13 -21.11 40.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.783 0.325 . . . . 0.0 111.546 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.478 ' HB2' HG12 ' A' ' 191' ' ' VAL . 39.8 mt -109.45 -20.59 12.84 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.5 t30 60.43 48.89 7.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.425 -1.262 . . . . 0.0 109.843 -175.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' A' ' 189' ' ' LEU . 7.9 p -133.82 139.24 49.03 Favored 'Isoleucine or valine' 0 C--O 1.248 1.015 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.979 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 86.2 m -115.87 118.64 33.55 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 60.4 t -137.41 145.54 29.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.859 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -77.23 120.04 21.73 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.8 mp -123.02 145.4 45.75 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.788 0.327 . . . . 0.0 111.077 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.06 145.0 43.65 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.423 2.082 . . . . 0.0 110.051 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.726 HD12 HD12 ' A' ' 221' ' ' ILE . 31.7 mm -95.68 124.06 48.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.574 -178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.432 HD11 ' HB2' ' A' ' 224' ' ' ASN . 98.3 mt -70.37 -43.67 69.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.052 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 26.3 m -142.13 141.78 32.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.186 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 18.8 m -126.14 128.49 71.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.787 0.327 . . . . 0.0 111.098 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -141.18 149.97 42.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.972 0.415 . . . . 0.0 111.229 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -99.01 159.29 15.07 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 174.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -79.33 121.31 82.78 Favored Pre-proline 0 C--N 1.318 -0.793 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.346 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.2 -22.26 54.03 Favored 'Trans proline' 0 CA--C 1.523 -0.055 0 C-N-CA 122.527 2.152 . . . . 0.0 111.279 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 77.6 p -84.12 -3.83 58.36 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.533 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -112.1 98.91 44.33 Favored Pre-proline 0 C--O 1.237 0.414 0 CA-C-O 121.192 0.52 . . . . 0.0 111.621 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -94.09 111.53 0.18 Allowed 'Trans proline' 0 N--CA 1.439 -1.727 0 C-N-CA 122.947 2.431 . . . . 0.0 110.729 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.16 151.82 44.02 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.312 0.577 . . . . 0.0 111.864 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -60.73 -39.04 87.19 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.951 -1.022 . . . . 0.0 113.01 -173.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.0 t -150.38 -34.1 0.17 Allowed 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.707 -0.797 . . . . 0.0 112.664 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -92.56 96.92 10.5 Favored 'General case' 0 C--O 1.215 -0.737 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.447 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 90.2 mt -95.59 -19.16 19.99 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.859 0.361 . . . . 0.0 111.093 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 174' ' ' PRO . . . -90.49 2.35 80.5 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.89 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 75.4 t -116.62 128.33 74.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.61 HD23 ' H ' ' A' ' 215' ' ' LEU . 2.6 pt? -85.24 136.97 33.28 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.177 0.513 . . . . 0.0 110.707 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 39.1 p -109.67 171.78 7.24 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.276 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -61.68 150.85 35.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.971 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 96.87 4.18 59.0 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.735 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.625 ' OG1' ' HB ' ' A' ' 245' ' ' ILE . 1.9 p -79.35 157.2 27.69 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.557 0.218 . . . . 0.0 111.425 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.6 mm -108.43 127.76 64.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.269 0.556 . . . . 0.0 112.127 -174.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.726 HD12 HD12 ' A' ' 197' ' ' ILE . 26.9 pt -131.88 162.49 39.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.404 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -110.91 129.02 56.0 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.77 153.34 33.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.34 0.59 . . . . 0.0 111.637 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.432 ' HB2' HD11 ' A' ' 198' ' ' LEU . 60.2 t30 -103.01 104.89 15.11 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.531 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 6.1 p -101.32 80.1 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-O 122.277 1.037 . . . . 0.0 109.934 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 38.4 p -160.02 -32.59 0.06 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.055 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -85.97 21.42 1.96 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.575 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 98.4 mt -60.0 -38.15 81.77 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.617 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 150.37 -32.18 1.03 Allowed Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.901 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 44.9 pt -125.93 156.62 35.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.339 0.59 . . . . 0.0 111.68 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 30.6 m -138.15 152.7 26.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.425 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 34.8 p -85.7 -83.8 0.17 Allowed 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.42 ' H ' ' H ' ' A' ' 234' ' ' SER . . . -178.53 9.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.6 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' SER . . . . . 0.42 ' H ' ' H ' ' A' ' 233' ' ' ALA . 23.9 m -151.33 14.68 0.69 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.213 -176.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.74 30.42 72.69 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.624 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -61.77 -41.46 97.73 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.185 0.517 . . . . 0.0 110.977 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 12.6 pt -109.53 11.79 8.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.389 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -102.57 107.76 18.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.075 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -141.63 155.85 45.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.784 0.326 . . . . 0.0 111.186 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -107.94 110.31 3.12 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 170.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 31.6 mtp180 -131.0 169.39 15.9 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -102.56 146.02 28.75 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.276 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -131.19 168.15 17.97 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.525 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -114.04 130.85 56.53 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.424 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.625 ' HB ' ' OG1' ' A' ' 219' ' ' THR . 93.8 mt -81.33 130.1 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-O 120.82 0.343 . . . . 0.0 110.778 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.552 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 2.2 t -130.59 87.34 2.48 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -84.88 116.48 23.35 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.342 0.591 . . . . 0.0 111.437 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -129.1 72.06 81.99 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.459 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.46 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 33.4 Cg_exo -62.06 -24.9 77.04 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.618 2.212 . . . . 0.0 111.057 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.27 -34.97 79.2 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.702 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -96.9 -57.05 2.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.373 -177.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -98.14 -29.72 13.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.894 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 249' ' ' PRO . . . 83.99 5.82 87.32 Favored Glycine 0 C--N 1.315 -0.593 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.876 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 78.7 m -130.92 161.43 31.91 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 97.8 t -81.0 117.25 26.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 175.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.552 ' HB2' ' O ' ' A' ' 246' ' ' THR . 76.8 m-20 -103.32 147.57 26.93 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -174.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -136.53 144.92 44.51 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.1 p -132.03 136.28 56.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-O 121.18 0.514 . . . . 0.0 110.668 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.6 tt -95.3 119.88 34.58 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.407 ' H ' ' HG ' ' A' ' 260' ' ' LEU . 3.0 pp -90.46 137.96 31.93 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.305 0.574 . . . . 0.0 111.965 -176.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 C--O 1.276 2.46 0 CA-C-O 117.287 -1.339 . . . . 0.0 110.11 179.348 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.475 0.821 0 CA-C-O 121.119 0.485 . . . . 0.0 111.797 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.53 ' HB3' ' NH2' ' A' ' 173' ' ' ARG . 5.3 mp0 -67.97 -36.66 80.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.77 176.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 70.06 167.56 0.29 Allowed 'General case' 0 C--N 1.342 0.25 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.978 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -100.08 3.62 44.12 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.635 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 81.8 mt -106.94 110.92 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.946 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.53 ' NH2' ' HB3' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -159.74 150.53 15.76 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 177.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.532 ' HA ' ' HB3' ' A' ' 215' ' ' LEU . 30.2 Cg_endo -66.27 -42.66 9.91 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 121.811 1.674 . . . . 0.0 111.503 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 55.3 ttm -174.93 17.12 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 103.13 144.74 14.34 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -172.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -148.52 136.22 20.67 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 117.14 0.47 . . . . 0.0 111.134 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.9 ptt-85 -62.37 -43.96 97.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.841 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -138.11 149.1 45.62 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -81.09 79.4 7.76 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.91 148.43 51.22 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.178 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.1 151.39 51.36 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.814 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -84.93 99.85 11.23 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 65.7 t -91.77 120.47 40.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.717 -173.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.9 m -107.53 126.89 53.1 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.697 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -101.01 112.68 65.31 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.75 -22.43 63.91 Favored 'Trans proline' 0 N--CA 1.473 0.282 0 C-N-CA 122.925 2.417 . . . . 0.0 113.103 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 89.2 m -64.45 -42.61 95.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.137 0.494 . . . . 0.0 110.786 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.524 ' HB2' HG12 ' A' ' 191' ' ' VAL . 29.6 mt -105.82 -14.29 15.27 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.064 -176.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 20.3 m120 59.96 45.16 12.57 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.244 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.524 HG12 ' HB2' ' A' ' 189' ' ' LEU . 10.2 p -128.34 147.85 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 11.9 t -127.71 135.13 49.75 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.556 0.693 . . . . 0.0 111.416 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.489 HG23 ' CD1' ' A' ' 195' ' ' LEU . 7.8 m -139.89 152.08 22.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.709 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -92.94 122.53 35.4 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.002 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.489 ' CD1' HG23 ' A' ' 193' ' ' VAL . 6.9 mp -121.39 148.14 49.12 Favored Pre-proline 0 C--O 1.239 0.511 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.487 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.37 142.27 90.27 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.723 2.282 . . . . 0.0 111.65 175.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 78.9 mt -89.97 117.49 33.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' A' ' 224' ' ' ASN . 98.5 mt -70.14 -40.65 74.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.951 0.405 . . . . 0.0 111.123 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 33.5 t -157.68 148.19 20.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.17 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.6 m -112.93 139.64 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.835 0.35 . . . . 0.0 110.104 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -133.07 136.61 46.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.995 0.426 . . . . 0.0 110.587 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -89.91 159.53 16.89 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -67.73 148.4 98.53 Favored Pre-proline 0 C--N 1.311 -1.08 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.485 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.16 -35.23 65.46 Favored 'Trans proline' 0 N--CA 1.474 0.381 0 C-N-CA 122.956 2.437 . . . . 0.0 111.624 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 30.2 t -156.05 88.24 1.09 Allowed 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.583 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -127.56 79.77 72.9 Favored Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.314 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -71.06 139.39 35.64 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.51 2.14 . . . . 0.0 111.063 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 10.6 mp -84.95 144.68 28.18 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -61.42 -44.13 97.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.331 0.586 . . . . 0.0 109.478 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 73.5 p -77.46 161.92 27.58 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.949 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -62.03 -44.24 97.12 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.6 pp -147.4 172.83 13.3 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.198 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 162.76 -169.82 38.1 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.819 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 35.0 m -82.44 -177.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.532 ' HB3' ' HA ' ' A' ' 174' ' ' PRO . 55.3 tp -65.7 128.99 38.17 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 11.9 t -92.09 158.52 16.16 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.611 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -68.79 152.99 44.59 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.953 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.77 8.87 27.55 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.932 -0.652 . . . . 0.0 111.949 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.475 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 91.4 m -76.25 139.82 41.31 Favored 'General case' 0 C--O 1.212 -0.894 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.6 mm -105.78 127.97 60.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 O-C-N 122.052 -0.405 . . . . 0.0 111.476 -176.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.561 HD13 HD11 ' A' ' 245' ' ' ILE . 45.2 pt -122.88 158.56 27.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.704 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -103.95 123.14 46.62 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.16 159.3 43.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.871 0.367 . . . . 0.0 110.226 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.437 ' HB2' HD11 ' A' ' 198' ' ' LEU . 21.2 t-20 -112.61 123.41 50.24 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 46.8 t -76.42 77.3 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 121.476 0.655 . . . . 0.0 109.968 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 68.6 m -158.38 -13.63 0.07 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.788 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -90.79 18.76 6.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.732 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.412 ' H ' HD22 ' A' ' 228' ' ' LEU . 3.1 mm? -59.75 -38.44 81.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.111 0.482 . . . . 0.0 110.084 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 94.56 -12.72 68.43 Favored Glycine 0 CA--C 1.506 -0.483 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.507 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.3 pt -136.15 165.19 29.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.33 127.45 71.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-O 121.217 0.532 . . . . 0.0 110.545 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 11.9 t -119.93 -14.22 8.96 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.313 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.474 ' HB3' HG12 ' A' ' 237' ' ' ILE . . . -143.5 27.08 1.56 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.322 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.0 m 55.08 23.92 5.65 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.741 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 80.28 7.56 88.42 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.367 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.405 ' O ' ' HD3' ' A' ' 236' ' ' LYS . 8.0 tmtm? -64.58 -38.45 91.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.597 0.713 . . . . 0.0 109.976 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.474 HG12 ' HB3' ' A' ' 233' ' ' ALA . 28.7 pt -85.86 10.33 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.343 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -64.71 124.2 21.32 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 121.132 -0.227 . . . . 0.0 110.427 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -173.36 157.27 3.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -86.89 120.74 5.56 Favored Glycine 0 C--O 1.224 -0.485 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.955 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 75.5 mtp85 -129.25 164.35 23.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.967 0.413 . . . . 0.0 111.099 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -104.25 134.83 46.82 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.404 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -114.63 146.75 40.47 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.722 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -95.55 124.72 39.71 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.241 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.561 HD11 HD13 ' A' ' 221' ' ' ILE . 49.9 mm -79.54 118.73 27.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.75 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 3.0 t -125.29 91.77 3.49 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -89.5 115.72 27.14 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.169 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -142.92 80.32 13.89 Favored Pre-proline 0 C--N 1.312 -1.025 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.374 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.533 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 33.7 Cg_exo -60.96 -28.06 85.73 Favored 'Trans proline' 0 C--O 1.218 -0.51 0 C-N-CA 122.981 2.454 . . . . 0.0 111.877 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -65.94 -37.08 85.11 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.845 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -91.64 -55.95 3.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.957 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.571 ' CB ' HD21 ' A' ' 256' ' ' ASN . 5.1 t70 -98.24 -30.18 12.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.114 0.483 . . . . 0.0 111.085 -176.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 95.09 6.22 60.35 Favored Glycine 0 C--N 1.319 -0.4 0 C-N-CA 120.89 -0.672 . . . . 0.0 113.328 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 27.9 p -156.02 171.55 19.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.065 0.433 . . . . 0.0 111.825 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 68.1 t -80.34 119.73 30.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.571 HD21 ' CB ' ' A' ' 252' ' ' ASP . 79.7 m-20 -112.43 151.64 29.62 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.413 -173.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -131.2 131.05 43.72 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.13 176.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.62 129.4 64.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.192 0.52 . . . . 0.0 110.193 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.0 tt -95.89 121.08 37.24 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.531 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.434 ' O ' HD12 ' A' ' 260' ' ' LEU . 1.4 pp -88.31 143.08 27.23 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.814 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--O 1.267 1.987 0 CA-C-O 117.699 -1.143 . . . . 0.0 110.768 -179.259 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 86.2 t80 . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 121.783 0.801 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -63.41 -40.26 96.72 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.975 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 88.7 mtt-85 60.07 69.32 0.71 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.098 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -66.05 -27.88 68.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.873 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' A' ' 202' ' ' LYS . 4.0 mp -78.34 121.56 31.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 120.991 0.424 . . . . 0.0 111.476 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.71 147.8 60.91 Favored Pre-proline 0 N--CA 1.443 -0.823 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.2 -62.15 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.587 2.192 . . . . 0.0 112.528 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 57.1 ttp -168.89 44.0 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 72.23 28.72 67.61 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.905 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -81.33 166.84 20.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.911 0.386 . . . . 0.0 111.063 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 10.4 ptm85 -59.08 -37.31 76.81 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.524 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -133.61 156.78 47.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.128 0.489 . . . . 0.0 111.832 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -80.03 85.56 5.61 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 196' ' ' PRO . 41.0 ttmt -136.15 137.42 40.94 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.84 -176.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -128.57 157.47 41.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.129 0.49 . . . . 0.0 111.715 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -85.61 100.8 12.2 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 192' ' ' THR . 48.7 t -93.97 120.18 42.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -172.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 92.5 m -109.33 128.0 54.76 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.376 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -105.83 105.67 53.97 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -57.07 -38.66 95.19 Favored 'Trans proline' 0 N--CA 1.483 0.889 0 C-N-CA 123.047 2.498 . . . . 0.0 113.366 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 89.6 m -63.23 -42.0 99.18 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.827 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.517 ' HB2' HG12 ' A' ' 191' ' ' VAL . 28.2 mt -99.72 -16.95 17.97 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.086 -175.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 65.5 t30 59.1 53.21 5.63 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.738 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.517 HG12 ' HB2' ' A' ' 189' ' ' LEU . 12.4 p -133.96 133.52 56.2 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.866 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 93.9 m -116.93 128.46 55.23 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.652 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.4 139.01 29.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.722 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -88.75 117.44 27.74 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.627 HD12 ' HD2' ' A' ' 196' ' ' PRO . 23.2 tp -134.24 141.56 39.77 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.251 -173.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.627 ' HD2' HD12 ' A' ' 195' ' ' LEU . 34.4 Cg_endo -65.28 146.33 85.89 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.916 1.744 . . . . 0.0 110.415 176.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.431 HD12 HD12 ' A' ' 221' ' ' ILE . 33.2 mm -81.14 119.93 31.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.012 0.434 . . . . 0.0 111.672 -175.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.95 -39.39 76.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.862 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 222' ' ' GLU . 35.3 t -149.59 143.68 25.72 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.424 HG23 HD13 ' A' ' 172' ' ' ILE . 15.3 m -126.12 141.84 44.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.78 0.324 . . . . 0.0 111.355 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -130.59 123.31 29.22 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-O 121.008 0.433 . . . . 0.0 110.689 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.579 ' HD2' ' O ' ' A' ' 203' ' ' ASN . 1.7 tmmt? -110.42 150.81 28.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.726 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.579 ' O ' ' HD2' ' A' ' 202' ' ' LYS . 3.2 m-20 -59.32 152.39 53.9 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.415 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.49 -30.66 89.04 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.635 2.223 . . . . 0.0 112.711 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 26.3 p -109.01 -92.58 0.43 Allowed 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -134.92 146.8 60.19 Favored Pre-proline 0 N--CA 1.442 -0.837 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.44 ' HG2' ' HA ' ' A' ' 215' ' ' LEU . 74.3 Cg_exo -56.73 -40.85 81.43 Favored 'Trans proline' 0 N--CA 1.471 0.203 0 C-N-CA 122.618 2.212 . . . . 0.0 110.155 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 71.9 mt -119.63 99.1 6.45 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.727 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -67.02 -40.35 87.25 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.52 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.3 t -64.14 -52.98 56.47 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.854 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 212' ' ' LEU . 50.0 tt0 -70.17 -36.24 74.54 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.418 0.151 . . . . 0.0 111.072 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 211' ' ' GLN . 85.3 mt 83.08 126.19 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.164 0.986 . . . . 0.0 113.652 176.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 79.51 -53.06 4.21 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 115.082 0.793 . . . . 0.0 115.082 174.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.404 HG21 ' CD ' ' A' ' 211' ' ' GLN . 35.1 m -58.28 155.44 2.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -174.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.44 ' HA ' ' HG2' ' A' ' 207' ' ' PRO . 2.1 mm? -93.13 163.03 13.79 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.355 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 12.0 t -156.6 173.89 16.27 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.236 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.437 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 18.0 ptpt -67.21 152.68 45.29 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.86 178.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.52 8.12 31.09 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -176.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.561 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 66.1 m -77.07 136.75 38.67 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 51.2 mm -92.32 127.14 44.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.78 0.324 . . . . 0.0 111.116 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.555 HD13 HD11 ' A' ' 245' ' ' ILE . 43.3 pt -130.85 161.08 41.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.093 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 199' ' ' SER . 35.7 tt0 -110.9 128.49 55.83 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.1 m -126.34 157.54 36.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.718 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -98.18 110.62 23.17 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.563 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 10.7 t -91.41 18.94 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.442 ' HB3' ' N ' ' A' ' 239' ' ' TRP . 23.5 p -120.06 -35.24 3.51 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.658 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -64.48 -39.3 93.55 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.649 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.73 -36.59 83.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.075 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 102.03 -88.17 0.67 Allowed Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 50.7 mt 62.2 -74.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.932 0.893 . . . . 0.0 111.435 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 42.0 t 57.11 77.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 123.872 0.869 . . . . 0.0 111.353 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 23.6 p -70.35 -40.62 73.98 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.228 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -161.37 110.36 1.57 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.017 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 22.4 m 58.39 13.23 2.34 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.384 0.673 . . . . 0.0 112.591 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.19 29.31 74.69 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.055 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -61.99 -43.54 98.63 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 120.992 0.425 . . . . 0.0 111.363 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 26.4 pt -78.3 -1.88 4.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.299 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -76.01 108.01 8.6 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.721 0.296 . . . . 0.0 111.274 -177.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' TRP . . . . . 0.442 ' N ' ' HB3' ' A' ' 226' ' ' SER . 6.8 t90 -178.75 163.22 1.42 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.938 178.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -74.66 123.47 7.58 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.214 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -129.98 165.26 22.51 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -177.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.425 ' CE1' ' HB2' ' A' ' 222' ' ' GLU . 96.8 m-85 -101.07 141.38 34.04 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.238 0.542 . . . . 0.0 111.892 -177.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -128.6 170.14 13.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.873 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -115.26 131.25 56.99 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.771 0.32 . . . . 0.0 111.096 -178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.561 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 44.3 mm -77.0 128.04 37.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.676 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.437 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 3.8 t -132.76 101.73 5.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.799 0.809 . . . . 0.0 109.36 175.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -73.03 117.67 15.04 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.3 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ASN . . . . . 0.423 ' HB2' ' ND2' ' A' ' 256' ' ' ASN . 17.5 m120 -130.82 70.81 82.58 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.856 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.78 -22.45 17.7 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.009 1.806 . . . . 0.0 112.079 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -76.26 -28.72 57.2 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.497 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -94.4 -57.55 2.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.683 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -100.01 -29.57 12.47 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 120.89 0.376 . . . . 0.0 111.914 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 84.46 8.41 83.29 Favored Glycine 0 C--N 1.316 -0.553 0 C-N-CA 120.311 -0.947 . . . . 0.0 110.91 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 68.8 m -129.5 161.59 30.08 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.333 -0.433 . . . . 0.0 109.992 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 81.7 t -83.1 118.46 30.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.423 ' ND2' ' HB2' ' A' ' 248' ' ' ASN . 81.4 m-20 -103.02 152.19 21.64 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.992 -172.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -130.96 137.21 49.16 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 176.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.7 p -128.71 136.37 60.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.022 0.439 . . . . 0.0 110.434 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 7.6 tt -86.2 119.79 26.87 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 260' ' ' LEU . 1.1 pp -81.54 133.75 35.42 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.997 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 C--O 1.27 2.133 0 CA-C-O 117.467 -1.254 . . . . 0.0 110.419 178.992 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.647 0.261 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -61.98 -39.57 92.63 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.148 0.499 . . . . 0.0 111.648 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -73.8 -14.44 61.1 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -115.41 -25.47 7.95 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.947 0.404 . . . . 0.0 111.899 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.447 HG22 ' HG3' ' A' ' 173' ' ' ARG . 85.7 mt -120.48 129.08 75.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.447 ' HG3' HG22 ' A' ' 172' ' ' ILE . 94.0 mtt180 66.65 79.11 0.24 Allowed Pre-proline 0 N--CA 1.469 0.514 0 O-C-N 123.644 0.59 . . . . 0.0 110.763 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -52.33 -68.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.976 2.45 . . . . 0.0 111.517 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 53.7 ttm -146.13 20.6 1.41 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.75 146.1 19.24 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -174.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -138.09 147.25 43.82 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -63.52 -38.63 91.86 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.428 ' CD2' ' HB2' ' A' ' 181' ' ' LYS . 66.3 t80 -162.82 143.37 9.59 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.131 -178.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -78.79 80.22 5.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.734 0.302 . . . . 0.0 111.091 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.691 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 84.3 tttt -154.27 129.69 9.83 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -122.74 157.27 32.7 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.26 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 15.2 m120 -87.04 106.19 17.68 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 61.8 t -98.34 119.79 46.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.351 0.596 . . . . 0.0 111.838 -174.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 192' ' ' THR . 85.1 m -93.48 125.93 38.36 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 176.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.42 ' NE2' HD22 ' A' ' 228' ' ' LEU . 69.9 m80 -104.14 110.89 64.85 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.7 -38.65 91.29 Favored 'Trans proline' 0 N--CA 1.483 0.877 0 C-N-CA 123.575 2.85 . . . . 0.0 114.02 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 8.0 t -70.64 -30.95 67.71 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.581 ' HB2' HG12 ' A' ' 191' ' ' VAL . 37.7 mt -98.68 -21.84 16.21 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.27 0.557 . . . . 0.0 109.608 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 23.7 m120 58.3 42.85 20.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.206 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.581 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.5 p -135.38 145.36 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.019 -178.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 185' ' ' THR . 8.8 t -106.12 121.57 44.42 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.419 0.628 . . . . 0.0 109.998 177.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.84 126.58 71.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.805 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.691 ' HG2' ' HG2' ' A' ' 181' ' ' LYS . 58.3 tt0 -79.11 122.61 26.45 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.428 ' C ' ' HG3' ' A' ' 181' ' ' LYS . 95.4 mt -128.18 150.52 74.18 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.832 -176.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.07 149.44 71.27 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.547 2.165 . . . . 0.0 112.085 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.471 HD12 HD12 ' A' ' 221' ' ' ILE . 35.5 mm -94.0 115.57 33.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.091 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 97.3 mt -70.39 -41.64 72.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.073 0.463 . . . . 0.0 110.462 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.5 t -160.9 153.11 20.19 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.129 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 33.4 m -118.72 146.18 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-O 121.005 0.431 . . . . 0.0 110.318 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -128.14 143.59 51.06 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -60.45 144.36 51.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.961 0.41 . . . . 0.0 111.141 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.41 ' HB3' ' HA ' ' A' ' 219' ' ' THR . 11.7 p30 -72.64 157.14 89.38 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.851 178.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.407 ' HB2' ' OD1' ' A' ' 206' ' ' ASN . 33.3 Cg_endo -63.78 -11.42 26.59 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.046 2.497 . . . . 0.0 112.428 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 22.4 m 67.56 21.06 9.58 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 123.403 0.681 . . . . 0.0 111.8 178.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.493 ' N ' ' HD2' ' A' ' 207' ' ' PRO . 4.6 m-20 -62.95 -49.29 82.43 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.827 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 206' ' ' ASN . 49.1 Cg_endo -68.35 -16.73 43.99 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.389 2.06 . . . . 0.0 112.87 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 85.0 mt -98.71 136.87 38.15 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.547 0.689 . . . . 0.0 111.563 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -117.71 -32.93 4.69 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.593 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 72.2 p -82.1 164.49 21.31 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.066 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -95.46 12.4 29.52 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.026 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 98.6 mt -61.92 -40.32 95.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.797 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 80.19 85.61 0.62 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.864 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.451 HG23 HG23 ' A' ' 216' ' ' THR . 35.8 m -129.74 159.81 41.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 5.1 tt -82.68 113.57 20.45 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.1 0.476 . . . . 0.0 109.917 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.451 HG23 HG23 ' A' ' 214' ' ' VAL . 70.6 p -126.34 167.48 15.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.078 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -63.77 152.58 38.99 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.221 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 102.49 7.33 45.81 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -176.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.565 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 90.8 m -79.9 140.96 36.52 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.9 mm -101.9 130.46 51.58 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.706 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.297 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.59 HD13 HD11 ' A' ' 245' ' ' ILE . 42.3 pt -126.9 159.87 36.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.773 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -109.94 127.85 55.01 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 32.3 m -130.23 159.08 42.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.179 0.514 . . . . 0.0 111.455 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -95.38 109.38 21.56 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 92.6 t -97.0 87.91 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 48.6 m -129.84 -50.87 1.14 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.158 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -98.3 -51.15 4.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.579 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.491 HD21 HG13 ' A' ' 225' ' ' VAL . 84.5 mt 60.49 26.4 16.03 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.661 -176.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 92.69 -9.25 75.99 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.978 -0.556 . . . . 0.0 113.019 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 47.1 pt -131.97 175.19 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.798 0.332 . . . . 0.0 110.762 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 64.5 t -117.69 119.36 61.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 10.0 p -89.27 -86.24 0.19 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.198 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -150.2 82.01 1.37 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.543 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 44.7 m 53.87 39.59 30.58 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.017 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.24 42.27 83.8 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.685 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -61.13 -40.73 94.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.344 0.592 . . . . 0.0 110.872 -176.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 13.9 pt -103.87 23.54 2.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.445 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -73.68 106.9 5.63 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.155 0.503 . . . . 0.0 111.975 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -139.49 149.28 43.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.755 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -78.04 125.83 7.39 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -128.72 155.91 44.33 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 120.883 0.373 . . . . 0.0 111.02 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.494 ' CE2' HD11 ' A' ' 260' ' ' LEU . 49.2 p90 -109.11 142.25 40.12 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -122.55 154.82 37.4 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 120.96 0.409 . . . . 0.0 111.308 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -94.0 122.69 36.76 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.056 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.59 HD11 HD13 ' A' ' 221' ' ' ILE . 42.8 mm -77.24 119.38 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.351 177.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 80.2 p -122.5 86.65 2.62 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -90.49 129.61 36.63 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.113 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -142.66 76.33 17.82 Favored Pre-proline 0 C--N 1.304 -1.384 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.285 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.517 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 58.7 Cg_endo -70.34 -17.52 34.87 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.326 2.017 . . . . 0.0 111.354 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -69.06 -37.54 78.59 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.124 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -105.7 -60.15 1.67 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.015 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.66 -39.71 61.87 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.48 0.657 . . . . 0.0 110.642 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 94.09 -7.11 72.88 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.999 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 79.4 m -131.67 168.02 18.46 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.053 0.454 . . . . 0.0 111.888 -177.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 75.5 t -83.35 119.23 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -111.46 152.96 26.82 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -133.26 150.6 51.92 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.4 p -126.91 136.57 60.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 120.901 0.381 . . . . 0.0 110.031 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 57.2 tp -87.64 125.16 34.22 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.966 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.494 HD11 ' CE2' ' A' ' 242' ' ' TYR . 4.2 pp -98.6 148.91 23.32 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.584 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 11.9 m . . . . . 0 C--O 1.263 1.799 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.851 -179.513 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 121.063 0.458 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.28 -35.7 81.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.605 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -67.43 -17.49 64.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.783 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -103.6 117.85 35.37 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.4 mp -104.11 129.19 56.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.98 -176.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -107.4 105.09 54.98 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.34 -41.91 46.08 Favored 'Trans proline' 0 N--CA 1.475 0.414 0 C-N-CA 122.348 2.032 . . . . 0.0 110.858 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 53.6 ttm -178.2 29.77 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 95.36 98.03 1.74 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.469 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.596 ' H ' HD23 ' A' ' 177' ' ' LEU . 2.5 pt? -112.35 116.34 30.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.446 0.641 . . . . 0.0 111.268 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -71.86 -25.75 62.08 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.147 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -161.08 146.33 14.11 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.571 ' HB3' ' HB ' ' A' ' 197' ' ' ILE . 10.1 mptt -79.53 88.81 5.06 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.572 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt -151.92 139.25 19.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.329 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -142.98 154.45 44.03 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.977 0.418 . . . . 0.0 111.367 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -89.19 108.42 19.6 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 61.3 t -100.2 125.52 53.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -171.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 94.7 m -103.69 127.36 51.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.143 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -104.72 107.62 58.77 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.34 -35.65 98.88 Favored 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 123.132 2.555 . . . . 0.0 113.504 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.438 HG23 ' HG ' ' A' ' 189' ' ' LEU . 5.3 t -73.88 -34.62 64.52 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -177.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.543 ' HB2' HG12 ' A' ' 191' ' ' VAL . 38.5 mt -95.86 -16.27 21.93 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 120.817 0.342 . . . . 0.0 110.125 -177.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 60.27 42.48 15.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.046 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.543 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.9 p -134.97 139.01 48.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.6 -176.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 87.0 m -114.32 119.02 35.55 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.806 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.571 HG21 HD22 ' A' ' 228' ' ' LEU . 9.6 m -135.54 147.19 28.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.435 -177.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.492 ' C ' HD12 ' A' ' 195' ' ' LEU . 64.4 tt0 -101.0 118.97 38.05 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.739 0.304 . . . . 0.0 110.614 -177.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 194' ' ' GLN . 5.6 mp -129.02 147.8 66.33 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.53 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -61.16 143.26 98.59 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.349 2.033 . . . . 0.0 110.02 172.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.571 ' HB ' ' HB3' ' A' ' 180' ' ' LYS . 82.4 mt -80.54 121.47 34.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 223' ' ' VAL . 4.1 mm? -67.77 -43.92 78.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.643 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 52.4 m -152.19 153.43 33.8 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.266 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 31.3 m -117.79 145.93 22.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -127.86 121.17 29.37 Favored 'General case' 0 C--O 1.256 1.427 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -66.44 138.96 57.93 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.425 ' OD1' ' HA ' ' A' ' 219' ' ' THR . 87.1 m-20 -63.19 121.67 70.77 Favored Pre-proline 0 C--N 1.309 -1.152 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.654 -174.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.29 -33.59 18.03 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.978 1.786 . . . . 0.0 110.693 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 35.7 t -70.04 -41.93 73.56 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.626 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 52.84 75.75 0.61 Allowed Pre-proline 0 N--CA 1.474 0.737 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.301 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -55.55 -38.87 93.67 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.437 2.091 . . . . 0.0 110.74 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.556 HD22 HG23 ' A' ' 216' ' ' THR . 10.8 mp -123.63 115.02 20.79 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.383 177.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -61.71 -48.88 78.74 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 11.2 t 176.87 141.16 0.07 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.219 174.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -142.55 -58.64 0.44 Allowed 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.3 10.01 41.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.281 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 91.34 -9.29 77.78 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.82 162.79 36.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 122.886 0.474 . . . . 0.0 109.808 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 11.1 mp -99.0 170.28 8.83 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.498 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.556 HG23 HD22 ' A' ' 208' ' ' LEU . 19.5 p -91.2 170.13 10.26 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.138 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -54.18 153.35 5.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.476 -0.783 . . . . 0.0 112.549 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 116.65 10.11 10.58 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.417 -175.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.425 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 59.8 m -67.09 137.04 56.07 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.9 mm -91.11 130.84 39.66 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.424 -174.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 46.9 pt -129.11 156.82 41.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.061 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 198' ' ' LEU . 52.9 mt-10 -114.74 125.95 54.29 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.424 ' HA ' HD23 ' A' ' 198' ' ' LEU . 35.9 m -130.59 155.9 42.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.248 0.547 . . . . 0.0 111.105 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -97.51 106.81 19.19 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.608 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 31.6 t -80.74 77.35 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 121.565 0.698 . . . . 0.0 110.394 -177.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.438 ' H ' ' H ' ' A' ' 227' ' ' ASP . 38.6 p -169.37 -16.0 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.329 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ASP . . . . . 0.438 ' H ' ' H ' ' A' ' 226' ' ' SER . 36.6 t70 -81.24 9.28 7.21 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.434 177.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.571 HD22 HG21 ' A' ' 193' ' ' VAL . 87.9 mt -63.19 -34.57 77.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.902 -176.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 83.79 22.39 55.73 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.094 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 42.0 pt -116.91 161.18 15.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.924 0.392 . . . . 0.0 110.495 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 66.8 t -117.7 123.86 72.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.806 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 19.1 p -117.05 -70.43 0.79 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.076 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -169.31 97.35 0.34 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.553 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 19.2 t 63.32 15.97 9.1 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.43 34.03 78.58 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.84 -1.171 . . . . 0.0 111.495 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -63.44 -18.56 63.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.98 0.419 . . . . 0.0 111.639 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 33.6 pt -90.9 -0.1 9.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.512 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -75.98 107.81 8.44 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.159 0.504 . . . . 0.0 111.711 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -164.73 131.74 3.06 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.488 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -70.78 113.57 4.85 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.133 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -129.54 157.11 42.96 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.93 0.395 . . . . 0.0 111.224 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -102.38 148.74 25.11 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.378 0.609 . . . . 0.0 111.446 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -131.84 170.18 15.21 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.129 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 219' ' ' THR . 11.8 pt20 -116.65 141.78 47.76 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.391 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 84.1 mt -83.25 124.47 39.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.43 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 2.8 t -141.28 100.91 3.9 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.753 176.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -75.35 135.11 40.86 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.063 0.459 . . . . 0.0 111.413 -177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -140.79 72.46 29.12 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.481 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.407 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 23.4 Cg_exo -66.84 -21.13 51.16 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.798 2.332 . . . . 0.0 111.554 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -67.68 -38.32 83.56 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.226 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -107.64 -57.97 2.02 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.53 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.54 -37.53 63.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.207 0.527 . . . . 0.0 110.667 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 89.27 5.5 72.6 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.139 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 33.0 t -145.49 177.4 8.88 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 96.9 t -80.21 122.14 34.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 246' ' ' THR . 8.1 m120 -105.95 152.97 22.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.287 0.565 . . . . 0.0 111.414 -174.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.586 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -134.73 140.01 45.62 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 174.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 12.5 p -126.25 135.69 63.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.811 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 64.7 tp -80.69 129.22 34.4 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.847 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 4.1 pp -95.52 143.63 26.67 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.164 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 C--O 1.269 2.101 0 CA-C-O 117.411 -1.281 . . . . 0.0 110.422 179.707 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 50.0 p90 . . . . . 0 N--CA 1.484 1.267 0 CA-C-O 121.16 0.505 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -124.99 73.52 1.3 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.318 0.58 . . . . 0.0 110.186 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 80.4 mtp85 -77.83 149.4 34.37 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.544 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -96.86 140.63 31.13 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.778 0.323 . . . . 0.0 111.31 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 172' ' ' ILE . 3.9 mp -86.03 105.94 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.509 ' O ' ' HB2' ' A' ' 215' ' ' LEU . 36.7 ptt180 -154.43 147.77 18.36 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.009 -176.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.24 -33.28 39.95 Favored 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 122.672 2.248 . . . . 0.0 111.054 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 59.7 ttm -179.32 -48.5 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -161.99 144.99 10.24 Favored Glycine 0 N--CA 1.41 -3.096 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.426 ' H ' HD13 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -140.5 145.3 36.7 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 117.054 0.427 . . . . 0.0 110.717 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -86.15 -26.0 25.41 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.52 -176.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -170.21 163.74 9.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -175.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -69.09 68.05 0.17 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.167 0.292 . . . . 0.0 110.717 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.469 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 41.1 ttmt -154.88 137.27 14.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.524 0.202 . . . . 0.0 110.531 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -135.15 151.05 50.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.883 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 53.8 t-20 -85.22 103.52 14.26 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 257' ' ' ALA . 54.1 t -93.59 121.91 44.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.177 0.513 . . . . 0.0 112.247 -173.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 62.9 m -98.26 124.78 43.04 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.207 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -106.04 106.87 58.38 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.24 -29.11 64.22 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.342 2.028 . . . . 0.0 112.796 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.2 t -73.73 -23.69 59.8 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.416 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.551 ' HB2' HG12 ' A' ' 191' ' ' VAL . 36.2 mt -104.85 -19.8 13.78 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.3 t30 61.16 47.56 7.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.568 -1.197 . . . . 0.0 109.405 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 189' ' ' LEU . 5.9 p -145.09 146.54 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -177.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.2 t -121.07 120.7 36.1 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 121.555 0.693 . . . . 0.0 109.639 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.4 t -129.09 135.18 62.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.156 -177.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 62.0 tt0 -87.66 119.75 28.29 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.852 0.358 . . . . 0.0 110.747 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.3 mp -125.21 155.34 71.39 Favored Pre-proline 0 C--O 1.237 0.407 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.375 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 181' ' ' LYS . 55.9 Cg_endo -69.39 151.75 71.16 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.473 2.115 . . . . 0.0 111.655 177.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 83.4 mt -88.57 111.92 23.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.848 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.0 mp -69.28 -43.98 72.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.101 0.476 . . . . 0.0 111.934 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 50.6 m -151.34 157.85 43.02 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.329 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 33.0 m -123.42 146.7 28.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.224 0.535 . . . . 0.0 111.315 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.446 ' HB2' ' HB ' ' A' ' 220' ' ' ILE . 74.3 mmtt -125.58 110.42 13.81 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.474 176.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.453 ' HD3' ' O ' ' A' ' 203' ' ' ASN . 1.6 tmtp? -75.3 125.34 28.78 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.456 ' HB3' ' OD1' ' A' ' 206' ' ' ASN . 95.1 m-20 -64.79 131.82 95.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 120.718 0.294 . . . . 0.0 110.54 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -60.02 -42.51 43.55 Favored 'Trans proline' 0 N--CA 1.476 0.47 0 C-N-CA 123.141 2.561 . . . . 0.0 113.656 -173.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 33.6 t -162.55 88.13 0.63 Allowed 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.227 0.536 . . . . 0.0 111.493 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.456 ' OD1' ' HB3' ' A' ' 203' ' ' ASN . 4.5 m-20 -102.44 149.77 36.98 Favored Pre-proline 0 C--N 1.308 -1.204 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.586 174.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.462 ' O ' HG21 ' A' ' 216' ' ' THR . 50.0 Cg_exo -55.37 112.58 1.09 Allowed 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.888 2.392 . . . . 0.0 112.6 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.509 HD23 HG23 ' A' ' 216' ' ' THR . 54.8 mt -104.49 55.88 0.71 Allowed 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 122.115 0.96 . . . . 0.0 109.51 178.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -62.49 -39.93 95.03 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 113.666 -1.606 . . . . 0.0 110.248 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.469 ' HB ' ' HG ' ' A' ' 212' ' ' LEU . 62.7 p -100.28 -40.43 7.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.395 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.419 ' HG2' ' HB3' ' A' ' 208' ' ' LEU . 49.0 mt-30 59.14 17.79 5.9 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.722 0.409 . . . . 0.0 111.711 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.469 ' HG ' ' HB ' ' A' ' 210' ' ' THR . 97.9 mt -64.96 -39.82 94.06 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -102.52 14.9 56.4 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.723 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.439 HG12 HD12 ' A' ' 215' ' ' LEU . 47.2 t 73.92 -55.74 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 173' ' ' ARG . 9.8 mp -105.0 175.44 5.49 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.509 HG23 HD23 ' A' ' 208' ' ' LEU . 71.2 p -114.46 155.08 27.03 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -62.74 150.69 40.6 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.99 10.55 34.41 Favored Glycine 0 N--CA 1.436 -1.309 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -173.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 95.1 m -68.08 138.78 56.04 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 201' ' ' LYS . 51.1 mm -90.46 129.63 40.99 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 CA-C-O 120.726 0.298 . . . . 0.0 111.703 -174.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.41 HG21 HD11 ' A' ' 245' ' ' ILE . 44.9 pt -131.62 159.06 43.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.558 175.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -107.22 126.05 51.92 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.87 151.88 35.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.611 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -106.55 106.67 17.3 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.089 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 3.0 p -82.21 85.34 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-O 121.912 0.863 . . . . 0.0 110.193 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 15.0 p -123.7 -84.87 0.65 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.176 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -64.43 -46.68 82.16 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.407 HD21 HG23 ' A' ' 225' ' ' VAL . 97.0 mt 56.45 16.18 2.36 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.109 0.481 . . . . 0.0 110.774 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 83.77 0.58 89.86 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 115.989 -0.551 . . . . 0.0 113.037 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 44.9 pt -133.67 171.71 17.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.297 0.57 . . . . 0.0 111.582 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 66.6 t -113.66 114.82 47.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 11.7 t -154.58 146.07 23.11 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.638 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . 52.93 25.18 3.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.147 0.579 . . . . 0.0 112.008 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 58.2 m 56.79 18.78 3.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.34 0.656 . . . . 0.0 111.971 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.57 26.21 74.72 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.077 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -66.01 -18.99 65.7 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.204 0.526 . . . . 0.0 111.135 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 30.9 pt -87.6 8.85 2.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.991 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -66.68 106.3 1.79 Allowed 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.084 0.469 . . . . 0.0 111.457 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -142.33 151.88 42.38 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.309 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -93.07 112.76 4.33 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 174.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.95 164.34 23.37 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 120.741 0.305 . . . . 0.0 111.065 -177.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 98.2 m-85 -102.35 139.92 37.32 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.221 0.534 . . . . 0.0 111.61 -175.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -127.63 154.51 45.17 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.775 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -97.81 132.73 43.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.593 0.235 . . . . 0.0 110.725 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.41 HD11 HG21 ' A' ' 221' ' ' ILE . 87.1 mt -79.71 119.9 29.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 4.3 t -133.83 98.51 4.19 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -81.19 123.64 28.62 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.947 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -129.76 72.1 82.01 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.017 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.529 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 59.5 Cg_endo -70.16 -22.24 30.53 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.267 1.978 . . . . 0.0 112.228 -178.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -70.22 -37.73 75.09 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.27 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -96.29 -57.51 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.923 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.409 ' CG ' HD21 ' A' ' 256' ' ' ASN . 34.6 t70 -82.36 -39.57 22.57 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.343 0.592 . . . . 0.0 110.767 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 96.78 8.96 56.77 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.239 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 14.0 t -153.61 -179.93 8.25 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 93.7 t -79.87 126.64 39.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 246' ' ' THR . 10.0 m120 -113.33 154.28 27.12 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.861 0.362 . . . . 0.0 110.764 -174.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.532 ' HB3' HG22 ' A' ' 184' ' ' VAL . . . -131.98 147.96 52.49 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.9 p -123.43 131.0 73.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.025 0.44 . . . . 0.0 110.418 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.9 tt -100.53 123.84 45.29 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.801 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 2.8 pp -92.51 151.29 20.26 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.139 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.262 1.728 0 CA-C-O 117.75 -1.119 . . . . 0.0 110.876 -179.231 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 47.9 p90 . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 121.4 0.619 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -82.52 61.33 5.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.294 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -124.09 148.11 47.37 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.33 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -87.8 151.48 22.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.813 0.339 . . . . 0.0 111.753 -177.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.552 HD11 ' HB3' ' A' ' 202' ' ' LYS . 83.1 mt 66.29 90.21 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.891 -175.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.442 ' HA ' ' HD2' ' A' ' 174' ' ' PRO . 79.4 mtp180 59.28 82.64 0.23 Allowed Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.275 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 173' ' ' ARG . 10.7 Cg_endo -55.75 -38.91 93.8 Favored 'Trans proline' 0 N--CA 1.478 0.611 0 C-N-CA 123.342 2.694 . . . . 0.0 112.196 -176.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 60.1 ttm 179.34 -25.21 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 151.04 176.16 23.64 Favored Glycine 1 N--CA 1.394 -4.126 0 N-CA-C 107.281 -2.327 . . . . 0.0 107.281 -177.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -153.77 175.48 13.25 Favored 'General case' 0 C--N 1.273 -2.75 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 178' ' ' ARG . 11.8 ptm85 -59.46 -41.93 90.86 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.015 0.197 . . . . 0.0 111.472 -177.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -176.28 152.78 1.15 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.457 ' HD2' ' N ' ' A' ' 180' ' ' LYS . 11.1 mptt -82.42 81.19 8.36 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -176.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -138.19 150.55 46.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.743 0.417 . . . . 0.0 110.921 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.457 ' HB2' HD11 ' A' ' 197' ' ' ILE . . . -141.94 151.16 42.32 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.714 177.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 20.0 m120 -86.53 100.44 12.39 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 120.557 -0.457 . . . . 0.0 109.833 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 64.5 t -85.34 120.31 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.72 -176.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 63.7 m -105.33 126.46 52.13 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.458 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -104.33 111.64 65.23 Favored Pre-proline 0 C--N 1.312 -1.035 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.34 -27.14 77.49 Favored 'Trans proline' 0 N--CA 1.474 0.334 0 C-N-CA 122.556 2.171 . . . . 0.0 112.462 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 89.3 m -63.35 -42.64 98.92 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.31 0.576 . . . . 0.0 110.568 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.553 ' HB2' HG12 ' A' ' 191' ' ' VAL . 28.3 mt -95.05 -21.38 18.6 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.364 -177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 65.6 t30 59.57 51.66 6.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.496 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.553 HG12 ' HB2' ' A' ' 189' ' ' LEU . 10.0 p -140.14 148.86 22.21 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.817 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 13.6 t -119.47 122.75 42.42 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.497 0.665 . . . . 0.0 110.44 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.477 HG11 ' HA3' ' A' ' 229' ' ' GLY . 57.3 t -128.88 131.06 68.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.665 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 29.6 tt0 -78.24 124.51 28.16 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.834 0.35 . . . . 0.0 111.099 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 194' ' ' GLN . 7.4 mp -127.27 149.33 69.43 Favored Pre-proline 0 C--O 1.238 0.499 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.155 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 180' ' ' LYS . 40.5 Cg_exo -61.4 142.58 96.03 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.844 2.363 . . . . 0.0 112.307 176.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.457 HD11 ' HB2' ' A' ' 182' ' ' ALA . 81.6 mt -90.84 120.78 40.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.9 mp -72.29 -45.13 61.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.771 0.32 . . . . 0.0 111.389 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.2 t -162.91 157.12 20.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.889 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.429 HG12 HG22 ' A' ' 221' ' ' ILE . 33.6 m -119.1 146.19 24.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-O 120.9 0.381 . . . . 0.0 110.72 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -129.31 142.45 50.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.827 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.552 ' HB3' HD11 ' A' ' 172' ' ' ILE . 26.4 pttm -77.92 158.57 29.32 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.586 0.708 . . . . 0.0 112.436 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -127.6 137.68 31.24 Favored Pre-proline 0 C--N 1.308 -1.212 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.32 -21.35 60.2 Favored 'Trans proline' 0 N--CA 1.478 0.583 0 C-N-CA 122.834 2.356 . . . . 0.0 113.575 -176.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 52.4 m -93.42 0.55 56.85 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -64.23 -52.42 54.81 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.95 109.23 2.8 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 121.691 1.594 . . . . 0.0 111.738 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 79.5 mt -125.87 -13.51 6.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.211 -0.449 . . . . 0.0 112.133 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.458 ' HD2' ' H ' ' A' ' 212' ' ' LEU . 51.9 t80 -64.8 -33.47 76.06 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.699 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 40.1 p 65.85 -41.28 0.34 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.369 1.468 . . . . 0.0 114.791 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.429 ' HB2' ' CE2' ' A' ' 209' ' ' TYR . 15.3 mm100 -68.89 -40.05 79.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.008 0.433 . . . . 0.0 110.924 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.458 ' H ' ' HD2' ' A' ' 209' ' ' TYR . 86.6 mt -137.08 -80.79 0.38 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.225 -178.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 178.5 157.38 19.03 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.584 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.429 HG12 ' H ' ' A' ' 209' ' ' TYR . 8.5 p -166.41 153.33 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 63.7 tp -104.03 123.7 47.7 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 40.2 m -115.18 141.66 47.72 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.974 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -46.83 151.23 0.63 Allowed 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.727 0.642 . . . . 0.0 111.927 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 111.3 8.58 23.18 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -176.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.535 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 25.7 m -74.49 144.44 44.15 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.2 mm -104.1 127.18 58.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.699 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.648 HD13 HD11 ' A' ' 245' ' ' ILE . 46.1 pt -125.97 160.18 33.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.876 0.369 . . . . 0.0 111.114 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -103.8 126.38 50.9 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.372 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.58 151.59 36.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.078 0.466 . . . . 0.0 110.885 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -92.36 105.87 17.98 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 22.8 t -93.86 70.45 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 121.423 0.63 . . . . 0.0 110.108 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 50.7 m -125.99 -42.85 1.86 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.496 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -73.48 -43.57 59.89 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.227 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.444 ' O ' HG11 ' A' ' 193' ' ' VAL . 7.1 mp 54.02 17.29 1.34 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.46 -176.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.477 ' HA3' HG11 ' A' ' 193' ' ' VAL . . . 77.33 -47.98 2.75 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -176.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 44.3 pt -128.27 157.86 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.6 m -96.74 43.97 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-O 121.099 0.476 . . . . 0.0 111.269 -177.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.1 t -48.93 -46.68 43.44 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.986 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -98.86 10.74 40.67 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -177.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 16.5 t 60.35 38.05 19.81 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.77 -127.78 28.6 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -174.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? 75.08 -45.54 0.57 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.64 0.776 . . . . 0.0 110.488 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 21.3 pt -88.85 18.57 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.801 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -69.46 112.94 6.32 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.38 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' TRP . . . . . 0.508 ' O ' ' HB ' ' A' ' 225' ' ' VAL . 23.1 t90 -169.25 138.21 2.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.718 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -68.11 131.84 28.0 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.083 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.44 176.08 8.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.821 0.343 . . . . 0.0 110.855 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -111.79 138.54 48.25 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.783 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -122.48 149.85 43.32 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.787 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -95.29 127.09 41.06 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.151 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.648 HD11 HD13 ' A' ' 221' ' ' ILE . 48.0 mm -78.47 120.7 29.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 178.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.8 t -134.97 98.32 3.98 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.934 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -80.5 126.24 30.97 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.875 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -135.82 72.18 62.59 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.518 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 35.5 Cg_exo -63.94 -26.52 66.71 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.062 2.508 . . . . 0.0 112.03 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -67.58 -37.44 82.62 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.403 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -96.68 -56.96 2.42 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.309 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -87.22 -40.2 14.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.072 0.463 . . . . 0.0 110.729 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 99.7 9.36 49.94 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.879 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 30.6 p -152.21 179.16 8.76 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.658 -0.319 . . . . 0.0 110.996 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 66.9 t -80.65 123.39 37.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -114.38 153.27 30.15 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.787 0.327 . . . . 0.0 110.147 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -128.3 146.88 50.63 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.6 p -122.39 129.71 75.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 121.127 0.489 . . . . 0.0 110.291 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 8.8 tt -105.32 124.43 49.52 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.906 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 260' ' ' LEU . 3.4 pp -99.43 150.34 22.27 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.375 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 23.9 m . . . . . 0 C--O 1.272 2.268 0 CA-C-O 117.679 -1.153 . . . . 0.0 110.71 179.742 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 52.9 p90 . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 121.114 0.483 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -142.55 96.77 3.0 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 121.592 0.71 . . . . 0.0 109.732 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -138.04 32.22 2.41 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.151 176.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -98.61 109.56 22.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.644 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.499 ' C ' ' HD2' ' A' ' 173' ' ' ARG . 4.5 mp -118.6 98.48 6.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.603 176.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.499 ' HD2' ' C ' ' A' ' 172' ' ' ILE . 2.3 mpt_? -123.19 103.52 35.93 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -55.51 -39.08 93.07 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.257 2.638 . . . . 0.0 112.738 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 57.4 ttp -151.28 14.9 0.7 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.278 0.561 . . . . 0.0 110.209 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 69.27 29.62 71.9 Favored Glycine 0 C--O 1.229 -0.211 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.831 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.441 ' N ' HD23 ' A' ' 177' ' ' LEU . 1.6 pt? -54.59 141.26 32.24 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.793 0.437 . . . . 0.0 111.895 -178.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -59.9 -34.86 73.75 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.545 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -139.2 142.29 37.9 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -69.38 85.51 0.41 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -177.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -151.8 137.6 18.0 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.978 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -140.1 159.21 42.7 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.145 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 89.9 m-20 -82.18 104.28 12.4 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 59.9 t -95.73 120.14 44.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.244 0.545 . . . . 0.0 112.119 -173.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 192' ' ' THR . 90.5 m -95.2 125.28 39.74 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.318 176.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -105.26 107.78 59.82 Favored Pre-proline 0 C--N 1.313 -1.009 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 34.0 Cg_endo -63.96 -26.23 66.64 Favored 'Trans proline' 0 N--CA 1.474 0.374 0 C-N-CA 122.548 2.165 . . . . 0.0 112.644 -176.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 86.4 m -64.6 -41.58 96.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.389 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.594 ' HB2' HG12 ' A' ' 191' ' ' VAL . 35.0 mt -99.3 -14.54 19.19 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.757 -177.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 60.22 45.23 11.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.26 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.8 p -138.79 144.72 29.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.439 -176.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 185' ' ' THR . 86.1 m -107.49 119.7 40.14 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.2 130.18 69.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 63.4 tt0 -75.51 120.26 20.69 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.49 HD21 HD22 ' A' ' 228' ' ' LEU . 87.2 mt -129.55 149.88 74.11 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.605 -174.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.74 144.98 50.23 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.353 2.036 . . . . 0.0 110.749 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.491 HG23 ' HB ' ' A' ' 221' ' ' ILE . 80.2 mt -93.48 116.85 35.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.248 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.4 mp -71.8 -46.15 59.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.675 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 39.2 m -141.25 148.33 39.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.597 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.454 HG12 HG22 ' A' ' 221' ' ' ILE . 29.2 m -129.72 137.66 56.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.628 0.251 . . . . 0.0 110.633 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -143.79 142.95 31.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.03 0.443 . . . . 0.0 110.835 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -112.07 146.67 37.54 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.991 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -120.07 140.22 29.54 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.432 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.58 -12.76 36.75 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.433 2.755 . . . . 0.0 111.98 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 47.0 t -60.0 -39.7 86.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.263 178.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.448 ' ND2' ' HA3' ' A' ' 218' ' ' GLY . 2.1 m-20 -76.29 130.46 77.42 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.835 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.01 -20.23 29.2 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.757 2.305 . . . . 0.0 112.143 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.7 mp 63.04 -166.67 0.22 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.255 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -64.06 -29.1 70.26 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 30.1 m 72.15 -59.01 0.57 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.801 177.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -61.85 -41.44 97.83 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -175.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 84.5 mt -93.68 -32.94 13.85 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.053 0.454 . . . . 0.0 111.164 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 89.46 -7.06 82.75 Favored Glycine 0 C--O 1.228 -0.224 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.672 -177.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 88.7 t -69.65 141.23 17.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 122.785 0.434 . . . . 0.0 110.021 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 10.3 mp -54.29 142.12 27.5 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.122 0.487 . . . . 0.0 110.63 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.3 m -133.28 162.99 30.32 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.175 -174.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 246' ' ' THR . 18.3 ptpt -47.18 151.01 0.74 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.486 0.66 . . . . 0.0 112.454 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.448 ' HA3' ' ND2' ' A' ' 206' ' ' ASN . . . 113.35 9.09 18.29 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.507 -176.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.574 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 60.5 m -76.27 139.05 40.93 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.4 mm -97.48 126.41 50.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 120.803 0.335 . . . . 0.0 110.364 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.681 HD13 HD11 ' A' ' 245' ' ' ILE . 44.6 pt -125.98 165.03 24.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.118 0.485 . . . . 0.0 111.561 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -112.09 128.11 56.11 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.798 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.82 158.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.93 0.395 . . . . 0.0 110.902 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -110.33 112.18 23.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.267 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 3.2 p -102.4 79.39 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.788 0.804 . . . . 0.0 109.683 176.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 32.4 t -156.85 -42.35 0.07 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.145 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -94.2 19.57 9.18 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.864 -178.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.49 HD22 HD21 ' A' ' 195' ' ' LEU . 39.8 mt -70.76 -16.96 62.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.621 -175.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 82.73 2.96 90.69 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.533 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.4 pt -113.31 162.01 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.81 124.62 44.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.862 0.839 . . . . 0.0 111.249 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 9.9 t -99.07 -151.57 0.39 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -67.2 85.71 0.15 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.936 0.398 . . . . 0.0 110.641 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 39.7 m 64.77 13.11 8.21 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.912 0.885 . . . . 0.0 112.298 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 63.31 33.36 87.03 Favored Glycine 0 C--O 1.225 -0.446 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.972 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -65.35 -14.58 61.15 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 23.7 pt -105.86 12.18 8.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.974 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -75.46 106.02 6.79 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.987 0.423 . . . . 0.0 111.483 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -165.53 177.22 7.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.844 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -87.94 118.78 5.13 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 173.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 62.6 mtp85 -127.38 166.74 17.29 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.971 0.386 . . . . 0.0 111.0 -173.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -108.28 139.38 43.07 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.289 0.566 . . . . 0.0 111.692 -176.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -127.28 161.69 27.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.28 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -106.17 130.93 53.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.885 0.374 . . . . 0.0 111.107 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.681 HD11 HD13 ' A' ' 221' ' ' ILE . 41.9 mm -80.29 125.61 39.15 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.127 177.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 4.9 t -135.5 90.17 2.58 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 173.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -80.17 123.53 28.0 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.249 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -130.42 71.71 82.18 Favored Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.615 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.511 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 51.3 Cg_endo -67.8 -23.38 41.78 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.985 1.79 . . . . 0.0 111.07 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -73.12 -26.34 61.19 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.464 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -104.57 -56.18 2.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.066 -176.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -90.86 -40.07 11.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.063 0.459 . . . . 0.0 110.717 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 105.08 -8.54 45.53 Favored Glycine 0 C--N 1.316 -0.578 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.424 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 75.2 m -132.72 175.94 8.9 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.702 0.287 . . . . 0.0 111.061 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 86.6 t -79.95 124.34 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 246' ' ' THR . 3.2 m120 -107.34 151.95 24.8 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -176.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -139.88 150.43 44.61 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 177.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.58 135.91 53.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 120.837 0.351 . . . . 0.0 110.429 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.409 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 64.3 tp -73.71 126.52 30.53 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 260' ' ' LEU . 3.2 pp -82.98 131.13 35.2 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.119 0.485 . . . . 0.0 111.117 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--O 1.272 2.24 0 CA-C-O 117.815 -1.088 . . . . 0.0 110.336 179.463 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 121.243 0.544 . . . . 0.0 111.802 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.488 ' HB2' ' NZ ' ' A' ' 180' ' ' LYS . 48.2 mt-10 -106.0 68.7 0.78 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -71.27 -22.4 61.97 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.756 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -79.04 156.17 28.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.795 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.441 HG12 ' HG3' ' A' ' 202' ' ' LYS . 4.8 mp 66.11 81.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.776 0.798 . . . . 0.0 109.534 -174.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -139.67 149.13 58.53 Favored Pre-proline 0 N--CA 1.439 -1.011 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.089 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.631 ' O ' ' HA ' ' A' ' 214' ' ' VAL . 44.8 Cg_exo -60.71 -40.94 50.65 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.627 2.218 . . . . 0.0 110.566 176.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 65.9 ttp 170.36 -50.06 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -154.03 111.36 0.48 Allowed Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.023 177.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.492 ' H ' HD13 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -136.22 151.09 49.33 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.726 0.298 . . . . 0.0 111.238 -177.556 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.406 ' HG3' ' N ' ' A' ' 179' ' ' TYR . 39.8 ptt180 -81.52 -50.89 8.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.448 177.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.406 ' N ' ' HG3' ' A' ' 178' ' ' ARG . 83.1 m-85 -141.4 158.82 43.37 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.029 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.488 ' NZ ' ' HB2' ' A' ' 169' ' ' GLU . 0.1 OUTLIER -88.65 116.12 26.67 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.231 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -149.13 140.13 22.93 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.6 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -138.45 157.29 46.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.953 0.406 . . . . 0.0 112.003 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -90.45 103.85 16.5 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 59.6 t -97.35 123.11 49.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.154 0.502 . . . . 0.0 111.95 -173.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 192' ' ' THR . 89.8 m -105.03 126.62 52.26 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.599 177.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -105.33 110.69 64.65 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.938 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.95 -33.64 89.7 Favored 'Trans proline' 0 N--CA 1.481 0.774 0 C-N-CA 123.331 2.688 . . . . 0.0 113.111 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 88.7 m -60.79 -44.4 96.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.255 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.537 ' HB2' HG12 ' A' ' 191' ' ' VAL . 32.0 mt -98.27 -17.0 19.17 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.647 -176.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 59.71 50.1 7.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.042 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.537 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.6 p -138.67 149.04 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.839 -178.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 185' ' ' THR . 12.4 t -119.67 129.57 54.62 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.405 0.622 . . . . 0.0 109.779 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 10.6 m -134.32 147.48 30.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.527 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.509 ' C ' HD12 ' A' ' 195' ' ' LEU . 35.5 tt0 -96.68 118.52 33.32 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.509 HD12 ' C ' ' A' ' 194' ' ' GLN . 7.0 mp -128.05 148.12 66.12 Favored Pre-proline 0 C--O 1.237 0.44 0 CA-C-O 120.664 0.269 . . . . 0.0 111.399 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.53 145.82 92.29 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.767 2.311 . . . . 0.0 110.978 173.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.475 HG23 ' HB ' ' A' ' 221' ' ' ILE . 83.9 mt -91.53 120.03 39.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 96.5 mt -68.02 -41.51 82.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.713 0.292 . . . . 0.0 111.356 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 93.4 p -156.1 157.25 35.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.713 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 17.7 m -122.25 135.58 61.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.338 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -136.24 137.17 40.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.779 0.324 . . . . 0.0 110.805 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.441 ' HG3' HG12 ' A' ' 172' ' ' ILE . 56.8 mtmt -111.74 145.52 39.2 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.369 174.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.486 ' ND2' ' HB2' ' A' ' 205' ' ' SER . 31.6 p-10 -74.49 157.2 86.52 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 176.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.0 -28.11 80.23 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.301 2.0 . . . . 0.0 112.602 -178.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.486 ' HB2' ' ND2' ' A' ' 203' ' ' ASN . 69.4 m -65.3 -39.63 92.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.99 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 58.2 t30 58.26 83.61 0.22 Allowed Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 122.913 0.485 . . . . 0.0 111.786 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.467 ' HD3' ' OD1' ' A' ' 203' ' ' ASN . 89.8 Cg_endo -81.94 52.97 4.39 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.826 2.351 . . . . 0.0 111.574 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 31.7 tp -79.89 95.52 6.1 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.157 0.503 . . . . 0.0 110.149 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.503 ' H ' HG21 ' A' ' 216' ' ' THR . 75.0 t80 -62.25 -45.59 92.62 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.657 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 20.8 p -69.16 151.43 46.36 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.779 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -62.6 -44.54 96.05 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 3.8 pp -174.85 172.01 3.02 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.614 0.245 . . . . 0.0 111.155 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 80.44 -79.81 1.71 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.914 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 174' ' ' PRO . 26.3 m -80.08 148.39 5.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.063 0.459 . . . . 0.0 111.802 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.9 mt -79.48 162.72 25.26 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.705 0.764 . . . . 0.0 112.122 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.503 HG21 ' H ' ' A' ' 209' ' ' TYR . 94.2 m -118.37 140.78 49.32 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.564 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.423 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 12.4 ptmm? -49.39 145.89 4.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.618 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 111.55 9.77 20.7 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.862 -176.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.462 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 61.7 m -84.35 134.86 34.48 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 220' ' ' ILE . 3.7 mp -95.98 127.08 48.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.905 0.384 . . . . 0.0 111.12 -178.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.614 HD13 HD11 ' A' ' 245' ' ' ILE . 46.0 pt -124.79 157.91 32.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.521 178.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -110.84 124.65 52.45 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.86 157.01 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.722 0.296 . . . . 0.0 110.633 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -98.15 123.14 42.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.315 0.578 . . . . 0.0 110.991 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 9.1 m -100.04 80.35 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-O 121.67 0.748 . . . . 0.0 110.114 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 18.5 m -112.93 -63.48 1.44 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.44 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -99.03 -39.73 8.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.157 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 8.2 mp 65.0 -2.57 0.7 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.441 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 83.22 7.5 86.7 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.082 -178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.5 pt -126.16 169.91 16.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 5.6 p -118.38 85.73 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 122.128 0.966 . . . . 0.0 111.57 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.3 t -113.14 -41.02 3.79 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 173.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.402 ' CB ' ' HE3' ' A' ' 236' ' ' LYS . . . -168.19 136.22 2.25 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.357 177.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 47.4 m -75.17 76.63 2.31 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.538 0.685 . . . . 0.0 111.167 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 70.75 40.63 64.94 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 114.998 -1.001 . . . . 0.0 115.25 175.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.402 ' HE3' ' CB ' ' A' ' 233' ' ' ALA . 18.3 ptpt -63.7 -25.53 68.24 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.936 0.868 . . . . 0.0 109.714 177.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 13.5 pt -129.65 33.71 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.541 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -63.66 105.71 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.098 0.475 . . . . 0.0 111.514 -177.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -151.83 166.43 31.45 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.629 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -93.13 118.73 5.72 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -127.29 163.24 24.38 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 120.9 0.381 . . . . 0.0 110.968 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 95.4 m-85 -103.33 139.51 38.65 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.491 -175.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -128.47 147.36 50.67 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.27 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 18.1 pm0 -98.34 131.34 44.72 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.476 0.655 . . . . 0.0 111.374 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.614 HD11 HD13 ' A' ' 221' ' ' ILE . 48.9 mm -77.54 125.22 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.29 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.423 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 4.1 t -134.46 102.95 5.5 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -84.69 126.81 33.71 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.285 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -127.6 72.29 77.9 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.17 -23.89 28.44 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.401 2.067 . . . . 0.0 112.381 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -77.65 -16.09 58.77 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.112 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -113.31 -56.25 2.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.032 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -93.29 -31.17 14.8 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.776 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 77.42 20.46 74.69 Favored Glycine 0 C--N 1.322 -0.22 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.86 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 48.8 t -151.15 164.87 35.52 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.695 0.283 . . . . 0.0 110.441 -177.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 95.1 t -79.91 121.84 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 246' ' ' THR . 19.7 m120 -112.55 152.8 28.41 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.198 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -132.5 141.91 48.98 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.83 133.27 69.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 7.4 tt -101.19 123.81 45.92 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.218 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.465 ' O ' HD12 ' A' ' 260' ' ' LEU . 3.1 pp -65.49 137.65 57.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.236 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.269 2.122 0 CA-C-O 117.3 -1.333 . . . . 0.0 110.717 -179.065 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 120.818 0.342 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 69.97 -13.7 0.41 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.156 0.982 . . . . 0.0 112.612 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -80.09 91.25 5.49 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.092 0.472 . . . . 0.0 111.049 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -120.96 116.12 24.49 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.063 176.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.484 HG23 ' H ' ' A' ' 202' ' ' LYS . 12.3 tt -80.72 103.98 8.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.806 0.812 . . . . 0.0 110.166 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.502 ' HB3' HG21 ' A' ' 200' ' ' VAL . 35.9 ptt-85 -135.36 161.78 61.27 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.587 -174.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.448 ' HG3' ' HB2' ' A' ' 215' ' ' LEU . 24.3 Cg_endo -85.86 -131.46 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 122.843 2.362 . . . . 0.0 110.924 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 63.0 ttp -90.75 44.16 1.18 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.554 0.692 . . . . 0.0 110.414 -176.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 80.02 1.2 87.35 Favored Glycine 0 CA--C 1.517 0.178 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.297 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 42.57 -150.26 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.475 0.71 . . . . 0.0 111.456 -177.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.425 ' HG3' ' N ' ' A' ' 179' ' ' TYR . 11.1 ptm85 -71.64 -47.38 54.84 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.024 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.425 ' N ' ' HG3' ' A' ' 178' ' ' ARG . 52.3 t80 -178.52 171.8 1.52 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -177.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -74.57 38.93 0.12 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.662 0.268 . . . . 0.0 111.005 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.5 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 40.3 ttmt -154.01 140.7 18.99 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -177.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.434 ' HB2' HD11 ' A' ' 197' ' ' ILE . . . -138.28 157.02 47.09 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.711 0.291 . . . . 0.0 111.509 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -87.0 101.49 13.49 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 58.9 t -90.56 125.94 43.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.859 -175.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.7 m -107.02 124.07 49.11 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.245 0.545 . . . . 0.0 110.011 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -104.51 115.91 62.03 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.841 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.83 -18.88 65.77 Favored 'Trans proline' 0 N--CA 1.476 0.458 0 C-N-CA 122.581 2.187 . . . . 0.0 111.258 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 72.0 m -64.11 -40.65 96.66 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.218 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.554 ' HB2' HG12 ' A' ' 191' ' ' VAL . 27.4 mt -107.3 -16.37 14.41 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.069 -177.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 60.16 41.32 17.08 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.986 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.554 HG12 ' HB2' ' A' ' 189' ' ' LEU . 6.6 p -134.94 148.84 28.97 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.74 -177.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 84.8 m -105.68 120.91 42.87 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.5 m -127.06 138.41 54.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.901 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.5 ' HG2' ' HG2' ' A' ' 181' ' ' LYS . 26.6 tt0 -94.21 119.54 33.17 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.156 -175.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -128.94 153.32 80.13 Favored Pre-proline 0 C--O 1.237 0.426 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.209 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.37 146.42 97.24 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.303 2.669 . . . . 0.0 112.645 177.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.434 HD11 ' HB2' ' A' ' 182' ' ' ALA . 76.9 mt -94.28 118.61 40.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.658 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.38 -46.52 15.89 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.808 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 27.3 m -140.64 150.29 43.37 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.177 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.502 HG21 ' HB3' ' A' ' 173' ' ' ARG . 30.9 m -128.19 144.13 38.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.521 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -140.34 102.54 4.37 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.281 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.484 ' H ' HG23 ' A' ' 172' ' ' ILE . 60.2 mtpt -70.8 146.01 50.01 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -85.78 116.97 67.78 Favored Pre-proline 0 C--N 1.312 -1.043 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.073 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.3 -22.47 21.91 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.036 1.824 . . . . 0.0 110.261 175.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 57.2 m -66.9 -40.13 87.63 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.004 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -69.01 127.93 92.92 Favored Pre-proline 0 CA--C 1.515 -0.371 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.731 -177.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.64 80.95 2.45 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.946 2.431 . . . . 0.0 113.168 -178.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 61.1 mt -70.79 142.85 51.32 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.942 174.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -60.64 -46.41 90.4 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.39 0.614 . . . . 0.0 109.593 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 59.3 m -111.76 132.6 54.55 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.96 -40.31 88.6 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.162 0.506 . . . . 0.0 110.431 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 87.3 mt -97.04 20.19 11.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.701 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.06 171.62 38.84 Favored Glycine 0 C--O 1.244 0.735 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.618 -176.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 33.2 m -63.87 167.25 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.548 0 CA-C-O 121.364 0.602 . . . . 0.0 112.209 -177.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.448 ' HB2' ' HG3' ' A' ' 174' ' ' PRO . 48.4 tp -75.31 128.7 36.0 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.688 -176.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 36.8 p -108.21 162.3 14.2 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.675 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.4 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 3.8 ptpp? -66.78 151.61 47.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.133 0.492 . . . . 0.0 111.589 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.02 4.3 41.75 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.235 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 88.1 m -80.12 134.9 36.21 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.522 0.201 . . . . 0.0 111.265 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 48.5 mm -93.78 126.29 46.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.863 0.363 . . . . 0.0 110.882 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.556 HG21 HD11 ' A' ' 245' ' ' ILE . 47.3 pt -130.73 165.17 31.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.368 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -108.68 129.41 55.35 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 31.5 m -126.82 153.66 36.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.106 0.479 . . . . 0.0 111.167 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -97.64 107.14 19.58 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.243 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 34.3 m -105.35 24.18 2.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.939 0.876 . . . . 0.0 110.255 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 238' ' ' ALA . 23.6 t -86.27 -23.5 26.33 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.395 175.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -60.68 -40.35 91.82 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.231 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.65 ' H ' HD23 ' A' ' 228' ' ' LEU . 2.3 pt? -98.11 -1.33 42.59 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.904 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' A' ' 238' ' ' ALA . . . -84.64 45.58 3.53 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.732 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 79.9 mt -82.77 -73.96 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.155 0.503 . . . . 0.0 110.877 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.04 11.15 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.426 0.631 . . . . 0.0 110.367 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 36.8 p -64.17 -38.56 91.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.474 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.642 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . -143.2 58.98 1.41 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.297 177.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 25.5 m 60.94 10.54 2.83 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.645 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 79.65 2.08 87.6 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.245 -0.503 . . . . 0.0 113.149 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.642 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 19.6 ptpt -71.51 -20.74 62.02 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -176.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 32.6 pt -81.65 -4.42 7.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 226' ' ' SER . . . -73.47 108.5 6.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.842 -178.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -169.35 -175.28 2.18 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -108.5 126.63 8.28 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -128.6 157.09 42.23 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 117.256 0.528 . . . . 0.0 111.748 -175.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.402 ' O ' HD12 ' A' ' 259' ' ' LEU . 77.1 m-85 -102.64 133.9 46.88 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.79 176.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -129.77 155.0 46.65 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.933 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -100.47 124.87 46.56 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.112 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.556 HD11 HG21 ' A' ' 221' ' ' ILE . 90.9 mt -76.71 125.77 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 CA-C-O 120.918 0.389 . . . . 0.0 110.934 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.4 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 4.3 t -132.35 94.56 3.46 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 174.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -81.21 117.16 21.5 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.65 -176.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -131.22 71.6 81.82 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.551 177.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.573 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 66.7 Cg_endo -71.78 -19.44 27.45 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.027 1.818 . . . . 0.0 112.461 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -86.92 -24.58 24.76 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.963 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -101.78 -58.09 1.95 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.921 0.391 . . . . 0.0 110.904 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -84.73 -39.27 18.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.414 0.625 . . . . 0.0 110.518 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 103.77 -9.31 51.73 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.171 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 70.2 m -135.93 169.23 17.92 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.783 0.325 . . . . 0.0 110.936 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.408 ' HB ' ' HD2' ' A' ' 178' ' ' ARG . 86.2 t -86.95 119.91 35.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 174.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -115.53 150.8 35.98 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 120.868 0.366 . . . . 0.0 111.045 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -121.63 140.96 51.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.4 p -119.12 137.48 52.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 120.697 0.284 . . . . 0.0 110.453 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 242' ' ' TYR . 60.6 tp -74.88 124.29 26.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.841 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.432 ' H ' HD23 ' A' ' 260' ' ' LEU . 0.3 OUTLIER -86.85 91.31 8.61 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.485 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.268 2.047 0 CA-C-O 117.68 -1.152 . . . . 0.0 110.666 -175.247 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 120.661 0.267 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -127.26 74.33 1.5 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.656 0.741 . . . . 0.0 110.357 -178.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -128.17 149.99 50.19 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.955 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -104.64 107.83 18.98 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 120.861 0.362 . . . . 0.0 110.804 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 172' ' ' ILE . 3.9 mp -104.19 100.97 11.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.481 ' HD2' ' HA2' ' A' ' 176' ' ' GLY . 38.3 ptt180 -161.77 153.67 16.13 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.941 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -60.43 -45.11 23.66 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.299 1.999 . . . . 0.0 111.257 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 17.2 tmm? -157.28 -48.58 0.07 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.481 ' HA2' ' HD2' ' A' ' 173' ' ' ARG . . . 148.88 84.01 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.17 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.703 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.557 ' H ' HD23 ' A' ' 177' ' ' LEU . 2.1 pt? -72.51 166.96 21.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.811 0.339 . . . . 0.0 111.498 -177.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -61.23 -28.65 69.32 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -175.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -156.7 143.77 18.77 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -69.3 90.77 0.51 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.492 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 41.0 ttmt -154.28 140.47 18.5 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.978 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -128.95 158.11 39.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.375 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 27.3 t-20 -84.55 106.14 15.9 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 257' ' ' ALA . 58.1 t -104.17 125.37 58.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.475 0.655 . . . . 0.0 112.504 -172.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 94.0 m -104.48 126.87 51.97 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -103.47 107.97 57.73 Favored Pre-proline 0 C--N 1.315 -0.93 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.18 -20.22 56.36 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 122.626 2.217 . . . . 0.0 112.158 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 70.1 m -63.68 -40.89 97.93 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.217 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.546 ' HB2' HG12 ' A' ' 191' ' ' VAL . 26.4 mt -107.74 -15.35 14.59 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.51 -178.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 67.2 t30 60.35 52.87 4.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.686 -175.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.546 HG12 ' HB2' ' A' ' 189' ' ' LEU . 12.2 p -135.24 143.39 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.667 -177.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 95.5 m -105.6 116.45 31.97 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.078 0.466 . . . . 0.0 110.249 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 63.7 t -131.19 129.9 63.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.144 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.492 ' HG2' ' HG2' ' A' ' 181' ' ' LYS . 48.3 tt0 -77.99 121.23 23.94 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.59 HD12 ' HD2' ' A' ' 196' ' ' PRO . 18.5 tp -126.86 141.2 39.8 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.216 -171.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.59 ' HD2' HD12 ' A' ' 195' ' ' LEU . 53.7 Cg_endo -67.88 151.48 78.19 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.75 2.3 . . . . 0.0 112.604 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 83.1 mt -97.12 118.2 43.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.231 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.2 mp -73.2 -43.79 60.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.147 0.499 . . . . 0.0 110.781 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 87.1 p -157.07 161.96 39.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.597 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.98 138.74 51.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.621 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -124.03 127.71 48.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.661 -177.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -90.08 125.2 35.34 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -107.2 143.08 26.42 Favored Pre-proline 0 C--N 1.313 -1.004 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.444 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.23 -17.99 35.08 Favored 'Trans proline' 0 N--CA 1.472 0.214 0 C-N-CA 123.156 2.571 . . . . 0.0 112.337 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 68.1 m -61.79 -40.43 95.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.537 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -118.53 101.88 50.47 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.059 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.22 148.05 67.67 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.384 2.056 . . . . 0.0 112.164 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.62 161.56 29.58 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.267 0.556 . . . . 0.0 111.687 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -60.16 -44.56 94.91 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.05 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 11.5 t -141.03 176.94 8.41 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.522 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -63.9 -39.06 93.3 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.409 ' O ' HD12 ' A' ' 212' ' ' LEU . 4.3 pp -143.46 133.73 24.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.785 0.326 . . . . 0.0 110.683 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.05 173.51 49.71 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 26.8 t 44.82 88.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.391 0.676 . . . . 0.0 112.668 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -83.7 175.26 9.82 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.102 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 14.9 t -131.28 174.44 10.05 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 120.786 0.327 . . . . 0.0 110.418 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -73.47 152.3 40.78 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.532 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.81 8.5 48.34 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.535 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 86.9 m -82.83 140.0 33.18 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 51.2 mm -102.17 127.36 55.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 O-C-N 121.919 -0.488 . . . . 0.0 111.093 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.597 HD13 HD11 ' A' ' 245' ' ' ILE . 43.0 pt -124.67 157.27 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.349 177.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -109.7 126.29 53.55 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 33.6 m -128.35 158.88 40.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 120.985 0.421 . . . . 0.0 110.954 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -89.94 107.09 18.91 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 43.6 t -90.92 78.76 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 30.0 t -167.76 -46.78 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.308 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -75.0 -4.59 39.22 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.495 ' HG ' ' H ' ' A' ' 230' ' ' ILE . 2.6 pt? -63.32 -15.56 57.71 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.893 0.378 . . . . 0.0 111.005 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 92.03 -12.68 68.91 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.933 174.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.495 ' H ' ' HG ' ' A' ' 228' ' ' LEU . 39.8 pt -131.98 153.86 39.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.587 0.708 . . . . 0.0 111.657 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 8.1 p -173.83 125.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 114.281 -1.327 . . . . 0.0 108.357 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 9.2 t -93.27 -10.76 34.43 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.264 0.554 . . . . 0.0 110.877 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.511 ' HB3' HG12 ' A' ' 237' ' ' ILE . . . -94.63 20.34 8.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.189 -177.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 37.0 m 59.59 27.88 17.18 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.004 0.43 . . . . 0.0 111.84 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 82.38 6.17 88.92 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.943 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -61.39 -39.26 90.04 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.056 0.455 . . . . 0.0 110.206 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.511 HG12 ' HB3' ' A' ' 233' ' ' ALA . 22.2 pt -98.12 15.42 3.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.04 -178.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -87.1 105.16 16.98 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.614 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -153.97 175.1 13.79 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.961 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -79.22 113.16 3.6 Favored Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 171.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -125.02 156.77 37.61 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 120.693 0.282 . . . . 0.0 110.407 -173.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 37.2 p90 -101.7 148.84 24.79 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.406 0.622 . . . . 0.0 112.185 -176.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -134.1 159.63 40.25 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.137 -177.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -99.31 127.73 45.35 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.183 0.516 . . . . 0.0 111.404 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.597 HD11 HD13 ' A' ' 221' ' ' ILE . 47.5 mm -76.22 125.62 36.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.341 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.7 t -129.61 101.91 6.13 Favored 'General case' 0 N--CA 1.425 -1.698 0 O-C-N 124.401 1.063 . . . . 0.0 108.679 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -76.32 121.07 22.44 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.4 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -129.78 71.33 82.16 Favored Pre-proline 0 C--N 1.314 -0.935 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.426 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 74.5 Cg_endo -72.31 -19.82 25.1 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.49 2.127 . . . . 0.0 112.545 -177.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -85.93 -24.08 26.71 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.042 0.449 . . . . 0.0 110.646 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -92.7 -55.3 3.43 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.155 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -105.67 -37.65 6.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.096 0.474 . . . . 0.0 110.664 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 100.91 10.94 41.59 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.817 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 30.6 p -147.04 177.69 8.96 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.491 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 96.4 t -79.58 122.12 34.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.693 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -112.94 150.15 32.24 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.739 -177.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.496 ' HB3' HG22 ' A' ' 184' ' ' VAL . . . -130.26 142.81 50.53 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 120.942 0.401 . . . . 0.0 110.73 177.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.8 p -123.67 131.42 73.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.94 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.1 tt -83.82 126.51 33.01 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.064 -177.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 4.1 pp -92.81 130.03 38.54 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.515 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.27 2.154 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.652 -178.302 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 120.691 0.281 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 59.55 28.76 18.24 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.538 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -127.69 -3.13 5.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.909 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.543 ' HA ' ' NH1' ' A' ' 173' ' ' ARG . 52.7 t80 -92.2 78.21 5.19 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.145 0.497 . . . . 0.0 110.785 -178.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.0 mp -122.58 117.73 52.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.075 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.543 ' NH1' ' HA ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -164.12 155.84 14.25 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.934 177.583 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.35 -43.38 23.24 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.343 2.029 . . . . 0.0 112.168 178.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 51.9 ttm 177.39 30.63 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 105.79 151.33 19.67 Favored Glycine 0 N--CA 1.423 -2.193 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -172.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -151.59 154.6 36.76 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 116.894 0.347 . . . . 0.0 110.588 -178.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -68.88 -35.38 76.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.612 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -168.08 150.4 5.47 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.49 ' HB3' ' HB ' ' A' ' 197' ' ' ILE . 98.4 mttt -76.23 89.05 3.1 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.698 0.285 . . . . 0.0 111.608 -178.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -124.79 143.99 50.51 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.573 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -137.07 144.28 43.05 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.863 176.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 66.5 t30 -85.7 99.8 11.56 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.7 t -91.68 120.98 41.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.265 0.555 . . . . 0.0 112.14 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 90.4 m -98.23 124.09 42.65 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.542 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -100.65 113.55 65.61 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.541 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.39 -16.51 51.56 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.647 2.231 . . . . 0.0 111.675 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 41.2 m -65.19 -43.13 92.6 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.264 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.597 ' HB2' HG12 ' A' ' 191' ' ' VAL . 23.8 mt -114.78 -9.17 12.56 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.699 -175.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 60.97 42.34 12.91 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.083 -176.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.597 HG12 ' HB2' ' A' ' 189' ' ' LEU . 10.5 p -129.26 147.7 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 14.8 t -123.77 129.63 51.35 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.307 0.575 . . . . 0.0 110.579 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 58.9 t -134.53 138.5 49.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.209 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 61.0 tt0 -80.51 113.31 18.61 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.302 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 7.6 mp -116.41 155.7 48.22 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.367 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 180' ' ' LYS . 58.7 Cg_endo -70.55 147.03 56.93 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.265 1.977 . . . . 0.0 111.535 177.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 180' ' ' LYS . 84.7 mt -87.3 107.27 16.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.892 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.87 -42.89 76.41 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.014 0.435 . . . . 0.0 111.088 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' A' ' 222' ' ' GLU . 18.8 m -141.67 146.09 35.71 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.428 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.7 138.62 44.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.019 0.438 . . . . 0.0 111.379 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.07 147.79 51.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.531 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -73.25 158.85 34.39 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.801 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.438 ' OD1' ' HB2' ' A' ' 205' ' ' SER . 26.3 t-20 -62.47 127.77 90.46 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.608 0.242 . . . . 0.0 110.695 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.4 -20.43 70.06 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.532 2.822 . . . . 0.0 113.965 -175.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.438 ' HB2' ' OD1' ' A' ' 203' ' ' ASN . 48.8 m -79.92 -10.03 59.74 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.931 0.396 . . . . 0.0 110.351 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 51.91 57.73 15.94 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -84.44 -5.56 10.1 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.501 2.134 . . . . 0.0 111.026 177.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.431 HD21 ' H ' ' A' ' 216' ' ' THR . 93.7 mt -72.94 148.74 44.0 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.016 -177.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.63 ' HB2' ' O ' ' A' ' 212' ' ' LEU . 62.8 m-85 -96.69 -11.48 25.08 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.753 177.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 35.4 m 67.09 -74.29 0.07 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.656 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -74.6 -16.21 60.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.893 0.377 . . . . 0.0 111.732 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.63 ' O ' ' HB2' ' A' ' 209' ' ' TYR . 96.4 mt -126.45 151.23 48.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.714 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 77.59 -171.37 55.15 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.613 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 30.9 m -127.94 172.11 15.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -58.88 128.26 36.33 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.129 0.49 . . . . 0.0 110.752 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.431 ' H ' HD21 ' A' ' 208' ' ' LEU . 75.1 p -91.68 163.67 14.01 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.531 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -70.57 151.36 45.12 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.894 0.378 . . . . 0.0 110.719 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.12 7.69 30.48 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.135 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.65 ' OG1' ' HB ' ' A' ' 245' ' ' ILE . 50.6 p -79.96 157.69 26.79 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.3 mm -115.78 129.04 72.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.017 0.437 . . . . 0.0 111.672 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.504 HG21 HD11 ' A' ' 245' ' ' ILE . 46.1 pt -125.86 158.3 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.999 178.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 199' ' ' SER . 44.1 tt0 -107.52 124.68 50.27 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.283 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.06 156.69 40.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.106 0.479 . . . . 0.0 110.951 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -100.64 113.49 26.38 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.338 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 22.3 t -83.96 70.6 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.408 ' H ' ' H ' ' A' ' 227' ' ' ASP . 18.7 m -159.78 -22.56 0.07 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.707 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ASP . . . . . 0.408 ' H ' ' H ' ' A' ' 226' ' ' SER . 5.4 m-20 -82.41 8.34 11.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.669 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.44 -22.26 65.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.049 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 95.73 -9.07 68.63 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.748 -0.66 . . . . 0.0 113.281 178.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 48.8 mm -115.8 135.52 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 CA-C-O 122.258 1.028 . . . . 0.0 112.515 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 4.7 m -112.46 118.22 57.24 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.475 0 CA-C-N 113.067 -1.879 . . . . 0.0 108.867 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 233' ' ' ALA . 61.1 p -68.48 -41.77 79.65 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.661 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 232' ' ' THR . . . 163.49 -39.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.079 0.952 . . . . 0.0 110.41 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 18.9 m -137.83 12.45 2.91 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.02 -176.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.35 50.67 54.7 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 119.724 -1.227 . . . . 0.0 110.74 -176.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.403 ' HD3' ' O ' ' A' ' 236' ' ' LYS . 9.0 tmtt? -57.22 -37.76 72.72 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 123.417 0.687 . . . . 0.0 110.332 -174.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 11.8 pt -118.66 19.19 6.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.814 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -81.17 107.71 14.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.82 0.343 . . . . 0.0 111.441 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 -159.34 169.43 24.03 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.568 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -94.05 119.14 5.94 Favored Glycine 0 N--CA 1.437 -1.241 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 172.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.44 ' CB ' HD11 ' A' ' 259' ' ' LEU . 37.3 mmt180 -127.86 164.05 23.08 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.953 0.406 . . . . 0.0 111.419 -174.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.545 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 96.6 m-85 -104.09 140.73 37.36 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.148 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -125.07 148.57 48.45 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.051 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 219' ' ' THR . 37.0 tt0 -98.68 125.69 44.06 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.195 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.65 ' HB ' ' OG1' ' A' ' 219' ' ' THR . 90.8 mt -80.75 127.77 39.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.048 0.452 . . . . 0.0 111.066 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 4.8 t -135.57 102.6 5.17 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.811 176.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -78.63 116.92 19.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.612 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -131.53 73.98 78.87 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.869 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.93 -23.14 41.21 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.285 1.99 . . . . 0.0 112.179 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -80.42 -12.55 59.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.333 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -113.1 -57.7 2.25 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.128 0.49 . . . . 0.0 111.001 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.549 ' HB2' HD21 ' A' ' 256' ' ' ASN . 26.9 m-20 -96.86 -27.6 14.61 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.881 -176.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 80.5 16.66 75.31 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.944 -178.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 48.5 t -155.48 165.3 37.01 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 96.1 t -81.06 121.95 35.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.549 HD21 ' HB2' ' A' ' 252' ' ' ASP . 48.1 m-80 -113.14 152.7 29.31 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 120.838 0.352 . . . . 0.0 111.257 -174.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -128.86 131.22 47.64 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.16 126.1 58.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.134 0.492 . . . . 0.0 109.908 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.44 HD11 ' CB ' ' A' ' 241' ' ' ARG . 51.5 tp -75.28 129.13 36.92 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.805 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 242' ' ' TYR . 3.0 pp -100.99 127.78 47.33 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 C--O 1.262 1.739 0 CA-C-O 117.951 -1.023 . . . . 0.0 111.065 -178.579 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 121.284 0.564 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -63.04 -41.51 99.51 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.385 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -87.51 12.36 12.54 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -100.25 114.46 27.93 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.427 HD12 ' N ' ' A' ' 172' ' ' ILE . 4.1 mp -93.23 126.95 45.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.178 -175.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -127.47 81.26 70.45 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.318 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.43 ' HA ' HD11 ' A' ' 215' ' ' LEU . 51.2 Cg_exo -58.62 -41.37 64.87 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.291 1.994 . . . . 0.0 111.077 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 56.7 ttm -173.84 13.02 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.505 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 85.64 101.31 0.71 Allowed Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -175.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.463 ' O ' HD12 ' A' ' 177' ' ' LEU . 4.1 pp -106.89 135.25 48.76 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.087 0.47 . . . . 0.0 111.301 -178.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -73.43 -29.68 62.72 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.392 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -160.51 143.41 13.25 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.486 ' HB3' ' HB ' ' A' ' 197' ' ' ILE . 56.3 mtmt -73.4 80.74 1.4 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.048 0.451 . . . . 0.0 111.92 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.474 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 84.8 tttt -155.72 135.2 12.44 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -141.96 160.54 40.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.97 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 17.8 m120 -80.9 103.56 10.82 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 64.1 t -85.68 122.06 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 121.338 0.59 . . . . 0.0 110.798 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.1 m -102.96 125.67 49.82 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.279 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -103.99 105.88 50.54 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.56 -32.39 79.76 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.465 2.11 . . . . 0.0 113.209 -176.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 87.9 m -67.22 -41.81 85.09 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.995 0.426 . . . . 0.0 110.872 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.48 ' HB2' HG12 ' A' ' 191' ' ' VAL . 41.7 mt -88.13 -20.66 25.35 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.414 0.626 . . . . 0.0 109.326 -178.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.4 t30 60.03 50.73 6.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.654 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.48 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.9 p -139.97 147.67 23.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.658 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 60.0 m -116.97 119.26 34.77 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 65.6 t -128.94 127.95 66.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 46.1 tt0 -78.2 118.98 20.94 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 91.7 mt -126.19 149.74 67.71 Favored Pre-proline 0 C--N 1.312 -1.022 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.28 -176.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.48 146.2 55.05 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.012 1.808 . . . . 0.0 110.919 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 180' ' ' LYS . 80.7 mt -91.47 117.77 35.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.66 -43.54 80.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.14 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 67.9 m -152.19 149.66 28.98 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.528 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.419 HG23 HD13 ' A' ' 172' ' ' ILE . 36.0 m -116.52 142.24 30.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -130.94 142.7 50.38 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.406 0.622 . . . . 0.0 110.827 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -71.9 134.65 46.16 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.981 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.46 ' HB2' ' HD2' ' A' ' 204' ' ' PRO . 9.6 p30 -75.14 159.9 81.51 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.565 ' HB2' ' OD1' ' A' ' 206' ' ' ASN . 19.0 Cg_endo -59.3 -21.21 59.41 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.506 2.137 . . . . 0.0 112.599 -178.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 34.8 m 61.21 34.22 18.88 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.262 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.565 ' OD1' ' HB2' ' A' ' 204' ' ' PRO . 19.5 m120 -70.36 -56.56 6.61 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.771 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.8 -32.48 11.49 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 121.937 1.758 . . . . 0.0 112.235 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 66.1 tp -126.06 108.59 11.51 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -122.04 10.38 10.08 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.535 ' O ' ' HG ' ' A' ' 212' ' ' LEU . 43.9 p -66.93 -46.22 75.44 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.124 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 62.3 -63.33 0.1 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.249 1.02 . . . . 0.0 113.222 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 210' ' ' THR . 2.6 pp -65.39 -18.19 65.12 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 123.191 0.596 . . . . 0.0 111.955 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.402 ' N ' HD12 ' A' ' 212' ' ' LEU . . . -92.15 17.31 57.39 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.778 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 59.8 t 76.49 128.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.548 0.739 . . . . 0.0 110.193 -178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.43 HD11 ' HA ' ' A' ' 174' ' ' PRO . 4.6 pp -89.23 175.49 7.34 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.681 -176.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 74.7 p -127.14 -172.51 2.67 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.455 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.517 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 18.2 ptpt -50.59 150.83 2.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.275 0.559 . . . . 0.0 112.409 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 114.99 6.11 19.2 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.804 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 244' ' ' GLN . 56.9 m -71.6 138.92 49.1 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.5 mm -92.37 125.69 44.96 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.717 0 CA-C-O 120.522 0.201 . . . . 0.0 110.502 -176.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.409 ' HB ' HG23 ' A' ' 197' ' ' ILE . 47.3 pt -133.54 160.12 42.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 120.961 0.41 . . . . 0.0 111.2 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -107.32 126.96 53.11 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.455 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.33 153.16 30.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.145 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -102.61 111.12 23.29 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.295 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 46.6 t -78.71 79.39 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 32.7 t -174.71 -27.55 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.949 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.31 5.11 9.2 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.291 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.65 -38.58 88.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.768 0.318 . . . . 0.0 110.677 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 83.39 7.01 87.11 Favored Glycine 0 CA--C 1.509 -0.325 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.531 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 49.3 pt -107.93 0.27 9.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 120.6 0.238 . . . . 0.0 110.822 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 39.7 t 62.74 96.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.903 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.453 HG22 HD11 ' A' ' 237' ' ' ILE . 14.0 m -85.08 101.13 12.18 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.982 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.535 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . 50.08 52.72 14.16 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.69 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 41.8 m 64.13 10.12 5.23 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.293 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 80.98 5.63 90.01 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.991 -0.623 . . . . 0.0 113.184 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 65.3 pttt -67.12 -24.22 65.89 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.211 0.529 . . . . 0.0 111.043 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 232' ' ' THR . 13.0 pt -110.5 19.76 6.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.37 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -78.0 105.68 9.37 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.168 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -145.11 158.14 43.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.888 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -81.25 132.28 11.07 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 175.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -128.5 172.42 11.16 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.915 0.388 . . . . 0.0 110.804 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -101.35 140.07 36.14 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.104 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -135.78 159.2 42.38 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.28 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 219' ' ' THR . 49.0 mt-30 -113.81 136.26 53.06 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.406 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.446 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 89.5 mt -79.85 124.19 37.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.517 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 4.9 t -124.72 92.45 3.65 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 122.12 0.962 . . . . 0.0 108.72 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ASN . . . . . 0.435 ' C ' ' HD3' ' A' ' 249' ' ' PRO . 20.1 p-10 -74.48 118.94 18.01 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.586 -177.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -130.22 67.87 80.41 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.88 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.435 ' HD3' ' C ' ' A' ' 247' ' ' ASN . 6.5 Cg_exo -77.35 -23.06 10.46 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.139 1.893 . . . . 0.0 109.99 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -67.9 -36.96 81.1 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.792 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -107.22 -58.09 1.99 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.421 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -72.27 -39.78 68.12 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.327 0.584 . . . . 0.0 110.854 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 100.77 7.24 51.21 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.404 -0.817 . . . . 0.0 112.399 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 39.4 t -152.44 164.71 36.99 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.781 0.324 . . . . 0.0 111.165 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 86.9 t -80.63 123.78 37.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -117.61 152.88 34.26 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.689 -174.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -124.41 145.68 49.34 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.5 p -121.09 131.94 71.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.043 0.449 . . . . 0.0 110.63 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.4 tt -100.86 128.35 46.94 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.251 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 2.7 pp -100.8 150.47 22.77 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.076 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.261 1.699 0 CA-C-O 118.102 -0.951 . . . . 0.0 111.037 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 . . . . . 0 N--CA 1.469 0.51 0 CA-C-O 120.676 0.274 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 49.92 75.87 0.15 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.964 177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.458 ' HA ' ' NE ' ' A' ' 170' ' ' ARG . 4.5 mmp_? -64.25 139.62 58.78 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.712 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -61.77 132.79 54.3 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.412 -174.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.423 HD11 ' HE3' ' A' ' 202' ' ' LYS . 97.2 mt -112.37 115.86 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.687 176.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.546 ' NH1' ' HA ' ' A' ' 175' ' ' MET . 3.0 tmt_? 55.0 85.27 0.19 Allowed Pre-proline 0 CA--C 1.535 0.367 0 O-C-N 123.72 0.638 . . . . 0.0 111.239 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -67.58 -74.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.618 1.545 . . . . 0.0 111.569 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.546 ' HA ' ' NH1' ' A' ' 173' ' ' ARG . 44.7 tpp -163.12 17.58 0.08 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.978 0.418 . . . . 0.0 110.63 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 66.07 40.3 95.05 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.18 -1.009 . . . . 0.0 112.098 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.626 ' H ' HD23 ' A' ' 177' ' ' LEU . 1.5 pt? -94.08 -164.3 1.16 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.658 0.266 . . . . 0.0 110.943 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -60.43 -25.57 66.07 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.108 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.474 ' H ' ' HG ' ' A' ' 177' ' ' LEU . 76.1 m-85 -94.67 147.96 22.77 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 64.19 43.72 4.79 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 122.284 1.04 . . . . 0.0 109.299 -170.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.567 ' HD3' ' HG2' ' A' ' 194' ' ' GLN . 4.0 tmmm? -124.26 133.69 53.43 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 113.597 -1.638 . . . . 0.0 107.561 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -135.7 159.79 40.54 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.221 0.534 . . . . 0.0 112.132 -175.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 58.2 t30 -87.22 105.68 17.38 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.92 119.02 41.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.441 0.639 . . . . 0.0 111.693 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 86.6 m -105.27 126.26 51.9 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.082 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -105.52 108.92 62.54 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 40.4 Cg_endo -66.69 -30.49 41.77 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 122.017 1.811 . . . . 0.0 112.576 -178.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 88.6 m -65.57 -43.37 90.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.283 0.563 . . . . 0.0 111.03 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.494 ' HB2' HG12 ' A' ' 191' ' ' VAL . 36.1 mt -96.17 -16.96 21.17 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.748 -177.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.4 t30 60.66 52.58 4.39 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.613 -176.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.494 HG12 ' HB2' ' A' ' 189' ' ' LEU . 10.2 p -138.04 137.25 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.002 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 9.3 t -115.94 116.86 28.68 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.529 0.681 . . . . 0.0 110.181 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 64.3 t -129.11 129.3 67.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.182 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.567 ' HG2' ' HD3' ' A' ' 181' ' ' LYS . 33.0 tt0 -77.38 124.29 27.67 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.619 HD12 ' HD2' ' A' ' 196' ' ' PRO . 25.2 tp -142.7 139.23 16.94 Favored Pre-proline 0 C--N 1.317 -0.848 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.767 -173.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.619 ' HD2' HD12 ' A' ' 195' ' ' LEU . 40.9 Cg_endo -67.87 147.24 74.3 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 121.882 1.721 . . . . 0.0 109.873 173.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.518 HG21 HG12 ' A' ' 200' ' ' VAL . 79.1 mt -84.48 124.5 39.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 120.918 0.39 . . . . 0.0 111.565 -175.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.65 -40.51 84.51 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.219 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 33.4 t -159.57 150.85 19.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.518 HG12 HG21 ' A' ' 197' ' ' ILE . 30.7 m -126.21 148.22 30.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.906 0.384 . . . . 0.0 110.932 -178.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -116.31 117.81 31.01 Favored 'General case' 0 C--O 1.253 1.283 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 174.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.423 ' HE3' HD11 ' A' ' 172' ' ' ILE . 41.1 ttmt -58.81 141.07 54.15 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 124.475 1.109 . . . . 0.0 111.292 -178.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -58.45 124.12 70.0 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.472 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.53 -35.83 4.42 Favored 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 123.188 2.592 . . . . 0.0 114.056 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 50.0 m -154.98 87.78 1.15 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -175.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -153.16 147.02 18.41 Favored Pre-proline 0 C--N 1.305 -1.344 0 CA-C-O 120.931 0.396 . . . . 0.0 110.718 172.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 208' ' ' LEU . 71.7 Cg_endo -76.26 -8.05 18.37 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.167 2.578 . . . . 0.0 112.687 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 207' ' ' PRO . 9.4 mp 71.96 -81.9 0.03 OUTLIER 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.432 0.693 . . . . 0.0 110.26 -176.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 86.4 t80 72.02 -21.93 0.22 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.514 0.725 . . . . 0.0 112.721 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 46.7 m -100.49 111.76 24.05 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.693 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 58.58 -179.67 0.07 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.434 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 94.7 mt -128.94 141.7 51.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.339 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 82.48 -1.49 87.53 Favored Glycine 0 C--N 1.323 -0.166 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.319 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.41 170.87 17.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 4.2 pp -98.61 175.0 6.15 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.649 0.738 . . . . 0.0 112.223 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 57.1 m -124.73 151.3 45.22 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.818 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.459 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 8.3 ptpp? -43.88 151.24 0.22 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 113.5 4.38 23.42 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.766 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.598 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 88.6 m -78.38 136.75 37.74 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.5 mm -100.82 128.56 52.84 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.741 HD13 HD11 ' A' ' 245' ' ' ILE . 46.8 pt -126.86 162.44 31.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -99.62 121.96 41.96 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.774 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 28.5 m -129.81 155.04 41.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 O-C-N 123.386 0.429 . . . . 0.0 110.519 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.432 ' OD1' HD21 ' A' ' 195' ' ' LEU . 16.5 p-10 -101.94 116.85 33.6 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.375 0.607 . . . . 0.0 110.961 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.545 ' HB ' HH11 ' A' ' 241' ' ' ARG . 53.0 t -109.76 87.69 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 38.7 t -118.83 -79.79 0.6 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.038 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -99.74 -30.13 12.25 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.021 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 91.7 mt 63.73 23.56 13.53 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.14 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 92.69 -8.3 76.8 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 121.016 -0.611 . . . . 0.0 113.228 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.8 pt -129.19 169.12 21.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.818 0.309 . . . . 0.0 110.607 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 15.9 m -90.3 89.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-O 121.712 0.768 . . . . 0.0 110.075 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.421 HG21 HD11 ' A' ' 237' ' ' ILE . 5.1 t -80.99 -51.47 8.49 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.747 -176.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.445 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . -170.42 53.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.641 0.258 . . . . 0.0 111.636 -177.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 19.9 m 58.52 20.01 7.14 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.096 177.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.89 21.59 76.75 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.082 -0.58 . . . . 0.0 113.545 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 19.2 ptpt -69.81 -18.94 63.49 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.622 0.711 . . . . 0.0 111.738 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.421 HD11 HG21 ' A' ' 232' ' ' THR . 28.9 pt -96.26 13.33 3.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.136 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -72.07 107.2 4.65 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.234 0.54 . . . . 0.0 112.195 -177.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -143.99 144.13 31.53 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.307 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -74.76 125.73 8.59 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.545 HH11 ' HB ' ' A' ' 225' ' ' VAL . 85.5 mtt85 -128.46 165.46 20.64 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.917 0.358 . . . . 0.0 111.185 -175.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.425 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 99.5 m-85 -101.03 136.08 41.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.542 -177.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -123.36 148.08 46.41 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.093 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -97.19 125.33 41.65 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.718 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.741 HD11 HD13 ' A' ' 221' ' ' ILE . 46.5 mm -83.11 122.38 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.918 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.018 177.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.459 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 1.3 t -128.64 86.86 2.5 Favored 'General case' 0 N--CA 1.428 -1.544 0 O-C-N 124.339 1.024 . . . . 0.0 108.78 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -80.5 115.87 20.25 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.339 0.59 . . . . 0.0 110.749 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -131.04 73.36 81.01 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.434 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.49 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 43.5 Cg_endo -66.73 -22.76 49.48 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.811 1.674 . . . . 0.0 110.673 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -69.1 -37.57 78.47 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.284 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -92.72 -55.9 3.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.262 -175.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -100.44 -32.31 10.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.194 0.521 . . . . 0.0 110.966 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 95.6 -4.95 66.81 Favored Glycine 0 C--N 1.315 -0.593 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.657 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 85.9 m -131.22 167.3 19.42 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.773 0.321 . . . . 0.0 110.77 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 87.5 t -80.74 121.37 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -108.47 146.5 33.06 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.578 -174.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -137.82 146.57 43.66 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.449 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.3 p -132.32 136.38 56.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.431 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 56.4 tp -73.05 130.53 40.51 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.098 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 242' ' ' TYR . 4.0 pp -102.82 144.46 31.12 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.861 176.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 26.5 m . . . . . 0 C--O 1.268 2.042 0 CA-C-O 117.905 -1.045 . . . . 0.0 111.043 -179.49 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 121.085 0.469 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -90.83 -33.78 15.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.033 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -112.91 108.39 17.32 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.043 -173.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -118.31 120.78 38.67 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.845 174.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.475 HG21 ' HB ' ' A' ' 200' ' ' VAL . 2.9 mp -114.14 21.97 5.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 122.046 0.927 . . . . 0.0 109.657 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.27 151.07 46.94 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.279 176.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -58.31 -72.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.832 2.355 . . . . 0.0 112.526 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 3.6 tpt -146.17 27.16 1.17 Allowed 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 104.57 143.74 12.49 Favored Glycine 0 N--CA 1.422 -2.237 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -174.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.408 ' H ' HD23 ' A' ' 177' ' ' LEU . 2.4 pt? -132.85 169.05 17.3 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 120.276 -0.569 . . . . 0.0 111.168 -178.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -61.37 -41.96 97.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.257 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -172.28 140.27 1.12 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -76.26 92.56 3.31 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 120.943 0.402 . . . . 0.0 110.995 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.492 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 22.5 ttmm -144.83 137.92 26.69 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.918 -177.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -139.07 154.78 48.23 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.787 0.327 . . . . 0.0 111.345 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -88.57 111.59 22.06 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.012 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 65.1 t -99.12 125.8 52.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.248 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.0 m -104.4 127.97 52.17 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.693 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -104.48 110.6 64.52 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -55.94 -36.36 95.65 Favored 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 123.448 2.766 . . . . 0.0 113.562 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 87.0 m -66.07 -41.27 90.97 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.127 0.489 . . . . 0.0 111.392 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.508 ' HB2' HG12 ' A' ' 191' ' ' VAL . 40.0 mt -94.42 -18.66 21.32 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.403 -175.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 58.77 44.14 17.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.141 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.508 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.9 p -134.23 144.49 35.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.75 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 86.2 m -113.73 120.25 40.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.173 0.511 . . . . 0.0 109.861 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 10.9 m -126.14 143.78 38.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.636 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.492 ' HG2' ' HG2' ' A' ' 181' ' ' LYS . 59.0 tt0 -97.76 122.37 40.77 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.603 -175.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.43 HD11 ' HA ' ' A' ' 228' ' ' LEU . 2.7 mm? -128.73 156.87 76.88 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.494 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.61 149.68 68.18 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.28 1.987 . . . . 0.0 110.674 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 79.3 mt -84.78 112.16 21.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.525 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 223' ' ' VAL . 3.9 mm? -68.0 -42.13 81.18 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.221 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 222' ' ' GLU . 37.3 t -150.91 148.6 28.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.222 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.475 ' HB ' HG21 ' A' ' 172' ' ' ILE . 16.7 m -123.03 140.85 45.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.999 0.428 . . . . 0.0 111.275 -178.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -133.8 131.91 39.85 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -111.01 144.77 39.59 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.223 177.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.538 ' HB2' ' HD3' ' A' ' 207' ' ' PRO . 2.6 m-20 -77.49 131.86 70.55 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.93 -19.64 64.04 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.836 2.357 . . . . 0.0 111.933 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 80.0 p -72.35 -13.2 61.42 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.694 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 59.73 81.02 0.25 Allowed Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.137 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 203' ' ' ASN . 98.5 Cg_endo -83.41 51.81 3.68 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.933 2.422 . . . . 0.0 111.613 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 9.1 mp -91.75 119.74 31.85 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -103.88 8.58 36.97 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.156 0.503 . . . . 0.0 110.312 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.536 HG22 ' H ' ' A' ' 212' ' ' LEU . 54.7 m -132.81 132.44 42.19 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.991 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -74.8 4.1 6.96 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.536 ' H ' HG22 ' A' ' 210' ' ' THR . 95.1 mt -81.59 0.6 37.57 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.76 0.314 . . . . 0.0 111.417 -177.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 72.68 32.78 61.17 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.468 -0.873 . . . . 0.0 111.944 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.81 153.66 27.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 78.8 mt -79.07 145.22 33.94 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 121.752 0.786 . . . . 0.0 111.905 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.2 p -116.43 -178.1 3.34 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.937 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.476 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 18.0 ptpt -60.68 144.91 51.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.286 0.565 . . . . 0.0 112.123 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 112.13 5.54 24.95 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.184 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.644 ' OG1' ' HB ' ' A' ' 245' ' ' ILE . 1.3 p -86.09 158.14 19.88 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 122.211 0.204 . . . . 0.0 111.239 178.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 48.4 mm -114.56 129.8 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -174.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.466 HG21 HD11 ' A' ' 245' ' ' ILE . 44.9 pt -132.65 162.94 39.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.025 0.44 . . . . 0.0 111.09 176.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 199' ' ' SER . 43.9 tt0 -112.86 131.39 55.73 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.438 ' HA ' HD23 ' A' ' 198' ' ' LEU . 26.8 m -129.08 150.88 35.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.092 0.472 . . . . 0.0 110.785 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -103.54 106.1 16.52 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.319 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 7.6 p -84.13 71.22 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-O 122.585 1.183 . . . . 0.0 110.149 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 14.9 m -154.37 -37.13 0.09 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.638 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -81.46 20.72 0.85 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.161 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.469 HD11 HG23 ' A' ' 225' ' ' VAL . 98.9 mt -61.33 -39.1 89.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.78 -177.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 174.22 -92.64 0.09 OUTLIER Glycine 0 N--CA 1.428 -1.841 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.617 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 63.9 mt -132.76 -86.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.075 0.464 . . . . 0.0 111.338 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.94 77.1 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.611 0.719 . . . . 0.0 110.759 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 23.9 p -71.14 -60.18 2.37 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.912 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -143.31 49.39 1.43 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.919 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 20.9 t 65.0 12.81 8.2 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.493 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 74.15 11.2 81.82 Favored Glycine 0 C--O 1.225 -0.411 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.859 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -67.66 -33.47 75.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.019 0.914 . . . . 0.0 109.499 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 35.9 pt -86.54 10.57 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.742 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -77.35 107.77 10.01 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -176.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' TRP . . . . . 0.476 ' O ' HG12 ' A' ' 225' ' ' VAL . 26.7 t90 -170.3 146.95 2.99 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.893 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -72.08 129.96 15.94 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.653 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -130.48 175.04 9.3 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -113.19 147.32 37.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.386 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -138.39 153.17 48.91 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.628 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -102.09 136.0 42.69 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.053 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.644 ' HB ' ' OG1' ' A' ' 219' ' ' THR . 87.3 mt -85.84 126.3 40.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.116 0.484 . . . . 0.0 110.777 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.476 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 3.1 t -127.24 87.83 2.7 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 174.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -68.7 117.22 10.14 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.371 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -128.2 69.62 78.08 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.795 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.445 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 65.1 Cg_endo -84.86 -13.29 6.83 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.569 2.179 . . . . 0.0 111.727 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -68.9 -37.67 79.13 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.095 -177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -115.18 -57.53 2.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.39 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.475 ' OD2' ' HB2' ' A' ' 254' ' ' CYS . 35.9 t70 -67.9 -39.5 83.59 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.345 0.593 . . . . 0.0 109.841 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.445 ' CA ' ' HA ' ' A' ' 249' ' ' PRO . . . 89.6 0.11 79.51 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.973 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.475 ' HB2' ' OD2' ' A' ' 252' ' ' ASP . 74.3 m -130.23 164.03 25.43 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.847 0.356 . . . . 0.0 111.181 -177.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 62.8 t -82.74 117.19 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -106.74 149.67 27.08 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.433 -176.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -136.35 144.36 44.57 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.12 131.06 70.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 121.146 0.498 . . . . 0.0 110.664 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.7 tt -99.51 125.36 45.26 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.672 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 260' ' ' LEU . 3.2 pp -92.9 144.52 25.18 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.244 0.545 . . . . 0.0 111.805 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.269 2.083 0 CA-C-O 117.729 -1.129 . . . . 0.0 110.442 179.441 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.898 0.38 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.409 ' C ' ' H ' ' A' ' 171' ' ' PHE . 48.5 mt-10 -83.77 -0.09 49.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.25 0.547 . . . . 0.0 110.949 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -84.29 25.26 0.87 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.559 0.695 . . . . 0.0 109.522 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.409 ' H ' ' C ' ' A' ' 169' ' ' GLU . 86.5 t80 -60.13 -39.11 85.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.071 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 86.5 mt -55.36 124.86 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.468 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.543 ' HG3' ' H ' ' A' ' 176' ' ' GLY . 18.4 ptp180 -144.26 154.03 56.86 Favored Pre-proline 0 N--CA 1.438 -1.043 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.419 -177.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.445 ' HB2' HD13 ' A' ' 177' ' ' LEU . 51.4 Cg_exo -57.62 -42.31 61.8 Favored 'Trans proline' 0 N--CA 1.482 0.794 0 C-N-CA 122.97 2.447 . . . . 0.0 113.302 -176.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 53.5 ttp -178.62 46.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.349 0.595 . . . . 0.0 109.531 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.543 ' H ' ' HG3' ' A' ' 173' ' ' ARG . . . 78.39 22.2 68.12 Favored Glycine 0 C--N 1.316 -0.555 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.079 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.445 HD13 ' HB2' ' A' ' 174' ' ' PRO . 10.2 mp -71.73 156.14 39.67 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.093 0.473 . . . . 0.0 110.75 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -59.66 -36.25 76.06 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.237 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -139.16 160.03 40.76 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.022 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -75.98 83.76 2.87 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.213 -177.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -128.24 144.58 51.14 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.956 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -132.69 150.62 52.13 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.646 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -87.88 100.46 12.9 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 192' ' ' THR . 67.3 t -84.21 117.37 29.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.202 -172.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.4 m -100.1 128.37 46.19 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.494 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -103.21 111.77 65.29 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.26 -25.0 57.56 Favored 'Trans proline' 0 N--CA 1.479 0.633 0 C-N-CA 122.986 2.457 . . . . 0.0 114.37 -175.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 39.6 p -66.79 -43.32 84.26 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.574 ' CD1' HG12 ' A' ' 191' ' ' VAL . 0.6 OUTLIER -116.52 -4.44 11.75 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.118 0.485 . . . . 0.0 111.802 -179.192 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.7 t30 59.44 61.59 1.98 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.218 -0.901 . . . . 0.0 113.292 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.574 HG12 ' CD1' ' A' ' 189' ' ' LEU . 3.2 p -138.52 147.77 25.08 Favored 'Isoleucine or valine' 0 C--O 1.248 1.005 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 175.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 15.3 t -127.62 135.88 50.87 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 120.266 -0.573 . . . . 0.0 111.529 -177.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.426 HG23 ' CD2' ' A' ' 195' ' ' LEU . 6.6 m -140.8 147.68 22.56 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.494 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -85.55 123.71 31.28 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.773 0.321 . . . . 0.0 111.582 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.426 ' CD2' HG23 ' A' ' 193' ' ' VAL . 3.1 mm? -128.08 151.51 76.12 Favored Pre-proline 0 C--O 1.24 0.558 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.314 176.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.91 144.42 47.87 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.365 2.044 . . . . 0.0 111.169 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.522 HG23 ' HB ' ' A' ' 221' ' ' ILE . 73.0 mt -92.24 119.37 39.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.423 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.4 -42.16 68.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.853 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 44.3 m -141.7 144.28 33.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.394 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.9 m -127.35 139.64 51.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.009 0.433 . . . . 0.0 111.683 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.436 ' O ' HG23 ' A' ' 219' ' ' THR . 57.3 mtpt -139.23 132.01 29.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.38 174.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -92.0 160.14 15.39 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.482 ' HB2' ' HB2' ' A' ' 206' ' ' ASN . 15.8 m120 -65.36 127.95 93.37 Favored Pre-proline 0 C--N 1.314 -0.966 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.81 -29.75 50.24 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.619 2.213 . . . . 0.0 113.673 -176.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 20.4 m -111.18 -15.03 13.76 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -177.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.482 ' HB2' ' HB2' ' A' ' 203' ' ' ASN . 79.9 m-20 -98.56 118.92 62.54 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 121.092 0.473 . . . . 0.0 111.458 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.83 170.23 18.36 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 123.507 2.805 . . . . 0.0 112.67 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 92.4 mt -76.8 166.06 23.87 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.241 177.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.543 ' CE2' ' HA ' ' A' ' 216' ' ' THR . 75.0 m-85 -61.76 -38.96 89.93 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.732 -178.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 11.2 m -110.97 -73.12 0.69 Allowed 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.435 ' HG3' ' HG ' ' A' ' 212' ' ' LEU . 12.7 pt20 177.21 -26.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.859 0.864 . . . . 0.0 109.026 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.435 ' HG ' ' HG3' ' A' ' 211' ' ' GLN . 4.0 pp -154.24 172.01 18.31 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.366 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 85.22 -82.05 1.71 Allowed Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.69 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 28.7 m -82.18 142.59 13.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.199 0.524 . . . . 0.0 111.556 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 173' ' ' ARG . 60.2 tp -96.12 149.76 21.26 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.564 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.543 ' HA ' ' CE2' ' A' ' 209' ' ' TYR . 14.8 t -89.84 148.72 23.02 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.444 ' HE2' ' OG1' ' A' ' 246' ' ' THR . 14.1 ptmm? -74.5 148.16 41.23 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.614 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.72 7.98 49.74 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.591 -176.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.438 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 79.9 m -71.09 134.33 46.95 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 122.416 0.286 . . . . 0.0 110.623 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.451 HD13 ' HG2' ' A' ' 244' ' ' GLN . 45.5 mm -93.19 124.06 45.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.591 -176.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.522 ' HB ' HG23 ' A' ' 197' ' ' ILE . 47.3 pt -131.71 160.64 42.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.314 0.578 . . . . 0.0 112.027 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -109.3 126.11 53.02 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.326 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 31.6 m -131.13 157.5 43.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.103 0.478 . . . . 0.0 111.281 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -107.02 106.72 17.38 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.439 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 44.9 t -82.39 78.67 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 22.2 t -179.3 -21.7 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.411 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -60.34 -35.42 75.61 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.726 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.467 ' HG ' ' H ' ' A' ' 230' ' ' ILE . 2.3 pt? -53.32 -23.56 9.58 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.901 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 91.42 -12.13 70.17 Favored Glycine 0 C--N 1.329 0.174 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.833 175.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.467 ' H ' ' HG ' ' A' ' 228' ' ' LEU . 45.2 pt -122.37 159.25 25.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.134 0.492 . . . . 0.0 110.371 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.35 149.95 31.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.336 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 6.8 t -72.81 -41.92 64.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.252 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.04 91.14 1.25 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.343 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 50.1 m 58.56 23.83 11.3 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 173.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.05 32.98 82.16 Favored Glycine 0 C--O 1.222 -0.602 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.82 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.25 -39.88 88.34 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.424 0.631 . . . . 0.0 110.71 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 15.5 pt -102.05 12.41 7.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.837 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -83.35 106.47 15.14 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.518 -176.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 -166.67 176.8 6.95 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.172 0.989 . . . . 0.0 109.037 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.411 ' C ' ' HD2' ' A' ' 241' ' ' ARG . . . -76.13 125.32 7.72 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 174.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.411 ' HD2' ' C ' ' A' ' 240' ' ' GLY . 2.4 mpt_? -128.36 177.92 6.63 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.118 0.485 . . . . 0.0 111.164 -177.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -120.05 145.88 46.43 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.533 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -135.45 158.43 44.39 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.394 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.451 ' HG2' HD13 ' A' ' 220' ' ' ILE . 78.8 mt-30 -114.26 128.45 56.37 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.694 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.472 HD11 HG21 ' A' ' 221' ' ' ILE . 86.2 mt -82.18 127.13 39.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.176 0.512 . . . . 0.0 111.67 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.444 ' OG1' ' HE2' ' A' ' 217' ' ' LYS . 4.0 t -137.72 102.68 4.81 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.275 175.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ASN . . . . . 0.408 ' HB3' HG13 ' A' ' 255' ' ' VAL . 5.5 p30 -75.44 124.84 27.85 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.553 -178.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -128.67 71.32 80.9 Favored Pre-proline 0 N--CA 1.443 -0.8 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.156 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.565 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 54.7 Cg_endo -68.99 -19.6 39.61 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.92 1.747 . . . . 0.0 110.089 178.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -66.6 -37.87 85.81 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.917 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -98.21 -57.1 2.29 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.033 0.444 . . . . 0.0 110.76 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.422 ' HB3' HD21 ' A' ' 256' ' ' ASN . 34.3 t70 -94.5 -37.33 11.45 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.384 -176.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 249' ' ' PRO . . . 100.73 -4.39 56.36 Favored Glycine 0 C--N 1.312 -0.783 0 C-N-CA 120.657 -0.783 . . . . 0.0 111.55 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 79.9 m -128.04 167.95 16.01 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.806 0.336 . . . . 0.0 110.965 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 247' ' ' ASN . 81.5 t -80.55 121.03 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.422 HD21 ' HB3' ' A' ' 252' ' ' ASP . 78.8 m-20 -115.95 152.83 32.72 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.935 -173.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -124.63 141.51 52.05 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.0 p -108.69 134.08 51.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.082 0.468 . . . . 0.0 110.549 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 62.0 tp -88.29 123.39 32.84 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.458 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.57 105.5 17.65 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.476 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.278 2.585 0 CA-C-O 117.481 -1.247 . . . . 0.0 110.224 178.485 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 121.078 0.466 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.9 -40.13 83.51 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.135 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.463 ' HD2' ' N ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 52.43 96.9 0.01 OUTLIER 'General case' 0 C--N 1.34 0.189 0 O-C-N 124.227 0.954 . . . . 0.0 113.194 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -62.46 -37.34 85.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.952 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.454 HG23 HG23 ' A' ' 200' ' ' VAL . 6.4 tp -67.2 125.32 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 176.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -136.0 152.06 74.91 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.137 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.419 ' HA ' ' HB3' ' A' ' 215' ' ' LEU . 8.4 Cg_endo -63.39 -73.47 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.81 1.673 . . . . 0.0 111.294 176.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.558 ' SD ' HG23 ' A' ' 214' ' ' VAL . 95.4 mmm -131.54 -0.3 3.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.335 0.588 . . . . 0.0 109.8 176.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 102.17 101.94 2.61 Favored Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -177.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.461 ' O ' HD12 ' A' ' 177' ' ' LEU . 1.5 pp -115.25 149.78 37.22 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.784 0.326 . . . . 0.0 110.938 -178.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -72.75 -34.23 66.88 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.452 ' O ' HD13 ' A' ' 177' ' ' LEU . 93.4 m-85 -138.2 148.49 44.87 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 177.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 196' ' ' PRO . 3.2 mppt? -80.88 73.06 7.9 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.636 -0.426 . . . . 0.0 109.954 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -123.08 139.02 54.51 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.585 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.635 ' HB3' HD11 ' A' ' 197' ' ' ILE . . . -136.55 148.2 47.45 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.563 176.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -84.74 102.04 12.7 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 257' ' ' ALA . 58.9 t -93.72 120.34 42.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.312 0.577 . . . . 0.0 111.908 -173.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 90.5 m -112.13 128.71 56.3 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.04 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -104.44 108.39 60.39 Favored Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.55 -27.65 61.59 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 122.535 2.157 . . . . 0.0 113.557 -175.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.438 HG23 ' HG ' ' A' ' 189' ' ' LEU . 9.3 t -77.77 -27.92 50.45 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.748 0.309 . . . . 0.0 111.695 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.472 ' HB2' HG12 ' A' ' 191' ' ' VAL . 37.4 mt -104.25 -22.02 13.44 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.276 0.56 . . . . 0.0 109.801 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.8 t30 60.21 52.79 4.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.928 -175.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.472 HG12 ' HB2' ' A' ' 189' ' ' LEU . 11.2 p -133.41 137.09 53.76 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.512 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 92.9 m -119.29 124.33 46.4 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.984 0.421 . . . . 0.0 111.042 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 10.3 m -142.95 149.59 18.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.127 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.504 ' C ' HD12 ' A' ' 195' ' ' LEU . 35.3 tt0 -102.89 119.82 39.52 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.85 178.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.504 HD12 ' C ' ' A' ' 194' ' ' GLN . 7.1 mp -128.38 150.59 74.71 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.58 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 180' ' ' LYS . 38.3 Cg_exo -61.37 141.09 91.37 Favored 'Trans proline' 0 C--O 1.24 0.608 0 C-N-CA 122.556 2.17 . . . . 0.0 111.23 175.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.71 HD12 HD12 ' A' ' 221' ' ' ILE . 34.8 mm -91.67 119.85 39.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.193 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.403 HD11 ' ND2' ' A' ' 224' ' ' ASN . 96.6 mt -69.25 -42.19 75.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.597 -177.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.4 t -154.39 149.57 26.99 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.767 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.603 HG12 HG22 ' A' ' 221' ' ' ILE . 32.1 m -128.96 148.09 33.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.451 ' O ' HG23 ' A' ' 219' ' ' THR . 14.5 ptmm? -139.65 149.33 43.6 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -66.75 154.96 39.4 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.351 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -80.07 116.61 62.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.144 0.497 . . . . 0.0 110.986 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.43 -33.25 9.05 Favored 'Trans proline' 0 N--CA 1.472 0.212 0 C-N-CA 122.737 2.291 . . . . 0.0 113.033 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 49.6 m -133.92 69.44 1.47 Allowed 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.325 0.583 . . . . 0.0 111.568 -177.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -153.5 139.08 11.93 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.625 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.0 140.11 40.99 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.495 2.13 . . . . 0.0 112.906 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.45 ' HA ' HG21 ' A' ' 216' ' ' THR . 4.9 mp -117.96 145.04 45.0 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.81 177.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -67.68 -42.27 82.36 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.8 m 63.32 -11.78 0.09 Allowed 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 173.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -61.68 -40.48 95.12 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.8 pp -119.34 15.23 13.02 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.731 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 75.29 76.78 0.74 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.188 -1.006 . . . . 0.0 110.797 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.558 HG23 ' SD ' ' A' ' 175' ' ' MET . 7.6 p -135.34 140.5 44.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 120.909 0.385 . . . . 0.0 111.428 -176.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.419 ' HB3' ' HA ' ' A' ' 174' ' ' PRO . 61.4 tp -97.66 128.88 44.68 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.45 HG21 ' HA ' ' A' ' 208' ' ' LEU . 32.1 p -91.11 168.3 11.73 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -176.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -60.94 153.94 23.68 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.812 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 106.7 10.19 29.24 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -176.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.612 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 87.8 m -71.57 128.5 36.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 201' ' ' LYS . 48.5 mm -90.36 129.03 41.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.762 0.315 . . . . 0.0 110.301 -177.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.71 HD12 HD12 ' A' ' 197' ' ' ILE . 39.0 pt -127.56 154.82 38.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -177.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -102.04 119.32 38.6 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.347 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.31 156.73 40.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.596 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.403 ' ND2' HD11 ' A' ' 198' ' ' LEU . 96.0 m-20 -103.55 108.57 19.89 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.005 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.472 HG23 ' H ' ' A' ' 239' ' ' TRP . 35.2 m -87.58 21.06 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 122.067 0.937 . . . . 0.0 109.288 176.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 21.2 m -105.21 -14.0 15.51 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.561 173.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.85 1.11 55.32 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.287 -174.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.492 HD13 HG12 ' A' ' 230' ' ' ILE . 0.3 OUTLIER -64.35 -31.14 72.22 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.582 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 69.5 31.97 71.26 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.92 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.492 HG12 HD13 ' A' ' 228' ' ' LEU . 42.2 pt -119.39 151.83 21.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 117.214 0.507 . . . . 0.0 110.649 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 27.1 m -121.75 8.35 5.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.694 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 14.6 t -58.66 -18.38 30.28 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.769 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.54 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . -119.26 29.13 7.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.847 0.356 . . . . 0.0 110.553 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 23.0 m 66.75 3.26 2.92 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.637 0.775 . . . . 0.0 112.138 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 81.04 0.71 89.26 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.942 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 19.2 ptpt -70.14 -15.52 62.97 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.122 0.487 . . . . 0.0 111.333 -179.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 33.8 pt -80.93 -4.64 7.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.568 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.16 109.26 2.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.0 0.428 . . . . 0.0 110.149 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' TRP . . . . . 0.472 ' H ' HG23 ' A' ' 225' ' ' VAL . 5.0 m95 -151.96 176.29 11.64 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.627 -178.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -109.8 112.73 3.43 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 171.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -129.44 161.32 30.64 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 117.118 0.459 . . . . 0.0 111.882 -174.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -102.62 133.81 47.02 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.193 175.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -114.68 162.73 16.41 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.613 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -110.24 128.41 55.49 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.083 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.612 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 89.1 mt -81.85 127.23 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.773 0 CA-C-O 120.969 0.414 . . . . 0.0 111.18 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 2.7 t -128.17 101.32 6.21 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.166 175.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.35 117.81 19.94 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.451 0.643 . . . . 0.0 112.148 -178.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -128.57 72.12 80.72 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.355 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.46 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 56.5 Cg_endo -68.77 -19.55 40.96 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.389 2.059 . . . . 0.0 111.568 -178.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -70.13 -30.63 67.85 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.026 177.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -94.1 -56.49 2.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.316 -177.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -104.39 -28.03 11.6 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 249' ' ' PRO . . . 83.43 10.4 82.04 Favored Glycine 0 C--N 1.315 -0.585 0 C-N-CA 120.34 -0.933 . . . . 0.0 111.755 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 83.4 m -135.32 173.48 11.67 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 122.408 0.283 . . . . 0.0 110.263 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 86.3 t -79.56 122.42 34.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.621 ' HB2' ' O ' ' A' ' 246' ' ' THR . 6.3 m120 -103.82 152.09 22.31 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -176.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.424 ' HB3' HG22 ' A' ' 184' ' ' VAL . . . -136.48 143.88 44.06 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 11.0 p -134.54 140.84 44.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-O 120.903 0.382 . . . . 0.0 110.445 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 63.0 tp -79.04 126.02 30.16 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.468 ' O ' HD12 ' A' ' 260' ' ' LEU . 2.8 pp -67.04 133.96 50.96 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.169 0.509 . . . . 0.0 111.512 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 C--O 1.263 1.777 0 CA-C-O 117.684 -1.151 . . . . 0.0 110.794 179.571 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 11.4 t80 . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -78.91 58.21 2.32 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.038 0.447 . . . . 0.0 111.678 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -138.37 148.65 44.75 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.293 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.499 ' HB3' HD11 ' A' ' 197' ' ' ILE . . . -145.93 149.64 34.58 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.472 176.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -81.33 103.24 10.96 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.479 HG22 ' HB3' ' A' ' 257' ' ' ALA . 58.6 t -92.65 118.82 39.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.237 0.541 . . . . 0.0 110.604 -176.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.4 m -94.13 122.53 36.75 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.272 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -105.06 108.33 61.03 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.3 -28.0 63.7 Favored 'Trans proline' 0 N--CA 1.471 0.192 0 C-N-CA 122.261 1.974 . . . . 0.0 112.007 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 81.1 m -65.66 -41.69 92.21 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.722 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.534 ' HB2' HG12 ' A' ' 191' ' ' VAL . 33.4 mt -96.05 -19.0 19.77 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.066 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 64.3 t30 61.47 51.32 4.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.424 -175.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.534 HG12 ' HB2' ' A' ' 189' ' ' LEU . 5.9 p -149.92 144.12 17.63 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.912 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 11.4 t -111.6 124.34 52.09 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.423 0.63 . . . . 0.0 109.466 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 67.4 t -131.82 136.53 56.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.249 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -79.91 116.76 20.24 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.04 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.442 HD21 HD11 ' A' ' 228' ' ' LEU . 7.5 mp -111.73 150.82 42.83 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.841 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.61 140.21 38.98 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.66 1.574 . . . . 0.0 110.028 174.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' A' ' 182' ' ' ALA . 37.5 mm -86.98 114.82 26.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.082 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 223' ' ' VAL . 4.1 mm? -69.28 -42.41 75.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.802 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.4 t -161.77 149.43 14.69 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.349 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.614 HG12 HG22 ' A' ' 221' ' ' ILE . 32.0 m -119.79 146.62 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -119.97 122.91 42.25 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -52.57 155.2 2.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.638 -1.164 . . . . 0.0 112.585 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 . . . . . 0 N--CA 1.438 -1.06 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 170.498 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.489 HD13 HG21 ' A' ' 219' ' ' THR . 83.9 mt . . . . . 0 CA--C 1.503 -0.835 0 CA-C-O 121.32 0.581 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 66.7 p -90.15 166.6 13.3 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.138 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.612 ' HA ' ' O ' ' A' ' 245' ' ' ILE . 19.2 ptpt -65.37 142.62 58.15 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.873 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.4 1.64 55.61 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.209 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.609 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 85.4 m -66.81 138.12 57.11 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.8 mm -94.38 128.84 45.36 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.046 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.323 -174.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.614 HG22 HG12 ' A' ' 200' ' ' VAL . 47.1 pt -126.1 159.39 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 CA-C-O 120.774 0.321 . . . . 0.0 110.314 176.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -116.8 117.91 31.06 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.417 ' HA ' HD23 ' A' ' 198' ' ' LEU . 28.1 m -130.69 157.83 43.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.288 0.566 . . . . 0.0 111.635 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -105.17 106.61 17.18 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.438 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 239' ' ' TRP . 7.2 p -83.84 78.26 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 122.43 1.11 . . . . 0.0 110.446 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 22.2 m -158.77 -34.06 0.07 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.058 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -75.47 9.77 2.0 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.216 -176.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.442 HD11 HD21 ' A' ' 195' ' ' LEU . 7.0 mp -63.52 -40.68 97.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.131 0.491 . . . . 0.0 109.689 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 79.43 -2.03 73.94 Favored Glycine 0 C--O 1.226 -0.351 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.799 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.8 pt -80.1 -31.24 13.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 122.71 -0.288 . . . . 0.0 111.684 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 20.8 t 48.91 72.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 O-C-N 123.558 0.536 . . . . 0.0 110.643 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 13.5 t -110.96 -8.27 14.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.564 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.686 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . -128.06 31.89 5.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.717 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 19.7 m 59.86 9.79 1.85 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 79.78 3.07 89.04 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.962 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.686 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 65.0 pttt -72.02 -11.37 60.73 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.188 0.518 . . . . 0.0 111.804 -177.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 34.9 pt -95.91 -0.86 10.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.641 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -62.48 112.15 2.34 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 123.354 0.409 . . . . 0.0 111.965 -175.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . 0.505 ' O ' HG12 ' A' ' 225' ' ' VAL . 71.0 t-105 -175.13 146.91 0.88 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.875 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -73.7 120.39 6.88 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -128.6 162.76 26.55 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.912 0.387 . . . . 0.0 111.214 -173.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -102.45 136.28 42.56 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.94 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -127.02 158.3 37.31 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.096 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -105.73 132.31 52.01 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.875 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 217' ' ' LYS . 49.1 mm -79.07 130.28 36.37 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.192 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.536 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 4.4 t -140.09 104.14 4.77 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -80.76 119.75 23.75 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 120.842 0.354 . . . . 0.0 110.748 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -128.09 72.17 79.31 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-O 121.405 0.622 . . . . 0.0 109.381 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.485 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 71.8 Cg_endo -71.53 -17.84 29.8 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.884 2.389 . . . . 0.0 112.964 -176.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -82.2 -21.61 36.36 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.797 0.332 . . . . 0.0 110.803 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -105.67 -56.86 2.12 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.141 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.442 ' CB ' HD21 ' A' ' 256' ' ' ASN . 18.9 m-20 -93.37 -31.08 14.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.936 0.398 . . . . 0.0 111.44 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 82.99 4.85 89.81 Favored Glycine 0 C--N 1.321 -0.281 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.503 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 65.3 m -132.6 174.14 10.59 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.515 0.197 . . . . 0.0 110.935 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 90.6 t -79.48 121.87 33.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.536 ' HB2' ' O ' ' A' ' 246' ' ' THR . 5.3 m120 -110.13 152.28 26.21 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.612 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.479 ' HB3' HG22 ' A' ' 184' ' ' VAL . . . -134.38 144.83 48.44 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.508 177.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.68 135.94 61.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.006 0.431 . . . . 0.0 110.215 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 64.7 tp -95.57 127.06 41.29 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.23 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.464 ' H ' ' HG ' ' A' ' 260' ' ' LEU . 2.1 pp -90.31 136.71 32.88 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.405 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.266 1.957 0 CA-C-O 117.702 -1.142 . . . . 0.0 111.011 -178.106 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -97.39 34.71 1.75 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.069 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.428 ' HB3' ' HG2' ' A' ' 194' ' ' GLN . 59.5 mtmt -118.2 144.83 45.42 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.15 0.5 . . . . 0.0 111.114 -176.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -129.44 152.22 49.22 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.026 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -81.53 99.57 8.88 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.3 t -89.68 126.05 42.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.211 -174.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.9 m -114.87 128.3 56.21 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.576 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.518 ' NE2' HD21 ' A' ' 228' ' ' LEU . 30.9 m170 -104.46 117.96 57.85 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.04 -24.89 77.1 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 122.829 2.353 . . . . 0.0 113.492 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 11.6 t -79.67 -23.53 42.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.834 0.35 . . . . 0.0 111.628 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.479 ' HB2' HG12 ' A' ' 191' ' ' VAL . 40.5 mt -103.55 -24.32 13.43 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 59.06 46.95 12.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.513 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.479 HG12 ' HB2' ' A' ' 189' ' ' LEU . 8.9 p -133.49 145.27 33.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.174 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 87.9 m -116.42 119.43 35.62 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.436 HG11 ' O ' ' A' ' 228' ' ' LEU . 61.0 t -133.73 138.84 49.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.428 ' HG2' ' HB3' ' A' ' 181' ' ' LYS . 33.7 tt0 -87.57 118.25 26.92 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.881 0.372 . . . . 0.0 111.037 -177.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.71 153.5 77.81 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.195 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.85 146.86 54.52 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.334 2.023 . . . . 0.0 111.26 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.422 HG23 ' HB ' ' A' ' 221' ' ' ILE . 80.6 mt -89.46 116.51 31.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.323 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 95.8 mt -71.78 -42.18 67.45 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.528 ' HB2' ' HB3' ' A' ' 222' ' ' GLU . 16.6 m -140.92 147.19 38.46 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 26.7 m -125.97 146.09 32.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.328 0.585 . . . . 0.0 111.508 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -127.65 106.91 9.47 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.094 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -56.6 156.91 5.72 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.44 0.462 . . . . 0.0 111.661 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 C--N 1.32 -0.676 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.202 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 61.6 tp . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 24.2 p -95.75 159.18 15.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.863 0.363 . . . . 0.0 111.23 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -61.7 152.15 31.82 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.049 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 109.69 9.76 24.33 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.618 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 21.2 m -73.08 142.12 47.58 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.5 mm -100.2 127.84 52.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.961 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.554 HD13 HD11 ' A' ' 245' ' ' ILE . 45.5 pt -127.53 163.16 31.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.591 0.234 . . . . 0.0 110.598 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.528 ' HB3' ' HB2' ' A' ' 199' ' ' SER . 8.4 tm-20 -124.43 125.65 44.62 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.035 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.3 m -131.15 141.86 44.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.145 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.601 ' HA ' ' HA2' ' A' ' 240' ' ' GLY . 50.8 t-20 -114.82 107.1 14.98 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.967 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.718 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 7.8 p -175.03 -56.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.902 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.422 ' N ' HG13 ' A' ' 225' ' ' VAL . 10.8 t 72.76 -56.16 0.66 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.396 0.678 . . . . 0.0 111.268 -177.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' A' ' 230' ' ' ILE . 1.6 m-20 -63.01 -21.95 66.51 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.344 0.258 . . . . 0.0 111.678 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.518 HD21 ' NE2' ' A' ' 186' ' ' HIS . 96.7 mt 67.23 18.29 10.32 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 92.68 -5.29 76.73 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.63 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.451 ' O ' ' HB3' ' A' ' 227' ' ' ASP . 48.2 pt -107.23 170.46 2.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 231' ' ' VAL . 7.7 p -96.42 90.41 2.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.693 0.758 . . . . 0.0 111.929 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 10.6 t -101.37 -34.96 9.39 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 174.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.689 ' HB3' HG12 ' A' ' 237' ' ' ILE . . . -138.44 9.87 2.71 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.736 174.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 9.3 t 63.37 31.52 15.13 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.155 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 85.13 3.44 87.45 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.083 -0.58 . . . . 0.0 113.192 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -65.12 -39.8 93.59 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 121.25 0.548 . . . . 0.0 111.205 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.689 HG12 ' HB3' ' A' ' 233' ' ' ALA . 30.4 pt -93.04 18.88 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.468 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.718 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -54.01 120.59 6.59 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -153.07 150.68 29.39 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.886 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 224' ' ' ASN . . . -96.22 116.01 5.33 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.847 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -129.3 171.97 11.95 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.735 0.302 . . . . 0.0 111.151 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 96.8 m-85 -102.2 140.48 36.43 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.282 0.563 . . . . 0.0 111.214 -177.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -129.48 154.49 46.94 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.36 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -101.17 133.15 46.15 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.618 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 47.9 mm -80.39 124.64 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.709 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 12.6 p -119.42 76.29 1.12 Allowed 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.082 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -68.66 121.8 17.2 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.352 0.596 . . . . 0.0 110.964 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -128.95 71.29 81.79 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.275 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -72.19 -25.33 19.05 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 121.4 1.4 . . . . 0.0 112.216 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -74.05 -33.02 63.56 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.062 0.458 . . . . 0.0 110.609 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -96.9 -57.1 2.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.937 -176.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -95.0 -29.91 14.38 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.77 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 76.62 18.56 78.9 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.375 -0.917 . . . . 0.0 110.875 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 49.7 t -149.18 160.71 43.12 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.375 -0.413 . . . . 0.0 109.96 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 85.3 t -80.39 126.85 39.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.946 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 246' ' ' THR . 42.3 m-80 -110.46 153.74 24.6 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.19 148.54 35.12 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.703 0.287 . . . . 0.0 110.65 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.59 130.64 56.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 8.9 tt -75.46 127.96 34.27 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.102 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.467 ' O ' HD12 ' A' ' 260' ' ' LEU . 4.2 pp -84.94 132.5 34.35 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.133 0.492 . . . . 0.0 111.229 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 10.6 m . . . . . 0 C--O 1.279 2.641 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.924 179.646 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 . . . . . 0 CA--C 1.511 -0.553 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -79.47 87.82 5.07 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -156.91 137.28 12.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.489 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.545 ' HB3' HD11 ' A' ' 197' ' ' ILE . . . -145.86 157.07 43.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.963 0.411 . . . . 0.0 111.392 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 56.8 t30 -83.5 99.46 10.14 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.479 HG22 ' HB3' ' A' ' 257' ' ' ALA . 53.1 t -92.65 118.93 39.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.279 0.562 . . . . 0.0 112.067 -172.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 89.6 m -94.31 124.18 38.17 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.259 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.419 ' CE1' HD21 ' A' ' 228' ' ' LEU . 64.1 m80 -104.84 111.18 65.22 Favored Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -62.93 -28.2 75.1 Favored 'Trans proline' 0 N--CA 1.475 0.407 0 C-N-CA 122.543 2.162 . . . . 0.0 112.621 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.9 t -70.99 -31.88 68.54 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.309 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.547 ' HB2' HG12 ' A' ' 191' ' ' VAL . 43.6 mt -98.53 -22.36 16.03 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.3 t30 60.47 44.89 11.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.99 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.547 HG12 ' HB2' ' A' ' 189' ' ' LEU . 4.0 p -145.75 150.5 15.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.984 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.588 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 14.4 t -121.87 128.79 52.0 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 121.343 0.592 . . . . 0.0 110.175 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.83 138.24 52.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 63.0 tt0 -81.18 118.36 22.49 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.41 HD12 ' C ' ' A' ' 194' ' ' GLN . 7.1 mp -128.11 151.85 76.72 Favored Pre-proline 0 C--O 1.239 0.507 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.894 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 180' ' ' LYS . 45.2 Cg_exo -61.05 143.81 99.25 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.642 2.228 . . . . 0.0 110.921 173.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.545 HD11 ' HB3' ' A' ' 182' ' ' ALA . 46.1 mm -84.8 117.79 30.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 223' ' ' VAL . 3.6 mm? -70.05 -40.85 74.88 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 38.2 t -155.02 150.24 27.09 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.451 HG12 HG22 ' A' ' 221' ' ' ILE . 35.6 m -127.58 146.2 33.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.093 0.473 . . . . 0.0 110.975 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -133.64 143.52 48.64 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.493 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -79.34 151.43 31.02 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.178 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 . . . . . 0 C--N 1.311 -1.099 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 174.416 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.7 t -117.64 -170.83 1.94 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.114 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.514 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 14.0 ptmm? -54.02 148.42 10.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.381 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 114.49 4.77 21.58 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.145 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.5 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 50.5 m -72.09 140.08 48.75 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.2 mm -92.8 127.33 45.0 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.963 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.451 HG22 HG12 ' A' ' 200' ' ' VAL . 46.3 pt -133.46 165.38 32.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 120.814 0.34 . . . . 0.0 110.943 178.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -121.21 126.77 50.46 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.485 ' HA ' HD23 ' A' ' 198' ' ' LEU . 35.6 m -131.25 156.65 42.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.213 0.53 . . . . 0.0 111.717 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -99.92 107.01 18.88 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.025 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 7.5 p -85.52 79.35 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 122.276 1.036 . . . . 0.0 110.536 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 57.0 p -175.77 -26.39 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.711 -1.586 . . . . 0.0 108.569 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -62.04 -13.48 26.49 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.324 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.419 HD21 ' CE1' ' A' ' 186' ' ' HIS . 6.9 mp -60.11 -37.3 79.59 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.015 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 90.62 8.11 66.04 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.425 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 41.3 pt -122.91 155.41 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 77.9 t -127.0 123.81 63.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.911 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.3 t -79.16 -52.22 8.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.099 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -161.64 98.95 1.12 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.675 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 25.8 t 65.26 -2.61 0.75 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.72 31.2 70.37 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.764 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.6 pttp -64.08 -13.63 48.76 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -177.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 19.9 pt -107.5 4.2 9.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.188 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -71.11 107.58 4.23 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.777 0.323 . . . . 0.0 111.658 -176.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 -164.09 176.58 9.16 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.041 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -91.47 122.77 6.89 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 108.894 -1.683 . . . . 0.0 108.894 173.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 75.9 mtt-85 -128.93 168.35 16.1 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 117.233 0.516 . . . . 0.0 111.319 -174.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.448 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 93.1 m-85 -101.36 143.55 31.26 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.164 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -136.92 166.3 23.96 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.359 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.432 ' HG3' HD23 ' A' ' 260' ' ' LEU . 98.3 mt-30 -116.6 136.98 52.52 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.054 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.5 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 88.2 mt -81.59 121.06 34.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.555 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 71.8 p -123.52 92.62 3.73 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.757 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -83.76 125.51 31.99 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.256 -176.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -131.59 70.28 81.44 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.51 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 73.4 Cg_endo -73.83 -17.8 22.43 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.032 1.822 . . . . 0.0 111.858 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -86.96 -14.82 40.67 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.235 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -111.3 -57.16 2.28 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.249 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -93.42 -28.14 16.31 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.846 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 92.08 -6.34 78.84 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.896 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 81.8 m -128.65 164.7 22.32 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.709 0.29 . . . . 0.0 111.069 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 92.6 t -80.38 118.09 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.555 ' HB2' ' O ' ' A' ' 246' ' ' THR . 78.4 m-20 -105.89 154.89 19.92 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.152 -174.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.479 ' HB3' HG22 ' A' ' 184' ' ' VAL . . . -135.2 146.55 48.79 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 10.7 p -123.44 134.99 64.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 120.997 0.427 . . . . 0.0 110.78 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 57.9 tp -84.1 130.77 34.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.353 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 242' ' ' TYR . 4.1 pp -101.4 146.01 28.17 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.857 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 C--O 1.268 2.068 0 CA-C-O 117.801 -1.095 . . . . 0.0 110.184 177.348 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 32.6 t80 . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -79.0 97.77 6.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.982 0.42 . . . . 0.0 111.625 -177.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -129.55 144.03 51.09 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.024 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.546 ' HB3' HD11 ' A' ' 197' ' ' ILE . . . -137.18 153.0 50.53 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.753 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -87.07 101.66 13.68 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 60.3 t -95.29 125.84 47.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.452 0.644 . . . . 0.0 112.266 -172.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 92.8 m -107.08 127.77 53.78 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.74 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -104.27 108.93 61.7 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.2 -23.99 59.26 Favored 'Trans proline' 0 N--CA 1.476 0.449 0 C-N-CA 123.002 2.468 . . . . 0.0 113.629 -175.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 13.2 t -81.13 -21.11 40.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.783 0.325 . . . . 0.0 111.546 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.478 ' HB2' HG12 ' A' ' 191' ' ' VAL . 39.8 mt -109.45 -20.59 12.84 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.5 t30 60.43 48.89 7.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.425 -1.262 . . . . 0.0 109.843 -175.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' A' ' 189' ' ' LEU . 7.9 p -133.82 139.24 49.03 Favored 'Isoleucine or valine' 0 C--O 1.248 1.015 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.979 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 86.2 m -115.87 118.64 33.55 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 60.4 t -137.41 145.54 29.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.859 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -77.23 120.04 21.73 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.8 mp -123.02 145.4 45.75 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.788 0.327 . . . . 0.0 111.077 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.06 145.0 43.65 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.423 2.082 . . . . 0.0 110.051 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.726 HD12 HD12 ' A' ' 221' ' ' ILE . 31.7 mm -95.68 124.06 48.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.574 -178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.432 HD11 ' HB2' ' A' ' 224' ' ' ASN . 98.3 mt -70.37 -43.67 69.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.052 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 26.3 m -142.13 141.78 32.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.186 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 18.8 m -126.14 128.49 71.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.787 0.327 . . . . 0.0 111.098 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -141.18 149.97 42.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.972 0.415 . . . . 0.0 111.229 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -99.01 159.29 15.07 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 174.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 . . . . . 0 C--N 1.318 -0.793 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.346 178.278 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.6 pt? . . . . . 0 N--CA 1.449 -0.521 0 CA-C-O 121.177 0.513 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 39.1 p -109.67 171.78 7.24 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.276 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -61.68 150.85 35.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.971 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 96.87 4.18 59.0 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.735 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.625 ' OG1' ' HB ' ' A' ' 245' ' ' ILE . 1.9 p -79.35 157.2 27.69 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.557 0.218 . . . . 0.0 111.425 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.6 mm -108.43 127.76 64.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.269 0.556 . . . . 0.0 112.127 -174.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.726 HD12 HD12 ' A' ' 197' ' ' ILE . 26.9 pt -131.88 162.49 39.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.404 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -110.91 129.02 56.0 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.77 153.34 33.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.34 0.59 . . . . 0.0 111.637 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.432 ' HB2' HD11 ' A' ' 198' ' ' LEU . 60.2 t30 -103.01 104.89 15.11 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.531 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 6.1 p -101.32 80.1 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-O 122.277 1.037 . . . . 0.0 109.934 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 38.4 p -160.02 -32.59 0.06 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.055 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -85.97 21.42 1.96 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.575 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 98.4 mt -60.0 -38.15 81.77 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.617 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 150.37 -32.18 1.03 Allowed Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.901 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 44.9 pt -125.93 156.62 35.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.339 0.59 . . . . 0.0 111.68 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 30.6 m -138.15 152.7 26.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.425 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 34.8 p -85.7 -83.8 0.17 Allowed 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.42 ' H ' ' H ' ' A' ' 234' ' ' SER . . . -178.53 9.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.6 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . 0.42 ' H ' ' H ' ' A' ' 233' ' ' ALA . 23.9 m -151.33 14.68 0.69 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.213 -176.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.74 30.42 72.69 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.624 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -61.77 -41.46 97.73 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.185 0.517 . . . . 0.0 110.977 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 12.6 pt -109.53 11.79 8.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.389 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -102.57 107.76 18.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.075 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -141.63 155.85 45.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.784 0.326 . . . . 0.0 111.186 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -107.94 110.31 3.12 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 170.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 31.6 mtp180 -131.0 169.39 15.9 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -102.56 146.02 28.75 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.276 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -131.19 168.15 17.97 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.525 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -114.04 130.85 56.53 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.424 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.625 ' HB ' ' OG1' ' A' ' 219' ' ' THR . 93.8 mt -81.33 130.1 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-O 120.82 0.343 . . . . 0.0 110.778 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.552 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 2.2 t -130.59 87.34 2.48 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -84.88 116.48 23.35 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.342 0.591 . . . . 0.0 111.437 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -129.1 72.06 81.99 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.459 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.46 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 33.4 Cg_exo -62.06 -24.9 77.04 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.618 2.212 . . . . 0.0 111.057 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.27 -34.97 79.2 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.702 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -96.9 -57.05 2.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.373 -177.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -98.14 -29.72 13.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.894 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 249' ' ' PRO . . . 83.99 5.82 87.32 Favored Glycine 0 C--N 1.315 -0.593 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.876 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 78.7 m -130.92 161.43 31.91 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 97.8 t -81.0 117.25 26.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 175.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.552 ' HB2' ' O ' ' A' ' 246' ' ' THR . 76.8 m-20 -103.32 147.57 26.93 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -174.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -136.53 144.92 44.51 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.1 p -132.03 136.28 56.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-O 121.18 0.514 . . . . 0.0 110.668 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.6 tt -95.3 119.88 34.58 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.407 ' H ' ' HG ' ' A' ' 260' ' ' LEU . 3.0 pp -90.46 137.96 31.93 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.305 0.574 . . . . 0.0 111.965 -176.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 C--O 1.276 2.46 0 CA-C-O 117.287 -1.339 . . . . 0.0 110.11 179.348 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 . . . . . 0 CA--C 1.501 -0.937 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -81.09 79.4 7.76 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.91 148.43 51.22 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.178 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.1 151.39 51.36 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.814 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -84.93 99.85 11.23 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 65.7 t -91.77 120.47 40.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.717 -173.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.9 m -107.53 126.89 53.1 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.697 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -101.01 112.68 65.31 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.75 -22.43 63.91 Favored 'Trans proline' 0 N--CA 1.473 0.282 0 C-N-CA 122.925 2.417 . . . . 0.0 113.103 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 89.2 m -64.45 -42.61 95.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.137 0.494 . . . . 0.0 110.786 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.524 ' HB2' HG12 ' A' ' 191' ' ' VAL . 29.6 mt -105.82 -14.29 15.27 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.064 -176.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 20.3 m120 59.96 45.16 12.57 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.244 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.524 HG12 ' HB2' ' A' ' 189' ' ' LEU . 10.2 p -128.34 147.85 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 11.9 t -127.71 135.13 49.75 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.556 0.693 . . . . 0.0 111.416 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.489 HG23 ' CD1' ' A' ' 195' ' ' LEU . 7.8 m -139.89 152.08 22.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.709 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -92.94 122.53 35.4 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.002 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.489 ' CD1' HG23 ' A' ' 193' ' ' VAL . 6.9 mp -121.39 148.14 49.12 Favored Pre-proline 0 C--O 1.239 0.511 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.487 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.37 142.27 90.27 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.723 2.282 . . . . 0.0 111.65 175.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 78.9 mt -89.97 117.49 33.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' A' ' 224' ' ' ASN . 98.5 mt -70.14 -40.65 74.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.951 0.405 . . . . 0.0 111.123 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 33.5 t -157.68 148.19 20.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.17 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.6 m -112.93 139.64 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.835 0.35 . . . . 0.0 110.104 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -133.07 136.61 46.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.995 0.426 . . . . 0.0 110.587 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -89.91 159.53 16.89 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 . . . . . 0 C--N 1.311 -1.08 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.485 178.202 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 55.3 tp . . . . . 0 C--O 1.235 0.323 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 11.9 t -92.09 158.52 16.16 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.611 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -68.79 152.99 44.59 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.953 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.77 8.87 27.55 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.932 -0.652 . . . . 0.0 111.949 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.475 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 91.4 m -76.25 139.82 41.31 Favored 'General case' 0 C--O 1.212 -0.894 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.6 mm -105.78 127.97 60.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 O-C-N 122.052 -0.405 . . . . 0.0 111.476 -176.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.561 HD13 HD11 ' A' ' 245' ' ' ILE . 45.2 pt -122.88 158.56 27.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.704 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -103.95 123.14 46.62 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.16 159.3 43.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.871 0.367 . . . . 0.0 110.226 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.437 ' HB2' HD11 ' A' ' 198' ' ' LEU . 21.2 t-20 -112.61 123.41 50.24 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 46.8 t -76.42 77.3 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 121.476 0.655 . . . . 0.0 109.968 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 68.6 m -158.38 -13.63 0.07 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.788 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -90.79 18.76 6.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.732 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.412 ' H ' HD22 ' A' ' 228' ' ' LEU . 3.1 mm? -59.75 -38.44 81.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.111 0.482 . . . . 0.0 110.084 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 94.56 -12.72 68.43 Favored Glycine 0 CA--C 1.506 -0.483 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.507 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.3 pt -136.15 165.19 29.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.33 127.45 71.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-O 121.217 0.532 . . . . 0.0 110.545 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 11.9 t -119.93 -14.22 8.96 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.313 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.474 ' HB3' HG12 ' A' ' 237' ' ' ILE . . . -143.5 27.08 1.56 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.322 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.0 m 55.08 23.92 5.65 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.741 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 80.28 7.56 88.42 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.367 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.405 ' O ' ' HD3' ' A' ' 236' ' ' LYS . 8.0 tmtm? -64.58 -38.45 91.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.597 0.713 . . . . 0.0 109.976 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.474 HG12 ' HB3' ' A' ' 233' ' ' ALA . 28.7 pt -85.86 10.33 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.343 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -64.71 124.2 21.32 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 121.132 -0.227 . . . . 0.0 110.427 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -173.36 157.27 3.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -86.89 120.74 5.56 Favored Glycine 0 C--O 1.224 -0.485 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.955 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 75.5 mtp85 -129.25 164.35 23.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.967 0.413 . . . . 0.0 111.099 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -104.25 134.83 46.82 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.404 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -114.63 146.75 40.47 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.722 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -95.55 124.72 39.71 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.241 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.561 HD11 HD13 ' A' ' 221' ' ' ILE . 49.9 mm -79.54 118.73 27.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.75 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 3.0 t -125.29 91.77 3.49 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -89.5 115.72 27.14 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.169 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -142.92 80.32 13.89 Favored Pre-proline 0 C--N 1.312 -1.025 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.374 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.533 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 33.7 Cg_exo -60.96 -28.06 85.73 Favored 'Trans proline' 0 C--O 1.218 -0.51 0 C-N-CA 122.981 2.454 . . . . 0.0 111.877 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -65.94 -37.08 85.11 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.845 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -91.64 -55.95 3.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.957 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.571 ' CB ' HD21 ' A' ' 256' ' ' ASN . 5.1 t70 -98.24 -30.18 12.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.114 0.483 . . . . 0.0 111.085 -176.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 95.09 6.22 60.35 Favored Glycine 0 C--N 1.319 -0.4 0 C-N-CA 120.89 -0.672 . . . . 0.0 113.328 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 27.9 p -156.02 171.55 19.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.065 0.433 . . . . 0.0 111.825 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 68.1 t -80.34 119.73 30.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.571 HD21 ' CB ' ' A' ' 252' ' ' ASP . 79.7 m-20 -112.43 151.64 29.62 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.413 -173.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -131.2 131.05 43.72 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.13 176.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.62 129.4 64.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.192 0.52 . . . . 0.0 110.193 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.0 tt -95.89 121.08 37.24 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.531 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.434 ' O ' HD12 ' A' ' 260' ' ' LEU . 1.4 pp -88.31 143.08 27.23 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.814 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--O 1.267 1.987 0 CA-C-O 117.699 -1.143 . . . . 0.0 110.768 -179.259 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 . . . . . 0 CA--C 1.513 -0.466 0 CA-C-O 121.128 0.489 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -80.03 85.56 5.61 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 196' ' ' PRO . 41.0 ttmt -136.15 137.42 40.94 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.84 -176.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -128.57 157.47 41.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.129 0.49 . . . . 0.0 111.715 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -85.61 100.8 12.2 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 192' ' ' THR . 48.7 t -93.97 120.18 42.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -172.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 92.5 m -109.33 128.0 54.76 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.376 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -105.83 105.67 53.97 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -57.07 -38.66 95.19 Favored 'Trans proline' 0 N--CA 1.483 0.889 0 C-N-CA 123.047 2.498 . . . . 0.0 113.366 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 89.6 m -63.23 -42.0 99.18 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.827 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.517 ' HB2' HG12 ' A' ' 191' ' ' VAL . 28.2 mt -99.72 -16.95 17.97 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.086 -175.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 65.5 t30 59.1 53.21 5.63 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.738 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.517 HG12 ' HB2' ' A' ' 189' ' ' LEU . 12.4 p -133.96 133.52 56.2 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.866 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 93.9 m -116.93 128.46 55.23 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.652 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.4 139.01 29.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.722 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -88.75 117.44 27.74 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.627 HD12 ' HD2' ' A' ' 196' ' ' PRO . 23.2 tp -134.24 141.56 39.77 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.251 -173.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.627 ' HD2' HD12 ' A' ' 195' ' ' LEU . 34.4 Cg_endo -65.28 146.33 85.89 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.916 1.744 . . . . 0.0 110.415 176.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.431 HD12 HD12 ' A' ' 221' ' ' ILE . 33.2 mm -81.14 119.93 31.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.012 0.434 . . . . 0.0 111.672 -175.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.95 -39.39 76.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.862 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 222' ' ' GLU . 35.3 t -149.59 143.68 25.72 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 15.3 m -126.12 141.84 44.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.78 0.324 . . . . 0.0 111.355 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -130.59 123.31 29.22 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-O 121.008 0.433 . . . . 0.0 110.689 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.579 ' HD2' ' O ' ' A' ' 203' ' ' ASN . 1.7 tmmt? -110.42 150.81 28.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.726 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.579 ' O ' ' HD2' ' A' ' 202' ' ' LYS . 3.2 m-20 . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.415 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 CA--C 1.507 -0.692 0 CA-C-O 120.942 0.401 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 12.0 t -156.6 173.89 16.27 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.236 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.437 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 18.0 ptpt -67.21 152.68 45.29 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.86 178.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.52 8.12 31.09 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -176.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.561 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 66.1 m -77.07 136.75 38.67 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 51.2 mm -92.32 127.14 44.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.78 0.324 . . . . 0.0 111.116 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.555 HD13 HD11 ' A' ' 245' ' ' ILE . 43.3 pt -130.85 161.08 41.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.093 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 199' ' ' SER . 35.7 tt0 -110.9 128.49 55.83 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.1 m -126.34 157.54 36.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.718 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -98.18 110.62 23.17 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.563 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 10.7 t -91.41 18.94 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.442 ' HB3' ' N ' ' A' ' 239' ' ' TRP . 23.5 p -120.06 -35.24 3.51 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.658 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -64.48 -39.3 93.55 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.649 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.73 -36.59 83.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.075 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 102.03 -88.17 0.67 Allowed Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 50.7 mt 62.2 -74.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.932 0.893 . . . . 0.0 111.435 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 42.0 t 57.11 77.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 123.872 0.869 . . . . 0.0 111.353 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 23.6 p -70.35 -40.62 73.98 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.228 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -161.37 110.36 1.57 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.017 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 22.4 m 58.39 13.23 2.34 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.384 0.673 . . . . 0.0 112.591 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.19 29.31 74.69 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.055 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -61.99 -43.54 98.63 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 120.992 0.425 . . . . 0.0 111.363 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 26.4 pt -78.3 -1.88 4.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.299 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -76.01 108.01 8.6 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.721 0.296 . . . . 0.0 111.274 -177.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . 0.442 ' N ' ' HB3' ' A' ' 226' ' ' SER . 6.8 t90 -178.75 163.22 1.42 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.938 178.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -74.66 123.47 7.58 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.214 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -129.98 165.26 22.51 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -177.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.425 ' CE1' ' HB2' ' A' ' 222' ' ' GLU . 96.8 m-85 -101.07 141.38 34.04 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.238 0.542 . . . . 0.0 111.892 -177.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -128.6 170.14 13.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.873 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -115.26 131.25 56.99 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.771 0.32 . . . . 0.0 111.096 -178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.561 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 44.3 mm -77.0 128.04 37.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.676 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.437 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 3.8 t -132.76 101.73 5.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.799 0.809 . . . . 0.0 109.36 175.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -73.03 117.67 15.04 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.3 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . 0.423 ' HB2' ' ND2' ' A' ' 256' ' ' ASN . 17.5 m120 -130.82 70.81 82.58 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.856 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.78 -22.45 17.7 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.009 1.806 . . . . 0.0 112.079 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -76.26 -28.72 57.2 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.497 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -94.4 -57.55 2.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.683 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -100.01 -29.57 12.47 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 120.89 0.376 . . . . 0.0 111.914 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 84.46 8.41 83.29 Favored Glycine 0 C--N 1.316 -0.553 0 C-N-CA 120.311 -0.947 . . . . 0.0 110.91 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 68.8 m -129.5 161.59 30.08 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.333 -0.433 . . . . 0.0 109.992 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 81.7 t -83.1 118.46 30.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.423 ' ND2' ' HB2' ' A' ' 248' ' ' ASN . 81.4 m-20 -103.02 152.19 21.64 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.992 -172.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -130.96 137.21 49.16 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 176.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.7 p -128.71 136.37 60.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.022 0.439 . . . . 0.0 110.434 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 7.6 tt -86.2 119.79 26.87 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 260' ' ' LEU . 1.1 pp -81.54 133.75 35.42 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.997 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 C--O 1.27 2.133 0 CA-C-O 117.467 -1.254 . . . . 0.0 110.419 178.992 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.428 ' CD2' ' HB2' ' A' ' 181' ' ' LYS . 66.3 t80 . . . . . 0 N--CA 1.452 -0.367 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -78.79 80.22 5.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.734 0.302 . . . . 0.0 111.091 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.691 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 84.3 tttt -154.27 129.69 9.83 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -122.74 157.27 32.7 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.26 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 15.2 m120 -87.04 106.19 17.68 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 61.8 t -98.34 119.79 46.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.351 0.596 . . . . 0.0 111.838 -174.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 192' ' ' THR . 85.1 m -93.48 125.93 38.36 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 176.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.42 ' NE2' HD22 ' A' ' 228' ' ' LEU . 69.9 m80 -104.14 110.89 64.85 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.7 -38.65 91.29 Favored 'Trans proline' 0 N--CA 1.483 0.877 0 C-N-CA 123.575 2.85 . . . . 0.0 114.02 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 8.0 t -70.64 -30.95 67.71 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.581 ' HB2' HG12 ' A' ' 191' ' ' VAL . 37.7 mt -98.68 -21.84 16.21 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.27 0.557 . . . . 0.0 109.608 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 23.7 m120 58.3 42.85 20.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.206 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.581 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.5 p -135.38 145.36 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.019 -178.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 185' ' ' THR . 8.8 t -106.12 121.57 44.42 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.419 0.628 . . . . 0.0 109.998 177.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.84 126.58 71.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.805 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.691 ' HG2' ' HG2' ' A' ' 181' ' ' LYS . 58.3 tt0 -79.11 122.61 26.45 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.428 ' C ' ' HG3' ' A' ' 181' ' ' LYS . 95.4 mt -128.18 150.52 74.18 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.832 -176.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.07 149.44 71.27 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.547 2.165 . . . . 0.0 112.085 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.471 HD12 HD12 ' A' ' 221' ' ' ILE . 35.5 mm -94.0 115.57 33.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.091 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 97.3 mt -70.39 -41.64 72.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.073 0.463 . . . . 0.0 110.462 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.5 t -160.9 153.11 20.19 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.129 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 33.4 m -118.72 146.18 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-O 121.005 0.431 . . . . 0.0 110.318 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -128.14 143.59 51.06 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -60.45 144.36 51.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.961 0.41 . . . . 0.0 111.141 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.41 ' HB3' ' HA ' ' A' ' 219' ' ' THR . 11.7 p30 . . . . . 0 C--N 1.316 -0.853 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.851 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 5.1 tt . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 121.1 0.476 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 70.6 p -126.34 167.48 15.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.078 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -63.77 152.58 38.99 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.221 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 102.49 7.33 45.81 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -176.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.565 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 90.8 m -79.9 140.96 36.52 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.9 mm -101.9 130.46 51.58 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.706 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.297 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.59 HD13 HD11 ' A' ' 245' ' ' ILE . 42.3 pt -126.9 159.87 36.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.773 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -109.94 127.85 55.01 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 32.3 m -130.23 159.08 42.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.179 0.514 . . . . 0.0 111.455 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -95.38 109.38 21.56 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 92.6 t -97.0 87.91 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 48.6 m -129.84 -50.87 1.14 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.158 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -98.3 -51.15 4.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.579 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.491 HD21 HG13 ' A' ' 225' ' ' VAL . 84.5 mt 60.49 26.4 16.03 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.661 -176.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 92.69 -9.25 75.99 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.978 -0.556 . . . . 0.0 113.019 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 47.1 pt -131.97 175.19 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.798 0.332 . . . . 0.0 110.762 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 64.5 t -117.69 119.36 61.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 10.0 p -89.27 -86.24 0.19 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.198 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -150.2 82.01 1.37 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.543 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 44.7 m 53.87 39.59 30.58 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.017 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.24 42.27 83.8 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.685 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -61.13 -40.73 94.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.344 0.592 . . . . 0.0 110.872 -176.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 13.9 pt -103.87 23.54 2.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.445 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -73.68 106.9 5.63 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.155 0.503 . . . . 0.0 111.975 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -139.49 149.28 43.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.755 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -78.04 125.83 7.39 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -128.72 155.91 44.33 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 120.883 0.373 . . . . 0.0 111.02 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.494 ' CE2' HD11 ' A' ' 260' ' ' LEU . 49.2 p90 -109.11 142.25 40.12 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -122.55 154.82 37.4 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 120.96 0.409 . . . . 0.0 111.308 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -94.0 122.69 36.76 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.056 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.59 HD11 HD13 ' A' ' 221' ' ' ILE . 42.8 mm -77.24 119.38 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.351 177.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 80.2 p -122.5 86.65 2.62 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -90.49 129.61 36.63 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.113 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -142.66 76.33 17.82 Favored Pre-proline 0 C--N 1.304 -1.384 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.285 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.517 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 58.7 Cg_endo -70.34 -17.52 34.87 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.326 2.017 . . . . 0.0 111.354 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -69.06 -37.54 78.59 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.124 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -105.7 -60.15 1.67 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.015 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.66 -39.71 61.87 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.48 0.657 . . . . 0.0 110.642 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 94.09 -7.11 72.88 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.999 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 79.4 m -131.67 168.02 18.46 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.053 0.454 . . . . 0.0 111.888 -177.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 75.5 t -83.35 119.23 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -111.46 152.96 26.82 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -133.26 150.6 51.92 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.4 p -126.91 136.57 60.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 120.901 0.381 . . . . 0.0 110.031 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 57.2 tp -87.64 125.16 34.22 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.966 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.494 HD11 ' CE2' ' A' ' 242' ' ' TYR . 4.2 pp -98.6 148.91 23.32 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.584 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 11.9 m . . . . . 0 C--O 1.263 1.799 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.851 -179.513 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 63.2 t80 . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.571 ' HB3' ' HB ' ' A' ' 197' ' ' ILE . 10.1 mptt -79.53 88.81 5.06 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.572 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt -151.92 139.25 19.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.329 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -142.98 154.45 44.03 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.977 0.418 . . . . 0.0 111.367 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -89.19 108.42 19.6 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 61.3 t -100.2 125.52 53.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -171.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 94.7 m -103.69 127.36 51.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.143 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -104.72 107.62 58.77 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.34 -35.65 98.88 Favored 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 123.132 2.555 . . . . 0.0 113.504 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.438 HG23 ' HG ' ' A' ' 189' ' ' LEU . 5.3 t -73.88 -34.62 64.52 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -177.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.543 ' HB2' HG12 ' A' ' 191' ' ' VAL . 38.5 mt -95.86 -16.27 21.93 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 120.817 0.342 . . . . 0.0 110.125 -177.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 60.27 42.48 15.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.046 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.543 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.9 p -134.97 139.01 48.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.6 -176.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 87.0 m -114.32 119.02 35.55 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.806 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.571 HG21 HD22 ' A' ' 228' ' ' LEU . 9.6 m -135.54 147.19 28.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.435 -177.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.492 ' C ' HD12 ' A' ' 195' ' ' LEU . 64.4 tt0 -101.0 118.97 38.05 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.739 0.304 . . . . 0.0 110.614 -177.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 194' ' ' GLN . 5.6 mp -129.02 147.8 66.33 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.53 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -61.16 143.26 98.59 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.349 2.033 . . . . 0.0 110.02 172.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.571 ' HB ' ' HB3' ' A' ' 180' ' ' LYS . 82.4 mt -80.54 121.47 34.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 223' ' ' VAL . 4.1 mm? -67.77 -43.92 78.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.643 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 52.4 m -152.19 153.43 33.8 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.266 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 31.3 m -117.79 145.93 22.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -127.86 121.17 29.37 Favored 'General case' 0 C--O 1.256 1.427 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -66.44 138.96 57.93 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.425 ' OD1' ' HA ' ' A' ' 219' ' ' THR . 87.1 m-20 . . . . . 0 C--N 1.309 -1.152 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.654 -174.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.824 0.345 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 19.5 p -91.2 170.13 10.26 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.138 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -54.18 153.35 5.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.476 -0.783 . . . . 0.0 112.549 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 116.65 10.11 10.58 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.417 -175.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.425 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 59.8 m -67.09 137.04 56.07 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.9 mm -91.11 130.84 39.66 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.424 -174.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 46.9 pt -129.11 156.82 41.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.061 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 198' ' ' LEU . 52.9 mt-10 -114.74 125.95 54.29 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.424 ' HA ' HD23 ' A' ' 198' ' ' LEU . 35.9 m -130.59 155.9 42.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.248 0.547 . . . . 0.0 111.105 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -97.51 106.81 19.19 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.608 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 31.6 t -80.74 77.35 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 121.565 0.698 . . . . 0.0 110.394 -177.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.438 ' H ' ' H ' ' A' ' 227' ' ' ASP . 38.6 p -169.37 -16.0 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.329 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . 0.438 ' H ' ' H ' ' A' ' 226' ' ' SER . 36.6 t70 -81.24 9.28 7.21 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.434 177.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.571 HD22 HG21 ' A' ' 193' ' ' VAL . 87.9 mt -63.19 -34.57 77.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.902 -176.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 83.79 22.39 55.73 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.094 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 42.0 pt -116.91 161.18 15.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.924 0.392 . . . . 0.0 110.495 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 66.8 t -117.7 123.86 72.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.806 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 19.1 p -117.05 -70.43 0.79 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.076 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -169.31 97.35 0.34 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.553 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 19.2 t 63.32 15.97 9.1 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.43 34.03 78.58 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.84 -1.171 . . . . 0.0 111.495 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -63.44 -18.56 63.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.98 0.419 . . . . 0.0 111.639 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 33.6 pt -90.9 -0.1 9.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.512 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -75.98 107.81 8.44 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.159 0.504 . . . . 0.0 111.711 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -164.73 131.74 3.06 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.488 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -70.78 113.57 4.85 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.133 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -129.54 157.11 42.96 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.93 0.395 . . . . 0.0 111.224 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -102.38 148.74 25.11 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.378 0.609 . . . . 0.0 111.446 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -131.84 170.18 15.21 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.129 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 219' ' ' THR . 11.8 pt20 -116.65 141.78 47.76 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.391 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 84.1 mt -83.25 124.47 39.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.43 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 2.8 t -141.28 100.91 3.9 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.753 176.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -75.35 135.11 40.86 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.063 0.459 . . . . 0.0 111.413 -177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -140.79 72.46 29.12 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.481 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.407 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 23.4 Cg_exo -66.84 -21.13 51.16 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.798 2.332 . . . . 0.0 111.554 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -67.68 -38.32 83.56 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.226 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -107.64 -57.97 2.02 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.53 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.54 -37.53 63.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.207 0.527 . . . . 0.0 110.667 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 89.27 5.5 72.6 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.139 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 33.0 t -145.49 177.4 8.88 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 96.9 t -80.21 122.14 34.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 246' ' ' THR . 8.1 m120 -105.95 152.97 22.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.287 0.565 . . . . 0.0 111.414 -174.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.586 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -134.73 140.01 45.62 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 174.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 12.5 p -126.25 135.69 63.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.811 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 64.7 tp -80.69 129.22 34.4 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.847 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 4.1 pp -95.52 143.63 26.67 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.164 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 C--O 1.269 2.101 0 CA-C-O 117.411 -1.281 . . . . 0.0 110.422 179.707 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 80.4 t80 . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -69.09 68.05 0.17 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.167 0.292 . . . . 0.0 110.717 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.469 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 41.1 ttmt -154.88 137.27 14.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.524 0.202 . . . . 0.0 110.531 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -135.15 151.05 50.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.883 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 53.8 t-20 -85.22 103.52 14.26 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 257' ' ' ALA . 54.1 t -93.59 121.91 44.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.177 0.513 . . . . 0.0 112.247 -173.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 62.9 m -98.26 124.78 43.04 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.207 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -106.04 106.87 58.38 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.24 -29.11 64.22 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.342 2.028 . . . . 0.0 112.796 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.2 t -73.73 -23.69 59.8 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.416 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.551 ' HB2' HG12 ' A' ' 191' ' ' VAL . 36.2 mt -104.85 -19.8 13.78 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.3 t30 61.16 47.56 7.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.568 -1.197 . . . . 0.0 109.405 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 189' ' ' LEU . 5.9 p -145.09 146.54 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -177.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.2 t -121.07 120.7 36.1 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 121.555 0.693 . . . . 0.0 109.639 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.4 t -129.09 135.18 62.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.156 -177.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 62.0 tt0 -87.66 119.75 28.29 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.852 0.358 . . . . 0.0 110.747 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.3 mp -125.21 155.34 71.39 Favored Pre-proline 0 C--O 1.237 0.407 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.375 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 181' ' ' LYS . 55.9 Cg_endo -69.39 151.75 71.16 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.473 2.115 . . . . 0.0 111.655 177.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 83.4 mt -88.57 111.92 23.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.848 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.0 mp -69.28 -43.98 72.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.101 0.476 . . . . 0.0 111.934 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 50.6 m -151.34 157.85 43.02 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.329 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 33.0 m -123.42 146.7 28.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.224 0.535 . . . . 0.0 111.315 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.446 ' HB2' ' HB ' ' A' ' 220' ' ' ILE . 74.3 mmtt -125.58 110.42 13.81 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.474 176.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.453 ' HD3' ' O ' ' A' ' 203' ' ' ASN . 1.6 tmtp? -75.3 125.34 28.78 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.453 ' O ' ' HD3' ' A' ' 202' ' ' LYS . 95.1 m-20 . . . . . 0 C--N 1.324 -0.542 0 CA-C-O 120.718 0.294 . . . . 0.0 110.54 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 9.8 mp . . . . . 0 N--CA 1.447 -0.586 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 71.2 p -114.46 155.08 27.03 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -62.74 150.69 40.6 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.99 10.55 34.41 Favored Glycine 0 N--CA 1.436 -1.309 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -173.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 95.1 m -68.08 138.78 56.04 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 201' ' ' LYS . 51.1 mm -90.46 129.63 40.99 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 CA-C-O 120.726 0.298 . . . . 0.0 111.703 -174.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.41 HG21 HD11 ' A' ' 245' ' ' ILE . 44.9 pt -131.62 159.06 43.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.558 175.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -107.22 126.05 51.92 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.87 151.88 35.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.611 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -106.55 106.67 17.3 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.089 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 3.0 p -82.21 85.34 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-O 121.912 0.863 . . . . 0.0 110.193 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 15.0 p -123.7 -84.87 0.65 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.176 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -64.43 -46.68 82.16 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.407 HD21 HG23 ' A' ' 225' ' ' VAL . 97.0 mt 56.45 16.18 2.36 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.109 0.481 . . . . 0.0 110.774 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 83.77 0.58 89.86 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 115.989 -0.551 . . . . 0.0 113.037 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 44.9 pt -133.67 171.71 17.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.297 0.57 . . . . 0.0 111.582 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 66.6 t -113.66 114.82 47.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 11.7 t -154.58 146.07 23.11 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.638 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . 52.93 25.18 3.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.147 0.579 . . . . 0.0 112.008 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 58.2 m 56.79 18.78 3.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.34 0.656 . . . . 0.0 111.971 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.57 26.21 74.72 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.077 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -66.01 -18.99 65.7 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.204 0.526 . . . . 0.0 111.135 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 30.9 pt -87.6 8.85 2.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.991 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -66.68 106.3 1.79 Allowed 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.084 0.469 . . . . 0.0 111.457 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -142.33 151.88 42.38 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.309 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -93.07 112.76 4.33 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 174.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.95 164.34 23.37 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 120.741 0.305 . . . . 0.0 111.065 -177.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 98.2 m-85 -102.35 139.92 37.32 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.221 0.534 . . . . 0.0 111.61 -175.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -127.63 154.51 45.17 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.775 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -97.81 132.73 43.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.593 0.235 . . . . 0.0 110.725 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.41 HD11 HG21 ' A' ' 221' ' ' ILE . 87.1 mt -79.71 119.9 29.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 4.3 t -133.83 98.51 4.19 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -81.19 123.64 28.62 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.947 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -129.76 72.1 82.01 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.017 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.529 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 59.5 Cg_endo -70.16 -22.24 30.53 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.267 1.978 . . . . 0.0 112.228 -178.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -70.22 -37.73 75.09 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.27 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -96.29 -57.51 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.923 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.409 ' CG ' HD21 ' A' ' 256' ' ' ASN . 34.6 t70 -82.36 -39.57 22.57 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.343 0.592 . . . . 0.0 110.767 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 96.78 8.96 56.77 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.239 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 14.0 t -153.61 -179.93 8.25 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 93.7 t -79.87 126.64 39.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 246' ' ' THR . 10.0 m120 -113.33 154.28 27.12 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.861 0.362 . . . . 0.0 110.764 -174.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.532 ' HB3' HG22 ' A' ' 184' ' ' VAL . . . -131.98 147.96 52.49 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.9 p -123.43 131.0 73.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.025 0.44 . . . . 0.0 110.418 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.9 tt -100.53 123.84 45.29 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.801 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 2.8 pp -92.51 151.29 20.26 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.139 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.262 1.728 0 CA-C-O 117.75 -1.119 . . . . 0.0 110.876 -179.231 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 18.3 t80 . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.457 ' HD2' ' N ' ' A' ' 180' ' ' LYS . 11.1 mptt -82.42 81.19 8.36 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -176.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -138.19 150.55 46.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.743 0.417 . . . . 0.0 110.921 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.457 ' HB2' HD11 ' A' ' 197' ' ' ILE . . . -141.94 151.16 42.32 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.714 177.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 20.0 m120 -86.53 100.44 12.39 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 120.557 -0.457 . . . . 0.0 109.833 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 64.5 t -85.34 120.31 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.72 -176.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 63.7 m -105.33 126.46 52.13 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.458 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -104.33 111.64 65.23 Favored Pre-proline 0 C--N 1.312 -1.035 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.34 -27.14 77.49 Favored 'Trans proline' 0 N--CA 1.474 0.334 0 C-N-CA 122.556 2.171 . . . . 0.0 112.462 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 89.3 m -63.35 -42.64 98.92 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.31 0.576 . . . . 0.0 110.568 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.553 ' HB2' HG12 ' A' ' 191' ' ' VAL . 28.3 mt -95.05 -21.38 18.6 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.364 -177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 65.6 t30 59.57 51.66 6.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.496 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.553 HG12 ' HB2' ' A' ' 189' ' ' LEU . 10.0 p -140.14 148.86 22.21 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.817 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 13.6 t -119.47 122.75 42.42 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.497 0.665 . . . . 0.0 110.44 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.477 HG11 ' HA3' ' A' ' 229' ' ' GLY . 57.3 t -128.88 131.06 68.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.665 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 29.6 tt0 -78.24 124.51 28.16 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.834 0.35 . . . . 0.0 111.099 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 194' ' ' GLN . 7.4 mp -127.27 149.33 69.43 Favored Pre-proline 0 C--O 1.238 0.499 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.155 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 180' ' ' LYS . 40.5 Cg_exo -61.4 142.58 96.03 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.844 2.363 . . . . 0.0 112.307 176.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.457 HD11 ' HB2' ' A' ' 182' ' ' ALA . 81.6 mt -90.84 120.78 40.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.9 mp -72.29 -45.13 61.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.771 0.32 . . . . 0.0 111.389 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.2 t -162.91 157.12 20.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.889 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.429 HG12 HG22 ' A' ' 221' ' ' ILE . 33.6 m -119.1 146.19 24.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-O 120.9 0.381 . . . . 0.0 110.72 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -129.31 142.45 50.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.827 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -77.92 158.57 29.32 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.586 0.708 . . . . 0.0 112.436 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 . . . . . 0 C--N 1.308 -1.212 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.125 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 63.7 tp . . . . . 0 N--CA 1.442 -0.831 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 40.2 m -115.18 141.66 47.72 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.974 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -46.83 151.23 0.63 Allowed 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.727 0.642 . . . . 0.0 111.927 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 111.3 8.58 23.18 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -176.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.535 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 25.7 m -74.49 144.44 44.15 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.2 mm -104.1 127.18 58.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.699 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.648 HD13 HD11 ' A' ' 245' ' ' ILE . 46.1 pt -125.97 160.18 33.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.876 0.369 . . . . 0.0 111.114 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -103.8 126.38 50.9 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.372 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.58 151.59 36.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.078 0.466 . . . . 0.0 110.885 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -92.36 105.87 17.98 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 22.8 t -93.86 70.45 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 121.423 0.63 . . . . 0.0 110.108 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 50.7 m -125.99 -42.85 1.86 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.496 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -73.48 -43.57 59.89 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.227 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.444 ' O ' HG11 ' A' ' 193' ' ' VAL . 7.1 mp 54.02 17.29 1.34 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.46 -176.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.477 ' HA3' HG11 ' A' ' 193' ' ' VAL . . . 77.33 -47.98 2.75 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -176.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 44.3 pt -128.27 157.86 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.6 m -96.74 43.97 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-O 121.099 0.476 . . . . 0.0 111.269 -177.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.1 t -48.93 -46.68 43.44 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.986 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -98.86 10.74 40.67 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -177.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 16.5 t 60.35 38.05 19.81 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.77 -127.78 28.6 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -174.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? 75.08 -45.54 0.57 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.64 0.776 . . . . 0.0 110.488 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 21.3 pt -88.85 18.57 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.801 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -69.46 112.94 6.32 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.38 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . 0.508 ' O ' ' HB ' ' A' ' 225' ' ' VAL . 23.1 t90 -169.25 138.21 2.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.718 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -68.11 131.84 28.0 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.083 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.44 176.08 8.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.821 0.343 . . . . 0.0 110.855 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -111.79 138.54 48.25 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.783 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -122.48 149.85 43.32 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.787 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -95.29 127.09 41.06 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.151 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.648 HD11 HD13 ' A' ' 221' ' ' ILE . 48.0 mm -78.47 120.7 29.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 178.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.8 t -134.97 98.32 3.98 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.934 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -80.5 126.24 30.97 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.875 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -135.82 72.18 62.59 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.518 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 35.5 Cg_exo -63.94 -26.52 66.71 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.062 2.508 . . . . 0.0 112.03 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -67.58 -37.44 82.62 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.403 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -96.68 -56.96 2.42 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.309 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -87.22 -40.2 14.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.072 0.463 . . . . 0.0 110.729 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 99.7 9.36 49.94 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.879 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 30.6 p -152.21 179.16 8.76 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.658 -0.319 . . . . 0.0 110.996 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 66.9 t -80.65 123.39 37.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -114.38 153.27 30.15 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.787 0.327 . . . . 0.0 110.147 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -128.3 146.88 50.63 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.6 p -122.39 129.71 75.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 121.127 0.489 . . . . 0.0 110.291 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 8.8 tt -105.32 124.43 49.52 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.906 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 260' ' ' LEU . 3.4 pp -99.43 150.34 22.27 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.375 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 23.9 m . . . . . 0 C--O 1.272 2.268 0 CA-C-O 117.679 -1.153 . . . . 0.0 110.71 179.742 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 84.6 t80 . . . . . 0 N--CA 1.443 -0.809 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -69.38 85.51 0.41 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -177.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -151.8 137.6 18.0 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.978 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -140.1 159.21 42.7 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.145 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 89.9 m-20 -82.18 104.28 12.4 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 59.9 t -95.73 120.14 44.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.244 0.545 . . . . 0.0 112.119 -173.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 192' ' ' THR . 90.5 m -95.2 125.28 39.74 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.318 176.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -105.26 107.78 59.82 Favored Pre-proline 0 C--N 1.313 -1.009 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 34.0 Cg_endo -63.96 -26.23 66.64 Favored 'Trans proline' 0 N--CA 1.474 0.374 0 C-N-CA 122.548 2.165 . . . . 0.0 112.644 -176.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 86.4 m -64.6 -41.58 96.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.389 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.594 ' HB2' HG12 ' A' ' 191' ' ' VAL . 35.0 mt -99.3 -14.54 19.19 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.757 -177.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 60.22 45.23 11.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.26 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.8 p -138.79 144.72 29.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.439 -176.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 185' ' ' THR . 86.1 m -107.49 119.7 40.14 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.2 130.18 69.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 63.4 tt0 -75.51 120.26 20.69 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.49 HD21 HD22 ' A' ' 228' ' ' LEU . 87.2 mt -129.55 149.88 74.11 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.605 -174.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.74 144.98 50.23 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.353 2.036 . . . . 0.0 110.749 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.491 HG23 ' HB ' ' A' ' 221' ' ' ILE . 80.2 mt -93.48 116.85 35.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.248 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.4 mp -71.8 -46.15 59.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.675 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 39.2 m -141.25 148.33 39.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.597 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.454 HG12 HG22 ' A' ' 221' ' ' ILE . 29.2 m -129.72 137.66 56.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.628 0.251 . . . . 0.0 110.633 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -143.79 142.95 31.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.03 0.443 . . . . 0.0 110.835 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -112.07 146.67 37.54 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.991 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 C--N 1.316 -0.851 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.432 -176.77 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.122 0.487 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.3 m -133.28 162.99 30.32 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.175 -174.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 246' ' ' THR . 18.3 ptpt -47.18 151.01 0.74 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.486 0.66 . . . . 0.0 112.454 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 113.35 9.09 18.29 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.507 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.574 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 60.5 m -76.27 139.05 40.93 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.4 mm -97.48 126.41 50.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 120.803 0.335 . . . . 0.0 110.364 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.681 HD13 HD11 ' A' ' 245' ' ' ILE . 44.6 pt -125.98 165.03 24.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.118 0.485 . . . . 0.0 111.561 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -112.09 128.11 56.11 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.798 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.82 158.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.93 0.395 . . . . 0.0 110.902 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -110.33 112.18 23.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.267 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 3.2 p -102.4 79.39 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.788 0.804 . . . . 0.0 109.683 176.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 32.4 t -156.85 -42.35 0.07 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.145 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -94.2 19.57 9.18 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.864 -178.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.49 HD22 HD21 ' A' ' 195' ' ' LEU . 39.8 mt -70.76 -16.96 62.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.621 -175.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 82.73 2.96 90.69 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.533 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.4 pt -113.31 162.01 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.81 124.62 44.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.862 0.839 . . . . 0.0 111.249 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 9.9 t -99.07 -151.57 0.39 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -67.2 85.71 0.15 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.936 0.398 . . . . 0.0 110.641 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 39.7 m 64.77 13.11 8.21 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.912 0.885 . . . . 0.0 112.298 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 63.31 33.36 87.03 Favored Glycine 0 C--O 1.225 -0.446 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.972 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -65.35 -14.58 61.15 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 23.7 pt -105.86 12.18 8.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.974 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -75.46 106.02 6.79 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.987 0.423 . . . . 0.0 111.483 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -165.53 177.22 7.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.844 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -87.94 118.78 5.13 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 173.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 62.6 mtp85 -127.38 166.74 17.29 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.971 0.386 . . . . 0.0 111.0 -173.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -108.28 139.38 43.07 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.289 0.566 . . . . 0.0 111.692 -176.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -127.28 161.69 27.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.28 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -106.17 130.93 53.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.885 0.374 . . . . 0.0 111.107 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.681 HD11 HD13 ' A' ' 221' ' ' ILE . 41.9 mm -80.29 125.61 39.15 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.127 177.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 4.9 t -135.5 90.17 2.58 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 173.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -80.17 123.53 28.0 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.249 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -130.42 71.71 82.18 Favored Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.615 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.511 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 51.3 Cg_endo -67.8 -23.38 41.78 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.985 1.79 . . . . 0.0 111.07 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -73.12 -26.34 61.19 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.464 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -104.57 -56.18 2.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.066 -176.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -90.86 -40.07 11.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.063 0.459 . . . . 0.0 110.717 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 105.08 -8.54 45.53 Favored Glycine 0 C--N 1.316 -0.578 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.424 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 75.2 m -132.72 175.94 8.9 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.702 0.287 . . . . 0.0 111.061 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 86.6 t -79.95 124.34 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 246' ' ' THR . 3.2 m120 -107.34 151.95 24.8 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -176.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -139.88 150.43 44.61 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 177.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.58 135.91 53.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 120.837 0.351 . . . . 0.0 110.429 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.409 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 64.3 tp -73.71 126.52 30.53 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 260' ' ' LEU . 3.2 pp -82.98 131.13 35.2 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.119 0.485 . . . . 0.0 111.117 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--O 1.272 2.24 0 CA-C-O 117.815 -1.088 . . . . 0.0 110.336 179.463 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 . . . . . 0 N--CA 1.445 -0.684 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.438 ' HD2' ' N ' ' A' ' 180' ' ' LYS . 0.1 OUTLIER -88.65 116.12 26.67 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.231 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -149.13 140.13 22.93 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.6 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -138.45 157.29 46.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.953 0.406 . . . . 0.0 112.003 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -90.45 103.85 16.5 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 59.6 t -97.35 123.11 49.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.154 0.502 . . . . 0.0 111.95 -173.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 192' ' ' THR . 89.8 m -105.03 126.62 52.26 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.599 177.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -105.33 110.69 64.65 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.938 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.95 -33.64 89.7 Favored 'Trans proline' 0 N--CA 1.481 0.774 0 C-N-CA 123.331 2.688 . . . . 0.0 113.111 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 88.7 m -60.79 -44.4 96.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.255 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.537 ' HB2' HG12 ' A' ' 191' ' ' VAL . 32.0 mt -98.27 -17.0 19.17 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.647 -176.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 59.71 50.1 7.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.042 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.537 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.6 p -138.67 149.04 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.839 -178.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 185' ' ' THR . 12.4 t -119.67 129.57 54.62 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.405 0.622 . . . . 0.0 109.779 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 10.6 m -134.32 147.48 30.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.527 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.509 ' C ' HD12 ' A' ' 195' ' ' LEU . 35.5 tt0 -96.68 118.52 33.32 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.509 HD12 ' C ' ' A' ' 194' ' ' GLN . 7.0 mp -128.05 148.12 66.12 Favored Pre-proline 0 C--O 1.237 0.44 0 CA-C-O 120.664 0.269 . . . . 0.0 111.399 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.53 145.82 92.29 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.767 2.311 . . . . 0.0 110.978 173.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.475 HG23 ' HB ' ' A' ' 221' ' ' ILE . 83.9 mt -91.53 120.03 39.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 96.5 mt -68.02 -41.51 82.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.713 0.292 . . . . 0.0 111.356 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 93.4 p -156.1 157.25 35.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.713 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 17.7 m -122.25 135.58 61.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.338 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -136.24 137.17 40.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.779 0.324 . . . . 0.0 110.805 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -111.74 145.52 39.2 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.369 174.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 . . . . . 0 C--N 1.314 -0.939 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 176.014 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 CA--C 1.504 -0.796 0 CA-C-O 121.705 0.764 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 94.2 m -118.37 140.78 49.32 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.564 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.423 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 12.4 ptmm? -49.39 145.89 4.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.618 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 111.55 9.77 20.7 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.862 -176.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.462 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 61.7 m -84.35 134.86 34.48 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 220' ' ' ILE . 3.7 mp -95.98 127.08 48.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.905 0.384 . . . . 0.0 111.12 -178.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.614 HD13 HD11 ' A' ' 245' ' ' ILE . 46.0 pt -124.79 157.91 32.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.521 178.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -110.84 124.65 52.45 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.86 157.01 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.722 0.296 . . . . 0.0 110.633 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -98.15 123.14 42.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.315 0.578 . . . . 0.0 110.991 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 9.1 m -100.04 80.35 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-O 121.67 0.748 . . . . 0.0 110.114 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 18.5 m -112.93 -63.48 1.44 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.44 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -99.03 -39.73 8.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.157 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 8.2 mp 65.0 -2.57 0.7 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.441 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 83.22 7.5 86.7 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.082 -178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.5 pt -126.16 169.91 16.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 5.6 p -118.38 85.73 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 122.128 0.966 . . . . 0.0 111.57 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.3 t -113.14 -41.02 3.79 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 173.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.402 ' CB ' ' HE3' ' A' ' 236' ' ' LYS . . . -168.19 136.22 2.25 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.357 177.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 47.4 m -75.17 76.63 2.31 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.538 0.685 . . . . 0.0 111.167 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 70.75 40.63 64.94 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 114.998 -1.001 . . . . 0.0 115.25 175.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.402 ' HE3' ' CB ' ' A' ' 233' ' ' ALA . 18.3 ptpt -63.7 -25.53 68.24 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.936 0.868 . . . . 0.0 109.714 177.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 13.5 pt -129.65 33.71 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.541 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -63.66 105.71 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.098 0.475 . . . . 0.0 111.514 -177.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -151.83 166.43 31.45 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.629 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -93.13 118.73 5.72 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -127.29 163.24 24.38 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 120.9 0.381 . . . . 0.0 110.968 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 95.4 m-85 -103.33 139.51 38.65 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.491 -175.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -128.47 147.36 50.67 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.27 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 18.1 pm0 -98.34 131.34 44.72 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.476 0.655 . . . . 0.0 111.374 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.614 HD11 HD13 ' A' ' 221' ' ' ILE . 48.9 mm -77.54 125.22 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.29 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.423 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 4.1 t -134.46 102.95 5.5 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -84.69 126.81 33.71 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.285 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -127.6 72.29 77.9 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.17 -23.89 28.44 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.401 2.067 . . . . 0.0 112.381 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -77.65 -16.09 58.77 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.112 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -113.31 -56.25 2.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.032 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -93.29 -31.17 14.8 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.776 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 77.42 20.46 74.69 Favored Glycine 0 C--N 1.322 -0.22 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.86 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 48.8 t -151.15 164.87 35.52 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.695 0.283 . . . . 0.0 110.441 -177.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 95.1 t -79.91 121.84 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 246' ' ' THR . 78.8 m-20 -112.55 152.8 28.41 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.198 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -132.5 141.91 48.98 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.83 133.27 69.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 7.4 tt -101.19 123.81 45.92 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.218 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.465 ' O ' HD12 ' A' ' 260' ' ' LEU . 3.1 pp -65.49 137.65 57.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.236 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.269 2.122 0 CA-C-O 117.3 -1.333 . . . . 0.0 110.717 -179.065 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 52.3 t80 . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -74.57 38.93 0.12 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.662 0.268 . . . . 0.0 111.005 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.5 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 40.3 ttmt -154.01 140.7 18.99 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -177.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.434 ' HB2' HD11 ' A' ' 197' ' ' ILE . . . -138.28 157.02 47.09 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.711 0.291 . . . . 0.0 111.509 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -87.0 101.49 13.49 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 58.9 t -90.56 125.94 43.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.859 -175.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.7 m -107.02 124.07 49.11 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.245 0.545 . . . . 0.0 110.011 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -104.51 115.91 62.03 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.841 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.83 -18.88 65.77 Favored 'Trans proline' 0 N--CA 1.476 0.458 0 C-N-CA 122.581 2.187 . . . . 0.0 111.258 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 72.0 m -64.11 -40.65 96.66 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.218 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.554 ' HB2' HG12 ' A' ' 191' ' ' VAL . 27.4 mt -107.3 -16.37 14.41 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.069 -177.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 60.16 41.32 17.08 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.986 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.554 HG12 ' HB2' ' A' ' 189' ' ' LEU . 6.6 p -134.94 148.84 28.97 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.74 -177.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 84.8 m -105.68 120.91 42.87 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.5 m -127.06 138.41 54.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.901 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.5 ' HG2' ' HG2' ' A' ' 181' ' ' LYS . 36.0 tt0 -94.21 119.54 33.17 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.156 -175.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -128.94 153.32 80.13 Favored Pre-proline 0 C--O 1.237 0.426 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.209 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.37 146.42 97.24 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.303 2.669 . . . . 0.0 112.645 177.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.434 HD11 ' HB2' ' A' ' 182' ' ' ALA . 76.9 mt -94.28 118.61 40.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.658 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.38 -46.52 15.89 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.808 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 27.3 m -140.64 150.29 43.37 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.177 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.444 ' HA ' HG22 ' A' ' 221' ' ' ILE . 30.9 m -128.19 144.13 38.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.521 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -140.34 102.54 4.37 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.281 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -70.8 146.01 50.01 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 . . . . . 0 C--N 1.312 -1.043 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.073 -177.586 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 48.4 tp . . . . . 0 N--CA 1.446 -0.666 0 CA-C-O 120.795 0.331 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 36.8 p -108.21 162.3 14.2 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.675 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.4 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 3.8 ptpp? -66.78 151.61 47.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.133 0.492 . . . . 0.0 111.589 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.02 4.3 41.75 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.235 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 88.1 m -80.12 134.9 36.21 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.522 0.201 . . . . 0.0 111.265 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 48.5 mm -93.78 126.29 46.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.863 0.363 . . . . 0.0 110.882 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.556 HG21 HD11 ' A' ' 245' ' ' ILE . 47.3 pt -130.73 165.17 31.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.368 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -108.68 129.41 55.35 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 31.5 m -126.82 153.66 36.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.106 0.479 . . . . 0.0 111.167 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -97.64 107.14 19.58 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.243 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 34.3 m -105.35 24.18 2.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.939 0.876 . . . . 0.0 110.255 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 238' ' ' ALA . 23.6 t -86.27 -23.5 26.33 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.395 175.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -60.68 -40.35 91.82 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.231 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.65 HD23 ' H ' ' A' ' 228' ' ' LEU . 2.3 pt? -98.11 -1.33 42.59 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.904 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' A' ' 238' ' ' ALA . . . -84.64 45.58 3.53 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.732 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 79.9 mt -82.77 -73.96 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.155 0.503 . . . . 0.0 110.877 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.04 11.15 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.426 0.631 . . . . 0.0 110.367 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 36.8 p -64.17 -38.56 91.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.474 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.642 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . -143.2 58.98 1.41 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.297 177.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 25.5 m 60.94 10.54 2.83 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.645 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 79.65 2.08 87.6 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.245 -0.503 . . . . 0.0 113.149 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.642 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 19.6 ptpt -71.51 -20.74 62.02 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -176.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 32.6 pt -81.65 -4.42 7.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 226' ' ' SER . . . -73.47 108.5 6.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.842 -178.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -169.35 -175.28 2.18 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -108.5 126.63 8.28 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -128.6 157.09 42.23 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 117.256 0.528 . . . . 0.0 111.748 -175.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.402 ' O ' HD12 ' A' ' 259' ' ' LEU . 77.1 m-85 -102.64 133.9 46.88 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.79 176.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -129.77 155.0 46.65 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.933 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -100.47 124.87 46.56 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.112 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.556 HD11 HG21 ' A' ' 221' ' ' ILE . 90.9 mt -76.71 125.77 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 CA-C-O 120.918 0.389 . . . . 0.0 110.934 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.4 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 4.3 t -132.35 94.56 3.46 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 174.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -81.21 117.16 21.5 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.65 -176.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -131.22 71.6 81.82 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.551 177.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.573 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 66.7 Cg_endo -71.78 -19.44 27.45 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.027 1.818 . . . . 0.0 112.461 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -86.92 -24.58 24.76 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.963 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -101.78 -58.09 1.95 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.921 0.391 . . . . 0.0 110.904 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -84.73 -39.27 18.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.414 0.625 . . . . 0.0 110.518 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 103.77 -9.31 51.73 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.171 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 70.2 m -135.93 169.23 17.92 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.783 0.325 . . . . 0.0 110.936 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 86.2 t -86.95 119.91 35.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 174.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -115.53 150.8 35.98 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 120.868 0.366 . . . . 0.0 111.045 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -121.63 140.96 51.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.4 p -119.12 137.48 52.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 120.697 0.284 . . . . 0.0 110.453 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 242' ' ' TYR . 60.6 tp -74.88 124.29 26.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.841 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 260' ' ' LEU . 0.3 OUTLIER -86.85 91.31 8.61 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.485 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.268 2.047 0 CA-C-O 117.68 -1.152 . . . . 0.0 110.666 -175.247 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 56.1 t80 . . . . . 0 C--O 1.223 -0.339 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -69.3 90.77 0.51 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.492 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 41.0 ttmt -154.28 140.47 18.5 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.978 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -128.95 158.11 39.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.375 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 27.3 t-20 -84.55 106.14 15.9 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 257' ' ' ALA . 58.1 t -104.17 125.37 58.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.475 0.655 . . . . 0.0 112.504 -172.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 94.0 m -104.48 126.87 51.97 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -103.47 107.97 57.73 Favored Pre-proline 0 C--N 1.315 -0.93 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.18 -20.22 56.36 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 122.626 2.217 . . . . 0.0 112.158 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 70.1 m -63.68 -40.89 97.93 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.217 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.546 ' HB2' HG12 ' A' ' 191' ' ' VAL . 26.4 mt -107.74 -15.35 14.59 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.51 -178.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 67.2 t30 60.35 52.87 4.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.686 -175.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.546 HG12 ' HB2' ' A' ' 189' ' ' LEU . 12.2 p -135.24 143.39 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.667 -177.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 95.5 m -105.6 116.45 31.97 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.078 0.466 . . . . 0.0 110.249 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 63.7 t -131.19 129.9 63.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.144 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.492 ' HG2' ' HG2' ' A' ' 181' ' ' LYS . 48.3 tt0 -77.99 121.23 23.94 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.59 HD12 ' HD2' ' A' ' 196' ' ' PRO . 18.5 tp -126.86 141.2 39.8 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.216 -171.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.59 ' HD2' HD12 ' A' ' 195' ' ' LEU . 53.7 Cg_endo -67.88 151.48 78.19 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.75 2.3 . . . . 0.0 112.604 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 83.1 mt -97.12 118.2 43.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.231 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.2 mp -73.2 -43.79 60.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.147 0.499 . . . . 0.0 110.781 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 87.1 p -157.07 161.96 39.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.597 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.98 138.74 51.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.621 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -124.03 127.71 48.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.661 -177.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -90.08 125.2 35.34 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 9.1 p30 . . . . . 0 C--N 1.313 -1.004 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.444 179.456 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 14.9 t -131.28 174.44 10.05 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 120.786 0.327 . . . . 0.0 110.418 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -73.47 152.3 40.78 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.532 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.81 8.5 48.34 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.535 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 86.9 m -82.83 140.0 33.18 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 51.2 mm -102.17 127.36 55.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 O-C-N 121.919 -0.488 . . . . 0.0 111.093 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.597 HD13 HD11 ' A' ' 245' ' ' ILE . 43.0 pt -124.67 157.27 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.349 177.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -109.7 126.29 53.55 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 33.6 m -128.35 158.88 40.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 120.985 0.421 . . . . 0.0 110.954 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -89.94 107.09 18.91 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 43.6 t -90.92 78.76 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 30.0 t -167.76 -46.78 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.308 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -75.0 -4.59 39.22 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.495 ' HG ' ' H ' ' A' ' 230' ' ' ILE . 2.6 pt? -63.32 -15.56 57.71 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.893 0.378 . . . . 0.0 111.005 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 92.03 -12.68 68.91 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.933 174.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.495 ' H ' ' HG ' ' A' ' 228' ' ' LEU . 39.8 pt -131.98 153.86 39.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.587 0.708 . . . . 0.0 111.657 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 8.1 p -173.83 125.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 114.281 -1.327 . . . . 0.0 108.357 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 9.2 t -93.27 -10.76 34.43 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.264 0.554 . . . . 0.0 110.877 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.511 ' HB3' HG12 ' A' ' 237' ' ' ILE . . . -94.63 20.34 8.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.189 -177.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 37.0 m 59.59 27.88 17.18 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.004 0.43 . . . . 0.0 111.84 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 82.38 6.17 88.92 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.943 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -61.39 -39.26 90.04 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.056 0.455 . . . . 0.0 110.206 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.511 HG12 ' HB3' ' A' ' 233' ' ' ALA . 22.2 pt -98.12 15.42 3.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.04 -178.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -87.1 105.16 16.98 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.614 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -153.97 175.1 13.79 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.961 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -79.22 113.16 3.6 Favored Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 171.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -125.02 156.77 37.61 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 120.693 0.282 . . . . 0.0 110.407 -173.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 37.2 p90 -101.7 148.84 24.79 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.406 0.622 . . . . 0.0 112.185 -176.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -134.1 159.63 40.25 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.137 -177.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -99.31 127.73 45.35 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.183 0.516 . . . . 0.0 111.404 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.597 HD11 HD13 ' A' ' 221' ' ' ILE . 47.5 mm -76.22 125.62 36.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.341 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.7 t -129.61 101.91 6.13 Favored 'General case' 0 N--CA 1.425 -1.698 0 O-C-N 124.401 1.063 . . . . 0.0 108.679 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -76.32 121.07 22.44 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.4 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -129.78 71.33 82.16 Favored Pre-proline 0 C--N 1.314 -0.935 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.426 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 74.5 Cg_endo -72.31 -19.82 25.1 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.49 2.127 . . . . 0.0 112.545 -177.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -85.93 -24.08 26.71 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.042 0.449 . . . . 0.0 110.646 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -92.7 -55.3 3.43 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.155 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -105.67 -37.65 6.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.096 0.474 . . . . 0.0 110.664 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 100.91 10.94 41.59 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.817 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 30.6 p -147.04 177.69 8.96 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.491 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 96.4 t -79.58 122.12 34.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.693 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -112.94 150.15 32.24 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.739 -177.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.496 ' HB3' HG22 ' A' ' 184' ' ' VAL . . . -130.26 142.81 50.53 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 120.942 0.401 . . . . 0.0 110.73 177.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.8 p -123.67 131.42 73.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.94 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.1 tt -83.82 126.51 33.01 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.064 -177.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 4.1 pp -92.81 130.03 38.54 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.515 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.27 2.154 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.652 -178.302 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 38.6 t80 . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.49 ' HB3' ' HB ' ' A' ' 197' ' ' ILE . 98.4 mttt -76.23 89.05 3.1 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.698 0.285 . . . . 0.0 111.608 -178.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -124.79 143.99 50.51 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.573 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -137.07 144.28 43.05 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.863 176.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 66.5 t30 -85.7 99.8 11.56 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.7 t -91.68 120.98 41.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.265 0.555 . . . . 0.0 112.14 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 90.4 m -98.23 124.09 42.65 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.542 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -100.65 113.55 65.61 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.541 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.39 -16.51 51.56 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.647 2.231 . . . . 0.0 111.675 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 41.2 m -65.19 -43.13 92.6 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.264 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.597 ' HB2' HG12 ' A' ' 191' ' ' VAL . 23.8 mt -114.78 -9.17 12.56 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.699 -175.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 60.97 42.34 12.91 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.083 -176.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.597 HG12 ' HB2' ' A' ' 189' ' ' LEU . 10.5 p -129.26 147.7 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 14.8 t -123.77 129.63 51.35 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.307 0.575 . . . . 0.0 110.579 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 58.9 t -134.53 138.5 49.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.209 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 61.0 tt0 -80.51 113.31 18.61 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.302 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 7.6 mp -116.41 155.7 48.22 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.367 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 180' ' ' LYS . 58.7 Cg_endo -70.55 147.03 56.93 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.265 1.977 . . . . 0.0 111.535 177.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 180' ' ' LYS . 84.7 mt -87.3 107.27 16.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.892 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.87 -42.89 76.41 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.014 0.435 . . . . 0.0 111.088 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' A' ' 222' ' ' GLU . 18.8 m -141.67 146.09 35.71 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.428 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.7 138.62 44.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.019 0.438 . . . . 0.0 111.379 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.07 147.79 51.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.531 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -73.25 158.85 34.39 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.801 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 . . . . . 0 C--N 1.324 -0.522 0 CA-C-O 120.608 0.242 . . . . 0.0 110.695 179.881 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 C--O 1.238 0.466 0 CA-C-O 121.129 0.49 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 75.1 p -91.68 163.67 14.01 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.531 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -70.57 151.36 45.12 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.894 0.378 . . . . 0.0 110.719 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.12 7.69 30.48 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.135 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.65 ' OG1' ' HB ' ' A' ' 245' ' ' ILE . 50.6 p -79.96 157.69 26.79 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.3 mm -115.78 129.04 72.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.017 0.437 . . . . 0.0 111.672 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.504 HG21 HD11 ' A' ' 245' ' ' ILE . 46.1 pt -125.86 158.3 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.999 178.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 199' ' ' SER . 44.1 tt0 -107.52 124.68 50.27 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.283 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.06 156.69 40.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.106 0.479 . . . . 0.0 110.951 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -100.64 113.49 26.38 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.338 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 22.3 t -83.96 70.6 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.408 ' H ' ' H ' ' A' ' 227' ' ' ASP . 18.7 m -159.78 -22.56 0.07 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.707 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . 0.408 ' H ' ' H ' ' A' ' 226' ' ' SER . 5.4 m-20 -82.41 8.34 11.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.669 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.44 -22.26 65.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.049 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 95.73 -9.07 68.63 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.748 -0.66 . . . . 0.0 113.281 178.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 48.8 mm -115.8 135.52 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 CA-C-O 122.258 1.028 . . . . 0.0 112.515 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 4.7 m -112.46 118.22 57.24 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.475 0 CA-C-N 113.067 -1.879 . . . . 0.0 108.867 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 233' ' ' ALA . 61.1 p -68.48 -41.77 79.65 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.661 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 232' ' ' THR . . . 163.49 -39.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.079 0.952 . . . . 0.0 110.41 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 18.9 m -137.83 12.45 2.91 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.02 -176.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.35 50.67 54.7 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 119.724 -1.227 . . . . 0.0 110.74 -176.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.403 ' O ' ' HD3' ' A' ' 236' ' ' LYS . 9.0 tmtt? -57.22 -37.76 72.72 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 123.417 0.687 . . . . 0.0 110.332 -174.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 11.8 pt -118.66 19.19 6.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.814 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -81.17 107.71 14.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.82 0.343 . . . . 0.0 111.441 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 -159.34 169.43 24.03 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.568 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -94.05 119.14 5.94 Favored Glycine 0 N--CA 1.437 -1.241 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 172.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.44 ' CB ' HD11 ' A' ' 259' ' ' LEU . 37.3 mmt180 -127.86 164.05 23.08 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.953 0.406 . . . . 0.0 111.419 -174.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.545 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 96.6 m-85 -104.09 140.73 37.36 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.148 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -125.07 148.57 48.45 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.051 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 219' ' ' THR . 37.0 tt0 -98.68 125.69 44.06 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.195 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.65 ' HB ' ' OG1' ' A' ' 219' ' ' THR . 90.8 mt -80.75 127.77 39.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.048 0.452 . . . . 0.0 111.066 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 4.8 t -135.57 102.6 5.17 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.811 176.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -78.63 116.92 19.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.612 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -131.53 73.98 78.87 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.869 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.93 -23.14 41.21 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.285 1.99 . . . . 0.0 112.179 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -80.42 -12.55 59.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.333 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -113.1 -57.7 2.25 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.128 0.49 . . . . 0.0 111.001 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.549 ' HB2' HD21 ' A' ' 256' ' ' ASN . 26.9 m-20 -96.86 -27.6 14.61 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.881 -176.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 80.5 16.66 75.31 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.944 -178.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 48.5 t -155.48 165.3 37.01 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 96.1 t -81.06 121.95 35.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.549 HD21 ' HB2' ' A' ' 252' ' ' ASP . 48.1 m-80 -113.14 152.7 29.31 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 120.838 0.352 . . . . 0.0 111.257 -174.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -128.86 131.22 47.64 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.16 126.1 58.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.134 0.492 . . . . 0.0 109.908 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.44 HD11 ' CB ' ' A' ' 241' ' ' ARG . 51.5 tp -75.28 129.13 36.92 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.805 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 242' ' ' TYR . 3.0 pp -100.99 127.78 47.33 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 C--O 1.262 1.739 0 CA-C-O 117.951 -1.023 . . . . 0.0 111.065 -178.579 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 69.5 t80 . . . . . 0 N--CA 1.446 -0.671 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.486 ' HB3' ' HB ' ' A' ' 197' ' ' ILE . 56.3 mtmt -73.4 80.74 1.4 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.048 0.451 . . . . 0.0 111.92 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.474 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 84.8 tttt -155.72 135.2 12.44 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -141.96 160.54 40.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.97 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 17.8 m120 -80.9 103.56 10.82 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 64.1 t -85.68 122.06 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 121.338 0.59 . . . . 0.0 110.798 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.1 m -102.96 125.67 49.82 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.279 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -103.99 105.88 50.54 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.56 -32.39 79.76 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.465 2.11 . . . . 0.0 113.209 -176.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 87.9 m -67.22 -41.81 85.09 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.995 0.426 . . . . 0.0 110.872 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.48 ' HB2' HG12 ' A' ' 191' ' ' VAL . 41.7 mt -88.13 -20.66 25.35 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.414 0.626 . . . . 0.0 109.326 -178.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.4 t30 60.03 50.73 6.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.654 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.48 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.9 p -139.97 147.67 23.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.658 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 60.0 m -116.97 119.26 34.77 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 65.6 t -128.94 127.95 66.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 46.1 tt0 -78.2 118.98 20.94 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 91.7 mt -126.19 149.74 67.71 Favored Pre-proline 0 C--N 1.312 -1.022 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.28 -176.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.48 146.2 55.05 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.012 1.808 . . . . 0.0 110.919 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 180' ' ' LYS . 80.7 mt -91.47 117.77 35.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.66 -43.54 80.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.14 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 67.9 m -152.19 149.66 28.98 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.528 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.404 HG12 HG22 ' A' ' 221' ' ' ILE . 36.0 m -116.52 142.24 30.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -130.94 142.7 50.38 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.406 0.622 . . . . 0.0 110.827 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -71.9 134.65 46.16 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.981 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 9.6 p30 . . . . . 0 C--N 1.312 -1.039 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.863 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 N--CA 1.446 -0.629 0 CA-C-O 121.16 0.505 . . . . 0.0 111.681 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 74.7 p -127.14 -172.51 2.67 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.455 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.517 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 18.2 ptpt -50.59 150.83 2.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.275 0.559 . . . . 0.0 112.409 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 114.99 6.11 19.2 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.804 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 244' ' ' GLN . 56.9 m -71.6 138.92 49.1 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.5 mm -92.37 125.69 44.96 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.717 0 CA-C-O 120.522 0.201 . . . . 0.0 110.502 -176.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.409 ' HB ' HG23 ' A' ' 197' ' ' ILE . 47.3 pt -133.54 160.12 42.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 120.961 0.41 . . . . 0.0 111.2 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -107.32 126.96 53.11 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.455 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.33 153.16 30.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.145 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -102.61 111.12 23.29 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.295 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 46.6 t -78.71 79.39 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 32.7 t -174.71 -27.55 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.949 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.31 5.11 9.2 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.291 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.65 -38.58 88.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.768 0.318 . . . . 0.0 110.677 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 83.39 7.01 87.11 Favored Glycine 0 CA--C 1.509 -0.325 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.531 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 49.3 pt -107.93 0.27 9.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 120.6 0.238 . . . . 0.0 110.822 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 39.7 t 62.74 96.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.903 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.453 HG22 HD11 ' A' ' 237' ' ' ILE . 14.0 m -85.08 101.13 12.18 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.982 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.535 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . 50.08 52.72 14.16 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.69 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 41.8 m 64.13 10.12 5.23 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.293 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 80.98 5.63 90.01 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.991 -0.623 . . . . 0.0 113.184 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 65.3 pttt -67.12 -24.22 65.89 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.211 0.529 . . . . 0.0 111.043 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 232' ' ' THR . 13.0 pt -110.5 19.76 6.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.37 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -78.0 105.68 9.37 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.168 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -145.11 158.14 43.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.888 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -81.25 132.28 11.07 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 175.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -128.5 172.42 11.16 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.915 0.388 . . . . 0.0 110.804 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -101.35 140.07 36.14 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.104 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -135.78 159.2 42.38 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.28 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 219' ' ' THR . 49.0 mt-30 -113.81 136.26 53.06 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.406 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.446 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 89.5 mt -79.85 124.19 37.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.517 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 4.9 t -124.72 92.45 3.65 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 122.12 0.962 . . . . 0.0 108.72 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . 0.435 ' C ' ' HD3' ' A' ' 249' ' ' PRO . 20.1 p-10 -74.48 118.94 18.01 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.586 -177.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -130.22 67.87 80.41 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.88 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.435 ' HD3' ' C ' ' A' ' 247' ' ' ASN . 6.5 Cg_exo -77.35 -23.06 10.46 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.139 1.893 . . . . 0.0 109.99 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -67.9 -36.96 81.1 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.792 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -107.22 -58.09 1.99 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.421 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -72.27 -39.78 68.12 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.327 0.584 . . . . 0.0 110.854 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 100.77 7.24 51.21 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.404 -0.817 . . . . 0.0 112.399 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 39.4 t -152.44 164.71 36.99 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.781 0.324 . . . . 0.0 111.165 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 86.9 t -80.63 123.78 37.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -117.61 152.88 34.26 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.689 -174.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -124.41 145.68 49.34 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.5 p -121.09 131.94 71.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.043 0.449 . . . . 0.0 110.63 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.4 tt -100.86 128.35 46.94 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.251 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 2.7 pp -100.8 150.47 22.77 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.076 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.261 1.699 0 CA-C-O 118.102 -0.951 . . . . 0.0 111.037 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 . . . . . 0 N--CA 1.445 -0.714 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 64.19 43.72 4.79 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 122.284 1.04 . . . . 0.0 109.299 -170.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.567 ' HD3' ' HG2' ' A' ' 194' ' ' GLN . 4.0 tmmm? -124.26 133.69 53.43 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 113.597 -1.638 . . . . 0.0 107.561 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -135.7 159.79 40.54 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.221 0.534 . . . . 0.0 112.132 -175.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 58.2 t30 -87.22 105.68 17.38 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.92 119.02 41.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.441 0.639 . . . . 0.0 111.693 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 86.6 m -105.27 126.26 51.9 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.082 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -105.52 108.92 62.54 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 40.4 Cg_endo -66.69 -30.49 41.77 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 122.017 1.811 . . . . 0.0 112.576 -178.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 88.6 m -65.57 -43.37 90.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.283 0.563 . . . . 0.0 111.03 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.494 ' HB2' HG12 ' A' ' 191' ' ' VAL . 36.1 mt -96.17 -16.96 21.17 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.748 -177.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.4 t30 60.66 52.58 4.39 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.613 -176.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.494 HG12 ' HB2' ' A' ' 189' ' ' LEU . 10.2 p -138.04 137.25 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.002 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 9.3 t -115.94 116.86 28.68 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.529 0.681 . . . . 0.0 110.181 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 64.3 t -129.11 129.3 67.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.182 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.567 ' HG2' ' HD3' ' A' ' 181' ' ' LYS . 33.0 tt0 -77.38 124.29 27.67 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.619 HD12 ' HD2' ' A' ' 196' ' ' PRO . 25.2 tp -142.7 139.23 16.94 Favored Pre-proline 0 C--N 1.317 -0.848 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.767 -173.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.619 ' HD2' HD12 ' A' ' 195' ' ' LEU . 40.9 Cg_endo -67.87 147.24 74.3 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 121.882 1.721 . . . . 0.0 109.873 173.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.518 HG21 HG12 ' A' ' 200' ' ' VAL . 79.1 mt -84.48 124.5 39.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 120.918 0.39 . . . . 0.0 111.565 -175.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.65 -40.51 84.51 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.219 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 33.4 t -159.57 150.85 19.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.518 HG12 HG21 ' A' ' 197' ' ' ILE . 30.7 m -126.21 148.22 30.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.906 0.384 . . . . 0.0 110.932 -178.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -116.31 117.81 31.01 Favored 'General case' 0 C--O 1.253 1.283 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 174.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.81 141.07 54.15 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 124.475 1.109 . . . . 0.0 111.292 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 . . . . . 0 C--O 1.233 0.208 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.472 -178.647 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 N--CA 1.444 -0.76 0 CA-C-O 121.649 0.738 . . . . 0.0 112.223 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 57.1 m -124.73 151.3 45.22 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.818 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.459 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 8.3 ptpp? -43.88 151.24 0.22 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 113.5 4.38 23.42 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.766 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.598 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 88.6 m -78.38 136.75 37.74 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.5 mm -100.82 128.56 52.84 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.741 HD13 HD11 ' A' ' 245' ' ' ILE . 46.8 pt -126.86 162.44 31.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -99.62 121.96 41.96 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.774 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 28.5 m -129.81 155.04 41.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 O-C-N 123.386 0.429 . . . . 0.0 110.519 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.432 ' OD1' HD21 ' A' ' 195' ' ' LEU . 16.5 p-10 -101.94 116.85 33.6 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.375 0.607 . . . . 0.0 110.961 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.545 ' HB ' HH11 ' A' ' 241' ' ' ARG . 53.0 t -109.76 87.69 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 38.7 t -118.83 -79.79 0.6 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.038 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -99.74 -30.13 12.25 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.021 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 91.7 mt 63.73 23.56 13.53 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.14 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 92.69 -8.3 76.8 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 121.016 -0.611 . . . . 0.0 113.228 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.8 pt -129.19 169.12 21.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.818 0.309 . . . . 0.0 110.607 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 15.9 m -90.3 89.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-O 121.712 0.768 . . . . 0.0 110.075 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.421 HG21 HD11 ' A' ' 237' ' ' ILE . 5.1 t -80.99 -51.47 8.49 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.747 -176.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.445 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . -170.42 53.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.641 0.258 . . . . 0.0 111.636 -177.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 19.9 m 58.52 20.01 7.14 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.096 177.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.89 21.59 76.75 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.082 -0.58 . . . . 0.0 113.545 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 19.2 ptpt -69.81 -18.94 63.49 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.622 0.711 . . . . 0.0 111.738 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.421 HD11 HG21 ' A' ' 232' ' ' THR . 28.9 pt -96.26 13.33 3.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.136 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -72.07 107.2 4.65 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.234 0.54 . . . . 0.0 112.195 -177.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -143.99 144.13 31.53 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.307 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -74.76 125.73 8.59 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.545 HH11 ' HB ' ' A' ' 225' ' ' VAL . 85.5 mtt85 -128.46 165.46 20.64 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.917 0.358 . . . . 0.0 111.185 -175.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.425 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 99.5 m-85 -101.03 136.08 41.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.542 -177.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -123.36 148.08 46.41 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.093 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -97.19 125.33 41.65 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.718 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.741 HD11 HD13 ' A' ' 221' ' ' ILE . 46.5 mm -83.11 122.38 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.918 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.018 177.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.459 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 1.3 t -128.64 86.86 2.5 Favored 'General case' 0 N--CA 1.428 -1.544 0 O-C-N 124.339 1.024 . . . . 0.0 108.78 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -80.5 115.87 20.25 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.339 0.59 . . . . 0.0 110.749 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -131.04 73.36 81.01 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.434 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.49 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 43.5 Cg_endo -66.73 -22.76 49.48 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.811 1.674 . . . . 0.0 110.673 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -69.1 -37.57 78.47 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.284 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' ASN . . . . . 0.449 ' C ' HD22 ' A' ' 251' ' ' ASN . 0.2 OUTLIER -92.72 -55.9 3.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.262 -175.043 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -100.44 -32.31 10.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.194 0.521 . . . . 0.0 110.966 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 95.6 -4.95 66.81 Favored Glycine 0 C--N 1.315 -0.593 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.657 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 85.9 m -131.22 167.3 19.42 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.773 0.321 . . . . 0.0 110.77 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 87.5 t -80.74 121.37 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -108.47 146.5 33.06 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.578 -174.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -137.82 146.57 43.66 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.449 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.3 p -132.32 136.38 56.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.431 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 56.4 tp -73.05 130.53 40.51 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.098 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 242' ' ' TYR . 4.0 pp -102.82 144.46 31.12 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.861 176.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 26.5 m . . . . . 0 C--O 1.268 2.042 0 CA-C-O 117.905 -1.045 . . . . 0.0 111.043 -179.49 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 20.7 t80 . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -76.26 92.56 3.31 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 120.943 0.402 . . . . 0.0 110.995 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.492 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 22.5 ttmm -144.83 137.92 26.69 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.918 -177.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -139.07 154.78 48.23 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.787 0.327 . . . . 0.0 111.345 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -88.57 111.59 22.06 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.012 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 65.1 t -99.12 125.8 52.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.248 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.0 m -104.4 127.97 52.17 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.693 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -104.48 110.6 64.52 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -55.94 -36.36 95.65 Favored 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 123.448 2.766 . . . . 0.0 113.562 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 87.0 m -66.07 -41.27 90.97 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.127 0.489 . . . . 0.0 111.392 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.508 ' HB2' HG12 ' A' ' 191' ' ' VAL . 40.0 mt -94.42 -18.66 21.32 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.403 -175.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 58.77 44.14 17.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.141 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.508 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.9 p -134.23 144.49 35.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.75 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 86.2 m -113.73 120.25 40.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.173 0.511 . . . . 0.0 109.861 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 10.9 m -126.14 143.78 38.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.636 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.492 ' HG2' ' HG2' ' A' ' 181' ' ' LYS . 59.0 tt0 -97.76 122.37 40.77 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.603 -175.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.43 HD11 ' HA ' ' A' ' 228' ' ' LEU . 2.7 mm? -128.73 156.87 76.88 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.494 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.61 149.68 68.18 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.28 1.987 . . . . 0.0 110.674 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 79.3 mt -84.78 112.16 21.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.525 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 223' ' ' VAL . 3.9 mm? -68.0 -42.13 81.18 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.221 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 222' ' ' GLU . 37.3 t -150.91 148.6 28.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.222 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.03 140.85 45.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.999 0.428 . . . . 0.0 111.275 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -133.8 131.91 39.85 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -111.01 144.77 39.59 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.223 177.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--N 1.315 -0.914 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.077 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 78.8 mt . . . . . 0 CA--C 1.495 -1.162 0 CA-C-O 121.752 0.786 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.2 p -116.43 -178.1 3.34 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.937 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.476 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 18.0 ptpt -60.68 144.91 51.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.286 0.565 . . . . 0.0 112.123 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 112.13 5.54 24.95 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.184 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.644 ' OG1' ' HB ' ' A' ' 245' ' ' ILE . 1.3 p -86.09 158.14 19.88 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 122.211 0.204 . . . . 0.0 111.239 178.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 48.4 mm -114.56 129.8 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -174.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.466 HG21 HD11 ' A' ' 245' ' ' ILE . 44.9 pt -132.65 162.94 39.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.025 0.44 . . . . 0.0 111.09 176.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 199' ' ' SER . 43.9 tt0 -112.86 131.39 55.73 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.438 ' HA ' HD23 ' A' ' 198' ' ' LEU . 26.8 m -129.08 150.88 35.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.092 0.472 . . . . 0.0 110.785 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -103.54 106.1 16.52 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.319 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 7.6 p -84.13 71.22 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-O 122.585 1.183 . . . . 0.0 110.149 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 14.9 m -154.37 -37.13 0.09 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.638 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -81.46 20.72 0.85 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.161 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.469 HD11 HG23 ' A' ' 225' ' ' VAL . 98.9 mt -61.33 -39.1 89.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.78 -177.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 174.22 -92.64 0.09 OUTLIER Glycine 0 N--CA 1.428 -1.841 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.617 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 63.9 mt -132.76 -86.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.075 0.464 . . . . 0.0 111.338 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.94 77.1 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.611 0.719 . . . . 0.0 110.759 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 23.9 p -71.14 -60.18 2.37 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.912 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -143.31 49.39 1.43 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.919 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 20.9 t 65.0 12.81 8.2 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.493 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 74.15 11.2 81.82 Favored Glycine 0 C--O 1.225 -0.411 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.859 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -67.66 -33.47 75.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.019 0.914 . . . . 0.0 109.499 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 35.9 pt -86.54 10.57 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.742 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -77.35 107.77 10.01 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -176.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . 0.476 ' O ' HG12 ' A' ' 225' ' ' VAL . 26.7 t90 -170.3 146.95 2.99 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.893 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -72.08 129.96 15.94 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.653 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -130.48 175.04 9.3 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -113.19 147.32 37.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.386 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -138.39 153.17 48.91 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.628 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -102.09 136.0 42.69 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.053 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.644 ' HB ' ' OG1' ' A' ' 219' ' ' THR . 87.3 mt -85.84 126.3 40.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.116 0.484 . . . . 0.0 110.777 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.476 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 3.1 t -127.24 87.83 2.7 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 174.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -68.7 117.22 10.14 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.371 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -128.2 69.62 78.08 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.795 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.445 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 65.1 Cg_endo -84.86 -13.29 6.83 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.569 2.179 . . . . 0.0 111.727 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -68.9 -37.67 79.13 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.095 -177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -115.18 -57.53 2.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.39 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.475 ' OD2' ' HB2' ' A' ' 254' ' ' CYS . 35.9 t70 -67.9 -39.5 83.59 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.345 0.593 . . . . 0.0 109.841 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.445 ' CA ' ' HA ' ' A' ' 249' ' ' PRO . . . 89.6 0.11 79.51 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.973 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.475 ' HB2' ' OD2' ' A' ' 252' ' ' ASP . 74.3 m -130.23 164.03 25.43 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.847 0.356 . . . . 0.0 111.181 -177.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 62.8 t -82.74 117.19 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -106.74 149.67 27.08 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.433 -176.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -136.35 144.36 44.57 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.12 131.06 70.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 121.146 0.498 . . . . 0.0 110.664 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.7 tt -99.51 125.36 45.26 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.672 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 260' ' ' LEU . 3.2 pp -92.9 144.52 25.18 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.244 0.545 . . . . 0.0 111.805 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.269 2.083 0 CA-C-O 117.729 -1.129 . . . . 0.0 110.442 179.441 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 . . . . . 0 CA--C 1.507 -0.708 0 CA-C-O 120.636 0.255 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -75.98 83.76 2.87 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.213 -177.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -128.24 144.58 51.14 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.956 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -132.69 150.62 52.13 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.646 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -87.88 100.46 12.9 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 192' ' ' THR . 67.3 t -84.21 117.37 29.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.202 -172.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.4 m -100.1 128.37 46.19 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.494 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -103.21 111.77 65.29 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.26 -25.0 57.56 Favored 'Trans proline' 0 N--CA 1.479 0.633 0 C-N-CA 122.986 2.457 . . . . 0.0 114.37 -175.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 39.6 p -66.79 -43.32 84.26 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.574 ' CD1' HG12 ' A' ' 191' ' ' VAL . 0.6 OUTLIER -116.52 -4.44 11.75 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.118 0.485 . . . . 0.0 111.802 -179.192 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.7 t30 59.44 61.59 1.98 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.218 -0.901 . . . . 0.0 113.292 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.574 HG12 ' CD1' ' A' ' 189' ' ' LEU . 3.2 p -138.52 147.77 25.08 Favored 'Isoleucine or valine' 0 C--O 1.248 1.005 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 175.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 15.3 t -127.62 135.88 50.87 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 120.266 -0.573 . . . . 0.0 111.529 -177.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.426 HG23 ' CD2' ' A' ' 195' ' ' LEU . 6.6 m -140.8 147.68 22.56 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.494 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -85.55 123.71 31.28 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.773 0.321 . . . . 0.0 111.582 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.426 ' CD2' HG23 ' A' ' 193' ' ' VAL . 3.1 mm? -128.08 151.51 76.12 Favored Pre-proline 0 C--O 1.24 0.558 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.314 176.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.91 144.42 47.87 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.365 2.044 . . . . 0.0 111.169 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.522 HG23 ' HB ' ' A' ' 221' ' ' ILE . 73.0 mt -92.24 119.37 39.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.423 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.4 -42.16 68.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.853 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 44.3 m -141.7 144.28 33.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.394 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.9 m -127.35 139.64 51.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.009 0.433 . . . . 0.0 111.683 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.436 ' O ' HG23 ' A' ' 219' ' ' THR . 57.3 mtpt -139.23 132.01 29.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.38 174.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -92.0 160.14 15.39 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 15.8 m120 . . . . . 0 C--N 1.314 -0.966 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.358 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 60.2 tp . . . . . 0 N--CA 1.444 -0.771 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 14.8 t -89.84 148.72 23.02 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.444 ' HE2' ' OG1' ' A' ' 246' ' ' THR . 14.1 ptmm? -74.5 148.16 41.23 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.614 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.72 7.98 49.74 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.591 -176.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.438 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 79.9 m -71.09 134.33 46.95 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 122.416 0.286 . . . . 0.0 110.623 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.451 HD13 ' HG2' ' A' ' 244' ' ' GLN . 45.5 mm -93.19 124.06 45.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.591 -176.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.522 ' HB ' HG23 ' A' ' 197' ' ' ILE . 47.3 pt -131.71 160.64 42.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.314 0.578 . . . . 0.0 112.027 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -109.3 126.11 53.02 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.326 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 31.6 m -131.13 157.5 43.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.103 0.478 . . . . 0.0 111.281 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -107.02 106.72 17.38 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.439 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 44.9 t -82.39 78.67 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 22.2 t -179.3 -21.7 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.411 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -60.34 -35.42 75.61 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.726 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.467 ' HG ' ' H ' ' A' ' 230' ' ' ILE . 2.3 pt? -53.32 -23.56 9.58 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.901 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 91.42 -12.13 70.17 Favored Glycine 0 C--N 1.329 0.174 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.833 175.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.467 ' H ' ' HG ' ' A' ' 228' ' ' LEU . 45.2 pt -122.37 159.25 25.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.134 0.492 . . . . 0.0 110.371 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.35 149.95 31.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.336 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 6.8 t -72.81 -41.92 64.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.252 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.04 91.14 1.25 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.343 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 50.1 m 58.56 23.83 11.3 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 173.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.05 32.98 82.16 Favored Glycine 0 C--O 1.222 -0.602 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.82 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.25 -39.88 88.34 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.424 0.631 . . . . 0.0 110.71 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 15.5 pt -102.05 12.41 7.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.837 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -83.35 106.47 15.14 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.518 -176.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 -166.67 176.8 6.95 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.172 0.989 . . . . 0.0 109.037 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.411 ' C ' ' HD2' ' A' ' 241' ' ' ARG . . . -76.13 125.32 7.72 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 174.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.411 ' HD2' ' C ' ' A' ' 240' ' ' GLY . 2.4 mpt_? -128.36 177.92 6.63 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.118 0.485 . . . . 0.0 111.164 -177.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -120.05 145.88 46.43 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.533 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -135.45 158.43 44.39 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.394 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.451 ' HG2' HD13 ' A' ' 220' ' ' ILE . 78.8 mt-30 -114.26 128.45 56.37 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.694 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.472 HD11 HG21 ' A' ' 221' ' ' ILE . 86.2 mt -82.18 127.13 39.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.176 0.512 . . . . 0.0 111.67 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.444 ' OG1' ' HE2' ' A' ' 217' ' ' LYS . 4.0 t -137.72 102.68 4.81 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.275 175.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . 0.408 ' HB3' HG13 ' A' ' 255' ' ' VAL . 5.5 p30 -75.44 124.84 27.85 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.553 -178.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -128.67 71.32 80.9 Favored Pre-proline 0 N--CA 1.443 -0.8 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.156 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.565 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 54.7 Cg_endo -68.99 -19.6 39.61 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.92 1.747 . . . . 0.0 110.089 178.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -66.6 -37.87 85.81 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.917 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -98.21 -57.1 2.29 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.033 0.444 . . . . 0.0 110.76 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.422 ' HB3' HD21 ' A' ' 256' ' ' ASN . 34.3 t70 -94.5 -37.33 11.45 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.384 -176.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 249' ' ' PRO . . . 100.73 -4.39 56.36 Favored Glycine 0 C--N 1.312 -0.783 0 C-N-CA 120.657 -0.783 . . . . 0.0 111.55 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 79.9 m -128.04 167.95 16.01 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.806 0.336 . . . . 0.0 110.965 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 247' ' ' ASN . 81.5 t -80.55 121.03 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.422 HD21 ' HB3' ' A' ' 252' ' ' ASP . 78.8 m-20 -115.95 152.83 32.72 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.935 -173.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -124.63 141.51 52.05 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.0 p -108.69 134.08 51.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.082 0.468 . . . . 0.0 110.549 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 62.0 tp -88.29 123.39 32.84 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.458 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.57 105.5 17.65 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.476 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.278 2.585 0 CA-C-O 117.481 -1.247 . . . . 0.0 110.224 178.485 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 . . . . . 0 CA--C 1.499 -0.993 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 196' ' ' PRO . 3.2 mppt? -80.88 73.06 7.9 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.636 -0.426 . . . . 0.0 109.954 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -123.08 139.02 54.51 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.585 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.635 ' HB3' HD11 ' A' ' 197' ' ' ILE . . . -136.55 148.2 47.45 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.563 176.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -84.74 102.04 12.7 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 257' ' ' ALA . 58.9 t -93.72 120.34 42.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.312 0.577 . . . . 0.0 111.908 -173.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 90.5 m -112.13 128.71 56.3 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.04 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -104.44 108.39 60.39 Favored Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.55 -27.65 61.59 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 122.535 2.157 . . . . 0.0 113.557 -175.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.438 HG23 ' HG ' ' A' ' 189' ' ' LEU . 9.3 t -77.77 -27.92 50.45 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.748 0.309 . . . . 0.0 111.695 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.472 ' HB2' HG12 ' A' ' 191' ' ' VAL . 37.4 mt -104.25 -22.02 13.44 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.276 0.56 . . . . 0.0 109.801 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.8 t30 60.21 52.79 4.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.928 -175.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.472 HG12 ' HB2' ' A' ' 189' ' ' LEU . 11.2 p -133.41 137.09 53.76 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.512 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 92.9 m -119.29 124.33 46.4 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.984 0.421 . . . . 0.0 111.042 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 10.3 m -142.95 149.59 18.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.127 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.504 ' C ' HD12 ' A' ' 195' ' ' LEU . 35.3 tt0 -102.89 119.82 39.52 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.85 178.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.504 HD12 ' C ' ' A' ' 194' ' ' GLN . 7.1 mp -128.38 150.59 74.71 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.58 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 180' ' ' LYS . 38.3 Cg_exo -61.37 141.09 91.37 Favored 'Trans proline' 0 C--O 1.24 0.608 0 C-N-CA 122.556 2.17 . . . . 0.0 111.23 175.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.71 HD12 HD12 ' A' ' 221' ' ' ILE . 34.8 mm -91.67 119.85 39.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.193 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.403 HD11 ' ND2' ' A' ' 224' ' ' ASN . 96.6 mt -69.25 -42.19 75.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.597 -177.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.4 t -154.39 149.57 26.99 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.767 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.603 HG12 HG22 ' A' ' 221' ' ' ILE . 32.1 m -128.96 148.09 33.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.451 ' O ' HG23 ' A' ' 219' ' ' THR . 14.5 ptmm? -139.65 149.33 43.6 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -66.75 154.96 39.4 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.351 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 11.7 p30 . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 121.144 0.497 . . . . 0.0 110.986 179.031 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 61.4 tp . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 32.1 p -91.11 168.3 11.73 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -176.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -60.94 153.94 23.68 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.812 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 106.7 10.19 29.24 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -176.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.612 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 87.8 m -71.57 128.5 36.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 201' ' ' LYS . 48.5 mm -90.36 129.03 41.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.762 0.315 . . . . 0.0 110.301 -177.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.71 HD12 HD12 ' A' ' 197' ' ' ILE . 39.0 pt -127.56 154.82 38.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -177.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -102.04 119.32 38.6 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.347 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.31 156.73 40.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.596 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.403 ' ND2' HD11 ' A' ' 198' ' ' LEU . 96.0 m-20 -103.55 108.57 19.89 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.005 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.472 HG23 ' H ' ' A' ' 239' ' ' TRP . 35.2 m -87.58 21.06 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 122.067 0.937 . . . . 0.0 109.288 176.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 21.2 m -105.21 -14.0 15.51 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.561 173.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.85 1.11 55.32 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.287 -174.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.492 HD13 HG12 ' A' ' 230' ' ' ILE . 0.3 OUTLIER -64.35 -31.14 72.22 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.582 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 69.5 31.97 71.26 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.92 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.492 HG12 HD13 ' A' ' 228' ' ' LEU . 42.2 pt -119.39 151.83 21.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 117.214 0.507 . . . . 0.0 110.649 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 27.1 m -121.75 8.35 5.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.694 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 14.6 t -58.66 -18.38 30.28 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.769 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.54 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . -119.26 29.13 7.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.847 0.356 . . . . 0.0 110.553 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 23.0 m 66.75 3.26 2.92 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.637 0.775 . . . . 0.0 112.138 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 81.04 0.71 89.26 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.942 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 19.2 ptpt -70.14 -15.52 62.97 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.122 0.487 . . . . 0.0 111.333 -179.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 33.8 pt -80.93 -4.64 7.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.568 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.16 109.26 2.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.0 0.428 . . . . 0.0 110.149 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . 0.472 ' H ' HG23 ' A' ' 225' ' ' VAL . 5.0 m95 -151.96 176.29 11.64 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.627 -178.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -109.8 112.73 3.43 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 171.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -129.44 161.32 30.64 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 117.118 0.459 . . . . 0.0 111.882 -174.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -102.62 133.81 47.02 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.193 175.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -114.68 162.73 16.41 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.613 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -110.24 128.41 55.49 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.083 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.612 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 89.1 mt -81.85 127.23 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.773 0 CA-C-O 120.969 0.414 . . . . 0.0 111.18 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 2.7 t -128.17 101.32 6.21 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.166 175.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -78.35 117.81 19.94 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.451 0.643 . . . . 0.0 112.148 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -128.57 72.12 80.72 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.355 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.46 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 56.5 Cg_endo -68.77 -19.55 40.96 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.389 2.059 . . . . 0.0 111.568 -178.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -70.13 -30.63 67.85 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.026 177.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -94.1 -56.49 2.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.316 -177.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -104.39 -28.03 11.6 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 249' ' ' PRO . . . 83.43 10.4 82.04 Favored Glycine 0 C--N 1.315 -0.585 0 C-N-CA 120.34 -0.933 . . . . 0.0 111.755 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 83.4 m -135.32 173.48 11.67 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 122.408 0.283 . . . . 0.0 110.263 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 86.3 t -79.56 122.42 34.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.621 ' HB2' ' O ' ' A' ' 246' ' ' THR . 6.3 m120 -103.82 152.09 22.31 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -176.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.424 ' HB3' HG22 ' A' ' 184' ' ' VAL . . . -136.48 143.88 44.06 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 11.0 p -134.54 140.84 44.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-O 120.903 0.382 . . . . 0.0 110.445 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 63.0 tp -79.04 126.02 30.16 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.468 ' O ' HD12 ' A' ' 260' ' ' LEU . 2.8 pp -67.04 133.96 50.96 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.169 0.509 . . . . 0.0 111.512 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 C--O 1.263 1.777 0 CA-C-O 117.684 -1.151 . . . . 0.0 110.794 179.571 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 46.9 p90 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 121.315 0.579 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -89.49 -9.66 49.2 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.445 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -83.34 131.98 35.03 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -94.68 120.78 35.45 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.174 0.512 . . . . 0.0 111.103 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.466 HD11 ' HB3' ' A' ' 202' ' ' LYS . 4.9 tt -142.12 134.77 27.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.876 -176.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.22 165.72 17.73 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -81.29 -81.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.189 1.926 . . . . 0.0 111.062 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 60.2 ttm -160.86 92.45 0.94 Allowed 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.263 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.53 44.57 94.96 Favored Glycine 0 C--N 1.323 -0.18 0 C-N-CA 120.743 -0.742 . . . . 0.0 113.747 174.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -59.85 157.81 11.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -51.59 -50.91 59.24 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -177.53 173.08 1.71 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 176.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -78.91 58.21 2.32 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.038 0.447 . . . . 0.0 111.678 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -138.37 148.65 44.75 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.293 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.499 ' HB3' HD11 ' A' ' 197' ' ' ILE . . . -145.93 149.64 34.58 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.472 176.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -81.33 103.24 10.96 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.479 HG22 ' HB3' ' A' ' 257' ' ' ALA . 58.6 t -92.65 118.82 39.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.237 0.541 . . . . 0.0 110.604 -176.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.4 m -94.13 122.53 36.75 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.272 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -105.06 108.33 61.03 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.3 -28.0 63.7 Favored 'Trans proline' 0 N--CA 1.471 0.192 0 C-N-CA 122.261 1.974 . . . . 0.0 112.007 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 81.1 m -65.66 -41.69 92.21 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.722 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.534 ' HB2' HG12 ' A' ' 191' ' ' VAL . 33.4 mt -96.05 -19.0 19.77 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.066 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 64.3 t30 61.47 51.32 4.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.424 -175.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.534 HG12 ' HB2' ' A' ' 189' ' ' LEU . 5.9 p -149.92 144.12 17.63 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.912 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 11.4 t -111.6 124.34 52.09 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.423 0.63 . . . . 0.0 109.466 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 67.4 t -131.82 136.53 56.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.249 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -79.91 116.76 20.24 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.04 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.442 HD21 HD11 ' A' ' 228' ' ' LEU . 7.5 mp -111.73 150.82 42.83 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.841 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.61 140.21 38.98 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.66 1.574 . . . . 0.0 110.028 174.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' A' ' 182' ' ' ALA . 37.5 mm -86.98 114.82 26.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.082 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 223' ' ' VAL . 4.1 mm? -69.28 -42.41 75.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.802 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.4 t -161.77 149.43 14.69 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.349 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.614 HG12 HG22 ' A' ' 221' ' ' ILE . 32.0 m -119.79 146.62 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -119.97 122.91 42.25 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.466 ' HB3' HD11 ' A' ' 172' ' ' ILE . 20.0 ptpt -52.57 155.2 2.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.638 -1.164 . . . . 0.0 112.585 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -74.38 131.2 80.76 Favored Pre-proline 0 N--CA 1.438 -1.06 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 170.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -59.1 -30.9 94.46 Favored 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 122.547 2.165 . . . . 0.0 114.14 -172.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 25.1 t -108.84 -17.9 13.82 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.129 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 58.18 84.41 0.2 Allowed Pre-proline 0 N--CA 1.472 0.665 0 CA-C-O 121.174 0.511 . . . . 0.0 110.79 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.84 -5.37 16.73 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.359 2.706 . . . . 0.0 114.093 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.403 HD22 ' HB2' ' A' ' 211' ' ' GLN . 75.7 mt -59.13 127.08 30.37 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.396 0.617 . . . . 0.0 111.332 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -90.87 60.52 4.44 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.372 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.3 m 63.08 20.58 12.37 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.464 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.403 ' HB2' HD22 ' A' ' 208' ' ' LEU . 16.1 mm100 -63.29 -40.97 98.86 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.291 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 86.0 mt 56.58 24.11 8.39 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.309 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -105.48 -86.45 1.91 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.014 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.31 162.12 28.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.489 HD13 HG21 ' A' ' 219' ' ' THR . 83.9 mt -72.84 162.65 29.23 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.32 0.581 . . . . 0.0 111.467 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 66.7 p -90.15 166.6 13.3 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.138 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.612 ' HA ' ' O ' ' A' ' 245' ' ' ILE . 19.2 ptpt -65.37 142.62 58.15 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.873 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.4 1.64 55.61 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.209 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.609 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 85.4 m -66.81 138.12 57.11 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.8 mm -94.38 128.84 45.36 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.046 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.323 -174.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.614 HG22 HG12 ' A' ' 200' ' ' VAL . 47.1 pt -126.1 159.39 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 CA-C-O 120.774 0.321 . . . . 0.0 110.314 176.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -116.8 117.91 31.06 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.417 ' HA ' HD23 ' A' ' 198' ' ' LEU . 28.1 m -130.69 157.83 43.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.288 0.566 . . . . 0.0 111.635 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -105.17 106.61 17.18 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.438 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 239' ' ' TRP . 7.2 p -83.84 78.26 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 122.43 1.11 . . . . 0.0 110.446 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 22.2 m -158.77 -34.06 0.07 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.058 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -75.47 9.77 2.0 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.216 -176.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.442 HD11 HD21 ' A' ' 195' ' ' LEU . 7.0 mp -63.52 -40.68 97.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.131 0.491 . . . . 0.0 109.689 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 79.43 -2.03 73.94 Favored Glycine 0 C--O 1.226 -0.351 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.799 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.8 pt -80.1 -31.24 13.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 122.71 -0.288 . . . . 0.0 111.684 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 20.8 t 48.91 72.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 O-C-N 123.558 0.536 . . . . 0.0 110.643 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 13.5 t -110.96 -8.27 14.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.564 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.686 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . -128.06 31.89 5.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.717 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 19.7 m 59.86 9.79 1.85 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 79.78 3.07 89.04 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.962 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.686 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 65.0 pttt -72.02 -11.37 60.73 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.188 0.518 . . . . 0.0 111.804 -177.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 34.9 pt -95.91 -0.86 10.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.641 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -62.48 112.15 2.34 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 123.354 0.409 . . . . 0.0 111.965 -175.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . 0.505 ' O ' HG12 ' A' ' 225' ' ' VAL . 71.0 t-105 -175.13 146.91 0.88 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.875 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -73.7 120.39 6.88 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -128.6 162.76 26.55 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.912 0.387 . . . . 0.0 111.214 -173.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -102.45 136.28 42.56 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.94 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -127.02 158.3 37.31 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.096 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -105.73 132.31 52.01 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.875 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 217' ' ' LYS . 49.1 mm -79.07 130.28 36.37 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.192 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.536 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 4.4 t -140.09 104.14 4.77 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -80.76 119.75 23.75 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 120.842 0.354 . . . . 0.0 110.748 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -128.09 72.17 79.31 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-O 121.405 0.622 . . . . 0.0 109.381 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.485 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 71.8 Cg_endo -71.53 -17.84 29.8 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.884 2.389 . . . . 0.0 112.964 -176.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -82.2 -21.61 36.36 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.797 0.332 . . . . 0.0 110.803 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -105.67 -56.86 2.12 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.141 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.442 ' CB ' HD21 ' A' ' 256' ' ' ASN . 18.9 m-20 -93.37 -31.08 14.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.936 0.398 . . . . 0.0 111.44 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 82.99 4.85 89.81 Favored Glycine 0 C--N 1.321 -0.281 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.503 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 65.3 m -132.6 174.14 10.59 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.515 0.197 . . . . 0.0 110.935 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 90.6 t -79.48 121.87 33.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.536 ' HB2' ' O ' ' A' ' 246' ' ' THR . 5.3 m120 -110.13 152.28 26.21 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.612 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.479 ' HB3' HG22 ' A' ' 184' ' ' VAL . . . -134.38 144.83 48.44 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.508 177.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.68 135.94 61.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.006 0.431 . . . . 0.0 110.215 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 64.7 tp -95.57 127.06 41.29 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.23 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.464 ' H ' ' HG ' ' A' ' 260' ' ' LEU . 2.1 pp -90.31 136.71 32.88 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.405 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.266 1.957 0 CA-C-O 117.702 -1.142 . . . . 0.0 111.011 -178.106 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 44.2 p90 . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 120.824 0.345 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -63.9 -39.64 94.66 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.644 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -80.41 -28.91 37.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.25 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 25.0 t80 71.74 -54.93 0.67 Allowed 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.432 1.093 . . . . 0.0 110.605 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.464 HG12 ' HB3' ' A' ' 202' ' ' LYS . 5.8 tp -67.89 136.43 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.431 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 49.4 ptt85 -135.91 145.61 53.42 Favored Pre-proline 0 N--CA 1.436 -1.174 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.499 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 173' ' ' ARG . 16.2 Cg_exo -69.34 -67.43 0.03 OUTLIER 'Trans proline' 0 CA--C 1.512 -0.587 0 C-N-CA 121.944 1.762 . . . . 0.0 110.129 174.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 95.3 mmm -135.83 -4.25 2.24 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.257 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 66.87 36.29 90.86 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.412 HD21 HG23 ' A' ' 255' ' ' VAL . 3.2 pp -82.49 -165.7 1.1 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -173.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 179' ' ' TYR . 28.6 ptt180 -54.84 -44.54 74.02 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -173.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.4 ' N ' ' HG3' ' A' ' 178' ' ' ARG . 87.5 m-85 -138.96 167.3 22.35 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -174.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -97.39 34.71 1.75 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.069 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.428 ' HB3' ' HG2' ' A' ' 194' ' ' GLN . 59.5 mtmt -118.2 144.83 45.42 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.15 0.5 . . . . 0.0 111.114 -176.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -129.44 152.22 49.22 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.026 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -81.53 99.57 8.88 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.3 t -89.68 126.05 42.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.211 -174.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.9 m -114.87 128.3 56.21 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.576 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.518 ' NE2' HD21 ' A' ' 228' ' ' LEU . 30.9 m170 -104.46 117.96 57.85 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.04 -24.89 77.1 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 122.829 2.353 . . . . 0.0 113.492 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 11.6 t -79.67 -23.53 42.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.834 0.35 . . . . 0.0 111.628 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.479 ' HB2' HG12 ' A' ' 191' ' ' VAL . 40.5 mt -103.55 -24.32 13.43 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 59.06 46.95 12.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.513 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.479 HG12 ' HB2' ' A' ' 189' ' ' LEU . 8.9 p -133.49 145.27 33.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.174 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 87.9 m -116.42 119.43 35.62 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.436 HG11 ' O ' ' A' ' 228' ' ' LEU . 61.0 t -133.73 138.84 49.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.428 ' HG2' ' HB3' ' A' ' 181' ' ' LYS . 33.7 tt0 -87.57 118.25 26.92 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.881 0.372 . . . . 0.0 111.037 -177.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.71 153.5 77.81 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.195 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.85 146.86 54.52 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.334 2.023 . . . . 0.0 111.26 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.422 HG23 ' HB ' ' A' ' 221' ' ' ILE . 80.6 mt -89.46 116.51 31.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.323 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 95.8 mt -71.78 -42.18 67.45 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.528 ' HB2' ' HB3' ' A' ' 222' ' ' GLU . 16.6 m -140.92 147.19 38.46 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 26.7 m -125.97 146.09 32.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.328 0.585 . . . . 0.0 111.508 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -127.65 106.91 9.47 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.094 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.464 ' HB3' HG12 ' A' ' 172' ' ' ILE . 18.7 ptpt -56.6 156.91 5.72 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.44 0.462 . . . . 0.0 111.661 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 206' ' ' ASN . 3.3 m-20 -71.55 119.74 75.75 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.44 -40.37 5.92 Favored 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.343 2.028 . . . . 0.0 114.048 -174.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 17.6 m -154.74 22.75 0.45 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.826 0.346 . . . . 0.0 111.043 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 203' ' ' ASN . 1.9 m-20 -71.38 133.34 85.25 Favored Pre-proline 0 C--N 1.318 -0.774 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.16 141.31 68.92 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 122.284 1.989 . . . . 0.0 112.113 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 75.3 mt -107.35 119.65 39.98 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.624 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -113.03 -18.27 12.23 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.277 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.5 p -89.87 112.99 24.52 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 121.03 0.443 . . . . 0.0 111.53 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -70.49 -39.72 74.03 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.177 0.513 . . . . 0.0 110.011 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 213' ' ' GLY . 4.2 pp -62.46 -38.23 88.99 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.916 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.447 ' N ' HD12 ' A' ' 212' ' ' LEU . . . -119.45 126.94 6.96 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.767 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.54 -25.53 24.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 120.704 0.288 . . . . 0.0 111.532 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 61.6 tp -105.41 125.14 50.65 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.473 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 24.2 p -95.75 159.18 15.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.863 0.363 . . . . 0.0 111.23 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -61.7 152.15 31.82 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.049 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 109.69 9.76 24.33 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.618 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 21.2 m -73.08 142.12 47.58 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.5 mm -100.2 127.84 52.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.961 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.554 HD13 HD11 ' A' ' 245' ' ' ILE . 45.5 pt -127.53 163.16 31.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.591 0.234 . . . . 0.0 110.598 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.528 ' HB3' ' HB2' ' A' ' 199' ' ' SER . 8.4 tm-20 -124.43 125.65 44.62 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.035 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.3 m -131.15 141.86 44.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.145 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.601 ' HA ' ' HA2' ' A' ' 240' ' ' GLY . 50.8 t-20 -114.82 107.1 14.98 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.967 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.718 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 7.8 p -175.03 -56.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.902 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.422 ' N ' HG13 ' A' ' 225' ' ' VAL . 10.8 t 72.76 -56.16 0.66 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.396 0.678 . . . . 0.0 111.268 -177.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' A' ' 230' ' ' ILE . 1.6 m-20 -63.01 -21.95 66.51 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.344 0.258 . . . . 0.0 111.678 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.518 HD21 ' NE2' ' A' ' 186' ' ' HIS . 96.7 mt 67.23 18.29 10.32 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 92.68 -5.29 76.73 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.63 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.451 ' O ' ' HB3' ' A' ' 227' ' ' ASP . 48.2 pt -107.23 170.46 2.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 231' ' ' VAL . 7.7 p -96.42 90.41 2.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.693 0.758 . . . . 0.0 111.929 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 10.6 t -101.37 -34.96 9.39 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 174.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.689 ' HB3' HG12 ' A' ' 237' ' ' ILE . . . -138.44 9.87 2.71 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.736 174.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 9.3 t 63.37 31.52 15.13 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.155 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 85.13 3.44 87.45 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.083 -0.58 . . . . 0.0 113.192 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -65.12 -39.8 93.59 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 121.25 0.548 . . . . 0.0 111.205 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.689 HG12 ' HB3' ' A' ' 233' ' ' ALA . 30.4 pt -93.04 18.88 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.468 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.718 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -54.01 120.59 6.59 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -153.07 150.68 29.39 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.886 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 224' ' ' ASN . . . -96.22 116.01 5.33 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.847 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -129.3 171.97 11.95 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.735 0.302 . . . . 0.0 111.151 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 96.8 m-85 -102.2 140.48 36.43 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.282 0.563 . . . . 0.0 111.214 -177.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -129.48 154.49 46.94 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.36 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -101.17 133.15 46.15 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.618 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 47.9 mm -80.39 124.64 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.709 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 12.6 p -119.42 76.29 1.12 Allowed 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.082 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -68.66 121.8 17.2 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.352 0.596 . . . . 0.0 110.964 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -128.95 71.29 81.79 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.275 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -72.19 -25.33 19.05 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 121.4 1.4 . . . . 0.0 112.216 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -74.05 -33.02 63.56 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.062 0.458 . . . . 0.0 110.609 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -96.9 -57.1 2.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.937 -176.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -95.0 -29.91 14.38 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.77 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 76.62 18.56 78.9 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.375 -0.917 . . . . 0.0 110.875 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 49.7 t -149.18 160.71 43.12 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.375 -0.413 . . . . 0.0 109.96 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.412 HG23 HD21 ' A' ' 177' ' ' LEU . 85.3 t -80.39 126.85 39.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.946 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 246' ' ' THR . 42.3 m-80 -110.46 153.74 24.6 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.19 148.54 35.12 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.703 0.287 . . . . 0.0 110.65 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.59 130.64 56.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 8.9 tt -75.46 127.96 34.27 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.102 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.467 ' O ' HD12 ' A' ' 260' ' ' LEU . 4.2 pp -84.94 132.5 34.35 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.133 0.492 . . . . 0.0 111.229 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 10.6 m . . . . . 0 C--O 1.279 2.641 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.924 179.646 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.712 0.291 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -63.31 -43.85 96.67 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.712 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 53.08 40.2 30.81 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 123.667 0.604 . . . . 0.0 111.241 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -81.11 50.34 1.39 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.789 0.804 . . . . 0.0 111.099 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.74 116.68 44.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -135.48 87.49 26.88 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -60.65 -33.03 93.86 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 122.748 2.299 . . . . 0.0 110.347 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 53.2 tpp -163.05 -37.91 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.708 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 142.73 86.94 0.09 OUTLIER Glycine 0 N--CA 1.44 -1.082 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.6 pp -88.42 111.52 21.87 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.658 0.742 . . . . 0.0 111.756 -176.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.438 ' HG3' ' CD2' ' A' ' 179' ' ' TYR . 17.0 ptp180 -69.04 -30.29 68.62 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.982 176.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.438 ' CD2' ' HG3' ' A' ' 178' ' ' ARG . 89.8 m-85 -140.0 154.62 47.2 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.828 176.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -79.47 87.82 5.07 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -156.91 137.28 12.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.489 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.545 ' HB3' HD11 ' A' ' 197' ' ' ILE . . . -145.86 157.07 43.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.963 0.411 . . . . 0.0 111.392 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 56.8 t30 -83.5 99.46 10.14 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.479 HG22 ' HB3' ' A' ' 257' ' ' ALA . 53.1 t -92.65 118.93 39.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.279 0.562 . . . . 0.0 112.067 -172.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 89.6 m -94.31 124.18 38.17 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.259 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.419 ' CE1' HD21 ' A' ' 228' ' ' LEU . 64.1 m80 -104.84 111.18 65.22 Favored Pre-proline 0 C--N 1.311 -1.107 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -62.93 -28.2 75.1 Favored 'Trans proline' 0 N--CA 1.475 0.407 0 C-N-CA 122.543 2.162 . . . . 0.0 112.621 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.9 t -70.99 -31.88 68.54 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.309 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.547 ' HB2' HG12 ' A' ' 191' ' ' VAL . 43.6 mt -98.53 -22.36 16.03 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.3 t30 60.47 44.89 11.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.99 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.547 HG12 ' HB2' ' A' ' 189' ' ' LEU . 4.0 p -145.75 150.5 15.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.984 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.588 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 14.4 t -121.87 128.79 52.0 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 121.343 0.592 . . . . 0.0 110.175 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.83 138.24 52.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 63.0 tt0 -81.18 118.36 22.49 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.41 HD12 ' C ' ' A' ' 194' ' ' GLN . 7.1 mp -128.11 151.85 76.72 Favored Pre-proline 0 C--O 1.239 0.507 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.894 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 180' ' ' LYS . 45.2 Cg_exo -61.05 143.81 99.25 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.642 2.228 . . . . 0.0 110.921 173.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.545 HD11 ' HB3' ' A' ' 182' ' ' ALA . 46.1 mm -84.8 117.79 30.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 223' ' ' VAL . 3.6 mm? -70.05 -40.85 74.88 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 38.2 t -155.02 150.24 27.09 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.451 HG12 HG22 ' A' ' 221' ' ' ILE . 35.6 m -127.58 146.2 33.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.093 0.473 . . . . 0.0 110.975 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -133.64 143.52 48.64 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.493 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -79.34 151.43 31.02 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.178 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -129.46 105.58 17.47 Favored Pre-proline 0 C--N 1.311 -1.099 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 174.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.05 -18.73 35.47 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.168 2.578 . . . . 0.0 116.013 -172.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 30.7 p -121.2 -45.96 2.32 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -174.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -60.81 -51.53 78.9 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -172.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.611 ' O ' HG22 ' A' ' 216' ' ' THR . 68.8 Cg_endo -84.79 7.06 5.39 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 122.419 2.079 . . . . 0.0 114.33 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 9.9 mp -104.99 108.83 20.55 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.184 -0.607 . . . . 0.0 111.351 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -70.03 -39.65 75.65 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.358 0.599 . . . . 0.0 110.331 177.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.3 p -130.66 -177.4 4.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.965 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -63.84 -39.55 94.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.532 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 4.6 pp -140.62 162.34 35.61 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.365 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 143.41 -114.11 0.81 Allowed Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.929 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 13.7 p -139.46 147.02 24.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.3 mp -73.66 145.94 44.91 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.611 HG22 ' O ' ' A' ' 207' ' ' PRO . 7.7 t -117.64 -170.83 1.94 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.114 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.514 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 14.0 ptmm? -54.02 148.42 10.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.381 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 114.49 4.77 21.58 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.145 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.5 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 50.5 m -72.09 140.08 48.75 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.2 mm -92.8 127.33 45.0 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.963 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.451 HG22 HG12 ' A' ' 200' ' ' VAL . 46.3 pt -133.46 165.38 32.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 120.814 0.34 . . . . 0.0 110.943 178.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -121.21 126.77 50.46 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.485 ' HA ' HD23 ' A' ' 198' ' ' LEU . 35.6 m -131.25 156.65 42.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.213 0.53 . . . . 0.0 111.717 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -99.92 107.01 18.88 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.025 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 7.5 p -85.52 79.35 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 122.276 1.036 . . . . 0.0 110.536 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 57.0 p -175.77 -26.39 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.711 -1.586 . . . . 0.0 108.569 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -62.04 -13.48 26.49 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.324 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.419 HD21 ' CE1' ' A' ' 186' ' ' HIS . 6.9 mp -60.11 -37.3 79.59 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.015 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 90.62 8.11 66.04 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.425 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 41.3 pt -122.91 155.41 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 77.9 t -127.0 123.81 63.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.911 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.3 t -79.16 -52.22 8.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.099 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -161.64 98.95 1.12 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.675 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 25.8 t 65.26 -2.61 0.75 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.72 31.2 70.37 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.764 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.6 pttp -64.08 -13.63 48.76 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -177.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 19.9 pt -107.5 4.2 9.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.188 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -71.11 107.58 4.23 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.777 0.323 . . . . 0.0 111.658 -176.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 -164.09 176.58 9.16 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.041 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -91.47 122.77 6.89 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 108.894 -1.683 . . . . 0.0 108.894 173.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 75.9 mtt-85 -128.93 168.35 16.1 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 117.233 0.516 . . . . 0.0 111.319 -174.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.448 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 93.1 m-85 -101.36 143.55 31.26 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.164 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -136.92 166.3 23.96 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.359 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.432 ' HG3' HD23 ' A' ' 260' ' ' LEU . 98.3 mt-30 -116.6 136.98 52.52 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.054 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.5 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 88.2 mt -81.59 121.06 34.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.555 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 71.8 p -123.52 92.62 3.73 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.757 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -83.76 125.51 31.99 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.256 -176.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -131.59 70.28 81.44 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.51 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 73.4 Cg_endo -73.83 -17.8 22.43 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.032 1.822 . . . . 0.0 111.858 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -86.96 -14.82 40.67 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.235 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -111.3 -57.16 2.28 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.249 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -93.42 -28.14 16.31 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.846 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 92.08 -6.34 78.84 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.896 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 81.8 m -128.65 164.7 22.32 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.709 0.29 . . . . 0.0 111.069 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 92.6 t -80.38 118.09 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.555 ' HB2' ' O ' ' A' ' 246' ' ' THR . 78.4 m-20 -105.89 154.89 19.92 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.152 -174.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.479 ' HB3' HG22 ' A' ' 184' ' ' VAL . . . -135.2 146.55 48.79 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 10.7 p -123.44 134.99 64.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 120.997 0.427 . . . . 0.0 110.78 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 57.9 tp -84.1 130.77 34.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.353 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 242' ' ' TYR . 4.1 pp -101.4 146.01 28.17 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.857 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 C--O 1.268 2.068 0 CA-C-O 117.801 -1.095 . . . . 0.0 110.184 177.348 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 121.45 0.643 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -103.15 -5.14 23.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.737 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -59.69 141.62 54.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.146 0.498 . . . . 0.0 111.338 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -74.81 149.66 39.57 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.31 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.67 113.65 44.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.749 0.309 . . . . 0.0 111.037 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -121.01 110.17 34.98 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.347 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 213' ' ' GLY . 13.2 Cg_endo -60.8 -61.65 0.17 Allowed 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.55 2.167 . . . . 0.0 112.226 -178.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 55.5 ttm -154.63 25.32 0.45 Allowed 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 89.25 134.42 5.2 Favored Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.452 ' O ' HD12 ' A' ' 177' ' ' LEU . 4.2 pp -139.14 143.88 38.4 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 120.714 0.292 . . . . 0.0 110.477 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -76.23 -36.96 58.3 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.101 0.477 . . . . 0.0 111.407 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -165.25 140.57 5.21 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -176.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -79.0 97.77 6.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.982 0.42 . . . . 0.0 111.625 -177.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -129.55 144.03 51.09 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.024 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.546 ' HB3' HD11 ' A' ' 197' ' ' ILE . . . -137.18 153.0 50.53 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.753 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -87.07 101.66 13.68 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 60.3 t -95.29 125.84 47.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.452 0.644 . . . . 0.0 112.266 -172.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 92.8 m -107.08 127.77 53.78 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.74 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -104.27 108.93 61.7 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.2 -23.99 59.26 Favored 'Trans proline' 0 N--CA 1.476 0.449 0 C-N-CA 123.002 2.468 . . . . 0.0 113.629 -175.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 13.2 t -81.13 -21.11 40.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.783 0.325 . . . . 0.0 111.546 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.478 ' HB2' HG12 ' A' ' 191' ' ' VAL . 39.8 mt -109.45 -20.59 12.84 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.5 t30 60.43 48.89 7.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.425 -1.262 . . . . 0.0 109.843 -175.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' A' ' 189' ' ' LEU . 7.9 p -133.82 139.24 49.03 Favored 'Isoleucine or valine' 0 C--O 1.248 1.015 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.979 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 86.2 m -115.87 118.64 33.55 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 60.4 t -137.41 145.54 29.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.859 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -77.23 120.04 21.73 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.8 mp -123.02 145.4 45.75 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.788 0.327 . . . . 0.0 111.077 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.06 145.0 43.65 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.423 2.082 . . . . 0.0 110.051 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.726 HD12 HD12 ' A' ' 221' ' ' ILE . 31.7 mm -95.68 124.06 48.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.574 -178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.432 HD11 ' HB2' ' A' ' 224' ' ' ASN . 98.3 mt -70.37 -43.67 69.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.052 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 26.3 m -142.13 141.78 32.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.186 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 18.8 m -126.14 128.49 71.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.787 0.327 . . . . 0.0 111.098 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -141.18 149.97 42.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.972 0.415 . . . . 0.0 111.229 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -99.01 159.29 15.07 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 174.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -79.33 121.31 82.78 Favored Pre-proline 0 C--N 1.318 -0.793 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.346 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.2 -22.26 54.03 Favored 'Trans proline' 0 CA--C 1.523 -0.055 0 C-N-CA 122.527 2.152 . . . . 0.0 111.279 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 77.6 p -84.12 -3.83 58.36 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.533 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -112.1 98.91 44.33 Favored Pre-proline 0 C--O 1.237 0.414 0 CA-C-O 121.192 0.52 . . . . 0.0 111.621 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -94.09 111.53 0.18 Allowed 'Trans proline' 0 N--CA 1.439 -1.727 0 C-N-CA 122.947 2.431 . . . . 0.0 110.729 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.16 151.82 44.02 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.312 0.577 . . . . 0.0 111.864 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -60.73 -39.04 87.19 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.951 -1.022 . . . . 0.0 113.01 -173.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.0 t -150.38 -34.1 0.17 Allowed 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.707 -0.797 . . . . 0.0 112.664 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -92.56 96.92 10.5 Favored 'General case' 0 C--O 1.215 -0.737 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.447 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 90.2 mt -95.59 -19.16 19.99 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.859 0.361 . . . . 0.0 111.093 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 174' ' ' PRO . . . -90.49 2.35 80.5 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.89 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 75.4 t -116.62 128.33 74.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.61 HD23 ' H ' ' A' ' 215' ' ' LEU . 2.6 pt? -85.24 136.97 33.28 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.177 0.513 . . . . 0.0 110.707 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 39.1 p -109.67 171.78 7.24 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.276 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -61.68 150.85 35.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.971 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 96.87 4.18 59.0 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.735 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.625 ' OG1' ' HB ' ' A' ' 245' ' ' ILE . 1.9 p -79.35 157.2 27.69 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.557 0.218 . . . . 0.0 111.425 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.6 mm -108.43 127.76 64.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.269 0.556 . . . . 0.0 112.127 -174.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.726 HD12 HD12 ' A' ' 197' ' ' ILE . 26.9 pt -131.88 162.49 39.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.404 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -110.91 129.02 56.0 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.77 153.34 33.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.34 0.59 . . . . 0.0 111.637 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.432 ' HB2' HD11 ' A' ' 198' ' ' LEU . 60.2 t30 -103.01 104.89 15.11 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.531 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 6.1 p -101.32 80.1 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-O 122.277 1.037 . . . . 0.0 109.934 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 38.4 p -160.02 -32.59 0.06 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.055 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -85.97 21.42 1.96 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.575 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 98.4 mt -60.0 -38.15 81.77 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.617 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 150.37 -32.18 1.03 Allowed Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.901 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 44.9 pt -125.93 156.62 35.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.339 0.59 . . . . 0.0 111.68 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 30.6 m -138.15 152.7 26.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.425 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 34.8 p -85.7 -83.8 0.17 Allowed 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.42 ' H ' ' H ' ' A' ' 234' ' ' SER . . . -178.53 9.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.6 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . 0.42 ' H ' ' H ' ' A' ' 233' ' ' ALA . 23.9 m -151.33 14.68 0.69 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.213 -176.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.74 30.42 72.69 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.624 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -61.77 -41.46 97.73 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.185 0.517 . . . . 0.0 110.977 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 12.6 pt -109.53 11.79 8.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.389 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -102.57 107.76 18.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.075 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -141.63 155.85 45.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.784 0.326 . . . . 0.0 111.186 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -107.94 110.31 3.12 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 170.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 31.6 mtp180 -131.0 169.39 15.9 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -102.56 146.02 28.75 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.276 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -131.19 168.15 17.97 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.525 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -114.04 130.85 56.53 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.424 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.625 ' HB ' ' OG1' ' A' ' 219' ' ' THR . 93.8 mt -81.33 130.1 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-O 120.82 0.343 . . . . 0.0 110.778 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.552 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 2.2 t -130.59 87.34 2.48 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -84.88 116.48 23.35 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.342 0.591 . . . . 0.0 111.437 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -129.1 72.06 81.99 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.459 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.46 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 33.4 Cg_exo -62.06 -24.9 77.04 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.618 2.212 . . . . 0.0 111.057 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.27 -34.97 79.2 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.702 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -96.9 -57.05 2.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.373 -177.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -98.14 -29.72 13.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.894 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 249' ' ' PRO . . . 83.99 5.82 87.32 Favored Glycine 0 C--N 1.315 -0.593 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.876 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 78.7 m -130.92 161.43 31.91 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 97.8 t -81.0 117.25 26.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 175.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.552 ' HB2' ' O ' ' A' ' 246' ' ' THR . 76.8 m-20 -103.32 147.57 26.93 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -174.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -136.53 144.92 44.51 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.1 p -132.03 136.28 56.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-O 121.18 0.514 . . . . 0.0 110.668 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.6 tt -95.3 119.88 34.58 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.407 ' H ' ' HG ' ' A' ' 260' ' ' LEU . 3.0 pp -90.46 137.96 31.93 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.305 0.574 . . . . 0.0 111.965 -176.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 C--O 1.276 2.46 0 CA-C-O 117.287 -1.339 . . . . 0.0 110.11 179.348 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.475 0.821 0 CA-C-O 121.119 0.485 . . . . 0.0 111.797 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.53 ' HB3' ' NH2' ' A' ' 173' ' ' ARG . 5.3 mp0 -67.97 -36.66 80.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.77 176.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 70.06 167.56 0.29 Allowed 'General case' 0 C--N 1.342 0.25 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.978 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -100.08 3.62 44.12 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.635 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 81.8 mt -106.94 110.92 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.946 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.53 ' NH2' ' HB3' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -159.74 150.53 15.76 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 177.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.532 ' HA ' ' HB3' ' A' ' 215' ' ' LEU . 30.2 Cg_endo -66.27 -42.66 9.91 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 121.811 1.674 . . . . 0.0 111.503 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 55.3 ttm -174.93 17.12 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 103.13 144.74 14.34 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -172.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -148.52 136.22 20.67 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 117.14 0.47 . . . . 0.0 111.134 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.9 ptt-85 -62.37 -43.96 97.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.841 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -138.11 149.1 45.62 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -81.09 79.4 7.76 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -133.91 148.43 51.22 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.178 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.1 151.39 51.36 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.814 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -84.93 99.85 11.23 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 65.7 t -91.77 120.47 40.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.717 -173.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.9 m -107.53 126.89 53.1 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.697 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -101.01 112.68 65.31 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.75 -22.43 63.91 Favored 'Trans proline' 0 N--CA 1.473 0.282 0 C-N-CA 122.925 2.417 . . . . 0.0 113.103 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 89.2 m -64.45 -42.61 95.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.137 0.494 . . . . 0.0 110.786 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.524 ' HB2' HG12 ' A' ' 191' ' ' VAL . 29.6 mt -105.82 -14.29 15.27 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.064 -176.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 20.3 m120 59.96 45.16 12.57 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.244 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.524 HG12 ' HB2' ' A' ' 189' ' ' LEU . 10.2 p -128.34 147.85 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 11.9 t -127.71 135.13 49.75 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.556 0.693 . . . . 0.0 111.416 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.489 HG23 ' CD1' ' A' ' 195' ' ' LEU . 7.8 m -139.89 152.08 22.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.709 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -92.94 122.53 35.4 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.002 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.489 ' CD1' HG23 ' A' ' 193' ' ' VAL . 6.9 mp -121.39 148.14 49.12 Favored Pre-proline 0 C--O 1.239 0.511 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.487 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.37 142.27 90.27 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.723 2.282 . . . . 0.0 111.65 175.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 78.9 mt -89.97 117.49 33.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' A' ' 224' ' ' ASN . 98.5 mt -70.14 -40.65 74.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.951 0.405 . . . . 0.0 111.123 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 33.5 t -157.68 148.19 20.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.17 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.6 m -112.93 139.64 36.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.835 0.35 . . . . 0.0 110.104 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -133.07 136.61 46.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.995 0.426 . . . . 0.0 110.587 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -89.91 159.53 16.89 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -67.73 148.4 98.53 Favored Pre-proline 0 C--N 1.311 -1.08 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.485 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.16 -35.23 65.46 Favored 'Trans proline' 0 N--CA 1.474 0.381 0 C-N-CA 122.956 2.437 . . . . 0.0 111.624 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 30.2 t -156.05 88.24 1.09 Allowed 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.583 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -127.56 79.77 72.9 Favored Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.314 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -71.06 139.39 35.64 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.51 2.14 . . . . 0.0 111.063 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 10.6 mp -84.95 144.68 28.18 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -61.42 -44.13 97.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.331 0.586 . . . . 0.0 109.478 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 73.5 p -77.46 161.92 27.58 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.949 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -62.03 -44.24 97.12 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.6 pp -147.4 172.83 13.3 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.198 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 162.76 -169.82 38.1 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.819 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 35.0 m -82.44 -177.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.532 ' HB3' ' HA ' ' A' ' 174' ' ' PRO . 55.3 tp -65.7 128.99 38.17 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 11.9 t -92.09 158.52 16.16 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.611 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -68.79 152.99 44.59 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.953 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.77 8.87 27.55 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.932 -0.652 . . . . 0.0 111.949 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.475 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 91.4 m -76.25 139.82 41.31 Favored 'General case' 0 C--O 1.212 -0.894 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.6 mm -105.78 127.97 60.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 O-C-N 122.052 -0.405 . . . . 0.0 111.476 -176.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.561 HD13 HD11 ' A' ' 245' ' ' ILE . 45.2 pt -122.88 158.56 27.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.704 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -103.95 123.14 46.62 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.16 159.3 43.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.871 0.367 . . . . 0.0 110.226 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.437 ' HB2' HD11 ' A' ' 198' ' ' LEU . 21.2 t-20 -112.61 123.41 50.24 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 46.8 t -76.42 77.3 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 121.476 0.655 . . . . 0.0 109.968 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 68.6 m -158.38 -13.63 0.07 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.788 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -90.79 18.76 6.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.732 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.412 ' H ' HD22 ' A' ' 228' ' ' LEU . 3.1 mm? -59.75 -38.44 81.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.111 0.482 . . . . 0.0 110.084 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 94.56 -12.72 68.43 Favored Glycine 0 CA--C 1.506 -0.483 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.507 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.3 pt -136.15 165.19 29.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.33 127.45 71.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-O 121.217 0.532 . . . . 0.0 110.545 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 11.9 t -119.93 -14.22 8.96 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.313 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.474 ' HB3' HG12 ' A' ' 237' ' ' ILE . . . -143.5 27.08 1.56 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.322 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.0 m 55.08 23.92 5.65 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.741 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 80.28 7.56 88.42 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.367 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.405 ' O ' ' HD3' ' A' ' 236' ' ' LYS . 8.0 tmtm? -64.58 -38.45 91.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.597 0.713 . . . . 0.0 109.976 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.474 HG12 ' HB3' ' A' ' 233' ' ' ALA . 28.7 pt -85.86 10.33 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.343 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -64.71 124.2 21.32 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 121.132 -0.227 . . . . 0.0 110.427 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -173.36 157.27 3.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -86.89 120.74 5.56 Favored Glycine 0 C--O 1.224 -0.485 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.955 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 75.5 mtp85 -129.25 164.35 23.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.967 0.413 . . . . 0.0 111.099 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -104.25 134.83 46.82 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.404 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -114.63 146.75 40.47 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.722 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -95.55 124.72 39.71 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.241 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.561 HD11 HD13 ' A' ' 221' ' ' ILE . 49.9 mm -79.54 118.73 27.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.75 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 3.0 t -125.29 91.77 3.49 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -89.5 115.72 27.14 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.169 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -142.92 80.32 13.89 Favored Pre-proline 0 C--N 1.312 -1.025 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.374 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.533 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 33.7 Cg_exo -60.96 -28.06 85.73 Favored 'Trans proline' 0 C--O 1.218 -0.51 0 C-N-CA 122.981 2.454 . . . . 0.0 111.877 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -65.94 -37.08 85.11 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.845 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -91.64 -55.95 3.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.957 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.571 ' CB ' HD21 ' A' ' 256' ' ' ASN . 5.1 t70 -98.24 -30.18 12.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.114 0.483 . . . . 0.0 111.085 -176.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 95.09 6.22 60.35 Favored Glycine 0 C--N 1.319 -0.4 0 C-N-CA 120.89 -0.672 . . . . 0.0 113.328 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 27.9 p -156.02 171.55 19.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.065 0.433 . . . . 0.0 111.825 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 68.1 t -80.34 119.73 30.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.571 HD21 ' CB ' ' A' ' 252' ' ' ASP . 79.7 m-20 -112.43 151.64 29.62 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.413 -173.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -131.2 131.05 43.72 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.13 176.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.62 129.4 64.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.192 0.52 . . . . 0.0 110.193 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.0 tt -95.89 121.08 37.24 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.531 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.434 ' O ' HD12 ' A' ' 260' ' ' LEU . 1.4 pp -88.31 143.08 27.23 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.814 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--O 1.267 1.987 0 CA-C-O 117.699 -1.143 . . . . 0.0 110.768 -179.259 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 86.2 t80 . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 121.783 0.801 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -63.41 -40.26 96.72 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.975 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 88.7 mtt-85 60.07 69.32 0.71 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.098 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -66.05 -27.88 68.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.873 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' A' ' 202' ' ' LYS . 4.0 mp -78.34 121.56 31.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 120.991 0.424 . . . . 0.0 111.476 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.71 147.8 60.91 Favored Pre-proline 0 N--CA 1.443 -0.823 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.2 -62.15 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.587 2.192 . . . . 0.0 112.528 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 57.1 ttp -168.89 44.0 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 72.23 28.72 67.61 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.905 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -81.33 166.84 20.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.911 0.386 . . . . 0.0 111.063 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 10.4 ptm85 -59.08 -37.31 76.81 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.524 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -133.61 156.78 47.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.128 0.489 . . . . 0.0 111.832 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -80.03 85.56 5.61 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 196' ' ' PRO . 41.0 ttmt -136.15 137.42 40.94 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.84 -176.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -128.57 157.47 41.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.129 0.49 . . . . 0.0 111.715 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -85.61 100.8 12.2 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 192' ' ' THR . 48.7 t -93.97 120.18 42.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -172.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 92.5 m -109.33 128.0 54.76 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.376 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -105.83 105.67 53.97 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -57.07 -38.66 95.19 Favored 'Trans proline' 0 N--CA 1.483 0.889 0 C-N-CA 123.047 2.498 . . . . 0.0 113.366 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 89.6 m -63.23 -42.0 99.18 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.827 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.517 ' HB2' HG12 ' A' ' 191' ' ' VAL . 28.2 mt -99.72 -16.95 17.97 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.086 -175.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 65.5 t30 59.1 53.21 5.63 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.738 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.517 HG12 ' HB2' ' A' ' 189' ' ' LEU . 12.4 p -133.96 133.52 56.2 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.866 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 93.9 m -116.93 128.46 55.23 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.652 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.4 139.01 29.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.722 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -88.75 117.44 27.74 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.627 HD12 ' HD2' ' A' ' 196' ' ' PRO . 23.2 tp -134.24 141.56 39.77 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.251 -173.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.627 ' HD2' HD12 ' A' ' 195' ' ' LEU . 34.4 Cg_endo -65.28 146.33 85.89 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.916 1.744 . . . . 0.0 110.415 176.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.431 HD12 HD12 ' A' ' 221' ' ' ILE . 33.2 mm -81.14 119.93 31.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.012 0.434 . . . . 0.0 111.672 -175.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.95 -39.39 76.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.862 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 222' ' ' GLU . 35.3 t -149.59 143.68 25.72 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.424 HG23 HD13 ' A' ' 172' ' ' ILE . 15.3 m -126.12 141.84 44.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.78 0.324 . . . . 0.0 111.355 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -130.59 123.31 29.22 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-O 121.008 0.433 . . . . 0.0 110.689 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.579 ' HD2' ' O ' ' A' ' 203' ' ' ASN . 1.7 tmmt? -110.42 150.81 28.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.726 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.579 ' O ' ' HD2' ' A' ' 202' ' ' LYS . 3.2 m-20 -59.32 152.39 53.9 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.415 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.49 -30.66 89.04 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.635 2.223 . . . . 0.0 112.711 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 26.3 p -109.01 -92.58 0.43 Allowed 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -134.92 146.8 60.19 Favored Pre-proline 0 N--CA 1.442 -0.837 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.44 ' HG2' ' HA ' ' A' ' 215' ' ' LEU . 74.3 Cg_exo -56.73 -40.85 81.43 Favored 'Trans proline' 0 N--CA 1.471 0.203 0 C-N-CA 122.618 2.212 . . . . 0.0 110.155 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 71.9 mt -119.63 99.1 6.45 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.727 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -67.02 -40.35 87.25 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.52 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.3 t -64.14 -52.98 56.47 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.854 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 212' ' ' LEU . 50.0 tt0 -70.17 -36.24 74.54 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.418 0.151 . . . . 0.0 111.072 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 211' ' ' GLN . 85.3 mt 83.08 126.19 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.164 0.986 . . . . 0.0 113.652 176.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 79.51 -53.06 4.21 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 115.082 0.793 . . . . 0.0 115.082 174.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.404 HG21 ' CD ' ' A' ' 211' ' ' GLN . 35.1 m -58.28 155.44 2.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -174.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.44 ' HA ' ' HG2' ' A' ' 207' ' ' PRO . 2.1 mm? -93.13 163.03 13.79 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.355 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 12.0 t -156.6 173.89 16.27 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.236 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.437 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 18.0 ptpt -67.21 152.68 45.29 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.86 178.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.52 8.12 31.09 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -176.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.561 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 66.1 m -77.07 136.75 38.67 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 51.2 mm -92.32 127.14 44.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.78 0.324 . . . . 0.0 111.116 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.555 HD13 HD11 ' A' ' 245' ' ' ILE . 43.3 pt -130.85 161.08 41.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.093 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 199' ' ' SER . 35.7 tt0 -110.9 128.49 55.83 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.1 m -126.34 157.54 36.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.718 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -98.18 110.62 23.17 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.563 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 10.7 t -91.41 18.94 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.442 ' HB3' ' N ' ' A' ' 239' ' ' TRP . 23.5 p -120.06 -35.24 3.51 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.658 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -64.48 -39.3 93.55 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.649 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.73 -36.59 83.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.075 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 102.03 -88.17 0.67 Allowed Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 50.7 mt 62.2 -74.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.932 0.893 . . . . 0.0 111.435 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 42.0 t 57.11 77.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 123.872 0.869 . . . . 0.0 111.353 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 23.6 p -70.35 -40.62 73.98 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.228 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -161.37 110.36 1.57 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.017 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 22.4 m 58.39 13.23 2.34 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.384 0.673 . . . . 0.0 112.591 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.19 29.31 74.69 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.055 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -61.99 -43.54 98.63 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 120.992 0.425 . . . . 0.0 111.363 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 26.4 pt -78.3 -1.88 4.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.299 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -76.01 108.01 8.6 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.721 0.296 . . . . 0.0 111.274 -177.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . 0.442 ' N ' ' HB3' ' A' ' 226' ' ' SER . 6.8 t90 -178.75 163.22 1.42 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.938 178.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -74.66 123.47 7.58 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.214 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -129.98 165.26 22.51 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -177.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.425 ' CE1' ' HB2' ' A' ' 222' ' ' GLU . 96.8 m-85 -101.07 141.38 34.04 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.238 0.542 . . . . 0.0 111.892 -177.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -128.6 170.14 13.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.873 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -115.26 131.25 56.99 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.771 0.32 . . . . 0.0 111.096 -178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.561 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 44.3 mm -77.0 128.04 37.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.676 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.437 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 3.8 t -132.76 101.73 5.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.799 0.809 . . . . 0.0 109.36 175.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -73.03 117.67 15.04 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.3 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . 0.423 ' HB2' ' ND2' ' A' ' 256' ' ' ASN . 17.5 m120 -130.82 70.81 82.58 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.856 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.78 -22.45 17.7 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.009 1.806 . . . . 0.0 112.079 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -76.26 -28.72 57.2 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.497 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -94.4 -57.55 2.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.683 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -100.01 -29.57 12.47 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 120.89 0.376 . . . . 0.0 111.914 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 84.46 8.41 83.29 Favored Glycine 0 C--N 1.316 -0.553 0 C-N-CA 120.311 -0.947 . . . . 0.0 110.91 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 68.8 m -129.5 161.59 30.08 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.333 -0.433 . . . . 0.0 109.992 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 81.7 t -83.1 118.46 30.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.423 ' ND2' ' HB2' ' A' ' 248' ' ' ASN . 81.4 m-20 -103.02 152.19 21.64 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.992 -172.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -130.96 137.21 49.16 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 176.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.7 p -128.71 136.37 60.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.022 0.439 . . . . 0.0 110.434 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 7.6 tt -86.2 119.79 26.87 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 260' ' ' LEU . 1.1 pp -81.54 133.75 35.42 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.997 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 C--O 1.27 2.133 0 CA-C-O 117.467 -1.254 . . . . 0.0 110.419 178.992 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.647 0.261 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -61.98 -39.57 92.63 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.148 0.499 . . . . 0.0 111.648 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -73.8 -14.44 61.1 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -115.41 -25.47 7.95 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.947 0.404 . . . . 0.0 111.899 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.447 HG22 ' HG3' ' A' ' 173' ' ' ARG . 85.7 mt -120.48 129.08 75.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.447 ' HG3' HG22 ' A' ' 172' ' ' ILE . 94.0 mtt180 66.65 79.11 0.24 Allowed Pre-proline 0 N--CA 1.469 0.514 0 O-C-N 123.644 0.59 . . . . 0.0 110.763 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -52.33 -68.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.976 2.45 . . . . 0.0 111.517 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 53.7 ttm -146.13 20.6 1.41 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.75 146.1 19.24 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -174.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -138.09 147.25 43.82 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -63.52 -38.63 91.86 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.428 ' CD2' ' HB2' ' A' ' 181' ' ' LYS . 66.3 t80 -162.82 143.37 9.59 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.131 -178.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -78.79 80.22 5.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.734 0.302 . . . . 0.0 111.091 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.691 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 84.3 tttt -154.27 129.69 9.83 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -122.74 157.27 32.7 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.26 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 15.2 m120 -87.04 106.19 17.68 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 61.8 t -98.34 119.79 46.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.351 0.596 . . . . 0.0 111.838 -174.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 192' ' ' THR . 85.1 m -93.48 125.93 38.36 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 176.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.42 ' NE2' HD22 ' A' ' 228' ' ' LEU . 69.9 m80 -104.14 110.89 64.85 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.7 -38.65 91.29 Favored 'Trans proline' 0 N--CA 1.483 0.877 0 C-N-CA 123.575 2.85 . . . . 0.0 114.02 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 8.0 t -70.64 -30.95 67.71 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.581 ' HB2' HG12 ' A' ' 191' ' ' VAL . 37.7 mt -98.68 -21.84 16.21 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.27 0.557 . . . . 0.0 109.608 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 23.7 m120 58.3 42.85 20.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.206 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.581 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.5 p -135.38 145.36 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.019 -178.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 185' ' ' THR . 8.8 t -106.12 121.57 44.42 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.419 0.628 . . . . 0.0 109.998 177.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.84 126.58 71.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.805 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.691 ' HG2' ' HG2' ' A' ' 181' ' ' LYS . 58.3 tt0 -79.11 122.61 26.45 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.428 ' C ' ' HG3' ' A' ' 181' ' ' LYS . 95.4 mt -128.18 150.52 74.18 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.832 -176.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.07 149.44 71.27 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.547 2.165 . . . . 0.0 112.085 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.471 HD12 HD12 ' A' ' 221' ' ' ILE . 35.5 mm -94.0 115.57 33.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.091 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 97.3 mt -70.39 -41.64 72.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.073 0.463 . . . . 0.0 110.462 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.5 t -160.9 153.11 20.19 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.129 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 33.4 m -118.72 146.18 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-O 121.005 0.431 . . . . 0.0 110.318 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -128.14 143.59 51.06 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -60.45 144.36 51.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.961 0.41 . . . . 0.0 111.141 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.41 ' HB3' ' HA ' ' A' ' 219' ' ' THR . 11.7 p30 -72.64 157.14 89.38 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.851 178.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.407 ' HB2' ' OD1' ' A' ' 206' ' ' ASN . 33.3 Cg_endo -63.78 -11.42 26.59 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.046 2.497 . . . . 0.0 112.428 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 22.4 m 67.56 21.06 9.58 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 123.403 0.681 . . . . 0.0 111.8 178.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.493 ' N ' ' HD2' ' A' ' 207' ' ' PRO . 4.6 m-20 -62.95 -49.29 82.43 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.827 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 206' ' ' ASN . 49.1 Cg_endo -68.35 -16.73 43.99 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.389 2.06 . . . . 0.0 112.87 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 85.0 mt -98.71 136.87 38.15 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.547 0.689 . . . . 0.0 111.563 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -117.71 -32.93 4.69 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.593 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 72.2 p -82.1 164.49 21.31 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.066 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -95.46 12.4 29.52 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.026 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 98.6 mt -61.92 -40.32 95.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.797 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 80.19 85.61 0.62 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.864 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.451 HG23 HG23 ' A' ' 216' ' ' THR . 35.8 m -129.74 159.81 41.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 5.1 tt -82.68 113.57 20.45 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.1 0.476 . . . . 0.0 109.917 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.451 HG23 HG23 ' A' ' 214' ' ' VAL . 70.6 p -126.34 167.48 15.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.078 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -63.77 152.58 38.99 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.221 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 102.49 7.33 45.81 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -176.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.565 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 90.8 m -79.9 140.96 36.52 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.9 mm -101.9 130.46 51.58 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.706 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.297 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.59 HD13 HD11 ' A' ' 245' ' ' ILE . 42.3 pt -126.9 159.87 36.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.773 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -109.94 127.85 55.01 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 32.3 m -130.23 159.08 42.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.179 0.514 . . . . 0.0 111.455 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -95.38 109.38 21.56 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 92.6 t -97.0 87.91 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 48.6 m -129.84 -50.87 1.14 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.158 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -98.3 -51.15 4.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.579 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.491 HD21 HG13 ' A' ' 225' ' ' VAL . 84.5 mt 60.49 26.4 16.03 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.661 -176.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 92.69 -9.25 75.99 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.978 -0.556 . . . . 0.0 113.019 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 47.1 pt -131.97 175.19 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.798 0.332 . . . . 0.0 110.762 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 64.5 t -117.69 119.36 61.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 10.0 p -89.27 -86.24 0.19 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.198 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -150.2 82.01 1.37 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.543 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 44.7 m 53.87 39.59 30.58 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.017 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.24 42.27 83.8 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.685 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -61.13 -40.73 94.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.344 0.592 . . . . 0.0 110.872 -176.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 13.9 pt -103.87 23.54 2.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.445 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -73.68 106.9 5.63 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.155 0.503 . . . . 0.0 111.975 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -139.49 149.28 43.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.755 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -78.04 125.83 7.39 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -128.72 155.91 44.33 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 120.883 0.373 . . . . 0.0 111.02 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.494 ' CE2' HD11 ' A' ' 260' ' ' LEU . 49.2 p90 -109.11 142.25 40.12 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -122.55 154.82 37.4 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 120.96 0.409 . . . . 0.0 111.308 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -94.0 122.69 36.76 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.056 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.59 HD11 HD13 ' A' ' 221' ' ' ILE . 42.8 mm -77.24 119.38 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.351 177.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 80.2 p -122.5 86.65 2.62 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -90.49 129.61 36.63 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.113 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -142.66 76.33 17.82 Favored Pre-proline 0 C--N 1.304 -1.384 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.285 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.517 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 58.7 Cg_endo -70.34 -17.52 34.87 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.326 2.017 . . . . 0.0 111.354 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -69.06 -37.54 78.59 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.124 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -105.7 -60.15 1.67 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.015 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.66 -39.71 61.87 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.48 0.657 . . . . 0.0 110.642 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 94.09 -7.11 72.88 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.999 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 79.4 m -131.67 168.02 18.46 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.053 0.454 . . . . 0.0 111.888 -177.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 75.5 t -83.35 119.23 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -111.46 152.96 26.82 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -133.26 150.6 51.92 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.4 p -126.91 136.57 60.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 120.901 0.381 . . . . 0.0 110.031 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 57.2 tp -87.64 125.16 34.22 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.966 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.494 HD11 ' CE2' ' A' ' 242' ' ' TYR . 4.2 pp -98.6 148.91 23.32 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.584 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 11.9 m . . . . . 0 C--O 1.263 1.799 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.851 -179.513 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 121.063 0.458 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.28 -35.7 81.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.605 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -67.43 -17.49 64.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.783 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -103.6 117.85 35.37 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.4 mp -104.11 129.19 56.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.98 -176.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -107.4 105.09 54.98 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.34 -41.91 46.08 Favored 'Trans proline' 0 N--CA 1.475 0.414 0 C-N-CA 122.348 2.032 . . . . 0.0 110.858 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 53.6 ttm -178.2 29.77 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 95.36 98.03 1.74 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.469 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.596 HD23 ' H ' ' A' ' 177' ' ' LEU . 2.5 pt? -112.35 116.34 30.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.446 0.641 . . . . 0.0 111.268 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -71.86 -25.75 62.08 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.147 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -161.08 146.33 14.11 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.571 ' HB3' ' HB ' ' A' ' 197' ' ' ILE . 10.1 mptt -79.53 88.81 5.06 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.572 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt -151.92 139.25 19.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.329 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -142.98 154.45 44.03 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.977 0.418 . . . . 0.0 111.367 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -89.19 108.42 19.6 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 61.3 t -100.2 125.52 53.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -171.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 94.7 m -103.69 127.36 51.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.143 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -104.72 107.62 58.77 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.34 -35.65 98.88 Favored 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 123.132 2.555 . . . . 0.0 113.504 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.438 HG23 ' HG ' ' A' ' 189' ' ' LEU . 5.3 t -73.88 -34.62 64.52 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -177.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.543 ' HB2' HG12 ' A' ' 191' ' ' VAL . 38.5 mt -95.86 -16.27 21.93 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 120.817 0.342 . . . . 0.0 110.125 -177.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 60.27 42.48 15.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.046 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.543 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.9 p -134.97 139.01 48.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.6 -176.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 87.0 m -114.32 119.02 35.55 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.806 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.571 HG21 HD22 ' A' ' 228' ' ' LEU . 9.6 m -135.54 147.19 28.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.435 -177.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.492 ' C ' HD12 ' A' ' 195' ' ' LEU . 64.4 tt0 -101.0 118.97 38.05 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.739 0.304 . . . . 0.0 110.614 -177.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.492 HD12 ' C ' ' A' ' 194' ' ' GLN . 5.6 mp -129.02 147.8 66.33 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.53 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -61.16 143.26 98.59 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.349 2.033 . . . . 0.0 110.02 172.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.571 ' HB ' ' HB3' ' A' ' 180' ' ' LYS . 82.4 mt -80.54 121.47 34.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 223' ' ' VAL . 4.1 mm? -67.77 -43.92 78.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.643 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 52.4 m -152.19 153.43 33.8 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.266 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 31.3 m -117.79 145.93 22.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -127.86 121.17 29.37 Favored 'General case' 0 C--O 1.256 1.427 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -66.44 138.96 57.93 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.425 ' OD1' ' HA ' ' A' ' 219' ' ' THR . 87.1 m-20 -63.19 121.67 70.77 Favored Pre-proline 0 C--N 1.309 -1.152 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.654 -174.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.29 -33.59 18.03 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.978 1.786 . . . . 0.0 110.693 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 35.7 t -70.04 -41.93 73.56 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.626 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 52.84 75.75 0.61 Allowed Pre-proline 0 N--CA 1.474 0.737 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.301 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -55.55 -38.87 93.67 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.437 2.091 . . . . 0.0 110.74 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.556 HD22 HG23 ' A' ' 216' ' ' THR . 10.8 mp -123.63 115.02 20.79 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.383 177.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -61.71 -48.88 78.74 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 11.2 t 176.87 141.16 0.07 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.219 174.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -142.55 -58.64 0.44 Allowed 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.3 10.01 41.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.281 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 91.34 -9.29 77.78 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.82 162.79 36.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 122.886 0.474 . . . . 0.0 109.808 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 11.1 mp -99.0 170.28 8.83 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.498 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.556 HG23 HD22 ' A' ' 208' ' ' LEU . 19.5 p -91.2 170.13 10.26 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.138 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -54.18 153.35 5.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.476 -0.783 . . . . 0.0 112.549 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 116.65 10.11 10.58 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.417 -175.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.425 ' HA ' ' OD1' ' A' ' 203' ' ' ASN . 59.8 m -67.09 137.04 56.07 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.9 mm -91.11 130.84 39.66 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.424 -174.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 46.9 pt -129.11 156.82 41.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.061 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 198' ' ' LEU . 52.9 mt-10 -114.74 125.95 54.29 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.424 ' HA ' HD23 ' A' ' 198' ' ' LEU . 35.9 m -130.59 155.9 42.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.248 0.547 . . . . 0.0 111.105 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -97.51 106.81 19.19 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.608 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 31.6 t -80.74 77.35 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 121.565 0.698 . . . . 0.0 110.394 -177.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.438 ' H ' ' H ' ' A' ' 227' ' ' ASP . 38.6 p -169.37 -16.0 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.329 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . 0.438 ' H ' ' H ' ' A' ' 226' ' ' SER . 36.6 t70 -81.24 9.28 7.21 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.434 177.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.571 HD22 HG21 ' A' ' 193' ' ' VAL . 87.9 mt -63.19 -34.57 77.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.902 -176.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 83.79 22.39 55.73 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.094 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 42.0 pt -116.91 161.18 15.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.924 0.392 . . . . 0.0 110.495 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 66.8 t -117.7 123.86 72.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.806 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 19.1 p -117.05 -70.43 0.79 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.076 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -169.31 97.35 0.34 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.553 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 19.2 t 63.32 15.97 9.1 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.43 34.03 78.58 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.84 -1.171 . . . . 0.0 111.495 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -63.44 -18.56 63.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.98 0.419 . . . . 0.0 111.639 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 33.6 pt -90.9 -0.1 9.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.512 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -75.98 107.81 8.44 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.159 0.504 . . . . 0.0 111.711 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -164.73 131.74 3.06 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.488 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -70.78 113.57 4.85 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.133 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -129.54 157.11 42.96 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.93 0.395 . . . . 0.0 111.224 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -102.38 148.74 25.11 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.378 0.609 . . . . 0.0 111.446 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -131.84 170.18 15.21 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.129 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 219' ' ' THR . 11.8 pt20 -116.65 141.78 47.76 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.391 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 84.1 mt -83.25 124.47 39.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.43 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 2.8 t -141.28 100.91 3.9 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.753 176.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -75.35 135.11 40.86 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.063 0.459 . . . . 0.0 111.413 -177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -140.79 72.46 29.12 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.481 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.407 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 23.4 Cg_exo -66.84 -21.13 51.16 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.798 2.332 . . . . 0.0 111.554 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -67.68 -38.32 83.56 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.226 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -107.64 -57.97 2.02 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.53 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.54 -37.53 63.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.207 0.527 . . . . 0.0 110.667 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 89.27 5.5 72.6 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.139 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 33.0 t -145.49 177.4 8.88 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 96.9 t -80.21 122.14 34.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 246' ' ' THR . 8.1 m120 -105.95 152.97 22.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.287 0.565 . . . . 0.0 111.414 -174.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.586 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -134.73 140.01 45.62 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 174.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 12.5 p -126.25 135.69 63.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.811 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 64.7 tp -80.69 129.22 34.4 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.847 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 4.1 pp -95.52 143.63 26.67 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.164 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 C--O 1.269 2.101 0 CA-C-O 117.411 -1.281 . . . . 0.0 110.422 179.707 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 50.0 p90 . . . . . 0 N--CA 1.484 1.267 0 CA-C-O 121.16 0.505 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -124.99 73.52 1.3 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.318 0.58 . . . . 0.0 110.186 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 80.4 mtp85 -77.83 149.4 34.37 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.544 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -96.86 140.63 31.13 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.778 0.323 . . . . 0.0 111.31 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 172' ' ' ILE . 3.9 mp -86.03 105.94 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.509 ' O ' ' HB2' ' A' ' 215' ' ' LEU . 36.7 ptt180 -154.43 147.77 18.36 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.009 -176.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.24 -33.28 39.95 Favored 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 122.672 2.248 . . . . 0.0 111.054 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 59.7 ttm -179.32 -48.5 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -161.99 144.99 10.24 Favored Glycine 0 N--CA 1.41 -3.096 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.426 ' H ' HD13 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -140.5 145.3 36.7 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 117.054 0.427 . . . . 0.0 110.717 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -86.15 -26.0 25.41 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.52 -176.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -170.21 163.74 9.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -175.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -69.09 68.05 0.17 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.167 0.292 . . . . 0.0 110.717 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.469 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 41.1 ttmt -154.88 137.27 14.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.524 0.202 . . . . 0.0 110.531 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -135.15 151.05 50.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.883 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 53.8 t-20 -85.22 103.52 14.26 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 257' ' ' ALA . 54.1 t -93.59 121.91 44.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.177 0.513 . . . . 0.0 112.247 -173.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 62.9 m -98.26 124.78 43.04 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.207 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -106.04 106.87 58.38 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.24 -29.11 64.22 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.342 2.028 . . . . 0.0 112.796 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.2 t -73.73 -23.69 59.8 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.416 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.551 ' HB2' HG12 ' A' ' 191' ' ' VAL . 36.2 mt -104.85 -19.8 13.78 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.3 t30 61.16 47.56 7.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.568 -1.197 . . . . 0.0 109.405 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 189' ' ' LEU . 5.9 p -145.09 146.54 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -177.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.2 t -121.07 120.7 36.1 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 121.555 0.693 . . . . 0.0 109.639 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.4 t -129.09 135.18 62.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.156 -177.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 62.0 tt0 -87.66 119.75 28.29 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.852 0.358 . . . . 0.0 110.747 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.3 mp -125.21 155.34 71.39 Favored Pre-proline 0 C--O 1.237 0.407 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.375 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 181' ' ' LYS . 55.9 Cg_endo -69.39 151.75 71.16 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.473 2.115 . . . . 0.0 111.655 177.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 83.4 mt -88.57 111.92 23.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.848 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.0 mp -69.28 -43.98 72.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.101 0.476 . . . . 0.0 111.934 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 50.6 m -151.34 157.85 43.02 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.329 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 33.0 m -123.42 146.7 28.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.224 0.535 . . . . 0.0 111.315 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.446 ' HB2' ' HB ' ' A' ' 220' ' ' ILE . 74.3 mmtt -125.58 110.42 13.81 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.474 176.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.453 ' HD3' ' O ' ' A' ' 203' ' ' ASN . 1.6 tmtp? -75.3 125.34 28.78 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.456 ' HB3' ' OD1' ' A' ' 206' ' ' ASN . 95.1 m-20 -64.79 131.82 95.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 120.718 0.294 . . . . 0.0 110.54 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -60.02 -42.51 43.55 Favored 'Trans proline' 0 N--CA 1.476 0.47 0 C-N-CA 123.141 2.561 . . . . 0.0 113.656 -173.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 33.6 t -162.55 88.13 0.63 Allowed 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.227 0.536 . . . . 0.0 111.493 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.456 ' OD1' ' HB3' ' A' ' 203' ' ' ASN . 4.5 m-20 -102.44 149.77 36.98 Favored Pre-proline 0 C--N 1.308 -1.204 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.586 174.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.462 ' O ' HG21 ' A' ' 216' ' ' THR . 50.0 Cg_exo -55.37 112.58 1.09 Allowed 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.888 2.392 . . . . 0.0 112.6 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.509 HD23 HG23 ' A' ' 216' ' ' THR . 54.8 mt -104.49 55.88 0.71 Allowed 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 122.115 0.96 . . . . 0.0 109.51 178.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -62.49 -39.93 95.03 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 113.666 -1.606 . . . . 0.0 110.248 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.469 ' HB ' ' HG ' ' A' ' 212' ' ' LEU . 62.7 p -100.28 -40.43 7.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.395 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.419 ' HG2' ' HB3' ' A' ' 208' ' ' LEU . 49.0 mt-30 59.14 17.79 5.9 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.722 0.409 . . . . 0.0 111.711 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.469 ' HG ' ' HB ' ' A' ' 210' ' ' THR . 97.9 mt -64.96 -39.82 94.06 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -102.52 14.9 56.4 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.723 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.439 HG12 HD12 ' A' ' 215' ' ' LEU . 47.2 t 73.92 -55.74 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 173' ' ' ARG . 9.8 mp -105.0 175.44 5.49 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.509 HG23 HD23 ' A' ' 208' ' ' LEU . 71.2 p -114.46 155.08 27.03 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -62.74 150.69 40.6 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.99 10.55 34.41 Favored Glycine 0 N--CA 1.436 -1.309 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -173.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 95.1 m -68.08 138.78 56.04 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 201' ' ' LYS . 51.1 mm -90.46 129.63 40.99 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 CA-C-O 120.726 0.298 . . . . 0.0 111.703 -174.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.41 HG21 HD11 ' A' ' 245' ' ' ILE . 44.9 pt -131.62 159.06 43.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.558 175.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -107.22 126.05 51.92 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.87 151.88 35.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.611 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -106.55 106.67 17.3 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.089 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 3.0 p -82.21 85.34 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-O 121.912 0.863 . . . . 0.0 110.193 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 15.0 p -123.7 -84.87 0.65 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.176 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -64.43 -46.68 82.16 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.407 HD21 HG23 ' A' ' 225' ' ' VAL . 97.0 mt 56.45 16.18 2.36 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.109 0.481 . . . . 0.0 110.774 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 83.77 0.58 89.86 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 115.989 -0.551 . . . . 0.0 113.037 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 44.9 pt -133.67 171.71 17.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.297 0.57 . . . . 0.0 111.582 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 66.6 t -113.66 114.82 47.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 11.7 t -154.58 146.07 23.11 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.638 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . 52.93 25.18 3.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.147 0.579 . . . . 0.0 112.008 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 58.2 m 56.79 18.78 3.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.34 0.656 . . . . 0.0 111.971 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.57 26.21 74.72 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.077 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -66.01 -18.99 65.7 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.204 0.526 . . . . 0.0 111.135 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 30.9 pt -87.6 8.85 2.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.991 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -66.68 106.3 1.79 Allowed 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.084 0.469 . . . . 0.0 111.457 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -142.33 151.88 42.38 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.309 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -93.07 112.76 4.33 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 174.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.95 164.34 23.37 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 120.741 0.305 . . . . 0.0 111.065 -177.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 98.2 m-85 -102.35 139.92 37.32 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.221 0.534 . . . . 0.0 111.61 -175.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -127.63 154.51 45.17 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.775 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -97.81 132.73 43.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.593 0.235 . . . . 0.0 110.725 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.41 HD11 HG21 ' A' ' 221' ' ' ILE . 87.1 mt -79.71 119.9 29.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 4.3 t -133.83 98.51 4.19 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -81.19 123.64 28.62 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.947 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -129.76 72.1 82.01 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.017 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.529 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 59.5 Cg_endo -70.16 -22.24 30.53 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.267 1.978 . . . . 0.0 112.228 -178.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -70.22 -37.73 75.09 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.27 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -96.29 -57.51 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.923 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.409 ' CG ' HD21 ' A' ' 256' ' ' ASN . 34.6 t70 -82.36 -39.57 22.57 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.343 0.592 . . . . 0.0 110.767 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 96.78 8.96 56.77 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.239 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 14.0 t -153.61 -179.93 8.25 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 93.7 t -79.87 126.64 39.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 246' ' ' THR . 10.0 m120 -113.33 154.28 27.12 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.861 0.362 . . . . 0.0 110.764 -174.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.532 ' HB3' HG22 ' A' ' 184' ' ' VAL . . . -131.98 147.96 52.49 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.9 p -123.43 131.0 73.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.025 0.44 . . . . 0.0 110.418 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.9 tt -100.53 123.84 45.29 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.801 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 2.8 pp -92.51 151.29 20.26 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.139 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.262 1.728 0 CA-C-O 117.75 -1.119 . . . . 0.0 110.876 -179.231 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 47.9 p90 . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 121.4 0.619 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -82.52 61.33 5.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.294 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -124.09 148.11 47.37 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.33 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -87.8 151.48 22.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.813 0.339 . . . . 0.0 111.753 -177.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.552 HD11 ' HB3' ' A' ' 202' ' ' LYS . 83.1 mt 66.29 90.21 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.891 -175.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.442 ' HA ' ' HD2' ' A' ' 174' ' ' PRO . 79.4 mtp180 59.28 82.64 0.23 Allowed Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.275 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 173' ' ' ARG . 10.7 Cg_endo -55.75 -38.91 93.8 Favored 'Trans proline' 0 N--CA 1.478 0.611 0 C-N-CA 123.342 2.694 . . . . 0.0 112.196 -176.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 60.1 ttm 179.34 -25.21 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 151.04 176.16 23.64 Favored Glycine 1 N--CA 1.394 -4.126 0 N-CA-C 107.281 -2.327 . . . . 0.0 107.281 -177.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -153.77 175.48 13.25 Favored 'General case' 0 C--N 1.273 -2.75 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 178' ' ' ARG . 11.8 ptm85 -59.46 -41.93 90.86 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.015 0.197 . . . . 0.0 111.472 -177.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -176.28 152.78 1.15 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.457 ' HD2' ' N ' ' A' ' 180' ' ' LYS . 11.1 mptt -82.42 81.19 8.36 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -176.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -138.19 150.55 46.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.743 0.417 . . . . 0.0 110.921 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.457 ' HB2' HD11 ' A' ' 197' ' ' ILE . . . -141.94 151.16 42.32 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.714 177.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 20.0 m120 -86.53 100.44 12.39 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 120.557 -0.457 . . . . 0.0 109.833 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 64.5 t -85.34 120.31 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.72 -176.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 63.7 m -105.33 126.46 52.13 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.458 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -104.33 111.64 65.23 Favored Pre-proline 0 C--N 1.312 -1.035 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.34 -27.14 77.49 Favored 'Trans proline' 0 N--CA 1.474 0.334 0 C-N-CA 122.556 2.171 . . . . 0.0 112.462 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 89.3 m -63.35 -42.64 98.92 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.31 0.576 . . . . 0.0 110.568 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.553 ' HB2' HG12 ' A' ' 191' ' ' VAL . 28.3 mt -95.05 -21.38 18.6 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.364 -177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 65.6 t30 59.57 51.66 6.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.496 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.553 HG12 ' HB2' ' A' ' 189' ' ' LEU . 10.0 p -140.14 148.86 22.21 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.817 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 13.6 t -119.47 122.75 42.42 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.497 0.665 . . . . 0.0 110.44 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.477 HG11 ' HA3' ' A' ' 229' ' ' GLY . 57.3 t -128.88 131.06 68.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.665 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 29.6 tt0 -78.24 124.51 28.16 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.834 0.35 . . . . 0.0 111.099 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 194' ' ' GLN . 7.4 mp -127.27 149.33 69.43 Favored Pre-proline 0 C--O 1.238 0.499 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.155 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 180' ' ' LYS . 40.5 Cg_exo -61.4 142.58 96.03 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.844 2.363 . . . . 0.0 112.307 176.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.457 HD11 ' HB2' ' A' ' 182' ' ' ALA . 81.6 mt -90.84 120.78 40.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.9 mp -72.29 -45.13 61.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.771 0.32 . . . . 0.0 111.389 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.2 t -162.91 157.12 20.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.889 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.429 HG12 HG22 ' A' ' 221' ' ' ILE . 33.6 m -119.1 146.19 24.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-O 120.9 0.381 . . . . 0.0 110.72 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -129.31 142.45 50.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.827 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.552 ' HB3' HD11 ' A' ' 172' ' ' ILE . 26.4 pttm -77.92 158.57 29.32 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.586 0.708 . . . . 0.0 112.436 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -127.6 137.68 31.24 Favored Pre-proline 0 C--N 1.308 -1.212 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.32 -21.35 60.2 Favored 'Trans proline' 0 N--CA 1.478 0.583 0 C-N-CA 122.834 2.356 . . . . 0.0 113.575 -176.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 52.4 m -93.42 0.55 56.85 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -64.23 -52.42 54.81 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.95 109.23 2.8 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 121.691 1.594 . . . . 0.0 111.738 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 79.5 mt -125.87 -13.51 6.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.211 -0.449 . . . . 0.0 112.133 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.458 ' HD2' ' H ' ' A' ' 212' ' ' LEU . 51.9 t80 -64.8 -33.47 76.06 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.699 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 40.1 p 65.85 -41.28 0.34 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.369 1.468 . . . . 0.0 114.791 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.429 ' HB2' ' CE2' ' A' ' 209' ' ' TYR . 15.3 mm100 -68.89 -40.05 79.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.008 0.433 . . . . 0.0 110.924 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.458 ' H ' ' HD2' ' A' ' 209' ' ' TYR . 86.6 mt -137.08 -80.79 0.38 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.225 -178.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 178.5 157.38 19.03 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.584 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.429 HG12 ' H ' ' A' ' 209' ' ' TYR . 8.5 p -166.41 153.33 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 63.7 tp -104.03 123.7 47.7 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 40.2 m -115.18 141.66 47.72 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.974 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -46.83 151.23 0.63 Allowed 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.727 0.642 . . . . 0.0 111.927 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 111.3 8.58 23.18 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -176.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.535 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 25.7 m -74.49 144.44 44.15 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.2 mm -104.1 127.18 58.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.699 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.648 HD13 HD11 ' A' ' 245' ' ' ILE . 46.1 pt -125.97 160.18 33.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.876 0.369 . . . . 0.0 111.114 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -103.8 126.38 50.9 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.372 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.58 151.59 36.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.078 0.466 . . . . 0.0 110.885 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -92.36 105.87 17.98 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 22.8 t -93.86 70.45 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 121.423 0.63 . . . . 0.0 110.108 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 50.7 m -125.99 -42.85 1.86 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.496 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -73.48 -43.57 59.89 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.227 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.444 ' O ' HG11 ' A' ' 193' ' ' VAL . 7.1 mp 54.02 17.29 1.34 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.46 -176.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.477 ' HA3' HG11 ' A' ' 193' ' ' VAL . . . 77.33 -47.98 2.75 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -176.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 44.3 pt -128.27 157.86 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.6 m -96.74 43.97 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-O 121.099 0.476 . . . . 0.0 111.269 -177.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.1 t -48.93 -46.68 43.44 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.986 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -98.86 10.74 40.67 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -177.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 16.5 t 60.35 38.05 19.81 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.77 -127.78 28.6 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -174.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? 75.08 -45.54 0.57 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.64 0.776 . . . . 0.0 110.488 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 21.3 pt -88.85 18.57 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.801 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -69.46 112.94 6.32 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.38 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . 0.508 ' O ' ' HB ' ' A' ' 225' ' ' VAL . 23.1 t90 -169.25 138.21 2.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.718 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -68.11 131.84 28.0 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.083 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.44 176.08 8.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.821 0.343 . . . . 0.0 110.855 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -111.79 138.54 48.25 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.783 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -122.48 149.85 43.32 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.787 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -95.29 127.09 41.06 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.151 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.648 HD11 HD13 ' A' ' 221' ' ' ILE . 48.0 mm -78.47 120.7 29.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 178.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.8 t -134.97 98.32 3.98 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.934 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -80.5 126.24 30.97 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.875 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -135.82 72.18 62.59 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.518 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 35.5 Cg_exo -63.94 -26.52 66.71 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.062 2.508 . . . . 0.0 112.03 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -67.58 -37.44 82.62 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.403 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -96.68 -56.96 2.42 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.309 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -87.22 -40.2 14.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.072 0.463 . . . . 0.0 110.729 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 99.7 9.36 49.94 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.879 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 30.6 p -152.21 179.16 8.76 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.658 -0.319 . . . . 0.0 110.996 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 66.9 t -80.65 123.39 37.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -114.38 153.27 30.15 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.787 0.327 . . . . 0.0 110.147 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -128.3 146.88 50.63 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.6 p -122.39 129.71 75.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 121.127 0.489 . . . . 0.0 110.291 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 8.8 tt -105.32 124.43 49.52 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.906 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 260' ' ' LEU . 3.4 pp -99.43 150.34 22.27 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.375 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 23.9 m . . . . . 0 C--O 1.272 2.268 0 CA-C-O 117.679 -1.153 . . . . 0.0 110.71 179.742 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 52.9 p90 . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 121.114 0.483 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -142.55 96.77 3.0 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 121.592 0.71 . . . . 0.0 109.732 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -138.04 32.22 2.41 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.151 176.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -98.61 109.56 22.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.644 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.499 ' C ' ' HD2' ' A' ' 173' ' ' ARG . 4.5 mp -118.6 98.48 6.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.603 176.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.499 ' HD2' ' C ' ' A' ' 172' ' ' ILE . 2.3 mpt_? -123.19 103.52 35.93 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -55.51 -39.08 93.07 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.257 2.638 . . . . 0.0 112.738 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 57.4 ttp -151.28 14.9 0.7 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.278 0.561 . . . . 0.0 110.209 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 69.27 29.62 71.9 Favored Glycine 0 C--O 1.229 -0.211 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.831 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 177' ' ' LEU . 1.6 pt? -54.59 141.26 32.24 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.793 0.437 . . . . 0.0 111.895 -178.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -59.9 -34.86 73.75 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.545 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -139.2 142.29 37.9 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -69.38 85.51 0.41 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -177.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -151.8 137.6 18.0 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.978 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -140.1 159.21 42.7 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.145 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 89.9 m-20 -82.18 104.28 12.4 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 59.9 t -95.73 120.14 44.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.244 0.545 . . . . 0.0 112.119 -173.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 192' ' ' THR . 90.5 m -95.2 125.28 39.74 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.318 176.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -105.26 107.78 59.82 Favored Pre-proline 0 C--N 1.313 -1.009 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 34.0 Cg_endo -63.96 -26.23 66.64 Favored 'Trans proline' 0 N--CA 1.474 0.374 0 C-N-CA 122.548 2.165 . . . . 0.0 112.644 -176.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 86.4 m -64.6 -41.58 96.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.389 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.594 ' HB2' HG12 ' A' ' 191' ' ' VAL . 35.0 mt -99.3 -14.54 19.19 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.757 -177.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 60.22 45.23 11.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.26 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.8 p -138.79 144.72 29.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.439 -176.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 185' ' ' THR . 86.1 m -107.49 119.7 40.14 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.2 130.18 69.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 63.4 tt0 -75.51 120.26 20.69 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.49 HD21 HD22 ' A' ' 228' ' ' LEU . 87.2 mt -129.55 149.88 74.11 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.605 -174.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.74 144.98 50.23 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.353 2.036 . . . . 0.0 110.749 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.491 HG23 ' HB ' ' A' ' 221' ' ' ILE . 80.2 mt -93.48 116.85 35.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.248 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.4 mp -71.8 -46.15 59.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.675 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 39.2 m -141.25 148.33 39.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.597 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.454 HG12 HG22 ' A' ' 221' ' ' ILE . 29.2 m -129.72 137.66 56.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.628 0.251 . . . . 0.0 110.633 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -143.79 142.95 31.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.03 0.443 . . . . 0.0 110.835 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -112.07 146.67 37.54 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.991 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -120.07 140.22 29.54 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.432 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.58 -12.76 36.75 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.433 2.755 . . . . 0.0 111.98 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 47.0 t -60.0 -39.7 86.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.263 178.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.448 ' ND2' ' HA3' ' A' ' 218' ' ' GLY . 2.1 m-20 -76.29 130.46 77.42 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.835 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.01 -20.23 29.2 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.757 2.305 . . . . 0.0 112.143 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 8.7 mp 63.04 -166.67 0.22 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.255 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -64.06 -29.1 70.26 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 30.1 m 72.15 -59.01 0.57 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.801 177.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -61.85 -41.44 97.83 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -175.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 84.5 mt -93.68 -32.94 13.85 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.053 0.454 . . . . 0.0 111.164 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 89.46 -7.06 82.75 Favored Glycine 0 C--O 1.228 -0.224 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.672 -177.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 88.7 t -69.65 141.23 17.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 122.785 0.434 . . . . 0.0 110.021 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 10.3 mp -54.29 142.12 27.5 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.122 0.487 . . . . 0.0 110.63 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.3 m -133.28 162.99 30.32 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.175 -174.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 246' ' ' THR . 18.3 ptpt -47.18 151.01 0.74 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.486 0.66 . . . . 0.0 112.454 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.448 ' HA3' ' ND2' ' A' ' 206' ' ' ASN . . . 113.35 9.09 18.29 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.507 -176.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.574 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 60.5 m -76.27 139.05 40.93 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.4 mm -97.48 126.41 50.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 120.803 0.335 . . . . 0.0 110.364 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.681 HD13 HD11 ' A' ' 245' ' ' ILE . 44.6 pt -125.98 165.03 24.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.118 0.485 . . . . 0.0 111.561 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -112.09 128.11 56.11 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.798 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.82 158.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.93 0.395 . . . . 0.0 110.902 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -110.33 112.18 23.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.267 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 3.2 p -102.4 79.39 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.788 0.804 . . . . 0.0 109.683 176.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 32.4 t -156.85 -42.35 0.07 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.145 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -94.2 19.57 9.18 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.864 -178.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.49 HD22 HD21 ' A' ' 195' ' ' LEU . 39.8 mt -70.76 -16.96 62.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.621 -175.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 82.73 2.96 90.69 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.533 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.4 pt -113.31 162.01 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.81 124.62 44.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.862 0.839 . . . . 0.0 111.249 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 9.9 t -99.07 -151.57 0.39 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -67.2 85.71 0.15 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.936 0.398 . . . . 0.0 110.641 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 39.7 m 64.77 13.11 8.21 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.912 0.885 . . . . 0.0 112.298 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 63.31 33.36 87.03 Favored Glycine 0 C--O 1.225 -0.446 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.972 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -65.35 -14.58 61.15 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 23.7 pt -105.86 12.18 8.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.974 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -75.46 106.02 6.79 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.987 0.423 . . . . 0.0 111.483 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -165.53 177.22 7.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.844 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -87.94 118.78 5.13 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 173.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 62.6 mtp85 -127.38 166.74 17.29 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.971 0.386 . . . . 0.0 111.0 -173.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -108.28 139.38 43.07 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.289 0.566 . . . . 0.0 111.692 -176.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -127.28 161.69 27.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.28 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -106.17 130.93 53.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.885 0.374 . . . . 0.0 111.107 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.681 HD11 HD13 ' A' ' 221' ' ' ILE . 41.9 mm -80.29 125.61 39.15 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.127 177.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 4.9 t -135.5 90.17 2.58 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 173.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -80.17 123.53 28.0 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.249 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -130.42 71.71 82.18 Favored Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.615 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.511 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 51.3 Cg_endo -67.8 -23.38 41.78 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.985 1.79 . . . . 0.0 111.07 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -73.12 -26.34 61.19 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.464 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -104.57 -56.18 2.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.066 -176.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -90.86 -40.07 11.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.063 0.459 . . . . 0.0 110.717 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 105.08 -8.54 45.53 Favored Glycine 0 C--N 1.316 -0.578 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.424 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 75.2 m -132.72 175.94 8.9 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.702 0.287 . . . . 0.0 111.061 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 86.6 t -79.95 124.34 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 246' ' ' THR . 3.2 m120 -107.34 151.95 24.8 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -176.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -139.88 150.43 44.61 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 177.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.9 p -134.58 135.91 53.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 120.837 0.351 . . . . 0.0 110.429 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.409 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 64.3 tp -73.71 126.52 30.53 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 260' ' ' LEU . 3.2 pp -82.98 131.13 35.2 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.119 0.485 . . . . 0.0 111.117 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--O 1.272 2.24 0 CA-C-O 117.815 -1.088 . . . . 0.0 110.336 179.463 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 121.243 0.544 . . . . 0.0 111.802 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.488 ' HB2' ' NZ ' ' A' ' 180' ' ' LYS . 48.2 mt-10 -106.0 68.7 0.78 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -71.27 -22.4 61.97 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.756 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -79.04 156.17 28.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.795 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.441 HG12 ' HG3' ' A' ' 202' ' ' LYS . 4.8 mp 66.11 81.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.776 0.798 . . . . 0.0 109.534 -174.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -139.67 149.13 58.53 Favored Pre-proline 0 N--CA 1.439 -1.011 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.089 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.631 ' O ' ' HA ' ' A' ' 214' ' ' VAL . 44.8 Cg_exo -60.71 -40.94 50.65 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.627 2.218 . . . . 0.0 110.566 176.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 65.9 ttp 170.36 -50.06 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -154.03 111.36 0.48 Allowed Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.023 177.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.492 ' H ' HD13 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -136.22 151.09 49.33 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.726 0.298 . . . . 0.0 111.238 -177.556 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.406 ' HG3' ' N ' ' A' ' 179' ' ' TYR . 39.8 ptt180 -81.52 -50.89 8.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.448 177.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.406 ' N ' ' HG3' ' A' ' 178' ' ' ARG . 83.1 m-85 -141.4 158.82 43.37 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.029 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.488 ' NZ ' ' HB2' ' A' ' 169' ' ' GLU . 0.1 OUTLIER -88.65 116.12 26.67 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.231 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -149.13 140.13 22.93 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.6 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -138.45 157.29 46.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.953 0.406 . . . . 0.0 112.003 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -90.45 103.85 16.5 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 59.6 t -97.35 123.11 49.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.154 0.502 . . . . 0.0 111.95 -173.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 192' ' ' THR . 89.8 m -105.03 126.62 52.26 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.599 177.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -105.33 110.69 64.65 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.938 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.95 -33.64 89.7 Favored 'Trans proline' 0 N--CA 1.481 0.774 0 C-N-CA 123.331 2.688 . . . . 0.0 113.111 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 88.7 m -60.79 -44.4 96.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.255 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.537 ' HB2' HG12 ' A' ' 191' ' ' VAL . 32.0 mt -98.27 -17.0 19.17 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.647 -176.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 59.71 50.1 7.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.042 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.537 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.6 p -138.67 149.04 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.839 -178.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 185' ' ' THR . 12.4 t -119.67 129.57 54.62 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.405 0.622 . . . . 0.0 109.779 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 10.6 m -134.32 147.48 30.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.527 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.509 ' C ' HD12 ' A' ' 195' ' ' LEU . 35.5 tt0 -96.68 118.52 33.32 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.509 HD12 ' C ' ' A' ' 194' ' ' GLN . 7.0 mp -128.05 148.12 66.12 Favored Pre-proline 0 C--O 1.237 0.44 0 CA-C-O 120.664 0.269 . . . . 0.0 111.399 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.53 145.82 92.29 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.767 2.311 . . . . 0.0 110.978 173.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.475 HG23 ' HB ' ' A' ' 221' ' ' ILE . 83.9 mt -91.53 120.03 39.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 96.5 mt -68.02 -41.51 82.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.713 0.292 . . . . 0.0 111.356 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 93.4 p -156.1 157.25 35.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.713 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 17.7 m -122.25 135.58 61.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.338 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -136.24 137.17 40.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.779 0.324 . . . . 0.0 110.805 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.441 ' HG3' HG12 ' A' ' 172' ' ' ILE . 56.8 mtmt -111.74 145.52 39.2 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.369 174.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.486 ' ND2' ' HB2' ' A' ' 205' ' ' SER . 31.6 p-10 -74.49 157.2 86.52 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 176.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.0 -28.11 80.23 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.301 2.0 . . . . 0.0 112.602 -178.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.486 ' HB2' ' ND2' ' A' ' 203' ' ' ASN . 69.4 m -65.3 -39.63 92.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.99 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 58.2 t30 58.26 83.61 0.22 Allowed Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 122.913 0.485 . . . . 0.0 111.786 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.467 ' HD3' ' OD1' ' A' ' 203' ' ' ASN . 89.8 Cg_endo -81.94 52.97 4.39 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.826 2.351 . . . . 0.0 111.574 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 31.7 tp -79.89 95.52 6.1 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.157 0.503 . . . . 0.0 110.149 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.503 ' H ' HG21 ' A' ' 216' ' ' THR . 75.0 t80 -62.25 -45.59 92.62 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.657 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 20.8 p -69.16 151.43 46.36 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.779 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -62.6 -44.54 96.05 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 3.8 pp -174.85 172.01 3.02 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.614 0.245 . . . . 0.0 111.155 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 80.44 -79.81 1.71 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.914 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 174' ' ' PRO . 26.3 m -80.08 148.39 5.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.063 0.459 . . . . 0.0 111.802 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.9 mt -79.48 162.72 25.26 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.705 0.764 . . . . 0.0 112.122 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.503 HG21 ' H ' ' A' ' 209' ' ' TYR . 94.2 m -118.37 140.78 49.32 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.564 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.423 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 12.4 ptmm? -49.39 145.89 4.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.618 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 111.55 9.77 20.7 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.862 -176.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.462 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 61.7 m -84.35 134.86 34.48 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 220' ' ' ILE . 3.7 mp -95.98 127.08 48.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.905 0.384 . . . . 0.0 111.12 -178.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.614 HD13 HD11 ' A' ' 245' ' ' ILE . 46.0 pt -124.79 157.91 32.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.521 178.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -110.84 124.65 52.45 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.86 157.01 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.722 0.296 . . . . 0.0 110.633 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -98.15 123.14 42.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.315 0.578 . . . . 0.0 110.991 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 9.1 m -100.04 80.35 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-O 121.67 0.748 . . . . 0.0 110.114 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 18.5 m -112.93 -63.48 1.44 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.44 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -99.03 -39.73 8.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.157 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 8.2 mp 65.0 -2.57 0.7 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.441 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 83.22 7.5 86.7 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.082 -178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.5 pt -126.16 169.91 16.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 5.6 p -118.38 85.73 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 122.128 0.966 . . . . 0.0 111.57 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.3 t -113.14 -41.02 3.79 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 173.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.402 ' CB ' ' HE3' ' A' ' 236' ' ' LYS . . . -168.19 136.22 2.25 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.357 177.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 47.4 m -75.17 76.63 2.31 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.538 0.685 . . . . 0.0 111.167 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 70.75 40.63 64.94 Favored Glycine 0 N--CA 1.431 -1.641 0 CA-C-N 114.998 -1.001 . . . . 0.0 115.25 175.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.402 ' HE3' ' CB ' ' A' ' 233' ' ' ALA . 18.3 ptpt -63.7 -25.53 68.24 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.936 0.868 . . . . 0.0 109.714 177.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 13.5 pt -129.65 33.71 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.541 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -63.66 105.71 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.098 0.475 . . . . 0.0 111.514 -177.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -151.83 166.43 31.45 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.629 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -93.13 118.73 5.72 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -127.29 163.24 24.38 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 120.9 0.381 . . . . 0.0 110.968 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 95.4 m-85 -103.33 139.51 38.65 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.491 -175.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -128.47 147.36 50.67 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.27 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 18.1 pm0 -98.34 131.34 44.72 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.476 0.655 . . . . 0.0 111.374 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.614 HD11 HD13 ' A' ' 221' ' ' ILE . 48.9 mm -77.54 125.22 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.29 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.423 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 4.1 t -134.46 102.95 5.5 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -84.69 126.81 33.71 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.285 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -127.6 72.29 77.9 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.17 -23.89 28.44 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.401 2.067 . . . . 0.0 112.381 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -77.65 -16.09 58.77 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.112 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -113.31 -56.25 2.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.032 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -93.29 -31.17 14.8 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.776 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 77.42 20.46 74.69 Favored Glycine 0 C--N 1.322 -0.22 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.86 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 48.8 t -151.15 164.87 35.52 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.695 0.283 . . . . 0.0 110.441 -177.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 95.1 t -79.91 121.84 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 246' ' ' THR . 78.8 m-20 -112.55 152.8 28.41 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.198 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -132.5 141.91 48.98 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.83 133.27 69.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 7.4 tt -101.19 123.81 45.92 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.218 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.465 ' O ' HD12 ' A' ' 260' ' ' LEU . 3.1 pp -65.49 137.65 57.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.236 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.269 2.122 0 CA-C-O 117.3 -1.333 . . . . 0.0 110.717 -179.065 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 120.818 0.342 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 69.97 -13.7 0.41 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.156 0.982 . . . . 0.0 112.612 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -80.09 91.25 5.49 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.092 0.472 . . . . 0.0 111.049 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -120.96 116.12 24.49 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.063 176.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.484 HG23 ' H ' ' A' ' 202' ' ' LYS . 12.3 tt -80.72 103.98 8.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.806 0.812 . . . . 0.0 110.166 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.502 ' HB3' HG21 ' A' ' 200' ' ' VAL . 35.9 ptt-85 -135.36 161.78 61.27 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.587 -174.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.448 ' HG3' ' HB2' ' A' ' 215' ' ' LEU . 24.3 Cg_endo -85.86 -131.46 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 122.843 2.362 . . . . 0.0 110.924 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 63.0 ttp -90.75 44.16 1.18 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.554 0.692 . . . . 0.0 110.414 -176.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 80.02 1.2 87.35 Favored Glycine 0 CA--C 1.517 0.178 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.297 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 42.57 -150.26 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.475 0.71 . . . . 0.0 111.456 -177.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.425 ' HG3' ' N ' ' A' ' 179' ' ' TYR . 11.1 ptm85 -71.64 -47.38 54.84 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.024 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.425 ' N ' ' HG3' ' A' ' 178' ' ' ARG . 52.3 t80 -178.52 171.8 1.52 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -177.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -74.57 38.93 0.12 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.662 0.268 . . . . 0.0 111.005 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.5 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 40.3 ttmt -154.01 140.7 18.99 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -177.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.434 ' HB2' HD11 ' A' ' 197' ' ' ILE . . . -138.28 157.02 47.09 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.711 0.291 . . . . 0.0 111.509 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -87.0 101.49 13.49 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 58.9 t -90.56 125.94 43.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.859 -175.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.7 m -107.02 124.07 49.11 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.245 0.545 . . . . 0.0 110.011 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -104.51 115.91 62.03 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.841 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.83 -18.88 65.77 Favored 'Trans proline' 0 N--CA 1.476 0.458 0 C-N-CA 122.581 2.187 . . . . 0.0 111.258 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 72.0 m -64.11 -40.65 96.66 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.218 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.554 ' HB2' HG12 ' A' ' 191' ' ' VAL . 27.4 mt -107.3 -16.37 14.41 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.069 -177.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 60.16 41.32 17.08 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.986 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.554 HG12 ' HB2' ' A' ' 189' ' ' LEU . 6.6 p -134.94 148.84 28.97 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.74 -177.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 84.8 m -105.68 120.91 42.87 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.5 m -127.06 138.41 54.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.901 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.5 ' HG2' ' HG2' ' A' ' 181' ' ' LYS . 36.0 tt0 -94.21 119.54 33.17 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.156 -175.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -128.94 153.32 80.13 Favored Pre-proline 0 C--O 1.237 0.426 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.209 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.37 146.42 97.24 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.303 2.669 . . . . 0.0 112.645 177.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.434 HD11 ' HB2' ' A' ' 182' ' ' ALA . 76.9 mt -94.28 118.61 40.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.658 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.38 -46.52 15.89 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.808 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 27.3 m -140.64 150.29 43.37 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.177 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.502 HG21 ' HB3' ' A' ' 173' ' ' ARG . 30.9 m -128.19 144.13 38.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.521 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -140.34 102.54 4.37 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.281 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.484 ' H ' HG23 ' A' ' 172' ' ' ILE . 60.2 mtpt -70.8 146.01 50.01 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -85.78 116.97 67.78 Favored Pre-proline 0 C--N 1.312 -1.043 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.073 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.3 -22.47 21.91 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.036 1.824 . . . . 0.0 110.261 175.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 57.2 m -66.9 -40.13 87.63 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.004 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -69.01 127.93 92.92 Favored Pre-proline 0 CA--C 1.515 -0.371 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.731 -177.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.64 80.95 2.45 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.946 2.431 . . . . 0.0 113.168 -178.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 61.1 mt -70.79 142.85 51.32 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.942 174.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -60.64 -46.41 90.4 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.39 0.614 . . . . 0.0 109.593 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 59.3 m -111.76 132.6 54.55 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.96 -40.31 88.6 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.162 0.506 . . . . 0.0 110.431 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 87.3 mt -97.04 20.19 11.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.701 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.06 171.62 38.84 Favored Glycine 0 C--O 1.244 0.735 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.618 -176.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 33.2 m -63.87 167.25 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.548 0 CA-C-O 121.364 0.602 . . . . 0.0 112.209 -177.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.448 ' HB2' ' HG3' ' A' ' 174' ' ' PRO . 48.4 tp -75.31 128.7 36.0 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.688 -176.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 36.8 p -108.21 162.3 14.2 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.675 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.4 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 3.8 ptpp? -66.78 151.61 47.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.133 0.492 . . . . 0.0 111.589 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.02 4.3 41.75 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.235 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 88.1 m -80.12 134.9 36.21 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.522 0.201 . . . . 0.0 111.265 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 48.5 mm -93.78 126.29 46.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.863 0.363 . . . . 0.0 110.882 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.556 HG21 HD11 ' A' ' 245' ' ' ILE . 47.3 pt -130.73 165.17 31.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.368 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -108.68 129.41 55.35 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 31.5 m -126.82 153.66 36.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.106 0.479 . . . . 0.0 111.167 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -97.64 107.14 19.58 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.243 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 34.3 m -105.35 24.18 2.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.939 0.876 . . . . 0.0 110.255 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 238' ' ' ALA . 23.6 t -86.27 -23.5 26.33 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.395 175.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -60.68 -40.35 91.82 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.231 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.65 HD23 ' H ' ' A' ' 228' ' ' LEU . 2.3 pt? -98.11 -1.33 42.59 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.904 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' A' ' 238' ' ' ALA . . . -84.64 45.58 3.53 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.732 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 79.9 mt -82.77 -73.96 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.155 0.503 . . . . 0.0 110.877 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.04 11.15 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.426 0.631 . . . . 0.0 110.367 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 36.8 p -64.17 -38.56 91.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.474 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.642 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . -143.2 58.98 1.41 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.297 177.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 25.5 m 60.94 10.54 2.83 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.645 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 79.65 2.08 87.6 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.245 -0.503 . . . . 0.0 113.149 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.642 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 19.6 ptpt -71.51 -20.74 62.02 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -176.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 32.6 pt -81.65 -4.42 7.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 226' ' ' SER . . . -73.47 108.5 6.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.842 -178.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -169.35 -175.28 2.18 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -108.5 126.63 8.28 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -128.6 157.09 42.23 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 117.256 0.528 . . . . 0.0 111.748 -175.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.402 ' O ' HD12 ' A' ' 259' ' ' LEU . 77.1 m-85 -102.64 133.9 46.88 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.79 176.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -129.77 155.0 46.65 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.933 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -100.47 124.87 46.56 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.112 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.556 HD11 HG21 ' A' ' 221' ' ' ILE . 90.9 mt -76.71 125.77 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 CA-C-O 120.918 0.389 . . . . 0.0 110.934 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.4 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 4.3 t -132.35 94.56 3.46 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 174.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -81.21 117.16 21.5 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.65 -176.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -131.22 71.6 81.82 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.551 177.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.573 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 66.7 Cg_endo -71.78 -19.44 27.45 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.027 1.818 . . . . 0.0 112.461 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -86.92 -24.58 24.76 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.963 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -101.78 -58.09 1.95 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.921 0.391 . . . . 0.0 110.904 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -84.73 -39.27 18.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.414 0.625 . . . . 0.0 110.518 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 103.77 -9.31 51.73 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.171 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 70.2 m -135.93 169.23 17.92 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.783 0.325 . . . . 0.0 110.936 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.408 ' HB ' ' HD2' ' A' ' 178' ' ' ARG . 86.2 t -86.95 119.91 35.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 174.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -115.53 150.8 35.98 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 120.868 0.366 . . . . 0.0 111.045 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -121.63 140.96 51.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 9.4 p -119.12 137.48 52.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 120.697 0.284 . . . . 0.0 110.453 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 242' ' ' TYR . 60.6 tp -74.88 124.29 26.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.841 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 260' ' ' LEU . 0.3 OUTLIER -86.85 91.31 8.61 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.485 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.268 2.047 0 CA-C-O 117.68 -1.152 . . . . 0.0 110.666 -175.247 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 120.661 0.267 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -127.26 74.33 1.5 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.656 0.741 . . . . 0.0 110.357 -178.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -128.17 149.99 50.19 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.955 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -104.64 107.83 18.98 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 120.861 0.362 . . . . 0.0 110.804 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.405 ' N ' HD12 ' A' ' 172' ' ' ILE . 3.9 mp -104.19 100.97 11.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.481 ' HD2' ' HA2' ' A' ' 176' ' ' GLY . 38.3 ptt180 -161.77 153.67 16.13 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.941 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -60.43 -45.11 23.66 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.299 1.999 . . . . 0.0 111.257 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 17.2 tmm? -157.28 -48.58 0.07 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.481 ' HA2' ' HD2' ' A' ' 173' ' ' ARG . . . 148.88 84.01 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.17 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.703 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.557 HD23 ' H ' ' A' ' 177' ' ' LEU . 2.1 pt? -72.51 166.96 21.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.811 0.339 . . . . 0.0 111.498 -177.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -61.23 -28.65 69.32 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -175.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -156.7 143.77 18.77 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -69.3 90.77 0.51 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.492 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 41.0 ttmt -154.28 140.47 18.5 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.978 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -128.95 158.11 39.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.375 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 27.3 t-20 -84.55 106.14 15.9 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 257' ' ' ALA . 58.1 t -104.17 125.37 58.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.475 0.655 . . . . 0.0 112.504 -172.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 94.0 m -104.48 126.87 51.97 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -103.47 107.97 57.73 Favored Pre-proline 0 C--N 1.315 -0.93 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.18 -20.22 56.36 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 122.626 2.217 . . . . 0.0 112.158 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 70.1 m -63.68 -40.89 97.93 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.217 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.546 ' HB2' HG12 ' A' ' 191' ' ' VAL . 26.4 mt -107.74 -15.35 14.59 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.51 -178.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 67.2 t30 60.35 52.87 4.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.686 -175.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.546 HG12 ' HB2' ' A' ' 189' ' ' LEU . 12.2 p -135.24 143.39 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.667 -177.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 95.5 m -105.6 116.45 31.97 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.078 0.466 . . . . 0.0 110.249 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 63.7 t -131.19 129.9 63.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.144 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.492 ' HG2' ' HG2' ' A' ' 181' ' ' LYS . 48.3 tt0 -77.99 121.23 23.94 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.59 HD12 ' HD2' ' A' ' 196' ' ' PRO . 18.5 tp -126.86 141.2 39.8 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.216 -171.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.59 ' HD2' HD12 ' A' ' 195' ' ' LEU . 53.7 Cg_endo -67.88 151.48 78.19 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.75 2.3 . . . . 0.0 112.604 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 83.1 mt -97.12 118.2 43.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.231 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.2 mp -73.2 -43.79 60.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.147 0.499 . . . . 0.0 110.781 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 87.1 p -157.07 161.96 39.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.597 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.98 138.74 51.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.621 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -124.03 127.71 48.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.661 -177.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -90.08 125.2 35.34 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -107.2 143.08 26.42 Favored Pre-proline 0 C--N 1.313 -1.004 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.444 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.23 -17.99 35.08 Favored 'Trans proline' 0 N--CA 1.472 0.214 0 C-N-CA 123.156 2.571 . . . . 0.0 112.337 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 68.1 m -61.79 -40.43 95.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.537 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -118.53 101.88 50.47 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.059 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.22 148.05 67.67 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.384 2.056 . . . . 0.0 112.164 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.62 161.56 29.58 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.267 0.556 . . . . 0.0 111.687 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -60.16 -44.56 94.91 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.05 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 11.5 t -141.03 176.94 8.41 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.522 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -63.9 -39.06 93.3 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.409 ' O ' HD12 ' A' ' 212' ' ' LEU . 4.3 pp -143.46 133.73 24.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.785 0.326 . . . . 0.0 110.683 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.05 173.51 49.71 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 26.8 t 44.82 88.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.391 0.676 . . . . 0.0 112.668 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -83.7 175.26 9.82 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.102 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 14.9 t -131.28 174.44 10.05 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 120.786 0.327 . . . . 0.0 110.418 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -73.47 152.3 40.78 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.532 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.81 8.5 48.34 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.535 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 86.9 m -82.83 140.0 33.18 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 51.2 mm -102.17 127.36 55.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 O-C-N 121.919 -0.488 . . . . 0.0 111.093 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.597 HD13 HD11 ' A' ' 245' ' ' ILE . 43.0 pt -124.67 157.27 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.349 177.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -109.7 126.29 53.55 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 33.6 m -128.35 158.88 40.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 120.985 0.421 . . . . 0.0 110.954 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -89.94 107.09 18.91 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 43.6 t -90.92 78.76 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 30.0 t -167.76 -46.78 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.308 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -75.0 -4.59 39.22 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.495 ' HG ' ' H ' ' A' ' 230' ' ' ILE . 2.6 pt? -63.32 -15.56 57.71 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.893 0.378 . . . . 0.0 111.005 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 92.03 -12.68 68.91 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.933 174.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.495 ' H ' ' HG ' ' A' ' 228' ' ' LEU . 39.8 pt -131.98 153.86 39.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.587 0.708 . . . . 0.0 111.657 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 8.1 p -173.83 125.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 114.281 -1.327 . . . . 0.0 108.357 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 9.2 t -93.27 -10.76 34.43 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.264 0.554 . . . . 0.0 110.877 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.511 ' HB3' HG12 ' A' ' 237' ' ' ILE . . . -94.63 20.34 8.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.189 -177.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 37.0 m 59.59 27.88 17.18 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.004 0.43 . . . . 0.0 111.84 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 82.38 6.17 88.92 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.943 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -61.39 -39.26 90.04 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.056 0.455 . . . . 0.0 110.206 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.511 HG12 ' HB3' ' A' ' 233' ' ' ALA . 22.2 pt -98.12 15.42 3.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.04 -178.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -87.1 105.16 16.98 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.614 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -153.97 175.1 13.79 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.961 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -79.22 113.16 3.6 Favored Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 171.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -125.02 156.77 37.61 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 120.693 0.282 . . . . 0.0 110.407 -173.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 37.2 p90 -101.7 148.84 24.79 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.406 0.622 . . . . 0.0 112.185 -176.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -134.1 159.63 40.25 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.137 -177.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -99.31 127.73 45.35 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.183 0.516 . . . . 0.0 111.404 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.597 HD11 HD13 ' A' ' 221' ' ' ILE . 47.5 mm -76.22 125.62 36.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.341 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.7 t -129.61 101.91 6.13 Favored 'General case' 0 N--CA 1.425 -1.698 0 O-C-N 124.401 1.063 . . . . 0.0 108.679 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -76.32 121.07 22.44 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.4 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -129.78 71.33 82.16 Favored Pre-proline 0 C--N 1.314 -0.935 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.426 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 74.5 Cg_endo -72.31 -19.82 25.1 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.49 2.127 . . . . 0.0 112.545 -177.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -85.93 -24.08 26.71 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.042 0.449 . . . . 0.0 110.646 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -92.7 -55.3 3.43 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.155 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -105.67 -37.65 6.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.096 0.474 . . . . 0.0 110.664 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 100.91 10.94 41.59 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.817 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 30.6 p -147.04 177.69 8.96 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.491 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 96.4 t -79.58 122.12 34.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.693 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -112.94 150.15 32.24 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.739 -177.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.496 ' HB3' HG22 ' A' ' 184' ' ' VAL . . . -130.26 142.81 50.53 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 120.942 0.401 . . . . 0.0 110.73 177.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.8 p -123.67 131.42 73.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.94 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.1 tt -83.82 126.51 33.01 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.064 -177.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 4.1 pp -92.81 130.03 38.54 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.515 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.27 2.154 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.652 -178.302 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 120.691 0.281 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 59.55 28.76 18.24 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.538 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -127.69 -3.13 5.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.909 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.543 ' HA ' ' NH1' ' A' ' 173' ' ' ARG . 52.7 t80 -92.2 78.21 5.19 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.145 0.497 . . . . 0.0 110.785 -178.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.0 mp -122.58 117.73 52.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.075 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.543 ' NH1' ' HA ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -164.12 155.84 14.25 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.934 177.583 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.35 -43.38 23.24 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.343 2.029 . . . . 0.0 112.168 178.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 51.9 ttm 177.39 30.63 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 105.79 151.33 19.67 Favored Glycine 0 N--CA 1.423 -2.193 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -172.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -151.59 154.6 36.76 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 116.894 0.347 . . . . 0.0 110.588 -178.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -68.88 -35.38 76.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.612 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -168.08 150.4 5.47 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.49 ' HB3' ' HB ' ' A' ' 197' ' ' ILE . 98.4 mttt -76.23 89.05 3.1 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.698 0.285 . . . . 0.0 111.608 -178.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -124.79 143.99 50.51 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.573 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -137.07 144.28 43.05 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.863 176.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 66.5 t30 -85.7 99.8 11.56 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.7 t -91.68 120.98 41.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.265 0.555 . . . . 0.0 112.14 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 90.4 m -98.23 124.09 42.65 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.542 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -100.65 113.55 65.61 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.541 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.39 -16.51 51.56 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.647 2.231 . . . . 0.0 111.675 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 41.2 m -65.19 -43.13 92.6 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.264 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.597 ' HB2' HG12 ' A' ' 191' ' ' VAL . 23.8 mt -114.78 -9.17 12.56 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.699 -175.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 60.97 42.34 12.91 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.083 -176.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.597 HG12 ' HB2' ' A' ' 189' ' ' LEU . 10.5 p -129.26 147.7 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 14.8 t -123.77 129.63 51.35 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.307 0.575 . . . . 0.0 110.579 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 58.9 t -134.53 138.5 49.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.209 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 61.0 tt0 -80.51 113.31 18.61 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.302 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 7.6 mp -116.41 155.7 48.22 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.367 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 180' ' ' LYS . 58.7 Cg_endo -70.55 147.03 56.93 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.265 1.977 . . . . 0.0 111.535 177.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 180' ' ' LYS . 84.7 mt -87.3 107.27 16.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.892 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.87 -42.89 76.41 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.014 0.435 . . . . 0.0 111.088 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' A' ' 222' ' ' GLU . 18.8 m -141.67 146.09 35.71 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.428 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.7 138.62 44.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.019 0.438 . . . . 0.0 111.379 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.07 147.79 51.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.531 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -73.25 158.85 34.39 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.801 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.438 ' OD1' ' HB2' ' A' ' 205' ' ' SER . 26.3 t-20 -62.47 127.77 90.46 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 120.608 0.242 . . . . 0.0 110.695 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.4 -20.43 70.06 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.532 2.822 . . . . 0.0 113.965 -175.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.438 ' HB2' ' OD1' ' A' ' 203' ' ' ASN . 48.8 m -79.92 -10.03 59.74 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.931 0.396 . . . . 0.0 110.351 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 51.91 57.73 15.94 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -84.44 -5.56 10.1 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.501 2.134 . . . . 0.0 111.026 177.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.431 HD21 ' H ' ' A' ' 216' ' ' THR . 93.7 mt -72.94 148.74 44.0 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.016 -177.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.63 ' HB2' ' O ' ' A' ' 212' ' ' LEU . 62.8 m-85 -96.69 -11.48 25.08 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.753 177.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 35.4 m 67.09 -74.29 0.07 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.656 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -74.6 -16.21 60.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.893 0.377 . . . . 0.0 111.732 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.63 ' O ' ' HB2' ' A' ' 209' ' ' TYR . 96.4 mt -126.45 151.23 48.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.714 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 77.59 -171.37 55.15 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.613 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 30.9 m -127.94 172.11 15.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -58.88 128.26 36.33 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.129 0.49 . . . . 0.0 110.752 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.431 ' H ' HD21 ' A' ' 208' ' ' LEU . 75.1 p -91.68 163.67 14.01 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.531 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -70.57 151.36 45.12 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.894 0.378 . . . . 0.0 110.719 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.12 7.69 30.48 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.135 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.65 ' OG1' ' HB ' ' A' ' 245' ' ' ILE . 50.6 p -79.96 157.69 26.79 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.3 mm -115.78 129.04 72.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.017 0.437 . . . . 0.0 111.672 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.504 HG21 HD11 ' A' ' 245' ' ' ILE . 46.1 pt -125.86 158.3 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.999 178.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 199' ' ' SER . 44.1 tt0 -107.52 124.68 50.27 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.283 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.06 156.69 40.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.106 0.479 . . . . 0.0 110.951 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -100.64 113.49 26.38 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.338 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 22.3 t -83.96 70.6 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.408 ' H ' ' H ' ' A' ' 227' ' ' ASP . 18.7 m -159.78 -22.56 0.07 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.707 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . 0.408 ' H ' ' H ' ' A' ' 226' ' ' SER . 5.4 m-20 -82.41 8.34 11.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.669 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.44 -22.26 65.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.049 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 95.73 -9.07 68.63 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.748 -0.66 . . . . 0.0 113.281 178.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 48.8 mm -115.8 135.52 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 CA-C-O 122.258 1.028 . . . . 0.0 112.515 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 4.7 m -112.46 118.22 57.24 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.475 0 CA-C-N 113.067 -1.879 . . . . 0.0 108.867 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 233' ' ' ALA . 61.1 p -68.48 -41.77 79.65 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.661 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 232' ' ' THR . . . 163.49 -39.09 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.079 0.952 . . . . 0.0 110.41 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 18.9 m -137.83 12.45 2.91 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.02 -176.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.35 50.67 54.7 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 119.724 -1.227 . . . . 0.0 110.74 -176.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.403 ' HD3' ' O ' ' A' ' 236' ' ' LYS . 9.0 tmtt? -57.22 -37.76 72.72 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 123.417 0.687 . . . . 0.0 110.332 -174.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 11.8 pt -118.66 19.19 6.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.814 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -81.17 107.71 14.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.82 0.343 . . . . 0.0 111.441 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 -159.34 169.43 24.03 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.568 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -94.05 119.14 5.94 Favored Glycine 0 N--CA 1.437 -1.241 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 172.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.44 ' CB ' HD11 ' A' ' 259' ' ' LEU . 37.3 mmt180 -127.86 164.05 23.08 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.953 0.406 . . . . 0.0 111.419 -174.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.545 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 96.6 m-85 -104.09 140.73 37.36 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.148 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -125.07 148.57 48.45 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.051 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 219' ' ' THR . 37.0 tt0 -98.68 125.69 44.06 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.195 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.65 ' HB ' ' OG1' ' A' ' 219' ' ' THR . 90.8 mt -80.75 127.77 39.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.048 0.452 . . . . 0.0 111.066 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 4.8 t -135.57 102.6 5.17 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.811 176.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -78.63 116.92 19.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.612 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -131.53 73.98 78.87 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.869 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.93 -23.14 41.21 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.285 1.99 . . . . 0.0 112.179 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -80.42 -12.55 59.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.333 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -113.1 -57.7 2.25 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.128 0.49 . . . . 0.0 111.001 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.549 ' HB2' HD21 ' A' ' 256' ' ' ASN . 26.9 m-20 -96.86 -27.6 14.61 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.881 -176.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 80.5 16.66 75.31 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.944 -178.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 48.5 t -155.48 165.3 37.01 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 96.1 t -81.06 121.95 35.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.549 HD21 ' HB2' ' A' ' 252' ' ' ASP . 48.1 m-80 -113.14 152.7 29.31 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 120.838 0.352 . . . . 0.0 111.257 -174.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -128.86 131.22 47.64 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.16 126.1 58.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.134 0.492 . . . . 0.0 109.908 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.44 HD11 ' CB ' ' A' ' 241' ' ' ARG . 51.5 tp -75.28 129.13 36.92 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.805 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 242' ' ' TYR . 3.0 pp -100.99 127.78 47.33 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 C--O 1.262 1.739 0 CA-C-O 117.951 -1.023 . . . . 0.0 111.065 -178.579 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 121.284 0.564 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -63.04 -41.51 99.51 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.385 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -87.51 12.36 12.54 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -100.25 114.46 27.93 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.427 ' N ' HD12 ' A' ' 172' ' ' ILE . 4.1 mp -93.23 126.95 45.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.178 -175.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -127.47 81.26 70.45 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.318 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.43 ' HA ' HD11 ' A' ' 215' ' ' LEU . 51.2 Cg_exo -58.62 -41.37 64.87 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.291 1.994 . . . . 0.0 111.077 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 56.7 ttm -173.84 13.02 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.505 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 85.64 101.31 0.71 Allowed Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -175.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.463 ' O ' HD12 ' A' ' 177' ' ' LEU . 4.1 pp -106.89 135.25 48.76 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.087 0.47 . . . . 0.0 111.301 -178.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -73.43 -29.68 62.72 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.392 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -160.51 143.41 13.25 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.486 ' HB3' ' HB ' ' A' ' 197' ' ' ILE . 56.3 mtmt -73.4 80.74 1.4 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.048 0.451 . . . . 0.0 111.92 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.474 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 84.8 tttt -155.72 135.2 12.44 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -141.96 160.54 40.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.97 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 17.8 m120 -80.9 103.56 10.82 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 64.1 t -85.68 122.06 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 121.338 0.59 . . . . 0.0 110.798 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.1 m -102.96 125.67 49.82 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.279 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -103.99 105.88 50.54 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.56 -32.39 79.76 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.465 2.11 . . . . 0.0 113.209 -176.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 87.9 m -67.22 -41.81 85.09 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.995 0.426 . . . . 0.0 110.872 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.48 ' HB2' HG12 ' A' ' 191' ' ' VAL . 41.7 mt -88.13 -20.66 25.35 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.414 0.626 . . . . 0.0 109.326 -178.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.4 t30 60.03 50.73 6.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.654 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.48 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.9 p -139.97 147.67 23.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.658 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 60.0 m -116.97 119.26 34.77 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 65.6 t -128.94 127.95 66.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 183' ' ' ASN . 46.1 tt0 -78.2 118.98 20.94 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 91.7 mt -126.19 149.74 67.71 Favored Pre-proline 0 C--N 1.312 -1.022 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.28 -176.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.48 146.2 55.05 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.012 1.808 . . . . 0.0 110.919 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 180' ' ' LYS . 80.7 mt -91.47 117.77 35.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.66 -43.54 80.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.14 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 67.9 m -152.19 149.66 28.98 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.528 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.419 HG23 HD13 ' A' ' 172' ' ' ILE . 36.0 m -116.52 142.24 30.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -130.94 142.7 50.38 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.406 0.622 . . . . 0.0 110.827 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -71.9 134.65 46.16 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.981 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.46 ' HB2' ' HD2' ' A' ' 204' ' ' PRO . 9.6 p30 -75.14 159.9 81.51 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.565 ' HB2' ' OD1' ' A' ' 206' ' ' ASN . 19.0 Cg_endo -59.3 -21.21 59.41 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.506 2.137 . . . . 0.0 112.599 -178.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 34.8 m 61.21 34.22 18.88 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.262 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.565 ' OD1' ' HB2' ' A' ' 204' ' ' PRO . 19.5 m120 -70.36 -56.56 6.61 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.771 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.8 -32.48 11.49 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 121.937 1.758 . . . . 0.0 112.235 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 66.1 tp -126.06 108.59 11.51 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -122.04 10.38 10.08 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.535 ' O ' ' HG ' ' A' ' 212' ' ' LEU . 43.9 p -66.93 -46.22 75.44 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.124 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 62.3 -63.33 0.1 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.249 1.02 . . . . 0.0 113.222 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 210' ' ' THR . 2.6 pp -65.39 -18.19 65.12 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 123.191 0.596 . . . . 0.0 111.955 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.402 ' N ' HD12 ' A' ' 212' ' ' LEU . . . -92.15 17.31 57.39 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.778 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 59.8 t 76.49 128.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.548 0.739 . . . . 0.0 110.193 -178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.43 HD11 ' HA ' ' A' ' 174' ' ' PRO . 4.6 pp -89.23 175.49 7.34 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.681 -176.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 74.7 p -127.14 -172.51 2.67 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.455 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.517 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 18.2 ptpt -50.59 150.83 2.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.275 0.559 . . . . 0.0 112.409 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 114.99 6.11 19.2 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.804 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 244' ' ' GLN . 56.9 m -71.6 138.92 49.1 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 49.5 mm -92.37 125.69 44.96 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.717 0 CA-C-O 120.522 0.201 . . . . 0.0 110.502 -176.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.409 ' HB ' HG23 ' A' ' 197' ' ' ILE . 47.3 pt -133.54 160.12 42.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 120.961 0.41 . . . . 0.0 111.2 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -107.32 126.96 53.11 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.455 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.33 153.16 30.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.145 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -102.61 111.12 23.29 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.295 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 46.6 t -78.71 79.39 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 32.7 t -174.71 -27.55 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.949 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.31 5.11 9.2 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.291 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.65 -38.58 88.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.768 0.318 . . . . 0.0 110.677 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 83.39 7.01 87.11 Favored Glycine 0 CA--C 1.509 -0.325 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.531 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 49.3 pt -107.93 0.27 9.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 120.6 0.238 . . . . 0.0 110.822 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 39.7 t 62.74 96.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.903 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.453 HG22 HD11 ' A' ' 237' ' ' ILE . 14.0 m -85.08 101.13 12.18 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.982 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.535 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . 50.08 52.72 14.16 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.69 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 41.8 m 64.13 10.12 5.23 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.293 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 80.98 5.63 90.01 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.991 -0.623 . . . . 0.0 113.184 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 65.3 pttt -67.12 -24.22 65.89 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.211 0.529 . . . . 0.0 111.043 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 232' ' ' THR . 13.0 pt -110.5 19.76 6.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.37 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -78.0 105.68 9.37 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.168 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -145.11 158.14 43.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.888 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -81.25 132.28 11.07 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 175.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -128.5 172.42 11.16 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.915 0.388 . . . . 0.0 110.804 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -101.35 140.07 36.14 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.104 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -135.78 159.2 42.38 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.28 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 219' ' ' THR . 49.0 mt-30 -113.81 136.26 53.06 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.406 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.446 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 89.5 mt -79.85 124.19 37.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.517 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 4.9 t -124.72 92.45 3.65 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 122.12 0.962 . . . . 0.0 108.72 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . 0.435 ' C ' ' HD3' ' A' ' 249' ' ' PRO . 20.1 p-10 -74.48 118.94 18.01 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.586 -177.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -130.22 67.87 80.41 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.88 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.435 ' HD3' ' C ' ' A' ' 247' ' ' ASN . 6.5 Cg_exo -77.35 -23.06 10.46 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.139 1.893 . . . . 0.0 109.99 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -67.9 -36.96 81.1 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.792 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -107.22 -58.09 1.99 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.421 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -72.27 -39.78 68.12 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.327 0.584 . . . . 0.0 110.854 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 100.77 7.24 51.21 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.404 -0.817 . . . . 0.0 112.399 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 39.4 t -152.44 164.71 36.99 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.781 0.324 . . . . 0.0 111.165 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 86.9 t -80.63 123.78 37.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -117.61 152.88 34.26 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.689 -174.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -124.41 145.68 49.34 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.5 p -121.09 131.94 71.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.043 0.449 . . . . 0.0 110.63 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.4 tt -100.86 128.35 46.94 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.251 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 2.7 pp -100.8 150.47 22.77 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.076 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.261 1.699 0 CA-C-O 118.102 -0.951 . . . . 0.0 111.037 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 . . . . . 0 N--CA 1.469 0.51 0 CA-C-O 120.676 0.274 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 49.92 75.87 0.15 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.964 177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.458 ' NE ' ' HA ' ' A' ' 170' ' ' ARG . 4.5 mmp_? -64.25 139.62 58.78 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.712 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -61.77 132.79 54.3 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.412 -174.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.423 HD11 ' HE3' ' A' ' 202' ' ' LYS . 97.2 mt -112.37 115.86 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.687 176.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.546 ' NH1' ' HA ' ' A' ' 175' ' ' MET . 3.0 tmt_? 55.0 85.27 0.19 Allowed Pre-proline 0 CA--C 1.535 0.367 0 O-C-N 123.72 0.638 . . . . 0.0 111.239 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -67.58 -74.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.618 1.545 . . . . 0.0 111.569 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.546 ' HA ' ' NH1' ' A' ' 173' ' ' ARG . 44.7 tpp -163.12 17.58 0.08 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.978 0.418 . . . . 0.0 110.63 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 66.07 40.3 95.05 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.18 -1.009 . . . . 0.0 112.098 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.626 HD23 ' H ' ' A' ' 177' ' ' LEU . 1.5 pt? -94.08 -164.3 1.16 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.658 0.266 . . . . 0.0 110.943 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -60.43 -25.57 66.07 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.108 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.474 ' H ' ' HG ' ' A' ' 177' ' ' LEU . 76.1 m-85 -94.67 147.96 22.77 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 64.19 43.72 4.79 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 122.284 1.04 . . . . 0.0 109.299 -170.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.567 ' HD3' ' HG2' ' A' ' 194' ' ' GLN . 4.0 tmmm? -124.26 133.69 53.43 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 113.597 -1.638 . . . . 0.0 107.561 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -135.7 159.79 40.54 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.221 0.534 . . . . 0.0 112.132 -175.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 194' ' ' GLN . 58.2 t30 -87.22 105.68 17.38 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.92 119.02 41.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.441 0.639 . . . . 0.0 111.693 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 86.6 m -105.27 126.26 51.9 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.082 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -105.52 108.92 62.54 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 259' ' ' LEU . 40.4 Cg_endo -66.69 -30.49 41.77 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 122.017 1.811 . . . . 0.0 112.576 -178.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 88.6 m -65.57 -43.37 90.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.283 0.563 . . . . 0.0 111.03 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.494 ' HB2' HG12 ' A' ' 191' ' ' VAL . 36.1 mt -96.17 -16.96 21.17 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.748 -177.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.4 t30 60.66 52.58 4.39 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.613 -176.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.494 HG12 ' HB2' ' A' ' 189' ' ' LEU . 10.2 p -138.04 137.25 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.002 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 9.3 t -115.94 116.86 28.68 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.529 0.681 . . . . 0.0 110.181 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 64.3 t -129.11 129.3 67.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.182 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.567 ' HG2' ' HD3' ' A' ' 181' ' ' LYS . 33.0 tt0 -77.38 124.29 27.67 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.619 HD12 ' HD2' ' A' ' 196' ' ' PRO . 25.2 tp -142.7 139.23 16.94 Favored Pre-proline 0 C--N 1.317 -0.848 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.767 -173.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.619 ' HD2' HD12 ' A' ' 195' ' ' LEU . 40.9 Cg_endo -67.87 147.24 74.3 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 121.882 1.721 . . . . 0.0 109.873 173.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.518 HG21 HG12 ' A' ' 200' ' ' VAL . 79.1 mt -84.48 124.5 39.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 120.918 0.39 . . . . 0.0 111.565 -175.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.65 -40.51 84.51 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.219 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 33.4 t -159.57 150.85 19.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.518 HG12 HG21 ' A' ' 197' ' ' ILE . 30.7 m -126.21 148.22 30.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.906 0.384 . . . . 0.0 110.932 -178.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -116.31 117.81 31.01 Favored 'General case' 0 C--O 1.253 1.283 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 174.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.423 ' HE3' HD11 ' A' ' 172' ' ' ILE . 41.1 ttmt -58.81 141.07 54.15 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 124.475 1.109 . . . . 0.0 111.292 -178.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -58.45 124.12 70.0 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.472 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.53 -35.83 4.42 Favored 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 123.188 2.592 . . . . 0.0 114.056 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 50.0 m -154.98 87.78 1.15 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -175.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -153.16 147.02 18.41 Favored Pre-proline 0 C--N 1.305 -1.344 0 CA-C-O 120.931 0.396 . . . . 0.0 110.718 172.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 208' ' ' LEU . 71.7 Cg_endo -76.26 -8.05 18.37 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.167 2.578 . . . . 0.0 112.687 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 207' ' ' PRO . 9.4 mp 71.96 -81.9 0.03 OUTLIER 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.432 0.693 . . . . 0.0 110.26 -176.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 86.4 t80 72.02 -21.93 0.22 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.514 0.725 . . . . 0.0 112.721 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 46.7 m -100.49 111.76 24.05 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.693 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 58.58 -179.67 0.07 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.434 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 94.7 mt -128.94 141.7 51.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.339 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 82.48 -1.49 87.53 Favored Glycine 0 C--N 1.323 -0.166 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.319 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.41 170.87 17.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 4.2 pp -98.61 175.0 6.15 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.649 0.738 . . . . 0.0 112.223 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 57.1 m -124.73 151.3 45.22 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.818 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.459 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 8.3 ptpp? -43.88 151.24 0.22 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 113.5 4.38 23.42 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.766 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.598 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 88.6 m -78.38 136.75 37.74 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 50.5 mm -100.82 128.56 52.84 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.741 HD13 HD11 ' A' ' 245' ' ' ILE . 46.8 pt -126.86 162.44 31.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -99.62 121.96 41.96 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.774 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 28.5 m -129.81 155.04 41.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 O-C-N 123.386 0.429 . . . . 0.0 110.519 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.432 ' OD1' HD21 ' A' ' 195' ' ' LEU . 16.5 p-10 -101.94 116.85 33.6 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.375 0.607 . . . . 0.0 110.961 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.545 ' HB ' HH11 ' A' ' 241' ' ' ARG . 53.0 t -109.76 87.69 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 38.7 t -118.83 -79.79 0.6 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.038 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -99.74 -30.13 12.25 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.021 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 91.7 mt 63.73 23.56 13.53 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.14 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 92.69 -8.3 76.8 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 121.016 -0.611 . . . . 0.0 113.228 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 46.8 pt -129.19 169.12 21.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.818 0.309 . . . . 0.0 110.607 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 15.9 m -90.3 89.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-O 121.712 0.768 . . . . 0.0 110.075 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.421 HG21 HD11 ' A' ' 237' ' ' ILE . 5.1 t -80.99 -51.47 8.49 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.747 -176.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.445 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . -170.42 53.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.641 0.258 . . . . 0.0 111.636 -177.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 19.9 m 58.52 20.01 7.14 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.096 177.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.89 21.59 76.75 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.082 -0.58 . . . . 0.0 113.545 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 19.2 ptpt -69.81 -18.94 63.49 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.622 0.711 . . . . 0.0 111.738 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.421 HD11 HG21 ' A' ' 232' ' ' THR . 28.9 pt -96.26 13.33 3.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.136 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -72.07 107.2 4.65 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.234 0.54 . . . . 0.0 112.195 -177.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -143.99 144.13 31.53 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.307 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -74.76 125.73 8.59 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.545 HH11 ' HB ' ' A' ' 225' ' ' VAL . 85.5 mtt85 -128.46 165.46 20.64 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.917 0.358 . . . . 0.0 111.185 -175.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.425 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 99.5 m-85 -101.03 136.08 41.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.542 -177.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -123.36 148.08 46.41 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.093 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -97.19 125.33 41.65 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.718 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.741 HD11 HD13 ' A' ' 221' ' ' ILE . 46.5 mm -83.11 122.38 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.918 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.018 177.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.459 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 1.3 t -128.64 86.86 2.5 Favored 'General case' 0 N--CA 1.428 -1.544 0 O-C-N 124.339 1.024 . . . . 0.0 108.78 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -80.5 115.87 20.25 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.339 0.59 . . . . 0.0 110.749 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -131.04 73.36 81.01 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.434 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.49 ' O ' ' HA2' ' A' ' 253' ' ' GLY . 43.5 Cg_endo -66.73 -22.76 49.48 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.811 1.674 . . . . 0.0 110.673 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -69.1 -37.57 78.47 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.284 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . 0.449 ' C ' HD22 ' A' ' 251' ' ' ASN . 0.2 OUTLIER -92.72 -55.9 3.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.262 -175.043 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -100.44 -32.31 10.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.194 0.521 . . . . 0.0 110.966 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 249' ' ' PRO . . . 95.6 -4.95 66.81 Favored Glycine 0 C--N 1.315 -0.593 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.657 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 85.9 m -131.22 167.3 19.42 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.773 0.321 . . . . 0.0 110.77 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 87.5 t -80.74 121.37 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -108.47 146.5 33.06 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.578 -174.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -137.82 146.57 43.66 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.449 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.3 p -132.32 136.38 56.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.431 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 187' ' ' PRO . 56.4 tp -73.05 130.53 40.51 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.098 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 242' ' ' TYR . 4.0 pp -102.82 144.46 31.12 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.861 176.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 26.5 m . . . . . 0 C--O 1.268 2.042 0 CA-C-O 117.905 -1.045 . . . . 0.0 111.043 -179.49 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 121.085 0.469 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -90.83 -33.78 15.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.033 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -112.91 108.39 17.32 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.043 -173.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -118.31 120.78 38.67 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.845 174.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.475 HG21 ' HB ' ' A' ' 200' ' ' VAL . 2.9 mp -114.14 21.97 5.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 122.046 0.927 . . . . 0.0 109.657 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.27 151.07 46.94 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.279 176.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -58.31 -72.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.832 2.355 . . . . 0.0 112.526 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 3.6 tpt -146.17 27.16 1.17 Allowed 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 104.57 143.74 12.49 Favored Glycine 0 N--CA 1.422 -2.237 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -174.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.408 ' H ' HD23 ' A' ' 177' ' ' LEU . 2.4 pt? -132.85 169.05 17.3 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 120.276 -0.569 . . . . 0.0 111.168 -178.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -61.37 -41.96 97.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.257 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -172.28 140.27 1.12 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -76.26 92.56 3.31 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 120.943 0.402 . . . . 0.0 110.995 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.492 ' HG2' ' HG2' ' A' ' 194' ' ' GLN . 22.5 ttmm -144.83 137.92 26.69 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.918 -177.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -139.07 154.78 48.23 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.787 0.327 . . . . 0.0 111.345 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -88.57 111.59 22.06 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.012 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 65.1 t -99.12 125.8 52.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.248 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.0 m -104.4 127.97 52.17 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.693 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -104.48 110.6 64.52 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -55.94 -36.36 95.65 Favored 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 123.448 2.766 . . . . 0.0 113.562 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 87.0 m -66.07 -41.27 90.97 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.127 0.489 . . . . 0.0 111.392 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.508 ' HB2' HG12 ' A' ' 191' ' ' VAL . 40.0 mt -94.42 -18.66 21.32 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.403 -175.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 58.77 44.14 17.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.141 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.508 HG12 ' HB2' ' A' ' 189' ' ' LEU . 9.9 p -134.23 144.49 35.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.75 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 86.2 m -113.73 120.25 40.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.173 0.511 . . . . 0.0 109.861 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 10.9 m -126.14 143.78 38.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.636 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.492 ' HG2' ' HG2' ' A' ' 181' ' ' LYS . 59.0 tt0 -97.76 122.37 40.77 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.603 -175.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.43 HD11 ' HA ' ' A' ' 228' ' ' LEU . 2.7 mm? -128.73 156.87 76.88 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.494 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.61 149.68 68.18 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.28 1.987 . . . . 0.0 110.674 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 79.3 mt -84.78 112.16 21.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.525 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 223' ' ' VAL . 3.9 mm? -68.0 -42.13 81.18 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.221 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 222' ' ' GLU . 37.3 t -150.91 148.6 28.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.222 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.475 ' HB ' HG21 ' A' ' 172' ' ' ILE . 16.7 m -123.03 140.85 45.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.999 0.428 . . . . 0.0 111.275 -178.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -133.8 131.91 39.85 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -111.01 144.77 39.59 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.223 177.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.538 ' HB2' ' HD3' ' A' ' 207' ' ' PRO . 2.6 m-20 -77.49 131.86 70.55 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.93 -19.64 64.04 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.836 2.357 . . . . 0.0 111.933 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 80.0 p -72.35 -13.2 61.42 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.694 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 59.73 81.02 0.25 Allowed Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.137 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 203' ' ' ASN . 98.5 Cg_endo -83.41 51.81 3.68 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.933 2.422 . . . . 0.0 111.613 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 9.1 mp -91.75 119.74 31.85 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -103.88 8.58 36.97 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.156 0.503 . . . . 0.0 110.312 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.536 HG22 ' H ' ' A' ' 212' ' ' LEU . 54.7 m -132.81 132.44 42.19 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.991 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -74.8 4.1 6.96 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.536 ' H ' HG22 ' A' ' 210' ' ' THR . 95.1 mt -81.59 0.6 37.57 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.76 0.314 . . . . 0.0 111.417 -177.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 72.68 32.78 61.17 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.468 -0.873 . . . . 0.0 111.944 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.81 153.66 27.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 78.8 mt -79.07 145.22 33.94 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 121.752 0.786 . . . . 0.0 111.905 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.2 p -116.43 -178.1 3.34 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.937 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.476 ' CB ' ' HA ' ' A' ' 246' ' ' THR . 18.0 ptpt -60.68 144.91 51.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.286 0.565 . . . . 0.0 112.123 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 112.13 5.54 24.95 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.184 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.644 ' OG1' ' HB ' ' A' ' 245' ' ' ILE . 1.3 p -86.09 158.14 19.88 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 122.211 0.204 . . . . 0.0 111.239 178.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 48.4 mm -114.56 129.8 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -174.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.466 HG21 HD11 ' A' ' 245' ' ' ILE . 44.9 pt -132.65 162.94 39.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.025 0.44 . . . . 0.0 111.09 176.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 199' ' ' SER . 43.9 tt0 -112.86 131.39 55.73 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.438 ' HA ' HD23 ' A' ' 198' ' ' LEU . 26.8 m -129.08 150.88 35.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.092 0.472 . . . . 0.0 110.785 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -103.54 106.1 16.52 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.319 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 7.6 p -84.13 71.22 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-O 122.585 1.183 . . . . 0.0 110.149 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 14.9 m -154.37 -37.13 0.09 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.638 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -81.46 20.72 0.85 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.161 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.469 HD11 HG23 ' A' ' 225' ' ' VAL . 98.9 mt -61.33 -39.1 89.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.78 -177.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 174.22 -92.64 0.09 OUTLIER Glycine 0 N--CA 1.428 -1.841 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.617 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 63.9 mt -132.76 -86.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.075 0.464 . . . . 0.0 111.338 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.94 77.1 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.611 0.719 . . . . 0.0 110.759 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 23.9 p -71.14 -60.18 2.37 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.912 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -143.31 49.39 1.43 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.919 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 20.9 t 65.0 12.81 8.2 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.493 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 74.15 11.2 81.82 Favored Glycine 0 C--O 1.225 -0.411 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.859 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -67.66 -33.47 75.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.019 0.914 . . . . 0.0 109.499 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 35.9 pt -86.54 10.57 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.742 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -77.35 107.77 10.01 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -176.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . 0.476 ' O ' HG12 ' A' ' 225' ' ' VAL . 26.7 t90 -170.3 146.95 2.99 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.893 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -72.08 129.96 15.94 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.653 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -130.48 175.04 9.3 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -113.19 147.32 37.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.386 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -138.39 153.17 48.91 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.628 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -102.09 136.0 42.69 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.053 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.644 ' HB ' ' OG1' ' A' ' 219' ' ' THR . 87.3 mt -85.84 126.3 40.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.116 0.484 . . . . 0.0 110.777 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.476 ' HA ' ' CB ' ' A' ' 217' ' ' LYS . 3.1 t -127.24 87.83 2.7 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 174.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -68.7 117.22 10.14 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.371 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -128.2 69.62 78.08 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.795 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.445 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 65.1 Cg_endo -84.86 -13.29 6.83 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.569 2.179 . . . . 0.0 111.727 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -68.9 -37.67 79.13 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.095 -177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -115.18 -57.53 2.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.39 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.475 ' OD2' ' HB2' ' A' ' 254' ' ' CYS . 35.9 t70 -67.9 -39.5 83.59 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.345 0.593 . . . . 0.0 109.841 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.445 ' CA ' ' HA ' ' A' ' 249' ' ' PRO . . . 89.6 0.11 79.51 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.973 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.475 ' HB2' ' OD2' ' A' ' 252' ' ' ASP . 74.3 m -130.23 164.03 25.43 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.847 0.356 . . . . 0.0 111.181 -177.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 62.8 t -82.74 117.19 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -106.74 149.67 27.08 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.433 -176.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . -136.35 144.36 44.57 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.12 131.06 70.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 121.146 0.498 . . . . 0.0 110.664 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.7 tt -99.51 125.36 45.26 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.672 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 260' ' ' LEU . 3.2 pp -92.9 144.52 25.18 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.244 0.545 . . . . 0.0 111.805 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.269 2.083 0 CA-C-O 117.729 -1.129 . . . . 0.0 110.442 179.441 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.898 0.38 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.409 ' C ' ' H ' ' A' ' 171' ' ' PHE . 48.5 mt-10 -83.77 -0.09 49.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.25 0.547 . . . . 0.0 110.949 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -84.29 25.26 0.87 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.559 0.695 . . . . 0.0 109.522 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.409 ' H ' ' C ' ' A' ' 169' ' ' GLU . 86.5 t80 -60.13 -39.11 85.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.071 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 86.5 mt -55.36 124.86 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.468 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.543 ' HG3' ' H ' ' A' ' 176' ' ' GLY . 18.4 ptp180 -144.26 154.03 56.86 Favored Pre-proline 0 N--CA 1.438 -1.043 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.419 -177.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.445 ' HB2' HD13 ' A' ' 177' ' ' LEU . 51.4 Cg_exo -57.62 -42.31 61.8 Favored 'Trans proline' 0 N--CA 1.482 0.794 0 C-N-CA 122.97 2.447 . . . . 0.0 113.302 -176.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 53.5 ttp -178.62 46.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.349 0.595 . . . . 0.0 109.531 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.543 ' H ' ' HG3' ' A' ' 173' ' ' ARG . . . 78.39 22.2 68.12 Favored Glycine 0 C--N 1.316 -0.555 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.079 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.445 HD13 ' HB2' ' A' ' 174' ' ' PRO . 10.2 mp -71.73 156.14 39.67 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.093 0.473 . . . . 0.0 110.75 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -59.66 -36.25 76.06 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.237 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -139.16 160.03 40.76 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.022 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -75.98 83.76 2.87 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.213 -177.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -128.24 144.58 51.14 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.956 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -132.69 150.62 52.13 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.646 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -87.88 100.46 12.9 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 192' ' ' THR . 67.3 t -84.21 117.37 29.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.202 -172.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.4 m -100.1 128.37 46.19 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.494 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -103.21 111.77 65.29 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.26 -25.0 57.56 Favored 'Trans proline' 0 N--CA 1.479 0.633 0 C-N-CA 122.986 2.457 . . . . 0.0 114.37 -175.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 39.6 p -66.79 -43.32 84.26 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.574 ' CD1' HG12 ' A' ' 191' ' ' VAL . 0.6 OUTLIER -116.52 -4.44 11.75 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.118 0.485 . . . . 0.0 111.802 -179.192 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.7 t30 59.44 61.59 1.98 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.218 -0.901 . . . . 0.0 113.292 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.574 HG12 ' CD1' ' A' ' 189' ' ' LEU . 3.2 p -138.52 147.77 25.08 Favored 'Isoleucine or valine' 0 C--O 1.248 1.005 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 175.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 184' ' ' VAL . 15.3 t -127.62 135.88 50.87 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 120.266 -0.573 . . . . 0.0 111.529 -177.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.426 HG23 ' CD2' ' A' ' 195' ' ' LEU . 6.6 m -140.8 147.68 22.56 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.494 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -85.55 123.71 31.28 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.773 0.321 . . . . 0.0 111.582 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.426 ' CD2' HG23 ' A' ' 193' ' ' VAL . 3.1 mm? -128.08 151.51 76.12 Favored Pre-proline 0 C--O 1.24 0.558 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.314 176.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.91 144.42 47.87 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.365 2.044 . . . . 0.0 111.169 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.522 HG23 ' HB ' ' A' ' 221' ' ' ILE . 73.0 mt -92.24 119.37 39.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.423 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.4 -42.16 68.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.853 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 44.3 m -141.7 144.28 33.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.394 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.9 m -127.35 139.64 51.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.009 0.433 . . . . 0.0 111.683 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.436 ' O ' HG23 ' A' ' 219' ' ' THR . 57.3 mtpt -139.23 132.01 29.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.38 174.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -92.0 160.14 15.39 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.482 ' HB2' ' HB2' ' A' ' 206' ' ' ASN . 15.8 m120 -65.36 127.95 93.37 Favored Pre-proline 0 C--N 1.314 -0.966 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 177.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.81 -29.75 50.24 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.619 2.213 . . . . 0.0 113.673 -176.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 20.4 m -111.18 -15.03 13.76 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -177.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.482 ' HB2' ' HB2' ' A' ' 203' ' ' ASN . 79.9 m-20 -98.56 118.92 62.54 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 121.092 0.473 . . . . 0.0 111.458 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.83 170.23 18.36 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 123.507 2.805 . . . . 0.0 112.67 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 92.4 mt -76.8 166.06 23.87 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.241 177.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.543 ' CE2' ' HA ' ' A' ' 216' ' ' THR . 75.0 m-85 -61.76 -38.96 89.93 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.732 -178.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 11.2 m -110.97 -73.12 0.69 Allowed 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.435 ' HG3' ' HG ' ' A' ' 212' ' ' LEU . 12.7 pt20 177.21 -26.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.859 0.864 . . . . 0.0 109.026 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.435 ' HG ' ' HG3' ' A' ' 211' ' ' GLN . 4.0 pp -154.24 172.01 18.31 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.366 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 85.22 -82.05 1.71 Allowed Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.69 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 28.7 m -82.18 142.59 13.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.199 0.524 . . . . 0.0 111.556 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 173' ' ' ARG . 60.2 tp -96.12 149.76 21.26 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.564 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.543 ' HA ' ' CE2' ' A' ' 209' ' ' TYR . 14.8 t -89.84 148.72 23.02 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.444 ' HE2' ' OG1' ' A' ' 246' ' ' THR . 14.1 ptmm? -74.5 148.16 41.23 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.614 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.72 7.98 49.74 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.591 -176.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.438 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 79.9 m -71.09 134.33 46.95 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 122.416 0.286 . . . . 0.0 110.623 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.451 HD13 ' HG2' ' A' ' 244' ' ' GLN . 45.5 mm -93.19 124.06 45.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.591 -176.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.522 ' HB ' HG23 ' A' ' 197' ' ' ILE . 47.3 pt -131.71 160.64 42.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.314 0.578 . . . . 0.0 112.027 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -109.3 126.11 53.02 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.326 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 31.6 m -131.13 157.5 43.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.103 0.478 . . . . 0.0 111.281 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -107.02 106.72 17.38 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.439 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 238' ' ' ALA . 44.9 t -82.39 78.67 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 22.2 t -179.3 -21.7 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.411 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -60.34 -35.42 75.61 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.726 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.467 ' HG ' ' H ' ' A' ' 230' ' ' ILE . 2.3 pt? -53.32 -23.56 9.58 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.901 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 91.42 -12.13 70.17 Favored Glycine 0 C--N 1.329 0.174 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.833 175.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.467 ' H ' ' HG ' ' A' ' 228' ' ' LEU . 45.2 pt -122.37 159.25 25.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.134 0.492 . . . . 0.0 110.371 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.35 149.95 31.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.336 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 6.8 t -72.81 -41.92 64.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.252 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.04 91.14 1.25 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.343 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 50.1 m 58.56 23.83 11.3 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 173.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.05 32.98 82.16 Favored Glycine 0 C--O 1.222 -0.602 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.82 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.25 -39.88 88.34 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.424 0.631 . . . . 0.0 110.71 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 15.5 pt -102.05 12.41 7.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.837 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 225' ' ' VAL . . . -83.35 106.47 15.14 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.518 -176.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 -166.67 176.8 6.95 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.172 0.989 . . . . 0.0 109.037 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.411 ' C ' ' HD2' ' A' ' 241' ' ' ARG . . . -76.13 125.32 7.72 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 174.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.411 ' HD2' ' C ' ' A' ' 240' ' ' GLY . 2.4 mpt_? -128.36 177.92 6.63 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.118 0.485 . . . . 0.0 111.164 -177.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -120.05 145.88 46.43 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.533 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -135.45 158.43 44.39 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.394 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.451 ' HG2' HD13 ' A' ' 220' ' ' ILE . 78.8 mt-30 -114.26 128.45 56.37 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.694 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.472 HD11 HG21 ' A' ' 221' ' ' ILE . 86.2 mt -82.18 127.13 39.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.176 0.512 . . . . 0.0 111.67 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.444 ' OG1' ' HE2' ' A' ' 217' ' ' LYS . 4.0 t -137.72 102.68 4.81 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.275 175.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . 0.408 ' HB3' HG13 ' A' ' 255' ' ' VAL . 5.5 p30 -75.44 124.84 27.85 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.553 -178.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -128.67 71.32 80.9 Favored Pre-proline 0 N--CA 1.443 -0.8 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.156 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.565 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 54.7 Cg_endo -68.99 -19.6 39.61 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.92 1.747 . . . . 0.0 110.089 178.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -66.6 -37.87 85.81 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.917 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -98.21 -57.1 2.29 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.033 0.444 . . . . 0.0 110.76 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.422 ' HB3' HD21 ' A' ' 256' ' ' ASN . 34.3 t70 -94.5 -37.33 11.45 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.384 -176.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 249' ' ' PRO . . . 100.73 -4.39 56.36 Favored Glycine 0 C--N 1.312 -0.783 0 C-N-CA 120.657 -0.783 . . . . 0.0 111.55 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 79.9 m -128.04 167.95 16.01 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.806 0.336 . . . . 0.0 110.965 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 247' ' ' ASN . 81.5 t -80.55 121.03 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.422 HD21 ' HB3' ' A' ' 252' ' ' ASP . 78.8 m-20 -115.95 152.83 32.72 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.935 -173.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -124.63 141.51 52.05 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 8.0 p -108.69 134.08 51.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.082 0.468 . . . . 0.0 110.549 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 62.0 tp -88.29 123.39 32.84 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.458 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.57 105.5 17.65 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.476 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.278 2.585 0 CA-C-O 117.481 -1.247 . . . . 0.0 110.224 178.485 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 121.078 0.466 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.9 -40.13 83.51 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.135 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.463 ' HD2' ' N ' ' A' ' 170' ' ' ARG . 0.0 OUTLIER 52.43 96.9 0.01 OUTLIER 'General case' 0 C--N 1.34 0.189 0 O-C-N 124.227 0.954 . . . . 0.0 113.194 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -62.46 -37.34 85.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.952 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.454 HG23 HG23 ' A' ' 200' ' ' VAL . 6.4 tp -67.2 125.32 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 176.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -136.0 152.06 74.91 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.137 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.419 ' HA ' ' HB3' ' A' ' 215' ' ' LEU . 8.4 Cg_endo -63.39 -73.47 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.81 1.673 . . . . 0.0 111.294 176.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.558 ' SD ' HG23 ' A' ' 214' ' ' VAL . 95.4 mmm -131.54 -0.3 3.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.335 0.588 . . . . 0.0 109.8 176.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 102.17 101.94 2.61 Favored Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -177.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.461 ' O ' HD12 ' A' ' 177' ' ' LEU . 1.5 pp -115.25 149.78 37.22 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.784 0.326 . . . . 0.0 110.938 -178.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -72.75 -34.23 66.88 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.452 ' O ' HD13 ' A' ' 177' ' ' LEU . 93.4 m-85 -138.2 148.49 44.87 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 177.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 196' ' ' PRO . 3.2 mppt? -80.88 73.06 7.9 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.636 -0.426 . . . . 0.0 109.954 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -123.08 139.02 54.51 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.585 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.635 ' HB3' HD11 ' A' ' 197' ' ' ILE . . . -136.55 148.2 47.45 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.563 176.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -84.74 102.04 12.7 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 257' ' ' ALA . 58.9 t -93.72 120.34 42.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.312 0.577 . . . . 0.0 111.908 -173.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 90.5 m -112.13 128.71 56.3 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.04 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -104.44 108.39 60.39 Favored Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.55 -27.65 61.59 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 122.535 2.157 . . . . 0.0 113.557 -175.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.438 HG23 ' HG ' ' A' ' 189' ' ' LEU . 9.3 t -77.77 -27.92 50.45 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.748 0.309 . . . . 0.0 111.695 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.472 ' HB2' HG12 ' A' ' 191' ' ' VAL . 37.4 mt -104.25 -22.02 13.44 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.276 0.56 . . . . 0.0 109.801 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 66.8 t30 60.21 52.79 4.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.928 -175.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.472 HG12 ' HB2' ' A' ' 189' ' ' LEU . 11.2 p -133.41 137.09 53.76 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.512 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 92.9 m -119.29 124.33 46.4 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.984 0.421 . . . . 0.0 111.042 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 10.3 m -142.95 149.59 18.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.127 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.504 ' C ' HD12 ' A' ' 195' ' ' LEU . 35.3 tt0 -102.89 119.82 39.52 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.85 178.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.504 HD12 ' C ' ' A' ' 194' ' ' GLN . 7.1 mp -128.38 150.59 74.71 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.58 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 180' ' ' LYS . 38.3 Cg_exo -61.37 141.09 91.37 Favored 'Trans proline' 0 C--O 1.24 0.608 0 C-N-CA 122.556 2.17 . . . . 0.0 111.23 175.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.71 HD12 HD12 ' A' ' 221' ' ' ILE . 34.8 mm -91.67 119.85 39.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.193 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.403 HD11 ' ND2' ' A' ' 224' ' ' ASN . 96.6 mt -69.25 -42.19 75.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.597 -177.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.4 t -154.39 149.57 26.99 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.767 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.603 HG12 HG22 ' A' ' 221' ' ' ILE . 32.1 m -128.96 148.09 33.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.451 ' O ' HG23 ' A' ' 219' ' ' THR . 14.5 ptmm? -139.65 149.33 43.6 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -66.75 154.96 39.4 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.351 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -80.07 116.61 62.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.144 0.497 . . . . 0.0 110.986 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.43 -33.25 9.05 Favored 'Trans proline' 0 N--CA 1.472 0.212 0 C-N-CA 122.737 2.291 . . . . 0.0 113.033 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 49.6 m -133.92 69.44 1.47 Allowed 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.325 0.583 . . . . 0.0 111.568 -177.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -153.5 139.08 11.93 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.625 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.0 140.11 40.99 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.495 2.13 . . . . 0.0 112.906 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.45 ' HA ' HG21 ' A' ' 216' ' ' THR . 4.9 mp -117.96 145.04 45.0 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.81 177.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -67.68 -42.27 82.36 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.8 m 63.32 -11.78 0.09 Allowed 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 173.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -61.68 -40.48 95.12 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.8 pp -119.34 15.23 13.02 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.731 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 75.29 76.78 0.74 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.188 -1.006 . . . . 0.0 110.797 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.558 HG23 ' SD ' ' A' ' 175' ' ' MET . 7.6 p -135.34 140.5 44.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 120.909 0.385 . . . . 0.0 111.428 -176.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.419 ' HB3' ' HA ' ' A' ' 174' ' ' PRO . 61.4 tp -97.66 128.88 44.68 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.45 HG21 ' HA ' ' A' ' 208' ' ' LEU . 32.1 p -91.11 168.3 11.73 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -176.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -60.94 153.94 23.68 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.812 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 106.7 10.19 29.24 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -176.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.612 ' HB ' ' HB ' ' A' ' 245' ' ' ILE . 87.8 m -71.57 128.5 36.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 201' ' ' LYS . 48.5 mm -90.36 129.03 41.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.762 0.315 . . . . 0.0 110.301 -177.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.71 HD12 HD12 ' A' ' 197' ' ' ILE . 39.0 pt -127.56 154.82 38.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -177.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -102.04 119.32 38.6 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.347 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.31 156.73 40.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.596 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.403 ' ND2' HD11 ' A' ' 198' ' ' LEU . 96.0 m-20 -103.55 108.57 19.89 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.005 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.472 HG23 ' H ' ' A' ' 239' ' ' TRP . 35.2 m -87.58 21.06 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 122.067 0.937 . . . . 0.0 109.288 176.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 21.2 m -105.21 -14.0 15.51 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.561 173.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.85 1.11 55.32 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.287 -174.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.492 HD13 HG12 ' A' ' 230' ' ' ILE . 0.3 OUTLIER -64.35 -31.14 72.22 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.582 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 69.5 31.97 71.26 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.92 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.492 HG12 HD13 ' A' ' 228' ' ' LEU . 42.2 pt -119.39 151.83 21.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 117.214 0.507 . . . . 0.0 110.649 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 27.1 m -121.75 8.35 5.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.694 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 14.6 t -58.66 -18.38 30.28 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.769 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.54 ' O ' ' HG2' ' A' ' 236' ' ' LYS . . . -119.26 29.13 7.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.847 0.356 . . . . 0.0 110.553 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 23.0 m 66.75 3.26 2.92 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.637 0.775 . . . . 0.0 112.138 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 81.04 0.71 89.26 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.942 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 233' ' ' ALA . 19.2 ptpt -70.14 -15.52 62.97 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.122 0.487 . . . . 0.0 111.333 -179.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 33.8 pt -80.93 -4.64 7.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.568 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -67.16 109.26 2.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.0 0.428 . . . . 0.0 110.149 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . 0.472 ' H ' HG23 ' A' ' 225' ' ' VAL . 5.0 m95 -151.96 176.29 11.64 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.627 -178.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -109.8 112.73 3.43 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 171.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -129.44 161.32 30.64 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 117.118 0.459 . . . . 0.0 111.882 -174.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -102.62 133.81 47.02 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.193 175.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -114.68 162.73 16.41 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.613 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -110.24 128.41 55.49 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.083 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.612 ' HB ' ' HB ' ' A' ' 219' ' ' THR . 89.1 mt -81.85 127.23 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.773 0 CA-C-O 120.969 0.414 . . . . 0.0 111.18 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 256' ' ' ASN . 2.7 t -128.17 101.32 6.21 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.166 175.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -78.35 117.81 19.94 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.451 0.643 . . . . 0.0 112.148 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -128.57 72.12 80.72 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.355 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.46 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 56.5 Cg_endo -68.77 -19.55 40.96 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.389 2.059 . . . . 0.0 111.568 -178.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -70.13 -30.63 67.85 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.026 177.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -94.1 -56.49 2.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.316 -177.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -104.39 -28.03 11.6 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 249' ' ' PRO . . . 83.43 10.4 82.04 Favored Glycine 0 C--N 1.315 -0.585 0 C-N-CA 120.34 -0.933 . . . . 0.0 111.755 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 83.4 m -135.32 173.48 11.67 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 122.408 0.283 . . . . 0.0 110.263 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 86.3 t -79.56 122.42 34.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.621 ' HB2' ' O ' ' A' ' 246' ' ' THR . 6.3 m120 -103.82 152.09 22.31 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -176.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.424 ' HB3' HG22 ' A' ' 184' ' ' VAL . . . -136.48 143.88 44.06 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 11.0 p -134.54 140.84 44.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-O 120.903 0.382 . . . . 0.0 110.445 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 63.0 tp -79.04 126.02 30.16 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.468 ' O ' HD12 ' A' ' 260' ' ' LEU . 2.8 pp -67.04 133.96 50.96 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.169 0.509 . . . . 0.0 111.512 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 C--O 1.263 1.777 0 CA-C-O 117.684 -1.151 . . . . 0.0 110.794 179.571 . . . . . . . . 0 0 . 1 stop_ save_